Virus name	Accession ID	Collection date	Location	Host	Passage	Specimen	Additional host information	Sequencing technology	Assembly method	Comment	Comment type	Lineage	Clade
hCoV-19/Latvia/06/2020	EPI_ISL_426286	2020-03-30	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.59	GR
hCoV-19/Latvia/07/2020	EPI_ISL_426287	2020-03-30	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.59	GR
hCoV-19/Australia/VIC339/2020	EPI_ISL_426648	2020-03-20	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v1 amplicons, NexteraXT library, minimap2 v2.17, ivar v1.2, samtools v1.10			B.1.1.71	GR
hCoV-19/Australia/VIC594/2020	EPI_ISL_426851	2020-03-25	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3 amplicons, NexteraXT library, minimap2 v2.17, ivar v1.2, samtools v1.10			B.1.1	GR
hCoV-19/Czech Republic/IAB_1/2020	EPI_ISL_426883	2020-03-27	Europe / Czech Republic	Human	Original			Illumina MiSeq	De-novo assembly- viral-ngs: genomic analysis pipelines for viral sequencing			B.1	G
hCoV-19/Czech Republic/IAB_15/2020	EPI_ISL_426890	2020-03-26	Europe / Czech Republic	Human	Original			Illumina MiSeq	De-novo assembly- viral-ngs: genomic analysis pipelines for viral sequencing			B.1	G
hCoV-19/Luxembourg/LNS0001029/2020	EPI_ISL_445064	2020-04-28	Europe / Luxembourg	Human	Original			Illumina MiniSeq (Amplicon, ARTIC primer set V1)	Bowtie2, BCFtools			B.1.1.198	GR
hCoV-19/USA/TX_GCID_192000072/2020	EPI_ISL_445080	2020-03-21	North America / USA / Texas / Houston County	Human	Original	Nasal swab		NovaSeq 6000 S4	VirMAP			B.59	GR
hCoV-19/USA/CA-CZB-1123/2020	EPI_ISL_445171	2020-03-27	North America / USA / California / San Francisco County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1	O
hCoV-19/Sweden/20-06208/2020	EPI_ISL_445223	2020-03-23	Europe / Sweden / Skane	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Wales/PHWC-2BC38/2020	EPI_ISL_445823	2020-04-09	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-2E2CA/2020	EPI_ISL_446083	2020-04-16	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-2EC44/2020	EPI_ISL_446131	2020-04-07	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-2ED14/2020	EPI_ISL_446143	2020-04-06	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1.249	GR
hCoV-19/Wales/PHWC-2ED9C/2020	EPI_ISL_446151	2020-04-07	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-2EFD2/2020	EPI_ISL_446184	2020-04-04	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/USA/NY-NYUMC723/2020	EPI_ISL_451438	2020-03-26	North America / USA / New York / Bronx	Human	Original			Illumina NovaSeq (Ribo-depleted)	BWA v0.7.17, bases below 20x coverage masked			B.1.1.61	GR
hCoV-19/Australia/NSW291/2020	EPI_ISL_451555	2020-04-03	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.1	GR
hCoV-19/Poland/Pom11/2020	EPI_ISL_451652	2020-04-30	Europe / Poland / Pomorze	Human	Original			Nanopore MinION	ARTICv3 / Geneious Prime 2020.1.2			B.1.1	GR
hCoV-19/Switzerland/VS-ETHZ-100798/2020	EPI_ISL_451748	2020-03-25	Europe / Switzerland / Valais	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1	G
hCoV-19/Switzerland/VD-ETHZ-100802/2020	EPI_ISL_451752	2020-03-25	Europe / Switzerland / Vaud	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.71	GR
hCoV-19/Switzerland/GR-ETHZ-100838/2020	EPI_ISL_451786	2020-03-25	Europe / Switzerland / Grisons	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/BE-ETHZ-101144/2020	EPI_ISL_451811	2020-03-31	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1	G
hCoV-19/Switzerland/ZH-ETHZ-101172/2020	EPI_ISL_451835	2020-03-31	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/BE-ETHZ-110497/2020	EPI_ISL_451905	2020-04-07	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.164	GR
hCoV-19/Germany/BY-MVP-0155/2020	EPI_ISL_451945	2020-04-01	Europe / Germany / Bavaria / Munich	Human	Original	Nasopharyngeal swab		Illumina Hiseq 1500	ARTIC V3 amplicons, Nextera XT library, bwa v0.7.17, iVar v1.2.2			B.1.1.515	GR
hCoV-19/Russia/SCPM-O-07/2020	EPI_ISL_451969	2020-03-22	Europe / Russia / Moscow	Human	Original			BGISEQ-500	Unicycler v0.4.7			B.1.1	GR
hCoV-19/Poland/PL_P10/2020	EPI_ISL_451971	2020-04-01	Europe / Poland / Malopolska / Kraków	Human	Original			MiSeq V3 2x75 paired reads (Illumina) +Nextera Flex Enrichment Library with Respiratory Virus Oligo Panel capture (Illumina).	BWA, Mark Duplicates Pipeline Spark (GATK v.4.1.5.0)			B.1.1	GR
hCoV-19/Poland/PL_P12/2020	EPI_ISL_451973	2020-03-31	Europe / Poland / Malopolska / Kraków	Human	Original			MiSeq V3 2x75 paired reads (Illumina) +Nextera Flex Enrichment Library with Respiratory Virus Oligo Panel capture (Illumina).	BWA, Mark Duplicates Pipeline Spark (GATK v.4.1.5.0)			B.1.1	GR
hCoV-19/Poland/PL_P14/2020	EPI_ISL_451975	2020-03-31	Europe / Poland / Malopolska / Kraków	Human	Original			MiSeq V3 2x75 paired reads (Illumina) +Nextera Flex Enrichment Library with Respiratory Virus Oligo Panel capture (Illumina).	BWA, Mark Duplicates Pipeline Spark (GATK v.4.1.5.0)			B.1.1	GR
hCoV-19/Poland/PL_P19/2020	EPI_ISL_451980	2020-04-02	Europe / Poland / Malopolska / Kraków	Human	Original			MiSeq V3 2x75 paired reads (Illumina) +Nextera Flex Enrichment Library with Respiratory Virus Oligo Panel capture (Illumina).	BWA, Mark Duplicates Pipeline Spark (GATK v.4.1.5.0)			B.1.1	GR
hCoV-19/Poland/PL_P20/2020	EPI_ISL_451981	2020-04-07	Europe / Poland / Malopolska / Kraków	Human	Original			MiSeq V3 2x75 paired reads (Illumina) +Nextera Flex Enrichment Library with Respiratory Virus Oligo Panel capture (Illumina).	BWA, Mark Duplicates Pipeline Spark (GATK v.4.1.5.0)			B.1.1	GR
hCoV-19/Poland/PL_P21/2020	EPI_ISL_451982	2020-03-29	Europe / Poland / Malopolska / Kraków	Human	Original			MiSeq V3 2x75 paired reads (Illumina) +Nextera Flex Enrichment Library with Respiratory Virus Oligo Panel capture (Illumina).	BWA, Mark Duplicates Pipeline Spark (GATK v.4.1.5.0)			B.1.1	GR
hCoV-19/Poland/PL_P23/2020	EPI_ISL_451984	2020-03-29	Europe / Poland / Malopolska / Kraków	Human	Original			MiSeq V3 2x75 paired reads (Illumina) +Nextera Flex Enrichment Library with Respiratory Virus Oligo Panel capture (Illumina).	BWA, Mark Duplicates Pipeline Spark (GATK v.4.1.5.0)			B.1.1	GR
hCoV-19/Poland/PL_P24/2020	EPI_ISL_451985	2020-03-29	Europe / Poland / Malopolska / Kraków	Human	Original			MiSeq V3 2x75 paired reads (Illumina) +Nextera Flex Enrichment Library with Respiratory Virus Oligo Panel capture (Illumina).	BWA, Mark Duplicates Pipeline Spark (GATK v.4.1.5.0)			B.1.1	GR
hCoV-19/Poland/PL_P25/2020	EPI_ISL_451986	2020-04-07	Europe / Poland / Malopolska / Kraków	Human	Original			MiSeq V3 2x75 paired reads (Illumina) +Nextera Flex Enrichment Library with Respiratory Virus Oligo Panel capture (Illumina).	BWA, Mark Duplicates Pipeline Spark (GATK v.4.1.5.0)			B.1.1	GR
hCoV-19/Scotland/GCVR-170592/2020	EPI_ISL_459594	2020-03-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/GCVR-170CCA/2020	EPI_ISL_459654	2020-03-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/GCVR-1713F1/2020	EPI_ISL_459684	2020-03-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.43	GR
hCoV-19/Scotland/GCVR-170C24/2020	EPI_ISL_459718	2020-03-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Chile/RM-CMM-25669/2020	EPI_ISL_459862	2020-03-17	South America / Chile / Region Metropolitana de Santiago / Santiago	Human	Original			Nanopore MinION	Artic Minion Procotol			B.1	G
hCoV-19/Canada/ON_QGLO-01/2020	EPI_ISL_459866	2020-03-18	North America / Canada / Ontario	Human	Original			Ion Torrent				B.1.1	GR
hCoV-19/India/DL-MaxCov0010-CSIR-IGIB/2020	EPI_ISL_459913	2020-05-03	Asia / India / Delhi	Human	Original	Nasal swab		Illumina MiSeq	Reference based			B.1.1	O
hCoV-19/India/DL-MaxCov0022-CSIR-IGIB/2020	EPI_ISL_459924	2020-05-08	Asia / India / Delhi	Human	Original	Nasal swab		Illumina MiSeq	Reference based			B.1.1	O
hCoV-19/England/20119027704/2020	EPI_ISL_465037	2020-03-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.71	GR
hCoV-19/England/20119049904/2020	EPI_ISL_465073	2020-03-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1	G
hCoV-19/England/20119054604/2020	EPI_ISL_465075	2020-03-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20119062704/2020	EPI_ISL_465085	2020-03-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20119063404/2020	EPI_ISL_465087	2020-03-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.71	GR
hCoV-19/England/20169002104/2020	EPI_ISL_465169	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20169002204/2020	EPI_ISL_465170	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20169005204/2020	EPI_ISL_465180	2020-04-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.164	GR
hCoV-19/England/20169005304/2020	EPI_ISL_465181	2020-04-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.164	GR
hCoV-19/England/20169020604/2020	EPI_ISL_465208	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20169022304/2020	EPI_ISL_465213	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20169030004/2020	EPI_ISL_465224	2020-04-10	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.610	G
hCoV-19/England/20170032004/2020	EPI_ISL_465276	2020-04-09	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20170032204/2020	EPI_ISL_465278	2020-04-09	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)	NSP11 without BLAST coverage.	warn	B.1.1	GR
hCoV-19/England/20170037604/2020	EPI_ISL_465289	2020-04-09	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20170042504/2020	EPI_ISL_465294	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20170048604/2020	EPI_ISL_465302	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20172039304/2020	EPI_ISL_465339	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20172045804/2020	EPI_ISL_465348	2020-04-09	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20172045904/2020	EPI_ISL_465349	2020-04-09	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20172055004/2020	EPI_ISL_465359	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20172059204/2020	EPI_ISL_465370	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20172060104/2020	EPI_ISL_465371	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20188072804/2020	EPI_ISL_465514	2020-04-29	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20189163501/2020	EPI_ISL_465566	2020-05-01	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20189166001/2020	EPI_ISL_465569	2020-05-01	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20189166901/2020	EPI_ISL_465570	2020-05-01	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20190003901/2020	EPI_ISL_465581	2020-05-01	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20190141101/2020	EPI_ISL_465592	2020-05-04	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20190142001/2020	EPI_ISL_465593	2020-05-04	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20192020301/2020	EPI_ISL_465598	2020-05-04	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20194008304/2020	EPI_ISL_465607	2020-05-04	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.164	GR
hCoV-19/England/20194099704/2020	EPI_ISL_465611	2020-05-05	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20194102101/2020	EPI_ISL_465612	2020-05-04	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20194103201/2020	EPI_ISL_465613	2020-05-05	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20194104301/2020	EPI_ISL_465614	2020-05-04	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20194106101/2020	EPI_ISL_465615	2020-05-05	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20194106301/2020	EPI_ISL_465616	2020-05-05	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20194106601/2020	EPI_ISL_465617	2020-05-05	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20194106801/2020	EPI_ISL_465618	2020-05-05	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20196026804/2020	EPI_ISL_465623	2020-05-05	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20196064904/2020	EPI_ISL_465626	2020-05-04	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Canada/Qc-LSPQ-L00240569/2020	EPI_ISL_465679	2020-03-27	North America / Canada / Quebec	Human	Original			MGI CleanPlex		Stretches of NNNs (1.15% of overall sequence).	warn	B.1.1	GR
hCoV-19/Canada/Qc-LSPQ-L00241214/2020	EPI_ISL_465700	2020-03-23	North America / Canada / Quebec	Human	Original			MGI CleanPlex		Stretches of NNNs (1.19% of overall sequence).	warn	B.1	G
hCoV-19/England/20126004604/2020	EPI_ISL_465796	2020-03-19	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.164	GR
hCoV-19/England/20129067504/2020	EPI_ISL_465808	2020-03-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20134058904/2020	EPI_ISL_465811	2020-03-23	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20136103004/2020	EPI_ISL_465822	2020-03-26	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20136103104/2020	EPI_ISL_465823	2020-03-26	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20142015404/2020	EPI_ISL_465922	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20142026704/2020	EPI_ISL_465939	2020-03-29	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20144021704/2020	EPI_ISL_465987	2020-03-29	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20144023504/2020	EPI_ISL_465995	2020-03-27	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/CAMB-1ABE48/2020	EPI_ISL_470096	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AAC9A/2020	EPI_ISL_470141	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1ABB9C/2020	EPI_ISL_470148	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/CAMB-1AA605/2020	EPI_ISL_470167	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AB992/2020	EPI_ISL_470194	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AB798/2020	EPI_ISL_470214	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AA73F/2020	EPI_ISL_470233	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/OXON-B1FF2/2020	EPI_ISL_479105	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B2076/2020	EPI_ISL_479110	2020-04-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B21EC/2020	EPI_ISL_479126	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B228F/2020	EPI_ISL_479133	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B23D7/2020	EPI_ISL_479140	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B254A/2020	EPI_ISL_479154	2020-04-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B2559/2020	EPI_ISL_479155	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B25FF/2020	EPI_ISL_479160	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B26ED/2020	EPI_ISL_479167	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1	G
hCoV-19/England/SHEF-D321F/2020	EPI_ISL_479283	2020-05-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/India/MH-NIV-20878/2020	EPI_ISL_479515	2020-05-05	Asia / India / Maharashtra	Human	Original			Ion Torrent, Gene Studio				B.1.1	GR
hCoV-19/Russia/CRIE161454/2020	EPI_ISL_479621	2020-03-31	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq 1500	CLC Genomics Workbench 8.5			B.1.1	GR
hCoV-19/Russia/CRIE155506/2020	EPI_ISL_479624	2020-03-30	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq 1500	CLC Genomics Workbench 8.5			B.1.1	GR
hCoV-19/Canada/NB-237/2020	EPI_ISL_479650	2020-03-31	North America / Canada / New Brunswick	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.1	GR
hCoV-19/Vietnam/IBT-NIHE-03/2020	EPI_ISL_479756	2020-03-28	Asia / Vietnam / Hanoi	Human	Vero	Oropharyngeal swab		PacBio	Canu v2.0			B.1.1	GR
hCoV-19/Vietnam/IBT-NIHE-05/2020	EPI_ISL_479757	2020-03-25	Asia / Vietnam / Hanoi	Human	Vero	Oropharyngeal swab		PacBio	Canu v2.0			B.1.1	GR
hCoV-19/Vietnam/IBT-NIHE-16/2020	EPI_ISL_479758	2020-03-28	Asia / Vietnam / Hanoi	Human	Vero	Oropharyngeal swab		PacBio	Canu v2.0			B.1.1	GR
hCoV-19/Japan/PG-0243/2020	EPI_ISL_479933	2020-03-16	Asia / Japan / Kanto	Human	Original	Pharyngeal swab		Illumina NextSeq500	SKESA v. 2.3.0			B.1.1.164	GR
hCoV-19/Japan/PG-0247/2020	EPI_ISL_479935	2020-03-18	Asia / Japan / Kanto	Human	Original	Pharyngeal swab		Illumina NextSeq500	SKESA v. 2.3.0			B.1.1	GR
hCoV-19/England/SHEF-D1466/2020	EPI_ISL_484515	2020-06-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.171	GR
hCoV-19/England/SHEF-D1AEC/2020	EPI_ISL_484516	2020-06-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.171	GR
hCoV-19/Scotland/CVR1890/2020	EPI_ISL_484523	2020-04-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.43	GR
hCoV-19/Scotland/CVR1932/2020	EPI_ISL_484525	2020-04-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.43	GR
hCoV-19/Scotland/CVR2481/2020	EPI_ISL_484591	2020-04-15	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/CVR2621/2020	EPI_ISL_484618	2020-04-17	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/CVR2639/2020	EPI_ISL_484625	2020-04-17	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/CVR2683/2020	EPI_ISL_484637	2020-04-17	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/CVR2697/2020	EPI_ISL_484645	2020-04-18	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/CVR3007/2020	EPI_ISL_484656	2020-04-23	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.43	GR
hCoV-19/Scotland/CVR3877/2020	EPI_ISL_484666	2020-05-30	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.174	GR
hCoV-19/Wales/PHWC-1655EB/2020	EPI_ISL_484686	2020-06-26	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				B.1.1.1	GR
hCoV-19/Poland/IHG_PAS_4_273/2020	EPI_ISL_485400	2020-06-01	Europe / Poland / Łódzkie	Human	Original	Oropharyngeal swab		Illumina NovaSeq 6000	STAR v.2.5.2b, samtools v.1.10, bcftools v.1.10.2			B.1.1	GR
hCoV-19/Australia/NSW634/2020	EPI_ISL_490043	2020-07-05	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.1.133	GR
hCoV-19/Bangladesh/BCSIR-NILMRC-247/2020	EPI_ISL_490110	2020-07-07	Asia / Bangladesh / Khulna	Human	Original	Nasopharyngeal swab		MiniSeq	DRAGEN RNA Pathogen Detection 3.5.14			B.1.1.25	GR
hCoV-19/England/LIVE-A1793/2020	EPI_ISL_490337	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-A17B1/2020	EPI_ISL_490338	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-A1B5B/2020	EPI_ISL_490354	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.95	GR
hCoV-19/England/LIVE-A1D19/2020	EPI_ISL_490364	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.95	GR
hCoV-19/England/LIVE-A1FAA/2020	EPI_ISL_490371	2020-05-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LOND-124C874/2020	EPI_ISL_490438	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.164	GR
hCoV-19/England/NORT-29310D/2020	EPI_ISL_490444	2020-06-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-29EAAD/2020	EPI_ISL_490472	2020-05-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-29ECA7/2020	EPI_ISL_490481	2020-05-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-29ECF2/2020	EPI_ISL_490482	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-29EF26/2020	EPI_ISL_490487	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C2107/2020	EPI_ISL_490587	2020-05-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C73DF/2020	EPI_ISL_490607	2020-05-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-CBE43/2020	EPI_ISL_490622	2020-04-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.137	GR
hCoV-19/England/SHEF-CE280/2020	EPI_ISL_490629	2020-04-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-CE2F9/2020	EPI_ISL_490630	2020-04-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.137	GR
hCoV-19/England/PORT-2D3AF7/2020	EPI_ISL_499309	2020-04-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LIVE-A602A/2020	EPI_ISL_499676	2020-03-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-A6233/2020	EPI_ISL_499695	2020-03-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1	G
hCoV-19/England/LIVE-A6901/2020	EPI_ISL_499755	2020-03-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-A6910/2020	EPI_ISL_499756	2020-03-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/CAMB-1B5670/2020	EPI_ISL_499973	2020-07-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LIVE-A120B/2020	EPI_ISL_499984	2020-05-17	Europe / United Kingdom / England	Human	Original			Illumina		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.238	G
hCoV-19/England/LIVE-A1229/2020	EPI_ISL_499985	2020-05-18	Europe / United Kingdom / England	Human	Original			Illumina		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.238	G
hCoV-19/England/LIVE-A1247/2020	EPI_ISL_499986	2020-05-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.238	G
hCoV-19/England/LIVE-A1283/2020	EPI_ISL_499987	2020-05-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.238	G
hCoV-19/England/LIVE-A1292/2020	EPI_ISL_499988	2020-05-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.238	G
hCoV-19/England/LIVE-A12A1/2020	EPI_ISL_499989	2020-05-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.238	G
hCoV-19/England/LIVE-A12B0/2020	EPI_ISL_499990	2020-05-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.238	G
hCoV-19/England/LIVE-A12CF/2020	EPI_ISL_499991	2020-05-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.238	G
hCoV-19/England/LIVE-A12ED/2020	EPI_ISL_499992	2020-06-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.238	G
hCoV-19/England/LIVE-A1317/2020	EPI_ISL_499993	2020-06-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.238	G
hCoV-19/England/LIVE-A1344/2020	EPI_ISL_499994	2020-06-05	Europe / United Kingdom / England	Human	Original			Illumina		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.238	G
hCoV-19/Spain/AR-IBV-005082/2020	EPI_ISL_510365	2020-04-22	Europe / Spain / Aragon / Zaragoza	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/PV-IBV-004197/2020	EPI_ISL_510482	2020-04-03	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/PV-IBV-004205/2020	EPI_ISL_510490	2020-04-03	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/CT-IBV-005488/2020	EPI_ISL_510516	2020-05-21	Europe / Spain / Catalunya / Badalona	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Switzerland/UR-ETHZ-200013/2020	EPI_ISL_510702	2020-07-13	Europe / Switzerland / Uri	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/Switzerland/UR-ETHZ-200014/2020	EPI_ISL_510703	2020-07-13	Europe / Switzerland / Uri	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/Switzerland/BL-ETHZ-200015/2020	EPI_ISL_510704	2020-07-13	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BL-ETHZ-200018/2020	EPI_ISL_510707	2020-07-14	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-200019/2020	EPI_ISL_510708	2020-07-14	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/AG-ETHZ-200023/2020	EPI_ISL_510712	2020-07-14	Europe / Switzerland / Aargau	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BL-ETHZ-200024/2020	EPI_ISL_510713	2020-07-14	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-200026/2020	EPI_ISL_510715	2020-07-14	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-200028/2020	EPI_ISL_510717	2020-07-14	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BE-ETHZ-200032/2020	EPI_ISL_510721	2020-07-15	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BE-ETHZ-200035/2020	EPI_ISL_510723	2020-07-15	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.406	GR
hCoV-19/Switzerland/SZ-ETHZ-200049/2020	EPI_ISL_510734	2020-07-10	Europe / Switzerland / Schwyz	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BL-ETHZ-200056/2020	EPI_ISL_510740	2020-07-13	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BE-ETHZ-200060/2020	EPI_ISL_510742	2020-07-14	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/Switzerland/BL-ETHZ-210006/2020	EPI_ISL_510754	2020-07-17	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/LU-ETHZ-210009/2020	EPI_ISL_510757	2020-07-20	Europe / Switzerland / Lucerne	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-210012/2020	EPI_ISL_510759	2020-07-20	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-210021/2020	EPI_ISL_510766	2020-07-21	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-210022/2020	EPI_ISL_510767	2020-07-21	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/UR-ETHZ-210026/2020	EPI_ISL_510770	2020-07-21	Europe / Switzerland / Uri	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/AG-ETHZ-210028/2020	EPI_ISL_510771	2020-07-22	Europe / Switzerland / Aargau	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.198	GR
hCoV-19/Switzerland/ZH-ETHZ-210030/2020	EPI_ISL_510772	2020-07-22	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-210032/2020	EPI_ISL_510773	2020-07-22	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-210033/2020	EPI_ISL_510774	2020-07-22	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BE-ETHZ-210039/2020	EPI_ISL_510780	2020-07-23	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/SZ-ETHZ-210040/2020	EPI_ISL_510781	2020-07-23	Europe / Switzerland / Schwyz	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-210051/2020	EPI_ISL_510788	2020-07-19	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/UR-ETHZ-210055/2020	EPI_ISL_510789	2020-07-19	Europe / Switzerland / Uri	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/Switzerland/UR-ETHZ-210062/2020	EPI_ISL_510795	2020-07-20	Europe / Switzerland / Uri	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Sweden/20-08910/2020	EPI_ISL_510816	2020-05-28	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Sweden/20-50934/2020	EPI_ISL_510819	2020-04-21	Europe / Sweden / Vasternorrland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Sweden/20-51278/2020	EPI_ISL_510823	2020-05-05	Europe / Sweden / Varmland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Sweden/20-51769/2020	EPI_ISL_510847	2020-05-27	Europe / Sweden / Vastra Gotaland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-51771/2020	EPI_ISL_510848	2020-05-27	Europe / Sweden / Vastra Gotaland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-51772/2020	EPI_ISL_510849	2020-05-27	Europe / Sweden / Vastra Gotaland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-51847/2020	EPI_ISL_510853	2020-06-01	Europe / Sweden / Vasternorrland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Sweden/20-51848/2020	EPI_ISL_510854	2020-06-01	Europe / Sweden / Vasternorrland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Sweden/20-51849/2020	EPI_ISL_510855	2020-06-01	Europe / Sweden / Vasternorrland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Sweden/20-51852/2020	EPI_ISL_510856	2020-06-01	Europe / Sweden / Vasternorrland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Sweden/20-51853/2020	EPI_ISL_510857	2020-06-01	Europe / Sweden / Vasternorrland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Sweden/20-51894/2020	EPI_ISL_510859	2020-05-25	Europe / Sweden / Kalmar	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Sweden/20-51947/2020	EPI_ISL_510861	2020-06-05	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1	G
hCoV-19/Sweden/20-52079/2020	EPI_ISL_510876	2020-06-15	Europe / Sweden / Ostergotland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/USA/NM-NMDOH-2020242037/2020	EPI_ISL_510885	2020-07-22	North America / USA / New Mexico	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa v. 1.2.2/ivar v. 0.7.17			B.1.240	G
hCoV-19/USA/NM-NMDOH-2020242041/2020	EPI_ISL_510888	2020-07-22	North America / USA / New Mexico	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa v. 1.2.2/ivar v. 0.7.17			B.1.240	G
hCoV-19/Portugal/PT1521/2020	EPI_ISL_510889	2020-06-19	Europe / Portugal	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq550	INSaFLU			B.1	GR
hCoV-19/Portugal/PT1522/2020	EPI_ISL_510890	2020-06-22	Europe / Portugal	Human	Original	Feces		Illumina MiSeq	INSaFLU			B.1	GR
hCoV-19/Portugal/PT0695/2020	EPI_ISL_510954	2020-03-14	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0709/2020	EPI_ISL_510968	2020-03-23	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Russia/SPE-RII-13179V/2020	EPI_ISL_524003	2020-05-12	Europe / Russia / Saint Petersburg	Human	Vero P1	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Russia/SPE-RII-17217V/2020	EPI_ISL_524013	2020-05-24	Europe / Russia / Saint Petersburg	Human	Vero P1	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Russia/SPE-RII-17942V/2020	EPI_ISL_524016	2020-05-27	Europe / Russia / Saint Petersburg	Human	Vero P1	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Russia/SPE-RII-19109V/2020	EPI_ISL_524023	2020-06-01	Europe / Russia / Saint Petersburg	Human	Vero P1	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Russia/SPE-RII-19578V/2020	EPI_ISL_524026	2020-06-03	Europe / Russia / Saint Petersburg	Human	Vero P1	Nasopharyngeal swab		Illumina MiSeq				B.1.1.71	GR
hCoV-19/Russia/SPE-RII-20906V/2020	EPI_ISL_524030	2020-06-04	Europe / Russia / Saint Petersburg	Human	Vero P1	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Russia/SPE-RII-21119V/2020	EPI_ISL_524032	2020-06-04	Europe / Russia / Saint Petersburg	Human	Vero P1	Nasopharyngeal swab		Illumina MiSeq				B.1.1.71	GR
hCoV-19/USA/UT-08348/2020	EPI_ISL_524134	2020-05-14	North America / USA / Utah	Human	Original			Illumina NextSeq				B.1	G
hCoV-19/Scotland/GCVR-171B62/2020	EPI_ISL_524500	2020-03-30	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AE2C1/2020	EPI_ISL_524575	2020-04-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AE838/2020	EPI_ISL_524609	2020-04-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AE7FF/2020	EPI_ISL_524618	2020-04-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.13	GR
hCoV-19/England/LOND-12612C6/2020	EPI_ISL_524620	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.198	GR
hCoV-19/England/LOND-126027C/2020	EPI_ISL_524622	2020-03-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.13	GR
hCoV-19/England/LOND-1260E4B/2020	EPI_ISL_524643	2020-04-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/LOND-12607C8/2020	EPI_ISL_524691	2020-04-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/LOND-126169D/2020	EPI_ISL_524706	2020-03-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LOND-1261527/2020	EPI_ISL_524712	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/India/GJ-GBRC-376a/2020	EPI_ISL_524733	2020-07-06	Asia / India / Gujarat / Patan	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.1.101	GR
hCoV-19/India/GJ-GBRC-376b/2020	EPI_ISL_524734	2020-07-06	Asia / India / Gujarat / Patan	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.1.101	GR
hCoV-19/USA/SC-DHEC-0768/2020	EPI_ISL_538391	2020-06-26	North America / USA / South Carolina	Human	Original	Nasopharyngeal swab		Illumina	DRAGEN v. 3.5.14			B.1	G
hCoV-19/USA/SC-DHEC-0865/2020	EPI_ISL_538400	2020-06-26	North America / USA / South Carolina	Human	Original	Nasopharyngeal swab		Illumina	DRAGEN v. 3.5.14			B.1	G
hCoV-19/USA/SC-DHEC-0868/2020	EPI_ISL_538402	2020-06-26	North America / USA / South Carolina	Human	Original	Nasopharyngeal swab		Illumina	DRAGEN v. 3.5.14			B.1	G
hCoV-19/USA/SC-DHEC-0886/2020	EPI_ISL_538410	2020-06-26	North America / USA / South Carolina	Human	Original	Nasopharyngeal swab		Illumina	DRAGEN v. 3.5.14			B.1	G
hCoV-19/USA/SC-DHEC-0644/2020	EPI_ISL_538428	2020-06-19	North America / USA / South Carolina	Human	Original	Nasopharyngeal swab		Illumina	DRAGEN v. 3.5.14			B.1	G
hCoV-19/USA/SC-DHEC-0883/2020	EPI_ISL_538434	2020-06-26	North America / USA / South Carolina	Human	Original	Nasopharyngeal swab		Illumina	DRAGEN v. 3.5.14			B.1	G
hCoV-19/USA/NC-SLPH-0011/2020	EPI_ISL_538520	2020-07-31	North America / USA / North Carolina	Human	Original	Nasopharyngeal swab		Illumina	SeqMan NGen/DNASTAR v. 16.0.0			B.1.240	G
hCoV-19/England/LEED-2A974E/2020	EPI_ISL_538752	2020-04-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/LEED-2A9F73/2020	EPI_ISL_538761	2020-04-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/LEED-2A9E94/2020	EPI_ISL_538766	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/LEED-2A9FFB/2020	EPI_ISL_538767	2020-04-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/LEED-2A9F91/2020	EPI_ISL_538768	2020-04-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/LEED-2A9F19/2020	EPI_ISL_538770	2020-04-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/LEED-2A9F0A/2020	EPI_ISL_538777	2020-04-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/LEED-2AA19A/2020	EPI_ISL_538786	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/LEED-2AA419/2020	EPI_ISL_538789	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LEED-2AA1A9/2020	EPI_ISL_538807	2020-04-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/LEED-2A9AAF/2020	EPI_ISL_538809	2020-04-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LEED-2AA428/2020	EPI_ISL_538825	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/LEED-2AA552/2020	EPI_ISL_538826	2020-04-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/LEED-2AA103/2020	EPI_ISL_538829	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/LEED-2AA0CA/2020	EPI_ISL_538836	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/LEED-2A9C6D/2020	EPI_ISL_538839	2020-04-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/LEED-2AA31C/2020	EPI_ISL_538843	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/LEED-2AA0BB/2020	EPI_ISL_538854	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/LEED-2A9B7F/2020	EPI_ISL_538860	2020-04-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/LEED-2AA288/2020	EPI_ISL_538880	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/LEED-2AA4A0/2020	EPI_ISL_538892	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/LEED-2AA200/2020	EPI_ISL_538903	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/LEED-2AA640/2020	EPI_ISL_538905	2020-04-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/LEED-2A9B42/2020	EPI_ISL_538912	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/LEED-2A990C/2020	EPI_ISL_538914	2020-04-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LEED-2A9ABE/2020	EPI_ISL_538920	2020-04-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LEED-2AA07F/2020	EPI_ISL_538921	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/LEED-2A9C7C/2020	EPI_ISL_538929	2020-04-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/LEED-2A9DC4/2020	EPI_ISL_538939	2020-03-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/LEED-2AA042/2020	EPI_ISL_538949	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LEED-2A9CE5/2020	EPI_ISL_538955	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.43	GR
hCoV-19/England/LEED-2A9BF7/2020	EPI_ISL_538960	2020-04-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/LEED-2A9E1C/2020	EPI_ISL_538961	2020-03-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LEED-2A9DA6/2020	EPI_ISL_538963	2020-03-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LEED-2AA789/2020	EPI_ISL_538969	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/LEED-2AA72F/2020	EPI_ISL_538978	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/USA/TX-HMH-4311/2020	EPI_ISL_543520	2020-06-18	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1	GH
hCoV-19/USA/TX-HMH-4324/2020	EPI_ISL_543533	2020-06-20	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1	GH
hCoV-19/USA/TX-HMH-461/2020	EPI_ISL_543753	2020-04-03	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1	G
hCoV-19/USA/TX-HMH-3113/2020	EPI_ISL_544001	2020-05-26	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1	G
hCoV-19/USA/TX-HMH-3176/2020	EPI_ISL_544051	2020-06-11	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-3519/2020	EPI_ISL_544218	2020-06-10	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.396	G
hCoV-19/England/MILK-61AB75/2020	EPI_ISL_557956	2020-07-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-639CF5/2020	EPI_ISL_557972	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-61C6BE/2020	EPI_ISL_557974	2020-07-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.15	GR
hCoV-19/England/ALDP-6B712D/2020	EPI_ISL_557978	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-6BE8D6/2020	EPI_ISL_557985	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-658A7E/2020	EPI_ISL_557986	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-6762FA/2020	EPI_ISL_557991	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-69343D/2020	EPI_ISL_557992	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-65C98C/2020	EPI_ISL_558018	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-654EC1/2020	EPI_ISL_558028	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.97	GR
hCoV-19/England/ALDP-6511CB/2020	EPI_ISL_558033	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-65858C/2020	EPI_ISL_558048	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-673BD4/2020	EPI_ISL_558053	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/MILK-671CA6/2020	EPI_ISL_558058	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-64B48F/2020	EPI_ISL_558067	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/MILK-674F22/2020	EPI_ISL_558068	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.97	GR
hCoV-19/England/ALDP-645670/2020	EPI_ISL_558072	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-649463/2020	EPI_ISL_558076	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-64D432/2020	EPI_ISL_558084	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-64DEAD/2020	EPI_ISL_558088	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-655FBE/2020	EPI_ISL_558091	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-66ABC1/2020	EPI_ISL_558105	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-64A3A1/2020	EPI_ISL_558112	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-66B331/2020	EPI_ISL_558119	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-66D232/2020	EPI_ISL_558121	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-658AF6/2020	EPI_ISL_558125	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-658C78/2020	EPI_ISL_558132	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-6926ED/2020	EPI_ISL_558142	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-66E222/2020	EPI_ISL_558151	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-654007/2020	EPI_ISL_558155	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.231	G
hCoV-19/England/ALDP-6495E8/2020	EPI_ISL_558160	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-69063A/2020	EPI_ISL_558164	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-65BF30/2020	EPI_ISL_558191	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-64AB30/2020	EPI_ISL_558192	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-6754AA/2020	EPI_ISL_558195	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.97	GR
hCoV-19/England/ALDP-66A9D6/2020	EPI_ISL_558205	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-693673/2020	EPI_ISL_558217	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-658944/2020	EPI_ISL_558219	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-66B638/2020	EPI_ISL_558220	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-66F115/2020	EPI_ISL_558226	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-66F379/2020	EPI_ISL_558232	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-64831C/2020	EPI_ISL_558235	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-68EFBC/2020	EPI_ISL_558236	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.95	GR
hCoV-19/England/MILK-559ABA/2020	EPI_ISL_558243	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/MILK-559DA2/2020	EPI_ISL_558245	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/MILK-576ECA/2020	EPI_ISL_558251	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.1	GR
hCoV-19/England/MILK-559EFA/2020	EPI_ISL_558253	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/MILK-59460A/2020	EPI_ISL_558255	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-5660D6/2020	EPI_ISL_558262	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/MILK-576F4F/2020	EPI_ISL_558266	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/ALDP-599BCA/2020	EPI_ISL_558268	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-59B7E2/2020	EPI_ISL_558269	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-56B217/2020	EPI_ISL_558273	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-559E27/2020	EPI_ISL_558298	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/MILK-559C3C/2020	EPI_ISL_558301	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/ALDP-59985A/2020	EPI_ISL_558312	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-576ED9/2020	EPI_ISL_558318	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.1	GR
hCoV-19/England/MILK-5974EF/2020	EPI_ISL_558331	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.238	G
hCoV-19/England/ALDP-599BD9/2020	EPI_ISL_558343	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-56C4E3/2020	EPI_ISL_558353	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-559CF0/2020	EPI_ISL_558358	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/MILK-56DF0F/2020	EPI_ISL_558365	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.1	GR
hCoV-19/England/MILK-592763/2020	EPI_ISL_558376	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-568CD0/2020	EPI_ISL_558381	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-559F15/2020	EPI_ISL_558391	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/MILK-559DB1/2020	EPI_ISL_558393	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/ALDP-5C9569/2020	EPI_ISL_558423	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5CB136/2020	EPI_ISL_558427	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5D9A1C/2020	EPI_ISL_558430	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5CB215/2020	EPI_ISL_558453	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5D02FF/2020	EPI_ISL_558454	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-5CDC9D/2020	EPI_ISL_558464	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/ALDP-5CB36D/2020	EPI_ISL_558477	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5C96EE/2020	EPI_ISL_558479	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5D9A0D/2020	EPI_ISL_558486	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5CB38B/2020	EPI_ISL_558488	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5C936F/2020	EPI_ISL_558491	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5C5837/2020	EPI_ISL_558494	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5D49C9/2020	EPI_ISL_558498	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-5D31A4/2020	EPI_ISL_558502	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5C961B/2020	EPI_ISL_558504	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5CDC24/2020	EPI_ISL_558506	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5C5819/2020	EPI_ISL_558512	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-5D9AB2/2020	EPI_ISL_558514	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-5D9D13/2020	EPI_ISL_558519	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-5D1F15/2020	EPI_ISL_558521	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5CEF57/2020	EPI_ISL_558526	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5CB0C0/2020	EPI_ISL_558527	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5CB50D/2020	EPI_ISL_558528	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5D210F/2020	EPI_ISL_558544	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-5D5360/2020	EPI_ISL_558549	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/ALDP-5C78EA/2020	EPI_ISL_558559	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5D4EAC/2020	EPI_ISL_558579	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-5C9790/2020	EPI_ISL_558580	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5CB45B/2020	EPI_ISL_558581	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5D2390/2020	EPI_ISL_558590	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-5C9F5C/2020	EPI_ISL_558607	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5C94A8/2020	EPI_ISL_558616	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-59E6B5/2020	EPI_ISL_558619	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-5A9B7C/2020	EPI_ISL_558632	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5BE4E2/2020	EPI_ISL_558633	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.398	G
hCoV-19/England/ALDP-5C16C8/2020	EPI_ISL_558634	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-5A3F58/2020	EPI_ISL_558637	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-5AF0FF/2020	EPI_ISL_558648	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5AB257/2020	EPI_ISL_558658	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.253	GR
hCoV-19/England/ALDP-5AA971/2020	EPI_ISL_558677	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5A9F9E/2020	EPI_ISL_558680	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5A376F/2020	EPI_ISL_558686	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.95	GR
hCoV-19/England/ALDP-5B6F8F/2020	EPI_ISL_558691	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-5B1E2D/2020	EPI_ISL_558696	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/ALDP-5A9E37/2020	EPI_ISL_558726	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5A3DF4/2020	EPI_ISL_558769	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/ALDP-5B94F6/2020	EPI_ISL_558795	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5A4C23/2020	EPI_ISL_558797	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/ALDP-5C18E0/2020	EPI_ISL_558801	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-5B9E70/2020	EPI_ISL_558815	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-59F775/2020	EPI_ISL_558817	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5B23D2/2020	EPI_ISL_558818	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-5ABFE7/2020	EPI_ISL_558827	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5BD629/2020	EPI_ISL_558828	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5BE048/2020	EPI_ISL_558833	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-5AA698/2020	EPI_ISL_558857	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5A85F7/2020	EPI_ISL_558871	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5BA01F/2020	EPI_ISL_558878	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5B1959/2020	EPI_ISL_558890	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.254	GR
hCoV-19/England/ALDP-52A3E4/2020	EPI_ISL_558906	2020-06-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/ALDP-522FAC/2020	EPI_ISL_558918	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/ALDP-524247/2020	EPI_ISL_558942	2020-06-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-50CB95/2020	EPI_ISL_558959	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.231	G
hCoV-19/England/MILK-515012/2020	EPI_ISL_558970	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-99192E/2020	EPI_ISL_577003	2020-08-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/England/MILK-991988/2020	EPI_ISL_577007	2020-08-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/England/MILK-9919D3/2020	EPI_ISL_577011	2020-08-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.115	GR
hCoV-19/England/MILK-9919E2/2020	EPI_ISL_577012	2020-08-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.115	GR
hCoV-19/England/MILK-991A58/2020	EPI_ISL_577016	2020-08-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.39	GR
hCoV-19/England/MILK-991AD0/2020	EPI_ISL_577019	2020-08-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.227	GR
hCoV-19/England/MILK-991AEF/2020	EPI_ISL_577020	2020-08-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.227	GR
hCoV-19/England/MILK-991AFE/2020	EPI_ISL_577021	2020-08-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.227	GR
hCoV-19/England/MILK-991B28/2020	EPI_ISL_577023	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-991B37/2020	EPI_ISL_577024	2020-08-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.269	GR
hCoV-19/England/MILK-991B46/2020	EPI_ISL_577025	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS3_E239stop results in 13.5% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/England/MILK-991BEC/2020	EPI_ISL_577030	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-991C07/2020	EPI_ISL_577032	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-991C16/2020	EPI_ISL_577033	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-991C25/2020	EPI_ISL_577034	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.269	GR
hCoV-19/England/MILK-9E1716/2020	EPI_ISL_577083	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-9E17DA/2020	EPI_ISL_577087	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.255	GR
hCoV-19/USA/MI-MDHHS-SC22002/2020	EPI_ISL_577567	2020-08-20	North America / USA / Michigan	Human	Original			Illumina NextSeq	bwa v. 0.7.17; bcftools v. 1.7			B.1.240	G
hCoV-19/USA/MI-MDHHS-SC22019/2020	EPI_ISL_577578	2020-09-02	North America / USA / Michigan	Human	Original			Illumina NextSeq	bwa v. 0.7.17; bcftools v. 1.7			B.1.240	G
hCoV-19/USA/MI-MDHHS-SC22025/2020	EPI_ISL_577581	2020-09-03	North America / USA / Michigan	Human	Original			Illumina NextSeq	bwa v. 0.7.17; bcftools v. 1.7			B.1.240	G
hCoV-19/Czech Republic/NRL_8459/2020	EPI_ISL_577635	2020-08-24	Europe / Czech Republic / Central Bohemian Region / Prague	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC-Medaka			B.1	GR
hCoV-19/Slovakia/UKBA-212/2020	EPI_ISL_577742	2020-03-31	Europe / Slovakia / Bratislava	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC 400bp + 2000bp combination			B.1.1	GR
hCoV-19/Netherlands/NH-EMC-63/2020	EPI_ISL_577859	2020-08-18	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore		Gap of 121 nucleotides found at refpos 28007 (frameshift confirmed by the submitter). NS8 without BLAST coverage.	info	B.1.1.269	GR
hCoV-19/Netherlands/UT-EMC-88/2020	EPI_ISL_577904	2020-08-30	Europe / Netherlands / Utrecht	Human	Original			Nanopore				B.1.1.269	GR
hCoV-19/Netherlands/ZH-EMC-488/2020	EPI_ISL_577918	2020	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.1	GR
hCoV-19/Netherlands/ZH-EMC-493/2020	EPI_ISL_577922	2020	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.1.269	GR
hCoV-19/Netherlands/ZH-EMC-504/2020	EPI_ISL_577933	2020-08-25	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.1	GR
hCoV-19/USA/CA-CZB-6987/2020	EPI_ISL_582914	2020-09-01	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1	GR
hCoV-19/USA/CA-CZB-7003/2020	EPI_ISL_582928	2020-09-05	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-5746/2020	EPI_ISL_582967	2020-07-14	North America / USA / California / San Luis Obispo County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar	NS8_E19stop results in 85.1% truncation of the protein sequence.	info	B.1	G
hCoV-19/USA/CA-CZB-5140/2020	EPI_ISL_582974	2020-08-17	North America / USA / California / San Luis Obispo County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1	G
hCoV-19/USA/CA-CZB-6739/2020	EPI_ISL_582995	2020-08-19	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1	G
hCoV-19/USA/CA-CZB-10947/2020	EPI_ISL_583033	2020-09-15	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.239	G
hCoV-19/USA/CA-CZB-10961/2020	EPI_ISL_583044	2020-09-17	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.239	G
hCoV-19/USA/CA-CZB-10820/2020	EPI_ISL_583070	2020-07-13	North America / USA / California / Humboldt County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.240	G
hCoV-19/USA/CA-CZB-10821/2020	EPI_ISL_583071	2020-07-13	North America / USA / California / Humboldt County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.240	G
hCoV-19/USA/CA-CZB-10822/2020	EPI_ISL_583072	2020-07-13	North America / USA / California / Humboldt County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.240	G
hCoV-19/USA/CA-CZB-10823/2020	EPI_ISL_583073	2020-07-13	North America / USA / California / Humboldt County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.240	G
hCoV-19/USA/CA-CZB-10824/2020	EPI_ISL_583074	2020-07-13	North America / USA / California / Humboldt County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.240	G
hCoV-19/USA/CA-CZB-10825/2020	EPI_ISL_583075	2020-07-13	North America / USA / California / Humboldt County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.240	G
hCoV-19/USA/CA-CZB-10912/2020	EPI_ISL_583141	2020-08-27	North America / USA / California / Humboldt County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1	G
hCoV-19/USA/MI-UM-10035712935/2020	EPI_ISL_583254	2020-08-29	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.240	G
hCoV-19/USA/MI-UM-10035685450/2020	EPI_ISL_583257	2020-08-27	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.240	G
hCoV-19/USA/MI-UM-10035692188/2020	EPI_ISL_583262	2020-08-28	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.240	G
hCoV-19/USA/MI-UM-10035555295/2020	EPI_ISL_583264	2020-08-19	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.240	G
hCoV-19/USA/MI-UM-10035704378/2020	EPI_ISL_583283	2020-08-28	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.240	G
hCoV-19/USA/MI-UM-10035641365/2020	EPI_ISL_583285	2020-08-25	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1	G
hCoV-19/USA/MI-UM-10035747436/2020	EPI_ISL_583307	2020-09-01	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.240	G
hCoV-19/USA/MI-UM-10035731267/2020	EPI_ISL_583308	2020-08-31	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.240	G
hCoV-19/USA/MI-UM-10035987523/2020	EPI_ISL_583364	2020-09-16	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.240	G
hCoV-19/USA/MI-UM-10035893881/2020	EPI_ISL_583391	2020-09-10	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.240	G
hCoV-19/USA/MI-UM-10035908071/2020	EPI_ISL_583397	2020-09-11	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.240	G
hCoV-19/USA/MI-UM-10035884804/2020	EPI_ISL_583401	2020-09-10	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/USA/MI-UM-10036102177/2020	EPI_ISL_583406	2020-09-23	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.240	G
hCoV-19/USA/MI-UM-10036074663/2020	EPI_ISL_583419	2020-09-22	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.240	G
hCoV-19/Brazil/SP-359/2020	EPI_ISL_583497	2020-06-17	South America / Brazil / São Paulo / Campinas	Human	Original	Nasopharyngeal swab		Ion Torrent S5	IRMA			B.1.1.28	GR
hCoV-19/USA/MI-MDHHS-SC22062/2020	EPI_ISL_583519	2020-09-28	North America / USA / Michigan	Human	Original			Illumina MiSeq	bwa v. 0.7.17; bcftools v. 1.7			B.1.240	G
hCoV-19/USA/MI-MDHHS-SC22064/2020	EPI_ISL_583521	2020-09-28	North America / USA / Michigan	Human	Original			Illumina MiSeq	bwa v. 0.7.17; bcftools v. 1.7			B.1.240	G
hCoV-19/USA/MI-MDHHS-SC22074/2020	EPI_ISL_583531	2020-09-23	North America / USA / Michigan	Human	Original			Illumina MiSeq	bwa v. 0.7.17; bcftools v. 1.7			B.1.240	G
hCoV-19/Austria/CeMM0682/2020	EPI_ISL_583642	2020-04-18	Europe / Austria	Human	Original			Illumina NovaSeq	bwa			B.1.1.71	GR
hCoV-19/Austria/CeMM0731/2020	EPI_ISL_583674	2020-04-21	Europe / Austria	Human	Original			Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/Austria/CeMM0929/2020	EPI_ISL_583781	2020-03-19	Europe / Austria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/Austria/CeMM0932/2020	EPI_ISL_583784	2020-03-22	Europe / Austria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/Austria/CeMM0956/2020	EPI_ISL_583805	2020-03-29	Europe / Austria	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/Italy/TUS-DBM-8/2020	EPI_ISL_583962	2020-03-20	Europe / Italy / Tuscany / Siena	Human	Original			Nanopore MinION	Medaka v 0.12.1			B.1.1	G
hCoV-19/England/CAMC-A5899B/2020	EPI_ISL_597003	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A585E2/2020	EPI_ISL_597094	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A59235/2020	EPI_ISL_597098	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A57CC0/2020	EPI_ISL_597105	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A585F1/2020	EPI_ISL_597110	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A593BA/2020	EPI_ISL_597111	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A5860D/2020	EPI_ISL_597122	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A5898C/2020	EPI_ISL_597157	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A58AE3/2020	EPI_ISL_597163	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A594F3/2020	EPI_ISL_597175	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A57F21/2020	EPI_ISL_597178	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A585C4/2020	EPI_ISL_597183	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A585B5/2020	EPI_ISL_597208	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A586FE/2020	EPI_ISL_597210	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A581C0/2020	EPI_ISL_597211	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A58148/2020	EPI_ISL_597220	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A57B96/2020	EPI_ISL_597255	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A57404/2020	EPI_ISL_597305	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A57B2D/2020	EPI_ISL_597310	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A57422/2020	EPI_ISL_597327	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A5DE88/2020	EPI_ISL_597333	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A5DD8B/2020	EPI_ISL_597338	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A5738F/2020	EPI_ISL_597343	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A59C28/2020	EPI_ISL_597358	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A574C8/2020	EPI_ISL_597381	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A5DEC4/2020	EPI_ISL_597430	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A5747D/2020	EPI_ISL_597451	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A57413/2020	EPI_ISL_597477	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A510D9/2020	EPI_ISL_597532	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A50AFA/2020	EPI_ISL_597536	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A4FCBC/2020	EPI_ISL_597545	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A4FCDA/2020	EPI_ISL_597548	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A4FCAD/2020	EPI_ISL_597550	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A4FFB3/2020	EPI_ISL_597553	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A4FD04/2020	EPI_ISL_597556	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A5024D/2020	EPI_ISL_597563	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-A501C8/2020	EPI_ISL_597568	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A50D88/2020	EPI_ISL_597569	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A50ABE/2020	EPI_ISL_597576	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A500E9/2020	EPI_ISL_597581	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A50D97/2020	EPI_ISL_597585	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A50F91/2020	EPI_ISL_597601	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-A50650/2020	EPI_ISL_597645	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/ALDP-A50D3D/2020	EPI_ISL_597649	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A4FBCE/2020	EPI_ISL_597653	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A4FAC1/2020	EPI_ISL_597685	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A506D8/2020	EPI_ISL_597698	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-A4FBFB/2020	EPI_ISL_597709	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A502C5/2020	EPI_ISL_597711	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-A50D6A/2020	EPI_ISL_597728	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/ALDP-A500F8/2020	EPI_ISL_597747	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A50B33/2020	EPI_ISL_597807	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A50B24/2020	EPI_ISL_597842	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A4FC52/2020	EPI_ISL_597844	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A501E6/2020	EPI_ISL_597849	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A4F9D3/2020	EPI_ISL_597850	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A50E76/2020	EPI_ISL_597870	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-A51FCD/2020	EPI_ISL_597892	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A5173E/2020	EPI_ISL_597898	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A5281C/2020	EPI_ISL_597900	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A51297/2020	EPI_ISL_597910	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A51F27/2020	EPI_ISL_597914	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A527B5/2020	EPI_ISL_597957	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A520C9/2020	EPI_ISL_597960	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A522C3/2020	EPI_ISL_597970	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A514CE/2020	EPI_ISL_597972	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A51534/2020	EPI_ISL_597973	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A51EA2/2020	EPI_ISL_597994	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/USA/FL-BK0D/2020	EPI_ISL_602313	2020-08-28	North America / USA / Florida / Miami-Dade County	Human	Original	Nasopharyngeal		Ion Torrent	IRMAreport			B.1.240	G
hCoV-19/USA/FL-BMMG/2020	EPI_ISL_602320	2020-08-31	North America / USA / Florida / Miami-Dade County	Human	Original	Nasopharyngeal		Ion Torrent	IRMAreport			B.1.1	GR
hCoV-19/Russia/SPE-RII-MH1014S/2020	EPI_ISL_602329	2020-09-05	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.163	GR
hCoV-19/Russia/SPE-RII-MH1057S/2020	EPI_ISL_602330	2020-09-06	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.163	GR
hCoV-19/Russia/NGR-RII-MH1702S/2020	EPI_ISL_602346	2020-09-18	Europe / Russia / Novgorod / Veliky Novgorod	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/SVE-RII-MH1716S/2020	EPI_ISL_602353	2020-09-17	Europe / Russia / Sverdlovsk / Ekaterinburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.387	GR
hCoV-19/Russia/SVE-RII-MH1758S/2020	EPI_ISL_602362	2020-09-17	Europe / Russia / Sverdlovsk / Ekaterinburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.387	GR
hCoV-19/Russia/PSK-RII-MH2018S/2020	EPI_ISL_602378	2020-09-24	Europe / Russia / Pskov / Velikiye Luki	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/KDA-RII-MH2773S/2020	EPI_ISL_602443	2020-09-17	Europe / Russia / Krasnodar / Krasnodar	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Germany/NW-HHU-208/2020	EPI_ISL_602482	2020-04-12	Europe / Germany / North Rhine-Westphalia / Essen	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.1.71	GR
hCoV-19/Germany/NW-HHU-184/2020	EPI_ISL_602506	2020-03-27	Europe / Germany / North Rhine-Westphalia / Essen	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.1.71	GR
hCoV-19/Germany/NW-HHU-154/2020	EPI_ISL_602524	2020-03-10	Europe / Germany / North Rhine-Westphalia / Essen	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.1	GR
hCoV-19/Australia/SA0499/2020	EPI_ISL_602580	2020-10-12	Oceania / Australia / South Australia	Human	Original			Illumina MiSeq		Gap of 4 nucleotide(s) found at refpos 26158 (FRAMESHIFT). NS3 without BLAST coverage. Submitter Note: Submitter had confirmed the gap of 4 nucleotides.	info	B.1	G
hCoV-19/Australia/SA0500/2020	EPI_ISL_602581	2020-10-12	Oceania / Australia / South Australia	Human	Original			Illumina MiSeq		Gap of 4 nucleotide(s) found at refpos 26158 (FRAMESHIFT). NS3 without BLAST coverage. Submitter Note: Submitter had confirmed the gap of 4 nucleotides.	info	B.1	G
hCoV-19/Australia/SA0516/2020	EPI_ISL_603128	2020-10-23	Oceania / Australia / South Australia	Human	Original			Illumina MiSeq		Gap of 4 nucleotide(s) found at refpos 26158 (FRAMESHIFT). NS3 without BLAST coverage. Submitter Note: Submitter had confirmed the 4 nucleotide(s) deletion is correct.	info	B.1	G
hCoV-19/Bangladesh/BCSIR-NILMRC_397/2020	EPI_ISL_603240	2020-10-08	Asia / Bangladesh / Dhaka	Human	Original	Nasopharyngeal swab		NextSeq 550	DRAGEN RNA Pathogen Detection 3.5.15			B.1.1.25	GR
hCoV-19/Bangladesh/BCSIR-NILMRC_411/2020	EPI_ISL_603241	2020-10-18	Asia / Bangladesh / Dhaka / Narayanganj	Human	Original	Nasopharyngeal swab		NextSeq 550	DRAGEN RNA Pathogen Detection 3.5.15			B.1.1.25	GR
hCoV-19/Bangladesh/BCSIR-NILMRC_427/2020	EPI_ISL_603249	2020-10-05	Asia / Bangladesh / Dhaka	Human	Original	Nasopharyngeal swab		NextSeq 550	DRAGEN RNA Pathogen Detection 3.5.15			B.1.1.25	GR
hCoV-19/Switzerland/ZH-ETHZ-300235/2020	EPI_ISL_603268	2020-09-30	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BL-ETHZ-300237/2020	EPI_ISL_603270	2020-10-01	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/GR-ETHZ-300249/2020	EPI_ISL_603281	2020-09-30	Europe / Switzerland / Grisons	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/AG-ETHZ-300257/2020	EPI_ISL_603289	2020-10-01	Europe / Switzerland / Aargau	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-300261/2020	EPI_ISL_603293	2020-10-01	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-300262/2020	EPI_ISL_603294	2020-10-01	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-300283/2020	EPI_ISL_603315	2020-10-01	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-300284/2020	EPI_ISL_603316	2020-10-01	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	G
hCoV-19/Switzerland/ZH-ETHZ-300299/2020	EPI_ISL_603331	2020-09-25	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-300320/2020	EPI_ISL_603352	2020-09-25	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-300389/2020	EPI_ISL_603358	2020-09-29	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-300401/2020	EPI_ISL_603367	2020-09-29	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-300406/2020	EPI_ISL_603371	2020-09-29	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/GE-ETHZ-300408/2020	EPI_ISL_603372	2020-09-28	Europe / Switzerland / Geneva	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/Switzerland/AG-ETHZ-300414/2020	EPI_ISL_603375	2020-09-29	Europe / Switzerland / Aargau	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BE-ETHZ-300441/2020	EPI_ISL_603394	2020-09-30	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/BE-ETHZ-300443/2020	EPI_ISL_603396	2020-09-30	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/ZH-ETHZ-300459/2020	EPI_ISL_603409	2020-09-30	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/VD-ETHZ-300471/2020	EPI_ISL_603418	2020-09-30	Europe / Switzerland / Vaud	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.269	GR
hCoV-19/Switzerland/ZH-ETHZ-310344/2020	EPI_ISL_603423	2020-10-07	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-310365/2020	EPI_ISL_603439	2020-10-07	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-310366/2020	EPI_ISL_603440	2020-10-07	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-310367/2020	EPI_ISL_603441	2020-10-07	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/VD-ETHZ-310372/2020	EPI_ISL_603446	2020-10-08	Europe / Switzerland / Vaud	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.269	GR
hCoV-19/Switzerland/BL-ETHZ-310382/2020	EPI_ISL_603456	2020-10-08	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/BL-ETHZ-310385/2020	EPI_ISL_603459	2020-10-08	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BL-ETHZ-310386/2020	EPI_ISL_603460	2020-10-08	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BL-ETHZ-310387/2020	EPI_ISL_603461	2020-10-08	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/BL-ETHZ-310388/2020	EPI_ISL_603462	2020-10-08	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/AG-ETHZ-310407/2020	EPI_ISL_603481	2020-10-08	Europe / Switzerland / Aargau	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-310416/2020	EPI_ISL_603490	2020-10-08	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-310424/2020	EPI_ISL_603498	2020-10-08	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-310425/2020	EPI_ISL_603499	2020-10-08	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Denmark/DCGC-3032/2020	EPI_ISL_616810	2020-08-24	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-3074/2020	EPI_ISL_616854	2020-08-31	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-8093/2020	EPI_ISL_617156	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.408	G
hCoV-19/Denmark/DCGC-8066/2020	EPI_ISL_617171	2020-10-26	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.408	G
hCoV-19/Denmark/DCGC-8063/2020	EPI_ISL_617193	2020-10-26	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.198	GR
hCoV-19/Denmark/DCGC-8137/2020	EPI_ISL_617201	2020-10-26	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.398	G
hCoV-19/Denmark/DCGC-8156/2020	EPI_ISL_617223	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-8258/2020	EPI_ISL_617272	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.398	G
hCoV-19/Denmark/DCGC-8196/2020	EPI_ISL_617275	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.44	GR
hCoV-19/Denmark/DCGC-8197/2020	EPI_ISL_617279	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.44	GR
hCoV-19/Denmark/DCGC-8259/2020	EPI_ISL_617285	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.398	G
hCoV-19/Denmark/DCGC-8266/2020	EPI_ISL_617286	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.398	G
hCoV-19/Denmark/DCGC-8370/2020	EPI_ISL_617346	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.159	GR
hCoV-19/Denmark/DCGC-2448/2020	EPI_ISL_617408	2020-08-10	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2450/2020	EPI_ISL_617410	2020-08-10	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2456/2020	EPI_ISL_617416	2020-08-03	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.398	G
hCoV-19/Denmark/DCGC-2457/2020	EPI_ISL_617417	2020-08-03	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.398	G
hCoV-19/Denmark/DCGC-2251/2020	EPI_ISL_617431	2020-08-10	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2253/2020	EPI_ISL_617433	2020-08-10	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2255/2020	EPI_ISL_617435	2020-08-10	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.398	G
hCoV-19/Denmark/DCGC-2256/2020	EPI_ISL_617436	2020-08-10	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2257/2020	EPI_ISL_617437	2020-08-10	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2155/2020	EPI_ISL_617453	2020-08-10	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2162/2020	EPI_ISL_617461	2020-08-10	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2204/2020	EPI_ISL_617505	2020-08-10	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2205/2020	EPI_ISL_617506	2020-08-10	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2380/2020	EPI_ISL_617560	2020-08-10	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.236	G
hCoV-19/Denmark/DCGC-2382/2020	EPI_ISL_617562	2020-08-10	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.198	GR
hCoV-19/Denmark/DCGC-2407/2020	EPI_ISL_617589	2020-08-10	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2409/2020	EPI_ISL_617591	2020-08-10	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-2420/2020	EPI_ISL_617602	2020-08-10	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2433/2020	EPI_ISL_617608	2020-08-10	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2435/2020	EPI_ISL_617610	2020-08-10	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-2267/2020	EPI_ISL_617624	2020-08-10	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.163	GR
hCoV-19/Denmark/DCGC-2271/2020	EPI_ISL_617628	2020-08-10	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2324/2020	EPI_ISL_617661	2020-08-10	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2328/2020	EPI_ISL_617665	2020-08-10	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-2331/2020	EPI_ISL_617668	2020-08-10	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2340/2020	EPI_ISL_617678	2020-08-10	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2350/2020	EPI_ISL_617688	2020-08-10	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2351/2020	EPI_ISL_617689	2020-08-10	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2352/2020	EPI_ISL_617690	2020-08-10	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2358/2020	EPI_ISL_617698	2020-08-10	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2365/2020	EPI_ISL_617705	2020-08-10	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2366/2020	EPI_ISL_617706	2020-08-10	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2374/2020	EPI_ISL_617714	2020-08-10	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.236	G
hCoV-19/Denmark/DCGC-2475/2020	EPI_ISL_617743	2020-08-10	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2498/2020	EPI_ISL_617769	2020-08-10	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-2503/2020	EPI_ISL_617774	2020-08-10	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-2515/2020	EPI_ISL_617787	2020-08-10	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-2524/2020	EPI_ISL_617794	2020-08-17	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2588/2020	EPI_ISL_617824	2020-08-17	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2589/2020	EPI_ISL_617825	2020-08-17	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2609/2020	EPI_ISL_617846	2020-08-17	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2611/2020	EPI_ISL_617848	2020-08-17	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2672/2020	EPI_ISL_617892	2020-08-17	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2675/2020	EPI_ISL_617896	2020-08-17	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.39	GR
hCoV-19/Denmark/DCGC-2678/2020	EPI_ISL_617899	2020-08-17	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-8460/2020	EPI_ISL_617928	2020-10-26	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.159	GR
hCoV-19/Denmark/DCGC-6398/2020	EPI_ISL_622324	2020-09-28	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.236	G
hCoV-19/Denmark/DCGC-6736/2020	EPI_ISL_622362	2020-04-20	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-1433/2020	EPI_ISL_622434	2020-05-11	Europe / Denmark	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-1919/2020	EPI_ISL_622512	2020-04-20	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	G
hCoV-19/Denmark/DCGC-1835/2020	EPI_ISL_622554	2020-06-29	Europe / Denmark	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-1862/2020	EPI_ISL_622558	2020-06-29	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-1882/2020	EPI_ISL_622573	2020-07-13	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-1857/2020	EPI_ISL_622578	2020-05-04	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-1940/2020	EPI_ISL_622603	2020-07-13	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-1832/2020	EPI_ISL_622604	2020-07-13	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-1866/2020	EPI_ISL_622609	2020-07-13	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-3801/2020	EPI_ISL_622667	2020-07-27	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-3831/2020	EPI_ISL_622671	2020-08-17	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.236	G
hCoV-19/Denmark/DCGC-3849/2020	EPI_ISL_622739	2020-09-07	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Australia/SA0532/2020	EPI_ISL_622766	2020-10-29	Oceania / Australia / South Australia	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/England/204441525/2020	EPI_ISL_622881	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.240	GR
hCoV-19/England/204441526/2020	EPI_ISL_622882	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.240	GR
hCoV-19/England/204441527/2020	EPI_ISL_622883	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.240	GR
hCoV-19/England/204441528/2020	EPI_ISL_622884	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.240	GR
hCoV-19/England/204441529/2020	EPI_ISL_622885	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.240	GR
hCoV-19/England/204441530/2020	EPI_ISL_622886	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.240	GR
hCoV-19/England/204441532/2020	EPI_ISL_622888	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.240	GR
hCoV-19/England/204441533/2020	EPI_ISL_622889	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.240	GR
hCoV-19/England/204441534/2020	EPI_ISL_622890	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.240	GR
hCoV-19/Jordan/AM-ALSR-3936/2020	EPI_ISL_636300	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3937/2020	EPI_ISL_636301	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3938/2020	EPI_ISL_636302	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3939/2020	EPI_ISL_636303	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3940/2020	EPI_ISL_636304	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3941/2020	EPI_ISL_636305	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3944/2020	EPI_ISL_636308	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3945/2020	EPI_ISL_636309	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3946/2020	EPI_ISL_636310	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3947/2020	EPI_ISL_636311	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3948/2020	EPI_ISL_636312	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/IR-ALSR-3949/2020	EPI_ISL_636313	2020-09-30	Asia / Jordan / Irbid	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3950/2020	EPI_ISL_636314	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3951/2020	EPI_ISL_636315	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3952/2020	EPI_ISL_636316	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3954/2020	EPI_ISL_636317	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3955/2020	EPI_ISL_636318	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3977/2020	EPI_ISL_636340	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3978/2020	EPI_ISL_636341	2020-10-02	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3979/2020	EPI_ISL_636342	2020-10-02	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3982/2020	EPI_ISL_636345	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3983/2020	EPI_ISL_636346	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3984/2020	EPI_ISL_636347	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3985/2020	EPI_ISL_636348	2020-10-02	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3986/2020	EPI_ISL_636349	2020-10-02	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3987/2020	EPI_ISL_636350	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3988/2020	EPI_ISL_636351	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3989/2020	EPI_ISL_636352	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3990/2020	EPI_ISL_636353	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3991/2020	EPI_ISL_636354	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3992/2020	EPI_ISL_636355	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3994/2020	EPI_ISL_636357	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3996/2020	EPI_ISL_636359	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3997/2020	EPI_ISL_636360	2020-10-02	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3999/2020	EPI_ISL_636362	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4000/2020	EPI_ISL_636363	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4001/2020	EPI_ISL_636364	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4002/2020	EPI_ISL_636365	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4003/2020	EPI_ISL_636366	2020-10-02	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4004/2020	EPI_ISL_636367	2020-10-02	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4005/2020	EPI_ISL_636368	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4006/2020	EPI_ISL_636369	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4008/2020	EPI_ISL_636371	2020-10-02	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4009/2020	EPI_ISL_636372	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4010/2020	EPI_ISL_636373	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4011/2020	EPI_ISL_636374	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4012/2020	EPI_ISL_636375	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4013/2020	EPI_ISL_636376	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4014/2020	EPI_ISL_636377	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4015/2020	EPI_ISL_636378	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4016/2020	EPI_ISL_636379	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4041/2020	EPI_ISL_636401	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4042/2020	EPI_ISL_636402	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4043/2020	EPI_ISL_636403	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4044/2020	EPI_ISL_636404	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4045/2020	EPI_ISL_636405	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4046/2020	EPI_ISL_636406	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4047/2020	EPI_ISL_636407	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4048/2020	EPI_ISL_636408	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4049/2020	EPI_ISL_636409	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4052/2020	EPI_ISL_636412	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4053/2020	EPI_ISL_636413	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4054/2020	EPI_ISL_636414	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4055/2020	EPI_ISL_636415	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4056/2020	EPI_ISL_636416	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4057/2020	EPI_ISL_636417	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4058/2020	EPI_ISL_636418	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4059/2020	EPI_ISL_636419	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4060/2020	EPI_ISL_636420	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4061/2020	EPI_ISL_636421	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4062/2020	EPI_ISL_636422	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4063/2020	EPI_ISL_636423	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4064/2020	EPI_ISL_636424	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4065/2020	EPI_ISL_636425	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4066/2020	EPI_ISL_636426	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4067/2020	EPI_ISL_636427	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4068/2020	EPI_ISL_636428	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4069/2020	EPI_ISL_636429	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4070/2020	EPI_ISL_636430	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4071/2020	EPI_ISL_636431	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4074/2020	EPI_ISL_636434	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4075/2020	EPI_ISL_636435	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4076/2020	EPI_ISL_636436	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4077/2020	EPI_ISL_636437	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4079/2020	EPI_ISL_636439	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4080/2020	EPI_ISL_636440	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4081/2020	EPI_ISL_636441	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4082/2020	EPI_ISL_636442	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4083/2020	EPI_ISL_636443	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4084/2020	EPI_ISL_636444	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4085/2020	EPI_ISL_636445	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4086/2020	EPI_ISL_636446	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4087/2020	EPI_ISL_636447	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4088/2020	EPI_ISL_636448	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4089/2020	EPI_ISL_636449	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4090/2020	EPI_ISL_636450	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4091/2020	EPI_ISL_636451	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4093/2020	EPI_ISL_636453	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4094/2020	EPI_ISL_636454	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 2 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4095/2020	EPI_ISL_636455	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4096/2020	EPI_ISL_636456	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4097/2020	EPI_ISL_636457	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4098/2020	EPI_ISL_636458	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/Italy/VEN-IZSVe-2-2/2020	EPI_ISL_636472	2020-03-22	Europe / Italy / Veneto / Padova	Human	Original	Oropharyngeal swab		Illumina MiSeq	BWA v0.7.12			B.1.1	GR
hCoV-19/Aruba/AW-RIVM-10391/2020	EPI_ISL_636517	2020-08-07	South America / Aruba	Human	Original			Nanopore MinION				B.1.1.231	GR
hCoV-19/Netherlands/FL-RIVM-10337/2020	EPI_ISL_636523	2020	Europe / Netherlands / Flevoland	Human	Original			Nanopore MinION				B.1.1.71	GR
hCoV-19/Netherlands/GE-RIVM-10374/2020	EPI_ISL_636533	2020-09-23	Europe / Netherlands / Gelderland	Human	Original			Nanopore MinION				AD.2	GR
hCoV-19/Netherlands/NH-RIVM-10357/2020	EPI_ISL_636567	2020-07-30	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Netherlands/UT-RIVM-10350/2020	EPI_ISL_636574	2020-05-19	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Netherlands/UT-RIVM-10377/2020	EPI_ISL_636579	2020-09-29	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				AD.2	GR
hCoV-19/Lithuania/MR-LUHS-Eilnr172/2020	EPI_ISL_636604	2020-07-21	Europe / Lithuania / Taurages apskritis	Human	Original			Illumina NextSeq 550				B.1.1	GR
hCoV-19/England/C200024017/2020	EPI_ISL_636688	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			AD.2	GR
hCoV-19/England/C200028987/2020	EPI_ISL_636691	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.67	GR
hCoV-19/England/C200028988/2020	EPI_ISL_636692	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.67	GR
hCoV-19/England/C200028989/2020	EPI_ISL_636693	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.67	GR
hCoV-19/England/C200028991/2020	EPI_ISL_636694	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.67	GR
hCoV-19/England/C200028992/2020	EPI_ISL_636695	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.67	GR
hCoV-19/England/C200028993/2020	EPI_ISL_636696	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.67	GR
hCoV-19/England/C200028994/2020	EPI_ISL_636697	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.67	GR
hCoV-19/England/C200037134/2020	EPI_ISL_636728	2020	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.240	GR
hCoV-19/England/C200037197/2020	EPI_ISL_636729	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.240	GR
hCoV-19/England/C200037229/2020	EPI_ISL_636730	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.240	GR
hCoV-19/Lithuania/MR-LUHS-Eilnr173/2020	EPI_ISL_636839	2020-07-21	Europe / Lithuania / Taurages apskritis	Human	Original			Illumina NextSeq 550				B.1.1	GR
hCoV-19/Lithuania/MR-LUHS-Eilnr189/2020	EPI_ISL_636841	2020-07-27	Europe / Lithuania / Taurages apskritis	Human	Original			Illumina NextSeq 550				B.1.1	GR
hCoV-19/Canada/ON-PHL-20-01775/2020	EPI_ISL_636927	2020-07	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/Turkey/ETLKVET1/2020	EPI_ISL_636969	2020-04	Europe / Turkey / Ankara	Human	Vero E6/P2	Tracheal swab		Nanopore MinION		Insertion of 2 nucleotides found at refpos 28881 (frameshift confirmed by the submitter). N without BLAST coverage.	info	B.1.1.317	G
hCoV-19/Turkey/ETLKVET3/2020	EPI_ISL_636971	2020-03	Europe / Turkey / Ankara	Human	P5	Tracheal swab		Nanopore MinION				B.1	G
hCoV-19/Mozambique/KRISP-MZ158905/2020	EPI_ISL_636980	2020-07-14	Africa / Mozambique / Gaza / Xai Xai	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/England/QEUH-B13BD1/2020	EPI_ISL_641810	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.398	G
hCoV-19/England/QEUH-B0F77A/2020	EPI_ISL_641824	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B10776/2020	EPI_ISL_641829	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B1344F/2020	EPI_ISL_641873	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B13E9C/2020	EPI_ISL_641907	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1.398	G
hCoV-19/England/QEUH-B0F9B0/2020	EPI_ISL_641920	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0E8C3/2020	EPI_ISL_641926	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0E571/2020	EPI_ISL_641942	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0F376/2020	EPI_ISL_641967	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0E8A5/2020	EPI_ISL_641968	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0F2E2/2020	EPI_ISL_641975	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0E966/2020	EPI_ISL_641996	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-B0E131/2020	EPI_ISL_642016	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0E8D2/2020	EPI_ISL_642019	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0E201/2020	EPI_ISL_642023	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0E939/2020	EPI_ISL_642032	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0E25C/2020	EPI_ISL_642037	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0EC7C/2020	EPI_ISL_642041	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0E23E/2020	EPI_ISL_642042	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0E8F0/2020	EPI_ISL_642059	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0DFCF/2020	EPI_ISL_642061	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0DC8C/2020	EPI_ISL_642062	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0DF83/2020	EPI_ISL_642069	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0F3C1/2020	EPI_ISL_642104	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0EC9A/2020	EPI_ISL_642112	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-B0E69C/2020	EPI_ISL_642113	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0E33B/2020	EPI_ISL_642124	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0E92A/2020	EPI_ISL_642141	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-B0EA72/2020	EPI_ISL_642158	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0E22F/2020	EPI_ISL_642163	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0EAFA/2020	EPI_ISL_642186	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0E368/2020	EPI_ISL_642190	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0EB9D/2020	EPI_ISL_642197	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B10D83/2020	EPI_ISL_642216	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B10F05/2020	EPI_ISL_642231	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B11845/2020	EPI_ISL_642238	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B1155D/2020	EPI_ISL_642301	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B117B1/2020	EPI_ISL_642330	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B13694/2020	EPI_ISL_642336	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B115F3/2020	EPI_ISL_642346	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B122A0/2020	EPI_ISL_642357	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B118BE/2020	EPI_ISL_642370	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B13676/2020	EPI_ISL_642406	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-B11B00/2020	EPI_ISL_642457	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B130E1/2020	EPI_ISL_642477	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-B12343/2020	EPI_ISL_642492	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/QEUH-B1245F/2020	EPI_ISL_642502	2020-11-02	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-B1443F/2020	EPI_ISL_642534	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B14402/2020	EPI_ISL_642536	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B129E7/2020	EPI_ISL_642581	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B1005D/2020	EPI_ISL_642613	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0ECE5/2020	EPI_ISL_642629	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0EE2B/2020	EPI_ISL_642631	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B1437E/2020	EPI_ISL_642659	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B10020/2020	EPI_ISL_642683	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B1438D/2020	EPI_ISL_642722	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B12A3F/2020	EPI_ISL_642729	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B1447B/2020	EPI_ISL_642760	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B02382/2020	EPI_ISL_642772	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/MILK-B01E0A/2020	EPI_ISL_642799	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B02A14/2020	EPI_ISL_642811	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/MILK-B05DFA/2020	EPI_ISL_642831	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/England/MILK-B05E42/2020	EPI_ISL_642841	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-B02874/2020	EPI_ISL_642846	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/MILK-B0280B/2020	EPI_ISL_642924	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B031C3/2020	EPI_ISL_642926	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B02917/2020	EPI_ISL_642946	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B02865/2020	EPI_ISL_642950	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B02953/2020	EPI_ISL_642954	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.39	GR
hCoV-19/England/MILK-B0601E/2020	EPI_ISL_642989	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/ALDP-B4648F/2020	EPI_ISL_656008	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-B46759/2020	EPI_ISL_656031	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B45A60/2020	EPI_ISL_656062	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B46E90/2020	EPI_ISL_656075	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B46F33/2020	EPI_ISL_656082	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B472EE/2020	EPI_ISL_656154	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.398	G
hCoV-19/England/ALDP-B46C78/2020	EPI_ISL_656165	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-B46012/2020	EPI_ISL_656167	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B472B1/2020	EPI_ISL_656182	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.398	G
hCoV-19/England/ALDP-B46E09/2020	EPI_ISL_656215	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B46BC6/2020	EPI_ISL_656218	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B46D48/2020	EPI_ISL_656229	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B46F06/2020	EPI_ISL_656253	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B47293/2020	EPI_ISL_656300	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.398	G
hCoV-19/England/ALDP-B62441/2020	EPI_ISL_656378	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/ALDP-B629F7/2020	EPI_ISL_656406	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B622CF/2020	EPI_ISL_656423	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/ALDP-B62423/2020	EPI_ISL_656442	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/ALDP-B62450/2020	EPI_ISL_656490	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/ALDP-B63B0F/2020	EPI_ISL_656530	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B63B2D/2020	EPI_ISL_656550	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B633F8/2020	EPI_ISL_656584	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-B62942/2020	EPI_ISL_656602	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B62520/2020	EPI_ISL_656663	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B625C6/2020	EPI_ISL_656667	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B62353/2020	EPI_ISL_656675	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B53F8E/2020	EPI_ISL_656712	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B538B0/2020	EPI_ISL_656715	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B56B1E/2020	EPI_ISL_656733	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B525F6/2020	EPI_ISL_656752	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-B542C0/2020	EPI_ISL_656767	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/CAMC-B540F3/2020	EPI_ISL_656773	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B543FA/2020	EPI_ISL_656784	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B5420C/2020	EPI_ISL_656795	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-B5448E/2020	EPI_ISL_656822	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B5362F/2020	EPI_ISL_656826	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/CAMC-B53768/2020	EPI_ISL_656830	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.39	GR
hCoV-19/England/CAMC-B522A4/2020	EPI_ISL_656859	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B56A7B/2020	EPI_ISL_656865	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B52329/2020	EPI_ISL_656970	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/CAMC-B523FC/2020	EPI_ISL_656995	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/MILK-B5697E/2020	EPI_ISL_656997	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B679F2/2020	EPI_ISL_661404	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6894C/2020	EPI_ISL_661408	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B676CE/2020	EPI_ISL_661416	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B665B3/2020	EPI_ISL_661439	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6992D/2020	EPI_ISL_661484	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B699A5/2020	EPI_ISL_661496	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B662E9/2020	EPI_ISL_661510	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B67A86/2020	EPI_ISL_661512	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6895B/2020	EPI_ISL_661517	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B66586/2020	EPI_ISL_661530	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B677DA/2020	EPI_ISL_661539	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6643E/2020	EPI_ISL_661541	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6C535/2020	EPI_ISL_661558	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B662DA/2020	EPI_ISL_661566	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B68E4D/2020	EPI_ISL_661579	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6702A/2020	EPI_ISL_661585	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6636E/2020	EPI_ISL_661597	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-B822C9/2020	EPI_ISL_661669	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.39	GR
hCoV-19/England/QEUH-B7ECA4/2020	EPI_ISL_661760	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B7EF6F/2020	EPI_ISL_661786	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B7FDFB/2020	EPI_ISL_661841	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B7F3CC/2020	EPI_ISL_661899	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B782A8/2020	EPI_ISL_661925	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.398	G
hCoV-19/England/ALDP-B74CCC/2020	EPI_ISL_661968	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B959A0/2020	EPI_ISL_675121	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B84722/2020	EPI_ISL_675187	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8F3AB/2020	EPI_ISL_675212	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B842C7/2020	EPI_ISL_675235	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B85897/2020	EPI_ISL_675299	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8F217/2020	EPI_ISL_675301	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8EF6C/2020	EPI_ISL_675311	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.39	GR
hCoV-19/England/ALDP-B8428B/2020	EPI_ISL_675335	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/ALDP-B85AA0/2020	EPI_ISL_675336	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B8427C/2020	EPI_ISL_675343	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8EEC9/2020	EPI_ISL_675364	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B851BA/2020	EPI_ISL_675383	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B8432E/2020	EPI_ISL_675400	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B8591C/2020	EPI_ISL_675501	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/ALDP-B8592B/2020	EPI_ISL_675524	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/ALDP-B858D3/2020	EPI_ISL_675541	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/ALDP-B858C4/2020	EPI_ISL_675544	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/MILK-B89DEF/2020	EPI_ISL_675556	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B88C5C/2020	EPI_ISL_675914	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B84E4B/2020	EPI_ISL_676010	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/MILK-B96040/2020	EPI_ISL_676043	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/MILK-B93984/2020	EPI_ISL_676154	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.398	G
hCoV-19/England/MILK-B968DF/2020	EPI_ISL_676248	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/MILK-B94983/2020	EPI_ISL_676262	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/MILK-B943C1/2020	EPI_ISL_676268	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-B9612F/2020	EPI_ISL_676302	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-B675A3/2020	EPI_ISL_676338	2020-11-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-B6A661/2020	EPI_ISL_676340	2020-11-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/PHWC-48FC6B/2020	EPI_ISL_681208	2020-11-11	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-48FCC5/2020	EPI_ISL_681214	2020-11-11	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-BAA595/2020	EPI_ISL_681361	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-BA9B1C/2020	EPI_ISL_681400	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-BAA401/2020	EPI_ISL_681417	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-BAB479/2020	EPI_ISL_681471	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-BABC62/2020	EPI_ISL_681488	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-BAC645/2020	EPI_ISL_681501	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-BAA5C2/2020	EPI_ISL_681527	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-BA9CFB/2020	EPI_ISL_681590	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/MILK-BAB51C/2020	EPI_ISL_681602	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-BAB6CE/2020	EPI_ISL_681604	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/MILK-BA9B0D/2020	EPI_ISL_681618	2020-11-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Ecuador/ZZ-SARS-2/2020	EPI_ISL_681703	2020-04-30	South America / Ecuador / Quito	Human	Original			Illumina MiSeq				B.1.1.231	O
hCoV-19/Ireland/LK-UHL8/2020	EPI_ISL_681760	2020-04-01	Europe / Ireland / Limerick / Limerick City	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/TA-UHL40/2020	EPI_ISL_681773	2020-04-12	Europe / Ireland / Tipperary	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/USA/TX-DSHS-1558/2020	EPI_ISL_681880	2020-06-22	North America / USA / Texas / Hidalgo	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa v1.2.2/ivar 0.7.17			B.1	G
hCoV-19/USA/TX-DSHS-1574/2020	EPI_ISL_681882	2020-06-24	North America / USA / Texas / Hidalgo	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa v1.2.2/ivar 0.7.17			B.1.396	G
hCoV-19/USA/NY-NYUMC172/2020	EPI_ISL_427469	2020-04-01	North America / USA / New York / Manhattan	Human	Original			Targeted capture, Illumina Novaseq	bwa/0.7.17, mapped to NC_045512v2, bases below 30x coverage masked			B.1.1	GR
hCoV-19/USA/NY-NYUMC213/2020	EPI_ISL_427508	2020-04-03	North America / USA / New York / Brooklyn	Human	Original			Targeted capture, Illumina Novaseq	bwa/0.7.17, mapped to NC_045512v2, bases below 30x coverage masked			B.1.1	GR
hCoV-19/USA/NY-WCMP10B11P/2020	EPI_ISL_427560	2020-03-15	North America / USA / New York / Manhattan	Human	Original	Nasopharyngeal swab		Illumina NovaSeq	Metagenomic read filtering by kraken2, alignment by bwa-mem, variant and consensus calling by ivar. Also validated by SPAdes and IRMA assemblies.			B.1.1.231	GR
hCoV-19/Australia/NSW171/2020	EPI_ISL_427743	2020-03-21	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.1.71	GR
hCoV-19/Australia/NSW162/2020	EPI_ISL_427758	2020-03-23	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.59	GR
hCoV-19/Australia/NSW159/2020	EPI_ISL_427781	2020-03-24	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.1	GR
hCoV-19/Australia/NSW160/2020	EPI_ISL_427784	2020-03-24	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.1	GR
hCoV-19/Australia/NSW161/2020	EPI_ISL_427788	2020-03-24	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.1	GR
hCoV-19/Australia/NSW163/2020	EPI_ISL_427789	2020-03-20	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.59	GR
hCoV-19/England/SHEF-CCC93/2020	EPI_ISL_432533	2020-03-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1.137	GR
hCoV-19/England/SHEF-C1B64/2020	EPI_ISL_432734	2020-03-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1.137	GR
hCoV-19/England/SHEF-C2CF7/2020	EPI_ISL_432753	2020-03-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1.137	GR
hCoV-19/England/SHEF-C3212/2020	EPI_ISL_432766	2020-04-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1.137	GR
hCoV-19/England/SHEF-C4493/2020	EPI_ISL_432788	2020-03-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/SHEF-C5DD3/2020	EPI_ISL_432813	2020-03-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1	G
hCoV-19/England/SHEF-C715D/2020	EPI_ISL_432836	2020-04-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/Scotland/EDB924/2020	EPI_ISL_432883	2020-04-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/Chile/RM-ISPCH-65/2020	EPI_ISL_445361	2020-03-18	South America / Chile / Region Metropolitana de Santiago / Santiago	Human	Original	Throat swab		Illumina MiSeq	IRMA v0.9.3			B.1.1	GR
hCoV-19/Wales/PHWC-28A13/2020	EPI_ISL_445387	2020-04-01	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-28E44/2020	EPI_ISL_445448	2020-04-02	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1.249	GR
hCoV-19/Wales/PHWC-2A3DA/2020	EPI_ISL_445564	2020-04-06	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.249	GR
hCoV-19/Wales/PHWC-2A5B6/2020	EPI_ISL_445589	2020-04-05	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-2B8AD/2020	EPI_ISL_445775	2020-04-09	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Belgium/ULG-10151/2020	EPI_ISL_447148	2020-04-18	Europe / Belgium / Liege	Human	Original			Nanopore MinION	Artic network			B.1.1.71	GR
hCoV-19/Israel/701002455/2020	EPI_ISL_447299	2020-03-24	Asia / Israel / South Coast District	Human	Original	Nasopharyngeal swab		Illumina MiSeq	AccuNGS pipeline (BLAST based)			B.1.1	G
hCoV-19/Israel/51140539/2020	EPI_ISL_447323	2020-03-19	Asia / Israel / South District	Human	Original	Nasopharyngeal swab		Illumina MiSeq	AccuNGS pipeline (BLAST based)			B.1.1	GR
hCoV-19/Israel/2020087/2020	EPI_ISL_447409	2020-03-17	Asia / Israel / Jerusalem District	Human	Original	Nasopharyngeal swab		Illumina MiSeq	AccuNGS pipeline (BLAST based)			B.1.1	GR
hCoV-19/Israel/130710390/2020	EPI_ISL_447461	2020-04-17	Asia / Israel / Tel Aviv District	Human	Original	Nasopharyngeal swab		Illumina MiSeq	AccuNGS pipeline (BLAST based)			B.1	G
hCoV-19/Denmark/ALAB-HH-99/2020	EPI_ISL_452100	2020-03-07	Europe / Denmark	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Italy/VEN-IZSVe-17-11/2020	EPI_ISL_452183	2020-03-24	Europe / Italy / Veneto / Verona	Human	Original	Oropharyngeal swab		Illumina MiSeq	BWA v0.7.12			B.1.1	GR
hCoV-19/Italy/VEN-IZSVe-25-80/2020	EPI_ISL_452186	2020-03-28	Europe / Italy / Veneto / Verona	Human	Original	Oropharyngeal swab		Illumina MiSeq	BWA v0.7.12			B.1.1	GR
hCoV-19/Italy/VEN-IZSVe-31-18/2020	EPI_ISL_452187	2020-03-31	Europe / Italy / Veneto / Verona	Human	Original	Oropharyngeal swab		Illumina MiSeq	BWA v0.7.12			B.1.1	GR
hCoV-19/Sweden/20-06209/2020	EPI_ISL_452233	2020-03-23	Europe / Sweden / Skane	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-07909/2020	EPI_ISL_452239	2020-04-25	Europe / Sweden / Vastra Gotaland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1	GR
hCoV-19/Spain/NC-IBV-001427/2020	EPI_ISL_452474	2020-03-23	Europe / Spain / Navarra / Pamplona	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Spain/NC-IBV-001387/2020	EPI_ISL_452514	2020-03-16	Europe / Spain / Navarra / Pamplona	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/USA/VA-DCLS-0271/2020	EPI_ISL_452840	2020-04-22	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0274/2020	EPI_ISL_452843	2020-04-22	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0275/2020	EPI_ISL_452844	2020-04-22	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0276/2020	EPI_ISL_452845	2020-04-22	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0277/2020	EPI_ISL_452846	2020-04-22	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0278/2020	EPI_ISL_452847	2020-04-22	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0280/2020	EPI_ISL_452849	2020-04-22	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/England/CAMB-1AEDB1/2020	EPI_ISL_452863	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1AEF15/2020	EPI_ISL_452871	2020-05-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B0138/2020	EPI_ISL_452880	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B0147/2020	EPI_ISL_452881	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B0156/2020	EPI_ISL_452882	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B052D/2020	EPI_ISL_452888	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B055A/2020	EPI_ISL_452891	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B0569/2020	EPI_ISL_452892	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B0578/2020	EPI_ISL_452893	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B0596/2020	EPI_ISL_452894	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B05A5/2020	EPI_ISL_452895	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B05B4/2020	EPI_ISL_452896	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B0736/2020	EPI_ISL_452916	2020-05-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B09D6/2020	EPI_ISL_452926	2020-05-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B0A00/2020	EPI_ISL_452928	2020-05-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B0A79/2020	EPI_ISL_452934	2020-05-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/England/CAMB-1B0BD0/2020	EPI_ISL_452950	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B0C37/2020	EPI_ISL_452953	2020-05-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B0E5F/2020	EPI_ISL_452968	2020-05-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B0EC8/2020	EPI_ISL_452974	2020-05-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B1B1B/2020	EPI_ISL_452998	2020-05-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Morocco/6888/2020	EPI_ISL_459966	2020-03-15	Africa / Morocco	Human	Original			Illumina NextSeq 500	CLC Genomics Suite			B.1.1	GR
hCoV-19/England/20146008604/2020	EPI_ISL_466025	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20146016004/2020	EPI_ISL_466034	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20148003504/2020	EPI_ISL_466051	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20148034104/2020	EPI_ISL_466059	2020-04-02	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20149001804/2020	EPI_ISL_466084	2020-04-02	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20149003604/2020	EPI_ISL_466094	2020-04-02	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20149006904/2020	EPI_ISL_466122	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20149009204/2020	EPI_ISL_466144	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20149052904/2020	EPI_ISL_466208	2020-04-04	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20149054504/2020	EPI_ISL_466217	2020-04-04	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20149054604/2020	EPI_ISL_466218	2020-04-04	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20150040104/2020	EPI_ISL_466230	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Canada/BC_04869329/2020	EPI_ISL_466769	2020-04	North America / Canada / British Columbia	Human	Original		unknown	Oxford Nanopore	ARTIC protocol			B.1.1	GR
hCoV-19/Canada/BC_05023412/2020	EPI_ISL_466776	2020-04	North America / Canada / British Columbia	Human	Original		unknown	Oxford Nanopore	ARTIC protocol			B.1.1	GR
hCoV-19/Germany/BY-MVP-0219/2020	EPI_ISL_466892	2020-04-22	Europe / Germany / Bavaria / Munich	Human	Original	Nasopharyngeal swab		Illumina Hiseq 1500	ARTIC V3 amplicons, Nextera XT library, bwa v0.7.17, iVar v1.2.2			B.1.1.515	GR
hCoV-19/Germany/BY-MVP-0220/2020	EPI_ISL_466893	2020-04-22	Europe / Germany / Bavaria / Munich	Human	Original	Nasopharyngeal swab		Illumina Hiseq 1500	ARTIC V3 amplicons, Nextera XT library, bwa v0.7.17, iVar v1.2.2			B.1.1.515	GR
hCoV-19/Germany/BY-MVP-0283/2020	EPI_ISL_466909	2020-05-11	Europe / Germany / Bavaria / Munich	Human	Original	Endotracheal aspirate (ETA)		Nanopore MinION	ARTIC protocol: primer set V3 & bioinformatics protocol v1.1.0 (minimap2)			B.1.1.515	GR
hCoV-19/Switzerland/TI-ETHZ-100003/2020	EPI_ISL_466928	2020-03-04	Europe / Switzerland / Ticino	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/TI-ETHZ-100073/2020	EPI_ISL_466995	2020-03-12	Europe / Switzerland / Ticino	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/VD-ETHZ-130003/2020	EPI_ISL_466999	2020-05-05	Europe / Switzerland / Vaud	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1	G
hCoV-19/England/CAMB-1AB6B9/2020	EPI_ISL_470324	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AACA9/2020	EPI_ISL_470330	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AB65F/2020	EPI_ISL_470332	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AB69B/2020	EPI_ISL_470342	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7DDF8/2020	EPI_ISL_470381	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7F6BF/2020	EPI_ISL_470386	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-805EB/2020	EPI_ISL_470438	2020-04-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7DDBC/2020	EPI_ISL_470446	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7CE32/2020	EPI_ISL_470533	2020-04-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LIVE-9F895/2020	EPI_ISL_472020	2020-05-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LIVE-A00F3/2020	EPI_ISL_472090	2020-06-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.238	G
hCoV-19/England/LIVE-A01B4/2020	EPI_ISL_472093	2020-06-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.238	G
hCoV-19/England/LIVE-A03DC/2020	EPI_ISL_472109	2020-05-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.1	GR
hCoV-19/England/LIVE-A049D/2020	EPI_ISL_472113	2020-05-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.1	GR
hCoV-19/England/LIVE-A0530/2020	EPI_ISL_472119	2020-05-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.95	GR
hCoV-19/England/LIVE-A0767/2020	EPI_ISL_472133	2020-06-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.95	GR
hCoV-19/England/NORW-EB760/2020	EPI_ISL_472314	2020-05-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-EBF86/2020	EPI_ISL_472326	2020-05-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NOTT-111EC5/2020	EPI_ISL_472420	2020-05-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NOTT-111F1D/2020	EPI_ISL_472424	2020-05-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NOTT-111F2C/2020	EPI_ISL_472425	2020-05-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/OXON-B12CC/2020	EPI_ISL_479001	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1	G
hCoV-19/England/OXON-B12EA/2020	EPI_ISL_479003	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B1350/2020	EPI_ISL_479007	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B145D/2020	EPI_ISL_479015	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B14E4/2020	EPI_ISL_479022	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B1693/2020	EPI_ISL_479033	2020-04-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B16C0/2020	EPI_ISL_479036	2020-04-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.231	G
hCoV-19/England/OXON-B1754/2020	EPI_ISL_479041	2020-04-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B1772/2020	EPI_ISL_479043	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B1781/2020	EPI_ISL_479044	2020-05-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.231	G
hCoV-19/England/OXON-B1790/2020	EPI_ISL_479045	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B18D9/2020	EPI_ISL_479051	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B195E/2020	EPI_ISL_479055	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B198B/2020	EPI_ISL_479057	2020-04-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1	G
hCoV-19/England/OXON-B199A/2020	EPI_ISL_479058	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B1A00/2020	EPI_ISL_479062	2020-04-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B1A1F/2020	EPI_ISL_479063	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B1A4C/2020	EPI_ISL_479066	2020-04-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1	G
hCoV-19/England/OXON-B1A79/2020	EPI_ISL_479068	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B1AD3/2020	EPI_ISL_479070	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B1B1C/2020	EPI_ISL_479072	2020-04-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B1B76/2020	EPI_ISL_479077	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B1C28/2020	EPI_ISL_479080	2020-05-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.231	G
hCoV-19/England/OXON-B1CCE/2020	EPI_ISL_479085	2020-05-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.231	G
hCoV-19/England/OXON-B1D52/2020	EPI_ISL_479089	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1	G
hCoV-19/England/OXON-B1DAD/2020	EPI_ISL_479091	2020-04-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B1E31/2020	EPI_ISL_479096	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina		Insertion of 1 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/OXON-B1EAA/2020	EPI_ISL_479099	2020-05-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1	G
hCoV-19/USA/CA-CZB-1794/2020	EPI_ISL_486123	2020-04-16	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.61	GR
hCoV-19/USA/CA-CZB-1795/2020	EPI_ISL_486124	2020-04-16	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.61	GR
hCoV-19/USA/CA-CZB-1797/2020	EPI_ISL_486126	2020-04-16	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.61	GR
hCoV-19/USA/CA-CZB-1817/2020	EPI_ISL_486134	2020-04-22	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1	G
hCoV-19/USA/CA-CZB-1820/2020	EPI_ISL_486137	2020-04-23	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.61	GR
hCoV-19/USA/CA-CZB-1822/2020	EPI_ISL_486138	2020-04-23	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar	NSP11 without BLAST coverage.	warn	B.1.1.61	GR
hCoV-19/USA/CA-CZB-1840/2020	EPI_ISL_486153	2020-04-27	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.61	GR
hCoV-19/USA/CA-CZB-1841/2020	EPI_ISL_486154	2020-04-27	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.61	GR
hCoV-19/USA/CA-CZB-1844/2020	EPI_ISL_486157	2020-04-25	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.61	GR
hCoV-19/USA/CA-CZB-1845/2020	EPI_ISL_486158	2020-04-26	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.61	GR
hCoV-19/USA/CA-CZB-1846/2020	EPI_ISL_486159	2020-04-26	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.61	GR
hCoV-19/USA/CA-CZB-1849/2020	EPI_ISL_486161	2020-04-27	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.61	GR
hCoV-19/USA/CA-CZB-1851/2020	EPI_ISL_486162	2020-04-27	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.61	GR
hCoV-19/USA/CA-CZB-1855/2020	EPI_ISL_486164	2020-04-27	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.61	GR
hCoV-19/USA/CA-CZB-1861/2020	EPI_ISL_486167	2020-04-28	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.61	GR
hCoV-19/USA/CA-CZB-1863/2020	EPI_ISL_486168	2020-04-28	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.61	GR
hCoV-19/USA/CA-CZB-1871/2020	EPI_ISL_486171	2020-04-28	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.61	GR
hCoV-19/USA/CA-CZB-1872/2020	EPI_ISL_486172	2020-04-28	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.61	GR
hCoV-19/USA/CA-CZB-1873/2020	EPI_ISL_486173	2020-04-28	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.61	GR
hCoV-19/USA/CA-CZB-1874/2020	EPI_ISL_486174	2020-04-28	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.61	GR
hCoV-19/USA/CA-CZB-1877/2020	EPI_ISL_486176	2020-04-28	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.61	GR
hCoV-19/USA/CA-CZB-1878/2020	EPI_ISL_486177	2020-04-28	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.61	GR
hCoV-19/USA/CA-CZB-1879/2020	EPI_ISL_486178	2020-04-28	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.61	GR
hCoV-19/USA/CA-CZB-1894/2020	EPI_ISL_486193	2020-04-21	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1	GR
hCoV-19/USA/CA-CZB-1918/2020	EPI_ISL_486210	2020-04-22	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1	G
hCoV-19/USA/CA-CZB-1919/2020	EPI_ISL_486211	2020-04-22	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1	GR
hCoV-19/USA/CA-CZB-1920/2020	EPI_ISL_486212	2020-04-23	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.61	GR
hCoV-19/USA/CA-CZB-1921/2020	EPI_ISL_486213	2020-04-23	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.61	GR
hCoV-19/USA/CA-CZB-1922/2020	EPI_ISL_486214	2020-04-23	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.61	GR
hCoV-19/USA/CA-CZB-1923/2020	EPI_ISL_486215	2020-04-23	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.61	GR
hCoV-19/USA/CA-CZB-1926/2020	EPI_ISL_486216	2020-04-23	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.61	GR
hCoV-19/USA/CA-CZB-1944/2020	EPI_ISL_486222	2020-05-04	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.61	GR
hCoV-19/USA/CA-CZB-1972/2020	EPI_ISL_486244	2020-05-07	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.61	GR
hCoV-19/USA/CA-CZB-1978/2020	EPI_ISL_486247	2020-05-07	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.61	GR
hCoV-19/USA/CA-CZB-1992/2020	EPI_ISL_486255	2020-04-30	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1	GR
hCoV-19/USA/CA-CZB-1993/2020	EPI_ISL_486256	2020-04-30	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1	GR
hCoV-19/USA/CA-CZB-1994/2020	EPI_ISL_486257	2020-04-30	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1	GR
hCoV-19/USA/CA-CZB-1995/2020	EPI_ISL_486258	2020-04-30	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1	GR
hCoV-19/USA/CA-CZB-1999/2020	EPI_ISL_486259	2020-04-30	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1	GR
hCoV-19/USA/CA-CZB-2000/2020	EPI_ISL_486260	2020-04-30	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1	GR
hCoV-19/USA/CA-CZB-2001/2020	EPI_ISL_486261	2020-04-30	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1	GR
hCoV-19/USA/CA-CZB-2002/2020	EPI_ISL_486262	2020-04-30	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1	GR
hCoV-19/USA/CA-CZB-2003/2020	EPI_ISL_486263	2020-04-30	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1	GR
hCoV-19/USA/CA-CZB-2016/2020	EPI_ISL_486269	2020-05-01	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.61	GR
hCoV-19/USA/CA-CZB-2017/2020	EPI_ISL_486270	2020-05-01	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1	GR
hCoV-19/USA/CA-CZB-2018/2020	EPI_ISL_486271	2020-05-03	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.61	GR
hCoV-19/Latvia/047/2020	EPI_ISL_486431	2020-03-16	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina, MiSeq	bowtie2			B.1.1.71	GR
hCoV-19/Latvia/049/2020	EPI_ISL_486433	2020-03-16	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina, MiSeq	bowtie2			B.59	GR
hCoV-19/Latvia/050/2020	EPI_ISL_486434	2020-03-16	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina, MiSeq	bowtie2			B.59	GR
hCoV-19/Latvia/051/2020	EPI_ISL_486435	2020-03-23	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina, MiSeq	bowtie2			B.1.1	GR
hCoV-19/Latvia/053/2020	EPI_ISL_486437	2020-04-30	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.1	GR
hCoV-19/Switzerland/TI-ETHZ-110061/2020	EPI_ISL_486491	2020-04-01	Europe / Switzerland / Ticino	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Russia/CRIE159560/2020	EPI_ISL_486815	2020-03-30	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq 1500	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1	GR
hCoV-19/Russia/CRIE159932/2020	EPI_ISL_486817	2020-03-30	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq 1500	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1	GR
hCoV-19/Russia/CRIE160277/2020	EPI_ISL_486818	2020-03-30	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq 1500	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1	GR
hCoV-19/Russia/CRIE160790/2020	EPI_ISL_486819	2020-03-30	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq 1500	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1	GR
hCoV-19/Russia/CRIE161143/2020	EPI_ISL_486820	2020-03-31	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq 1500	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1	GR
hCoV-19/Russia/CRIE164399/2020	EPI_ISL_486823	2020-03-31	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq 1500	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1	GR
hCoV-19/Russia/CRIE170180/2020	EPI_ISL_486826	2020-03-31	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq 1500	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1	GR
hCoV-19/Russia/CRIE176675/2020	EPI_ISL_486828	2020-04-01	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq 1500	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1	GR
hCoV-19/Russia/CRIE187963/2020	EPI_ISL_486829	2020-04-01	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq 1500	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1.163	GR
hCoV-19/USA/WA-UW-3534/2020	EPI_ISL_491033	2020-03-24	North America / USA / Washington	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina				B.59	GR
hCoV-19/Romania/ROSV_12235/2020	EPI_ISL_491040	2020-06-08	Europe / Romania / Suceava	Human	Original			Ion Torrent				B.1.1	GR
hCoV-19/Romania/ROSV_12615/2020	EPI_ISL_491045	2020-06-09	Europe / Romania / Suceava	Human	Original			Ion Torrent				B.1.1	GR
hCoV-19/Czech Republic/NRL_4039/2020	EPI_ISL_491093	2020-03-18	Europe / Czech Republic / Zlin / Fryšták	Human	Original	Oropharyngeal swab	Import Italy, Sondrio, Madesimo 29.2.-.6.3.	Nanopore MinION	Muscle, Medaka, RAMPART			B.1.1.44	GR
hCoV-19/India/UN-17074/2020	EPI_ISL_491114	2020	Asia / India	Human	Original			Illumina MiSeq		NSP11 without BLAST coverage.	warn	B.1.1	GR
hCoV-19/Oman/C-6175/2020	EPI_ISL_491125	2020-04-25	Asia / Oman / Dhahirah / Ibri	Human	Original	Nasopharyngeal swab		Ion Torrent	Trinity			B.1.1	GR
hCoV-19/Oman/C-7102/2020	EPI_ISL_491136	2020-04-27	Asia / Oman / Dhahirah / Ibri	Human	Original	Nasopharyngeal swab		Ion Torrent	Trinity			B.1.1	GR
hCoV-19/Oman/24647/2020	EPI_ISL_491139	2020-04-18	Asia / Oman / Dhahirah / Ibri	Human	Original	Nasopharyngeal swab		Ion Torrent	Trinity			B.1.1	GR
hCoV-19/Oman/C-5174/2020	EPI_ISL_491140	2020-04-25	Asia / Oman / Dhahirah / Ibri	Human	Original	Nasopharyngeal swab		Ion Torrent	Trinity			B.1.1	GR
hCoV-19/Oman/C-6187/2020	EPI_ISL_491142	2020-04-25	Asia / Oman / Dhahirah / Ibri	Human	Original	Nasopharyngeal swab		Ion Torrent	Trinity			B.1.1	GR
hCoV-19/Oman/C-2673/2020	EPI_ISL_491162	2020-04-22	Asia / Oman / Dhahirah / Ibri	Human	Original	Nasopharyngeal swab		Ion Torrent	Trinity			B.1.1	GR
hCoV-19/Oman/C-2826/2020	EPI_ISL_491163	2020-04-22	Asia / Oman / Dhahirah / Ibri	Human	Original	Nasopharyngeal swab		Ion Torrent	Trinity			B.1.1	GR
hCoV-19/Oman/C-5401/2020	EPI_ISL_491164	2020-04-24	Asia / Oman / Dakhiliyah / Bahla	Human	Original	Nasopharyngeal swab		Ion Torrent	Trinity			B.1.1	GR
hCoV-19/Oman/C-1186/2020	EPI_ISL_491168	2020-04-21	Asia / Oman / Dhahirah / Ibri	Human	Original	Nasopharyngeal swab		Ion Torrent	Trinity			B.1.1	GR
hCoV-19/Portugal/IGC2885/2020	EPI_ISL_491175	2020-05-17	Europe / Portugal	Human	Original	Oropharyngeal swab		Illumina Nextseq 500	CDCgov/SARS-CoV-2_Sequencing			B.1.1	GR
hCoV-19/Portugal/IGC3009/2020	EPI_ISL_491184	2020-05-20	Europe / Portugal	Human	Original	Oropharyngeal swab		Illumina Nextseq 500	CDCgov/SARS-CoV-2_Sequencing			B.1.1	GR
hCoV-19/Portugal/IGC3012/2020	EPI_ISL_491187	2020-05-20	Europe / Portugal	Human	Original	Oropharyngeal swab		Illumina Nextseq 500	CDCgov/SARS-CoV-2_Sequencing			B.1.1.198	GR
hCoV-19/Scotland/EDB2546/2020	EPI_ISL_491678	2020-04-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.14	GR
hCoV-19/Scotland/EDB2248/2020	EPI_ISL_491695	2020-04-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/Scotland/EDB6741/2020	EPI_ISL_491696	2020-04-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/Ecuador/USFQ-147/2020	EPI_ISL_491937	2020-06-30	South America / Ecuador / Manabi / Calceta	Human	Original	Nasopharyngeal swab		Nanopore MinION	Artic Network			B.1.1	GR
hCoV-19/Ecuador/36230/2020	EPI_ISL_491950	2020-05-08	South America / Ecuador / Los Rios / Babahoyo	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/Ecuador/52255/2020	EPI_ISL_491952	2020-05-29	South America / Ecuador / Guayas / San Jacinto de Yaguachi	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/Portugal/PT0831/2020	EPI_ISL_511090	2020-03-21	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0835/2020	EPI_ISL_511094	2020-03-22	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0842/2020	EPI_ISL_511101	2020-03-22	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0845/2020	EPI_ISL_511104	2020-05-06	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.198	GR
hCoV-19/Portugal/PT0889/2020	EPI_ISL_511147	2020-03-20	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0900/2020	EPI_ISL_511157	2020-03-28	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0908/2020	EPI_ISL_511165	2020-03-28	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0909/2020	EPI_ISL_511166	2020-03-28	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT1230/2020	EPI_ISL_511191	2020-03-30	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.198	GR
hCoV-19/Portugal/PT1236/2020	EPI_ISL_511197	2020-03-31	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT1264/2020	EPI_ISL_511225	2020-03-19	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT1277/2020	EPI_ISL_511238	2020-03-23	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT1281/2020	EPI_ISL_511242	2020-03-23	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT1372/2020	EPI_ISL_511331	2020-03-25	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT1373/2020	EPI_ISL_511332	2020-03-25	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT1384/2020	EPI_ISL_511343	2020-03-27	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT1467/2020	EPI_ISL_511426	2020-03-16	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT1468/2020	EPI_ISL_511427	2020-03-16	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT1470/2020	EPI_ISL_511429	2020-03-18	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT1507/2020	EPI_ISL_511466	2020-03-29	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT1513/2020	EPI_ISL_511472	2020-03-18	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0942/2020	EPI_ISL_511492	2020-04-09	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.198	GR
hCoV-19/Portugal/PT0945/2020	EPI_ISL_511495	2020-04-10	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.198	GR
hCoV-19/Portugal/PT0949/2020	EPI_ISL_511499	2020-04-12	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.198	GR
hCoV-19/Portugal/PT0951/2020	EPI_ISL_511501	2020-04-13	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.198	GR
hCoV-19/Portugal/PT0952/2020	EPI_ISL_511502	2020-04-13	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0968/2020	EPI_ISL_511517	2020-03-29	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.198	GR
hCoV-19/Portugal/PT0977/2020	EPI_ISL_511526	2020-03-30	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.59	GR
hCoV-19/Portugal/PT1006/2020	EPI_ISL_511553	2020-03-27	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT1011/2020	EPI_ISL_511558	2020-03-27	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT1016/2020	EPI_ISL_511563	2020-03-26	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT1018/2020	EPI_ISL_511565	2020-03-26	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT1053/2020	EPI_ISL_511600	2020-03-28	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT1098/2020	EPI_ISL_511645	2020-03-16	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT1109/2020	EPI_ISL_511656	2020-03-31	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT1163/2020	EPI_ISL_511710	2020-04-02	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.198	GR
hCoV-19/Portugal/PT1169/2020	EPI_ISL_511715	2020-04-05	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.198	GR
hCoV-19/Portugal/PT1185/2020	EPI_ISL_511730	2020-03-25	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT1209/2020	EPI_ISL_511752	2020-03-26	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Switzerland/ZH-ETHZ-210031/2020	EPI_ISL_511988	2020-07-22	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-210044/2020	EPI_ISL_511989	2020-07-23	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-210057/2020	EPI_ISL_511991	2020-07-19	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-220010/2020	EPI_ISL_511997	2020-07-24	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/AG-ETHZ-220012/2020	EPI_ISL_511999	2020-07-27	Europe / Switzerland / Aargau	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Italy/APU-UniMI-5409/2020	EPI_ISL_525560	2020-04-11	Europe / Italy / Apulia / Brindisi	Human	Original	Oropharyngeal swab		Illumina	SPAdes			B.1.1	GR
hCoV-19/USA/NY-Wadsworth-33281-01/2020	EPI_ISL_525639	2020-03-30	North America / USA / New York	Human	Original	Upper respiratory swab		Ion Torrent	Ion AmpliSeq(tm) SARS-CoV-2 Research Panel with Ion SARS-CoV-2 Research Plug in package IRMAreport / Geneious 9.1.8			B.1.1.231	GR
hCoV-19/USA/WA-S2723/2020	EPI_ISL_525713	2020-07-03	North America / USA / Washington / King County	Human	Original			Illumina NextSeq	Seattle Flu Assembly Pipeline			B.1.240	G
hCoV-19/USA/WA-S2748/2020	EPI_ISL_525738	2020-07-13	North America / USA / Washington / King County	Human	Original			Illumina NextSeq	Seattle Flu Assembly Pipeline			B.1.240	G
hCoV-19/USA/OR-OHSU-0911/2020	EPI_ISL_525925	2020-06-01	North America / USA / Oregon / Hood River County	Human	Original	Nasopharyngeal swab		Illumina NextSeq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1	G
hCoV-19/USA/OR-OHSU-0985/2020	EPI_ISL_525943	2020-07-06	North America / USA / Oregon / Wasco County	Human	Original	Nasopharyngeal swab		Illumina NextSeq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.239	G
hCoV-19/USA/OR-OHSU-1597/2020	EPI_ISL_525985	2020-07-21	North America / USA / Oregon / Clackamas County	Human	Original	Nasopharyngeal swab		Illumina NextSeq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.1.61	GR
hCoV-19/England/QEUH-9697AD/2020	EPI_ISL_531000	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-964A5E/2020	EPI_ISL_531004	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9658CC/2020	EPI_ISL_531010	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-965835/2020	EPI_ISL_531011	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-96978F/2020	EPI_ISL_531014	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-964DFB/2020	EPI_ISL_531016	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/Scotland/QEUH-964CB2/2020	EPI_ISL_531017	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-965765/2020	EPI_ISL_531020	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-964D19/2020	EPI_ISL_531022	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-9656FF/2020	EPI_ISL_531024	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-9697E9/2020	EPI_ISL_531032	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96986E/2020	EPI_ISL_531033	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-969707/2020	EPI_ISL_531040	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9656E0/2020	EPI_ISL_531044	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-9697DA/2020	EPI_ISL_531048	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-969840/2020	EPI_ISL_531054	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Northern Ireland/QEUH-96996B/2020	EPI_ISL_531063	2020-08-14	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-964BF1/2020	EPI_ISL_531064	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-965853/2020	EPI_ISL_531067	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.198	GR
hCoV-19/England/QEUH-969497/2020	EPI_ISL_531070	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/Scotland/QEUH-964D46/2020	EPI_ISL_531079	2020-08-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96589F/2020	EPI_ISL_531081	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-965255/2020	EPI_ISL_531084	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.25	GR
hCoV-19/England/QEUH-9697CB/2020	EPI_ISL_531085	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-969752/2020	EPI_ISL_531087	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-969549/2020	EPI_ISL_531091	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-964B1F/2020	EPI_ISL_531096	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9698C8/2020	EPI_ISL_531100	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/QEUH-969AC2/2020	EPI_ISL_531102	2020-08-12	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-965589/2020	EPI_ISL_531104	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9695FE/2020	EPI_ISL_531113	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9655E3/2020	EPI_ISL_531116	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-964D73/2020	EPI_ISL_531125	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9654C8/2020	EPI_ISL_531126	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-969691/2020	EPI_ISL_531129	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-964DA0/2020	EPI_ISL_531146	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/Scotland/QEUH-96506A/2020	EPI_ISL_531154	2020-08-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9657A1/2020	EPI_ISL_531155	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-964F8C/2020	EPI_ISL_531156	2020-08-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-964AF4/2020	EPI_ISL_531157	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-964B88/2020	EPI_ISL_531167	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9698B9/2020	EPI_ISL_531175	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-965440/2020	EPI_ISL_531179	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-96538F/2020	EPI_ISL_531181	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-969743/2020	EPI_ISL_531189	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-965307/2020	EPI_ISL_531203	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/Scotland/QEUH-964A4F/2020	EPI_ISL_531207	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9695EF/2020	EPI_ISL_531215	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-969AA4/2020	EPI_ISL_531216	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-965817/2020	EPI_ISL_531217	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-96B143/2020	EPI_ISL_531229	2020-08-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/Wales/QEUH-96BE00/2020	EPI_ISL_531250	2020-08-14	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/QEUH-96BCF7/2020	EPI_ISL_531254	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96BE97/2020	EPI_ISL_531260	2020-08-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96AE4D/2020	EPI_ISL_531263	2020-08-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.408	G
hCoV-19/England/QEUH-96B996/2020	EPI_ISL_531271	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/QEUH-96AED4/2020	EPI_ISL_531274	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-96B41D/2020	EPI_ISL_531276	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/QEUH-96AEC5/2020	EPI_ISL_531277	2020-08-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.408	G
hCoV-19/England/QEUH-96B899/2020	EPI_ISL_531278	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-96BC7F/2020	EPI_ISL_531280	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-96B556/2020	EPI_ISL_531281	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96BBEB/2020	EPI_ISL_531284	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-96AEF2/2020	EPI_ISL_531285	2020-08-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.67	GR
hCoV-19/England/QEUH-96AE3E/2020	EPI_ISL_531298	2020-08-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.408	G
hCoV-19/Northern Ireland/QEUH-96B86C/2020	EPI_ISL_531306	2020-08-16	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1.133	GR
hCoV-19/England/QEUH-96AFB3/2020	EPI_ISL_531308	2020-08-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-96B082/2020	EPI_ISL_531310	2020-08-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-96BA66/2020	EPI_ISL_531311	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96B3D4/2020	EPI_ISL_531312	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/QEUH-96BEB5/2020	EPI_ISL_531313	2020-08-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Northern Ireland/QEUH-96AC61/2020	EPI_ISL_531317	2020-08-17	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1.133	GR
hCoV-19/England/QEUH-96BBDC/2020	EPI_ISL_531319	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/Spain/CT-ISCIII-2013595/2020	EPI_ISL_539547	2020-06-28	Europe / Spain / Catalunya	Human	Original	Oropharyngeal swab		Illumina MiSeq	Mapping consensus			B.1.1.406	GR
hCoV-19/Spain/ML-ISCIII-2013686/2020	EPI_ISL_539567	2020-08-01	Europe / Spain / Melilla	Human	Original	Oropharyngeal swab		Illumina MiSeq	Mapping consensus			B.1.1.269	GR
hCoV-19/Spain/ML-ISCIII-2013688/2020	EPI_ISL_539568	2020-08-01	Europe / Spain / Melilla	Human	Original	Oropharyngeal swab		Illumina MiSeq	Mapping consensus			B.1.1.269	GR
hCoV-19/USA/TX-HMH-2874/2020	EPI_ISL_543843	2020-06-08	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1	G
hCoV-19/USA/TX-HMH-2946/2020	EPI_ISL_543882	2020-06-09	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.362	GR
hCoV-19/USA/TX-HMH-2959/2020	EPI_ISL_543893	2020-06-08	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1	G
hCoV-19/USA/TX-HMH-3111/2020	EPI_ISL_543999	2020-06-10	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-2054/2020	EPI_ISL_545090	2020-05-04	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1	G
hCoV-19/USA/TX-HMH-2691/2020	EPI_ISL_545479	2020-06-06	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-2733/2020	EPI_ISL_545512	2020-06-05	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-2801/2020	EPI_ISL_545564	2020-06-08	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-7937/2020	EPI_ISL_545721	2020-06-26	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.437	GR
hCoV-19/USA/TX-HMH-7967/2020	EPI_ISL_545749	2020-06-29	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.396	G
hCoV-19/USA/TX-HMH-7978/2020	EPI_ISL_545759	2020-06-29	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.396	G
hCoV-19/USA/TX-HMH-855/2020	EPI_ISL_545875	2020-04-08	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-959/2020	EPI_ISL_545933	2020-04-07	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.61	GR
hCoV-19/England/MILK-9A66A7/2020	EPI_ISL_550018	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A507D/2020	EPI_ISL_550032	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A6DC0/2020	EPI_ISL_550056	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A5295/2020	EPI_ISL_550059	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/MILK-97788B/2020	EPI_ISL_550506	2020-07-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.97	GR
hCoV-19/England/MILK-99D89E/2020	EPI_ISL_550523	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-99DDCC/2020	EPI_ISL_550525	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99E2BD/2020	EPI_ISL_550528	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-99E077/2020	EPI_ISL_550531	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-99C54D/2020	EPI_ISL_550535	2020-08-30	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99E10B/2020	EPI_ISL_550540	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99DCCF/2020	EPI_ISL_550548	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-99C52F/2020	EPI_ISL_550552	2020-08-30	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99E341/2020	EPI_ISL_550553	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99E271/2020	EPI_ISL_550560	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-99CB1E/2020	EPI_ISL_550567	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/MILK-99DAA7/2020	EPI_ISL_550568	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99E53C/2020	EPI_ISL_550570	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99C6B3/2020	EPI_ISL_550571	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99CAE4/2020	EPI_ISL_550578	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-99DA2F/2020	EPI_ISL_550580	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99C6A4/2020	EPI_ISL_550586	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-99CA11/2020	EPI_ISL_550591	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-99C7ED/2020	EPI_ISL_550598	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99D209/2020	EPI_ISL_550602	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99C729/2020	EPI_ISL_550603	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/MILK-99C89F/2020	EPI_ISL_550604	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99DB59/2020	EPI_ISL_550605	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-99DB0E/2020	EPI_ISL_550612	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99DFF3/2020	EPI_ISL_550613	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-99C53E/2020	EPI_ISL_550614	2020-08-30	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99E44E/2020	EPI_ISL_550617	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99CB4B/2020	EPI_ISL_550618	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99DB1D/2020	EPI_ISL_550627	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-99E068/2020	EPI_ISL_550634	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99DC92/2020	EPI_ISL_550636	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99DC83/2020	EPI_ISL_550645	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99E2CC/2020	EPI_ISL_550658	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-99E350/2020	EPI_ISL_550659	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99DBFF/2020	EPI_ISL_550661	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99C71A/2020	EPI_ISL_550663	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/Wales/MILK-99DE8D/2020	EPI_ISL_550675	2020-08-30	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-99DA6B/2020	EPI_ISL_550682	2020-08-30	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99E323/2020	EPI_ISL_550685	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99C695/2020	EPI_ISL_550689	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-99D852/2020	EPI_ISL_550692	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/MILK-99D8BC/2020	EPI_ISL_550705	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99E29F/2020	EPI_ISL_550708	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/Wales/MILK-99C5B6/2020	EPI_ISL_550711	2020-08-30	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99E52D/2020	EPI_ISL_550714	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-99DF6C/2020	EPI_ISL_550716	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99DA3E/2020	EPI_ISL_550727	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99D7DD/2020	EPI_ISL_550737	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99C905/2020	EPI_ISL_550738	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99E39C/2020	EPI_ISL_550747	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99E587/2020	EPI_ISL_550753	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99DFA8/2020	EPI_ISL_550759	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-99C5C5/2020	EPI_ISL_550766	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/Wales/MILK-99CA7B/2020	EPI_ISL_550767	2020-08-31	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99C64A/2020	EPI_ISL_550774	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99E0FF/2020	EPI_ISL_550784	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99E208/2020	EPI_ISL_550786	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-9AA281/2020	EPI_ISL_550803	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9AA6C1/2020	EPI_ISL_550811	2020-08-30	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AACA1/2020	EPI_ISL_550812	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AA0A5/2020	EPI_ISL_550813	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AA56A/2020	EPI_ISL_550816	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/MILK-9AACB0/2020	EPI_ISL_550818	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-9AA0D2/2020	EPI_ISL_550832	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-9AA087/2020	EPI_ISL_550835	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AAB1D/2020	EPI_ISL_550843	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AAC92/2020	EPI_ISL_550854	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-9AA7A0/2020	EPI_ISL_550857	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AA48B/2020	EPI_ISL_550862	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-9AA89E/2020	EPI_ISL_550881	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/MILK-9AA096/2020	EPI_ISL_550882	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/England/MILK-9AAC38/2020	EPI_ISL_550886	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/Wales/MILK-9AADCC/2020	EPI_ISL_550901	2020-09-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A9880/2020	EPI_ISL_550905	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/MILK-9AACCF/2020	EPI_ISL_550915	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-9A9914/2020	EPI_ISL_550926	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AA3F7/2020	EPI_ISL_550928	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AA272/2020	EPI_ISL_550937	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AA55B/2020	EPI_ISL_550943	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/Wales/MILK-9AA6B2/2020	EPI_ISL_550945	2020-08-30	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AA49A/2020	EPI_ISL_550955	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.198	GR
hCoV-19/England/MILK-9AAA98/2020	EPI_ISL_550959	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AA45E/2020	EPI_ISL_550964	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9AAD62/2020	EPI_ISL_550987	2020-08-31	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-5297AD/2020	EPI_ISL_559008	2020-06-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-524353/2020	EPI_ISL_559038	2020-06-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-52B996/2020	EPI_ISL_559066	2020-06-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/ALDP-52B90F/2020	EPI_ISL_559069	2020-06-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-52A636/2020	EPI_ISL_559070	2020-06-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/ALDP-5087B3/2020	EPI_ISL_559105	2020-06-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-4F536B/2020	EPI_ISL_559127	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-50341B/2020	EPI_ISL_559177	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-5089EA/2020	EPI_ISL_559182	2020-06-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/MILK-4BC773/2020	EPI_ISL_559187	2020-06-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/England/ALDP-4FD776/2020	EPI_ISL_559188	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-4FF97E/2020	EPI_ISL_559191	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-4FF8BD/2020	EPI_ISL_559193	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-4B8A23/2020	EPI_ISL_559195	2020-06-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-4B3378/2020	EPI_ISL_559201	2020-06-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-50316F/2020	EPI_ISL_559229	2020-06-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-4F7CAA/2020	EPI_ISL_559239	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-4F551A/2020	EPI_ISL_559248	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-4F7B52/2020	EPI_ISL_559250	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-4C6767/2020	EPI_ISL_559278	2020-06-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-4F7EE0/2020	EPI_ISL_559291	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-4AD283/2020	EPI_ISL_559303	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.203	GR
hCoV-19/England/ALDP-4AECB1/2020	EPI_ISL_559307	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/ALDP-496706/2020	EPI_ISL_559317	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-4A21FA/2020	EPI_ISL_559382	2020-05-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-49A465/2020	EPI_ISL_559420	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-49CD86/2020	EPI_ISL_559471	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-4A9885/2020	EPI_ISL_559528	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-4AAE28/2020	EPI_ISL_559571	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.238	G
hCoV-19/England/ALDP-49DBA9/2020	EPI_ISL_559605	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-48249D/2020	EPI_ISL_559687	2020-04-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-4862AE/2020	EPI_ISL_559691	2020-05-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-461A74/2020	EPI_ISL_559728	2020-05-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-467B7B/2020	EPI_ISL_559737	2020-05-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-99B14A/2020	EPI_ISL_559765	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-99BC49/2020	EPI_ISL_559772	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.39	GR
hCoV-19/England/QEUH-99BE16/2020	EPI_ISL_559773	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-99BE34/2020	EPI_ISL_559774	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.255	GR
hCoV-19/England/QEUH-99C167/2020	EPI_ISL_559786	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-9ACB93/2020	EPI_ISL_559799	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9ACBEE/2020	EPI_ISL_559801	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9AD1BE/2020	EPI_ISL_559820	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9AD224/2020	EPI_ISL_559821	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9AD27F/2020	EPI_ISL_559823	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9AF222/2020	EPI_ISL_559829	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9AF29B/2020	EPI_ISL_559830	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9AF2E6/2020	EPI_ISL_559834	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9AF5DE/2020	EPI_ISL_559851	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_G38stop results in 69.4% truncation of the protein sequence.	info	B.1.532	GR
hCoV-19/England/QEUH-9B0C5D/2020	EPI_ISL_559856	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9B0C7B/2020	EPI_ISL_559858	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9B0D0F/2020	EPI_ISL_559861	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9B0D5A/2020	EPI_ISL_559865	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9B0DF0/2020	EPI_ISL_559866	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9B0E39/2020	EPI_ISL_559867	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9B0F36/2020	EPI_ISL_559868	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9B0F54/2020	EPI_ISL_559870	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9B0F63/2020	EPI_ISL_559871	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/SHEF-CC5B6/2020	EPI_ISL_559932	2020-09-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/USA/WA-UW-10159/2020	EPI_ISL_570270	2020-06-02	North America / USA / Washington	Human	Original			Illumina	custom			B.1	G
hCoV-19/USA/WA-UW-10471/2020	EPI_ISL_570317	2020-06-07	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1.231	GR
hCoV-19/USA/WA-UW-10612/2020	EPI_ISL_570337	2020-06-12	North America / USA / Washington	Human	Original			Illumina	custom			B.1	G
hCoV-19/USA/WA-UW-10669/2020	EPI_ISL_570346	2020-06-09	North America / USA / Washington	Human	Original			Illumina	custom			B.1.169	G
hCoV-19/USA/WA-UW-11325/2020	EPI_ISL_570394	2020-06-22	North America / USA / Washington	Human	Original			Illumina	custom	NSP4_L111stop results in 78.0% truncation of the protein sequence.	info	B.1.240	G
hCoV-19/USA/WA-UW-11425/2020	EPI_ISL_570404	2020-06-22	North America / USA / Washington	Human	Original			Illumina	custom	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.240	G
hCoV-19/USA/WA-UW-11443/2020	EPI_ISL_570409	2020-06-23	North America / USA / Washington	Human	Original			Illumina	custom			B.1.240	G
hCoV-19/USA/WA-UW-11484/2020	EPI_ISL_570419	2020-06-24	North America / USA / Washington	Human	Original			Illumina	custom			B.1.240	G
hCoV-19/USA/WA-UW-11499/2020	EPI_ISL_570423	2020-06-24	North America / USA / Washington	Human	Original			Illumina	custom			B.1.240	G
hCoV-19/USA/WA-UW-11512/2020	EPI_ISL_570424	2020-06-24	North America / USA / Washington	Human	Original			Illumina	custom			B.1.240	G
hCoV-19/USA/OR-UW-11742/2020	EPI_ISL_570465	2020-06-16	North America / USA / Oregon	Human	Original			Illumina	custom	NSP4_L111stop results in 78.0% truncation of the protein sequence.	info	B.1.240	G
hCoV-19/USA/WA-UW-11761/2020	EPI_ISL_570466	2020-06-24	North America / USA / Washington	Human	Original			Illumina	custom			B.1.240	G
hCoV-19/USA/WA-UW-12117/2020	EPI_ISL_570490	2020-06-24	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1	GR
hCoV-19/USA/WA-UW-12127/2020	EPI_ISL_570491	2020-06-25	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1.437	GR
hCoV-19/USA/WA-UW-12134/2020	EPI_ISL_570492	2020-06-26	North America / USA / Washington	Human	Original			Illumina	custom			B.1.240	G
hCoV-19/USA/WA-UW-12140/2020	EPI_ISL_570493	2020-06-26	North America / USA / Washington	Human	Original			Illumina	custom			B.1.240	G
hCoV-19/USA/WA-UW-12162/2020	EPI_ISL_570496	2020-06-26	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1	GR
hCoV-19/USA/WA-UW-12173/2020	EPI_ISL_570501	2020-06-26	North America / USA / Washington	Human	Original			Illumina	custom			B.1.240	G
hCoV-19/USA/WA-UW-12340/2020	EPI_ISL_570507	2020-06-27	North America / USA / Washington	Human	Original			Illumina	custom			B.1.240	G
hCoV-19/USA/WA-UW-12389/2020	EPI_ISL_570524	2020-06-27	North America / USA / Washington	Human	Original			Illumina	custom			B.1.240	G
hCoV-19/USA/WA-UW-12488/2020	EPI_ISL_570539	2020-06-29	North America / USA / Washington	Human	Original			Illumina	custom			B.1.169	G
hCoV-19/USA/WA-UW-26856/2020	EPI_ISL_570604	2020-09-01	North America / USA / Washington	Human	Original			Illumina	custom	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/USA/WA-UW-22051/2020	EPI_ISL_570620	2020-08-03	North America / USA / Washington	Human	Original			Illumina	custom			B.1.240	G
hCoV-19/USA/WA-UW-22112/2020	EPI_ISL_570626	2020-08-04	North America / USA / Washington	Human	Original			Illumina	custom			B.1.396	G
hCoV-19/USA/WA-UW-22148/2020	EPI_ISL_570630	2020-08-05	North America / USA / Washington	Human	Original			Illumina	custom			B.1.169	G
hCoV-19/USA/WA-UW-22316/2020	EPI_ISL_570658	2020-08-06	North America / USA / Washington	Human	Original			Illumina	custom			B.1.169	G
hCoV-19/USA/WA-UW-22365/2020	EPI_ISL_570669	2020-08-08	North America / USA / Washington	Human	Original			Illumina	custom			B.1.396	G
hCoV-19/USA/WA-UW-22409/2020	EPI_ISL_570678	2020-08-08	North America / USA / Washington	Human	Original			Illumina	custom			B.1.240	G
hCoV-19/USA/WA-UW-22495/2020	EPI_ISL_570698	2020-08-05	North America / USA / Washington	Human	Original			Illumina	custom			B.1.402	G
hCoV-19/USA/WA-UW-22804/2020	EPI_ISL_570720	2020-08-04	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1.61	GR
hCoV-19/USA/WA-UW-22885/2020	EPI_ISL_570729	2020-08-06	North America / USA / Washington	Human	Original			Illumina	custom			B.1.240	G
hCoV-19/USA/WA-UW-23483/2020	EPI_ISL_570759	2020-08-10	North America / USA / Washington	Human	Original			Illumina	custom			B.1.240	G
hCoV-19/USA/WA-UW-12601/2020	EPI_ISL_570833	2020-06-28	North America / USA / Washington	Human	Original			Illumina	custom	NSP4_L111stop results in 78.0% truncation of the protein sequence.	info	B.1.240	G
hCoV-19/USA/WA-UW-12772/2020	EPI_ISL_570858	2020-06-29	North America / USA / Washington	Human	Original			Illumina	custom	Gap of 2 nucleotides when compared to the reference sequence.	info	B.1.240	G
hCoV-19/USA/WA-UW-12602/2020	EPI_ISL_570872	2020-06-28	North America / USA / Washington	Human	Original			Illumina	custom			B.1.240	G
hCoV-19/USA/WA-UW-12785/2020	EPI_ISL_570902	2020-06-29	North America / USA / Washington	Human	Original			Illumina	custom			B.1.240	G
hCoV-19/USA/WA-UW-12797/2020	EPI_ISL_570903	2020-06-29	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1	GR
hCoV-19/USA/WA-UW-12832/2020	EPI_ISL_570908	2020-06-29	North America / USA / Washington	Human	Original			Illumina	custom			B.1.240	G
hCoV-19/USA/WA-UW-12839/2020	EPI_ISL_570910	2020-06-29	North America / USA / Washington	Human	Original			Illumina	custom			B.1.240	G
hCoV-19/England/NORW-F04AD/2020	EPI_ISL_577103	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-F0856/2020	EPI_ISL_577107	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NOTT-113FA2/2020	EPI_ISL_577126	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AE4E1/2020	EPI_ISL_577221	2020-09-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.240	GR
hCoV-19/England/QEUH-9AE51B/2020	EPI_ISL_577224	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AE539/2020	EPI_ISL_577225	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AE5FD/2020	EPI_ISL_577227	2020-09-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AE7AC/2020	EPI_ISL_577239	2020-09-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AE9B5/2020	EPI_ISL_577260	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEA2B/2020	EPI_ISL_577266	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEA3A/2020	EPI_ISL_577267	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEA85/2020	EPI_ISL_577271	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEAA3/2020	EPI_ISL_577272	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Wales/ALDP-9D8BF8/2020	EPI_ISL_577383	2020-09-18	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/MILK-9D52BA/2020	EPI_ISL_577387	2020-09-18	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Wales/MILK-9E153A/2020	EPI_ISL_577406	2020-09-19	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16D756/2020	EPI_ISL_577441	2020-09-24	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16DB2D/2020	EPI_ISL_577493	2020-09-26	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16DDEB/2020	EPI_ISL_577537	2020-09-27	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/New Zealand/20VR2012/2020	EPI_ISL_579204	2020	Oceania / New Zealand / Combined Wellington	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC protocol			B.1.1	GR
hCoV-19/New Zealand/20VR2013/2020	EPI_ISL_579205	2020	Oceania / New Zealand / Combined Wellington	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC protocol			B.1.1	GR
hCoV-19/England/20422148504/2020	EPI_ISL_584068	2020-09	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			AD.2	GR
hCoV-19/USA/TX-DSHS-0729/2020	EPI_ISL_584131	2020-05-14	North America / USA / Texas / Hidalgo County	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa v1.2.2/ivar 0.7.17			B.1.1	GR
hCoV-19/England/ALDP-9E96F3/2020	EPI_ISL_584238	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/England/CAMB-1B6378/2020	EPI_ISL_584285	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.315	GR
hCoV-19/England/CAMC-9D7212/2020	EPI_ISL_584353	2020-09-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/CAMC-9D731F/2020	EPI_ISL_584362	2020-09-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/CAMC-9D7379/2020	EPI_ISL_584364	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.236	G
hCoV-19/England/CAMC-9D7467/2020	EPI_ISL_584372	2020-09-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/CAMC-9EBEBD/2020	EPI_ISL_584425	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-9EBFF6/2020	EPI_ISL_584437	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/England/CWAR-24FDA68/2020	EPI_ISL_584471	2020-05-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CWAR-24FDB0B/2020	EPI_ISL_584480	2020-05-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LIVE-99E6C/2020	EPI_ISL_584612	2020-04-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LIVE-A0CC2/2020	EPI_ISL_584615	2020-06-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.67	GR
hCoV-19/England/LIVE-A404A/2020	EPI_ISL_584618	2020-06-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.95	GR
hCoV-19/England/LOND-124D952/2020	EPI_ISL_584625	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.198	GR
hCoV-19/England/LOND-124E1FF/2020	EPI_ISL_584668	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.15	GR
hCoV-19/England/NORT-2A7C8D/2020	EPI_ISL_584713	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.269	GR
hCoV-19/England/NORW-F06E3/2020	EPI_ISL_584737	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/NORW-F072C/2020	EPI_ISL_584738	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NOTT-1147C7/2020	EPI_ISL_584753	2020-10-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9DED1A/2020	EPI_ISL_584825	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 6 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-9DED29/2020	EPI_ISL_584826	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9DEF7E/2020	EPI_ISL_584835	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9DEF9C/2020	EPI_ISL_584836	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9DF03E/2020	EPI_ISL_584843	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9E36EA/2020	EPI_ISL_584866	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9E378D/2020	EPI_ISL_584870	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9E387B/2020	EPI_ISL_584876	2020-09-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-A005F8/2020	EPI_ISL_584892	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-A029AF/2020	EPI_ISL_584939	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-A51FBE/2020	EPI_ISL_598005	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A4723A/2020	EPI_ISL_598501	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.39	GR
hCoV-19/England/MILK-A48002/2020	EPI_ISL_598516	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A464AE/2020	EPI_ISL_598529	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A46277/2020	EPI_ISL_598536	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/England/MILK-A45C7A/2020	EPI_ISL_598541	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/MILK-A44D69/2020	EPI_ISL_598566	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A44A62/2020	EPI_ISL_598570	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A468C0/2020	EPI_ISL_598573	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A46286/2020	EPI_ISL_598581	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/England/MILK-A4671E/2020	EPI_ISL_598627	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/MILK-A458D0/2020	EPI_ISL_598659	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A463CF/2020	EPI_ISL_598662	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A46480/2020	EPI_ISL_598665	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/MILK-A46444/2020	EPI_ISL_598712	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A45F26/2020	EPI_ISL_598729	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A461F2/2020	EPI_ISL_598730	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-A44B23/2020	EPI_ISL_598737	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A462D1/2020	EPI_ISL_598738	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/MILK-A4615C/2020	EPI_ISL_598742	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A45867/2020	EPI_ISL_598763	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/MILK-A457A6/2020	EPI_ISL_598770	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/MILK-A457D3/2020	EPI_ISL_598787	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/England/MILK-A466D5/2020	EPI_ISL_598792	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A44B14/2020	EPI_ISL_598800	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A45EFC/2020	EPI_ISL_598802	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A468B1/2020	EPI_ISL_598806	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A456E5/2020	EPI_ISL_598809	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-A2EF23/2020	EPI_ISL_598827	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-A2EEDB/2020	EPI_ISL_598829	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-A2FECB/2020	EPI_ISL_598830	2020-10-06	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-A1E050/2020	EPI_ISL_598847	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/Scotland/QEUH-A218E9/2020	EPI_ISL_598889	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-A1E09C/2020	EPI_ISL_598901	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/Scotland/QEUH-A20422/2020	EPI_ISL_598942	2020-10-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/South Africa/KRISP-K003672/2020	EPI_ISL_602628	2020-06-29	Africa / South Africa / KwaZulu-Natal	Human	H1299	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K003674/2020	EPI_ISL_602630	2020-07-27	Africa / South Africa / KwaZulu-Natal	Human	H1299	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002812/2020	EPI_ISL_602633	2020-08-24	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002816/2020	EPI_ISL_602637	2020-08-21	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K002828/2020	EPI_ISL_602648	2020-09-01	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.40	GR
hCoV-19/South Africa/KRISP-K002840/2020	EPI_ISL_602656	2020-09-01	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K002846/2020	EPI_ISL_602662	2020-09-01	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K002847/2020	EPI_ISL_602663	2020-09-01	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K002848/2020	EPI_ISL_602664	2020-09-01	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K002866/2020	EPI_ISL_602680	2020-08-29	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002867/2020	EPI_ISL_602681	2020-08-29	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K002870/2020	EPI_ISL_602683	2020-09-04	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K002889/2020	EPI_ISL_602701	2020-09-04	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002893/2020	EPI_ISL_602705	2020-09-02	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K002903/2020	EPI_ISL_602714	2020-09-04	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K003322/2020	EPI_ISL_602715	2020-09-04	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K003325/2020	EPI_ISL_602718	2020-09-07	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K003330/2020	EPI_ISL_602723	2020-09-07	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K003334/2020	EPI_ISL_602726	2020-09-05	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.56	GR
hCoV-19/South Africa/KRISP-K003335/2020	EPI_ISL_602727	2020-09-07	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K003339/2020	EPI_ISL_602731	2020-09-07	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K003343/2020	EPI_ISL_602735	2020-09-05	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K003345/2020	EPI_ISL_602737	2020-09-06	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K003346/2020	EPI_ISL_602738	2020-09-07	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K003360/2020	EPI_ISL_602751	2020-09-04	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K003361/2020	EPI_ISL_602752	2020-09-04	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K003362/2020	EPI_ISL_602753	2020-09-04	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.40	GR
hCoV-19/South Africa/KRISP-K003363/2020	EPI_ISL_602754	2020-09-04	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K003370/2020	EPI_ISL_602760	2020-09-03	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K003372/2020	EPI_ISL_602762	2020-09-10	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K003378/2020	EPI_ISL_602767	2020-09-11	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K003384/2020	EPI_ISL_602772	2020-09-10	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1	G
hCoV-19/South Africa/KRISP-K003387/2020	EPI_ISL_602775	2020-09-10	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K003388/2020	EPI_ISL_602776	2020-09-10	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K003390/2020	EPI_ISL_602778	2020-09-10	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K003391/2020	EPI_ISL_602779	2020-09-09	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K003393/2020	EPI_ISL_602781	2020-09-09	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K003394/2020	EPI_ISL_602782	2020-09-11	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K003396/2020	EPI_ISL_602784	2020-09-11	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K003397/2020	EPI_ISL_602785	2020-09-11	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K003402/2020	EPI_ISL_602790	2020-09-12	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K003464/2020	EPI_ISL_602798	2020-09-13	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K003469/2020	EPI_ISL_602802	2020-09-11	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K003518/2020	EPI_ISL_602837	2020-09-25	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K003527/2020	EPI_ISL_602845	2020-09-24	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K003532/2020	EPI_ISL_602850	2020-09-23	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K003533/2020	EPI_ISL_602851	2020-09-23	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K003536/2020	EPI_ISL_602853	2020-09-26	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K003541/2020	EPI_ISL_602858	2020-09-25	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K003543/2020	EPI_ISL_602859	2020-09-25	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K003545/2020	EPI_ISL_602861	2020-09-25	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K003689/2020	EPI_ISL_602871	2020-10-06	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K003696/2020	EPI_ISL_602876	2020-10-05	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K003701/2020	EPI_ISL_602881	2020-10-04	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K003715/2020	EPI_ISL_602895	2020-10-06	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K003716/2020	EPI_ISL_602896	2020-10-07	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K003724/2020	EPI_ISL_602902	2020-10-06	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K003729/2020	EPI_ISL_602907	2020-10-06	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.56	GR
hCoV-19/South Africa/KRISP-K003730/2020	EPI_ISL_602908	2020-10-06	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K003733/2020	EPI_ISL_602911	2020-10-06	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K003734/2020	EPI_ISL_602912	2020-09-30	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K003745/2020	EPI_ISL_602919	2020-09-30	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.117	GR
hCoV-19/USA/CA-QDX-1813/2020	EPI_ISL_604101	2020-03-20	North America / USA / California	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1.61	GR
hCoV-19/USA/CA-QDX-1981/2020	EPI_ISL_604294	2020-03-17	North America / USA / California	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1	GR
hCoV-19/USA/CA-QDX-2047/2020	EPI_ISL_604320	2020-03-19	North America / USA / California	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.59	GR
hCoV-19/USA/CA-QDX-2099/2020	EPI_ISL_604409	2020-03-19	North America / USA / California	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1.61	GR
hCoV-19/USA/CA-QDX-2171/2020	EPI_ISL_604440	2020-03-19	North America / USA / California	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1.61	GR
hCoV-19/USA/MI-QDX-2261/2020	EPI_ISL_604545	2020-03-14	North America / USA / Michigan	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.59	GR
hCoV-19/USA/CA-QDX-2332/2020	EPI_ISL_604636	2020-03-16	North America / USA / California	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1	GR
hCoV-19/USA/CA-QDX-2489/2020	EPI_ISL_604756	2020-03-15	North America / USA / California	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.59	GR
hCoV-19/USA/CA-QDX-2515/2020	EPI_ISL_604762	2020-03-13	North America / USA / California	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1.61	GR
hCoV-19/Denmark/DCGC-1292/2020	EPI_ISL_618076	2020-06-08	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-1801/2020	EPI_ISL_618175	2020-07-06	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-1790/2020	EPI_ISL_618178	2020-07-13	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-1793/2020	EPI_ISL_618179	2020-07-13	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-1794/2020	EPI_ISL_618184	2020-07-13	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.39	GR
hCoV-19/Denmark/DCGC-1943/2020	EPI_ISL_618185	2020-07-06	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.39	GR
hCoV-19/Denmark/DCGC-1807/2020	EPI_ISL_618191	2020-07-13	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-1773/2020	EPI_ISL_618192	2020-07-13	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-1942/2020	EPI_ISL_618201	2020-07-13	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.236	G
hCoV-19/Denmark/DCGC-1803/2020	EPI_ISL_618206	2020-07-13	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-1796/2020	EPI_ISL_618214	2020-07-20	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-1800/2020	EPI_ISL_618222	2020-07-20	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-2031/2020	EPI_ISL_618225	2020-07-20	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.236	G
hCoV-19/Denmark/DCGC-2015/2020	EPI_ISL_618229	2020-07-20	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-2018/2020	EPI_ISL_618230	2020-07-06	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.39	GR
hCoV-19/Denmark/DCGC-2009/2020	EPI_ISL_618235	2020-07-27	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.236	G
hCoV-19/Denmark/DCGC-2013/2020	EPI_ISL_618236	2020-07-27	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.236	G
hCoV-19/Denmark/DCGC-2005/2020	EPI_ISL_618240	2020-07-13	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.39	GR
hCoV-19/Denmark/DCGC-2010/2020	EPI_ISL_618241	2020-07-13	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.39	GR
hCoV-19/Denmark/DCGC-2003/2020	EPI_ISL_618251	2020-07-20	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-1984/2020	EPI_ISL_618270	2020-07-20	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-1956/2020	EPI_ISL_618272	2020-06-29	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-1991/2020	EPI_ISL_618277	2020-07-20	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-1959/2020	EPI_ISL_618278	2020-07-06	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-1961/2020	EPI_ISL_618281	2020-07-06	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-1987/2020	EPI_ISL_618298	2020-07-20	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-2063/2020	EPI_ISL_618307	2020-07-13	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-1975/2020	EPI_ISL_618310	2020-07-13	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-2065/2020	EPI_ISL_618316	2020-07-20	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.236	G
hCoV-19/Denmark/DCGC-2067/2020	EPI_ISL_618321	2020-07-20	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-1983/2020	EPI_ISL_618329	2020-07-20	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-1990/2020	EPI_ISL_618331	2020-07-20	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-1998/2020	EPI_ISL_618333	2020-07-13	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.39	GR
hCoV-19/Denmark/DCGC-2088/2020	EPI_ISL_618347	2020-08-03	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-7526/2020	EPI_ISL_618424	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1	G
hCoV-19/Denmark/DCGC-7548/2020	EPI_ISL_618454	2020-10-12	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.159	GR
hCoV-19/Denmark/DCGC-7597/2020	EPI_ISL_618461	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				AD.2	GR
hCoV-19/Denmark/DCGC-7598/2020	EPI_ISL_618471	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1	G
hCoV-19/Denmark/DCGC-7646/2020	EPI_ISL_618530	2020-10-19	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.159	GR
hCoV-19/Denmark/DCGC-7776/2020	EPI_ISL_618671	2020-10-19	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.159	GR
hCoV-19/Denmark/DCGC-7788/2020	EPI_ISL_618673	2020-10-19	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.408	G
hCoV-19/Denmark/DCGC-7789/2020	EPI_ISL_618682	2020-10-19	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.408	G
hCoV-19/Denmark/DCGC-7736/2020	EPI_ISL_618691	2020-10-19	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.236	G
hCoV-19/Denmark/DCGC-7778/2020	EPI_ISL_618706	2020-10-19	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.159	GR
hCoV-19/Denmark/DCGC-7726/2020	EPI_ISL_618709	2020-10-19	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.398	G
hCoV-19/Denmark/DCGC-7852/2020	EPI_ISL_618783	2020-10-19	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.39	GR
hCoV-19/Denmark/DCGC-7104/2020	EPI_ISL_618974	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.204	GR
hCoV-19/Denmark/DCGC-7230/2020	EPI_ISL_618976	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.204	GR
hCoV-19/Denmark/DCGC-7242/2020	EPI_ISL_618977	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.204	GR
hCoV-19/England/MILK-AB83F5/2020	EPI_ISL_623303	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-AAFC32/2020	EPI_ISL_623333	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AB746C/2020	EPI_ISL_623381	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AB8717/2020	EPI_ISL_623401	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AB7D8F/2020	EPI_ISL_623406	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-AB7E5F/2020	EPI_ISL_623436	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/CAMC-AAFB62/2020	EPI_ISL_623444	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AB76EE/2020	EPI_ISL_623478	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AB7824/2020	EPI_ISL_623487	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/Scotland/QEUH-AADD31/2020	EPI_ISL_623907	2020-10-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AAD37B/2020	EPI_ISL_623908	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA2D4B/2020	EPI_ISL_623915	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA34FA/2020	EPI_ISL_623945	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA2DF0/2020	EPI_ISL_623969	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AAEF67/2020	EPI_ISL_623976	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA0E2C/2020	EPI_ISL_623985	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AAD399/2020	EPI_ISL_623991	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA33A2/2020	EPI_ISL_623997	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/USA/CA-ALSR-3435/2020	EPI_ISL_636027	2020-05-29	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-3436/2020	EPI_ISL_636028	2020-05-31	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-3442/2020	EPI_ISL_636032	2020-09-15	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-3460/2020	EPI_ISL_636039	2020-09-15	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-3495/2020	EPI_ISL_636051	2020-09-10	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-3496/2020	EPI_ISL_636052	2020-09-10	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-3505/2020	EPI_ISL_636057	2020-09-17	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-3522/2020	EPI_ISL_636067	2020-09-15	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-3555/2020	EPI_ISL_636081	2020-06-03	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-3579/2020	EPI_ISL_636092	2020-06-25	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-3582/2020	EPI_ISL_636095	2020-06-25	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-3583/2020	EPI_ISL_636096	2020-06-25	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-3614/2020	EPI_ISL_636112	2020-06-24	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/Mexico/BCN-ALSR-3622/2020	EPI_ISL_636115	2020-05-29	North America / Mexico / Baja California / Tijuana	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-3648/2020	EPI_ISL_636126	2020-09-29	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-3678/2020	EPI_ISL_636144	2020-09-28	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-3732/2020	EPI_ISL_636173	2020-05-27	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-3736/2020	EPI_ISL_636174	2020-06-04	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-3774/2020	EPI_ISL_636193	2020-05-29	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-3780/2020	EPI_ISL_636196	2020-05-27	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-3788/2020	EPI_ISL_636201	2020-05-27	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-3809/2020	EPI_ISL_636215	2020-05-27	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-3819/2020	EPI_ISL_636223	2020-06-12	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-3831/2020	EPI_ISL_636231	2020-06-15	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-3849/2020	EPI_ISL_636242	2020-06-29	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.240	G
hCoV-19/USA/CA-ALSR-3868/2020	EPI_ISL_636251	2020-06-30	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.240	G
hCoV-19/USA/CA-ALSR-3885/2020	EPI_ISL_636260	2020-06-29	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.240	G
hCoV-19/Jordan/AM-ALSR-3901/2020	EPI_ISL_636267	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3903/2020	EPI_ISL_636269	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3904/2020	EPI_ISL_636270	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3905/2020	EPI_ISL_636271	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3906/2020	EPI_ISL_636272	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3907/2020	EPI_ISL_636273	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3909/2020	EPI_ISL_636275	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3910/2020	EPI_ISL_636276	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3911/2020	EPI_ISL_636277	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3913/2020	EPI_ISL_636279	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3914/2020	EPI_ISL_636280	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 2 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3915/2020	EPI_ISL_636281	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3916/2020	EPI_ISL_636282	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3920/2020	EPI_ISL_636286	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3923/2020	EPI_ISL_636289	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3925/2020	EPI_ISL_636290	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3927/2020	EPI_ISL_636292	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3928/2020	EPI_ISL_636293	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3930/2020	EPI_ISL_636295	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3931/2020	EPI_ISL_636296	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3932/2020	EPI_ISL_636297	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3933/2020	EPI_ISL_636298	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3935/2020	EPI_ISL_636299	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3942/2020	EPI_ISL_636306	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3943/2020	EPI_ISL_636307	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3956/2020	EPI_ISL_636319	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3957/2020	EPI_ISL_636320	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3958/2020	EPI_ISL_636321	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3959/2020	EPI_ISL_636322	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3960/2020	EPI_ISL_636323	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3961/2020	EPI_ISL_636324	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3962/2020	EPI_ISL_636325	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3965/2020	EPI_ISL_636328	2020-09-30	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3966/2020	EPI_ISL_636329	2020-10-02	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3967/2020	EPI_ISL_636330	2020-10-02	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3968/2020	EPI_ISL_636331	2020-10-02	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3969/2020	EPI_ISL_636332	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3970/2020	EPI_ISL_636333	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3971/2020	EPI_ISL_636334	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3972/2020	EPI_ISL_636335	2020-10-02	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-3976/2020	EPI_ISL_636339	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	NS8_E59stop results in 52.1% truncation of the protein sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4017/2020	EPI_ISL_636380	2020-10-02	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4020/2020	EPI_ISL_636381	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4021/2020	EPI_ISL_636382	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4022/2020	EPI_ISL_636383	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4023/2020	EPI_ISL_636384	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4024/2020	EPI_ISL_636385	2020-10-02	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4025/2020	EPI_ISL_636386	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4027/2020	EPI_ISL_636388	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4028/2020	EPI_ISL_636389	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4031/2020	EPI_ISL_636391	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4032/2020	EPI_ISL_636392	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4034/2020	EPI_ISL_636394	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4035/2020	EPI_ISL_636395	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/Jordan/AM-ALSR-4036/2020	EPI_ISL_636396	2020-10-03	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/England/MILK-B02601/2020	EPI_ISL_643010	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B01D58/2020	EPI_ISL_643036	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B02829/2020	EPI_ISL_643038	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8B5D7/2020	EPI_ISL_643058	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C71C/2020	EPI_ISL_643072	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C785/2020	EPI_ISL_643074	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C433/2020	EPI_ISL_643086	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C6B5/2020	EPI_ISL_643093	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C48E/2020	EPI_ISL_643101	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C5E5/2020	EPI_ISL_643104	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8CA13/2020	EPI_ISL_643107	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C62E/2020	EPI_ISL_643115	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C697/2020	EPI_ISL_643139	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C293/2020	EPI_ISL_643144	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C4D9/2020	EPI_ISL_643150	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8B285/2020	EPI_ISL_643152	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C8BF/2020	EPI_ISL_643159	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/QEUH-A8C451/2020	EPI_ISL_643183	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8BC96/2020	EPI_ISL_643185	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-A8C372/2020	EPI_ISL_643189	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8BB20/2020	EPI_ISL_643192	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C406/2020	EPI_ISL_643195	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8B3BF/2020	EPI_ISL_643196	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C5F4/2020	EPI_ISL_643210	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C1B4/2020	EPI_ISL_643219	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/QEUH-A8C4E8/2020	EPI_ISL_643223	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C503/2020	EPI_ISL_643229	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C600/2020	EPI_ISL_643244	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C688/2020	EPI_ISL_643265	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C5C7/2020	EPI_ISL_643272	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C64C/2020	EPI_ISL_643281	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C318/2020	EPI_ISL_643283	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C309/2020	EPI_ISL_643293	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B0CC23/2020	EPI_ISL_643317	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-B0844D/2020	EPI_ISL_643321	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/CAMC-B07E5F/2020	EPI_ISL_643382	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B0C8D4/2020	EPI_ISL_643402	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B0CC32/2020	EPI_ISL_643406	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-B0B310/2020	EPI_ISL_643413	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/CAMC-B0B28C/2020	EPI_ISL_643414	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/CAMC-B0AE01/2020	EPI_ISL_643422	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B07DF8/2020	EPI_ISL_643430	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/CAMC-B0B5FC/2020	EPI_ISL_643447	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B0CAB0/2020	EPI_ISL_643455	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B080A3/2020	EPI_ISL_643462	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B07E8C/2020	EPI_ISL_643478	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B0B0FB/2020	EPI_ISL_643494	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/CAMC-B0A8F4/2020	EPI_ISL_643512	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B0B705/2020	EPI_ISL_643533	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B0C634/2020	EPI_ISL_643569	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-B0AB0A/2020	EPI_ISL_643574	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B084E3/2020	EPI_ISL_643579	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B0C83E/2020	EPI_ISL_643583	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B0AEE3/2020	EPI_ISL_643613	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B0B6F9/2020	EPI_ISL_643633	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B083E6/2020	EPI_ISL_643638	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B073BA/2020	EPI_ISL_643657	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B08902/2020	EPI_ISL_643687	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-B077DC/2020	EPI_ISL_643727	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B08911/2020	EPI_ISL_643796	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B086DE/2020	EPI_ISL_643800	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/CAMC-B0746C/2020	EPI_ISL_643852	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/CAMC-B08CEB/2020	EPI_ISL_643886	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B073AB/2020	EPI_ISL_643888	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B08920/2020	EPI_ISL_643906	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B07314/2020	EPI_ISL_643910	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/CAMC-B08753/2020	EPI_ISL_643949	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B423D1/2020	EPI_ISL_657311	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B423C2/2020	EPI_ISL_657317	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/MILK-B56361/2020	EPI_ISL_657360	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/MILK-B5645F/2020	EPI_ISL_657512	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B52A7F/2020	EPI_ISL_657516	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B567ED/2020	EPI_ISL_657531	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/England/CAMC-B5306D/2020	EPI_ISL_657546	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-B559AC/2020	EPI_ISL_657563	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/MILK-B55A7C/2020	EPI_ISL_657564	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/CAMC-B53030/2020	EPI_ISL_657566	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B55775/2020	EPI_ISL_657581	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B52F52/2020	EPI_ISL_657612	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.408	G
hCoV-19/England/CAMC-B53249/2020	EPI_ISL_657633	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/CAMC-B52FE9/2020	EPI_ISL_657649	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-B56352/2020	EPI_ISL_657663	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/CAMC-B5308B/2020	EPI_ISL_657679	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B54CFF/2020	EPI_ISL_657743	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/MILK-B54D47/2020	EPI_ISL_657758	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/CAMC-B51D4A/2020	EPI_ISL_657804	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-B51533/2020	EPI_ISL_657818	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/MILK-B54FAB/2020	EPI_ISL_657850	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/CAMC-B51F53/2020	EPI_ISL_657860	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B5124B/2020	EPI_ISL_657914	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-B51E47/2020	EPI_ISL_657924	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B5511D/2020	EPI_ISL_657938	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/MILK-B54AB9/2020	EPI_ISL_657954	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B51472/2020	EPI_ISL_657983	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-B551FF/2020	EPI_ISL_657996	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/USA/WI-GMF-30249/2020	EPI_ISL_661030	2020-10-30	North America / USA / Wisconsin / Monroe County	Human	Original			Ion Torrent				B.1.240	G
hCoV-19/USA/WI-GMF-31357/2020	EPI_ISL_661084	2020-11-04	North America / USA / Wisconsin / La Crosse County	Human	Original			Ion Torrent				B.1.396	G
hCoV-19/USA/IA-GMF-32700/2020	EPI_ISL_661164	2020-11-09	North America / USA / Iowa / Winneshiek County	Human	Original			Ion Torrent				B.1.396	G
hCoV-19/USA/IA-GMF-33129/2020	EPI_ISL_661170	2020-11-11	North America / USA / Iowa / Clayton County	Human	Original			Ion Torrent				B.1	G
hCoV-19/England/QEUH-B698B7/2020	EPI_ISL_661322	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B677BC/2020	EPI_ISL_661398	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF5ECE/2020	EPI_ISL_662920	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-AF4A43/2020	EPI_ISL_662927	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF49DD/2020	EPI_ISL_662930	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF52E0/2020	EPI_ISL_662932	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF3E75/2020	EPI_ISL_662945	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-AF6777/2020	EPI_ISL_662946	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF667A/2020	EPI_ISL_662960	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-AF672C/2020	EPI_ISL_662970	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF665C/2020	EPI_ISL_662971	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF52FF/2020	EPI_ISL_662976	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF6786/2020	EPI_ISL_662994	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF53FC/2020	EPI_ISL_663007	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF3E84/2020	EPI_ISL_663009	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-AF4120/2020	EPI_ISL_663015	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF5E28/2020	EPI_ISL_663018	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF567B/2020	EPI_ISL_663022	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF61B5/2020	EPI_ISL_663041	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF5DEF/2020	EPI_ISL_663045	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF5848/2020	EPI_ISL_663090	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF52A4/2020	EPI_ISL_663095	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-B858B5/2020	EPI_ISL_675587	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/ALDP-B858F1/2020	EPI_ISL_675591	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/ALDP-B85949/2020	EPI_ISL_675600	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/MILK-B8BF05/2020	EPI_ISL_675601	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/ALDP-B858E2/2020	EPI_ISL_675604	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/ALDP-B82FC2/2020	EPI_ISL_675635	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-B85A73/2020	EPI_ISL_675636	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B83B45/2020	EPI_ISL_675650	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8BFBA/2020	EPI_ISL_675667	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/ALDP-B8590D/2020	EPI_ISL_675671	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/MILK-B8C64B/2020	EPI_ISL_675762	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B88CA7/2020	EPI_ISL_675790	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B88C98/2020	EPI_ISL_675805	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8CB5B/2020	EPI_ISL_675866	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8CA7C/2020	EPI_ISL_675886	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/NY-Wadsworth-215212-01/2020	EPI_ISL_677099	2020-09-11	North America / USA / New York / Herkimer County	Human	Original			Illumina MiSeq	Artic nf pipeline			B.1.240	G
hCoV-19/USA/NY-Wadsworth-220230-01/2020	EPI_ISL_677102	2020-09-17	North America / USA / New York / Warren County	Human	Original			Illumina MiSeq	Artic nf pipeline			B.1.1.231	GR
hCoV-19/USA/NY-Wadsworth-226966-01/2020	EPI_ISL_677130	2020-09-24	North America / USA / New York / Washington County	Human	Original			Illumina MiSeq	Artic nf pipeline			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-2137/2020	EPI_ISL_677159	2020-10-27	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.239	G
hCoV-19/USA/VA-DCLS-2019/2020	EPI_ISL_677168	2020-10-14	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar	NS6_E55stop results in 11.5% truncation of the protein sequence.	info	B.1	G
hCoV-19/USA/VA-DCLS-2188/2020	EPI_ISL_677213	2020-11-12	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1	G
hCoV-19/USA/WI-UW-1944/2020	EPI_ISL_677352	2020-07-18	North America / USA / Wisconsin / Dane County	Human	Original	Nasal swab		Nanopore GridION - ARTIC protocol	custom - minimap2			B.1.240	G
hCoV-19/USA/IL-UW-1959/2020	EPI_ISL_677367	2020-09-24	North America / USA / Illinois / Winnebago County	Human	Original	Nasal swab		Nanopore GridION - ARTIC protocol	custom - minimap2			B.1.396	G
hCoV-19/USA/WI-UW-2023/2020	EPI_ISL_677430	2020-10-08	North America / USA / Wisconsin / Dane County	Human	Original	Nasal swab		Nanopore GridION - ARTIC protocol	custom - minimap2			B.1	G
hCoV-19/USA/IL-UW-2033/2020	EPI_ISL_677439	2020-09-19	North America / USA / Illinois / Winnebago County	Human	Original	Nasal swab		Nanopore GridION - ARTIC protocol	custom - minimap2			B.1	G
hCoV-19/USA/IL-UW-2046/2020	EPI_ISL_677451	2020-10-01	North America / USA / Illinois / Winnebago County	Human	Original	Nasal swab		Nanopore GridION - ARTIC protocol	custom - minimap2			B.1	G
hCoV-19/USA/IL-UW-2076/2020	EPI_ISL_677481	2020-10-17	North America / USA / Illinois / Winnebago County	Human	Original	Nasal swab		Nanopore GridION - ARTIC protocol	custom - minimap2			B.1	G
hCoV-19/USA/VAN4169/2020	EPI_ISL_677687	2020-05-11	North America / USA / New York / New York	Human	Original			Illumina MiSeq				B.1.1.231	GR
hCoV-19/Australia/VIC742/2020	EPI_ISL_427020	2020-03-29	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC v3 amplicons, NexteraXT library, minimap2 v2.17, ivar v1.2, samtools v1.10	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Australia/VIC828/2020	EPI_ISL_427096	2020-04-03	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC v3 amplicons, NexteraXT library, minimap2 v2.17, ivar v1.2, samtools v1.10			B.1.1	GR
hCoV-19/Taiwan/78/2020	EPI_ISL_428490	2020-03-16	Asia / Taiwan	Human	Vero							B.1.1.515	GR
hCoV-19/Wales/PHWC-27A9C/2020	EPI_ISL_432180	2020-03-30	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1	G
hCoV-19/Wales/PHWC-25375/2020	EPI_ISL_432220	2020-03-23	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-2B00F/2020	EPI_ISL_432263	2020-04-07	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1.249	GR
hCoV-19/Wales/PHWC-2B227/2020	EPI_ISL_432281	2020-04-08	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-274AD/2020	EPI_ISL_432282	2020-03-31	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1	G
hCoV-19/Wales/PHWC-2B05A/2020	EPI_ISL_432283	2020-04-08	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1	G
hCoV-19/Wales/PHWC-29C58/2020	EPI_ISL_432292	2020-04-05	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-29FF5/2020	EPI_ISL_432344	2020-04-03	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-28460/2020	EPI_ISL_432347	2020-03-29	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-28688/2020	EPI_ISL_432366	2020-03-31	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-27F7F/2020	EPI_ISL_432377	2020-03-24	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-2859A/2020	EPI_ISL_432397	2020-03-30	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/England/NOTT-10F01F/2020	EPI_ISL_432956	2020-03-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7E1BF/2020	EPI_ISL_434047	2020-04-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/Wales/PHWC-30BE8/2020	EPI_ISL_446335	2020-04-10	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-30CB8/2020	EPI_ISL_446347	2020-04-11	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-30E0D/2020	EPI_ISL_446363	2020-04-09	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-3159E/2020	EPI_ISL_446464	2020-04-12	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-32296/2020	EPI_ISL_446626	2020-04-08	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-32348/2020	EPI_ISL_446636	2020-04-08	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-33769/2020	EPI_ISL_446744	2020-04-17	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1.198	GR
hCoV-19/Wales/PHWC-3474A/2020	EPI_ISL_446968	2020-04-20	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-3480B/2020	EPI_ISL_446979	2020-04-16	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-348FC/2020	EPI_ISL_446992	2020-04-18	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/England/CAMB-1AD7E1/2020	EPI_ISL_448011	2020-05-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1ADBE5/2020	EPI_ISL_448046	2020-05-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1AEC78/2020	EPI_ISL_448066	2020-05-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1AEC96/2020	EPI_ISL_448068	2020-05-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1AED39/2020	EPI_ISL_448077	2020-05-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1AF64C/2020	EPI_ISL_448088	2020-05-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B0068/2020	EPI_ISL_448103	2020-05-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B05D2/2020	EPI_ISL_448114	2020-05-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/Scotland/CVR1840/2020	EPI_ISL_448134	2020-04-07	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.13	GR
hCoV-19/Scotland/CVR2973/2020	EPI_ISL_448213	2020-04-22	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/CVR2974/2020	EPI_ISL_448214	2020-04-22	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/CVR2976/2020	EPI_ISL_448216	2020-04-22	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/CVR2980/2020	EPI_ISL_448220	2020-04-22	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E86C0/2020	EPI_ISL_448223	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.164	GR
hCoV-19/England/NORW-E87BE/2020	EPI_ISL_448233	2020-04-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E88F7/2020	EPI_ISL_448249	2020-04-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E8921/2020	EPI_ISL_448250	2020-04-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E8A4C/2020	EPI_ISL_448267	2020-04-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E9401/2020	EPI_ISL_448311	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E954A/2020	EPI_ISL_448320	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E95A4/2020	EPI_ISL_448321	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E98BA/2020	EPI_ISL_448341	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E9CEB/2020	EPI_ISL_448360	2020-04-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NOTT-110DE7/2020	EPI_ISL_448420	2020-04-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NOTT-110F3C/2020	EPI_ISL_448438	2020-04-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/OXON-AC446/2020	EPI_ISL_448451	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AC5CB/2020	EPI_ISL_448465	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AC74D/2020	EPI_ISL_448481	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AC81D/2020	EPI_ISL_448486	2020-04-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AC91A/2020	EPI_ISL_448494	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AC929/2020	EPI_ISL_448495	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AC965/2020	EPI_ISL_448497	2020-04-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AC9ED/2020	EPI_ISL_448501	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-ACBAB/2020	EPI_ISL_448515	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-ACCD5/2020	EPI_ISL_448527	2020-04-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-ACD69/2020	EPI_ISL_448534	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-ACD87/2020	EPI_ISL_448535	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AD050/2020	EPI_ISL_448556	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AD0C9/2020	EPI_ISL_448561	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1	G
hCoV-19/England/OXON-AD13F/2020	EPI_ISL_448566	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AD23C/2020	EPI_ISL_448571	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AD454/2020	EPI_ISL_448580	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AD67C/2020	EPI_ISL_448587	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AD6F4/2020	EPI_ISL_448590	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AD75B/2020	EPI_ISL_448593	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-ADA34/2020	EPI_ISL_448610	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-ADADA/2020	EPI_ISL_448613	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-ADAF8/2020	EPI_ISL_448614	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-ADBB9/2020	EPI_ISL_448620	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-ADC5C/2020	EPI_ISL_448625	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-ADC7A/2020	EPI_ISL_448626	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-ADCF2/2020	EPI_ISL_448630	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-ADD3B/2020	EPI_ISL_448632	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-ADD77/2020	EPI_ISL_448634	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-ADDB3/2020	EPI_ISL_448636	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-ADF17/2020	EPI_ISL_448646	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-ADFBD/2020	EPI_ISL_448652	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AE05F/2020	EPI_ISL_448658	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AE07D/2020	EPI_ISL_448659	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AE0F5/2020	EPI_ISL_448663	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AE17A/2020	EPI_ISL_448667	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AE1B6/2020	EPI_ISL_448670	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AE1D4/2020	EPI_ISL_448671	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AE22C/2020	EPI_ISL_448674	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AE259/2020	EPI_ISL_448676	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AE31A/2020	EPI_ISL_448682	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AE338/2020	EPI_ISL_448684	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AE374/2020	EPI_ISL_448685	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AE392/2020	EPI_ISL_448686	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AE3DE/2020	EPI_ISL_448688	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AE3FC/2020	EPI_ISL_448689	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AE453/2020	EPI_ISL_448691	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AE49F/2020	EPI_ISL_448694	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AE4DB/2020	EPI_ISL_448697	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AE57E/2020	EPI_ISL_448702	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AE699/2020	EPI_ISL_448710	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AE6E4/2020	EPI_ISL_448712	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AE778/2020	EPI_ISL_448717	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AE7F0/2020	EPI_ISL_448722	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AE857/2020	EPI_ISL_448727	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AE909/2020	EPI_ISL_448733	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AE936/2020	EPI_ISL_448735	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AE954/2020	EPI_ISL_448736	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AE9FA/2020	EPI_ISL_448745	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AEA06/2020	EPI_ISL_448746	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AEA15/2020	EPI_ISL_448747	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AEAD9/2020	EPI_ISL_448754	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AEB03/2020	EPI_ISL_448756	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AEB21/2020	EPI_ISL_448758	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AEB9A/2020	EPI_ISL_448763	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AEBB8/2020	EPI_ISL_448765	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AEBC7/2020	EPI_ISL_448766	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AEC3D/2020	EPI_ISL_448772	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AEC5B/2020	EPI_ISL_448773	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AECB5/2020	EPI_ISL_448777	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/OXON-AEF8F/2020	EPI_ISL_448799	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AF06D/2020	EPI_ISL_448806	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AF08B/2020	EPI_ISL_448807	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-9F1C7/2020	EPI_ISL_453435	2020-05-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LIVE-9F26A/2020	EPI_ISL_453441	2020-05-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LIVE-9F2D3/2020	EPI_ISL_453442	2020-05-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LIVE-9F3C1/2020	EPI_ISL_453453	2020-05-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D5769/2020	EPI_ISL_453461	2020-04-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-101E31/2020	EPI_ISL_453467	2020-03-24	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-101EAA/2020	EPI_ISL_453473	2020-03-24	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NOTT-11134E/2020	EPI_ISL_453649	2020-05-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NOTT-11135D/2020	EPI_ISL_453650	2020-05-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NOTT-1113D5/2020	EPI_ISL_453658	2020-05-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C0A95/2020	EPI_ISL_453696	2020-04-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.137	GR
hCoV-19/England/SHEF-C225F/2020	EPI_ISL_453699	2020-04-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.83	GR
hCoV-19/England/SHEF-C33C4/2020	EPI_ISL_453705	2020-04-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.137	GR
hCoV-19/England/SHEF-CB423/2020	EPI_ISL_453742	2020-04-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/SHEF-CC4AA/2020	EPI_ISL_453746	2020-04-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-CDE8D/2020	EPI_ISL_453756	2020-04-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-D1D3E/2020	EPI_ISL_453768	2020-04-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.277	GR
hCoV-19/England/SHEF-D2DA6/2020	EPI_ISL_453775	2020-04-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/20154002504/2020	EPI_ISL_466246	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.164	GR
hCoV-19/England/20154083504/2020	EPI_ISL_466271	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20156051204/2020	EPI_ISL_466340	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.71	GR
hCoV-19/England/201580036/2020	EPI_ISL_466350	2020-04-10	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20166008604/2020	EPI_ISL_466520	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.164	GR
hCoV-19/England/20166010604/2020	EPI_ISL_466525	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.164	GR
hCoV-19/England/20166012904/2020	EPI_ISL_466532	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20166013104/2020	EPI_ISL_466533	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.164	GR
hCoV-19/England/20166016004/2020	EPI_ISL_466539	2020-04-12	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.254	GR
hCoV-19/England/20166054804/2020	EPI_ISL_466548	2020-04-13	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20166068404/2020	EPI_ISL_466572	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.164	GR
hCoV-19/England/20166069104/2020	EPI_ISL_466573	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20168038004/2020	EPI_ISL_466616	2020-04-13	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20168038104/2020	EPI_ISL_466617	2020-04-13	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20168038204/2020	EPI_ISL_466618	2020-04-13	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20168038604/2020	EPI_ISL_466620	2020-04-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20169000604/2020	EPI_ISL_466624	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Bangladesh/BCSIR-NILMRC-052/2020	EPI_ISL_466627	2020-06-01	Asia / Bangladesh / Dhaka / Narayanganj	Human	Original			Illumina Nextseq 550	NextSeq (TM) Control Software v4			B.1.1	GR
hCoV-19/Bangladesh/BCSIR-NILMRC-057/2020	EPI_ISL_466630	2020-05-10	Asia / Bangladesh / Dhaka / Narayanganj	Human	Original	Nasopharyngeal swab		Illumina Nextseq 550	NextSeq (TM) Control Software v4			B.1.1	GR
hCoV-19/Bangladesh/BCSIR-NILMRC-082/2020	EPI_ISL_466649	2020-06-01	Asia / Bangladesh / Dhaka / Dhaka / Agargaon	Human	Original	Nasopharyngeal swab		Illumina Nextseq 550	NextSeq (TM) Control Software v4			B.1.1.25	GR
hCoV-19/Bangladesh/BCSIR-NILMRC-085/2020	EPI_ISL_466650	2020-06-01	Asia / Bangladesh / Dhaka	Human	Original	Nasopharyngeal swab		Illumina Nextseq 550	NextSeq (TM) Control Software v4			B.1.1.25	GR
hCoV-19/USA/WI-WSLH-200042/2020	EPI_ISL_471207	2020-03-17	North America / USA / Wisconsin	Human	Original			Nanopore MinION	ARTIC Pipeline			B.1.1	GR
hCoV-19/Romania/Bucuresti-294285/2020	EPI_ISL_471422	2020-06-07	Europe / Romania / Bucuresti	Human	Original			Illumina MiSeq	DNASTAR Lasergene, Sequencher 5.4.6			B.1.408	G
hCoV-19/England/EXET-136D18/2020	EPI_ISL_471916	2020-04-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/EXET-136EAC/2020	EPI_ISL_471930	2020-04-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/EXET-136ED9/2020	EPI_ISL_471933	2020-04-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.164	GR
hCoV-19/England/EXET-136F4F/2020	EPI_ISL_471936	2020-04-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/EXET-1370F0/2020	EPI_ISL_471949	2020-04-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.164	GR
hCoV-19/England/EXET-137218/2020	EPI_ISL_471955	2020-04-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.164	GR
hCoV-19/England/EXET-137403/2020	EPI_ISL_471975	2020-03-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.164	GR
hCoV-19/England/EXET-137412/2020	EPI_ISL_471976	2020-03-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/EXET-1376D0/2020	EPI_ISL_471982	2020-05-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.164	GR
hCoV-19/England/EXET-137852/2020	EPI_ISL_471989	2020-05-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/EXET-1378BC/2020	EPI_ISL_471991	2020-05-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/EXET-1378DA/2020	EPI_ISL_471992	2020-05-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Wales/PHWC-160C81/2020	EPI_ISL_473034	2020-04-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/BIRM-5F08A/2020	EPI_ISL_473306	2020-05-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/BIRM-5F0E4/2020	EPI_ISL_473311	2020-05-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/BIRM-5F0F3/2020	EPI_ISL_473312	2020-05-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/BIRM-5F11E/2020	EPI_ISL_473314	2020-05-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/BIRM-5FB5C/2020	EPI_ISL_473379	2020-05-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/BIRM-5FB89/2020	EPI_ISL_473382	2020-05-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/England/BIRM-5FBA7/2020	EPI_ISL_473384	2020-05-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/England/BIRM-5FC59/2020	EPI_ISL_473392	2020-05-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/England/BIRM-603E7/2020	EPI_ISL_473406	2020-05-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/BIRM-60411/2020	EPI_ISL_473408	2020-05-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/BIRM-61164/2020	EPI_ISL_473434	2020-06-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/BIRM-6128F/2020	EPI_ISL_473448	2020-06-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/England/CAMB-1B4125/2020	EPI_ISL_473459	2020-06-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B426E/2020	EPI_ISL_473464	2020-05-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B42C8/2020	EPI_ISL_473466	2020-06-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B43E3/2020	EPI_ISL_473471	2020-06-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B442C/2020	EPI_ISL_473472	2020-06-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B45A1/2020	EPI_ISL_473477	2020-06-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B4671/2020	EPI_ISL_473479	2020-05-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B4A57/2020	EPI_ISL_473491	2020-06-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B4D03/2020	EPI_ISL_473507	2020-06-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.115	GR
hCoV-19/Scotland/CVR2588/2020	EPI_ISL_473522	2020-04-16	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/CVR2769/2020	EPI_ISL_473557	2020-04-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.43	GR
hCoV-19/Scotland/CVR2772/2020	EPI_ISL_473558	2020-04-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.43	GR
hCoV-19/Scotland/CVR2790/2020	EPI_ISL_473568	2020-04-20	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/CVR2808/2020	EPI_ISL_473575	2020-04-21	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/CVR2816/2020	EPI_ISL_473580	2020-04-21	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/CVR2862/2020	EPI_ISL_473603	2020-04-21	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.43	GR
hCoV-19/Scotland/CVR2907/2020	EPI_ISL_473624	2020-04-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Scotland/CVR2918/2020	EPI_ISL_473631	2020-04-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Scotland/CVR3559/2020	EPI_ISL_473694	2020-05-16	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1	G
hCoV-19/Scotland/CVR3632/2020	EPI_ISL_473746	2020-05-25	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.43	GR
hCoV-19/USA/VA-DCLS-0548/2020	EPI_ISL_485849	2020-03-12	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.71	GR
hCoV-19/USA/VA-DCLS-0568/2020	EPI_ISL_485866	2020-03-18	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.59	GR
hCoV-19/Nigeria/OY094-CV57/2020	EPI_ISL_487099	2020-04-24	Africa / Nigeria / Oyo State	Human	Original	Nasal swab		Illumina MiSeq	viral-ngs v2.0			B.1.1	GR
hCoV-19/Nigeria/EK220-CV54/2020	EPI_ISL_487102	2020-05-14	Africa / Nigeria / Ekiti State	Human	Original			Illumina MiSeq	viral-ngs v2.0			B.1.1	GR
hCoV-19/England/LOND-D63CE/2020	EPI_ISL_487606	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/LOND-D658C/2020	EPI_ISL_487627	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12B87F/2020	EPI_ISL_487629	2020-05-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/EDB4068/2020	EPI_ISL_487694	2020-04-16	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/Scotland/EDB3330/2020	EPI_ISL_487770	2020-04-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/Scotland/EDB3494/2020	EPI_ISL_487870	2020-04-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/Portugal/IGC4033/2020	EPI_ISL_491225	2020-06-01	Europe / Portugal	Human	Original	Oropharyngeal swab		Illumina Nextseq 500	CDCgov/SARS-CoV-2_Sequencing			B.1.1.401	GR
hCoV-19/Portugal/IGC4089/2020	EPI_ISL_491226	2020-06-01	Europe / Portugal	Human	Original	Oropharyngeal swab		Illumina Nextseq 500	CDCgov/SARS-CoV-2_Sequencing			B.1.1.269	GR
hCoV-19/Portugal/IGC4124/2020	EPI_ISL_491235	2020-06-02	Europe / Portugal	Human	Original	Oropharyngeal swab		Illumina Nextseq 500	CDCgov/SARS-CoV-2_Sequencing	NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/Portugal/IGC4238/2020	EPI_ISL_491239	2020-06-03	Europe / Portugal	Human	Original	Oropharyngeal swab		Illumina Nextseq 500	CDCgov/SARS-CoV-2_Sequencing	NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/Portugal/IGC4391/2020	EPI_ISL_491244	2020-06-07	Europe / Portugal	Human	Original	Oropharyngeal swab		Illumina Nextseq 500	CDCgov/SARS-CoV-2_Sequencing	NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/Portugal/IGC4426/2020	EPI_ISL_491251	2020-06-08	Europe / Portugal	Human	Original	Oropharyngeal swab		Illumina Nextseq 500	CDCgov/SARS-CoV-2_Sequencing			B.1.1.401	GR
hCoV-19/Portugal/IGC4435/2020	EPI_ISL_491252	2020-06-08	Europe / Portugal	Human	Original	Oropharyngeal swab		Illumina Nextseq 500	CDCgov/SARS-CoV-2_Sequencing	NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.1.401	GR
hCoV-19/Portugal/IGC4466/2020	EPI_ISL_491253	2020-06-08	Europe / Portugal	Human	Original	Oropharyngeal swab		Illumina Nextseq 500	CDCgov/SARS-CoV-2_Sequencing			B.1.1.401	GR
hCoV-19/Portugal/IGC4467/2020	EPI_ISL_491254	2020-06-08	Europe / Portugal	Human	Original	Oropharyngeal swab		Illumina Nextseq 500	CDCgov/SARS-CoV-2_Sequencing	NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/Portugal/IGC4560/2020	EPI_ISL_491263	2020-06-12	Europe / Portugal	Human	Original	Oropharyngeal swab		Illumina Nextseq 500	CDCgov/SARS-CoV-2_Sequencing			B.1.1.401	GR
hCoV-19/Portugal/R1172/2020	EPI_ISL_491269	2020-06-09	Europe / Portugal	Human	Original	Oropharyngeal swab		Illumina Nextseq 500	CDCgov/SARS-CoV-2_Sequencing			B.1.1.401	GR
hCoV-19/Portugal/R1203/2020	EPI_ISL_491270	2020-06-12	Europe / Portugal	Human	Original	Oropharyngeal swab		Illumina Nextseq 500	CDCgov/SARS-CoV-2_Sequencing	NS7a_Q62stop results in 49.6% truncation of the protein sequence.	info	B.1.1.401	GR
hCoV-19/Portugal/R1237/2020	EPI_ISL_491271	2020-06-12	Europe / Portugal	Human	Original	Oropharyngeal swab		Illumina Nextseq 500	CDCgov/SARS-CoV-2_Sequencing			B.1.1.401	GR
hCoV-19/Portugal/R1294/2020	EPI_ISL_491274	2020-06-14	Europe / Portugal	Human	Original	Oropharyngeal swab		Illumina Nextseq 500	CDCgov/SARS-CoV-2_Sequencing	NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/Scotland/EDB2281/2020	EPI_ISL_491513	2020-04-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.14	GR
hCoV-19/Scotland/EDB969/2020	EPI_ISL_491546	2020-04-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/EDB2547/2020	EPI_ISL_491550	2020-04-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.14	GR
hCoV-19/Scotland/EDB2008/2020	EPI_ISL_491565	2020-04-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.14	GR
hCoV-19/Scotland/EDB2350/2020	EPI_ISL_491567	2020-04-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.14	GR
hCoV-19/Scotland/EDB2353/2020	EPI_ISL_491570	2020-04-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/Scotland/EDB2007/2020	EPI_ISL_491581	2020-04-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.14	GR
hCoV-19/Scotland/EDB1481/2020	EPI_ISL_491590	2020-04-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/Scotland/EDB6445/2020	EPI_ISL_491609	2020-04-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/EDB2009/2020	EPI_ISL_491654	2020-04-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.14	GR
hCoV-19/Saudi Arabia/KAIMRC02/2020	EPI_ISL_507011	2020-03-10	Asia / Saudi Arabia	Human	unknown	Nasopharyngeal swab		Illumina	SPADES v. 3.13.0			B.1	G
hCoV-19/England/LOND-124CF8E/2020	EPI_ISL_507047	2020-05-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.164	GR
hCoV-19/England/LOND-124D275/2020	EPI_ISL_507074	2020-03-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/EDB1334/2020	EPI_ISL_507180	2020-04-10	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/Scotland/EDB3854/2020	EPI_ISL_507181	2020-04-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/Russia/Novosibirsk-RII27313S/2020	EPI_ISL_507207	2020-04-29	Europe / Russia / Novosibirsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Russia/StPetersburg-RII10261S/2020	EPI_ISL_507229	2020-04-25	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Russia/StPetersburg-RII11142S/2020	EPI_ISL_507232	2020-05-02	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Russia/StPetersburg-RII11155S/2020	EPI_ISL_507238	2020-04-30	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Russia/StPetersburg-RII11184S/2020	EPI_ISL_507243	2020-05-02	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Russia/StPetersburg-RII11306S/2020	EPI_ISL_507254	2020-05-01	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Russia/StPetersburg-RII11311S/2020	EPI_ISL_507255	2020-05-03	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Russia/StPetersburg-RII15221S/2020	EPI_ISL_507261	2020-05-12	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Russia/StPetersburg-RII15933S/2020	EPI_ISL_507275	2020-05-16	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Russia/StPetersburg-RII17940S/2020	EPI_ISL_507280	2020-05-27	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1.163	GR
hCoV-19/Russia/StPetersburg-RII17941S/2020	EPI_ISL_507281	2020-05-27	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1.163	GR
hCoV-19/Russia/StPetersburg-RII17948S/2020	EPI_ISL_507282	2020-05-27	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1.163	GR
hCoV-19/Russia/StPetersburg-RII17949S/2020	EPI_ISL_507283	2020-05-27	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1.163	GR
hCoV-19/Russia/StPetersburg-RII18089S/2020	EPI_ISL_507285	2020-05-27	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Russia/StPetersburg-RII18090S/2020	EPI_ISL_507286	2020-05-27	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Russia/StPetersburg-RII21802S/2020	EPI_ISL_507290	2020-06-06	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Poland/1156085/2020	EPI_ISL_512301	2020-06-08	Europe / Poland / Pomorskie	Human	Original			Illumina MiSeq	BWA-MEM			B.1.1	GR
hCoV-19/England/PORT-2D166E/2020	EPI_ISL_512407	2020-06-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.194	GR
hCoV-19/Scotland/CVR1711/2020	EPI_ISL_512449	2020-04-06	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.164	GR
hCoV-19/Scotland/CVR3910/2020	EPI_ISL_512460	2020-06-15	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.174	GR
hCoV-19/Scotland/CVR3915/2020	EPI_ISL_512463	2020-06-17	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.14	GR
hCoV-19/Scotland/CVR3957/2020	EPI_ISL_512477	2020-07-25	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.406	GR
hCoV-19/Scotland/CVR3959/2020	EPI_ISL_512478	2020-07-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.406	GR
hCoV-19/Scotland/CVR3960/2020	EPI_ISL_512479	2020-07-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.406	GR
hCoV-19/Scotland/CVR3961/2020	EPI_ISL_512480	2020-07-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.406	GR
hCoV-19/Wales/PHWC-16968A/2020	EPI_ISL_512494	2020-07-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.171	GR
hCoV-19/Wales/PHWC-1696F3/2020	EPI_ISL_512501	2020-07-15	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.171	GR
hCoV-19/Wales/PHWC-16970F/2020	EPI_ISL_512502	2020-04-12	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Ireland/D-NVRL-71IRL94359/2020	EPI_ISL_525359	2020-07-29	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.133	GR
hCoV-19/Ireland/D-NVRL-71IRL95471/2020	EPI_ISL_525366	2020-07-31	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.406	GR
hCoV-19/USA/VA-DCLS-1032/2020	EPI_ISL_526917	2020-06-03	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/Spain/MD-HLP-R67/2020	EPI_ISL_530112	2020-03-17	Europe / Spain / Madrid	Human	Original	Oropharyngeal swab		Ion Torrent S5	IRMA			B.1	G
hCoV-19/Spain/MD-HLP-R68/2020	EPI_ISL_530113	2020-03-17	Europe / Spain / Madrid	Human	Original	Oropharyngeal swab		Ion Torrent S5	IRMA			B.1.157	G
hCoV-19/USA/WA-S2797/2020	EPI_ISL_530154	2020-08-19	North America / USA / Washington / King County	Human	Original			Illumina NextSeq	Seattle Flu Assembly Pipeline			B.1.240	G
hCoV-19/Czech Republic/NRL_4038/2020	EPI_ISL_530347	2020-03-18	Europe / Czech Republic / Zlin / Frystak	Human	Original	Nasopharyngeal swab	Putative import from Italy, region Sondrio, city Madesimo, stay 29.2. - 6.3.2020	MinION	Medaka			B.1.1.44	GR
hCoV-19/England/QEUH-99046A/2020	EPI_ISL_530374	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-99027F/2020	EPI_ISL_530375	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96E08F/2020	EPI_ISL_530403	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/England/QEUH-96F0AC/2020	EPI_ISL_530430	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.133	GR
hCoV-19/England/QEUH-96F40A/2020	EPI_ISL_530459	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/QEUH-96E7F3/2020	EPI_ISL_530467	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/Scotland/QEUH-96EC12/2020	EPI_ISL_530480	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-96F570/2020	EPI_ISL_530490	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-96F24C/2020	EPI_ISL_530494	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/QEUH-96E9A2/2020	EPI_ISL_530503	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-96E623/2020	EPI_ISL_530507	2020-08-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-96DF74/2020	EPI_ISL_530511	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-96E9B1/2020	EPI_ISL_530523	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/Scotland/QEUH-96E580/2020	EPI_ISL_530533	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-96F279/2020	EPI_ISL_530555	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/QEUH-96DF83/2020	EPI_ISL_530556	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/QEUH-96F006/2020	EPI_ISL_530557	2020-08-18	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1.133	GR
hCoV-19/England/QEUH-96F437/2020	EPI_ISL_530572	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/QEUH-96DF47/2020	EPI_ISL_530590	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-96F1F4/2020	EPI_ISL_530616	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/QEUH-96DF38/2020	EPI_ISL_530628	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.39	GR
hCoV-19/England/QEUH-96D026/2020	EPI_ISL_530661	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/QEUH-96D554/2020	EPI_ISL_530671	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/Scotland/QEUH-96D4C0/2020	EPI_ISL_530673	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96D27B/2020	EPI_ISL_530687	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/QEUH-96DC8C/2020	EPI_ISL_530705	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/Northern Ireland/QEUH-96CB44/2020	EPI_ISL_530742	2020-08-21	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-96D2F3/2020	EPI_ISL_530755	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/QEUH-96E0AD/2020	EPI_ISL_530793	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-96DAFB/2020	EPI_ISL_530796	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.39	GR
hCoV-19/England/QEUH-96C83E/2020	EPI_ISL_530798	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/QEUH-96A8B8/2020	EPI_ISL_530807	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-96C4FE/2020	EPI_ISL_530815	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-969F3C/2020	EPI_ISL_530817	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-96A01A/2020	EPI_ISL_530818	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/QEUH-96C485/2020	EPI_ISL_530829	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/Northern Ireland/QEUH-969EA8/2020	EPI_ISL_530830	2020-08-14	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-96C19D/2020	EPI_ISL_530831	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-96A108/2020	EPI_ISL_530832	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/QEUH-969E99/2020	EPI_ISL_530834	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/Scotland/QEUH-96C212/2020	EPI_ISL_530836	2020-08-15	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96C458/2020	EPI_ISL_530845	2020-08-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-96C1CA/2020	EPI_ISL_530849	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-96C2E5/2020	EPI_ISL_530858	2020-08-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-969C71/2020	EPI_ISL_530859	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/Scotland/QEUH-96C722/2020	EPI_ISL_530862	2020-08-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-96C4A3/2020	EPI_ISL_530864	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/Scotland/QEUH-96C203/2020	EPI_ISL_530871	2020-08-15	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96A0ED/2020	EPI_ISL_530876	2020-08-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96C40D/2020	EPI_ISL_530878	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/Northern Ireland/QEUH-96C045/2020	EPI_ISL_530883	2020-08-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-96C555/2020	EPI_ISL_530886	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-96C018/2020	EPI_ISL_530900	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-96C124/2020	EPI_ISL_530901	2020-08-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96A074/2020	EPI_ISL_530915	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/Scotland/QEUH-969FE1/2020	EPI_ISL_530923	2020-08-15	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-96C670/2020	EPI_ISL_530938	2020-08-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-9698D7/2020	EPI_ISL_530952	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/Scotland/QEUH-969637/2020	EPI_ISL_530953	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-969A0E/2020	EPI_ISL_530954	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/QEUH-965501/2020	EPI_ISL_530957	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-964D28/2020	EPI_ISL_530962	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9656C2/2020	EPI_ISL_530967	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-9657CF/2020	EPI_ISL_530968	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-965774/2020	EPI_ISL_530973	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-965792/2020	EPI_ISL_530979	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-964D91/2020	EPI_ISL_530981	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-969646/2020	EPI_ISL_530983	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96570B/2020	EPI_ISL_530989	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Scotland/QEUH-9659BA/2020	EPI_ISL_530997	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-964A9A/2020	EPI_ISL_530999	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/Scotland/QEUH-960797/2020	EPI_ISL_532005	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9612B3/2020	EPI_ISL_532009	2020-08-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-96109B/2020	EPI_ISL_532018	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-960E74/2020	EPI_ISL_532023	2020-08-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-960955/2020	EPI_ISL_532029	2020-08-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/QEUH-9605F7/2020	EPI_ISL_532034	2020-08-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-96015D/2020	EPI_ISL_532041	2020-08-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-96106E/2020	EPI_ISL_532042	2020-08-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-96064F/2020	EPI_ISL_532046	2020-08-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/Scotland/QEUH-960542/2020	EPI_ISL_532049	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-960515/2020	EPI_ISL_532053	2020-08-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-961347/2020	EPI_ISL_532057	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9606F4/2020	EPI_ISL_532062	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-960BB9/2020	EPI_ISL_532067	2020-08-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-96122C/2020	EPI_ISL_532076	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-960CF2/2020	EPI_ISL_532078	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-961198/2020	EPI_ISL_532080	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/Scotland/QEUH-9611B6/2020	EPI_ISL_532081	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96068B/2020	EPI_ISL_532083	2020-08-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-960700/2020	EPI_ISL_532084	2020-08-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/Scotland/QEUH-960C01/2020	EPI_ISL_532093	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9611C5/2020	EPI_ISL_532094	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9611D4/2020	EPI_ISL_532102	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-960867/2020	EPI_ISL_532104	2020-08-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/QEUH-960EED/2020	EPI_ISL_532107	2020-08-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/QEUH-960B31/2020	EPI_ISL_532112	2020-08-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-961338/2020	EPI_ISL_532113	2020-08-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-96083A/2020	EPI_ISL_532117	2020-08-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/Scotland/QEUH-96073D/2020	EPI_ISL_532123	2020-08-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96116B/2020	EPI_ISL_532125	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9604AF/2020	EPI_ISL_532130	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96120E/2020	EPI_ISL_532138	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-554C9B/2020	EPI_ISL_532143	2020-05-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-557041/2020	EPI_ISL_532148	2020-05-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-554CB9/2020	EPI_ISL_532164	2020-05-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-541EB9/2020	EPI_ISL_532165	2020-05-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-54E46F/2020	EPI_ISL_532170	2020-05-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-554D98/2020	EPI_ISL_532188	2020-05-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-555D97/2020	EPI_ISL_532205	2020-05-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-5428D8/2020	EPI_ISL_532222	2020-05-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-544108/2020	EPI_ISL_532223	2020-05-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-5574FA/2020	EPI_ISL_532245	2020-05-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-5319CA/2020	EPI_ISL_532262	2020-05-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-95F740/2020	EPI_ISL_532283	2020-08-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95F0DC/2020	EPI_ISL_532288	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-95ED8B/2020	EPI_ISL_532289	2020-08-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-95FB17/2020	EPI_ISL_532295	2020-08-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-95F555/2020	EPI_ISL_532309	2020-08-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/Scotland/QEUH-95E8F3/2020	EPI_ISL_532311	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-95F93B/2020	EPI_ISL_532314	2020-08-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/Scotland/QEUH-95F9B3/2020	EPI_ISL_532316	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E86C/2020	EPI_ISL_532317	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95EA48/2020	EPI_ISL_532321	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-95E94B/2020	EPI_ISL_532330	2020-08-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/Scotland/QEUH-95F27C/2020	EPI_ISL_532334	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95F9A4/2020	EPI_ISL_532335	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E705/2020	EPI_ISL_532338	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-95FC23/2020	EPI_ISL_532339	2020-08-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/Scotland/QEUH-95F9E0/2020	EPI_ISL_532340	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-95F5FB/2020	EPI_ISL_532343	2020-08-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-95EF3A/2020	EPI_ISL_532347	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E90F/2020	EPI_ISL_532349	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95FA92/2020	EPI_ISL_532351	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-95FA83/2020	EPI_ISL_532352	2020-08-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/Scotland/QEUH-95F9FF/2020	EPI_ISL_532353	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-95E8D5/2020	EPI_ISL_532354	2020-08-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/Scotland/QEUH-95FB71/2020	EPI_ISL_532355	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95EE97/2020	EPI_ISL_532356	2020-08-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E617/2020	EPI_ISL_532363	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-95FB08/2020	EPI_ISL_532366	2020-08-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/QEUH-95E7E7/2020	EPI_ISL_532380	2020-08-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/Scotland/QEUH-95F9D1/2020	EPI_ISL_532384	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95EA1B/2020	EPI_ISL_532388	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95FA47/2020	EPI_ISL_532390	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E996/2020	EPI_ISL_532394	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/QEUH-95F25E/2020	EPI_ISL_532398	2020-08-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/Scotland/QEUH-95F90E/2020	EPI_ISL_532399	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95EA57/2020	EPI_ISL_532402	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95F9C2/2020	EPI_ISL_532404	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-95E565/2020	EPI_ISL_532408	2020-08-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/Scotland/QEUH-95ECF7/2020	EPI_ISL_532414	2020-08-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Northern Ireland/QEUH-95EF85/2020	EPI_ISL_532420	2020-08-06	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-95F8E3/2020	EPI_ISL_532426	2020-08-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/Scotland/QEUH-95EDA9/2020	EPI_ISL_532430	2020-08-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-95F230/2020	EPI_ISL_532436	2020-08-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/Scotland/QEUH-95E8A8/2020	EPI_ISL_532440	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-95F8D4/2020	EPI_ISL_532442	2020-08-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-95F41C/2020	EPI_ISL_532444	2020-08-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95F731/2020	EPI_ISL_532446	2020-08-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-95FC41/2020	EPI_ISL_532449	2020-08-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/Scotland/QEUH-95ED03/2020	EPI_ISL_532452	2020-08-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E653/2020	EPI_ISL_532454	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95F713/2020	EPI_ISL_532456	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-95E8E4/2020	EPI_ISL_532462	2020-08-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/Scotland/QEUH-95F616/2020	EPI_ISL_532463	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95F33D/2020	EPI_ISL_532464	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-95EF1C/2020	EPI_ISL_532470	2020-08-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/Scotland/QEUH-95F6AD/2020	EPI_ISL_532472	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Northern Ireland/QEUH-95EC51/2020	EPI_ISL_532474	2020-08-08	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/Scotland/QEUH-95ED6D/2020	EPI_ISL_532480	2020-08-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E8B7/2020	EPI_ISL_532484	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-95FB44/2020	EPI_ISL_532485	2020-08-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-95E91E/2020	EPI_ISL_532488	2020-08-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/Scotland/QEUH-95FBCC/2020	EPI_ISL_532492	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E88A/2020	EPI_ISL_532493	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-95F0BE/2020	EPI_ISL_532500	2020-08-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/QEUH-95FAED/2020	EPI_ISL_532505	2020-08-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-95E714/2020	EPI_ISL_532506	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/QEUH-95E7BA/2020	EPI_ISL_532507	2020-08-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/Scotland/QEUH-95EA2A/2020	EPI_ISL_532510	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E85D/2020	EPI_ISL_532512	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95EA0C/2020	EPI_ISL_532514	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95F4FE/2020	EPI_ISL_532515	2020-08-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E662/2020	EPI_ISL_532518	2020-08-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95F106/2020	EPI_ISL_532523	2020-08-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95F4EF/2020	EPI_ISL_532531	2020-08-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E6F9/2020	EPI_ISL_532538	2020-08-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/Scotland/QEUH-9439B2/2020	EPI_ISL_532540	2020-08-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-94367F/2020	EPI_ISL_532550	2020-07-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-94393A/2020	EPI_ISL_532554	2020-07-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/QEUH-9434DF/2020	EPI_ISL_532559	2020-07-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/Scotland/QEUH-9436E8/2020	EPI_ISL_532572	2020-08-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-943387/2020	EPI_ISL_532574	2020-07-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	B.1.1.97	GR
hCoV-19/England/QEUH-943AEC/2020	EPI_ISL_532585	2020-07-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/Scotland/QEUH-9435AF/2020	EPI_ISL_532587	2020-08-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9437E5/2020	EPI_ISL_532589	2020-07-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/QEUH-943509/2020	EPI_ISL_532593	2020-07-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/Scotland/QEUH-9439C1/2020	EPI_ISL_532594	2020-07-31	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-943712/2020	EPI_ISL_532598	2020-08-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-94342A/2020	EPI_ISL_532604	2020-07-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/QEUH-94378B/2020	EPI_ISL_532607	2020-07-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-943581/2020	EPI_ISL_532610	2020-07-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-9435EB/2020	EPI_ISL_532619	2020-07-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/Scotland/QEUH-943703/2020	EPI_ISL_532620	2020-08-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-943439/2020	EPI_ISL_532621	2020-08-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9437B8/2020	EPI_ISL_532625	2020-07-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/Scotland/QEUH-943ABF/2020	EPI_ISL_532626	2020-08-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-943C6E/2020	EPI_ISL_532627	2020-07-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/Scotland/QEUH-89D1C1/2020	EPI_ISL_532659	2020-07-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/LEED-2A8888/2020	EPI_ISL_539047	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LEED-2A8C5F/2020	EPI_ISL_539090	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/LEED-2A8FA1/2020	EPI_ISL_539133	2020-04-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/LEED-2A8CF5/2020	EPI_ISL_539134	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LEED-2A8554/2020	EPI_ISL_539172	2020-03-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LEED-2A84EE/2020	EPI_ISL_539195	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Switzerland/UR-ETHZ-260018/2020	EPI_ISL_539353	2020-08-21	Europe / Switzerland / Uri	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/Switzerland/BL-ETHZ-260024/2020	EPI_ISL_539358	2020-08-22	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.39	GR
hCoV-19/Switzerland/BS-ETHZ-260049/2020	EPI_ISL_539377	2020-08-24	Europe / Switzerland / Basel-Stadt	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-260052/2020	EPI_ISL_539379	2020-08-24	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/AG-ETHZ-260060/2020	EPI_ISL_539386	2020-08-23	Europe / Switzerland / Aargau	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/Switzerland/AG-ETHZ-260091/2020	EPI_ISL_539412	2020-08-24	Europe / Switzerland / Aargau	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/Switzerland/ZH-ETHZ-260122/2020	EPI_ISL_539429	2020-08-26	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-260143/2020	EPI_ISL_539439	2020-08-25	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/AG-ETHZ-260148/2020	EPI_ISL_539444	2020-08-26	Europe / Switzerland / Aargau	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/AG-ETHZ-260149/2020	EPI_ISL_539445	2020-08-26	Europe / Switzerland / Aargau	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/AG-ETHZ-260153/2020	EPI_ISL_539448	2020-08-26	Europe / Switzerland / Aargau	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/AG-ETHZ-260158/2020	EPI_ISL_539452	2020-08-26	Europe / Switzerland / Aargau	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Sweden/20-51958/2020	EPI_ISL_539882	2020-06-09	Europe / Sweden / Vastra Gotaland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/BRIS-13355F/2020	EPI_ISL_539896	2020-06-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-998426/2020	EPI_ISL_539900	2020-08-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-9983DE/2020	EPI_ISL_539901	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.39	GR
hCoV-19/England/QEUH-99035E/2020	EPI_ISL_539922	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.15	GR
hCoV-19/England/QEUH-9982C2/2020	EPI_ISL_539931	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.39	GR
hCoV-19/England/QEUH-98FB3C/2020	EPI_ISL_539934	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-998338/2020	EPI_ISL_539987	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-9903A9/2020	EPI_ISL_539998	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/USA/TX-HMH-5403/2020	EPI_ISL_544748	2020-06-25	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.396	G
hCoV-19/USA/TX-HMH-5572/2020	EPI_ISL_544870	2020-06-25	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-7013/2020	EPI_ISL_546432	2020-06-28	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-730/2020	EPI_ISL_546656	2020-04-06	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.61	GR
hCoV-19/USA/TX-HMH-7366/2020	EPI_ISL_546710	2020-06-29	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.396	G
hCoV-19/USA/TX-HMH-7626/2020	EPI_ISL_546896	2020-06-26	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-5711/2020	EPI_ISL_546961	2020-06-29	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1	G
hCoV-19/England/MILK-9A5602/2020	EPI_ISL_550095	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.39	GR
hCoV-19/England/MILK-9A6A9C/2020	EPI_ISL_550102	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A6F15/2020	EPI_ISL_550106	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/MILK-9A8C67/2020	EPI_ISL_550108	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A855D/2020	EPI_ISL_550118	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A5013/2020	EPI_ISL_550126	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-9A53FC/2020	EPI_ISL_550142	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9A6CC3/2020	EPI_ISL_550145	2020-09-03	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A6EBE/2020	EPI_ISL_550148	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A846F/2020	EPI_ISL_550158	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A6B20/2020	EPI_ISL_550160	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A5541/2020	EPI_ISL_550172	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A83BD/2020	EPI_ISL_550181	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-9A8D73/2020	EPI_ISL_550184	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/MILK-9A8669/2020	EPI_ISL_550190	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A5408/2020	EPI_ISL_550199	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-9A862D/2020	EPI_ISL_550203	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/MILK-9A6BF3/2020	EPI_ISL_550213	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A66F2/2020	EPI_ISL_550217	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/MILK-9A8DA0/2020	EPI_ISL_550225	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9A53ED/2020	EPI_ISL_550244	2020-09-03	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A69BD/2020	EPI_ISL_550246	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A52A4/2020	EPI_ISL_550253	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-9A8450/2020	EPI_ISL_550255	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/MILK-99A80A/2020	EPI_ISL_550263	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-99A15A/2020	EPI_ISL_550265	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-999FD9/2020	EPI_ISL_550270	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-99A73A/2020	EPI_ISL_550272	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-999E36/2020	EPI_ISL_550279	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-999F51/2020	EPI_ISL_550280	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-99A7A3/2020	EPI_ISL_550281	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99A0E4/2020	EPI_ISL_550285	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-999D66/2020	EPI_ISL_550287	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99A600/2020	EPI_ISL_550291	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99A372/2020	EPI_ISL_550293	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99A749/2020	EPI_ISL_550294	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-99A3FA/2020	EPI_ISL_550305	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/MILK-999F42/2020	EPI_ISL_550315	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/MILK-999F8E/2020	EPI_ISL_550316	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/MILK-99A882/2020	EPI_ISL_550317	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-99A6A6/2020	EPI_ISL_550328	2020-08-29	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.315	G
hCoV-19/England/MILK-99A9DA/2020	EPI_ISL_550329	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-99A187/2020	EPI_ISL_550341	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-999D57/2020	EPI_ISL_550343	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-999C3C/2020	EPI_ISL_550347	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99A0C6/2020	EPI_ISL_550350	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-999C5A/2020	EPI_ISL_550354	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-999CC3/2020	EPI_ISL_550357	2020-08-29	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-999CD2/2020	EPI_ISL_550373	2020-08-29	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-999D84/2020	EPI_ISL_550380	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99A04E/2020	EPI_ISL_550382	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99A61F/2020	EPI_ISL_550383	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-999CF0/2020	EPI_ISL_550396	2020-08-29	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-99A697/2020	EPI_ISL_550397	2020-08-29	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99A5A9/2020	EPI_ISL_550399	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-99A679/2020	EPI_ISL_550400	2020-08-29	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99B4F6/2020	EPI_ISL_550402	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-99A688/2020	EPI_ISL_550406	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99A354/2020	EPI_ISL_550407	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-99A8CE/2020	EPI_ISL_550409	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9773E4/2020	EPI_ISL_550418	2020-07-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/MILK-9787C9/2020	EPI_ISL_550419	2020-07-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/Wales/MILK-9789C3/2020	EPI_ISL_550421	2020-08-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/MILK-9776EB/2020	EPI_ISL_550430	2020-07-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/MILK-97741E/2020	EPI_ISL_550431	2020-07-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/MILK-9780CE/2020	EPI_ISL_550432	2020-07-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-978608/2020	EPI_ISL_550434	2020-07-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/MILK-9789A5/2020	EPI_ISL_550438	2020-08-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.15	GR
hCoV-19/England/MILK-9777E8/2020	EPI_ISL_550442	2020-07-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-9781AD/2020	EPI_ISL_550445	2020-07-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-977FA4/2020	EPI_ISL_550446	2020-07-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/MILK-977469/2020	EPI_ISL_550447	2020-07-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-9780DD/2020	EPI_ISL_550450	2020-07-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-977F59/2020	EPI_ISL_550451	2020-07-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.15	GR
hCoV-19/England/MILK-97779D/2020	EPI_ISL_550454	2020-07-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.231	G
hCoV-19/England/MILK-978741/2020	EPI_ISL_550457	2020-07-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Wales/MILK-9775C0/2020	EPI_ISL_550458	2020-07-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-978107/2020	EPI_ISL_550461	2020-07-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-977627/2020	EPI_ISL_550462	2020-07-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.198	GR
hCoV-19/England/MILK-9780FB/2020	EPI_ISL_550465	2020-07-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-977F77/2020	EPI_ISL_550469	2020-07-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_E92stop results in 24.8% truncation of the protein sequence.	info	B.1.1.406	GR
hCoV-19/England/MILK-9779A6/2020	EPI_ISL_550471	2020-07-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-9777BB/2020	EPI_ISL_550473	2020-07-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/MILK-978046/2020	EPI_ISL_550481	2020-07-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-977E01/2020	EPI_ISL_550483	2020-07-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NSP11 without BLAST coverage.	warn	B.1.1	GR
hCoV-19/England/MILK-978705/2020	EPI_ISL_550486	2020-07-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/MILK-978073/2020	EPI_ISL_550492	2020-07-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/MILK-978A66/2020	EPI_ISL_550498	2020-08-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/MILK-693A4A/2020	EPI_ISL_551800	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.15	GR
hCoV-19/England/MILK-6A383E/2020	EPI_ISL_551802	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/ALDP-67CB71/2020	EPI_ISL_551804	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-678A96/2020	EPI_ISL_551807	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-689959/2020	EPI_ISL_551808	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/CAMC-990D8D/2020	EPI_ISL_551913	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-9910ED/2020	EPI_ISL_551917	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-99341C/2020	EPI_ISL_551923	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-993449/2020	EPI_ISL_551930	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/MILK-992A1B/2020	EPI_ISL_551942	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/MILK-9937C8/2020	EPI_ISL_551945	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-991F1D/2020	EPI_ISL_551947	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-992CF7/2020	EPI_ISL_551949	2020-08-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-992ED3/2020	EPI_ISL_551954	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-992D7C/2020	EPI_ISL_551957	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-992A39/2020	EPI_ISL_551960	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-993300/2020	EPI_ISL_551962	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/Wales/MILK-9936BC/2020	EPI_ISL_551974	2020-08-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-992750/2020	EPI_ISL_551979	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/CA-QDX-915/2020	EPI_ISL_571574	2020-03-23	North America / USA / California	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1	GR
hCoV-19/USA/IL-QDX-1101/2020	EPI_ISL_571844	2020-03-18	North America / USA / Illinois	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.59	GR
hCoV-19/USA/MI-QDX-1136/2020	EPI_ISL_571866	2020-03-20	North America / USA / Michigan	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.59	GR
hCoV-19/Ireland/G-NVRL-72IRL53006/2020	EPI_ISL_578277	2020-08-20	Europe / Ireland / Galway	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.269	GR
hCoV-19/USA/LA-EVTL526/2020	EPI_ISL_578930	2020-08-03	North America / USA / Louisiana / Lincoln Parish	Human	Original	Nasopharyngeal swab		Illumina NextSeq	breseq v0.34.1; genome diff, mapping to EPI_ISL_402124			B.1	G
hCoV-19/Scotland/CVR4442/2020	EPI_ISL_585311	2020-09-19	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4451/2020	EPI_ISL_585318	2020-09-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4470/2020	EPI_ISL_585334	2020-09-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4473/2020	EPI_ISL_585337	2020-09-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4474/2020	EPI_ISL_585338	2020-09-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4475/2020	EPI_ISL_585339	2020-09-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4477/2020	EPI_ISL_585341	2020-09-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4488/2020	EPI_ISL_585352	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4490/2020	EPI_ISL_585353	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4494/2020	EPI_ISL_585357	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4499/2020	EPI_ISL_585362	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4500/2020	EPI_ISL_585363	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4508/2020	EPI_ISL_585370	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4512/2020	EPI_ISL_585373	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4515/2020	EPI_ISL_585376	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4516/2020	EPI_ISL_585377	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4525/2020	EPI_ISL_585385	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4527/2020	EPI_ISL_585387	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4529/2020	EPI_ISL_585389	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4531/2020	EPI_ISL_585391	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4534/2020	EPI_ISL_585394	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4541/2020	EPI_ISL_585400	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4552/2020	EPI_ISL_585411	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4561/2020	EPI_ISL_585419	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4732/2020	EPI_ISL_585425	2020-09-28	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/QEUH-9E386C/2020	EPI_ISL_585519	2020-09-23	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/QEUH-9E39A5/2020	EPI_ISL_585531	2020-09-24	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.236	G
hCoV-19/Scotland/QEUH-A00DB4/2020	EPI_ISL_585573	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/QEUH-A00DC3/2020	EPI_ISL_585574	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.532	GR
hCoV-19/England/ALDP-A51A35/2020	EPI_ISL_598024	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/ALDP-A52463/2020	EPI_ISL_598029	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A514A0/2020	EPI_ISL_598043	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A511F4/2020	EPI_ISL_598046	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A517B6/2020	EPI_ISL_598067	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A51200/2020	EPI_ISL_598080	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A51E93/2020	EPI_ISL_598088	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A516D7/2020	EPI_ISL_598128	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A5184A/2020	EPI_ISL_598141	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A51DD2/2020	EPI_ISL_598146	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A51F81/2020	EPI_ISL_598159	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/ALDP-A51BBA/2020	EPI_ISL_598165	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/ALDP-A5213F/2020	EPI_ISL_598166	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A51DE1/2020	EPI_ISL_598194	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/ALDP-A51516/2020	EPI_ISL_598198	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A51BE7/2020	EPI_ISL_598217	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A517A7/2020	EPI_ISL_598223	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/England/ALDP-A527C4/2020	EPI_ISL_598230	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/ALDP-A52551/2020	EPI_ISL_598235	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/MILK-A472B2/2020	EPI_ISL_598263	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.39	GR
hCoV-19/England/MILK-A47285/2020	EPI_ISL_598270	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.39	GR
hCoV-19/England/MILK-A46D85/2020	EPI_ISL_598272	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A47B8A/2020	EPI_ISL_598280	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A47FAC/2020	EPI_ISL_598291	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A47F51/2020	EPI_ISL_598298	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A46C6A/2020	EPI_ISL_598326	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A469FA/2020	EPI_ISL_598327	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A46C4C/2020	EPI_ISL_598333	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/England/MILK-A46B03/2020	EPI_ISL_598354	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A46AF7/2020	EPI_ISL_598357	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/England/MILK-A46972/2020	EPI_ISL_598394	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.159	GR
hCoV-19/England/MILK-A47531/2020	EPI_ISL_598409	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-A46D58/2020	EPI_ISL_598414	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A46CE2/2020	EPI_ISL_598434	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-A46E37/2020	EPI_ISL_598459	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A46B6D/2020	EPI_ISL_598461	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/MILK-A471B5/2020	EPI_ISL_598463	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A47391/2020	EPI_ISL_598481	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A06A8A/2020	EPI_ISL_599916	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-A05D55/2020	EPI_ISL_599917	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A066C2/2020	EPI_ISL_599942	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.39	GR
hCoV-19/England/MILK-A05C67/2020	EPI_ISL_599969	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A05BC4/2020	EPI_ISL_599981	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A06A20/2020	EPI_ISL_599992	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-A062A0/2020	EPI_ISL_599996	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/Switzerland/BE-ETHZ-310427/2020	EPI_ISL_603501	2020-10-08	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-310428/2020	EPI_ISL_603502	2020-10-08	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-310429/2020	EPI_ISL_603503	2020-10-08	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/SG-ETHZ-310430/2020	EPI_ISL_603504	2020-10-08	Europe / Switzerland / St Gallen	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-310431/2020	EPI_ISL_603505	2020-10-08	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-310434/2020	EPI_ISL_603508	2020-10-08	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-310435/2020	EPI_ISL_603509	2020-10-08	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BE-ETHZ-310440/2020	EPI_ISL_603513	2020-10-08	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-310441/2020	EPI_ISL_603514	2020-10-08	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/VD-ETHZ-310451/2020	EPI_ISL_603523	2020-10-07	Europe / Switzerland / Vaud	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.269	GR
hCoV-19/Switzerland/BE-ETHZ-310452/2020	EPI_ISL_603524	2020-10-07	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BE-ETHZ-310467/2020	EPI_ISL_603538	2020-10-07	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/AG-ETHZ-310481/2020	EPI_ISL_603551	2020-10-08	Europe / Switzerland / Aargau	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-310484/2020	EPI_ISL_603554	2020-10-08	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-310490/2020	EPI_ISL_603560	2020-10-08	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/VD-ETHZ-310496/2020	EPI_ISL_603565	2020-10-08	Europe / Switzerland / Vaud	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.242	GR
hCoV-19/Switzerland/BL-ETHZ-310499/2020	EPI_ISL_603567	2020-10-08	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BE-ETHZ-321396/2020	EPI_ISL_603637	2020-10-13	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-321423/2020	EPI_ISL_603660	2020-10-14	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.398	G
hCoV-19/Switzerland/VS-ETHZ-321460/2020	EPI_ISL_603675	2020-10-14	Europe / Switzerland / Valais	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.269	GR
hCoV-19/Switzerland/GE-ETHZ-321473/2020	EPI_ISL_603686	2020-10-14	Europe / Switzerland / Geneva	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.242	GR
hCoV-19/Switzerland/VS-ETHZ-321478/2020	EPI_ISL_603690	2020-10-15	Europe / Switzerland / Valais	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.269	GR
hCoV-19/Switzerland/BE-ETHZ-321491/2020	EPI_ISL_603703	2020-10-15	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/VD-ETHZ-321495/2020	EPI_ISL_603707	2020-10-15	Europe / Switzerland / Vaud	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.269	GR
hCoV-19/Switzerland/AG-ETHZ-321520/2020	EPI_ISL_603729	2020-10-15	Europe / Switzerland / Aargau	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-321524/2020	EPI_ISL_603733	2020-10-15	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/VD-ETHZ-321545/2020	EPI_ISL_603754	2020-10-15	Europe / Switzerland / Vaud	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.269	GR
hCoV-19/USA/CA-QDX-1587/2020	EPI_ISL_603897	2020-03-19	North America / USA / California	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1	GR
hCoV-19/USA/CA-QDX-1633/2020	EPI_ISL_603909	2020-03-18	North America / USA / California	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1.61	GR
hCoV-19/USA/UT-UPHL-2009585/2020	EPI_ISL_605263	2020-07-19	North America / USA / Utah	Human	Original			Illumina NextSeq	minimap2 & freebayes			B.1.240	G
hCoV-19/USA/UT-UPHL-2009664/2020	EPI_ISL_605339	2020-07-27	North America / USA / Utah	Human	Original			Illumina NextSeq	minimap2 & freebayes			B.1.240	G
hCoV-19/USA/UT-UPHL-2009724/2020	EPI_ISL_605396	2020-07-26	North America / USA / Utah	Human	Original			Illumina NextSeq	minimap2 & freebayes			B.1.240	G
hCoV-19/Bangladesh/JUST-GC91.124/2020	EPI_ISL_605783	2020-08-08	Asia / Bangladesh / Khulna / Jashore / Chowgacha / Mohespur	Human	Original			Ion Torrent GeneStudio™ S5	SAMtools, BCFtools, and Burrows-Wheeler Aligner			B.1.1.25	GR
hCoV-19/South Africa/KRISP-K003682/2020	EPI_ISL_605786	2020-09-26	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup	NS7a_G38stop results in 69.4% truncation of the protein sequence.	info	B.1.1.273	GR
hCoV-19/South Africa/KRISP-K003720/2020	EPI_ISL_605787	2020-10-07	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.56	GR
hCoV-19/Singapore/1109/2020	EPI_ISL_605818	2020-10-19	Asia / Singapore	Human	Original			Illumina MiSeq				AD.2	GR
hCoV-19/Bangladesh/DNAS-CPH-isl-475/2020	EPI_ISL_605883	2020-04-29	Asia / Bangladesh	Human	Original	Oropharyngeal swab		IonTorrent	IRMA v. 1.2.1.0			B.1.1.25	GR
hCoV-19/Bangladesh/DNAS-P-isl-T/2020	EPI_ISL_605886	2020-04-29	Asia / Bangladesh	Human	Original	Oropharyngeal swab		IonTorrent	IRMA v. 1.2.1.0			B.1.1.25	GR
hCoV-19/Bangladesh/DNAS-BSH-isl-1/2020	EPI_ISL_605898	2020-04-29	Asia / Bangladesh	Human	Original	Oropharyngeal swab		IonTorrent	IRMA v. 1.2.1.0			B.1.1.25	GR
hCoV-19/Bangladesh/DNAS-isl-113/2020	EPI_ISL_605909	2020-05-24	Asia / Bangladesh	Human	Original	Oropharyngeal swab		IonTorrent	IRMA v. 1.2.1.0			B.1.1	GR
hCoV-19/Bangladesh/DNAS-isl-6299/2020	EPI_ISL_605914	2020-05-18	Asia / Bangladesh	Human	Original	Oropharyngeal swab		IonTorrent	IRMA v. 1.2.1.0			B.1.1.25	GR
hCoV-19/Bangladesh/DNAS-isl-6841/2020	EPI_ISL_605916	2020-05-18	Asia / Bangladesh	Human	Original	Oropharyngeal swab		IonTorrent	IRMA v. 1.2.1.0			B.1.1.25	GR
hCoV-19/Bangladesh/DNAS-isl-8225/2020	EPI_ISL_605917	2020-05-18	Asia / Bangladesh	Human	Original	Oropharyngeal swab		IonTorrent	IRMA v. 1.2.1.0			B.1.1	GR
hCoV-19/Bangladesh/DNAS-isl-17/2020	EPI_ISL_605921	2020-05-18	Asia / Bangladesh	Human	Original	Oropharyngeal swab		IonTorrent	IRMA v. 1.2.1.0			B.1.1.25	GR
hCoV-19/Bangladesh/DNAS-isl-6301/2020	EPI_ISL_605922	2020-05-18	Asia / Bangladesh	Human	Original	Oropharyngeal swab		IonTorrent	IRMA v. 1.2.1.0			B.1.1.25	GR
hCoV-19/England/ALDP-A86DE3/2020	EPI_ISL_605967	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/ALDP-A871C8/2020	EPI_ISL_605968	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A86C40/2020	EPI_ISL_605978	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A81C09/2020	EPI_ISL_610722	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/England/CAMC-A81243/2020	EPI_ISL_610745	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/CAMC-A82172/2020	EPI_ISL_610749	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/England/CAMC-A82B0B/2020	EPI_ISL_610754	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A82CEA/2020	EPI_ISL_610761	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A81E6D/2020	EPI_ISL_610770	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A82989/2020	EPI_ISL_610782	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/CAMC-A8241F/2020	EPI_ISL_610788	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A82BFC/2020	EPI_ISL_610799	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A829B6/2020	EPI_ISL_610811	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A82AB3/2020	EPI_ISL_610815	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A8102B/2020	EPI_ISL_610831	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A82190/2020	EPI_ISL_610901	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/England/CAMC-A81AF0/2020	EPI_ISL_610902	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/CAMC-A81BC0/2020	EPI_ISL_610911	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/England/CAMC-A829F2/2020	EPI_ISL_610920	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A92E5A/2020	EPI_ISL_610990	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Denmark/DCGC-7115/2020	EPI_ISL_619150	2020-10-12	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.159	GR
hCoV-19/Denmark/DCGC-7270/2020	EPI_ISL_619242	2020-10-12	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.159	GR
hCoV-19/Denmark/DCGC-7285/2020	EPI_ISL_619251	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.398	G
hCoV-19/Denmark/DCGC-1619/2020	EPI_ISL_619271	2020-04-06	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-7438/2020	EPI_ISL_619325	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.159	GR
hCoV-19/Denmark/DCGC-7425/2020	EPI_ISL_619366	2020-10-12	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.159	GR
hCoV-19/Denmark/DCGC-7494/2020	EPI_ISL_619386	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-5680/2020	EPI_ISL_619967	2020-09-28	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.236	G
hCoV-19/Sweden/20-21502/2020	EPI_ISL_623076	2020-06-03	Europe / Sweden / Uppsala	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-21504/2020	EPI_ISL_623078	2020-06-24	Europe / Sweden / Uppsala	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Sweden/20-22153/2020	EPI_ISL_623084	2020-06-02	Europe / Sweden / Skane	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Sweden/20-52117/2020	EPI_ISL_623090	2020-06-21	Europe / Sweden / Vasternorrland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Sweden/20-52704/2020	EPI_ISL_623093	2020-06-03	Europe / Sweden / Jonkoping	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/England/MILK-AB7A88/2020	EPI_ISL_623244	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-AAFC23/2020	EPI_ISL_623268	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-AAF959/2020	EPI_ISL_623273	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AB77FA/2020	EPI_ISL_623291	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.39	GR
hCoV-19/England/MILK-AB7F3E/2020	EPI_ISL_623564	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AB7CEC/2020	EPI_ISL_623621	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/MILK-AB753C/2020	EPI_ISL_623636	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-AB15E7/2020	EPI_ISL_623654	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AB8735/2020	EPI_ISL_623718	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-AB1408/2020	EPI_ISL_623794	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AB795E/2020	EPI_ISL_623814	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/CAMC-AB1EFB/2020	EPI_ISL_623846	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-AB1E91/2020	EPI_ISL_623854	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.398	G
hCoV-19/England/ALDP-AA34CD/2020	EPI_ISL_623890	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC784F/2020	EPI_ISL_630243	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/MILK-ACE0F5/2020	EPI_ISL_630331	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-ACCFDC/2020	EPI_ISL_630337	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A67A0F/2020	EPI_ISL_630376	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-A675FF/2020	EPI_ISL_630383	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A670C1/2020	EPI_ISL_630505	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A67C45/2020	EPI_ISL_630509	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/ALDP-A68D7E/2020	EPI_ISL_630531	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6737D/2020	EPI_ISL_630548	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A66AC4/2020	EPI_ISL_630553	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A68664/2020	EPI_ISL_630556	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A67629/2020	EPI_ISL_630566	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/ALDP-A67119/2020	EPI_ISL_630567	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A673B9/2020	EPI_ISL_630573	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A67999/2020	EPI_ISL_630586	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A67717/2020	EPI_ISL_630616	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6761A/2020	EPI_ISL_630646	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/ALDP-A67076/2020	EPI_ISL_630698	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-A6700D/2020	EPI_ISL_630699	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-AAE77E/2020	EPI_ISL_630703	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA26AA/2020	EPI_ISL_630713	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence. NSP11 without BLAST coverage.	warn	B.1.532	GR
hCoV-19/England/QEUH-AAE644/2020	EPI_ISL_630718	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AAE073/2020	EPI_ISL_630761	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA2A44/2020	EPI_ISL_630772	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AAE107/2020	EPI_ISL_630778	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA2A17/2020	EPI_ISL_630783	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AAE0CE/2020	EPI_ISL_630787	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA38EF/2020	EPI_ISL_630796	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA4E46/2020	EPI_ISL_630812	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA4DB2/2020	EPI_ISL_630816	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA4E55/2020	EPI_ISL_630845	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AAE028/2020	EPI_ISL_630851	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AAE6F9/2020	EPI_ISL_630853	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA2A53/2020	EPI_ISL_630878	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA4EBF/2020	EPI_ISL_630899	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AAE7E7/2020	EPI_ISL_630900	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AAF27C/2020	EPI_ISL_630915	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AAE7AB/2020	EPI_ISL_630923	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-AA4D58/2020	EPI_ISL_630945	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA3FBD/2020	EPI_ISL_630946	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AADFFF/2020	EPI_ISL_630949	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA4DFE/2020	EPI_ISL_630950	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AAE055/2020	EPI_ISL_630959	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ABBFEF/2020	EPI_ISL_630978	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/NORW-F39AB/2020	EPI_ISL_637857	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/Wales/MILK-B054AA/2020	EPI_ISL_639010	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				B.1.1.240	GR
hCoV-19/Wales/PHWC-486D16/2020	EPI_ISL_639126	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-487085/2020	EPI_ISL_639162	2020-10-23	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-4876ED/2020	EPI_ISL_639228	2020-10-29	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	G
hCoV-19/Wales/PHWC-488206/2020	EPI_ISL_639367	2020-10-29	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1	G
hCoV-19/Wales/PHWC-488BCF/2020	EPI_ISL_639477	2020-11-02	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-AA2A80/2020	EPI_ISL_644103	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA4DA3/2020	EPI_ISL_644113	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Ireland/D-NVRL-AIIDM0017v1/2020	EPI_ISL_644252	2020-06-09	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/WW-NVRL-AIIDV0379v2/2020	EPI_ISL_644255	2020-05-08	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-NVRL-AIIDV0072v2/2020	EPI_ISL_644257	2020-04-12	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/WW-NVRL-AIIDV0063v2/2020	EPI_ISL_644259	2020-04-10	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-NVRL-AIIDV0125v1/2020	EPI_ISL_644261	2020-04-16	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-NVRL-AIIDV0080v1/2020	EPI_ISL_644271	2020-04-26	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-NVRL-AIIDV0083v1/2020	EPI_ISL_644273	2020-03-27	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.59	GR
hCoV-19/Ireland/LD-NVRL-AIIDV0197v1/2020	EPI_ISL_644275	2020-04-21	Europe / Ireland / Longford	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-NVRL-AIIDV0072v1/2020	EPI_ISL_644276	2020-04-10	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-NVRL-AIIDV0432v2/2020	EPI_ISL_644278	2020-04-03	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/WW-NVRL-AIIDV0082v1/2020	EPI_ISL_644282	2020-04-03	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.174	GR
hCoV-19/Ireland/WW-NVRL-AIIDV0082v2/2020	EPI_ISL_644283	2020-04-05	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.174	GR
hCoV-19/Ireland/D-NVRL-AIIDV0432v4/2020	EPI_ISL_644287	2020-04-07	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/WW-NVRL-AIIDV0099v1/2020	EPI_ISL_644291	2020-04-14	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.174	GR
hCoV-19/Ireland/D-NVRL-AIIDV0432v5/2020	EPI_ISL_644292	2020-04-09	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-NVRL-AIIDV0072v3/2020	EPI_ISL_644296	2020-04-14	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/WW-NVRL-AIIDV0486v1/2020	EPI_ISL_644298	2020-04-26	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/WW-NVRL-AIIDV0063v1/2020	EPI_ISL_644303	2020-04-08	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-NVRL-AIIDV0432v7/2020	EPI_ISL_644305	2020-04-13	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/WW-NVRL-AIIDV0063v3/2020	EPI_ISL_644306	2020-04-12	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-NVRL-AIIDV0206v1/2020	EPI_ISL_644310	2020-03-27	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.59	GR
hCoV-19/Ireland/WW-NVRL-AIIDV0485v1/2020	EPI_ISL_644311	2020-05-20	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/WW-NVRL-AIIDV0485v2/2020	EPI_ISL_644312	2020-05-22	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/WW-NVRL-AIIDV0063v4/2020	EPI_ISL_644313	2020-04-14	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-NVRL-AIIDV0432v9/2020	EPI_ISL_644314	2020-04-17	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-NVRL-AIIDV0071v1/2020	EPI_ISL_644316	2020-04-07	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/D-NVRL-AIIDV0084v1/2020	EPI_ISL_644318	2020-04-13	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-NVRL-AIIDV0002v1/2020	EPI_ISL_644321	2020-03-26	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.59	GR
hCoV-19/Ireland/D-NVRL-AIIDV0363v1/2020	EPI_ISL_644323	2020-05-05	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-NVRL-AIIDV0432v10/2020	EPI_ISL_644324	2020-04-19	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/WW-NVRL-AIIDV0063v5/2020	EPI_ISL_644327	2020-04-16	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-NVRL-AIIDV0072v4/2020	EPI_ISL_644328	2020-04-16	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-NVRL-AIIDV0380v1/2020	EPI_ISL_644329	2020-04-29	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/WW-NVRL-AIIDV0379v1/2020	EPI_ISL_644330	2020-05-06	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/WW-NVRL-AIIDV0063v6/2020	EPI_ISL_644334	2020-04-18	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-NVRL-AIIDV0361v2/2020	EPI_ISL_644336	2020-05-01	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/WW-NVRL-AIIDV0379v3/2020	EPI_ISL_644337	2020-05-10	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-NVRL-AIIDV1114v1/2020	EPI_ISL_644342	2020-03-29	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/WW-NVRL-AIIDV0010v1/2020	EPI_ISL_644343	2020-03-24	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-NVRL-AIIDV0380v3/2020	EPI_ISL_644344	2020-05-03	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/WW-NVRL-AIIDV0379v4/2020	EPI_ISL_644345	2020-05-12	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/USA/MI-MDHHS-SC22198/2020	EPI_ISL_644366	2020-10-27	North America / USA / Michigan	Human	Original			Illumina MiSeq	bwa v. 0.7.17; bcftools v. 1.7			B.1.240	G
hCoV-19/USA/MI-MDHHS-SC22202/2020	EPI_ISL_644370	2020-10-27	North America / USA / Michigan	Human	Original			Illumina MiSeq	bwa v. 0.7.17; bcftools v. 1.7			B.1.240	G
hCoV-19/USA/MI-MDHHS-SC22206/2020	EPI_ISL_644374	2020-10-27	North America / USA / Michigan	Human	Original			Illumina MiSeq	bwa v. 0.7.17; bcftools v. 1.7			B.1.240	G
hCoV-19/USA/VA-DCLS-1671/2020	EPI_ISL_644839	2020-08-29	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.240	G
hCoV-19/USA/VA-DCLS-1753/2020	EPI_ISL_644853	2020-09-10	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.240	G
hCoV-19/USA/VA-DCLS-1788/2020	EPI_ISL_644873	2020-09-16	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.240	G
hCoV-19/USA/VA-DCLS-2000/2020	EPI_ISL_644903	2020-10-13	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.240	G
hCoV-19/USA/VA-DCLS-1948/2020	EPI_ISL_644930	2020-09-29	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.240	G
hCoV-19/USA/VA-DCLS-1949/2020	EPI_ISL_644931	2020-09-29	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.240	G
hCoV-19/USA/MN-MDH-2002/2020	EPI_ISL_644933	2020-10-29	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1	G
hCoV-19/England/MILK-B56DDC/2020	EPI_ISL_657023	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B3FFE2/2020	EPI_ISL_657027	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B4241A/2020	EPI_ISL_657033	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B42474/2020	EPI_ISL_657077	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B432E2/2020	EPI_ISL_657107	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B42395/2020	EPI_ISL_657119	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B402A9/2020	EPI_ISL_657122	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B40106/2020	EPI_ISL_657154	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B40160/2020	EPI_ISL_657187	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B4367D/2020	EPI_ISL_657200	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B43428/2020	EPI_ISL_657203	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B40027/2020	EPI_ISL_657220	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B4017F/2020	EPI_ISL_657268	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B434BF/2020	EPI_ISL_657284	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/QEUH-B435DA/2020	EPI_ISL_657293	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-B418F1/2020	EPI_ISL_658721	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B416D9/2020	EPI_ISL_658738	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-B38909/2020	EPI_ISL_658742	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/MILK-B39179/2020	EPI_ISL_658757	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B3868A/2020	EPI_ISL_658801	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B38769/2020	EPI_ISL_658828	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B38444/2020	EPI_ISL_658842	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Mexico/AGS-InDRE-79/2020	EPI_ISL_658865	2020-11-02	North America / Mexico / Aguascalientes	Human	Original	Oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20			B.1.396	G
hCoV-19/England/MILK-B38699/2020	EPI_ISL_658887	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B394BC/2020	EPI_ISL_658895	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B3955F/2020	EPI_ISL_658935	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B37E38/2020	EPI_ISL_658948	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B74DAB/2020	EPI_ISL_662071	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/QEUH-B68636/2020	EPI_ISL_662090	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-B68F95/2020	EPI_ISL_662091	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/ALDP-B75056/2020	EPI_ISL_662141	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B75645/2020	EPI_ISL_662183	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B746DD/2020	EPI_ISL_662200	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B75575/2020	EPI_ISL_662229	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B691F8/2020	EPI_ISL_662230	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B750A1/2020	EPI_ISL_662252	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/ALDP-B74093/2020	EPI_ISL_662260	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-B691DA/2020	EPI_ISL_662283	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6819F/2020	EPI_ISL_662288	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-B6A564/2020	EPI_ISL_662350	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B735B3/2020	EPI_ISL_662391	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B73717/2020	EPI_ISL_662393	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B66410/2020	EPI_ISL_662417	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B735A4/2020	EPI_ISL_662452	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B675B2/2020	EPI_ISL_662454	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6B09F/2020	EPI_ISL_662481	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6B6E8/2020	EPI_ISL_662517	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6752B/2020	EPI_ISL_662546	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6A115/2020	EPI_ISL_662560	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6751C/2020	EPI_ISL_662567	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-B67567/2020	EPI_ISL_662569	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6AE1E/2020	EPI_ISL_662573	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6A555/2020	EPI_ISL_662585	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B7360B/2020	EPI_ISL_662588	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6A1F7/2020	EPI_ISL_662620	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B3875A/2020	EPI_ISL_662643	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF28B4/2020	EPI_ISL_662663	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF46D6/2020	EPI_ISL_662691	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AEFFD3/2020	EPI_ISL_662766	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF2957/2020	EPI_ISL_662784	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF476A/2020	EPI_ISL_662800	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF480D/2020	EPI_ISL_662833	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF46E5/2020	EPI_ISL_662837	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF48D0/2020	EPI_ISL_662890	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-B31BCE/2020	EPI_ISL_676416	2020-11-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Sweden/20-53093/2020	EPI_ISL_676495	2020-07-10	Europe / Sweden / Gavleborg	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins	NS8_Y31stop results in 75.2% truncation of the protein sequence.	info	B.1.1.261	GR
hCoV-19/Sweden/20-53532/2020	EPI_ISL_676505	2020-11-10	Europe / Sweden / Jonkoping	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins	Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/204881375/2020	EPI_ISL_676511	2020-11-19	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.236	G
hCoV-19/Sweden/20-08962/2020	EPI_ISL_676519	2020-08-25	Europe / Sweden / Ostergotland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1	G
hCoV-19/USA/TX-DSHS-1468/2020	EPI_ISL_676644	2020-06-22	North America / USA / Texas / Hidalgo	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa v1.2.2/ivar 0.7.17			B.1.396	G
hCoV-19/USA/TX-DSHS-1480/2020	EPI_ISL_676645	2020-06-22	North America / USA / Texas / Hidalgo	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa v1.2.2/ivar 0.7.17			B.1.396	G
hCoV-19/USA/TX-DSHS-1484/2020	EPI_ISL_676646	2020-06-22	North America / USA / Texas / Hidalgo	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa v1.2.2/ivar 0.7.17			B.1.396	G
hCoV-19/Saudi Arabia/KAUST-RIYADH1195/2020	EPI_ISL_678201	2020-06-15	Asia / Saudi Arabia / Riyadh	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.398	G
hCoV-19/Saudi Arabia/KAUST-RIYADH1214/2020	EPI_ISL_678206	2020-06-05	Asia / Saudi Arabia / Riyadh	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.398	G
hCoV-19/Saudi Arabia/KAUST-RIYADH1222/2020	EPI_ISL_678211	2020-07-29	Asia / Saudi Arabia / Riyadh	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.398	G
hCoV-19/Saudi Arabia/KAUST-RIYADH1235/2020	EPI_ISL_678212	2020-08-11	Asia / Saudi Arabia / Riyadh	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.398	G
hCoV-19/Saudi Arabia/KAUST-RIYADH1243/2020	EPI_ISL_678214	2020-07-29	Asia / Saudi Arabia / Riyadh	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.398	G
hCoV-19/Saudi Arabia/KAUST-RIYADH1251/2020	EPI_ISL_678217	2020-08-11	Asia / Saudi Arabia / Riyadh	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.398	G
hCoV-19/Saudi Arabia/KAUST-RIYADH1240/2020	EPI_ISL_678239	2020-07-29	Asia / Saudi Arabia / Riyadh	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.398	G
hCoV-19/Russia/SAR-RARI-3187/2020	EPI_ISL_678274	2020-07-30	Europe / Russia / Saratov	Human	Original	Trachea		IonTorrent	SPAdes v. 3.12			B.1.1	GR
hCoV-19/Australia/NSW2939/2020	EPI_ISL_678371	2020-10-16	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina MiSeq				B.1.1.315	GR
hCoV-19/South Africa/KRISP-K005306/2020	EPI_ISL_678599	2020-10-29	Africa / South Africa / KwaZulu-Natal / Ugu	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K005326/2020	EPI_ISL_678616	2020-11-16	Africa / South Africa / KwaZulu-Natal / Ugu	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/England/204540971/2020	EPI_ISL_678658	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			AD.2	GR
hCoV-19/England/204720526/2020	EPI_ISL_678716	2020-11-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.39	GR
hCoV-19/England/204720536/2020	EPI_ISL_678719	2020-11-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.39	GR
hCoV-19/England/204720537/2020	EPI_ISL_678720	2020-11-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.39	GR
hCoV-19/England/ALDP-B5D31F/2020	EPI_ISL_678887	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.398	G
hCoV-19/England/ALDP-B74E02/2020	EPI_ISL_678993	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.67	GR
hCoV-19/Netherlands/ZuidHolland_13/2020	EPI_ISL_414470	2020-03-06	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.1	GR
hCoV-19/Russia/Moscow-62508/2020	EPI_ISL_428863	2020-03-11	Europe / Russia / Moscow	Human	Vero	Oropharyngeal swab		Illumina MiSeq	bwa v0.7.15, IGV v2.4.14			B.1.1	GR
hCoV-19/Russia/Moscow-62502/2020	EPI_ISL_428864	2020-03-11	Europe / Russia / Moscow	Human	Vero	Oropharyngeal swab		Illumina MiSeq	bwa v0.7.15, IGV v2.4.14			B.1.1	GR
hCoV-19/Russia/Novosibirsk-84101/2020	EPI_ISL_428918	2020-03-27	Europe / Russia / Novosibirsk	Human	Vero	Oropharyngeal swab		Illumina MiSeq	bwa v0.7.15, IGV v2.4.14			B.1.1	GR
hCoV-19/England/NOTT-10F53E/2020	EPI_ISL_433016	2020-04-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/Scotland/EDB1536/2020	EPI_ISL_433075	2020-04-12	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1	G
hCoV-19/Scotland/EDB1541/2020	EPI_ISL_433077	2020-04-12	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1	G
hCoV-19/Scotland/EDB1544/2020	EPI_ISL_433078	2020-04-12	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1	G
hCoV-19/Scotland/EDB1559/2020	EPI_ISL_433081	2020-04-12	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1	G
hCoV-19/Scotland/EDB1609/2020	EPI_ISL_433089	2020-04-14	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1	G
hCoV-19/Scotland/EDB1610/2020	EPI_ISL_433090	2020-04-14	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1	G
hCoV-19/Scotland/EDB1617/2020	EPI_ISL_433091	2020-04-14	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1	G
hCoV-19/Scotland/EDB1683/2020	EPI_ISL_433117	2020-04-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1.1.14	GR
hCoV-19/Scotland/EDB1821/2020	EPI_ISL_433143	2020-04-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1	G
hCoV-19/Scotland/EDB1830/2020	EPI_ISL_433150	2020-04-16	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1	G
hCoV-19/Scotland/EDB1842/2020	EPI_ISL_433154	2020-04-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1	G
hCoV-19/Scotland/EDB2011/2020	EPI_ISL_433162	2020-04-18	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1	G
hCoV-19/Scotland/EDB2057/2020	EPI_ISL_433169	2020-04-18	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1	G
hCoV-19/Scotland/EDB2066/2020	EPI_ISL_433173	2020-04-18	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1	G
hCoV-19/Scotland/EDB2077/2020	EPI_ISL_433176	2020-04-19	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1.1.14	GR
hCoV-19/Scotland/EDB2085/2020	EPI_ISL_433184	2020-04-19	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1	G
hCoV-19/Scotland/EDB703/2020	EPI_ISL_433226	2020-04-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/Scotland/EDB734/2020	EPI_ISL_433233	2020-04-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/Scotland/CVR702/2020	EPI_ISL_433327	2020-03-25	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore MinION				B.1.1.43	GR
hCoV-19/Scotland/EDB1071/2020	EPI_ISL_433381	2020-04-06	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/Scotland/EDB1072/2020	EPI_ISL_433382	2020-04-06	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/Scotland/EDB1081/2020	EPI_ISL_433388	2020-04-07	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1	G
hCoV-19/Scotland/EDB1093/2020	EPI_ISL_433389	2020-04-07	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/Scotland/EDB1101/2020	EPI_ISL_433394	2020-04-07	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1	G
hCoV-19/Scotland/EDB1164/2020	EPI_ISL_433415	2020-04-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1	G
hCoV-19/Scotland/EDB1411/2020	EPI_ISL_433440	2020-04-10	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1	G
hCoV-19/Scotland/CVR1334/2020	EPI_ISL_433544	2020-03-31	Europe / United Kingdom / Scotland	Human	Original			ILLUMINA MiSeq				B.1.1.43	GR
hCoV-19/Scotland/CVR1498/2020	EPI_ISL_433602	2020-04-02	Europe / United Kingdom / Scotland	Human	Original			ILLUMINA MiSeq				B.1.1.13	GR
hCoV-19/Scotland/CVR1673/2020	EPI_ISL_433648	2020-04-06	Europe / United Kingdom / Scotland	Human	Original			ILLUMINA MiSeq				B.1.1.43	GR
hCoV-19/Scotland/CVR1677/2020	EPI_ISL_433651	2020-04-05	Europe / United Kingdom / Scotland	Human	Original			ILLUMINA MiSeq				B.1.1	GR
hCoV-19/Scotland/CVR1698/2020	EPI_ISL_433656	2020-04-05	Europe / United Kingdom / Scotland	Human	Original			ILLUMINA MiSeq				B.1.1.43	GR
hCoV-19/England/CAMB-78461/2020	EPI_ISL_433735	2020-04-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-78470/2020	EPI_ISL_433736	2020-04-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1.164	GR
hCoV-19/England/CAMB-7862F/2020	EPI_ISL_433757	2020-04-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-787E0/2020	EPI_ISL_433775	2020-04-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/CAMB-78838/2020	EPI_ISL_433779	2020-04-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-78874/2020	EPI_ISL_433782	2020-04-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-788ED/2020	EPI_ISL_433789	2020-04-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-78917/2020	EPI_ISL_433791	2020-04-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-78971/2020	EPI_ISL_433797	2020-04-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-79A40/2020	EPI_ISL_433815	2020-03-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1.164	GR
hCoV-19/England/CAMB-7AAF4/2020	EPI_ISL_433839	2020-04-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7ABA6/2020	EPI_ISL_433847	2020-04-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7AE70/2020	EPI_ISL_433886	2020-04-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1.164	GR
hCoV-19/England/CAMB-7AEDA/2020	EPI_ISL_433890	2020-04-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1.208	GR
hCoV-19/England/CAMB-7AF40/2020	EPI_ISL_433897	2020-04-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7B06A/2020	EPI_ISL_433909	2020-04-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7B079/2020	EPI_ISL_433910	2020-04-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7B10D/2020	EPI_ISL_433919	2020-04-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7B11C/2020	EPI_ISL_433920	2020-04-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7B273/2020	EPI_ISL_433934	2020-04-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7B3BC/2020	EPI_ISL_433949	2020-04-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7B45F/2020	EPI_ISL_433959	2020-04-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7B4AA/2020	EPI_ISL_433963	2020-04-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7B510/2020	EPI_ISL_433970	2020-04-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/Australia/QLDID941/2020	EPI_ISL_447594	2020-03-24	Oceania / Australia / Queensland / Sunshine Coast	Human	Original	Swab		Illumina NextSeq	Geneious 11.1.5			B.1.1	GR
hCoV-19/Greece/227_35969/2020	EPI_ISL_447644	2020-03-11	Europe / Greece / Athens	Human	unknown			IonTorrent	Iterative Refinement Meta-Assembler (IRMA)			B.1.1	GR
hCoV-19/Colombia/NAR-GUR-0609/2020	EPI_ISL_447748	2020-03-29	South America / Colombia / Narino / Ipiales	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.231	GR
hCoV-19/Greece/55_36015/2020	EPI_ISL_447834	2020-03-23	Europe / Greece / Athens	Human	unknown			IonTorrent	Iterative Refinement Meta-Assembler (IRMA)			B.1.1	GR
hCoV-19/England/BIRM-5EC1E/2020	EPI_ISL_447933	2020-04-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1ACFF9/2020	EPI_ISL_447955	2020-04-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1AD16B/2020	EPI_ISL_447971	2020-04-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1AD6F3/2020	EPI_ISL_447998	2020-05-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B2048/2020	EPI_ISL_453001	2020-05-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/Scotland/CVR2258/2020	EPI_ISL_453035	2020-04-12	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.43	GR
hCoV-19/Scotland/CVR2798/2020	EPI_ISL_453078	2020-04-20	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.14	GR
hCoV-19/Scotland/EDB4739/2020	EPI_ISL_453142	2020-05-10	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.14	GR
hCoV-19/Scotland/EDB4743/2020	EPI_ISL_453143	2020-05-10	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.14	GR
hCoV-19/Scotland/EDB4746/2020	EPI_ISL_453146	2020-05-11	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/Scotland/EDB4802/2020	EPI_ISL_453153	2020-05-12	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.14	GR
hCoV-19/Scotland/EDB4885/2020	EPI_ISL_453172	2020-05-13	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/Portugal/PT0104/2020	EPI_ISL_453820	2020-03-21	Europe / Portugal	Human	Original			Illumina MiSeq	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0106/2020	EPI_ISL_453822	2020-03-21	Europe / Portugal	Human	Original			Illumina MiSeq	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0107/2020	EPI_ISL_453823	2020-03-21	Europe / Portugal	Human	Original			Illumina MiSeq	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0108/2020	EPI_ISL_453824	2020-03-21	Europe / Portugal	Human	Original			Illumina MiSeq	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0173/2020	EPI_ISL_453889	2020-03-28	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.198	GR
hCoV-19/Portugal/PT0182/2020	EPI_ISL_453898	2020-03-28	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.198	GR
hCoV-19/Portugal/PT0213/2020	EPI_ISL_453927	2020-03-30	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.198	GR
hCoV-19/Portugal/PT0215/2020	EPI_ISL_453929	2020-03-30	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.198	GR
hCoV-19/Portugal/PT0250/2020	EPI_ISL_453964	2020-04-02	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0263/2020	EPI_ISL_453977	2020-04-04	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1.198	GR
hCoV-19/Portugal/PT0270/2020	EPI_ISL_453984	2020-04-05	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0273/2020	EPI_ISL_453987	2020-04-05	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0275/2020	EPI_ISL_453989	2020-04-05	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0276/2020	EPI_ISL_453990	2020-04-05	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Switzerland/VD-ETHZ-130008/2020	EPI_ISL_467004	2020-05-06	Europe / Switzerland / Vaud	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1	G
hCoV-19/Spain/PV-IBV-001525/2020	EPI_ISL_467167	2020-03-17	Europe / Spain / Basque Country / Vitoria	Human	Original			Illumina MiSeq	BWA/IVAR			B.1	G
hCoV-19/USA/AZ-ASU2949/2020	EPI_ISL_467373	2020-03-19	North America / USA / Arizona	Human	Original	Nasopharyngeal swab		Illumina NovaSeq	BWA-MEM, version 0.7.17-r1188, Primerclip v0.3.8beta			B.59	GR
hCoV-19/South Africa/KRISP-0126/2020	EPI_ISL_467478	2020-05-13	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.40	GR
hCoV-19/South Africa/KRISP-0132/2020	EPI_ISL_467484	2020-05-13	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.40	GR
hCoV-19/South Africa/KRISP-0143/2020	EPI_ISL_467493	2020-05-21	Africa / South Africa / KwaZulu-Natal / Stanger	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.56	GR
hCoV-19/South Africa/KRISP-0157/2020	EPI_ISL_467507	2020-05-25	Africa / South Africa / KwaZulu-Natal / Umbilo	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-0170/2020	EPI_ISL_467520	2020-05-31	Africa / South Africa / KwaZulu-Natal / Umbilo	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/USA/CA-SR0463/2020	EPI_ISL_467984	2020-05-19	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2			B.1	G
hCoV-19/Wales/PHWC-15CD94/2020	EPI_ISL_472618	2020-04-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-15D11F/2020	EPI_ISL_472669	2020-05-04	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-160629/2020	EPI_ISL_472955	2020-04-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/South Africa/KRISP-0336/2020	EPI_ISL_487304	2020-06-18	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-0367/2020	EPI_ISL_487318	2020-06-25	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/Greece/9060_HPI/2020	EPI_ISL_487381	2020-04-05	Europe / Greece / Athens	Human	Original	Rhino-pharyngeal swab		Illumina NextSeq				B.1.1	GR
hCoV-19/England/BRIS-12B5C3/2020	EPI_ISL_487524	2020-05-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LOND-D6513/2020	EPI_ISL_487525	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12B648/2020	EPI_ISL_487530	2020-05-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12B2CC/2020	EPI_ISL_487532	2020-05-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LOND-D6452/2020	EPI_ISL_487540	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/LOND-D6531/2020	EPI_ISL_487550	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LOND-D6470/2020	EPI_ISL_487564	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/LOND-D662F/2020	EPI_ISL_487572	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/LOND-D655F/2020	EPI_ISL_487582	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LOND-D6407/2020	EPI_ISL_487589	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/Oman/205039788/2020	EPI_ISL_492008	2020-05-29	Asia / Oman / Muscat	Human	Original	Oropharyngeal swab		Ion Torrent	AssemblyTrinity			B.1.1	GR
hCoV-19/Poland/PL_P41/2020	EPI_ISL_492066	2020-04-02	Europe / Poland / Mazowieckie / Radom	Human	Original	Throat swab		MiSeq V3 2x75 paired reads (Illumina) +Nextera Flex Enrichment Library with Respiratory Virus Oligo Panel capture (Illumina).	BWA, Mark Duplicates Pipeline Spark (GATK v.4.1.5.0)			B.1.1	GR
hCoV-19/Poland/PL_P43/2020	EPI_ISL_492068	2020-04-01	Europe / Poland / Mazowieckie / Radom	Human	Original	Throat swab		MiSeq V3 2x75 paired reads (Illumina) +Nextera Flex Enrichment Library with Respiratory Virus Oligo Panel capture (Illumina).	BWA, Mark Duplicates Pipeline Spark (GATK v.4.1.5.0)			B.1.1	GR
hCoV-19/Poland/PL_P44/2020	EPI_ISL_492069	2020-04-02	Europe / Poland / Mazowieckie / Radom	Human	Original	Throat swab		MiSeq V3 2x75 paired reads (Illumina) +Nextera Flex Enrichment Library with Respiratory Virus Oligo Panel capture (Illumina).	BWA, Mark Duplicates Pipeline Spark (GATK v.4.1.5.0)			B.1.1	GR
hCoV-19/Poland/PL_P45/2020	EPI_ISL_492070	2020-04-13	Europe / Poland / Mazowieckie / Radom	Human	Original	Throat swab		MiSeq V3 2x75 paired reads (Illumina) +Nextera Flex Enrichment Library with Respiratory Virus Oligo Panel capture (Illumina).	BWA, Mark Duplicates Pipeline Spark (GATK v.4.1.5.0)			B.1.1	GR
hCoV-19/Poland/PL_P48/2020	EPI_ISL_492073	2020-04-18	Europe / Poland / Mazowieckie / Warszawa	Human	Original	Throat swab		MiSeq V3 2x75 paired reads (Illumina) +Nextera Flex Enrichment Library with Respiratory Virus Oligo Panel capture (Illumina).	BWA, Mark Duplicates Pipeline Spark (GATK v.4.1.5.0)			B.1.1	GR
hCoV-19/Australia/SA0389/2020	EPI_ISL_492154	2020-03-22	Oceania / Australia / South Australia	Human	Original			Illumina NextSeq 550				B.1.1	GR
hCoV-19/USA/AR-UAMS002/2020	EPI_ISL_492182	2020-07-02	North America / USA / Arkansas	Human	Original	Nasal swab		Nanopore MinION	Artic-network/fieldbioinformatics v1.1.3			B.1.1	GR
hCoV-19/England/CAMB-1B451A/2020	EPI_ISL_492190	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/CAMB-1B45DE/2020	EPI_ISL_492191	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/CAMB-1B4565/2020	EPI_ISL_492194	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/CAMB-1B4626/2020	EPI_ISL_492196	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/CAMB-1B3E89/2020	EPI_ISL_492200	2020-05-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/CAMB-1B44D1/2020	EPI_ISL_492206	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/BRIS-1853E09/2020	EPI_ISL_492232	2020-04-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1853E90/2020	EPI_ISL_492270	2020-04-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1853B4E/2020	EPI_ISL_492284	2020-04-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-185315B/2020	EPI_ISL_492309	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-18532C1/2020	EPI_ISL_492334	2020-04-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/BRIS-1853EBE/2020	EPI_ISL_492349	2020-04-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-29ABF9/2020	EPI_ISL_492458	2020-05-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-2995A1/2020	EPI_ISL_492459	2020-04-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-2994C2/2020	EPI_ISL_492485	2020-04-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-299592/2020	EPI_ISL_492487	2020-04-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LOND-D7EAE/2020	EPI_ISL_492496	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/BRIS-12FE4C/2020	EPI_ISL_492513	2020-04-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1301C7/2020	EPI_ISL_492527	2020-04-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1304CE/2020	EPI_ISL_492586	2020-04-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/BRIS-12FBCD/2020	EPI_ISL_492636	2020-04-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1307D4/2020	EPI_ISL_492641	2020-04-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/BRIS-130455/2020	EPI_ISL_492648	2020-04-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/BRIS-130AF9/2020	EPI_ISL_492664	2020-03-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12FDA9/2020	EPI_ISL_492742	2020-04-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LOND-D88BE/2020	EPI_ISL_492756	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/WSFT-25C0E43/2020	EPI_ISL_492836	2020-05-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.71	GR
hCoV-19/England/WSFT-25C0FD7/2020	EPI_ISL_492838	2020-05-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.71	GR
hCoV-19/England/WSFT-25C1370/2020	EPI_ISL_492841	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.71	GR
hCoV-19/England/LOND-124C337/2020	EPI_ISL_492844	2020-04-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LOND-124C59B/2020	EPI_ISL_492845	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.198	GR
hCoV-19/England/WSFT-25C13CB/2020	EPI_ISL_492849	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LOND-124C470/2020	EPI_ISL_492856	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/LOND-124C522/2020	EPI_ISL_492865	2020-04-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/WSFT-25C0D55/2020	EPI_ISL_492866	2020-05-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LOND-124C5C8/2020	EPI_ISL_492868	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.198	GR
hCoV-19/England/LOND-124C294/2020	EPI_ISL_492880	2020-04-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.198	GR
hCoV-19/England/WSFT-25C13AD/2020	EPI_ISL_492886	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.71	GR
hCoV-19/England/LOND-124C5E6/2020	EPI_ISL_492894	2020-03-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/WSFT-25C110D/2020	EPI_ISL_492899	2020-05-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/WSFT-25C0DEC/2020	EPI_ISL_492900	2020-04-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.71	GR
hCoV-19/England/WSFT-25C0DA0/2020	EPI_ISL_492909	2020-04-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.71	GR
hCoV-19/England/WSFT-25C10A6/2020	EPI_ISL_492910	2020-05-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.71	GR
hCoV-19/England/WSFT-25C1334/2020	EPI_ISL_492915	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.71	GR
hCoV-19/England/NORT-28AF5A/2020	EPI_ISL_492925	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-28BFC2/2020	EPI_ISL_492930	2020-05-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-28C2D7/2020	EPI_ISL_492949	2020-05-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/NORT-28ADE7/2020	EPI_ISL_492959	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-28ADF6/2020	EPI_ISL_492968	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-28B083/2020	EPI_ISL_492974	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Italy/VEN-UniVR-2/2020	EPI_ISL_492981	2020-04-07	Europe / Italy / Veneto / Verona	Human	Original	Oropharyngeal swab		Illumina NextSeq 500	Artic amplicon V3; BWA 0.7.17; Ivar v1.2.2			B.1.1	GR
hCoV-19/South Korea/KCDC2183/2020	EPI_ISL_506977	2020-03-26	Asia / South Korea	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/Switzerland/ZH-ETHZ-220016/2020	EPI_ISL_512000	2020-07-27	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-220018/2020	EPI_ISL_512001	2020-07-27	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/UR-ETHZ-220021/2020	EPI_ISL_512004	2020-07-27	Europe / Switzerland / Uri	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/Switzerland/ZH-ETHZ-220023/2020	EPI_ISL_512006	2020-07-28	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/SH-ETHZ-220027/2020	EPI_ISL_512010	2020-07-28	Europe / Switzerland / Schaffhausen	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.39	GR
hCoV-19/Switzerland/LU-ETHZ-220028/2020	EPI_ISL_512011	2020-07-27	Europe / Switzerland / Lucerne	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/AG-ETHZ-220032/2020	EPI_ISL_512014	2020-07-29	Europe / Switzerland / Aargau	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.406	GR
hCoV-19/Switzerland/BL-ETHZ-220036/2020	EPI_ISL_512017	2020-07-29	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/SG-ETHZ-220043/2020	EPI_ISL_512023	2020-07-30	Europe / Switzerland / St Gallen	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BL-ETHZ-220046/2020	EPI_ISL_512024	2020-07-30	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BE-ETHZ-220059/2020	EPI_ISL_512029	2020-07-25	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/Switzerland/BE-ETHZ-220062/2020	EPI_ISL_512031	2020-07-25	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/Switzerland/BE-ETHZ-220065/2020	EPI_ISL_512034	2020-07-25	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BE-ETHZ-220068/2020	EPI_ISL_512037	2020-07-26	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-220069/2020	EPI_ISL_512038	2020-07-26	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-220070/2020	EPI_ISL_512039	2020-07-26	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BS-ETHZ-220074/2020	EPI_ISL_512043	2020-07-27	Europe / Switzerland / Basel-Stadt	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/GR-ETHZ-220077/2020	EPI_ISL_512045	2020-07-27	Europe / Switzerland / Grisons	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/GR-ETHZ-220078/2020	EPI_ISL_512046	2020-07-27	Europe / Switzerland / Grisons	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-220080/2020	EPI_ISL_512048	2020-07-27	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-220081/2020	EPI_ISL_512049	2020-07-27	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BE-ETHZ-220084/2020	EPI_ISL_512050	2020-07-28	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/Switzerland/BL-ETHZ-220088/2020	EPI_ISL_512053	2020-07-28	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/GR-ETHZ-220089/2020	EPI_ISL_512054	2020-07-28	Europe / Switzerland / Grisons	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Ireland/D-NVRL-71IRL72362/2020	EPI_ISL_512089	2020-07-23	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.406	GR
hCoV-19/Ireland/CO-NVRL-71IRL82463/2020	EPI_ISL_512100	2020-07-24	Europe / Ireland / Cork	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/USA/CA-ALSR-1791/2020	EPI_ISL_512187	2020-05-13	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-1866/2020	EPI_ISL_512212	2020-05-20	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-1894/2020	EPI_ISL_512221	2020-04-22	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-1898/2020	EPI_ISL_512222	2020-04-22	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-1906/2020	EPI_ISL_512227	2020-04-17	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-1907/2020	EPI_ISL_512228	2020-04-23	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-1975/2020	EPI_ISL_512273	2020-04-22	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	IVar 1.2.2			B.1	G
hCoV-19/Ukraine/203100338/2020	EPI_ISL_512617	2020-07-10	Europe / Ukraine	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Costa Rica/INC-0053/2020	EPI_ISL_512659	2020-06-08	North America / Costa Rica / Alajuela / San Carlos	Human	Original	Pharyngeal swab		Illumina MiSeq	metaSPADES (Bankevich et al.,2012); Genome detective virus tool Version 1.126			B.1.1.516	GR
hCoV-19/Costa Rica/INC-0054/2020	EPI_ISL_512660	2020-06-11	North America / Costa Rica / Alajuela / Foreigner	Human	Original	Pharyngeal swab		Illumina MiSeq	metaSPADES (Bankevich et al.,2012); Genome detective virus tool Version 1.126			B.1.1.516	GR
hCoV-19/Costa Rica/INC-0055/2020	EPI_ISL_512661	2020-06-11	North America / Costa Rica / Alajuela / Foreigner	Human	Original	Pharyngeal swab		Illumina MiSeq	metaSPADES (Bankevich et al.,2012); Genome detective virus tool Version 1.126			B.1.1.516	GR
hCoV-19/Costa Rica/INC-0064/2020	EPI_ISL_512670	2020-06-19	North America / Costa Rica / Alajuela / Grecia	Human	Original	Pharyngeal swab		Illumina MiSeq	metaSPADES (Bankevich et al.,2012); Genome detective virus tool Version 1.126			B.1.1.516	GR
hCoV-19/Saudi Arabia/KAUST-JEDDAH494/2020	EPI_ISL_512937	2020-04-09	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.533	G
hCoV-19/Saudi Arabia/KAUST-JEDDAH545/2020	EPI_ISL_512955	2020-04-28	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.1	GR
hCoV-19/Saudi Arabia/KAUST-JEDDAH546/2020	EPI_ISL_512956	2020-04-21	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.533	G
hCoV-19/Saudi Arabia/KAUST-JEDDAH576/2020	EPI_ISL_512969	2020-04-30	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.533	G
hCoV-19/Saudi Arabia/KAUST-JEDDAH755/2020	EPI_ISL_512998	2020-04-02	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.398	G
hCoV-19/USA/OR-OHSU-1689/2020	EPI_ISL_526004	2020-07-23	North America / USA / Oregon / Clackamas County	Human	Original	Nasopharyngeal swab		Illumina NextSeq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1	G
hCoV-19/USA/OR-OHSU-1729/2020	EPI_ISL_526015	2020-07-24	North America / USA / Oregon / Yamhill County	Human	Original	Nasopharyngeal swab		Illumina NextSeq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.1	GR
hCoV-19/USA/WA-OHSU-1647/2020	EPI_ISL_526105	2020-07-22	North America / USA / Washington / Clark County	Human	Original	Nasopharyngeal swab		Illumina NextSeq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.1.61	GR
hCoV-19/USA/WA-OHSU-1909/2020	EPI_ISL_526110	2020-07-28	North America / USA / Washington / Clark County	Human	Original	Nasopharyngeal swab		Illumina NextSeq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1	G
hCoV-19/Hungary/MH-13211/2020	EPI_ISL_526225	2020-07-06	Europe / Hungary / Pest county	Human	Original	Oropharyngeal swab		Nanopore MinION, Sanger	Geneious 10.2.4.			B.1	G
hCoV-19/Canada/ON-UHTC_0139/2020	EPI_ISL_526275	2020-05-31	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3			B.1.1	GR
hCoV-19/England/ALDP-97BDF1/2020	EPI_ISL_526294	2020-07-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/England/ALDP-97BFA0/2020	EPI_ISL_526295	2020-07-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/England/ALDP-97BFBF/2020	EPI_ISL_526296	2020-07-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.171	GR
hCoV-19/England/ALDP-97BFFB/2020	EPI_ISL_526298	2020-07-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.171	GR
hCoV-19/England/ALDP-97C385/2020	EPI_ISL_526301	2020-07-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.171	GR
hCoV-19/England/ALDP-97CB9C/2020	EPI_ISL_526309	2020-07-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/England/ALDP-97CF90/2020	EPI_ISL_526318	2020-07-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/England/ALDP-97CFAF/2020	EPI_ISL_526319	2020-07-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/England/ALDP-97D6A9/2020	EPI_ISL_526327	2020-07-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/England/ALDP-97DD4A/2020	EPI_ISL_526332	2020-07-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/England/ALDP-97DDB3/2020	EPI_ISL_526333	2020-07-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/England/ALDP-97FB5D/2020	EPI_ISL_526340	2020-08-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.25	GR
hCoV-19/England/ALDP-9802AF/2020	EPI_ISL_526346	2020-08-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.269	GR
hCoV-19/England/ALDP-980579/2020	EPI_ISL_526348	2020-08-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/England/LIVE-A97AA/2020	EPI_ISL_526394	2020-06-01	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/MILK-9772C9/2020	EPI_ISL_526395	2020-07-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.227	GR
hCoV-19/England/MILK-9773C6/2020	EPI_ISL_526396	2020-07-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.227	GR
hCoV-19/England/MILK-97742D/2020	EPI_ISL_526397	2020-07-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.227	GR
hCoV-19/England/MILK-97743C/2020	EPI_ISL_526398	2020-07-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.227	GR
hCoV-19/England/MILK-977663/2020	EPI_ISL_526399	2020-07-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.227	GR
hCoV-19/England/MILK-977B64/2020	EPI_ISL_526401	2020-07-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.227	GR
hCoV-19/England/MILK-977DAA/2020	EPI_ISL_526402	2020-07-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.227	GR
hCoV-19/England/MILK-977DC8/2020	EPI_ISL_526403	2020-07-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.227	GR
hCoV-19/England/MILK-97828C/2020	EPI_ISL_526405	2020-07-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.227	GR
hCoV-19/England/MILK-9782D7/2020	EPI_ISL_526406	2020-07-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.227	GR
hCoV-19/England/MILK-9782E6/2020	EPI_ISL_526407	2020-07-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.227	GR
hCoV-19/England/MILK-9782F5/2020	EPI_ISL_526408	2020-07-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.227	GR
hCoV-19/England/MILK-97832F/2020	EPI_ISL_526410	2020-07-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.227	GR
hCoV-19/England/MILK-97833E/2020	EPI_ISL_526411	2020-07-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.227	GR
hCoV-19/England/MILK-978389/2020	EPI_ISL_526412	2020-07-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.227	GR
hCoV-19/England/MILK-978477/2020	EPI_ISL_526413	2020-07-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.227	GR
hCoV-19/England/MILK-978486/2020	EPI_ISL_526414	2020-07-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.227	GR
hCoV-19/England/MILK-978495/2020	EPI_ISL_526415	2020-07-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.227	GR
hCoV-19/England/MILK-978583/2020	EPI_ISL_526418	2020-07-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.227	GR
hCoV-19/England/MILK-9785A1/2020	EPI_ISL_526419	2020-07-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.227	GR
hCoV-19/England/MILK-9785B0/2020	EPI_ISL_526420	2020-07-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.227	GR
hCoV-19/England/MILK-978AB1/2020	EPI_ISL_526423	2020-08-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.227	GR
hCoV-19/England/MILK-978AC0/2020	EPI_ISL_526424	2020-08-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.227	GR
hCoV-19/Scotland/CVR3969/2020	EPI_ISL_526458	2020-08-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.269	GR
hCoV-19/Scotland/EDB1491/2020	EPI_ISL_526459	2020-04-12	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/Scotland/EDB1496/2020	EPI_ISL_526460	2020-04-12	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/Scotland/EDB1729/2020	EPI_ISL_526465	2020-04-15	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/Scotland/EDB1757/2020	EPI_ISL_526466	2020-04-14	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/Scotland/EDB1762/2020	EPI_ISL_526467	2020-04-14	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/Scotland/EDB1785/2020	EPI_ISL_526469	2020-04-15	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/Scotland/EDB3785/2020	EPI_ISL_526473	2020-04-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/Scotland/EDB7185/2020	EPI_ISL_526521	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7275/2020	EPI_ISL_526526	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7358/2020	EPI_ISL_526532	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7359/2020	EPI_ISL_526533	2020-08-13	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7360/2020	EPI_ISL_526534	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7365/2020	EPI_ISL_526536	2020-04-18	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/England/201720576/2020	EPI_ISL_526755	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/201720577/2020	EPI_ISL_526756	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/201780590/2020	EPI_ISL_526758	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/201780626/2020	EPI_ISL_526759	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.164	GR
hCoV-19/USA/VA-DCLS-0722/2020	EPI_ISL_526845	2020-07-06	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0723/2020	EPI_ISL_526846	2020-07-06	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0724/2020	EPI_ISL_526847	2020-07-09	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0725/2020	EPI_ISL_526848	2020-07-09	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0726/2020	EPI_ISL_526849	2020-07-09	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0727/2020	EPI_ISL_526850	2020-07-09	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0728/2020	EPI_ISL_526851	2020-07-09	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0729/2020	EPI_ISL_526852	2020-07-09	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0731/2020	EPI_ISL_526853	2020-07-08	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0732/2020	EPI_ISL_526854	2020-07-08	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0733/2020	EPI_ISL_526855	2020-07-16	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0734/2020	EPI_ISL_526856	2020-07-16	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0760/2020	EPI_ISL_526876	2020-06-24	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0761/2020	EPI_ISL_526877	2020-06-23	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0762/2020	EPI_ISL_526878	2020-06-29	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0763/2020	EPI_ISL_526879	2020-06-30	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0764/2020	EPI_ISL_526880	2020-06-29	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0765/2020	EPI_ISL_526881	2020-06-30	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/England/QEUH-96B43B/2020	EPI_ISL_531338	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96BE1F/2020	EPI_ISL_531341	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/QEUH-96AC16/2020	EPI_ISL_531343	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96BC15/2020	EPI_ISL_531346	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/QEUH-96B037/2020	EPI_ISL_531348	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-96B723/2020	EPI_ISL_531350	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96BE6A/2020	EPI_ISL_531353	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/QEUH-96B3E3/2020	EPI_ISL_531396	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/QEUH-96BB72/2020	EPI_ISL_531431	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Wales/QEUH-96BF94/2020	EPI_ISL_531433	2020-08-14	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/QEUH-96BCCA/2020	EPI_ISL_531444	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/QEUH-96BEA6/2020	EPI_ISL_531447	2020-08-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96A40F/2020	EPI_ISL_531468	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/Scotland/QEUH-96313C/2020	EPI_ISL_531483	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-963DFC/2020	EPI_ISL_531484	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-963E71/2020	EPI_ISL_531486	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/QEUH-963A5F/2020	EPI_ISL_531499	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/QEUH-96A6FA/2020	EPI_ISL_531507	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-96A5A2/2020	EPI_ISL_531511	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-96A42D/2020	EPI_ISL_531514	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-9639F8/2020	EPI_ISL_531515	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-963CA4/2020	EPI_ISL_531518	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-963011/2020	EPI_ISL_531519	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/QEUH-963CC2/2020	EPI_ISL_531521	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/Scotland/QEUH-963E08/2020	EPI_ISL_531524	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-963970/2020	EPI_ISL_531535	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-96314B/2020	EPI_ISL_531546	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96315A/2020	EPI_ISL_531548	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9639BC/2020	EPI_ISL_531557	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-963BE3/2020	EPI_ISL_531564	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96A663/2020	EPI_ISL_531565	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96A672/2020	EPI_ISL_531570	2020-08-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96303F/2020	EPI_ISL_531575	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-963758/2020	EPI_ISL_531596	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-963907/2020	EPI_ISL_531598	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-961FAD/2020	EPI_ISL_531599	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-962FE8/2020	EPI_ISL_531607	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-963354/2020	EPI_ISL_531617	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Northern Ireland/QEUH-963406/2020	EPI_ISL_531622	2020-08-11	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1.133	GR
hCoV-19/Scotland/QEUH-96280B/2020	EPI_ISL_531625	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-961FDA/2020	EPI_ISL_531631	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96363D/2020	EPI_ISL_531638	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-962276/2020	EPI_ISL_531639	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-962C69/2020	EPI_ISL_531649	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96358B/2020	EPI_ISL_531650	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/QEUH-962A50/2020	EPI_ISL_531651	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/Scotland/QEUH-965AE4/2020	EPI_ISL_531660	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-962AC9/2020	EPI_ISL_531671	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/Scotland/QEUH-962FCA/2020	EPI_ISL_531672	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9631D2/2020	EPI_ISL_531678	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-963002/2020	EPI_ISL_531690	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96357C/2020	EPI_ISL_531743	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9620D6/2020	EPI_ISL_531746	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-962470/2020	EPI_ISL_531748	2020-08-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/Scotland/QEUH-9636E2/2020	EPI_ISL_531754	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96372B/2020	EPI_ISL_531755	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9636F1/2020	EPI_ISL_531757	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-962C5A/2020	EPI_ISL_531764	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/QEUH-9636A6/2020	EPI_ISL_531777	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-962A8D/2020	EPI_ISL_531798	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-961F43/2020	EPI_ISL_531799	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/QEUH-96021E/2020	EPI_ISL_531903	2020-08-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/Scotland/QEUH-960032/2020	EPI_ISL_531905	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-95FDD5/2020	EPI_ISL_531906	2020-08-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/QEUH-95FBDB/2020	EPI_ISL_531908	2020-08-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-95FDF3/2020	EPI_ISL_531910	2020-08-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/Scotland/QEUH-960023/2020	EPI_ISL_531912	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95FCD8/2020	EPI_ISL_531913	2020-08-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95FDB7/2020	EPI_ISL_531918	2020-08-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95FF66/2020	EPI_ISL_531919	2020-08-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-95FCBA/2020	EPI_ISL_531920	2020-08-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/Northern Ireland/QEUH-95FD20/2020	EPI_ISL_531921	2020-08-05	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/Northern Ireland/QEUH-95FEC3/2020	EPI_ISL_531924	2020-08-07	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1.133	GR
hCoV-19/Scotland/QEUH-95FFEE/2020	EPI_ISL_531925	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-95FC6F/2020	EPI_ISL_531926	2020-08-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-960102/2020	EPI_ISL_531927	2020-08-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/Scotland/QEUH-95FE1E/2020	EPI_ISL_531929	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-960005/2020	EPI_ISL_531930	2020-08-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/QEUH-96009C/2020	EPI_ISL_531931	2020-08-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/Scotland/QEUH-960041/2020	EPI_ISL_531932	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-961189/2020	EPI_ISL_531933	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-960849/2020	EPI_ISL_531934	2020-08-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/QEUH-961286/2020	EPI_ISL_531940	2020-08-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/QEUH-96082B/2020	EPI_ISL_531944	2020-07-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.133	GR
hCoV-19/Scotland/QEUH-9610B9/2020	EPI_ISL_531945	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9610AA/2020	EPI_ISL_531951	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96080D/2020	EPI_ISL_531952	2020-08-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/QEUH-96071F/2020	EPI_ISL_531953	2020-08-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-96059D/2020	EPI_ISL_531957	2020-08-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-960B40/2020	EPI_ISL_531962	2020-08-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/Scotland/QEUH-96131A/2020	EPI_ISL_531963	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9612A4/2020	EPI_ISL_531967	2020-08-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/Scotland/QEUH-96121D/2020	EPI_ISL_531973	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-960287/2020	EPI_ISL_531975	2020-08-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/Scotland/QEUH-960F35/2020	EPI_ISL_531978	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/Scotland/QEUH-960C10/2020	EPI_ISL_531979	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9606E5/2020	EPI_ISL_531982	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96105F/2020	EPI_ISL_531983	2020-08-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/Scotland/QEUH-960E83/2020	EPI_ISL_531984	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-9607F1/2020	EPI_ISL_531989	2020-08-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-960560/2020	EPI_ISL_531990	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-960472/2020	EPI_ISL_531994	2020-08-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/Scotland/QEUH-960C2F/2020	EPI_ISL_531995	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/TX-HMH-686/2020	EPI_ISL_546295	2020-04-15	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.61	GR
hCoV-19/England/MILK-9A8DFB/2020	EPI_ISL_551004	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/Wales/MILK-9A970B/2020	EPI_ISL_551005	2020-09-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A9291/2020	EPI_ISL_551008	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A8EF8/2020	EPI_ISL_551022	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AB48A/2020	EPI_ISL_551032	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A954D/2020	EPI_ISL_551034	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.39	GR
hCoV-19/England/MILK-9A8F6E/2020	EPI_ISL_551041	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9A9D90/2020	EPI_ISL_551044	2020-08-31	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A94F5/2020	EPI_ISL_551045	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-9A9AF3/2020	EPI_ISL_551052	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AAE14/2020	EPI_ISL_551055	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/Wales/MILK-9A94AA/2020	EPI_ISL_551057	2020-09-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AB341/2020	EPI_ISL_551059	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AB4B7/2020	EPI_ISL_551062	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AB059/2020	EPI_ISL_551069	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/MILK-9A9C48/2020	EPI_ISL_551070	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A9185/2020	EPI_ISL_551073	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/MILK-9A9EE8/2020	EPI_ISL_551074	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A9176/2020	EPI_ISL_551080	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A9BA5/2020	EPI_ISL_551082	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AB314/2020	EPI_ISL_551093	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A9CC0/2020	EPI_ISL_551094	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.198	GR
hCoV-19/England/MILK-9AB4D5/2020	EPI_ISL_551099	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AB39C/2020	EPI_ISL_551113	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/MILK-9A9AE4/2020	EPI_ISL_551117	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-9A963B/2020	EPI_ISL_551122	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.39	G
hCoV-19/England/MILK-9A903D/2020	EPI_ISL_551149	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A912B/2020	EPI_ISL_551150	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A9194/2020	EPI_ISL_551155	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AB4C6/2020	EPI_ISL_551162	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A956B/2020	EPI_ISL_551165	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9A9255/2020	EPI_ISL_551166	2020-09-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A99C9/2020	EPI_ISL_551205	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9A91D0/2020	EPI_ISL_551220	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9A9AD5/2020	EPI_ISL_551225	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-9AAF8A/2020	EPI_ISL_551230	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A964A/2020	EPI_ISL_551231	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A9B3C/2020	EPI_ISL_551232	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-9AB03B/2020	EPI_ISL_551241	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9A9C1B/2020	EPI_ISL_551244	2020-09-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AB29F/2020	EPI_ISL_551245	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A9695/2020	EPI_ISL_551246	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/MILK-9A96FF/2020	EPI_ISL_551252	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/MILK-9AB4A8/2020	EPI_ISL_551260	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9A8E43/2020	EPI_ISL_551263	2020-08-30	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9AAEC9/2020	EPI_ISL_551272	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/MILK-9A9E24/2020	EPI_ISL_551274	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A8E52/2020	EPI_ISL_551278	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/ALDP-951D6A/2020	EPI_ISL_551304	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/ALDP-951FCE/2020	EPI_ISL_551309	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/ALDP-951EA3/2020	EPI_ISL_551311	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/ALDP-951EB2/2020	EPI_ISL_551320	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/ALDP-951FA0/2020	EPI_ISL_551325	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-951D88/2020	EPI_ISL_551330	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/ALDP-951B51/2020	EPI_ISL_551344	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.238	G
hCoV-19/England/ALDP-951E1C/2020	EPI_ISL_551345	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-90B8D7/2020	EPI_ISL_551357	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.97	GR
hCoV-19/England/ALDP-90655D/2020	EPI_ISL_551359	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.15	GR
hCoV-19/England/ALDP-8FEC72/2020	EPI_ISL_551368	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-9101A7/2020	EPI_ISL_551372	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/ALDP-92BD2D/2020	EPI_ISL_551373	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-90D6AE/2020	EPI_ISL_551381	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-93328D/2020	EPI_ISL_551450	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/ALDP-92BBBA/2020	EPI_ISL_551455	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-91AF94/2020	EPI_ISL_551459	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-900702/2020	EPI_ISL_551469	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/ALDP-91B106/2020	EPI_ISL_551488	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-9044BC/2020	EPI_ISL_551491	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-904856/2020	EPI_ISL_551497	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9009B1/2020	EPI_ISL_551504	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.253	GR
hCoV-19/England/ALDP-92D1F2/2020	EPI_ISL_551508	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-90456E/2020	EPI_ISL_551515	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-90069C/2020	EPI_ISL_551523	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.253	GR
hCoV-19/England/ALDP-90CDD7/2020	EPI_ISL_551535	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.95	GR
hCoV-19/England/ALDP-92EA50/2020	EPI_ISL_551536	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/ALDP-9058A0/2020	EPI_ISL_551539	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-90E573/2020	EPI_ISL_551543	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-925DAB/2020	EPI_ISL_551544	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-91A18F/2020	EPI_ISL_551556	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-92E8FC/2020	EPI_ISL_551559	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/MILK-993FFD/2020	EPI_ISL_551587	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-994071/2020	EPI_ISL_551596	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/MILK-995C4F/2020	EPI_ISL_551604	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-995B24/2020	EPI_ISL_551605	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/MILK-995ADC/2020	EPI_ISL_551607	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-9959A2/2020	EPI_ISL_551617	2020-08-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-995984/2020	EPI_ISL_551621	2020-08-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-995AFA/2020	EPI_ISL_551622	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9958B4/2020	EPI_ISL_551629	2020-08-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-9958C3/2020	EPI_ISL_551636	2020-08-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/Wales/MILK-993DD5/2020	EPI_ISL_551637	2020-08-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99423F/2020	EPI_ISL_551638	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-994053/2020	EPI_ISL_551662	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/MILK-993FC0/2020	EPI_ISL_551670	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-995939/2020	EPI_ISL_551671	2020-08-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-995993/2020	EPI_ISL_551680	2020-08-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-995948/2020	EPI_ISL_551690	2020-08-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-993FEE/2020	EPI_ISL_551691	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/Wales/MILK-993F66/2020	EPI_ISL_551692	2020-08-25	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-994202/2020	EPI_ISL_551700	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-993DE4/2020	EPI_ISL_551704	2020-08-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9941F6/2020	EPI_ISL_551730	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-680196/2020	EPI_ISL_551736	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/MILK-6A027F/2020	EPI_ISL_551747	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.15	GR
hCoV-19/England/MILK-69C0B8/2020	EPI_ISL_551748	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.15	GR
hCoV-19/England/ALDP-68397D/2020	EPI_ISL_551755	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-683852/2020	EPI_ISL_551763	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-67901B/2020	EPI_ISL_551764	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-67E09E/2020	EPI_ISL_551772	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-68696B/2020	EPI_ISL_551776	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-6789B7/2020	EPI_ISL_551780	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-683D08/2020	EPI_ISL_551785	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/MILK-6A69DE/2020	EPI_ISL_551790	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-6A185E/2020	EPI_ISL_551791	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.15	GR
hCoV-19/England/ALDP-6839B9/2020	EPI_ISL_551795	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-67D7C7/2020	EPI_ISL_551799	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/MILK-6A7120/2020	EPI_ISL_551814	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.15	GR
hCoV-19/England/MILK-6ABF04/2020	EPI_ISL_551817	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/ALDP-693682/2020	EPI_ISL_551818	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-67FB6F/2020	EPI_ISL_551825	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-688019/2020	EPI_ISL_551827	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/MILK-69ECA3/2020	EPI_ISL_551829	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-67A6DC/2020	EPI_ISL_551831	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-6832DC/2020	EPI_ISL_551834	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-990A95/2020	EPI_ISL_551845	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/CAMC-9911DB/2020	EPI_ISL_551853	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/CAMC-990A3B/2020	EPI_ISL_551859	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/CAMC-9911AE/2020	EPI_ISL_551870	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-990DF6/2020	EPI_ISL_551883	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.39	GR
hCoV-19/USA/WA-UW-12911/2020	EPI_ISL_570929	2020-06-29	North America / USA / Washington	Human	Original			Illumina	custom			B.1.169	G
hCoV-19/USA/WA-UW-13068/2020	EPI_ISL_570945	2020-06-30	North America / USA / Washington	Human	Original			Illumina	custom			B.1.240	G
hCoV-19/USA/WA-UW-13082/2020	EPI_ISL_570949	2020-06-30	North America / USA / Washington	Human	Original			Illumina	custom			B.1.240	G
hCoV-19/USA/WA-UW-13084/2020	EPI_ISL_570951	2020-06-30	North America / USA / Washington	Human	Original			Illumina	custom			B.1.240	G
hCoV-19/USA/WA-UW-13110/2020	EPI_ISL_570955	2020-06-30	North America / USA / Washington	Human	Original			Illumina	custom			B.1.240	G
hCoV-19/USA/WA-UW-13370/2020	EPI_ISL_570967	2020-07-01	North America / USA / Washington	Human	Original			Illumina	custom			B.1.240	G
hCoV-19/USA/WA-UW-19695/2020	EPI_ISL_570985	2020-08-02	North America / USA / Washington	Human	Original			Illumina	custom			B.1.240	G
hCoV-19/USA/IL-QDX-282/2020	EPI_ISL_571033	2020-03-18	North America / USA / Illinois	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.59	GR
hCoV-19/USA/MI-QDX-357/2020	EPI_ISL_571100	2020-03-23	North America / USA / Michigan	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.59	GR
hCoV-19/USA/MI-QDX-376/2020	EPI_ISL_571119	2020-03-24	North America / USA / Michigan	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.59	GR
hCoV-19/USA/MI-QDX-379/2020	EPI_ISL_571121	2020-03-22	North America / USA / Michigan	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.59	GR
hCoV-19/USA/CA-QDX-513/2020	EPI_ISL_571176	2020-03-27	North America / USA / California	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1.61	GR
hCoV-19/New Zealand/20VR2723/2020	EPI_ISL_579341	2020	Oceania / New Zealand / Auckland	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC protocol			B.1.1	GR
hCoV-19/New Zealand/20VR3031/2020	EPI_ISL_579395	2020	Oceania / New Zealand / Combined Wellington	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC protocol			B.59	GR
hCoV-19/Canada/NS-NML-884/2020	EPI_ISL_579537	2020-03-18	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.1	GR
hCoV-19/Canada/NS-NML-901/2020	EPI_ISL_579550	2020-03-21	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.1.176	GR
hCoV-19/Canada/NS-NML-908/2020	EPI_ISL_579557	2020-03-22	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.1.176	GR
hCoV-19/Canada/NS-NML-957/2020	EPI_ISL_579586	2020-03-28	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.1	GR
hCoV-19/Canada/NS-NML-1196/2020	EPI_ISL_579597	2020-03-31	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.1.176	GR
hCoV-19/Canada/NS-NML-1207/2020	EPI_ISL_579607	2020-04-02	North America / Canada / Nova Scotia	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.1.176	GR
hCoV-19/England/QEUH-9E4BAE/2020	EPI_ISL_579858	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9E5475/2020	EPI_ISL_579861	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9E4616/2020	EPI_ISL_579867	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9E4E5A/2020	EPI_ISL_579871	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9E4F93/2020	EPI_ISL_579875	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/QEUH-9E478C/2020	EPI_ISL_579890	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9E477D/2020	EPI_ISL_579899	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9E4B44/2020	EPI_ISL_579901	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9E493B/2020	EPI_ISL_579912	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9EA355/2020	EPI_ISL_579942	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/ALDP-9EA892/2020	EPI_ISL_579954	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9EAC4B/2020	EPI_ISL_579962	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_E33stop results in 73.6% truncation of the protein sequence.	info	B.1.1.67	GR
hCoV-19/England/ALDP-9EA197/2020	EPI_ISL_579965	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9EA1C4/2020	EPI_ISL_579990	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9E9CA6/2020	EPI_ISL_579992	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/SHEF-C5720/2020	EPI_ISL_585023	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/SHEF-CF28F/2020	EPI_ISL_585074	2020-10-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Northern Ireland/NIRE-106F93/2020	EPI_ISL_585092	2020-03-28	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-1071D8/2020	EPI_ISL_585122	2020-03-27	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-1074A2/2020	EPI_ISL_585156	2020-03-30	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-1075BE/2020	EPI_ISL_585172	2020-03-29	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.198	GR
hCoV-19/Northern Ireland/NIRE-108289/2020	EPI_ISL_585180	2020-04-01	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-1082D4/2020	EPI_ISL_585183	2020-03-31	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-1083B3/2020	EPI_ISL_585187	2020-09-12	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-1083D1/2020	EPI_ISL_585188	2020-09-09	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-1083FF/2020	EPI_ISL_585189	2020-09-09	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-108438/2020	EPI_ISL_585190	2020-09-09	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-1086F6/2020	EPI_ISL_585196	2020-09-13	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-108711/2020	EPI_ISL_585197	2020-09-13	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-1087B7/2020	EPI_ISL_585204	2020-09-14	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-10881E/2020	EPI_ISL_585206	2020-09-12	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-10883C/2020	EPI_ISL_585207	2020-09-12	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-10885A/2020	EPI_ISL_585208	2020-09-11	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-108896/2020	EPI_ISL_585211	2020-09-11	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-1088B4/2020	EPI_ISL_585213	2020-09-11	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-1088D2/2020	EPI_ISL_585215	2020-09-11	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-1088E1/2020	EPI_ISL_585216	2020-09-10	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-10892A/2020	EPI_ISL_585218	2020-09-10	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-108948/2020	EPI_ISL_585220	2020-09-10	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-FB2A8/2020	EPI_ISL_585223	2020-08-30	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-FB2C6/2020	EPI_ISL_585224	2020-08-30	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-FB2E4/2020	EPI_ISL_585225	2020-08-29	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-FB34B/2020	EPI_ISL_585227	2020-08-31	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-FB369/2020	EPI_ISL_585228	2020-08-31	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-FB387/2020	EPI_ISL_585229	2020-08-25	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-FB3A5/2020	EPI_ISL_585230	2020-08-29	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-FB527/2020	EPI_ISL_585232	2020-08-24	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-FB545/2020	EPI_ISL_585234	2020-08-24	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-FB563/2020	EPI_ISL_585236	2020-08-24	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-FB572/2020	EPI_ISL_585237	2020-08-25	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-FB581/2020	EPI_ISL_585238	2020-08-24	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-FB590/2020	EPI_ISL_585239	2020-08-25	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-FB5DC/2020	EPI_ISL_585241	2020-08-26	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-FB5FA/2020	EPI_ISL_585242	2020-08-26	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-FB606/2020	EPI_ISL_585243	2020-09-09	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-FB624/2020	EPI_ISL_585244	2020-08-30	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-FB642/2020	EPI_ISL_585245	2020-08-30	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Scotland/CVR4398/2020	EPI_ISL_585272	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4421/2020	EPI_ISL_585295	2020-09-19	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/Wales/CAMC-9D70EB/2020	EPI_ISL_585625	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Wales/PHWC-16DF8B/2020	EPI_ISL_585646	2020-09-28	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16E0D2/2020	EPI_ISL_585667	2020-09-30	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16EA10/2020	EPI_ISL_585806	2020-10-01	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16F077/2020	EPI_ISL_585906	2020-10-04	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16F129/2020	EPI_ISL_585916	2020-10-03	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9D112A/2020	EPI_ISL_590010	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CE4BE/2020	EPI_ISL_590016	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CE1F3/2020	EPI_ISL_590024	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CE472/2020	EPI_ISL_590028	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CF0C8/2020	EPI_ISL_590033	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CE5AC/2020	EPI_ISL_590037	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CF7F0/2020	EPI_ISL_590038	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CEB31/2020	EPI_ISL_590044	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CF3ED/2020	EPI_ISL_590048	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CF5BA/2020	EPI_ISL_590054	2020-09-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/England/QEUH-9CF59C/2020	EPI_ISL_590055	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CF963/2020	EPI_ISL_590060	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CE454/2020	EPI_ISL_590064	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CF65D/2020	EPI_ISL_590082	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CF09B/2020	EPI_ISL_590086	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/QEUH-9CEA43/2020	EPI_ISL_590089	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.310	GR
hCoV-19/England/QEUH-9CED95/2020	EPI_ISL_590090	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CF4EA/2020	EPI_ISL_590094	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CE1E4/2020	EPI_ISL_590097	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CE8D0/2020	EPI_ISL_590098	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CE7E2/2020	EPI_ISL_590099	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CE9FB/2020	EPI_ISL_590124	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CEE74/2020	EPI_ISL_590134	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CF259/2020	EPI_ISL_590137	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-9CE4CD/2020	EPI_ISL_590138	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CE849/2020	EPI_ISL_590144	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CE83A/2020	EPI_ISL_590146	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CE8A3/2020	EPI_ISL_590153	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CE876/2020	EPI_ISL_590155	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CF031/2020	EPI_ISL_590168	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9B5AE5/2020	EPI_ISL_590186	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/ALDP-9B5C3A/2020	EPI_ISL_590193	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-9B5890/2020	EPI_ISL_590194	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B46F1/2020	EPI_ISL_590196	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9B5C1C/2020	EPI_ISL_590210	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-9B5C58/2020	EPI_ISL_590214	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9B57EE/2020	EPI_ISL_590224	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/QEUH-9B4F50/2020	EPI_ISL_590233	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B48BF/2020	EPI_ISL_590243	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B5256/2020	EPI_ISL_590244	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-9B4AB9/2020	EPI_ISL_590248	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B4F41/2020	EPI_ISL_590249	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B47C1/2020	EPI_ISL_590254	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.198	GR
hCoV-19/England/ALDP-9B5A7C/2020	EPI_ISL_590257	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9B5BD3/2020	EPI_ISL_590260	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9B5B00/2020	EPI_ISL_590265	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9B57C0/2020	EPI_ISL_590276	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-9B5915/2020	EPI_ISL_590284	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-9B55B7/2020	EPI_ISL_590285	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-9B4891/2020	EPI_ISL_590293	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9B5827/2020	EPI_ISL_590295	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-9B4828/2020	EPI_ISL_590298	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B5362/2020	EPI_ISL_590299	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B5414/2020	EPI_ISL_590303	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-9B57B1/2020	EPI_ISL_590306	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/ALDP-9B5793/2020	EPI_ISL_590309	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9B5924/2020	EPI_ISL_590337	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/QEUH-9B49CB/2020	EPI_ISL_590339	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B4D74/2020	EPI_ISL_590343	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9B5818/2020	EPI_ISL_590346	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/QEUH-9B4916/2020	EPI_ISL_590356	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B50E3/2020	EPI_ISL_590360	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B4FF6/2020	EPI_ISL_590374	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B4864/2020	EPI_ISL_590376	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B50C5/2020	EPI_ISL_590377	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9B5B5B/2020	EPI_ISL_590383	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B5696/2020	EPI_ISL_590384	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-9B49DA/2020	EPI_ISL_590385	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9B5C0D/2020	EPI_ISL_590390	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/QEUH-9B5502/2020	EPI_ISL_590410	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/QEUH-9B49F8/2020	EPI_ISL_590417	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B4E62/2020	EPI_ISL_590430	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/QEUH-9B49BC/2020	EPI_ISL_590432	2020-09-03	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B5405/2020	EPI_ISL_590436	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Northern Ireland/QEUH-9B46D3/2020	EPI_ISL_590443	2020-09-04	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B4C1D/2020	EPI_ISL_590444	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/QEUH-9B49AD/2020	EPI_ISL_590454	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B562D/2020	EPI_ISL_590456	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-9B7685/2020	EPI_ISL_590464	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B81A1/2020	EPI_ISL_590466	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B7B59/2020	EPI_ISL_590470	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B7D08/2020	EPI_ISL_590473	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B7B77/2020	EPI_ISL_590474	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B701E/2020	EPI_ISL_590478	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B789E/2020	EPI_ISL_590485	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B78DA/2020	EPI_ISL_590510	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B79AA/2020	EPI_ISL_590524	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B744F/2020	EPI_ISL_590528	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B7FC6/2020	EPI_ISL_590534	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B7AF2/2020	EPI_ISL_590548	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B79C8/2020	EPI_ISL_590566	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B7719/2020	EPI_ISL_590569	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B6ED9/2020	EPI_ISL_590583	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B7A89/2020	EPI_ISL_590586	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-9B7272/2020	EPI_ISL_590589	2020-09-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B7870/2020	EPI_ISL_590591	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B78E9/2020	EPI_ISL_590609	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B77A0/2020	EPI_ISL_590614	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B7E23/2020	EPI_ISL_590625	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B702D/2020	EPI_ISL_590636	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B7649/2020	EPI_ISL_590639	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B795F/2020	EPI_ISL_590648	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B788F/2020	EPI_ISL_590651	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B78BC/2020	EPI_ISL_590652	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B74D6/2020	EPI_ISL_590668	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B6FA9/2020	EPI_ISL_590671	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/QEUH-9B7A3E/2020	EPI_ISL_590681	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/MI-UM-10036226294/2020	EPI_ISL_590723	2020-10-01	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.240	G
hCoV-19/USA/MI-UM-10036206650/2020	EPI_ISL_590736	2020-09-30	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.240	G
hCoV-19/Switzerland/AG-UZH-IMV11/2020	EPI_ISL_590833	2020-05-04	Europe / Switzerland / Aargau	Human	Vero P2	Oropharyngeal swab		Illumina MiSeq	SMALT, 50% ambiguity threshold			B.1	G
hCoV-19/Norway/3361/2020	EPI_ISL_590881	2020-09-08	Europe / Norway / Oslo	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1.39	G
hCoV-19/Norway/3426/2020	EPI_ISL_590899	2020-09-09	Europe / Norway / Vestland	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1	G
hCoV-19/Norway/3262/2020	EPI_ISL_590904	2020-08-31	Europe / Norway / Agder	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.236	G
hCoV-19/Norway/3263/2020	EPI_ISL_590905	2020-08-31	Europe / Norway / Agder	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.236	G
hCoV-19/Norway/3264/2020	EPI_ISL_590906	2020-08-31	Europe / Norway / Agder	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.236	G
hCoV-19/Norway/3281/2020	EPI_ISL_590912	2020-09-02	Europe / Norway / Oslo	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1.39	G
hCoV-19/Norway/3537/2020	EPI_ISL_590928	2020-09-13	Europe / Norway / Oslo	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1.39	G
hCoV-19/Norway/3539/2020	EPI_ISL_590935	2020-09-10	Europe / Norway / Oslo	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1.39	G
hCoV-19/England/QEUH-A0BF4A/2020	EPI_ISL_599162	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-A0BA58/2020	EPI_ISL_599188	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A0B584/2020	EPI_ISL_599207	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A0C88A/2020	EPI_ISL_599250	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-A0ADD8/2020	EPI_ISL_599256	2020-10-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A0BF77/2020	EPI_ISL_599288	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A0B0B0/2020	EPI_ISL_599319	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A0AF1E/2020	EPI_ISL_599346	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-A0BD9B/2020	EPI_ISL_599385	2020-10-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A0AEF3/2020	EPI_ISL_599441	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A0AED5/2020	EPI_ISL_599451	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A0C398/2020	EPI_ISL_599455	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A0BA3A/2020	EPI_ISL_599459	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DE239/2020	EPI_ISL_599494	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DCCB5/2020	EPI_ISL_599504	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/England/QEUH-9DCE64/2020	EPI_ISL_599518	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-9DD012/2020	EPI_ISL_599520	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DD908/2020	EPI_ISL_599523	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DCE46/2020	EPI_ISL_599526	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-9DDFAC/2020	EPI_ISL_599533	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DDA14/2020	EPI_ISL_599549	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DDEAF/2020	EPI_ISL_599583	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DDB5D/2020	EPI_ISL_599585	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DD980/2020	EPI_ISL_599586	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DDA9C/2020	EPI_ISL_599606	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DDCA5/2020	EPI_ISL_599610	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/Scotland/QEUH-9DCC97/2020	EPI_ISL_599635	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DD6A7/2020	EPI_ISL_599639	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DDB7B/2020	EPI_ISL_599652	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DDAC9/2020	EPI_ISL_599654	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9DD15B/2020	EPI_ISL_599677	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DD58C/2020	EPI_ISL_599679	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/QEUH-9DE257/2020	EPI_ISL_599686	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DDD0C/2020	EPI_ISL_599689	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-9DDA41/2020	EPI_ISL_599693	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DD8DE/2020	EPI_ISL_599705	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DE13C/2020	EPI_ISL_599710	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DDB8A/2020	EPI_ISL_599717	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9DD7A4/2020	EPI_ISL_599737	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DE460/2020	EPI_ISL_599744	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/QEUH-9DDBD5/2020	EPI_ISL_599751	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/QEUH-9DE187/2020	EPI_ISL_599752	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DE47F/2020	EPI_ISL_599767	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/QEUH-9DD892/2020	EPI_ISL_599768	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DD0F4/2020	EPI_ISL_599774	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DE21B/2020	EPI_ISL_599778	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DD416/2020	EPI_ISL_599780	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DDC3C/2020	EPI_ISL_599789	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DDA23/2020	EPI_ISL_599794	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DDC5A/2020	EPI_ISL_599802	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DCD1C/2020	EPI_ISL_599809	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-9DD373/2020	EPI_ISL_599817	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-A05FC8/2020	EPI_ISL_599873	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/USA/UT-QDX-2572/2020	EPI_ISL_604962	2020-03-13	North America / USA / Utah	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1.231	GR
hCoV-19/Ireland/D-NVRL-20G44567/2020	EPI_ISL_605058	2020-03-31	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1	G
hCoV-19/Ireland/D-NVRL-20G44520/2020	EPI_ISL_605062	2020-03-31	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.174	GR
hCoV-19/Ireland/D-NVRL-20G44565/2020	EPI_ISL_605063	2020-03-31	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.174	GR
hCoV-19/Ireland/D-NVRL-20G44517/2020	EPI_ISL_605066	2020-03-31	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/WW-NVRL-20G41355/2020	EPI_ISL_605076	2020-03-24	Europe / Ireland / Wicklow	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol	Stretches of NNNs (1.00% of overall sequence).	warn	B.1.1	GR
hCoV-19/Ireland/D-NVRL-20G44423/2020	EPI_ISL_605080	2020-03-28	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1	V
hCoV-19/USA/UT-UPHL-2009510/2020	EPI_ISL_605193	2020-07-19	North America / USA / Utah	Human	Original			Illumina NextSeq	minimap2 & freebayes			B.1.240	G
hCoV-19/Russia/CRIE5031464/2020	EPI_ISL_610231	2020-07-16	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq	Assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1	GR
hCoV-19/Russia/CRIE5021376/2020	EPI_ISL_610235	2020-07-16	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq	Assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1	GR
hCoV-19/Russia/CRIE5047165/2020	EPI_ISL_610236	2020-07-16	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq	Assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1	GR
hCoV-19/Russia/CRIE300223/2020	EPI_ISL_610238	2020-03-31	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab	Full genomes EPI_ISL_610237 and EPI_ISL_610238 were obtained from same patient at the same time. It is a case of double infection.	Illumina HiSeq	Assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1	GR
hCoV-19/Russia/CRIE7158978/2020	EPI_ISL_610239	2020-08-24	Europe / Russia / Moscow	Human	Original	Autopsy material		Illumina HiSeq	Assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1	GR
hCoV-19/Russia/CRIE7159118/2020	EPI_ISL_610240	2020-08-24	Europe / Russia / Moscow	Human	Original	Autopsy material		Illumina HiSeq	Assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1	GR
hCoV-19/England/ALDP-A84FFE/2020	EPI_ISL_610299	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A8495A/2020	EPI_ISL_610302	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A849C3/2020	EPI_ISL_610326	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A84DF4/2020	EPI_ISL_610328	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A85CE7/2020	EPI_ISL_610329	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A85A92/2020	EPI_ISL_610336	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A8583E/2020	EPI_ISL_610350	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A85995/2020	EPI_ISL_610363	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A858B6/2020	EPI_ISL_610387	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A84FA3/2020	EPI_ISL_610394	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A85BF9/2020	EPI_ISL_610409	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A85C14/2020	EPI_ISL_610427	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A858D4/2020	EPI_ISL_610437	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A85A1A/2020	EPI_ISL_610534	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A84D9A/2020	EPI_ISL_610542	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A85AB0/2020	EPI_ISL_610547	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A858C5/2020	EPI_ISL_610561	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A859C2/2020	EPI_ISL_610572	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/ALDP-A850EB/2020	EPI_ISL_610578	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A85CAB/2020	EPI_ISL_610583	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A85C41/2020	EPI_ISL_610584	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A85B08/2020	EPI_ISL_610597	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A85A47/2020	EPI_ISL_610608	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A85F2A/2020	EPI_ISL_610610	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A859FF/2020	EPI_ISL_610619	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A85801/2020	EPI_ISL_610628	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A81304/2020	EPI_ISL_610635	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A8103A/2020	EPI_ISL_610647	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/CAMC-A81C63/2020	EPI_ISL_610653	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A83092/2020	EPI_ISL_610665	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/England/CAMC-A81BEE/2020	EPI_ISL_610676	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/Denmark/DCGC-6640/2020	EPI_ISL_619542	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.204	GR
hCoV-19/Denmark/DCGC-6900/2020	EPI_ISL_619745	2020-10-12	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.204	GR
hCoV-19/Denmark/DCGC-6901/2020	EPI_ISL_619746	2020-10-12	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.204	GR
hCoV-19/Denmark/DCGC-6967/2020	EPI_ISL_619813	2020-10-12	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.204	GR
hCoV-19/Denmark/DCGC-7004/2020	EPI_ISL_619851	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.198	GR
hCoV-19/Denmark/DCGC-7006/2020	EPI_ISL_619853	2020-10-12	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.39	GR
hCoV-19/England/ALDP-AA2B23/2020	EPI_ISL_624030	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-AA2F18/2020	EPI_ISL_624036	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA1201/2020	EPI_ISL_624089	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA2E57/2020	EPI_ISL_624102	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA1966/2020	EPI_ISL_624106	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/ALDP-AA35AC/2020	EPI_ISL_624121	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/ALDP-AA40F5/2020	EPI_ISL_624134	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA1483/2020	EPI_ISL_624156	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/ALDP-AA357F/2020	EPI_ISL_624169	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA2D96/2020	EPI_ISL_624198	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-AA3DC2/2020	EPI_ISL_624205	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA284A/2020	EPI_ISL_624216	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA1E85/2020	EPI_ISL_624222	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/ALDP-AA3BD7/2020	EPI_ISL_624238	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA2789/2020	EPI_ISL_624270	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA3AAD/2020	EPI_ISL_624288	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA281D/2020	EPI_ISL_624305	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA2051/2020	EPI_ISL_624339	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA3E0B/2020	EPI_ISL_624365	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA3A70/2020	EPI_ISL_624375	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA39EC/2020	EPI_ISL_624387	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA1F0A/2020	EPI_ISL_624388	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA14FC/2020	EPI_ISL_624417	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/ALDP-AA1D3D/2020	EPI_ISL_624422	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA3BAA/2020	EPI_ISL_624425	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-AA3BC8/2020	EPI_ISL_624450	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-AA48A2/2020	EPI_ISL_624492	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A94ABE/2020	EPI_ISL_624635	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A961D5/2020	EPI_ISL_624678	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-A955AD/2020	EPI_ISL_624691	2020-10-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A95394/2020	EPI_ISL_624694	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/ALDP-A95A53/2020	EPI_ISL_624717	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A96032/2020	EPI_ISL_624748	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A958A4/2020	EPI_ISL_624820	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A94A81/2020	EPI_ISL_624887	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-A94571/2020	EPI_ISL_624890	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-AA53CE/2020	EPI_ISL_624947	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/Wales/ALDP-AA3797/2020	EPI_ISL_624978	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA0BF8/2020	EPI_ISL_624988	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD1833/2020	EPI_ISL_630003	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-ACDCD4/2020	EPI_ISL_630023	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACCF27/2020	EPI_ISL_630042	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/MILK-ACD0F6/2020	EPI_ISL_630077	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACE13E/2020	EPI_ISL_630092	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-ACDCB6/2020	EPI_ISL_630096	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC7681/2020	EPI_ISL_630141	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-AC7584/2020	EPI_ISL_630145	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/ALDP-9E766E/2020	EPI_ISL_638208	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/ALDP-9E767D/2020	EPI_ISL_638209	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/ALDP-9E77A7/2020	EPI_ISL_638219	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/ALDP-9E816C/2020	EPI_ISL_638240	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/ALDP-9E818A/2020	EPI_ISL_638242	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/ALDP-9E8199/2020	EPI_ISL_638243	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/ALDP-9E8858/2020	EPI_ISL_638259	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/ALDP-9E8AAD/2020	EPI_ISL_638279	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/ALDP-9E94EA/2020	EPI_ISL_638287	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/ALDP-9E9541/2020	EPI_ISL_638291	2020-09-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/England/CAMB-1B77B7/2020	EPI_ISL_638334	2020-10-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/CAMC-9DF423/2020	EPI_ISL_638406	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.165	G
hCoV-19/England/CAMC-9DF4AB/2020	EPI_ISL_638407	2020-09-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/England/CAMC-9DF57B/2020	EPI_ISL_638412	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/CAMC-9DF71B/2020	EPI_ISL_638419	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.532	GR
hCoV-19/England/CAMC-9DFA9A/2020	EPI_ISL_638439	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.308	GR
hCoV-19/England/CAMC-9DFB6A/2020	EPI_ISL_638442	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.269	GR
hCoV-19/England/CAMC-9DFB88/2020	EPI_ISL_638443	2020-09-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.269	GR
hCoV-19/England/MILK-A23A96/2020	EPI_ISL_638457	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-A7E0A9/2020	EPI_ISL_638483	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-A9150B/2020	EPI_ISL_638528	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-B05431/2020	EPI_ISL_638550	2020-10-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.240	GR
hCoV-19/England/NORT-2862DD/2020	EPI_ISL_638560	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-2863F8/2020	EPI_ISL_638562	2020-10-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-2865C5/2020	EPI_ISL_638564	2020-10-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-2867DE/2020	EPI_ISL_638569	2020-10-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-286AD5/2020	EPI_ISL_638573	2020-10-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-286AF3/2020	EPI_ISL_638574	2020-10-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9ADFF0/2020	EPI_ISL_638621	2020-09-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.240	GR
hCoV-19/England/QEUH-9AE0A1/2020	EPI_ISL_638622	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AE0B0/2020	EPI_ISL_638623	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AE0CF/2020	EPI_ISL_638624	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AE1DB/2020	EPI_ISL_638629	2020-09-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9F4DC3/2020	EPI_ISL_638643	2020-09-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9F5032/2020	EPI_ISL_638649	2020-09-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9F513F/2020	EPI_ISL_638657	2020-09-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9F515D/2020	EPI_ISL_638658	2020-09-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9F532A/2020	EPI_ISL_638664	2020-09-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9F5357/2020	EPI_ISL_638665	2020-09-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-A36C03/2020	EPI_ISL_638704	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A36D4C/2020	EPI_ISL_638712	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A3707F/2020	EPI_ISL_638724	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A370D9/2020	EPI_ISL_638727	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A778C6/2020	EPI_ISL_638737	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.240	GR
hCoV-19/England/QEUH-A77BDC/2020	EPI_ISL_638739	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A77BFA/2020	EPI_ISL_638740	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A77F0D/2020	EPI_ISL_638743	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.39	GR
hCoV-19/England/QEUH-A78546/2020	EPI_ISL_638759	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.165	G
hCoV-19/England/QEUH-A78D4E/2020	EPI_ISL_638780	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A794DF/2020	EPI_ISL_638806	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A89CC5/2020	EPI_ISL_638821	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A8A981/2020	EPI_ISL_638864	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A8A9FA/2020	EPI_ISL_638867	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A8AA9D/2020	EPI_ISL_638870	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A8AABB/2020	EPI_ISL_638871	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-9ADF5A/2020	EPI_ISL_638897	2020-09-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/QEUH-9ADF87/2020	EPI_ISL_638898	2020-09-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/QEUH-9F4F09/2020	EPI_ISL_638915	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/QEUH-A4B4C7/2020	EPI_ISL_638940	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.532	GR
hCoV-19/Scotland/QEUH-AD2AB4/2020	EPI_ISL_644002	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.159	GR
hCoV-19/France/PAC-MEPHI-1677/2020	EPI_ISL_644421	2020-09-14	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.269	GR
hCoV-19/France/PAC-MEPHI-1884/2020	EPI_ISL_644450	2020-09-21	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.269	GR
hCoV-19/France/PAC-MEPHI-2086/2020	EPI_ISL_644492	2020-08-30	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.269	GR
hCoV-19/France/PAC-MEPHI-2101/2020	EPI_ISL_644496	2020-09-23	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.269	GR
hCoV-19/France/PAC-MEPHI-2103/2020	EPI_ISL_644497	2020-09-26	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.269	GR
hCoV-19/France/PAC-MEPHI-2144/2020	EPI_ISL_644510	2020-09-28	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.269	GR
hCoV-19/France/PAC-MEPHI-2375/2020	EPI_ISL_644547	2020-10-10	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.269	GR
hCoV-19/France/PAC-MEPHI-2390/2020	EPI_ISL_644553	2020-10-12	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.269	GR
hCoV-19/England/CAMC-B521A7/2020	EPI_ISL_658007	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-B51D2C/2020	EPI_ISL_658010	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B553F9/2020	EPI_ISL_658018	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B51D1D/2020	EPI_ISL_658019	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B54EDB/2020	EPI_ISL_658040	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B54A9B/2020	EPI_ISL_658053	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/MILK-B54CE0/2020	EPI_ISL_658057	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B51AF8/2020	EPI_ISL_658119	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B546E2/2020	EPI_ISL_658187	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B54776/2020	EPI_ISL_658199	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B5499E/2020	EPI_ISL_658203	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B549E9/2020	EPI_ISL_658206	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B5A79E/2020	EPI_ISL_658248	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B54952/2020	EPI_ISL_658270	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B55BE2/2020	EPI_ISL_658273	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B519DD/2020	EPI_ISL_658317	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B5A770/2020	EPI_ISL_658336	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B549AD/2020	EPI_ISL_658356	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B5A78F/2020	EPI_ISL_658373	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B5A2E8/2020	EPI_ISL_658379	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B40FC0/2020	EPI_ISL_658450	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B3F29E/2020	EPI_ISL_658472	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E59stop results in 52.1% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/QEUH-B4142A/2020	EPI_ISL_658484	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B416AC/2020	EPI_ISL_658522	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B3F46B/2020	EPI_ISL_658556	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B3F735/2020	EPI_ISL_658586	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B41721/2020	EPI_ISL_658604	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B3FD33/2020	EPI_ISL_658685	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF5365/2020	EPI_ISL_663112	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF5A7F/2020	EPI_ISL_663113	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF4C3E/2020	EPI_ISL_663126	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF4B9B/2020	EPI_ISL_663135	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF566C/2020	EPI_ISL_663143	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AF3E39/2020	EPI_ISL_663183	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-AF4CE3/2020	EPI_ISL_663195	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/CA-IGI-0546/2020	EPI_ISL_677827	2020-08-01	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	Minimap2 v2.16-r922 / iVar 1.1 reference aligned			B.1.1.322	GR
hCoV-19/Saudi Arabia/KAUST-JEDDAH1295/2020	EPI_ISL_677924	2020-06-30	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.398	G
hCoV-19/Saudi Arabia/KAUST-MAKKAH106/2020	EPI_ISL_678079	2020-03-24	Asia / Saudi Arabia / Makkah	Human	Original			Illumina NovaSeq	Gatk bcftools consensus			B.1.533	O
hCoV-19/Netherlands/NA_2/2020	EPI_ISL_415476	2020-03-10	Europe / Netherlands	Human	Original			Nanopore				B.1.1	GR
hCoV-19/Netherlands/ZuidHolland_28/2020	EPI_ISL_415532	2020-03-09	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.1	GR
hCoV-19/Australia/VIC315/2020	EPI_ISL_420006	2020-03-24	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC V1 amplicons, Nextera XT library, minimap2 v2.17, ivar v1.1, samtools v1.10			B.1.1	GR
hCoV-19/Belgium/BJ-030767/2020	EPI_ISL_420323	2020-03-07	Europe / Belgium / Waterloo	Human	Original	Oropharyngeal swab	unknown	Nanopore MinION	Guppy, CLC Genomics Workbench 20, Porechop, Medaka.	Sequence updated by the Submitter following changes to the analytics pipeline to mitigate possible sequence errors	info	B.1.1	GR
hCoV-19/Belgium/VGA-030672/2020	EPI_ISL_420328	2020-03-06	Europe / Belgium / Alken	Human	Original	Oropharyngeal swab	unknown	Nanopore MinION	Guppy, CLC Genomics Workbench 20, Porechop, Medaka.	Sequence updated by the Submitter following changes to the analytics pipeline to mitigate possible sequence errors	info	B.1.1	GR
hCoV-19/Belgium/BM-030687/2020	EPI_ISL_420343	2020-03-06	Europe / Belgium / Andenne	Human	Original	Oropharyngeal swab	unknown	Nanopore MinION	Guppy, CLC Genomics Workbench 20, Porechop, Medaka.	Sequence updated by the Submitter following changes to the analytics pipeline to mitigate possible sequence errors	info	B.1	G
hCoV-19/Belgium/NMA-0324169/2020	EPI_ISL_420426	2020-03-24	Europe / Belgium / Lasne	Human	Original	Oropharyngeal swab	unknown	Nanopore MinION	Guppy, CLC Genomics Workbench 20, Porechop, Medaka.	Sequence updated by the Submitter following changes to the analytics pipeline to mitigate possible sequence errors	info	B.1.1.71	GR
hCoV-19/Italy/TE-IZSGC-TE5476/2020	EPI_ISL_420565	2020-03-19	Europe / Italy / Abruzzo / Teramo	Human	Original							B.1.1	GR
hCoV-19/England/20136097204/2020	EPI_ISL_420652	2020-03-23	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20139013406/2020	EPI_ISL_420661	2020-03-27	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20139046704/2020	EPI_ISL_420690	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20139048804/2020	EPI_ISL_420698	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20139053304/2020	EPI_ISL_420707	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.164	GR
hCoV-19/England/20139060804/2020	EPI_ISL_420734	2020-03-27	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.164	GR
hCoV-19/Australia/VIC-CBA3/2020	EPI_ISL_420877	2020-03-28	Oceania / Australia / Victoria	Human	Original	Oropharyngeal swab		Ion Torrent, AmpliSeq panel	Torrent Suite 5.10.1, IGV 2.6.3, MEGA 7			B.1.1.71	GR
hCoV-19/USA/CA-CZB085/2020	EPI_ISL_429004	2020-03-28	North America / USA / California / San Francisco County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1	G
hCoV-19/USA/CA-CZB0714/2020	EPI_ISL_429052	2020-03-23	North America / USA / California / San Francisco County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1	GR
hCoV-19/USA/CA-CZB0167/2020	EPI_ISL_429053	2020-04-08	North America / USA / California / San Francisco County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1	GR
hCoV-19/Sweden/20-50234/2020	EPI_ISL_429157	2020-03-10	Europe / Sweden / Orebro lan	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Thailand/Bangkok-0033/2020	EPI_ISL_429169	2020-03-17	Asia / Thailand / Bangkok	Human	Original			Illumina Miseq, 2 x 250bp paired end reads, ARTIC v2, Kapa ligation prep	Mapping with bwa v0.7.17, consensus calls from Ivar v1.1			B.1.1	GR
hCoV-19/Switzerland/GE-HUG-0304/2020	EPI_ISL_429218	2020-04-02	Europe / Switzerland / Geneve	Human	Original			unknown				B.1	G
hCoV-19/Switzerland/GE-HUG-2453/2020	EPI_ISL_429219	2020-04-03	Europe / Switzerland / Geneve	Human	Original			unknown				B.1	G
hCoV-19/Italy/ABR-IZSGC-TE6580/2020	EPI_ISL_429235	2020-03-24	Europe / Italy / Abruzzo	Human	Original							B.1.1	GR
hCoV-19/Luxembourg/LNS3652733/2020	EPI_ISL_429706	2020-04-09	Europe / Luxembourg	Human	Original			Illumina MiniSeq (Amplicon, ARTIC primer set V1)	Bowtie2, BCFtools			B.1.1.198	GR
hCoV-19/Luxembourg/LNS1995247/2020	EPI_ISL_429718	2020-03-19	Europe / Luxembourg	Human	Original			Illumina MiniSeq (Amplicon, ARTIC primer set V1)	Bowtie2, BCFtools			B.1.1.198	GR
hCoV-19/Luxembourg/LNS0756265/2020	EPI_ISL_429725	2020-03-30	Europe / Luxembourg	Human	Original			Illumina MiniSeq (Amplicon, ARTIC primer set V1)	Bowtie2, BCFtools			B.1	G
hCoV-19/Luxembourg/LNS7640155/2020	EPI_ISL_429736	2020-03-29	Europe / Luxembourg	Human	Original			Illumina MiniSeq (Amplicon, ARTIC primer set V1)	Bowtie2, BCFtools			B.1.1.198	GR
hCoV-19/Luxembourg/LNS3989293/2020	EPI_ISL_429749	2020-03-24	Europe / Luxembourg	Human	Original			Illumina MiniSeq (Amplicon, ARTIC primer set V1)	Bowtie2, BCFtools			B.1.1.198	GR
hCoV-19/Luxembourg/LNS8167314/2020	EPI_ISL_429758	2020-03-24	Europe / Luxembourg	Human	Original			Illumina MiniSeq (Amplicon, ARTIC primer set V1)	Bowtie2, BCFtools			B.1.1.198	GR
hCoV-19/Luxembourg/LNS7357097/2020	EPI_ISL_429779	2020-03-26	Europe / Luxembourg	Human	Original			Illumina MiniSeq (Amplicon, ARTIC primer set V1)	Bowtie2, BCFtools			B.1.1.198	GR
hCoV-19/Turkey/HSGM-11520/2020	EPI_ISL_429873	2020-03-23	Europe / Turkey / Kocaeli	Human	Original	Sputum		Illumina MiSeq	Burrows-Wheeler Alignerv.07.17-r1188			B.1.1.171	GR
hCoV-19/Jordan/SR-033/2020	EPI_ISL_429993	2020-03-16	Asia / Jordan / Amman	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2			B.1.1	GR
hCoV-19/Scotland/EDB1444/2020	EPI_ISL_433449	2020-04-13	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1	G
hCoV-19/Scotland/EDB1450/2020	EPI_ISL_433452	2020-04-13	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1	G
hCoV-19/Scotland/EDB1452/2020	EPI_ISL_433453	2020-04-13	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1	G
hCoV-19/Scotland/EDB1453/2020	EPI_ISL_433454	2020-04-13	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1	G
hCoV-19/Scotland/EDB1469/2020	EPI_ISL_433459	2020-04-11	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1	G
hCoV-19/Scotland/EDB1471/2020	EPI_ISL_433461	2020-04-11	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1	G
hCoV-19/England/CAMB-7E313/2020	EPI_ISL_433470	2020-04-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1.208	GR
hCoV-19/England/CAMB-7FB47/2020	EPI_ISL_433480	2020-04-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7FB56/2020	EPI_ISL_433481	2020-04-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7FB92/2020	EPI_ISL_433485	2020-04-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7FC08/2020	EPI_ISL_433491	2020-04-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7FC17/2020	EPI_ISL_433492	2020-04-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-7FC44/2020	EPI_ISL_433495	2020-04-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/USA/WA-S453/2020	EPI_ISL_434213	2020-03-30	North America / USA / Washington / Mason County	Human	Original			Illumina NextSeq	Seattle Flu Assembly Pipeline			B.59	GR
hCoV-19/Greece/140/2020	EPI_ISL_434480	2020-03-12	Europe / Greece / Athens	Human	Original	Nasopharyngeal swab		Ion Torrent	IRMA v0.9.3			B.1.1	GR
hCoV-19/Luxembourg/LNS0361493/2020	EPI_ISL_434496	2020-04-10	Europe / Luxembourg	Human	Original			Illumina MiniSeq (Amplicon, ARTIC primer set V1)	Bowtie2, BCFtools			B.1.1.198	GR
hCoV-19/Luxembourg/LNS9272998/2020	EPI_ISL_434512	2020-04-17	Europe / Luxembourg	Human	Original			Illumina MiniSeq (Amplicon, ARTIC primer set V1)	Bowtie2, BCFtools			B.1.1.198	GR
hCoV-19/France/OCC-1/2020	EPI_ISL_434616	2020-03	Europe / France / Occitanie	Human	Original			MinION				B.1.1.254	GR
hCoV-19/France/OCC-2/2020	EPI_ISL_434617	2020-03	Europe / France / Occitanie	Human	Original			MinION				B.1.1.254	GR
hCoV-19/France/OCC-3/2020	EPI_ISL_434618	2020-03	Europe / France / Occitanie	Human	Original			MinION				B.1.1.254	GR
hCoV-19/France/OCC-4/2020	EPI_ISL_434619	2020-03	Europe / France / Occitanie	Human	Original			MinION				B.1.1.254	GR
hCoV-19/France/OCC-5/2020	EPI_ISL_434620	2020-03	Europe / France / Occitanie	Human	Vero			MinION				B.1.1.254	GR
hCoV-19/France/OCC-11/2020	EPI_ISL_434626	2020-03-26	Europe / France / Occitanie	Human	Original			MinION				B.1.1.254	GR
hCoV-19/France/OCC-12/2020	EPI_ISL_434627	2020-03-26	Europe / France / Occitanie	Human	Original			MinION				B.1.1.254	GR
hCoV-19/France/OCC-13/2020	EPI_ISL_434628	2020-04-07	Europe / France / Occitanie	Human	Original			MinION				B.1.1.254	GR
hCoV-19/France/OCC-14/2020	EPI_ISL_434629	2020-04-07	Europe / France / Occitanie	Human	Original			MinION				B.1.1.254	GR
hCoV-19/France/OCC-15/2020	EPI_ISL_434630	2020-04-08	Europe / France / Occitanie	Human	Original			MinION				B.1	GR
hCoV-19/France/OCC-20/2020	EPI_ISL_434635	2020-04-11	Europe / France / Occitanie	Human	Original			MinION				B.1	G
hCoV-19/Sweden/20-05721/2020	EPI_ISL_434647	2020-03-16	Europe / Sweden / Skane	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-06306/2020	EPI_ISL_434651	2020-03-23	Europe / Sweden / Jamtland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-06376/2020	EPI_ISL_434653	2020-03-24	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/USA/TX-HMH0361/2020	EPI_ISL_434954	2020-03-29	North America / USA / Texas	Human	Original			Oxford Nanopore	ARTIC V1			B.1.1	GR
hCoV-19/USA/TX-HMH0413/2020	EPI_ISL_434998	2020-04-01	North America / USA / Texas	Human	Original			Oxford Nanopore	ARTIC V1			B.1.1.61	GR
hCoV-19/Italy/ABR-IZSGC-TE6644/2020	EPI_ISL_435145	2020-03-24	Europe / Italy / Abruzzo	Human	Original			ARTIC + Illumina MiniSeq				B.1.1	GR
hCoV-19/Italy/ABR-IZSGC-TE13491/2020	EPI_ISL_435148	2020-04-08	Europe / Italy / Abruzzo	Human	Original			ARTIC + Illumina MiniSeq				B.1.1	GR
hCoV-19/Italy/ABR-IZSGC-TE13457/2020	EPI_ISL_435149	2020-04-08	Europe / Italy / Abruzzo	Human	Original			ARTIC + Illumina MiniSeq				B.1.1	GR
hCoV-19/Italy/ABR-IZSGC-TE12774/2020	EPI_ISL_435150	2020-04-08	Europe / Italy / Abruzzo	Human	Original			ARTIC + Illumina MiniSeq				B.1.1	GR
hCoV-19/Italy/ABR-IZSGC-TE13484/2020	EPI_ISL_435151	2020-04-08	Europe / Italy / Abruzzo	Human	Original			ARTIC + Illumina MiniSeq				B.1.1	GR
hCoV-19/Italy/ABR-IZSGC-TE13858/2020	EPI_ISL_435152	2020-04-09	Europe / Italy / Abruzzo	Human	Original			ARTIC + Illumina MiniSeq				B.1.1	GR
hCoV-19/England/CAMB-72C05/2020	EPI_ISL_440059	2020-03-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-72D11/2020	EPI_ISL_440072	2020-03-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/CAMB-730CC/2020	EPI_ISL_440129	2020-03-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.71	GR
hCoV-19/England/CAMB-73475/2020	EPI_ISL_440290	2020-03-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-74210/2020	EPI_ISL_440319	2020-03-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-73EA4/2020	EPI_ISL_440342	2020-03-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-84839/2020	EPI_ISL_440507	2020-03-04	Europe / United Kingdom / England	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/England/CAMB-84A9D/2020	EPI_ISL_440519	2020-03-10	Europe / United Kingdom / England	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/England/CAMB-8482A/2020	EPI_ISL_440521	2020-03-04	Europe / United Kingdom / England	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/England/CAMB-7A3AE/2020	EPI_ISL_440561	2020-04-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7A11D/2020	EPI_ISL_440589	2020-04-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/BRIS-122ED0/2020	EPI_ISL_440635	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/BRIS-122F82/2020	EPI_ISL_440662	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1224ED/2020	EPI_ISL_440689	2020-04-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/BRIS-122492/2020	EPI_ISL_440692	2020-04-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1223A4/2020	EPI_ISL_440747	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/BRIS-122EFE/2020	EPI_ISL_440759	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/BRIS-122BD9/2020	EPI_ISL_440762	2020-04-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-122A27/2020	EPI_ISL_440763	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/LIVE-9B644/2020	EPI_ISL_440866	2020-04-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LIVE-9B8D5/2020	EPI_ISL_440884	2020-04-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LIVE-9BA39/2020	EPI_ISL_440895	2020-04-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LIVE-9BA84/2020	EPI_ISL_440897	2020-04-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LIVE-9BB90/2020	EPI_ISL_440900	2020-04-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/England/LIVE-9CA29/2020	EPI_ISL_440930	2020-04-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LIVE-9CE78/2020	EPI_ISL_440948	2020-04-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D359E/2020	EPI_ISL_440958	2020-03-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D3604/2020	EPI_ISL_440964	2020-04-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D3622/2020	EPI_ISL_440966	2020-04-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D36D7/2020	EPI_ISL_440975	2020-03-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D3798/2020	EPI_ISL_440984	2020-03-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D3868/2020	EPI_ISL_440997	2020-04-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D3886/2020	EPI_ISL_440999	2020-04-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.164	GR
hCoV-19/England/OXON-AF249/2020	EPI_ISL_448820	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/SHEF-C4E77/2020	EPI_ISL_448846	2020-04-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-D1660/2020	EPI_ISL_448909	2020-04-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-FAE1E/2020	EPI_ISL_448925	2020-03-26	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-FB721/2020	EPI_ISL_448971	2020-03-28	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E7227/2020	EPI_ISL_449013	2020-04-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E72DC/2020	EPI_ISL_449020	2020-04-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E747C/2020	EPI_ISL_449037	2020-05-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E7737/2020	EPI_ISL_449066	2020-05-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E82CC/2020	EPI_ISL_449136	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina				B.59	GR
hCoV-19/England/NORW-E86A2/2020	EPI_ISL_449174	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/CVR3169/2020	EPI_ISL_449199	2020-04-27	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/CVR3170/2020	EPI_ISL_449200	2020-04-27	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/CVR3171/2020	EPI_ISL_449201	2020-04-27	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/CVR3185/2020	EPI_ISL_449209	2020-04-28	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.43	GR
hCoV-19/Scotland/CVR3194/2020	EPI_ISL_449214	2020-04-28	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/CVR3210/2020	EPI_ISL_449229	2020-04-16	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.14	GR
hCoV-19/Scotland/CVR3227/2020	EPI_ISL_449238	2020-04-26	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.14	GR
hCoV-19/Scotland/EDB3983/2020	EPI_ISL_449271	2020-05-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore		NSP13_R178stop results in 70.5% truncation of the protein sequence.	info	B.1	O
hCoV-19/England/LOND-D3B32/2020	EPI_ISL_449629	2020-04-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.164	GR
hCoV-19/England/LOND-D3C3F/2020	EPI_ISL_449644	2020-04-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D3D96/2020	EPI_ISL_449651	2020-04-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D3DC3/2020	EPI_ISL_449654	2020-04-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.254	GR
hCoV-19/England/LOND-D3DD2/2020	EPI_ISL_449655	2020-04-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D4BD7/2020	EPI_ISL_449660	2020-04-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/England/LOND-D4BE6/2020	EPI_ISL_449661	2020-04-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D4C01/2020	EPI_ISL_449663	2020-04-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.164	GR
hCoV-19/England/LOND-D4C2F/2020	EPI_ISL_449665	2020-04-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.164	GR
hCoV-19/England/LOND-D4C3E/2020	EPI_ISL_449666	2020-04-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/England/LOND-D4C5C/2020	EPI_ISL_449668	2020-04-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.164	GR
hCoV-19/England/LOND-D4CA7/2020	EPI_ISL_449673	2020-04-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D4CF2/2020	EPI_ISL_449678	2020-04-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D514D/2020	EPI_ISL_449680	2020-04-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.164	GR
hCoV-19/England/LOND-D516B/2020	EPI_ISL_449682	2020-04-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D520E/2020	EPI_ISL_449689	2020-04-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D521D/2020	EPI_ISL_449690	2020-04-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.164	GR
hCoV-19/England/LOND-D5268/2020	EPI_ISL_449694	2020-04-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D55F6/2020	EPI_ISL_449704	2020-04-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D5611/2020	EPI_ISL_449706	2020-04-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D568A/2020	EPI_ISL_449711	2020-04-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D5699/2020	EPI_ISL_449712	2020-04-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D56A8/2020	EPI_ISL_449713	2020-04-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D56C6/2020	EPI_ISL_449714	2020-04-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D56F3/2020	EPI_ISL_449716	2020-04-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D574B/2020	EPI_ISL_449718	2020-04-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D582A/2020	EPI_ISL_449727	2020-04-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/USA/WA-S739/2020	EPI_ISL_449909	2020-04-13	North America / USA / Washington / Yakima County	Human	Original			Illumina NextSeq	Seattle Flu Assembly Pipeline			B.1.1	GR
hCoV-19/USA/WA-S741/2020	EPI_ISL_449911	2020-04-13	North America / USA / Washington / Yakima County	Human	Original			Illumina NextSeq	Seattle Flu Assembly Pipeline			B.1.1	GR
hCoV-19/Portugal/PT0309/2020	EPI_ISL_454025	2020-03-14	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0370/2020	EPI_ISL_454086	2020-03-19	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0376/2020	EPI_ISL_454092	2020-03-20	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0381/2020	EPI_ISL_454097	2020-03-20	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0387/2020	EPI_ISL_454103	2020-03-20	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0415/2020	EPI_ISL_454139	2020-03-23	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0435/2020	EPI_ISL_454159	2020-03-20	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1	G
hCoV-19/Portugal/PT0538/2020	EPI_ISL_454262	2020-04-07	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0556/2020	EPI_ISL_454279	2020-04-20	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0557/2020	EPI_ISL_454280	2020-04-20	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0559/2020	EPI_ISL_454282	2020-04-22	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0560/2020	EPI_ISL_454283	2020-04-22	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0561/2020	EPI_ISL_454284	2020-04-27	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0629/2020	EPI_ISL_454352	2020-04-06	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU			B.1.1	GR
hCoV-19/Sweden/20-08111/2020	EPI_ISL_454482	2020-03-09	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-08112/2020	EPI_ISL_454483	2020-03-09	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Netherlands/Utrecht_10034/2020	EPI_ISL_454783	2020-04-22	Europe / Netherlands / Utrecht	Human	Original			Illumina NextSeq				B.1.1.71	GR
hCoV-19/Netherlands/Utrecht_10035/2020	EPI_ISL_454784	2020-04-22	Europe / Netherlands / Utrecht	Human	Original			Illumina NextSeq				B.1.1.71	GR
hCoV-19/USA/MN-MDH-125/2020	EPI_ISL_460050	2020-03-15	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1	GR
hCoV-19/USA/MN-MDH-164/2020	EPI_ISL_460059	2020-03-23	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.59	GR
hCoV-19/USA/MN-MDH-71/2020	EPI_ISL_460061	2020-03-14	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1	GR
hCoV-19/Italy/LOM-INMI-BG-11639/2020	EPI_ISL_460080	2020-02-28	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		Ion Torrent	BWA 0.7.12 + Samtools 1.3.1 + Geneious 2019.2.3			B.1.1	GR
hCoV-19/Switzerland/BE-ETHZ-120050/2020	EPI_ISL_468235	2020-04-20	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/USA/CA-CZB-1433/2020	EPI_ISL_468403	2020-03-24	North America / USA / California / San Luis Obispo County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1	GR
hCoV-19/USA/CA-CZB-1488/2020	EPI_ISL_468438	2020-03-19	North America / USA / California / Humboldt County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1	GR
hCoV-19/USA/CA-CZB-1539/2020	EPI_ISL_468484	2020-04-21	North America / USA / California / Ventura County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1	GR
hCoV-19/USA/CA-CZB-1542/2020	EPI_ISL_468487	2020-04-23	North America / USA / California / Ventura County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1	GR
hCoV-19/USA/CA-CZB-1551/2020	EPI_ISL_468494	2020-04-29	North America / USA / California / Ventura County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.61	GR
hCoV-19/USA/CA-CZB-1572/2020	EPI_ISL_468504	2020-04-12	North America / USA / California / Ventura County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1	GR
hCoV-19/USA/CA-CZB-1573/2020	EPI_ISL_468505	2020-04-12	North America / USA / California / Ventura County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1	GR
hCoV-19/Chile/RM-CMM-05207/2020	EPI_ISL_468748	2020-04-30	South America / Chile / Region Metropolitana de Santiago / Santiago	Human	Original			Nanopore MinION	Artic Minion Procotol			B.1.1	GR
hCoV-19/Spain/PV-IBV-2140/2020	EPI_ISL_468906	2020-04-12	Europe / Spain / Basque Country / San Sebastian	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/Italy/APU-UniMI-703/2020	EPI_ISL_468914	2020-03-18	Europe / Italy / Apulia / Taranto	Human	Original			Illumina				B.1.1	GR
hCoV-19/Spain/IB-IBV-2542/2020	EPI_ISL_468975	2020-03-19	Europe / Spain / Balear Islands / Palma	Human	Original			Illumina MiSeq	BWA/IVAR			B.1	G
hCoV-19/Scotland/EDB4948/2020	EPI_ISL_473801	2020-05-14	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.14	GR
hCoV-19/Scotland/EDB4950/2020	EPI_ISL_473803	2020-05-14	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.14	GR
hCoV-19/Scotland/EDB4952/2020	EPI_ISL_473804	2020-05-14	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.14	GR
hCoV-19/Scotland/EDB4953/2020	EPI_ISL_473805	2020-05-14	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.14	GR
hCoV-19/Scotland/EDB4956/2020	EPI_ISL_473806	2020-05-14	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.14	GR
hCoV-19/Scotland/EDB4957/2020	EPI_ISL_473807	2020-05-14	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.14	GR
hCoV-19/Scotland/EDB4959/2020	EPI_ISL_473808	2020-05-14	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.14	GR
hCoV-19/Scotland/EDB4961/2020	EPI_ISL_473809	2020-05-14	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.14	GR
hCoV-19/Scotland/EDB4962/2020	EPI_ISL_473810	2020-05-14	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.14	GR
hCoV-19/Scotland/EDB5196/2020	EPI_ISL_473815	2020-05-18	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.43	GR
hCoV-19/Scotland/EDB5678/2020	EPI_ISL_473833	2020-05-27	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.14	GR
hCoV-19/Scotland/EDB5747/2020	EPI_ISL_473854	2020-06-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.14	GR
hCoV-19/Scotland/EDB6322/2020	EPI_ISL_473935	2020-06-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.14	GR
hCoV-19/Wales/PHWC-163714/2020	EPI_ISL_473986	2020-05-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.190	GR
hCoV-19/Wales/PHWC-16378D/2020	EPI_ISL_473992	2020-05-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-163F2B/2020	EPI_ISL_474103	2020-04-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-1640AF/2020	EPI_ISL_474125	2020-05-10	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.190	GR
hCoV-19/Wales/PHWC-16417F/2020	EPI_ISL_474136	2020-05-07	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-1643B5/2020	EPI_ISL_474169	2020-04-25	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-329DD/2020	EPI_ISL_474378	2020-04-14	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.249	GR
hCoV-19/Wales/PHWC-35952/2020	EPI_ISL_474501	2020-04-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-35AAA/2020	EPI_ISL_474522	2020-04-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-36010/2020	EPI_ISL_474607	2020-04-27	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.198	GR
hCoV-19/England/NORT-29D473/2020	EPI_ISL_488053	2020-05-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-297D23/2020	EPI_ISL_488085	2020-04-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-297D41/2020	EPI_ISL_488093	2020-04-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-29827E/2020	EPI_ISL_488096	2020-04-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-29C76C/2020	EPI_ISL_488099	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-29702A/2020	EPI_ISL_488102	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-297163/2020	EPI_ISL_488117	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-29700C/2020	EPI_ISL_488136	2020-04-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-297AD1/2020	EPI_ISL_488151	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-29C6AB/2020	EPI_ISL_488156	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-292FAA/2020	EPI_ISL_488179	2020-06-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-292F9B/2020	EPI_ISL_488180	2020-06-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12FA39/2020	EPI_ISL_488193	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12F87B/2020	EPI_ISL_488216	2020-03-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/BRIS-12F635/2020	EPI_ISL_488221	2020-03-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12F1DA/2020	EPI_ISL_488226	2020-04-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 5 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/BRIS-12EA85/2020	EPI_ISL_488236	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12F723/2020	EPI_ISL_488287	2020-03-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12E6EB/2020	EPI_ISL_488301	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/BRIS-12F1F8/2020	EPI_ISL_488303	2020-04-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/BRIS-12EE01/2020	EPI_ISL_488353	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12FAFD/2020	EPI_ISL_488390	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/BRIS-12E79D/2020	EPI_ISL_488395	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12EE7A/2020	EPI_ISL_488405	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/BRIS-12E7AC/2020	EPI_ISL_488407	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12E663/2020	EPI_ISL_488418	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/BRIS-12F78D/2020	EPI_ISL_488447	2020-03-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.71	GR
hCoV-19/England/BRIS-12E751/2020	EPI_ISL_488448	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12E742/2020	EPI_ISL_488449	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12F073/2020	EPI_ISL_488452	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-284A6E/2020	EPI_ISL_488483	2020-03-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-283B4E/2020	EPI_ISL_488502	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-295B1C/2020	EPI_ISL_488570	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-294BFF/2020	EPI_ISL_488638	2020-03-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-2836D4/2020	EPI_ISL_488671	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-2827E1/2020	EPI_ISL_488718	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-28125A/2020	EPI_ISL_488748	2020-03-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-2813B1/2020	EPI_ISL_488758	2020-03-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-28124B/2020	EPI_ISL_488807	2020-03-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-281C01/2020	EPI_ISL_488819	2020-03-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/Northern Ireland/NIRE-FF0B9/2020	EPI_ISL_488876	2020-06-01	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BIRM-61665/2020	EPI_ISL_493448	2020-04-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-2991DA/2020	EPI_ISL_493484	2020-04-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-29B660/2020	EPI_ISL_493497	2020-06-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-29DF72/2020	EPI_ISL_493502	2020-05-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORW-EEB07/2020	EPI_ISL_493543	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.115	GR
hCoV-19/England/NORW-EEB34/2020	EPI_ISL_493544	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.115	GR
hCoV-19/England/NOTT-112B45/2020	EPI_ISL_493590	2020-04-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/PORT-2CFA0D/2020	EPI_ISL_493615	2020-05-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.194	GR
hCoV-19/Scotland/CVR1838/2020	EPI_ISL_493744	2020-04-07	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.99	GR
hCoV-19/Scotland/CVR2075/2020	EPI_ISL_493762	2020-04-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.164	GR
hCoV-19/Scotland/EDB4665/2020	EPI_ISL_493911	2020-05-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/Scotland/EDB4689/2020	EPI_ISL_493912	2020-05-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.14	GR
hCoV-19/Scotland/EDB4698/2020	EPI_ISL_493916	2020-05-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Scotland/EDB4985/2020	EPI_ISL_493928	2020-05-14	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/Scotland/EDB5013/2020	EPI_ISL_493934	2020-05-15	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.14	GR
hCoV-19/Scotland/EDB5018/2020	EPI_ISL_493936	2020-05-15	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.14	GR
hCoV-19/Scotland/EDB5336/2020	EPI_ISL_493956	2020-05-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.14	GR
hCoV-19/USA/MN-MDH-1369/2020	EPI_ISL_507957	2020-06-30	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.240	G
hCoV-19/USA/MN-MDH-1370/2020	EPI_ISL_507958	2020-07-01	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.240	G
hCoV-19/USA/MN-MDH-1372/2020	EPI_ISL_507960	2020-06-30	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.240	G
hCoV-19/USA/NM-UNM-00323/2020	EPI_ISL_507986	2020-05-14	North America / USA / New Mexico	Human	Original			Illumina MiSeq	ARTIC/iVar			B.1	G
hCoV-19/India/UT-AR30/2020	EPI_ISL_508178	2020-05-29	Asia / India / Uttarakhand / Haridwar	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.1	GR
hCoV-19/India/UT-AR31/2020	EPI_ISL_508179	2020-05-29	Asia / India / Uttarakhand / Rudraprayag	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.1	GR
hCoV-19/India/UT-AR44/2020	EPI_ISL_508188	2020-05-28	Asia / India / Uttarakhand / Tehri Garhwal	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.1.101	GR
hCoV-19/India/UT-AR60/2020	EPI_ISL_508197	2020-06-09	Asia / India / Uttarakhand / Tehri Garhwal	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.1	GR
hCoV-19/India/UT-AR62/2020	EPI_ISL_508199	2020-06-08	Asia / India / Uttarakhand / Tehri Garhwal	Human	Original			Illumina NovaSeq	CLC Genomics Workbench 20			B.1.1	GR
hCoV-19/France/OCC-MP01829/2020	EPI_ISL_508909	2020-03-18	Europe / France / Occitanie / Caraman	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1.1	GR
hCoV-19/Saudi Arabia/KAUST-JEDDAH888/2020	EPI_ISL_513037	2020-05-24	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.533	O
hCoV-19/Saudi Arabia/KAUST-JEDDAH890/2020	EPI_ISL_513039	2020-05-24	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.533	O
hCoV-19/Saudi Arabia/KAUST-JEDDAH905/2020	EPI_ISL_513043	2020-04-06	Asia / Saudi Arabia / Jeddah	Human	Original			Illumina NovaSeq	Amplicon gatk bcftools consensus			B.1.1	GR
hCoV-19/USA/CA-CZB-2175/2020	EPI_ISL_513725	2020-05-25	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1	G
hCoV-19/USA/CA-CZB-2186/2020	EPI_ISL_513735	2020-05-26	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.61	GR
hCoV-19/USA/CA-CZB-2358/2020	EPI_ISL_513805	2020-05-13	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1	GR
hCoV-19/USA/CA-CZB-2360/2020	EPI_ISL_513806	2020-05-13	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1	GR
hCoV-19/USA/CA-CZB-2450/2020	EPI_ISL_513858	2020-05-22	North America / USA / California / San Francisco County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1	GR
hCoV-19/USA/CA-CZB-2454/2020	EPI_ISL_513862	2020-05-22	North America / USA / California / San Francisco County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1	GR
hCoV-19/England/20166003004/2020	EPI_ISL_527336	2020-04-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.164	GR
hCoV-19/England/20166003104/2020	EPI_ISL_527337	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20182001304/2020	EPI_ISL_527357	2020-04-24	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/USA/MN-MDH-1563/2020	EPI_ISL_527628	2020-08-04	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.240	G
hCoV-19/USA/MN-MDH-1564/2020	EPI_ISL_527629	2020-08-04	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.240	G
hCoV-19/USA/GA-CDC-6427/2020	EPI_ISL_527662	2020-07-29	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bcftools 1.9,bowtie2 2.3.3.1			B.1.240	G
hCoV-19/Nigeria/EK291-CV115/2020	EPI_ISL_527887	2020-06-02	Africa / Nigeria / Ekiti	Human	Original			Illumina MiSeq	viral-ngs			B.1.1	GR
hCoV-19/Nigeria/ON920-CV152/2020	EPI_ISL_527891	2020-06-16	Africa / Nigeria / Ondo	Human	Original			Illumina MiSeq	viral-ngs			B.1.1	GR
hCoV-19/Nigeria/OY608-CV172/2020	EPI_ISL_527903	2020-06-11	Africa / Nigeria / Oyo	Human	Original			Illumina MiSeq	viral-ngs			B.1.1	GR
hCoV-19/Nigeria/OY633-CV189/2020	EPI_ISL_527914	2020-06-16	Africa / Nigeria / Oyo	Human	Original			Illumina MiSeq	viral-ngs			B.1.1.71	GR
hCoV-19/Scotland/QEUH-9631E1/2020	EPI_ISL_531801	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-962BA8/2020	EPI_ISL_531805	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-963776/2020	EPI_ISL_531806	2020-08-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/Scotland/QEUH-962C0F/2020	EPI_ISL_531815	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/Scotland/QEUH-962EDC/2020	EPI_ISL_531821	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-963381/2020	EPI_ISL_531822	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-962328/2020	EPI_ISL_531824	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-963345/2020	EPI_ISL_531832	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-96248F/2020	EPI_ISL_531836	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-962F42/2020	EPI_ISL_531839	2020-08-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/Scotland/QEUH-962B20/2020	EPI_ISL_531842	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Northern Ireland/QEUH-962443/2020	EPI_ISL_531848	2020-08-10	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/QEUH-962407/2020	EPI_ISL_531849	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-963503/2020	EPI_ISL_531853	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/Scotland/QEUH-961F9E/2020	EPI_ISL_531856	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-963530/2020	EPI_ISL_531862	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96355E/2020	EPI_ISL_531863	2020-08-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95FE0F/2020	EPI_ISL_531865	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Northern Ireland/QEUH-95FEB4/2020	EPI_ISL_531866	2020-08-07	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/Scotland/QEUH-9600F6/2020	EPI_ISL_531873	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-960445/2020	EPI_ISL_531877	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/Scotland/QEUH-960014/2020	EPI_ISL_531880	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95FFFD/2020	EPI_ISL_531881	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9600D8/2020	EPI_ISL_531884	2020-08-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-95FC7E/2020	EPI_ISL_531888	2020-08-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/Scotland/QEUH-95FCF6/2020	EPI_ISL_531889	2020-08-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95FF39/2020	EPI_ISL_531890	2020-08-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95FE78/2020	EPI_ISL_531892	2020-08-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9601E4/2020	EPI_ISL_531893	2020-08-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-8AACC0/2020	EPI_ISL_532666	2020-07-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/Scotland/QEUH-89AAD8/2020	EPI_ISL_532683	2020-07-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/Scotland/QEUH-89BBD4/2020	EPI_ISL_532689	2020-07-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/QEUH-880E33/2020	EPI_ISL_532691	2020-07-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/Scotland/QEUH-89DB2D/2020	EPI_ISL_532697	2020-07-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/Scotland/QEUH-87C2F2/2020	EPI_ISL_532705	2020-07-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/QEUH-8865ED/2020	EPI_ISL_532708	2020-07-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1	GR
hCoV-19/England/QEUH-881342/2020	EPI_ISL_532714	2020-07-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/Scotland/QEUH-87EF35/2020	EPI_ISL_532715	2020-07-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/QEUH-8AD331/2020	EPI_ISL_532721	2020-07-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/QEUH-89E2AF/2020	EPI_ISL_532729	2020-07-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/Scotland/QEUH-89E46D/2020	EPI_ISL_532733	2020-07-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/Scotland/QEUH-89E6D0/2020	EPI_ISL_532738	2020-07-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/Scotland/QEUH-899FDA/2020	EPI_ISL_532755	2020-07-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/Scotland/QEUH-89DD18/2020	EPI_ISL_532767	2020-07-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/QEUH-883CCD/2020	EPI_ISL_532775	2020-07-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-881D53/2020	EPI_ISL_532777	2020-07-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/Scotland/QEUH-88E415/2020	EPI_ISL_532784	2020-07-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/Scotland/QEUH-8A6523/2020	EPI_ISL_532786	2020-07-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/QEUH-8830EF/2020	EPI_ISL_532787	2020-07-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-887160/2020	EPI_ISL_532790	2020-07-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/Scotland/QEUH-87E8EF/2020	EPI_ISL_532791	2020-07-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/QEUH-8A8EEA/2020	EPI_ISL_532798	2020-07-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-894CE7/2020	EPI_ISL_532800	2020-07-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-89D729/2020	EPI_ISL_532810	2020-07-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/Scotland/QEUH-89C0D4/2020	EPI_ISL_532811	2020-07-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-89EBA4/2020	EPI_ISL_532816	2020-07-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-89E315/2020	EPI_ISL_532834	2020-07-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/QEUH-7EDA7D/2020	EPI_ISL_532836	2020-07-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/Scotland/QEUH-7C5AB7/2020	EPI_ISL_532838	2020-07-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/QEUH-7BBA0F/2020	EPI_ISL_532849	2020-07-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/Scotland/QEUH-7FD48B/2020	EPI_ISL_532865	2020-07-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/QEUH-7ED846/2020	EPI_ISL_532867	2020-07-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/QEUH-7F7120/2020	EPI_ISL_532872	2020-07-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/Scotland/QEUH-7AC3BB/2020	EPI_ISL_532874	2020-07-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/Scotland/QEUH-7B57D1/2020	EPI_ISL_532878	2020-07-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/QEUH-7D7FB3/2020	EPI_ISL_532879	2020-07-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/Scotland/QEUH-7D36D0/2020	EPI_ISL_532885	2020-07-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/QEUH-7B73CC/2020	EPI_ISL_532890	2020-07-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/Scotland/QEUH-7D35A6/2020	EPI_ISL_532891	2020-07-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/Scotland/QEUH-7B19B1/2020	EPI_ISL_532894	2020-07-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/Scotland/QEUH-7BC303/2020	EPI_ISL_532896	2020-07-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/Scotland/QEUH-7B18C3/2020	EPI_ISL_532905	2020-07-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/Scotland/QEUH-7FA169/2020	EPI_ISL_532906	2020-07-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/QEUH-7C86B0/2020	EPI_ISL_532912	2020-07-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/Scotland/QEUH-7AC1A2/2020	EPI_ISL_532915	2020-07-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/QEUH-7EF273/2020	EPI_ISL_532927	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/QEUH-7D6813/2020	EPI_ISL_532930	2020-07-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/Scotland/QEUH-7FDED8/2020	EPI_ISL_532932	2020-07-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/Scotland/QEUH-7F0E4E/2020	EPI_ISL_532933	2020-07-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/QEUH-7F8FAD/2020	EPI_ISL_532957	2020-07-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/Scotland/QEUH-7BADF8/2020	EPI_ISL_532962	2020-07-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/QEUH-757470/2020	EPI_ISL_532971	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.15	GR
hCoV-19/England/QEUH-75FCBC/2020	EPI_ISL_532972	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-761D0F/2020	EPI_ISL_532973	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/Scotland/QEUH-759739/2020	EPI_ISL_532978	2020-07-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/QEUH-75E998/2020	EPI_ISL_532981	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/Scotland/QEUH-759502/2020	EPI_ISL_532983	2020-07-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/QEUH-75F40F/2020	EPI_ISL_532987	2020-07-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/Scotland/QEUH-75958A/2020	EPI_ISL_532990	2020-07-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/Scotland/QEUH-759F40/2020	EPI_ISL_532992	2020-07-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/Scotland/QEUH-758FD8/2020	EPI_ISL_532994	2020-07-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/QEUH-762111/2020	EPI_ISL_532998	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-78D918/2020	EPI_ISL_533014	2020-07-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-79ACE2/2020	EPI_ISL_533020	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/QEUH-78634E/2020	EPI_ISL_533023	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-79202A/2020	EPI_ISL_533039	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/QEUH-7A8FF7/2020	EPI_ISL_533042	2020-07-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-76CC52/2020	EPI_ISL_533043	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-792DE7/2020	EPI_ISL_533047	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/QEUH-788889/2020	EPI_ISL_533068	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/QEUH-784B1B/2020	EPI_ISL_533083	2020-07-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/QEUH-78C630/2020	EPI_ISL_533092	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-794B09/2020	EPI_ISL_533096	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-7A1EC4/2020	EPI_ISL_533104	2020-07-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-7A1DE5/2020	EPI_ISL_533118	2020-07-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.97	GR
hCoV-19/England/QEUH-79AC4C/2020	EPI_ISL_533120	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/QEUH-7897D6/2020	EPI_ISL_533123	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-77B82F/2020	EPI_ISL_533143	2020-07-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.15	GR
hCoV-19/England/QEUH-7A6ACB/2020	EPI_ISL_533150	2020-07-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-79BF33/2020	EPI_ISL_533156	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/QEUH-79AFE9/2020	EPI_ISL_533158	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/QEUH-76D073/2020	EPI_ISL_533159	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-798EEE/2020	EPI_ISL_533165	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/QEUH-79EED9/2020	EPI_ISL_533195	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/QEUH-796554/2020	EPI_ISL_533198	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/QEUH-77B722/2020	EPI_ISL_533221	2020-07-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.15	GR
hCoV-19/Scotland/QEUH-5FC442/2020	EPI_ISL_533228	2020-06-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-5FDA9A/2020	EPI_ISL_533232	2020-06-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.14	GR
hCoV-19/England/QEUH-5F5625/2020	EPI_ISL_533240	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-5FBFF7/2020	EPI_ISL_533241	2020-06-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-5FD0C5/2020	EPI_ISL_533247	2020-06-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-5F8CB7/2020	EPI_ISL_533252	2020-06-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-5EE434/2020	EPI_ISL_533255	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/Scotland/QEUH-5F41DA/2020	EPI_ISL_533262	2020-06-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-5FE64A/2020	EPI_ISL_533263	2020-06-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-5F6624/2020	EPI_ISL_533271	2020-06-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.14	GR
hCoV-19/England/QEUH-5DCC5F/2020	EPI_ISL_533274	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/Northern Ireland/QEUH-5E535E/2020	EPI_ISL_533281	2020-06-17	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/QEUH-5E542E/2020	EPI_ISL_533305	2020-06-17	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-5DE4A0/2020	EPI_ISL_533321	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-5DFB31/2020	EPI_ISL_533332	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-5460BE/2020	EPI_ISL_533361	2020-05-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-544733/2020	EPI_ISL_533364	2020-05-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/QEUH-5477A9/2020	EPI_ISL_533377	2020-05-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-54D433/2020	EPI_ISL_533379	2020-05-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-54DDB0/2020	EPI_ISL_533398	2020-05-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-54BA06/2020	EPI_ISL_533415	2020-05-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/USA/TX-HMH-5776/2020	EPI_ISL_547007	2020-06-30	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1	G
hCoV-19/USA/TX-HMH-5789/2020	EPI_ISL_547016	2020-06-30	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-5809/2020	EPI_ISL_547031	2020-06-30	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1	G
hCoV-19/USA/TX-HMH-586/2020	EPI_ISL_547069	2020-04-02	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1	GR
hCoV-19/USA/TX-HMH-5959/2020	EPI_ISL_547123	2020-06-30	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.396	G
hCoV-19/USA/TX-HMH-6072/2020	EPI_ISL_547213	2020-07-06	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1	G
hCoV-19/Gibraltar/203260482/2020	EPI_ISL_547436	2020-08-03	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.269	GR
hCoV-19/Gibraltar/203360722/2020	EPI_ISL_547438	2020-08-10	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.269	GR
hCoV-19/Gibraltar/203360724/2020	EPI_ISL_547439	2020-08-07	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.269	GR
hCoV-19/Gibraltar/203360725/2020	EPI_ISL_547440	2020-08-07	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.269	GR
hCoV-19/Gibraltar/203360728/2020	EPI_ISL_547443	2020-08-06	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.269	GR
hCoV-19/Netherlands/LI-RIVM-10130/2020	EPI_ISL_547474	2020-03-30	Europe / Netherlands / Limburg	Human	Original			Nanopore MinION				B.1.1.71	GR
hCoV-19/Netherlands/NH-RIVM-10058/2020	EPI_ISL_547493	2020-03-30	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Netherlands/NH-RIVM-10141/2020	EPI_ISL_547508	2020-04-22	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore MinION				B.1.1.71	GR
hCoV-19/Netherlands/UT-RIVM-10138/2020	EPI_ISL_547538	2020-04-22	Europe / Netherlands / Utrecht	Human	Original			Nanopore MinION				B.1.1.71	GR
hCoV-19/USA/WI-GMF-09884/2020	EPI_ISL_547603	2020-07-08	North America / USA / Wisconsin / La Crosse County	Human	Original			Ion Torrent				B.1	G
hCoV-19/USA/WI-GMF-12930/2020	EPI_ISL_547647	2020-07-28	North America / USA / Wisconsin / Juneau County	Human	Original			Ion Torrent				B.1.240	G
hCoV-19/USA/IL-GMF-18664/2020	EPI_ISL_547774	2020-09-03	North America / USA / Illinois / Winnebago County	Human	Original			Ion Torrent				B.1.1	GR
hCoV-19/England/MILK-993133/2020	EPI_ISL_552032	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-992D8B/2020	EPI_ISL_552033	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9925ED/2020	EPI_ISL_552041	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-993203/2020	EPI_ISL_552043	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/Wales/MILK-992C51/2020	EPI_ISL_552045	2020-08-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-991575/2020	EPI_ISL_552151	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-992CBB/2020	EPI_ISL_552154	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-992820/2020	EPI_ISL_552164	2020-08-27	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-99476D/2020	EPI_ISL_552205	2020-08-25	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9944EE/2020	EPI_ISL_552206	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-994EFF/2020	EPI_ISL_552217	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/MILK-9948A6/2020	EPI_ISL_552220	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9944B1/2020	EPI_ISL_552221	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/MILK-994AA0/2020	EPI_ISL_552224	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-994E95/2020	EPI_ISL_552231	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-993C14/2020	EPI_ISL_552234	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-9938D4/2020	EPI_ISL_552245	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-995526/2020	EPI_ISL_552248	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.198	GR
hCoV-19/England/MILK-994484/2020	EPI_ISL_552261	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-994F74/2020	EPI_ISL_552267	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-994A64/2020	EPI_ISL_552271	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/MILK-9948F1/2020	EPI_ISL_552280	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/MILK-994D2F/2020	EPI_ISL_552299	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-99386B/2020	EPI_ISL_552323	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-995359/2020	EPI_ISL_552324	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99394A/2020	EPI_ISL_552325	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-993C9C/2020	EPI_ISL_552326	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-993A0B/2020	EPI_ISL_552332	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-993A29/2020	EPI_ISL_552334	2020-08-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-993D6C/2020	EPI_ISL_552337	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-994B25/2020	EPI_ISL_552341	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/MILK-9954FC/2020	EPI_ISL_552347	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-993B62/2020	EPI_ISL_552355	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-994897/2020	EPI_ISL_552363	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-994A91/2020	EPI_ISL_552365	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-994F0B/2020	EPI_ISL_552380	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-993D5D/2020	EPI_ISL_552383	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-994A46/2020	EPI_ISL_552386	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/MILK-994A37/2020	EPI_ISL_552389	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/MILK-993CC9/2020	EPI_ISL_552394	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-993968/2020	EPI_ISL_552401	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-995517/2020	EPI_ISL_552433	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/ALDP-982999/2020	EPI_ISL_552446	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/MILK-974D70/2020	EPI_ISL_552452	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-97500D/2020	EPI_ISL_552455	2020-08-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/MILK-975832/2020	EPI_ISL_552456	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-974AB5/2020	EPI_ISL_552461	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/ALDP-982A5A/2020	EPI_ISL_552463	2020-08-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-982C09/2020	EPI_ISL_552464	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-974F3E/2020	EPI_ISL_552478	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_K85stop results in 30.6% truncation of the protein sequence. Gap of 6 nucleotides found at refpos 27644.	info	B.1.1.269	GR
hCoV-19/England/MILK-974D9E/2020	EPI_ISL_552484	2020-08-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/MILK-974DAD/2020	EPI_ISL_552487	2020-08-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-975A87/2020	EPI_ISL_552490	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/MILK-975B1B/2020	EPI_ISL_552501	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-97535F/2020	EPI_ISL_552502	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-975A78/2020	EPI_ISL_552505	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/ALDP-982BA2/2020	EPI_ISL_552506	2020-08-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-982BFD/2020	EPI_ISL_552508	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/MILK-974DDA/2020	EPI_ISL_552520	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/ALDP-982A4B/2020	EPI_ISL_552526	2020-08-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-982A96/2020	EPI_ISL_552530	2020-08-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/MILK-974E8C/2020	EPI_ISL_552531	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/MILK-974D8F/2020	EPI_ISL_552535	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.133	GR
hCoV-19/England/MILK-975577/2020	EPI_ISL_552545	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-975AC3/2020	EPI_ISL_552551	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-9759A8/2020	EPI_ISL_552554	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NSP11 without BLAST coverage.	warn	B.1.236	G
hCoV-19/England/MILK-975173/2020	EPI_ISL_552563	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-982CFA/2020	EPI_ISL_552580	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-974AD3/2020	EPI_ISL_552581	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/ALDP-982D15/2020	EPI_ISL_552583	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-982A87/2020	EPI_ISL_552590	2020-08-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/MILK-97598A/2020	EPI_ISL_552602	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/MILK-97596C/2020	EPI_ISL_552603	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/MILK-9756ED/2020	EPI_ISL_552604	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-97547A/2020	EPI_ISL_552616	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.39	GR
hCoV-19/England/MILK-975999/2020	EPI_ISL_552623	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/MILK-975841/2020	EPI_ISL_552627	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-97501C/2020	EPI_ISL_552628	2020-08-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/MILK-975AE1/2020	EPI_ISL_552667	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-9758F6/2020	EPI_ISL_552685	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-975049/2020	EPI_ISL_552696	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-97597B/2020	EPI_ISL_552705	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/MILK-975AA5/2020	EPI_ISL_552708	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-976039/2020	EPI_ISL_552718	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-981F7A/2020	EPI_ISL_552741	2020-08-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/Wales/MILK-975CBE/2020	EPI_ISL_552752	2020-08-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-976743/2020	EPI_ISL_552756	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-976752/2020	EPI_ISL_552763	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/Wales/MILK-97689B/2020	EPI_ISL_552765	2020-08-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-981C73/2020	EPI_ISL_552780	2020-08-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.25	GR
hCoV-19/England/MILK-976770/2020	EPI_ISL_552790	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-92D532/2020	EPI_ISL_552822	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-935959/2020	EPI_ISL_552835	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-93D13B/2020	EPI_ISL_552852	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-90321D/2020	EPI_ISL_552858	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.253	GR
hCoV-19/England/ALDP-935625/2020	EPI_ISL_552865	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-907D09/2020	EPI_ISL_552895	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.97	GR
hCoV-19/England/ALDP-935AA1/2020	EPI_ISL_552902	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-935564/2020	EPI_ISL_552903	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-931674/2020	EPI_ISL_552907	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-93036F/2020	EPI_ISL_552913	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-928C6F/2020	EPI_ISL_552922	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-92B570/2020	EPI_ISL_552927	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9032A4/2020	EPI_ISL_552942	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.253	GR
hCoV-19/England/ALDP-928B71/2020	EPI_ISL_552980	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-926D22/2020	EPI_ISL_552992	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.95	GR
hCoV-19/England/ALDP-931735/2020	EPI_ISL_552999	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/USA/MI-MDHHS-SC21971/2020	EPI_ISL_566022	2020-08-17	North America / USA / Michigan	Human	Original			Illumina MiSeq	bwa v. 0.7.17; bcftools v. 1.7			B.1	G
hCoV-19/USA/MI-MDHHS-SC21977/2020	EPI_ISL_566027	2020-08-12	North America / USA / Michigan	Human	Original			Illumina MiSeq	bwa v. 0.7.17; bcftools v. 1.7			B.1.1.437	GR
hCoV-19/England/202580750/2020	EPI_ISL_566053	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.171	GR
hCoV-19/England/202620695/2020	EPI_ISL_566055	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.15	GR
hCoV-19/England/202640035/2020	EPI_ISL_566056	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.171	GR
hCoV-19/England/203180881/2020	EPI_ISL_566064	2020-07-29	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.115	GR
hCoV-19/England/203420511/2020	EPI_ISL_566066	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1	G
hCoV-19/England/203580286/2020	EPI_ISL_566072	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.406	GR
hCoV-19/England/ALDP-9CD8FF/2020	EPI_ISL_566120	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-9CD6AA/2020	EPI_ISL_566151	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q90stop results in 26.4% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/ALDP-9CD69B/2020	EPI_ISL_566156	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CD77A/2020	EPI_ISL_566163	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CD68C/2020	EPI_ISL_566170	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q90stop results in 26.4% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/ALDP-9CD8C2/2020	EPI_ISL_566180	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CD9DE/2020	EPI_ISL_566190	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CD3EF/2020	EPI_ISL_566200	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CDCF3/2020	EPI_ISL_566202	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CE14E/2020	EPI_ISL_566213	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/ALDP-9CDD69/2020	EPI_ISL_566244	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CD9B0/2020	EPI_ISL_566247	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CCE85/2020	EPI_ISL_566260	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CDBC9/2020	EPI_ISL_566264	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/ALDP-9CDA08/2020	EPI_ISL_566275	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CCF64/2020	EPI_ISL_566317	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/ALDP-9CCD6A/2020	EPI_ISL_566319	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CDA80/2020	EPI_ISL_566323	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/ALDP-9CD65F/2020	EPI_ISL_566328	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/ALDP-9CDA44/2020	EPI_ISL_566358	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CDA53/2020	EPI_ISL_566382	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CCF73/2020	EPI_ISL_566396	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CD798/2020	EPI_ISL_566400	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/ALDP-9CCF19/2020	EPI_ISL_566405	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CD112/2020	EPI_ISL_566407	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q90stop results in 26.4% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/ALDP-9CDDB4/2020	EPI_ISL_566412	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CCE67/2020	EPI_ISL_566414	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CCE58/2020	EPI_ISL_566419	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9C26E1/2020	EPI_ISL_566675	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9C2C76/2020	EPI_ISL_566678	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9C3AB7/2020	EPI_ISL_566683	2020-09-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9C3501/2020	EPI_ISL_566802	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/MILK-9C43BB/2020	EPI_ISL_566818	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/MILK-9C3AA8/2020	EPI_ISL_566819	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9C3F6D/2020	EPI_ISL_566831	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9C41A2/2020	EPI_ISL_566848	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9C3E24/2020	EPI_ISL_566856	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/Wales/MILK-9C35F2/2020	EPI_ISL_566862	2020-09-10	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9C3DEB/2020	EPI_ISL_566865	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9C4342/2020	EPI_ISL_566891	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-9C312B/2020	EPI_ISL_566895	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9C3BD2/2020	EPI_ISL_566896	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/MILK-9C45F1/2020	EPI_ISL_566912	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/MILK-9C3422/2020	EPI_ISL_566933	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-9C3CEE/2020	EPI_ISL_566946	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.198	GR
hCoV-19/England/MILK-9C3CB1/2020	EPI_ISL_566949	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9C38EA/2020	EPI_ISL_566971	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/MILK-9C45A6/2020	EPI_ISL_566987	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9C4175/2020	EPI_ISL_566991	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/QEUH-9C8180/2020	EPI_ISL_566998	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C7B1A/2020	EPI_ISL_567010	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q90stop results in 26.4% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/QEUH-9C8566/2020	EPI_ISL_567013	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C7DD8/2020	EPI_ISL_567015	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C80B0/2020	EPI_ISL_567022	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C8900/2020	EPI_ISL_567039	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-9C896A/2020	EPI_ISL_567042	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C7FE1/2020	EPI_ISL_567058	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C8B28/2020	EPI_ISL_567093	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-9C85EE/2020	EPI_ISL_567107	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/QEUH-9C7DAB/2020	EPI_ISL_567109	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C87D9/2020	EPI_ISL_567150	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9C7AD1/2020	EPI_ISL_567151	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C7F69/2020	EPI_ISL_567168	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C834E/2020	EPI_ISL_567182	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/QEUH-9C8C8F/2020	EPI_ISL_567186	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q90stop results in 26.4% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/QEUH-9C7E4E/2020	EPI_ISL_567198	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C7DBA/2020	EPI_ISL_567212	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C8B19/2020	EPI_ISL_567219	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-9C91E9/2020	EPI_ISL_567226	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C835D/2020	EPI_ISL_567239	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C81AE/2020	EPI_ISL_567243	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C8654/2020	EPI_ISL_567248	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C81CC/2020	EPI_ISL_567254	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/QEUH-9C87AC/2020	EPI_ISL_567255	2020-09-11	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CA31F/2020	EPI_ISL_567282	2020-09-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/CA-QDX-1423/2020	EPI_ISL_572075	2020-03-18	North America / USA / California	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1	GR
hCoV-19/USA/CA-QDX-1427/2020	EPI_ISL_572079	2020-03-18	North America / USA / California	Human	Original			Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1.61	GR
hCoV-19/USA/VA-DCLS-1395/2020	EPI_ISL_572236	2020-07-08	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.240	G
hCoV-19/USA/VA-DCLS-1396/2020	EPI_ISL_572237	2020-07-08	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.240	G
hCoV-19/USA/VA-DCLS-1409/2020	EPI_ISL_572244	2020-07-11	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-1308/2020	EPI_ISL_572248	2020-07-22	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1	G
hCoV-19/USA/VA-DCLS-1311/2020	EPI_ISL_572253	2020-07-23	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-1328/2020	EPI_ISL_572259	2020-06-29	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-1346/2020	EPI_ISL_572265	2020-06-29	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-1350/2020	EPI_ISL_572266	2020-06-29	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-1217/2020	EPI_ISL_572284	2020-06-23	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/Brazil/PE-FIOCRUZ-IAM109/2020	EPI_ISL_572334	2020-04-08	South America / Brazil / Pernambuco / Olinda	Human	Original			Illumina MiSeq	Bowtie2 2.2.6/bedtools v2.25.0			B.1.1	GR
hCoV-19/Brazil/PE-FIOCRUZ-IAM711/2020	EPI_ISL_572351	2020-04-26	South America / Brazil / Pernambuco / Recife	Human	Original			Illumina MiSeq	Bowtie2 2.2.6/bedtools v2.25.0			B.1.1	GR
hCoV-19/England/MILK-9C72D9/2020	EPI_ISL_572712	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-9C1C77/2020	EPI_ISL_572714	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-9C47CE/2020	EPI_ISL_572715	2020-09-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-9C4A4D/2020	EPI_ISL_572716	2020-09-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-EF16E/2020	EPI_ISL_572717	2020-09-13	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-EF632/2020	EPI_ISL_572718	2020-09-13	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-EF7E4/2020	EPI_ISL_572719	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-EF82D/2020	EPI_ISL_572720	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/QEUH-9BA0DF/2020	EPI_ISL_572726	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina		NS7a_Q90stop results in 26.4% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/ALDP-9B5CD0/2020	EPI_ISL_572963	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.269	GR
hCoV-19/England/ALDP-9B5DFB/2020	EPI_ISL_572967	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9B5EE9/2020	EPI_ISL_572973	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.133	GR
hCoV-19/England/ALDP-9B5EF8/2020	EPI_ISL_572974	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.133	GR
hCoV-19/England/ALDP-9B5F04/2020	EPI_ISL_572975	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.133	GR
hCoV-19/England/ALDP-9B61EF/2020	EPI_ISL_572992	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9B62CE/2020	EPI_ISL_572996	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9B62FB/2020	EPI_ISL_572998	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9B6325/2020	EPI_ISL_572999	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9E4CBA/2020	EPI_ISL_579765	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/Northern Ireland/QEUH-9E4E2D/2020	EPI_ISL_579768	2020-09-21	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1.310	GR
hCoV-19/England/QEUH-9E5633/2020	EPI_ISL_579770	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9E4977/2020	EPI_ISL_579788	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9E426D/2020	EPI_ISL_579811	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9E3EE2/2020	EPI_ISL_579834	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9E47B9/2020	EPI_ISL_579847	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/PHWC-47CDF5/2020	EPI_ISL_586052	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-47D2D7/2020	EPI_ISL_586124	2020-10-07	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-47D86C/2020	EPI_ISL_586201	2020-10-08	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/USA/AK-PHL602/2020	EPI_ISL_586245	2020-06-24	North America / USA / Alaska / Anchorage-Mat Su	Human	Original	Upper Respiratory		Illumina MiSeq				B.1.240	G
hCoV-19/India/GJ-GBRC-423b/2020	EPI_ISL_586554	2020-07-14	Asia / India / Gujarat / Veraval	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.533	G
hCoV-19/England/ALDP-A2E284/2020	EPI_ISL_586591	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/ALDP-A2D13D/2020	EPI_ISL_586609	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2D768/2020	EPI_ISL_586618	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2D908/2020	EPI_ISL_586622	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2DFF7/2020	EPI_ISL_586627	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.159	GR
hCoV-19/England/ALDP-A2DF60/2020	EPI_ISL_586671	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2E1D2/2020	EPI_ISL_586703	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2D3EC/2020	EPI_ISL_586705	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2D4AD/2020	EPI_ISL_586713	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2E80A/2020	EPI_ISL_586720	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2E58B/2020	EPI_ISL_586757	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/ALDP-A2DA7E/2020	EPI_ISL_586759	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2D3A0/2020	EPI_ISL_586763	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2D689/2020	EPI_ISL_586784	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2DB6C/2020	EPI_ISL_586787	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.308	GR
hCoV-19/England/ALDP-A2E63D/2020	EPI_ISL_586802	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/ALDP-A2D8B0/2020	EPI_ISL_586840	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A2D944/2020	EPI_ISL_586859	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2E61F/2020	EPI_ISL_586864	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2E5C7/2020	EPI_ISL_586881	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-A2D829/2020	EPI_ISL_586885	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2D3FB/2020	EPI_ISL_586914	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2E5F4/2020	EPI_ISL_586921	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/ALDP-A2F317/2020	EPI_ISL_586951	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2ED38/2020	EPI_ISL_586959	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2E855/2020	EPI_ISL_586985	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-A2FC0D/2020	EPI_ISL_586991	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2E6D3/2020	EPI_ISL_586994	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CF7C3/2020	EPI_ISL_590102	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CF839/2020	EPI_ISL_590107	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CE490/2020	EPI_ISL_590114	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Norway/3753/2020	EPI_ISL_591003	2020-09-08	Europe / Norway / Viken	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1.39	GR
hCoV-19/Italy/TUS-UOS-8/2020	EPI_ISL_591335	2020-03-20	Europe / Italy / Tuscany / Siena	Human	Original	Nasopharyngeal swab		Oxford Nanopore	Medaka v. 0.12.1			B.1.1	G
hCoV-19/Japan/IC-0012/2020	EPI_ISL_591358	2020-03-26	Asia / Japan	Human	Original		COVID-19 positive case who entered from Spain.	Illumina NextSeq500	A5-miseq v. 20140604			B.1.1	GR
hCoV-19/England/ALDP-A87D2E/2020	EPI_ISL_606015	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A86FED/2020	EPI_ISL_606039	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A862B7/2020	EPI_ISL_606091	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A864C0/2020	EPI_ISL_606118	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A87869/2020	EPI_ISL_606146	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/ALDP-A8792A/2020	EPI_ISL_606148	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A87B7F/2020	EPI_ISL_606152	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A873B3/2020	EPI_ISL_606153	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/ALDP-A86509/2020	EPI_ISL_606167	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A8780F/2020	EPI_ISL_606205	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/ALDP-A872B6/2020	EPI_ISL_606231	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A86633/2020	EPI_ISL_606234	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A879C0/2020	EPI_ISL_606254	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A8624E/2020	EPI_ISL_606263	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A87052/2020	EPI_ISL_606268	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A87966/2020	EPI_ISL_606289	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/MILK-A7C0D8/2020	EPI_ISL_606303	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7DABB/2020	EPI_ISL_606345	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7C2B4/2020	EPI_ISL_606373	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/England/MILK-A7D23B/2020	EPI_ISL_606385	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7D453/2020	EPI_ISL_606391	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-A7C612/2020	EPI_ISL_606396	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7CB7D/2020	EPI_ISL_606409	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7AD6A/2020	EPI_ISL_606413	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7A957/2020	EPI_ISL_606417	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-A7DECE/2020	EPI_ISL_606455	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7C366/2020	EPI_ISL_606467	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7C0F6/2020	EPI_ISL_606469	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-A7C384/2020	EPI_ISL_606470	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-A7D2D1/2020	EPI_ISL_606477	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7DF34/2020	EPI_ISL_606504	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7ADB5/2020	EPI_ISL_606506	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7D7E1/2020	EPI_ISL_606550	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/England/MILK-A7D5E7/2020	EPI_ISL_606561	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7C3FD/2020	EPI_ISL_606580	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7A939/2020	EPI_ISL_606592	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7CF9F/2020	EPI_ISL_606611	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A79FA1/2020	EPI_ISL_606614	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7AE67/2020	EPI_ISL_606629	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/England/MILK-A7ADF1/2020	EPI_ISL_606638	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/England/MILK-A7AC4F/2020	EPI_ISL_606648	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-A79FB0/2020	EPI_ISL_606672	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-A797C7/2020	EPI_ISL_606779	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/England/MILK-A7A720/2020	EPI_ISL_606831	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A795AF/2020	EPI_ISL_606893	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.408	G
hCoV-19/England/MILK-A7A122/2020	EPI_ISL_606896	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7CE56/2020	EPI_ISL_606915	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6E130/2020	EPI_ISL_606934	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6E5AD/2020	EPI_ISL_606956	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6E4DD/2020	EPI_ISL_606961	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/ALDP-A943D1/2020	EPI_ISL_611013	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A92670/2020	EPI_ISL_611020	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A9277D/2020	EPI_ISL_611050	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/ALDP-A94896/2020	EPI_ISL_611073	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A93D10/2020	EPI_ISL_611076	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A92740/2020	EPI_ISL_611139	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A929A4/2020	EPI_ISL_611145	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A9282F/2020	EPI_ISL_611162	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A92731/2020	EPI_ISL_611169	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A936F7/2020	EPI_ISL_611183	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A92643/2020	EPI_ISL_611192	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A92ED2/2020	EPI_ISL_611194	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A92D20/2020	EPI_ISL_611195	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-A92BF9/2020	EPI_ISL_611226	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/ALDP-A927C8/2020	EPI_ISL_611228	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A929B3/2020	EPI_ISL_611251	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A92EA5/2020	EPI_ISL_611286	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A9AE16/2020	EPI_ISL_611302	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A9EF1F/2020	EPI_ISL_611323	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS3_E241stop results in 12.7% truncation of the protein sequence.	info	B.1.1.165	G
hCoV-19/England/QEUH-A9EDD9/2020	EPI_ISL_611325	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A9EE9A/2020	EPI_ISL_611341	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-AA0545/2020	EPI_ISL_611350	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-A9F01B/2020	EPI_ISL_611356	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A9F5D0/2020	EPI_ISL_611375	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-A9EEC7/2020	EPI_ISL_611385	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/QEUH-A9F52B/2020	EPI_ISL_611395	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A9F6FB/2020	EPI_ISL_611408	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A9EA4B/2020	EPI_ISL_611417	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A9F628/2020	EPI_ISL_611422	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AA02B7/2020	EPI_ISL_611435	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A9F02A/2020	EPI_ISL_611436	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A9F127/2020	EPI_ISL_611440	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A9E8AB/2020	EPI_ISL_611472	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMB-1B6C7D/2020	EPI_ISL_611964	2020-10-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMB-1B6D4D/2020	EPI_ISL_611965	2020-10-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMB-1B6D7A/2020	EPI_ISL_611967	2020-10-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/QEUH-AAD36C/2020	EPI_ISL_624077	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-AA0949/2020	EPI_ISL_625000	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA0C04/2020	EPI_ISL_625021	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-AA49AF/2020	EPI_ISL_625065	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA457E/2020	EPI_ISL_625067	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/England/ALDP-AA21F4/2020	EPI_ISL_625075	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA1887/2020	EPI_ISL_625082	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA5425/2020	EPI_ISL_625102	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA572C/2020	EPI_ISL_625127	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-AA5443/2020	EPI_ISL_625138	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-AA0C13/2020	EPI_ISL_625155	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/ALDP-AA32B4/2020	EPI_ISL_625162	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA380D/2020	EPI_ISL_625173	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA2200/2020	EPI_ISL_625187	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA0BE9/2020	EPI_ISL_625198	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-AA22A6/2020	EPI_ISL_625206	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AA563E/2020	EPI_ISL_625237	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-AA1623/2020	EPI_ISL_625258	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-A85643/2020	EPI_ISL_625277	2020-10-17	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/CA-CZB-11793/2020	EPI_ISL_625636	2020-09-22	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.239	G
hCoV-19/Denmark/DCGC-8554/2020	EPI_ISL_625684	2020-10-26	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.398	G
hCoV-19/Denmark/DCGC-8919/2020	EPI_ISL_626150	2020-10-26	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.398	G
hCoV-19/England/MILK-ABBFB2/2020	EPI_ISL_631007	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/ALDP-AC5D7F/2020	EPI_ISL_631027	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NSP11 without BLAST coverage.	warn	B.1.532	GR
hCoV-19/England/ALDP-AC5DCA/2020	EPI_ISL_631056	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NSP11 without BLAST coverage.	warn	B.1.532	GR
hCoV-19/England/ALDP-AC1256/2020	EPI_ISL_631060	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-ABD23F/2020	EPI_ISL_631116	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ABB86C/2020	EPI_ISL_631161	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ABB8A8/2020	EPI_ISL_631182	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AC5D06/2020	EPI_ISL_631189	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AC11D1/2020	EPI_ISL_631190	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ABBCCA/2020	EPI_ISL_631223	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/ALDP-ABD299/2020	EPI_ISL_631228	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ABBCAC/2020	EPI_ISL_631252	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-AC12A1/2020	EPI_ISL_631269	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Germany/NW-HHU-263/2020	EPI_ISL_631351	2020-09-21	Europe / Germany / North Rhine-Westphalia / Düsseldorf	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			AD.2	GR
hCoV-19/Germany/NW-HHU-276/2020	EPI_ISL_631364	2020-09-26	Europe / Germany / North Rhine-Westphalia / Düsseldorf	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.1.269	GR
hCoV-19/USA/NY-NYCPHL-000197/2020	EPI_ISL_631732	2020-04-16	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	Bwa version 0.7.17-r1188			B.1.1.61	GR
hCoV-19/Wales/PHWC-489487/2020	EPI_ISL_639579	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-4894D2/2020	EPI_ISL_639583	2020-10-25	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/QEUH-9AE00B/2020	EPI_ISL_639624	2020-09-01	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Wales/QEUH-9AE065/2020	EPI_ISL_639625	2020-09-02	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Latvia/186/2020	EPI_ISL_639683	2020-09-24	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		DNBSEQ-G400RS, MGI Tech Co., Ltd	bowtie2			B.1.1.159	GR
hCoV-19/Australia/NSW1168/2020	EPI_ISL_639736	2020-10-21	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/Australia/QLD1211/2020	EPI_ISL_639802	2020-03-22	Oceania / Australia / Queensland	Human	Original			Illumina	Samtools / iVar			B.1.1	GR
hCoV-19/Poland/PL_MCB_26/2020	EPI_ISL_645025	2020-05-12	Europe / Poland	Human	Original			IonTorrent	Torrent Suite v. 5.12.1; variantCaller v.			B.1.223	G
hCoV-19/Poland/PL_MCB_27/2020	EPI_ISL_645026	2020-05-12	Europe / Poland	Human	Original			IonTorrent	Torrent Suite v. 5.12.1; variantCaller v.			B.1.223	G
hCoV-19/Poland/PL_MCB_28/2020	EPI_ISL_645027	2020-05-12	Europe / Poland	Human	Original			IonTorrent	Torrent Suite v. 5.12.1; variantCaller v.			B.1.223	G
hCoV-19/Poland/PL_MCB_29/2020	EPI_ISL_645028	2020-05-12	Europe / Poland	Human	Original			IonTorrent	Torrent Suite v. 5.12.1; variantCaller v.			B.1.223	G
hCoV-19/Poland/PL_MCB_44/2020	EPI_ISL_645043	2020-05-12	Europe / Poland	Human	Original			IonTorrent	Torrent Suite v. 5.12.1; variantCaller v.			B.1.223	G
hCoV-19/Poland/PL_MCB_56/2020	EPI_ISL_645055	2020-06-06	Europe / Poland	Human	Original			IonTorrent	Torrent Suite v. 5.12.1; variantCaller v.			B.1.1	GR
hCoV-19/Poland/PL_MCB_60/2020	EPI_ISL_645059	2020-06-06	Europe / Poland	Human	Original			IonTorrent	Torrent Suite v. 5.12.1; variantCaller v.			B.1.1	GR
hCoV-19/Poland/PL_MCB_79/2020	EPI_ISL_645078	2020-06-06	Europe / Poland	Human	Original			IonTorrent	Torrent Suite v. 5.12.1; variantCaller v.			B.1.1	GR
hCoV-19/Poland/PL_MCB_80/2020	EPI_ISL_645079	2020-06-06	Europe / Poland	Human	Original			IonTorrent	Torrent Suite v. 5.12.1; variantCaller v.			B.1.1	GR
hCoV-19/Poland/PL_MCB_81/2020	EPI_ISL_645080	2020-06-06	Europe / Poland	Human	Original			IonTorrent	Torrent Suite v. 5.12.1; variantCaller v.			B.1.1	GR
hCoV-19/Poland/PL_MCB_82/2020	EPI_ISL_645081	2020-06-06	Europe / Poland	Human	Original			IonTorrent	Torrent Suite v. 5.12.1; variantCaller v.			B.1.1	GR
hCoV-19/Poland/PL_MCB_83/2020	EPI_ISL_645082	2020-06-06	Europe / Poland	Human	Original			IonTorrent	Torrent Suite v. 5.12.1; variantCaller v.			B.1.1	GR
hCoV-19/Poland/PL_MCB_110/2020	EPI_ISL_645109	2020-06-06	Europe / Poland	Human	Original			IonTorrent	Torrent Suite v. 5.12.1; variantCaller v.			B.1.1	GR
hCoV-19/England/CAMC-B360CA/2020	EPI_ISL_645223	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B36A26/2020	EPI_ISL_645238	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B3622E/2020	EPI_ISL_645326	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.240	GR
hCoV-19/England/CAMC-B363B2/2020	EPI_ISL_645371	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B3D4F4/2020	EPI_ISL_645391	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/CAMC-B36060/2020	EPI_ISL_645401	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/CAMC-B3615E/2020	EPI_ISL_645413	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-B375BB/2020	EPI_ISL_645470	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B364CE/2020	EPI_ISL_645526	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/ALDP-B1B2F2/2020	EPI_ISL_645532	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B1A080/2020	EPI_ISL_645538	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B1BB9D/2020	EPI_ISL_645568	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B1BF19/2020	EPI_ISL_645675	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B1CD87/2020	EPI_ISL_645677	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/ALDP-B1AF92/2020	EPI_ISL_645790	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/ALDP-B1B4A1/2020	EPI_ISL_645816	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B2228F/2020	EPI_ISL_645866	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B1D533/2020	EPI_ISL_645912	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B22410/2020	EPI_ISL_645917	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B2239B/2020	EPI_ISL_645925	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B21D07/2020	EPI_ISL_645949	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/CAMC-B223D7/2020	EPI_ISL_645958	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B22313/2020	EPI_ISL_645968	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/USA/MI-UM-10036625470/2020	EPI_ISL_650030	2020-10-26	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1	G
hCoV-19/USA/MI-UM-10036633055/2020	EPI_ISL_650044	2020-10-26	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1	G
hCoV-19/USA/MI-UM-10036671636/2020	EPI_ISL_650093	2020-10-28	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1.396	G
hCoV-19/USA/MI-UM-10036696400/2020	EPI_ISL_650094	2020-10-29	North America / USA / Michigan	Human	Original			Illumina MiSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.312	GR
hCoV-19/USA/MI-UM-10036669328/2020	EPI_ISL_650100	2020-10-28	North America / USA / Michigan	Human	Original			Illumina MiSeq				B.1	G
hCoV-19/England/MILK-B05BD2/2020	EPI_ISL_651089	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-F6823/2020	EPI_ISL_651090	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-F687E/2020	EPI_ISL_651091	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-F6B48/2020	EPI_ISL_651092	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-F7ED5/2020	EPI_ISL_651093	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-F7F1E/2020	EPI_ISL_651094	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-B38AE8/2020	EPI_ISL_659024	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B37CA7/2020	EPI_ISL_659054	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-B325FC/2020	EPI_ISL_659175	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B324B3/2020	EPI_ISL_659181	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B33616/2020	EPI_ISL_659221	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-B338F2/2020	EPI_ISL_659267	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B3387A/2020	EPI_ISL_659303	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B32E3D/2020	EPI_ISL_659347	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B330AF/2020	EPI_ISL_659369	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B33F84/2020	EPI_ISL_659374	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence. Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.171	GR
hCoV-19/England/CAMC-B33E4B/2020	EPI_ISL_659394	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B32FA3/2020	EPI_ISL_659401	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B34141/2020	EPI_ISL_659429	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.408	G
hCoV-19/England/CAMC-B348C4/2020	EPI_ISL_659498	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q90stop results in 26.4% truncation of the protein sequence.	info	B.1.1.130	GR
hCoV-19/England/CAMC-B350F8/2020	EPI_ISL_659509	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B34509/2020	EPI_ISL_659531	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B3467F/2020	EPI_ISL_659543	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B34378/2020	EPI_ISL_659564	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-B34387/2020	EPI_ISL_659601	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-B343F0/2020	EPI_ISL_659604	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-B32CAC/2020	EPI_ISL_659649	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B340BD/2020	EPI_ISL_659673	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B3279C/2020	EPI_ISL_659695	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B32B18/2020	EPI_ISL_659718	2020-11-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2F932/2020	EPI_ISL_659747	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/QEUH-B2DF8D/2020	EPI_ISL_659752	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2F316/2020	EPI_ISL_659758	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B30B1A/2020	EPI_ISL_659766	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B302E8/2020	EPI_ISL_659776	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2EC58/2020	EPI_ISL_659779	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2D5C7/2020	EPI_ISL_659790	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2D59A/2020	EPI_ISL_659792	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2E906/2020	EPI_ISL_659819	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2D239/2020	EPI_ISL_659823	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2EBD3/2020	EPI_ISL_659830	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2D266/2020	EPI_ISL_659836	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2F941/2020	EPI_ISL_659851	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2D284/2020	EPI_ISL_659875	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2EDDD/2020	EPI_ISL_659930	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2EEBC/2020	EPI_ISL_659936	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2EEAD/2020	EPI_ISL_659938	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2D336/2020	EPI_ISL_659939	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B3034F/2020	EPI_ISL_659949	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B30312/2020	EPI_ISL_659984	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2D3FA/2020	EPI_ISL_659988	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2EB2E/2020	EPI_ISL_659993	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2D248/2020	EPI_ISL_659998	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/LOND-124F99C/2020	EPI_ISL_664744	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/ALDP-B1CBF6/2020	EPI_ISL_664848	2020-11-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/ALDP-B1D07E/2020	EPI_ISL_664852	2020-11-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/ALDP-B73C81/2020	EPI_ISL_664879	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-B73C90/2020	EPI_ISL_664880	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.67	GR
hCoV-19/England/CAMB-1BAECE/2020	EPI_ISL_665000	2020-11-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/CAMC-B2337C/2020	EPI_ISL_665034	2020-11-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.532	GR
hCoV-19/England/EXET-138F3E/2020	EPI_ISL_665050	2020-10-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/LOND-124FE60/2020	EPI_ISL_665190	2020-04-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.164	GR
hCoV-19/England/LOND-1250303/2020	EPI_ISL_665207	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.164	GR
hCoV-19/Denmark/DCGC-10553/2020	EPI_ISL_670049	2020-11-02	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-10584/2020	EPI_ISL_670069	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-10726/2020	EPI_ISL_670164	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.39	GR
hCoV-19/Denmark/DCGC-10728/2020	EPI_ISL_670165	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.39	GR
hCoV-19/Denmark/DCGC-10756/2020	EPI_ISL_670187	2020-11-02	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.398	G
hCoV-19/Denmark/DCGC-10785/2020	EPI_ISL_670205	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-10815/2020	EPI_ISL_670225	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.39	G
hCoV-19/Denmark/DCGC-10836/2020	EPI_ISL_670242	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-10877/2020	EPI_ISL_670261	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.39	GR
hCoV-19/Denmark/DCGC-10909/2020	EPI_ISL_670279	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.39	GR
hCoV-19/Denmark/DCGC-10913/2020	EPI_ISL_670281	2020-11-02	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.39	GR
hCoV-19/Denmark/DCGC-10933/2020	EPI_ISL_670293	2020-11-02	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.398	G
hCoV-19/Denmark/DCGC-10940/2020	EPI_ISL_670299	2020-11-02	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.39	GR
hCoV-19/Denmark/DCGC-11166/2020	EPI_ISL_670430	2020-11-02	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.398	G
hCoV-19/Denmark/DCGC-11168/2020	EPI_ISL_670432	2020-11-02	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-11197/2020	EPI_ISL_670450	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-11242/2020	EPI_ISL_670580	2020-11-02	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.398	G
hCoV-19/Denmark/DCGC-11329/2020	EPI_ISL_670595	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.398	G
hCoV-19/Denmark/DCGC-11718/2020	EPI_ISL_670634	2020-10-26	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.398	G
hCoV-19/Denmark/DCGC-11273/2020	EPI_ISL_670806	2020-11-02	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.398	G
hCoV-19/Denmark/DCGC-11320/2020	EPI_ISL_670837	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-11321/2020	EPI_ISL_670838	2020-11-02	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.398	G
hCoV-19/Denmark/DCGC-11351/2020	EPI_ISL_670859	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.398	G
hCoV-19/Denmark/DCGC-11415/2020	EPI_ISL_670904	2020-11-02	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.398	G
hCoV-19/Denmark/DCGC-11419/2020	EPI_ISL_670908	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.159	GR
hCoV-19/Denmark/DCGC-11508/2020	EPI_ISL_670964	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.398	G
hCoV-19/Denmark/DCGC-11512/2020	EPI_ISL_670967	2020-11-02	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.398	G
hCoV-19/Denmark/DCGC-11513/2020	EPI_ISL_670968	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.398	G
hCoV-19/Denmark/DCGC-11561/2020	EPI_ISL_670996	2020-11-02	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.159	GR
hCoV-19/England/BIRM-6A2FF/2020	EPI_ISL_679039	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/CAMB-1B983A/2020	EPI_ISL_679143	2020-11-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/CAMB-1B9B40/2020	EPI_ISL_679153	2020-11-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.240	GR
hCoV-19/England/CAMB-1BBA9C/2020	EPI_ISL_679186	2020-11-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/CAMB-1BBB3F/2020	EPI_ISL_679196	2020-11-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/CAMB-1BBC69/2020	EPI_ISL_679214	2020-11-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/EXET-139C90/2020	EPI_ISL_679332	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/LOND-125152A/2020	EPI_ISL_679408	2020-09-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.240	GR
hCoV-19/England/LOND-1251539/2020	EPI_ISL_679409	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.240	GR
hCoV-19/England/LOND-1251548/2020	EPI_ISL_679410	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.240	GR
hCoV-19/England/MILK-B39883/2020	EPI_ISL_679647	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/MILK-B3A099/2020	EPI_ISL_679676	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-B3AB5C/2020	EPI_ISL_679707	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.130	GR
hCoV-19/England/MILK-B3AB98/2020	EPI_ISL_679710	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-B3ACB3/2020	EPI_ISL_679722	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-B3B9D9/2020	EPI_ISL_679783	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.255	GR
hCoV-19/England/MILK-B3BDA0/2020	EPI_ISL_679810	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-B3BDFB/2020	EPI_ISL_679812	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/USA/WA-UW138/2020	EPI_ISL_416676	2020-03-11	North America / USA / Washington	Human	Original			Illumina NextSeq	custom			B.1.1	GR
hCoV-19/England/SHEF-C0831/2020	EPI_ISL_420162	2020-03-26	Europe / United Kingdom / England / South Yorkshire	Human	Original	Nose-Throat		Nanopore				B.1.1.137	GR
hCoV-19/England/SHEF-C08C8/2020	EPI_ISL_420165	2020-03-25	Europe / United Kingdom / England / South Yorkshire	Human	Original	Nose-Throat		Nanopore				B.1.1.137	GR
hCoV-19/England/SHEF-C0804/2020	EPI_ISL_420167	2020-03-25	Europe / United Kingdom / England / South Yorkshire	Human	Original	Nose-Throat		Nanopore				B.1.1.137	GR
hCoV-19/England/SHEF-C08B9/2020	EPI_ISL_420171	2020-03-24	Europe / United Kingdom / England / South Yorkshire	Human	Original	Nose-Throat		Nanopore				B.1.1.137	GR
hCoV-19/England/SHEF-C089B/2020	EPI_ISL_420172	2020-03-24	Europe / United Kingdom / England / South Yorkshire	Human	Original	Throat		Nanopore		Stretches of NNNs (1.59% of overall sequence).		B.1.1.137	GR
hCoV-19/England/SHEF-C08F5/2020	EPI_ISL_420173	2020-03-24	Europe / United Kingdom / England / South Yorkshire	Human	Original	Nose-Throat		Nanopore				B.1.1.137	GR
hCoV-19/England/SHEF-C04A6/2020	EPI_ISL_420178	2020-03-27	Europe / United Kingdom / England / South Yorkshire	Human	Original			Nanopore				B.1.1.137	GR
hCoV-19/England/SHEF-C0242/2020	EPI_ISL_420187	2020-03-27	Europe / United Kingdom / England / South Yorkshire	Human	Original			Nanopore		Stretches of NNNs (1.13% of overall sequence).		B.59	GR
hCoV-19/England/SHEF-C0400/2020	EPI_ISL_420188	2020-03-27	Europe / United Kingdom / England / South Yorkshire	Human	Original			Nanopore				B.1.1.137	GR
hCoV-19/England/SHEF-C028E/2020	EPI_ISL_420194	2020-03-28	Europe / United Kingdom / England / South Yorkshire	Human	Original			Nanopore				B.59	GR
hCoV-19/England/SHEF-C04B5/2020	EPI_ISL_420202	2020-03-29	Europe / United Kingdom / England / South Yorkshire	Human	Original			Nanopore				B.1.1.137	GR
hCoV-19/England/SHEF-C02AC/2020	EPI_ISL_420208	2020-03-28	Europe / United Kingdom / England / South Yorkshire	Human	Original			Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C037C/2020	EPI_ISL_420219	2020-03-28	Europe / United Kingdom / England / South Yorkshire	Human	Original			Nanopore				B.1.1.137	GR
hCoV-19/England/SHEF-C035E/2020	EPI_ISL_420220	2020-03-28	Europe / United Kingdom / England / South Yorkshire	Human	Original			Nanopore				B.1.1.137	GR
hCoV-19/England/SHEF-C0594/2020	EPI_ISL_420224	2020-03-26	Europe / United Kingdom / England / South Yorkshire	Human	Original	Nose-Throat		Nanopore				B.1.1.137	GR
hCoV-19/England/SHEF-C052B/2020	EPI_ISL_420225	2020-03-25	Europe / United Kingdom / England / South Yorkshire	Human	Original	Nose		Nanopore				B.1.1	GR
hCoV-19/Belgium/RGE-0325122/2020	EPI_ISL_420379	2020-03-25	Europe / Belgium / Tienen	Human	Original	Oropharyngeal swab	unknown	Nanopore MinION	Guppy, CLC Genomics Workbench 20, Porechop, Medaka.	Sequence updated by the Submitter following changes to the analytics pipeline to mitigate possible sequence errors	info	B.1.1	GR
hCoV-19/England/201380036/2020	EPI_ISL_421800	2020-03-26	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/201380282/2020	EPI_ISL_421830	2020-03-25	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20138082704/2020	EPI_ISL_421836	2020-03-26	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20138082804/2020	EPI_ISL_421837	2020-03-27	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.164	GR
hCoV-19/England/20139020204/2020	EPI_ISL_421879	2020-03-27	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20144020004/2020	EPI_ISL_421942	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20144074804/2020	EPI_ISL_421963	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20148004904/2020	EPI_ISL_422001	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.164	GR
hCoV-19/Wales/PHWC-26444/2020	EPI_ISL_422102	2020-03-27	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-267B4/2020	EPI_ISL_422126	2020-03-28	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1	GR
hCoV-19/Wales/PHWC-26C1F/2020	EPI_ISL_422151	2020-03-28	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1.1.190	GR
hCoV-19/Wales/PHWC-26611/2020	EPI_ISL_422162	2020-03-27	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	Mapping consensus			B.1	G
hCoV-19/USA/TX-HMH0189/2020	EPI_ISL_434865	2020-03-23	North America / USA / Texas	Human	Original			Oxford Nanopore	ARTIC V1			B.1.1.61	GR
hCoV-19/USA/PA-MGSC11-04/2020	EPI_ISL_436466	2020-03-23	North America / USA / Pennsylvania / Allegheny County / Pittsburgh	Human	Original	Nasopharyngeal swab		Illumina NextSeq	breseq v0.34.1; genome diff, mapping to EPI_ISL_402124			B.1	G
hCoV-19/South Africa/KRISP-04/2020	EPI_ISL_436684	2020-03-31	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/Italy/ABR-IZSGC-TE5545/2020	EPI_ISL_436721	2020-03-20	Europe / Italy / Abruzzo	Human	Original			SISPA+ARBOR+Illumina MiniSeq				B.1.1	GR
hCoV-19/Italy/ABR-IZSGC-TE5547/2020	EPI_ISL_436722	2020-03-20	Europe / Italy / Abruzzo	Human	Original			SISPA+ARBOR+Illumina MiniSeq				B.1.1	GR
hCoV-19/Italy/ABR-IZSGC-TE26643/2020	EPI_ISL_436729	2020-04-27	Europe / Italy / Abruzzo	Human	Original			ARTIC + Illumina MiniSeq				B.1.1	GR
hCoV-19/England/LOND-D3938/2020	EPI_ISL_441010	2020-04-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-790F3/2020	EPI_ISL_441207	2020-04-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.198	GR
hCoV-19/England/CAMB-7A48D/2020	EPI_ISL_441253	2020-04-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-79DED/2020	EPI_ISL_441299	2020-04-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.43	GR
hCoV-19/England/CAMB-7A292/2020	EPI_ISL_441304	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7A1D1/2020	EPI_ISL_441321	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/CAMB-7B7B0/2020	EPI_ISL_441599	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7DF4D/2020	EPI_ISL_441602	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-FAA1A/2020	EPI_ISL_441662	2020-03-27	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-FA986/2020	EPI_ISL_441693	2020-04-06	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7DB49/2020	EPI_ISL_441734	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/CAMB-7D9A9/2020	EPI_ISL_441754	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.13	GR
hCoV-19/Northern Ireland/NIRE-FA652/2020	EPI_ISL_441766	2020-03-31	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-FA9B3/2020	EPI_ISL_441781	2020-03-26	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/SHEF-C6798/2020	EPI_ISL_441991	2020-04-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.137	GR
hCoV-19/Netherlands/NA_320/2020	EPI_ISL_455125	2020-04-02	Europe / Netherlands	Human	Original			Nanopore				B.1.1.71	GR
hCoV-19/Netherlands/NA_326/2020	EPI_ISL_455131	2020-04-02	Europe / Netherlands	Human	Original			Nanopore				B.1.1	GR
hCoV-19/Netherlands/NA_338/2020	EPI_ISL_455143	2020-04-04	Europe / Netherlands	Human	Original			Nanopore				B.1.1.71	GR
hCoV-19/Netherlands/NA_342/2020	EPI_ISL_455147	2020-04-04	Europe / Netherlands	Human	Original			Nanopore				B.1.1.71	GR
hCoV-19/Netherlands/NA_358/2020	EPI_ISL_455162	2020-04-07	Europe / Netherlands	Human	Original			Nanopore				B.1.1.71	GR
hCoV-19/Netherlands/NA_359/2020	EPI_ISL_455163	2020-04-07	Europe / Netherlands	Human	Original			Nanopore				B.1.1.185	GR
hCoV-19/Netherlands/NA_363/2020	EPI_ISL_455167	2020-04-08	Europe / Netherlands	Human	Original			Nanopore				B.1.1.71	GR
hCoV-19/Netherlands/NA_393/2020	EPI_ISL_455195	2020-04-02	Europe / Netherlands	Human	Original			Nanopore				B.1.1.185	GR
hCoV-19/Netherlands/NA_394/2020	EPI_ISL_455196	2020-03-31	Europe / Netherlands	Human	Original			Nanopore				B.1.1.185	GR
hCoV-19/Netherlands/NA_401/2020	EPI_ISL_455203	2020-04-05	Europe / Netherlands	Human	Original			Nanopore				B.1.1.185	GR
hCoV-19/Netherlands/NA_460/2020	EPI_ISL_455262	2020	Europe / Netherlands	Human	Original			Nanopore				B.1.1.185	GR
hCoV-19/Netherlands/NA_461/2020	EPI_ISL_455263	2020-04-08	Europe / Netherlands	Human	Original			Nanopore				B.1.1.185	GR
hCoV-19/Netherlands/ZuidHolland_111/2020	EPI_ISL_455300	2020-04-07	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1	G
hCoV-19/Poland/PL_P28/2020	EPI_ISL_455441	2020-04-01	Europe / Poland / Malopolska / Krakow	Human	Original	Oropharyngeal swab		MiSeq V3 2x75 paired reads (Illumina) +Nextera Flex Enrichment Library with Respiratory Virus Oligo Panel capture (Illumina).	BWA, Mark Duplicates Pipeline Spark (GATK v.4.1.5.0)			B.1.1	GR
hCoV-19/Poland/PL_P30/2020	EPI_ISL_455443	2020-04-01	Europe / Poland / Malopolska / Krakow	Human	Original	Oropharyngeal swab		MiSeq V3 2x75 paired reads (Illumina) +Nextera Flex Enrichment Library with Respiratory Virus Oligo Panel capture (Illumina).	BWA, Mark Duplicates Pipeline Spark (GATK v.4.1.5.0)			B.1.1	GR
hCoV-19/Poland/PL_P34/2020	EPI_ISL_455447	2020-03-25	Europe / Poland / Mazowieckie / Radom	Human	Original	Oropharyngeal swab		MiSeq V3 2x75 paired reads (Illumina) +Nextera Flex Enrichment Library with Respiratory Virus Oligo Panel capture (Illumina).	BWA, Mark Duplicates Pipeline Spark (GATK v.4.1.5.0)			B.1.1	GR
hCoV-19/Poland/PL_P35/2020	EPI_ISL_455448	2020-04-01	Europe / Poland / Malopolska / Krakow	Human	Original	Oropharyngeal swab		MiSeq V3 2x75 paired reads (Illumina) +Nextera Flex Enrichment Library with Respiratory Virus Oligo Panel capture (Illumina).	BWA, Mark Duplicates Pipeline Spark (GATK v.4.1.5.0)			B.1.1	GR
hCoV-19/Romania/283584/2020	EPI_ISL_455469	2020-05-12	Europe / Romania / Bucuresti	Human	Original	Nasopharyngeal swab		Illumina MiSeq	DNASTAR Lasergene, Sequencer			B.1.408	G
hCoV-19/Sweden/20-50249/2020	EPI_ISL_455888	2020-03-08	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Belgium/ULG-10170/2020	EPI_ISL_455958	2020-05-11	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.1.71	GR
hCoV-19/Belgium/ULG-10174/2020	EPI_ISL_455962	2020-05-08	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.1.71	GR
hCoV-19/Belgium/ULG-10179/2020	EPI_ISL_455967	2020-05-09	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.1.71	GR
hCoV-19/Belgium/ULG-10180/2020	EPI_ISL_455968	2020-05-09	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.1.71	GR
hCoV-19/Belgium/ULG-10191/2020	EPI_ISL_455979	2020-05-11	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/Netherlands/Limburg_47/2020	EPI_ISL_461035	2020-04-02	Europe / Netherlands / Limburg	Human	Original			Nanopore				B.1.1.71	GR
hCoV-19/Netherlands/Limburg_48/2020	EPI_ISL_461036	2020-04-02	Europe / Netherlands / Limburg	Human	Original			Nanopore				B.1.1.71	GR
hCoV-19/Netherlands/Limburg_49/2020	EPI_ISL_461037	2020-04-07	Europe / Netherlands / Limburg	Human	Original			Nanopore				B.1.1.71	GR
hCoV-19/Netherlands/Limburg_51/2020	EPI_ISL_461039	2020-03-28	Europe / Netherlands / Limburg	Human	Original			Nanopore				B.1.1.71	GR
hCoV-19/Netherlands/Limburg_54/2020	EPI_ISL_461042	2020-04-23	Europe / Netherlands / Limburg	Human	Original			Nanopore				B.1.1.71	GR
hCoV-19/Netherlands/Limburg_55/2020	EPI_ISL_461043	2020-04-23	Europe / Netherlands / Limburg	Human	Original			Nanopore				B.1.1.71	GR
hCoV-19/Netherlands/Limburg_56/2020	EPI_ISL_461044	2020-04-23	Europe / Netherlands / Limburg	Human	Original			Nanopore		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.71	GR
hCoV-19/Netherlands/Limburg_59/2020	EPI_ISL_461045	2020-04-24	Europe / Netherlands / Limburg	Human	Original			Nanopore				B.1.1.71	GR
hCoV-19/Netherlands/Limburg_60/2020	EPI_ISL_461046	2020-04-19	Europe / Netherlands / Limburg	Human	Original			Nanopore				B.1.1.71	GR
hCoV-19/Netherlands/Limburg_61/2020	EPI_ISL_461047	2020-04-25	Europe / Netherlands / Limburg	Human	Original			Nanopore				B.1.1.71	GR
hCoV-19/Netherlands/Limburg_62/2020	EPI_ISL_461048	2020-04-19	Europe / Netherlands / Limburg	Human	Original			Nanopore				B.1.1.71	GR
hCoV-19/Netherlands/NA_631/2020	EPI_ISL_461066	2020-03-27	Europe / Netherlands	Human	Original			Nanopore				B.1.1.71	GR
hCoV-19/Netherlands/NA_640/2020	EPI_ISL_461075	2020-05-03	Europe / Netherlands	Human	Original			Nanopore				B.1.1.71	GR
hCoV-19/Netherlands/NoordHolland_21/2020	EPI_ISL_461211	2020-04-24	Europe / Netherlands / Noord-Holland	Human	Original			Nanopore				B.1.1.71	GR
hCoV-19/England/BIRM-5F6A6/2020	EPI_ISL_461525	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/BIRM-5FE35/2020	EPI_ISL_461527	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B3A85/2020	EPI_ISL_461572	2020-05-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B3C61/2020	EPI_ISL_461582	2020-05-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B3CE9/2020	EPI_ISL_461583	2020-05-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B3E7A/2020	EPI_ISL_461587	2020-05-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/Scotland/CVR2920/2020	EPI_ISL_461589	2020-04-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.43	GR
hCoV-19/Scotland/CVR2925/2020	EPI_ISL_461592	2020-04-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.43	GR
hCoV-19/Scotland/CVR3013/2020	EPI_ISL_461622	2020-04-23	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.43	GR
hCoV-19/Scotland/CVR3050/2020	EPI_ISL_461638	2020-04-23	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.164	GR
hCoV-19/Scotland/CVR3056/2020	EPI_ISL_461642	2020-04-23	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.43	GR
hCoV-19/Scotland/CVR3071/2020	EPI_ISL_461655	2020-04-24	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.43	GR
hCoV-19/Scotland/CVR3073/2020	EPI_ISL_461657	2020-04-24	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.43	GR
hCoV-19/Scotland/CVR3081/2020	EPI_ISL_461665	2020-04-24	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.164	GR
hCoV-19/Scotland/CVR3084/2020	EPI_ISL_461667	2020-04-24	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.43	GR
hCoV-19/Scotland/CVR3113/2020	EPI_ISL_461685	2020-04-25	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.43	GR
hCoV-19/Scotland/CVR3116/2020	EPI_ISL_461688	2020-04-25	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/EDB4535/2020	EPI_ISL_461718	2020-05-06	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.14	GR
hCoV-19/Scotland/EDB4536/2020	EPI_ISL_461719	2020-05-06	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.14	GR
hCoV-19/England/LOND-D6A41/2020	EPI_ISL_461763	2020-04-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D6A8D/2020	EPI_ISL_461767	2020-04-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/England/NORT-2854E7/2020	EPI_ISL_461792	2020-05-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Romania/Bucuresti-12547/2020	EPI_ISL_468150	2020-04-12	Europe / Romania / Bucuresti	Human	Original	Oropharyngeal swab		Illumina MiSeq	Geneious Prime® 2020.1.2 and shovill			B.1.1	GR
hCoV-19/Romania/Bucuresti-14545/2020	EPI_ISL_468153	2020-04-17	Europe / Romania / Bucuresti	Human	Original	Oropharyngeal swab		Illumina MiSeq	Geneious Prime® 2020.1.2 and shovill			B.1.1	GR
hCoV-19/Romania/Bucuresti-14658/2020	EPI_ISL_468154	2020-04-17	Europe / Romania / Bucuresti	Human	Original	Oropharyngeal swab		Illumina MiSeq	Geneious Prime® 2020.1.2 and shovill			B.1.1	GR
hCoV-19/Romania/Bucuresti-15503/2020	EPI_ISL_468155	2020-04-18	Europe / Romania / Bucuresti	Human	Original	Oropharyngeal swab		Illumina MiSeq	Geneious Prime® 2020.1.2 and shovill			B.1.1	GR
hCoV-19/Northern Ireland/NIRE-FF2A4/2020	EPI_ISL_469854	2020-04-23	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-FF3CF/2020	EPI_ISL_469880	2020-04-23	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1B1F1F/2020	EPI_ISL_469896	2020-05-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/CAMB-1B1EF4/2020	EPI_ISL_469899	2020-05-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/SHEF-10B2547/2020	EPI_ISL_469928	2020-04-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.137	GR
hCoV-19/Scotland/GCVR-172062/2020	EPI_ISL_469931	2020-03-31	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/GCVR-172026/2020	EPI_ISL_469990	2020-03-30	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Israel/CVL-n-5908/2020	EPI_ISL_475013	2020-03-15	Asia / Israel	Human	Original	Oropharyngeal swab		Illumina NextSeq	BWA			B.1.1	GR
hCoV-19/India/GJ-GBRC203a/2020	EPI_ISL_475026	2020-06-07	Asia / India / Gujarat / Palanpur	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1.1	G
hCoV-19/Sweden/20-50673/2020	EPI_ISL_475155	2020-04-06	Europe / Sweden / Vasternorrland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Sweden/20-50931/2020	EPI_ISL_475160	2020-04-20	Europe / Sweden / Vasternorrland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Sweden/20-50933/2020	EPI_ISL_475161	2020-04-20	Europe / Sweden / Vasternorrland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Sweden/20-50935/2020	EPI_ISL_475162	2020-04-21	Europe / Sweden / Vasternorrland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Sweden/20-50936/2020	EPI_ISL_475163	2020-04-21	Europe / Sweden / Vasternorrland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Bangladesh/BCSIR-NILMRC-117/2020	EPI_ISL_475168	2020-06-07	Asia / Bangladesh / Rangpur	Human	Original	Nasopharyngeal swab		MiniSeq	DRAGEN RNA Pathogen Detection			B.1.1.25	GR
hCoV-19/England/PORT-2CF8C7/2020	EPI_ISL_475240	2020-05-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.194	GR
hCoV-19/England/PORT-2D0C8B/2020	EPI_ISL_475269	2020-04-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/PORT-2D0EA3/2020	EPI_ISL_475299	2020-03-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.194	GR
hCoV-19/England/PORT-2D0F82/2020	EPI_ISL_475312	2020-04-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.194	GR
hCoV-19/England/PORT-2D1024/2020	EPI_ISL_475319	2020-04-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C0D50/2020	EPI_ISL_475348	2020-05-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.171	GR
hCoV-19/England/SHEF-C1EF2/2020	EPI_ISL_475356	2020-05-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C9319/2020	EPI_ISL_475419	2020-04-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C999F/2020	EPI_ISL_475424	2020-04-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-CD245/2020	EPI_ISL_475454	2020-04-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.137	GR
hCoV-19/England/SHEF-CD4B8/2020	EPI_ISL_475456	2020-03-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Sweden/20-14519/2020	EPI_ISL_475517	2020-05-10	Europe / Sweden / Uppsala	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-14071/2020	EPI_ISL_475541	2020-04-28	Europe / Sweden / Jamtland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Sweden/20-06523/2020	EPI_ISL_475564	2020-03-26	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins	Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Sweden/20-51816/2020	EPI_ISL_475568	2020-06-01	Europe / Sweden / Vastmanland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/USA/CA-CSMC68/2020	EPI_ISL_475682	2020-03-28	North America / USA / California / Los Angeles County	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/USA/CA-CSMC76/2020	EPI_ISL_475691	2020-04-03	North America / USA / California / Los Angeles County	Human	Original			Illumina NovaSeq				B.59	GR
hCoV-19/Austria/CeMM0372/2020	EPI_ISL_475817	2020-03-26	Europe / Austria / Mayrhofen	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1.5	G
hCoV-19/Austria/CeMM0412/2020	EPI_ISL_475842	2020-04-21	Europe / Austria	Human	Original	Nasopharyngeal swab		Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/Austria/CeMM0546/2020	EPI_ISL_475903	2020-04-28	Europe / Austria	Human	Original	Tracheal secretion		Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/Austria/CeMM0563/2020	EPI_ISL_475913	2020-03-10	Europe / Austria / Losenstein	Human	Original	Nasopharyngeal swab		Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/Singapore/424/2020	EPI_ISL_475955	2020-03-21	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/Singapore/426/2020	EPI_ISL_475957	2020-03-20	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/Singapore/431/2020	EPI_ISL_475962	2020-03-17	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/Turkey/IST-GLAB-170/2020	EPI_ISL_480263	2020-05-03	Europe / Turkey / Istanbul	Human	Original	Oropharyngeal swab		Illumina NextSeq	BWA-MEM			B.1.1	GR
hCoV-19/Bangladesh/BCSIR-NILMRC-130/2020	EPI_ISL_480414	2020-06-17	Asia / Bangladesh / Dhaka / Dhaka / Kadamtali	Human	Original	Nasopharyngeal swab		MiniSeq	DRAGEN RNA Pathogen Detection 3.5.14			B.1.1	GR
hCoV-19/Bangladesh/BCSIR-NILMRC-131/2020	EPI_ISL_480415	2020-06-18	Asia / Bangladesh / Dhaka / Dhaka / Tejgaon	Human	Original	Nasopharyngeal swab		MiniSeq	DRAGEN RNA Pathogen Detection 3.5.14			B.1.1	GR
hCoV-19/USA/FL-BPHL-0176/2020	EPI_ISL_480827	2020-04-03	North America / USA / Florida	Human	Original			Illumina MiSeq	bwa v0.7.17; ivar v1.2.2			B.1.1	GR
hCoV-19/USA/FL-BPHL-0220/2020	EPI_ISL_480871	2020-04-19	North America / USA / Florida	Human	Original			Illumina MiSeq	bwa v0.7.17; ivar v1.2.2			B.1.1.231	GR
hCoV-19/Spain/CT-IBV-003733/2020	EPI_ISL_480995	2020-04-04	Europe / Spain / Catalunya / Barcelona	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/England/NORT-29271B/2020	EPI_ISL_489117	2020-05-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-2922ED/2020	EPI_ISL_489125	2020-05-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-2923AE/2020	EPI_ISL_489126	2020-05-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-291D92/2020	EPI_ISL_489131	2020-05-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-29298E/2020	EPI_ISL_489142	2020-05-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-292441/2020	EPI_ISL_489143	2020-05-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-100272/2020	EPI_ISL_489194	2020-05-01	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-10001E/2020	EPI_ISL_489257	2020-05-02	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-101C19/2020	EPI_ISL_489272	2020-05-12	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-101CFB/2020	EPI_ISL_489281	2020-05-08	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-101B76/2020	EPI_ISL_489301	2020-05-12	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-1002FA/2020	EPI_ISL_489343	2020-05-02	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-FD1A9/2020	EPI_ISL_489352	2020-04-25	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-10010C/2020	EPI_ISL_489373	2020-05-02	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/GCVR-171986/2020	EPI_ISL_489380	2020-03-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/GCVR-171A65/2020	EPI_ISL_489429	2020-03-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AC69A/2020	EPI_ISL_489456	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1ACEB0/2020	EPI_ISL_489482	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AD3B0/2020	EPI_ISL_489492	2020-04-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AC7E2/2020	EPI_ISL_489546	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AC82B/2020	EPI_ISL_489570	2020-04-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/GCVR-16FE7D/2020	EPI_ISL_489683	2020-03-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Peru/LIM-INS-006/2020	EPI_ISL_489838	2020-03-11	South America / Peru / Lima	Human	Original	Oropharyngeal swab		Illumina MiSeq	SPAdes			B.1.1	GR
hCoV-19/USA/MN-GMF-09331/2020	EPI_ISL_489903	2020-07-05	North America / USA / Minnesota / Winona County	Human	Original			Ion Torrent				B.1.240	G
hCoV-19/USA/WI-GMF-09683/2020	EPI_ISL_489953	2020-07-07	North America / USA / Wisconsin / Monroe County	Human	Original			Ion Torrent				B.1.240	G
hCoV-19/Switzerland/BL-ETHZ-180038/2020	EPI_ISL_489976	2020-07-01	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/VD-ETHZ-180052/2020	EPI_ISL_489986	2020-06-30	Europe / Switzerland / Vaud	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/Norway/2798/2020	EPI_ISL_493364	2020-06-26	Europe / Norway	Human	Original	Upper respiratory secretion		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti			B.1.1	GR
hCoV-19/Italy/CAM-INTPas-10/2020	EPI_ISL_494771	2020	Europe / Italy / Campania	Human	Original			Ion Torrent				B.1	G
hCoV-19/England/WSFT-25C1686/2020	EPI_ISL_495082	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.71	GR
hCoV-19/England/LIVE-A3CDE/2020	EPI_ISL_500022	2020-05-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-A3D53/2020	EPI_ISL_500025	2020-05-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-A3DAE/2020	EPI_ISL_500027	2020-05-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-A4499/2020	EPI_ISL_500029	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.95	GR
hCoV-19/England/LIVE-A46EE/2020	EPI_ISL_500033	2020-03-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-A4815/2020	EPI_ISL_500046	2020-03-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/Brazil/PE-FIOCRUZ-IAM10/2020	EPI_ISL_500461	2020-04-07	South America / Brazil / Pernambuco / Recife	Human	Original			Illumina MiSeq	Bowtie2 2.2.6/bedtools v2.25.0			B.1.1	GR
hCoV-19/Brazil/PE-FIOCRUZ-IAM103/2020	EPI_ISL_500462	2020-04-09	South America / Brazil / Pernambuco / Recife	Human	Original			Illumina MiSeq	Bowtie2 2.2.6/bedtools v2.25.0			B.1.1	GR
hCoV-19/Brazil/PE-FIOCRUZ-IAM215/2020	EPI_ISL_500471	2020-04-06	South America / Brazil / Pernambuco / Olinda	Human	Original			Illumina MiSeq	Bowtie2 2.2.6/bedtools v2.25.0			B.1.1	GR
hCoV-19/Brazil/PE-FIOCRUZ-IAM221/2020	EPI_ISL_500473	2020-04-08	South America / Brazil / Pernambuco / Recife	Human	Original			Illumina MiSeq	Bowtie2 2.2.6/bedtools v2.25.0			B.1.1	GR
hCoV-19/Brazil/PE-FIOCRUZ-IAM39/2020	EPI_ISL_500481	2020-04-08	South America / Brazil / Pernambuco / Recife	Human	Original			Illumina MiSeq	Bowtie2 2.2.6/bedtools v2.25.0			B.1.1	GR
hCoV-19/Brazil/PE-FIOCRUZ-IAM48/2020	EPI_ISL_500482	2020-04-08	South America / Brazil / Pernambuco / Recife	Human	Original			Illumina MiSeq	Bowtie2 2.2.6/bedtools v2.25.0			B.1.1	GR
hCoV-19/Brazil/PE-FIOCRUZ-IAM87/2020	EPI_ISL_500485	2020-04-08	South America / Brazil / Pernambuco / Sao Lourenco da Mata	Human	Original			Illumina MiSeq	Bowtie2 2.2.6/bedtools v2.25.0			B.1.1	GR
hCoV-19/Australia/NSW2173/2020	EPI_ISL_500644	2020-03-18	Oceania / Australia / New South Wales	Human	Original			Oxford Nanopore Technologies GridION X5 (Flongle flow-cell)	ARTIC bioinformatics pipeline (Medaka)			B.59	GR
hCoV-19/Australia/NSW2189/2020	EPI_ISL_500652	2020-03-21	Oceania / Australia / New South Wales	Human	Original			Oxford Nanopore Technologies GridION X5 (Flongle flow-cell)	ARTIC bioinformatics pipeline (Medaka)			B.1.1	GR
hCoV-19/Australia/NSW2239/2020	EPI_ISL_500681	2020-03-22	Oceania / Australia / New South Wales	Human	Original			Oxford Nanopore Technologies GridION X5 (Flongle flow-cell)	ARTIC bioinformatics pipeline (Medaka)			B.1.1.198	GR
hCoV-19/Australia/NSW2258/2020	EPI_ISL_500695	2020-03-21	Oceania / Australia / New South Wales	Human	Original			Oxford Nanopore Technologies GridION X5 (Flongle flow-cell)	ARTIC bioinformatics pipeline (Medaka)			B.1.1.71	GR
hCoV-19/Norway/2881/2020	EPI_ISL_500799	2020-07-13	Europe / Norway	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq; ARTIC v.3	Assembly by reference based mapping using Tanoti			B.1.236	G
hCoV-19/Brazil/PE-FIOCRUZ-IAM29/2020	EPI_ISL_500872	2020-04-08	South America / Brazil / Pernambuco / Olinda	Human	Original			Illumina MiSeq	Bowtie2 2.2.6/bedtools v2.25.0			B.1.1	GR
hCoV-19/Switzerland/ZH-ETHZ-190013/2020	EPI_ISL_500879	2020-07-06	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BL-ETHZ-190016/2020	EPI_ISL_500881	2020-07-06	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-190019/2020	EPI_ISL_500884	2020-07-06	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/Switzerland/UR-ETHZ-190027/2020	EPI_ISL_500891	2020-07-06	Europe / Switzerland / Uri	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/Switzerland/ZH-ETHZ-190031/2020	EPI_ISL_500894	2020-07-07	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/SZ-ETHZ-190033/2020	EPI_ISL_500896	2020-07-07	Europe / Switzerland / Schwyz	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-190035/2020	EPI_ISL_500898	2020-07-08	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/Switzerland/BE-ETHZ-190043/2020	EPI_ISL_500905	2020-07-08	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BL-ETHZ-190049/2020	EPI_ISL_500910	2020-07-09	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BL-ETHZ-190052/2020	EPI_ISL_500913	2020-07-09	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BL-ETHZ-190060/2020	EPI_ISL_500921	2020-07-09	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BE-ETHZ-190063/2020	EPI_ISL_500923	2020-07-09	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/Switzerland/SZ-ETHZ-190068/2020	EPI_ISL_500927	2020-07-03	Europe / Switzerland / Schwyz	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/Switzerland/BE-ETHZ-190079/2020	EPI_ISL_500936	2020-07-06	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/Switzerland/SO-ETHZ-190081/2020	EPI_ISL_500937	2020-07-06	Europe / Switzerland / Solothurn	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/Northern Ireland/NIRE-1066AD/2020	EPI_ISL_500961	2020-05-10	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-106C9C/2020	EPI_ISL_500966	2020-05-18	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-1069E0/2020	EPI_ISL_500974	2020-05-16	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-106A92/2020	EPI_ISL_500980	2020-05-20	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-1069A4/2020	EPI_ISL_500996	2020-05-16	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Poland/A_348r/2020	EPI_ISL_509017	2020-06	Europe / Poland / Lodzkie	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTICv3 (het.zyg. mod)			B.1.1	GR
hCoV-19/Poland/F_348r/2020	EPI_ISL_509021	2020-06	Europe / Poland / Lodzkie / Lodz	Human	Original	Oropharyngeal swab		Oxford Nanopore	ARTICv3 (het.zyg. mod)			B.1.1	GR
hCoV-19/Poland/K_348r/2020	EPI_ISL_509028	2020-06	Europe / Poland / Lodzkie	Human	Original	Oropharyngeal swab		Oxford Nanopore	ARTICv3 (het.zyg. mod)			B.1.1	GR
hCoV-19/Poland/M_348r/2020	EPI_ISL_509031	2020-06	Europe / Poland / Lodzkie / Belchatow County	Human	Original	Oropharyngeal swab		Oxford Nanopore	ARTICv3 (het.zyg. mod)			B.1.1	GR
hCoV-19/Poland/P_348r/2020	EPI_ISL_509035	2020-06	Europe / Poland / Lodzkie / Pajeczno County	Human	Original	Oropharyngeal swab		Oxford Nanopore	ARTICv3 (het.zyg. mod)			B.1.1	GR
hCoV-19/Poland/S_348r/2020	EPI_ISL_509037	2020-06	Europe / Poland / Lodzkie / Lodz	Human	Original	Oropharyngeal swab		Oxford Nanopore	ARTICv3 (het.zyg. mod)			B.1.1	GR
hCoV-19/Poland/W_348r/2020	EPI_ISL_509038	2020-06	Europe / Poland / Lodzkie / Lodz	Human	Original	Oropharyngeal swab		Oxford Nanopore	ARTICv3 (het.zyg. mod)			B.1.1	GR
hCoV-19/USA/OR-OHSU-0419/2020	EPI_ISL_509133	2020-05-24	North America / USA / Oregon / Wasco County	Human	Original	Nasopharyngeal swab		Illumina NextSeq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1	G
hCoV-19/USA/OR-OHSU-1427/2020	EPI_ISL_509198	2020-07-16	North America / USA / Oregon / Multnomah County	Human	Original	Nasopharyngeal swab		Illumina NextSeq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.1.61	GR
hCoV-19/USA/OR-OHSU-1469/2020	EPI_ISL_509210	2020-07-17	North America / USA / Oregon / Multnomah County	Human	Original	Nasopharyngeal swab		Illumina NextSeq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.1.61	GR
hCoV-19/South Africa/KRISP-K000584/2020	EPI_ISL_509240	2020-07-13	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K000592/2020	EPI_ISL_509246	2020-07-13	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K000597/2020	EPI_ISL_509250	2020-07-13	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K000599/2020	EPI_ISL_509252	2020-07-13	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K000641/2020	EPI_ISL_509290	2020-07-13	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K000652/2020	EPI_ISL_509296	2020-07-13	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K001038/2020	EPI_ISL_509303	2020-07-16	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K001041/2020	EPI_ISL_509304	2020-07-16	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K001049/2020	EPI_ISL_509308	2020-07-16	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K001057/2020	EPI_ISL_509314	2020-07-03	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K001059/2020	EPI_ISL_509316	2020-07-01	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K001064/2020	EPI_ISL_509320	2020-07-03	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K001066/2020	EPI_ISL_509322	2020-07-01	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K001071/2020	EPI_ISL_509325	2020-07-18	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K001079/2020	EPI_ISL_509333	2020-07-03	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K001082/2020	EPI_ISL_509335	2020-07-18	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K001087/2020	EPI_ISL_509339	2020-07-13	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.56	GR
hCoV-19/South Africa/KRISP-K001109/2020	EPI_ISL_509356	2020-07-16	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K001121/2020	EPI_ISL_509365	2020-07-16	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K001123/2020	EPI_ISL_509366	2020-07-15	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K001124/2020	EPI_ISL_509367	2020-07-16	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.40	GR
hCoV-19/USA/FL-BPHL-0698/2020	EPI_ISL_509756	2020-03-29	North America / USA / Florida	Human	Original			Illumina NextSeq	bwa v0.7.17; ivar v1.2.2			B.59	GR
hCoV-19/USA/WI-UW-1003/2020	EPI_ISL_509812	2020-07-18	North America / USA / Wisconsin / Dane County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	custom -- minimap2			B.1.240	G
hCoV-19/USA/WI-UW-862/2020	EPI_ISL_509865	2020-07-15	North America / USA / Wisconsin / Dane County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	custom -- minimap2			B.1.240	G
hCoV-19/USA/un-CDC-7404/2020	EPI_ISL_514062	2020-04-20	North America / USA	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bcftools 1.9,bowtie2 2.3.3.1			B.1.1	GR
hCoV-19/USA/un-CDC-7413/2020	EPI_ISL_514063	2020-04-20	North America / USA	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bcftools 1.9,bowtie2 2.3.3.1			B.1.1	GR
hCoV-19/USA/un-CDC-7425/2020	EPI_ISL_514066	2020-04-20	North America / USA	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bcftools 1.9,bowtie2 2.3.3.1			B.1.1	GR
hCoV-19/USA/un-CDC-7430/2020	EPI_ISL_514067	2020-04-20	North America / USA	Human	Original	Nasopharyngeal swab		Illumina MiSeq, Sanger	bcftools 1.9,bowtie2 2.3.3.1, Sequencher 5.4.6			B.1.1	GR
hCoV-19/USA/un-CDC-7432/2020	EPI_ISL_514068	2020-04-20	North America / USA	Human	Original	Nasopharyngeal swab		Illumina MiSeq, Sanger	bcftools 1.9,bowtie2 2.3.3.1, Sequencher 5.4.6			B.1.1	GR
hCoV-19/USA/un-CDC-7433/2020	EPI_ISL_514069	2020-04-20	North America / USA	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bcftools 1.9,bowtie2 2.3.3.1			B.1.1	GR
hCoV-19/USA/un-CDC-7441/2020	EPI_ISL_514070	2020-04-21	North America / USA	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bcftools 1.9,bowtie2 2.3.3.1			B.1.1	GR
hCoV-19/USA/un-CDC-7470/2020	EPI_ISL_514073	2020-04-21	North America / USA	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bcftools 1.9,bowtie2 2.3.3.1			B.1.1	GR
hCoV-19/USA/un-CDC-7481/2020	EPI_ISL_514075	2020-04-22	North America / USA	Human	Original	Nasopharyngeal swab		Illumina MiSeq, Sanger	bcftools 1.9,bowtie2 2.3.3.1, Sequencher 5.4.6			B.1.1	GR
hCoV-19/USA/un-CDC-7498/2020	EPI_ISL_514078	2020-04-22	North America / USA	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bcftools 1.9,bowtie2 2.3.3.1			B.1.1	GR
hCoV-19/USA/un-CDC-7520/2020	EPI_ISL_514079	2020-04-22	North America / USA	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bcftools 1.9,bowtie2 2.3.3.1			B.1.1	GR
hCoV-19/USA/un-CDC-7528/2020	EPI_ISL_514080	2020-04-22	North America / USA	Human	Original	Nasopharyngeal swab		Illumina MiSeq, Sanger	bcftools 1.9,bowtie2 2.3.3.1, Sequencher 5.4.6			B.1.1	GR
hCoV-19/USA/un-CDC-7529/2020	EPI_ISL_514081	2020-04-22	North America / USA	Human	Original	Nasopharyngeal swab		Illumina MiSeq, Sanger	bcftools 1.9,bowtie2 2.3.3.1, Sequencher 5.4.6			B.1.1	GR
hCoV-19/USA/un-CDC-7569/2020	EPI_ISL_514082	2020-04-23	North America / USA	Human	Original	Nasopharyngeal swab		Illumina MiSeq, Sanger	bcftools 1.9,bowtie2 2.3.3.1, Sequencher 5.4.6			B.1.1	GR
hCoV-19/USA/un-CDC-7618/2020	EPI_ISL_514083	2020-04-24	North America / USA	Human	Original	Nasopharyngeal swab		Illumina MiSeq, Sanger	bcftools 1.9,bowtie2 2.3.3.1, Sequencher 5.4.6			B.1.1	GR
hCoV-19/USA/un-CDC-7619/2020	EPI_ISL_514084	2020-04-24	North America / USA	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bcftools 1.9,bowtie2 2.3.3.1			B.1.1	GR
hCoV-19/USA/un-CDC-7625/2020	EPI_ISL_514085	2020-04-24	North America / USA	Human	Original	Nasopharyngeal swab		Illumina MiSeq, Sanger	bcftools 1.9,bowtie2 2.3.3.1, Sequencher 5.4.6			B.1.1	GR
hCoV-19/USA/un-CDC-7645/2020	EPI_ISL_514087	2020-04-24	North America / USA	Human	Original	Nasopharyngeal swab		Illumina MiSeq, Sanger	bcftools 1.9,bowtie2 2.3.3.1, Sequencher 5.4.6			B.1.1	GR
hCoV-19/USA/un-CDC-7651/2020	EPI_ISL_514088	2020-04-24	North America / USA	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bcftools 1.9,bowtie2 2.3.3.1			B.1.1	GR
hCoV-19/USA/un-CDC-7652/2020	EPI_ISL_514089	2020-04-24	North America / USA	Human	Original	Nasopharyngeal swab		Illumina MiSeq, Sanger	bcftools 1.9,bowtie2 2.3.3.1, Sequencher 5.4.6			B.1.1	GR
hCoV-19/USA/un-CDC-7657/2020	EPI_ISL_514091	2020-04-24	North America / USA	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bcftools 1.9,bowtie2 2.3.3.1			B.1.1	GR
hCoV-19/USA/un-CDC-7667/2020	EPI_ISL_514092	2020-04-24	North America / USA	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bcftools 1.9,bowtie2 2.3.3.1			B.1.1	GR
hCoV-19/USA/un-CDC-7650/2020	EPI_ISL_514128	2020-04-24	North America / USA	Human	Original	Nasopharyngeal swab		Illumina MiSeq, Sanger	bcftools 1.9,bowtie2 2.3.3.1, Sequencher 5.4.6	Gap of 74 nucleotide(s) found at refpos 27550 (FRAMESHIFT confirmed by the submitter).	info	B.1.1	GR
hCoV-19/Peru/LIM-INS-041/2020	EPI_ISL_514226	2020-04-11	South America / Peru / Lima	Human	Original	Oropharyngeal swab		Illumina MiSeq	SPAdes			B.1.1	GR
hCoV-19/Bangladesh/BCSIR-NILMRC-354/2020	EPI_ISL_514232	2020-07-15	Asia / Bangladesh / Khulna	Human	Original	Nasopharyngeal swab		Illumina MiniSeq	DRAGEN RNA Pathogen Detection 3.5.14			B.1.1.25	GR
hCoV-19/Bangladesh/BCSIR-NILMRC-361/2020	EPI_ISL_514234	2020-07-24	Asia / Bangladesh / Chittagong / Brahmanbaria	Human	Original	Nasopharyngeal swab		MiniSeq	DRAGEN RNA Pathogen Detection 3.5.14			B.1.1	GR
hCoV-19/Bangladesh/BCSIR-NILMRC-362/2020	EPI_ISL_514235	2020-07-24	Asia / Bangladesh / Chittagong / Brahmanbaria	Human	Original	Nasopharyngeal swab		MiniSeq	DRAGEN RNA Pathogen Detection 3.5.14			B.1.1	GR
hCoV-19/Bangladesh/BCSIR-NILMRC-371/2020	EPI_ISL_514248	2020-07-31	Asia / Bangladesh / Dhaka / Narayanganj	Human	Original	Nasopharyngeal swab		MiniSeq	DRAGEN RNA Pathogen Detection 3.5.14			B.1.1.25	GR
hCoV-19/Bangladesh/BCSIR-NILMRC-372/2020	EPI_ISL_514249	2020-07-31	Asia / Bangladesh / Dhaka / Narayanganj	Human	Original	Nasopharyngeal swab		MiniSeq	DRAGEN RNA Pathogen Detection 3.5.14			B.1.1	GR
hCoV-19/USA/MN-MDH-1408/2020	EPI_ISL_514627	2020-06-28	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.240	G
hCoV-19/South Korea/KCDC2589/2020	EPI_ISL_514992	2020-06-29	Asia / South Korea	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/United Arab Emirates/L3290165790/2020	EPI_ISL_520684	2020-05-13	Asia / United Arab Emirates	Human	Original			Illumina NovaSeq				B.1.1.133	GR
hCoV-19/Australia/NSW2474/2020	EPI_ISL_527020	2020-07-01	Oceania / Australia / New South Wales	Human	Original			Oxford Nanopore Technologies GridION X5 (Flongle flow-cell)	ARTIC bioinformatics pipeline (Medaka)			B.1.1.254	GR
hCoV-19/Australia/NSW2486/2020	EPI_ISL_527022	2020-06-30	Oceania / Australia / New South Wales	Human	Original			Oxford Nanopore Technologies GridION X5 (Flongle flow-cell)	ARTIC bioinformatics pipeline (Medaka)			B.1.1.133	GR
hCoV-19/Australia/NSW2487/2020	EPI_ISL_527023	2020-06-30	Oceania / Australia / New South Wales	Human	Original			Oxford Nanopore Technologies GridION X5 (Flongle flow-cell)	ARTIC bioinformatics pipeline (Medaka)			B.1.1.133	GR
hCoV-19/Australia/NSW2495/2020	EPI_ISL_527024	2020-06-30	Oceania / Australia / New South Wales	Human	Original			Oxford Nanopore Technologies GridION X5 (Flongle flow-cell)	ARTIC bioinformatics pipeline (Medaka)			B.1.1.254	GR
hCoV-19/Australia/NSW2496/2020	EPI_ISL_527025	2020-06-29	Oceania / Australia / New South Wales	Human	Original			Oxford Nanopore Technologies GridION X5 (Flongle flow-cell)	ARTIC bioinformatics pipeline (Medaka)			B.1.1.133	GR
hCoV-19/USA/VA-DCLS-1228/2020	EPI_ISL_528650	2020-07-29	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.240	G
hCoV-19/USA/VA-DCLS-1067/2020	EPI_ISL_528669	2020-06-10	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-1072/2020	EPI_ISL_528671	2020-06-10	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-1080/2020	EPI_ISL_528676	2020-06-10	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.231	GR
hCoV-19/Italy/LOM-IZSGC-TE31074/2020	EPI_ISL_528936	2020-05-02	Europe / Italy / Lombardy	Human	Original			Swift Amplicon SARS-CoV-2 Panel+Illumina MiniSeq				B.1.1	GR
hCoV-19/Italy/LOM-IZSGC-TE31135/2020	EPI_ISL_528937	2020-05-02	Europe / Italy / Lombardy	Human	Original			Swift Amplicon SARS-CoV-2 Panel+Illumina MiniSeq				B.1.1	GR
hCoV-19/Italy/LOM-IZSGC-TE31818/2020	EPI_ISL_528940	2020-05-02	Europe / Italy / Lombardy	Human	Original			Swift Amplicon SARS-CoV-2 Panel+Illumina MiniSeq				B.1.1	GR
hCoV-19/England/20166019404/2020	EPI_ISL_528950	2020-04-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)	Gap of 1 nucleotide found at refpos 16619 (FRAMESHIFT confirmed by the submitter). Gap of 1 nucleotide found at refpos 18440 (FRAMESHIFT confirmed by the submitter). Gap of 1 nucleotide found at refpos 22678 (FRAMESHIFT confirmed by the submitter).  NSP13 and NSP14 without BLAST coverage.	info	B.1.1.164	GR
hCoV-19/Italy/ABR-IZSGC-TE10007/2020	EPI_ISL_528991	2020-04-02	Europe / Italy / Abruzzo	Human	Original			ARTIC protocol+Illumina MiniSeq				B.1.1	GR
hCoV-19/Italy/ABR-IZSGC-TE10151/2020	EPI_ISL_529016	2020-04-02	Europe / Italy / Abruzzo	Human	Original			Swift Amplicon SARS-CoV-2 Panel+Illumina MiniSeq				B.1.1	GR
hCoV-19/Sweden/20-08935/2020	EPI_ISL_534227	2020-07-14	Europe / Sweden / Skane	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Sweden/20-52304/2020	EPI_ISL_534237	2020-06-26	Europe / Sweden / Kalmar	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-52537/2020	EPI_ISL_534250	2020-08-05	Europe / Sweden / Gavleborg	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins	NS8_Y31stop results in 75.2% truncation of the protein sequence.	info	B.1.1.261	GR
hCoV-19/Sweden/20-52588/2020	EPI_ISL_534256	2020-08-13	Europe / Sweden / Gavleborg	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Russia/CRIE181019/2020	EPI_ISL_534346	2020-04-01	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq 1500	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1	GR
hCoV-19/Russia/CRIE166064/2020	EPI_ISL_534348	2020-03-31	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq 1500	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1	GR
hCoV-19/Scotland/QEUH-963A7D/2020	EPI_ISL_534366	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-963FAB/2020	EPI_ISL_534368	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-963A6E/2020	EPI_ISL_534369	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-964344/2020	EPI_ISL_534371	2020-08-11	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-963A8C/2020	EPI_ISL_534384	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-964195/2020	EPI_ISL_534385	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-963F50/2020	EPI_ISL_534391	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9640C5/2020	EPI_ISL_534392	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9647A2/2020	EPI_ISL_534397	2020-08-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/Scotland/QEUH-964308/2020	EPI_ISL_534398	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96A28D/2020	EPI_ISL_534399	2020-08-15	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-964010/2020	EPI_ISL_534401	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96A1BD/2020	EPI_ISL_534404	2020-08-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-963AE6/2020	EPI_ISL_534405	2020-08-12	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E152/2020	EPI_ISL_534407	2020-08-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E082/2020	EPI_ISL_534409	2020-08-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E459/2020	EPI_ISL_534410	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E44A/2020	EPI_ISL_534411	2020-08-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E35C/2020	EPI_ISL_534412	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E468/2020	EPI_ISL_534414	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E19E/2020	EPI_ISL_534415	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E161/2020	EPI_ISL_534418	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E1AD/2020	EPI_ISL_534420	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95DFA4/2020	EPI_ISL_534421	2020-08-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E477/2020	EPI_ISL_534423	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E27D/2020	EPI_ISL_534425	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95DF95/2020	EPI_ISL_534426	2020-08-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E4C2/2020	EPI_ISL_534429	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E26E/2020	EPI_ISL_534434	2020-08-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E1F8/2020	EPI_ISL_534436	2020-08-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-95E091/2020	EPI_ISL_534437	2020-08-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96E447/2020	EPI_ISL_534458	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/Scotland/QEUH-96E6AB/2020	EPI_ISL_534483	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/Scotland/QEUH-96EF64/2020	EPI_ISL_534486	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96EDE2/2020	EPI_ISL_534490	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96EF73/2020	EPI_ISL_534496	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96E84B/2020	EPI_ISL_534497	2020-08-19	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96D31E/2020	EPI_ISL_534552	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96D34B/2020	EPI_ISL_534558	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/Scotland/QEUH-96C810/2020	EPI_ISL_534559	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96D28A/2020	EPI_ISL_534584	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96CCBA/2020	EPI_ISL_534589	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96C7AA/2020	EPI_ISL_534608	2020-08-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96D23F/2020	EPI_ISL_534632	2020-08-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96D32D/2020	EPI_ISL_534637	2020-08-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-964B3D/2020	EPI_ISL_534643	2020-08-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96BBFA/2020	EPI_ISL_534653	2020-08-13	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96B77E/2020	EPI_ISL_534662	2020-08-16	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96B0DD/2020	EPI_ISL_534664	2020-08-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96B635/2020	EPI_ISL_534679	2020-08-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96A9E2/2020	EPI_ISL_534680	2020-08-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-96ADE6/2020	EPI_ISL_534685	2020-08-16	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/MD-MDH-0174/2020	EPI_ISL_534711	2020-06-03	North America / USA / Maryland	Human	Original	Nasopharyngeal swab		Illumina MiSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.231	GR
hCoV-19/England/ALDP-98CDFD/2020	EPI_ISL_534732	2020-07-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/England/LIVE-1D290B/2020	EPI_ISL_534748	2020-08-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.67	GR
hCoV-19/England/LIVE-A97F5/2020	EPI_ISL_534751	2020-07-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.238	G
hCoV-19/England/LIVE-A9801/2020	EPI_ISL_534752	2020-06-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.238	G
hCoV-19/England/LIVE-A982F/2020	EPI_ISL_534753	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1	GR
hCoV-19/England/LIVE-A983E/2020	EPI_ISL_534754	2020-06-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.238	G
hCoV-19/England/OXON-AFFE8/2020	EPI_ISL_534766	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B0764/2020	EPI_ISL_534768	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B27EA/2020	EPI_ISL_534772	2020-04-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B2841/2020	EPI_ISL_534775	2020-04-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B2D24/2020	EPI_ISL_534810	2020-04-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B2DF7/2020	EPI_ISL_534816	2020-03-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B2E7C/2020	EPI_ISL_534820	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B2E8B/2020	EPI_ISL_534821	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B2EC7/2020	EPI_ISL_534823	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B2F00/2020	EPI_ISL_534825	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B2F1F/2020	EPI_ISL_534826	2020-05-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B2F4C/2020	EPI_ISL_534828	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B2F79/2020	EPI_ISL_534830	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.71	GR
hCoV-19/England/OXON-B31AF/2020	EPI_ISL_534840	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B31EB/2020	EPI_ISL_534843	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B32BB/2020	EPI_ISL_534848	2020-04-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B3321/2020	EPI_ISL_534851	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B339A/2020	EPI_ISL_534855	2020-03-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B3585/2020	EPI_ISL_534867	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B35A3/2020	EPI_ISL_534868	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B3637/2020	EPI_ISL_534875	2020-04-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.164	GR
hCoV-19/England/OXON-B37AD/2020	EPI_ISL_534888	2020-04-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B3B47/2020	EPI_ISL_534903	2020-03-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B3D8D/2020	EPI_ISL_534912	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B401A/2020	EPI_ISL_534924	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B4092/2020	EPI_ISL_534928	2020-05-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B40A1/2020	EPI_ISL_534929	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B4162/2020	EPI_ISL_534934	2020-03-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B4232/2020	EPI_ISL_534941	2020-05-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B4250/2020	EPI_ISL_534942	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B44F0/2020	EPI_ISL_534958	2020-05-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B4539/2020	EPI_ISL_534959	2020-05-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B45DF/2020	EPI_ISL_534963	2020-05-06	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B4654/2020	EPI_ISL_534964	2020-05-06	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 5 nucleotides when compared to the reference sequence.	info	B.1.1.194	GR
hCoV-19/England/OXON-B4715/2020	EPI_ISL_534969	2020-04-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B4724/2020	EPI_ISL_534970	2020-04-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B4821/2020	EPI_ISL_534978	2020-04-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B49B5/2020	EPI_ISL_534984	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B49E2/2020	EPI_ISL_534986	2020-03-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B4BCE/2020	EPI_ISL_534998	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/New Zealand/20VR3755/2020	EPI_ISL_548132	2020-06-21	Oceania / New Zealand / Auckland / Counties Manukau	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC protocol			B.1.239	G
hCoV-19/Switzerland/GE-SNRCI-7310/2020	EPI_ISL_548188	2020-03	Europe / Switzerland / Geneve	Human	Original			Illumina MiSeq				B.1	G
hCoV-19/USA/CA-CZB-3309/2020	EPI_ISL_548322	2020-07-17	North America / USA / California / San Luis Obispo County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1	G
hCoV-19/USA/CA-CZB-3699/2020	EPI_ISL_548423	2020-07-17	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1	GR
hCoV-19/USA/CA-CZB-3926/2020	EPI_ISL_548495	2020-07-26	North America / USA / California / Contra Costa County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1	GR
hCoV-19/USA/CA-CZB-4054/2020	EPI_ISL_548644	2020-07-16	North America / USA / California / San Luis Obispo County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1	G
hCoV-19/USA/CA-CZB-4057/2020	EPI_ISL_548663	2020-07-16	North America / USA / California / San Luis Obispo County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1	G
hCoV-19/Canada/ON-PHL-20-01178/2020	EPI_ISL_548800	2020-06	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/Canada/ON-PHL-20-01188/2020	EPI_ISL_548810	2020-06	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/Canada/ON-PHL-20-01189/2020	EPI_ISL_548811	2020-06	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/Canada/ON-PHL-20-01190/2020	EPI_ISL_548812	2020-06	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/Canada/ON-PHL-20-01192/2020	EPI_ISL_548814	2020-06	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/Canada/ON-PHL-20-01193/2020	EPI_ISL_548815	2020-06	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/Canada/ON-PHL-20-01194/2020	EPI_ISL_548816	2020-06	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/Canada/ON-PHL-20-01246/2020	EPI_ISL_548868	2020-06	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/Canada/ON-PHL-20-01247/2020	EPI_ISL_548869	2020-06	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/Canada/ON-PHL-20-01248/2020	EPI_ISL_548870	2020-06	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/Canada/ON-PHL-20-01260/2020	EPI_ISL_548875	2020-06	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1.88	GR
hCoV-19/Canada/ON-PHL-20-01261/2020	EPI_ISL_548876	2020-06	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/Canada/ON-PHL-20-01285/2020	EPI_ISL_548890	2020-06	North America / Canada / Ontario	Human	Original			Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/Canada/ON-PHL-20-01296/2020	EPI_ISL_548900	2020-06	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/Canada/ON-PHL-20-01300/2020	EPI_ISL_548904	2020-06	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/Canada/ON-PHL-20-01302/2020	EPI_ISL_548905	2020-06	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/Canada/ON-PHL-20-01303/2020	EPI_ISL_548906	2020-06	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/Canada/ON-PHL-20-01306/2020	EPI_ISL_548909	2020-06	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/Canada/ON-PHL-20-01307/2020	EPI_ISL_548910	2020-06	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/Canada/ON-PHL-20-01311/2020	EPI_ISL_548914	2020-06	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/Canada/ON-PHL-20-01313/2020	EPI_ISL_548916	2020-06	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/Canada/ON-PHL-20-01314/2020	EPI_ISL_548917	2020-06	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/Canada/ON-PHL-20-01321/2020	EPI_ISL_548924	2020-06	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/Canada/ON-PHL-20-01322/2020	EPI_ISL_548925	2020-06	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/Canada/ON-PHL-20-01323/2020	EPI_ISL_548926	2020-06	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1.10	GR
hCoV-19/Canada/ON-PHL-20-01324/2020	EPI_ISL_548927	2020-06	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/Canada/ON-PHL-20-01326/2020	EPI_ISL_548929	2020-06	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/Singapore/984/2020	EPI_ISL_548992	2020-03-22	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/England/MILK-992D12/2020	EPI_ISL_552055	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/Wales/MILK-9928A8/2020	EPI_ISL_552056	2020-08-27	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9928D5/2020	EPI_ISL_552066	2020-08-27	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-993124/2020	EPI_ISL_552069	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-993045/2020	EPI_ISL_552072	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/MILK-993546/2020	EPI_ISL_552078	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/MILK-992BDC/2020	EPI_ISL_552079	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-993230/2020	EPI_ISL_552087	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-993106/2020	EPI_ISL_552096	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-992FB2/2020	EPI_ISL_552104	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/Wales/MILK-99368F/2020	EPI_ISL_552117	2020-08-29	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-993528/2020	EPI_ISL_552119	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-992D21/2020	EPI_ISL_552123	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-992E88/2020	EPI_ISL_552127	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/MILK-993212/2020	EPI_ISL_552134	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-99285D/2020	EPI_ISL_552136	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.39	GR
hCoV-19/England/MILK-993485/2020	EPI_ISL_552143	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/Wales/MILK-9931BB/2020	EPI_ISL_552144	2020-08-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-992D5E/2020	EPI_ISL_552146	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9551F1/2020	EPI_ISL_553605	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-959FD5/2020	EPI_ISL_553619	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95C9B6/2020	EPI_ISL_553627	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-95308D/2020	EPI_ISL_553637	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9538FE/2020	EPI_ISL_553644	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/ALDP-9530AB/2020	EPI_ISL_553669	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-952E66/2020	EPI_ISL_553679	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-952E84/2020	EPI_ISL_553697	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/ALDP-91BACF/2020	EPI_ISL_553705	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-919F4A/2020	EPI_ISL_553708	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-909F3E/2020	EPI_ISL_553729	2020-06-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.203	GR
hCoV-19/England/ALDP-95459C/2020	EPI_ISL_553740	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-954480/2020	EPI_ISL_553747	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9538EF/2020	EPI_ISL_553791	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-9540E6/2020	EPI_ISL_553807	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/ALDP-9534EB/2020	EPI_ISL_553815	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95382B/2020	EPI_ISL_553816	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9540F5/2020	EPI_ISL_553828	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/ALDP-954365/2020	EPI_ISL_553842	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-9534FA/2020	EPI_ISL_553849	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95408C/2020	EPI_ISL_553858	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-95610F/2020	EPI_ISL_553872	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-9563EB/2020	EPI_ISL_553875	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95663D/2020	EPI_ISL_553890	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-9527B6/2020	EPI_ISL_553895	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-956688/2020	EPI_ISL_553899	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-952B14/2020	EPI_ISL_553904	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-956187/2020	EPI_ISL_553906	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-956318/2020	EPI_ISL_553925	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9563FA/2020	EPI_ISL_553937	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9566A6/2020	EPI_ISL_553938	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/MILK-957915/2020	EPI_ISL_553955	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.231	G
hCoV-19/England/ALDP-95666A/2020	EPI_ISL_553982	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/ALDP-955B02/2020	EPI_ISL_553986	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-957C2B/2020	EPI_ISL_553987	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-956433/2020	EPI_ISL_553991	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/MILK-9C212C/2020	EPI_ISL_566438	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-9C239F/2020	EPI_ISL_566454	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9C270C/2020	EPI_ISL_566484	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.198	GR
hCoV-19/England/MILK-9C28DC/2020	EPI_ISL_566485	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9B1ADA/2020	EPI_ISL_566493	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9C2229/2020	EPI_ISL_566510	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/MILK-9C2CB2/2020	EPI_ISL_566515	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9C2177/2020	EPI_ISL_566517	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-9B25C9/2020	EPI_ISL_566524	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9B1AE9/2020	EPI_ISL_566544	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9C2238/2020	EPI_ISL_566545	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9C2380/2020	EPI_ISL_566609	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9B1C3E/2020	EPI_ISL_566611	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9C2C49/2020	EPI_ISL_566620	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/CAMC-9B2839/2020	EPI_ISL_566625	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9C255D/2020	EPI_ISL_566626	2020-09-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9C26A5/2020	EPI_ISL_566641	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/Wales/MILK-9C2335/2020	EPI_ISL_566645	2020-09-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9C34AA/2020	EPI_ISL_566715	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/MILK-9C38F9/2020	EPI_ISL_566758	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/MILK-9C3EAC/2020	EPI_ISL_566780	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9BDCD8/2020	EPI_ISL_568009	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-9BE071/2020	EPI_ISL_568025	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/ALDP-9BC84E/2020	EPI_ISL_568034	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9BC811/2020	EPI_ISL_568035	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9BEAEC/2020	EPI_ISL_568036	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9BEB8F/2020	EPI_ISL_568042	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-9BE25D/2020	EPI_ISL_568049	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9BE81F/2020	EPI_ISL_568050	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q90stop results in 26.4% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/ALDP-9BED2F/2020	EPI_ISL_568052	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/ALDP-9BE080/2020	EPI_ISL_568066	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/ALDP-9BEC13/2020	EPI_ISL_568070	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-9BE4B1/2020	EPI_ISL_568081	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-9BEB61/2020	EPI_ISL_568084	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-9BEC31/2020	EPI_ISL_568086	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-9BDCAB/2020	EPI_ISL_568090	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9BE9D0/2020	EPI_ISL_568093	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9BE9EF/2020	EPI_ISL_568109	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9BEB34/2020	EPI_ISL_568120	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-9BE5BE/2020	EPI_ISL_568127	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9BE545/2020	EPI_ISL_568139	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/ALDP-9BDB62/2020	EPI_ISL_568153	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/ALDP-9BC8B7/2020	EPI_ISL_568160	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-9BE4A2/2020	EPI_ISL_568163	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-9BEA19/2020	EPI_ISL_568164	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9BC7D8/2020	EPI_ISL_568174	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9BC7E7/2020	EPI_ISL_568175	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9BE4EE/2020	EPI_ISL_568176	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/ALDP-9BEB07/2020	EPI_ISL_568177	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-9BE7F4/2020	EPI_ISL_568190	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q90stop results in 26.4% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/ALDP-9BE3C3/2020	EPI_ISL_568216	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.310	GR
hCoV-19/Scotland/QEUH-9B8657/2020	EPI_ISL_568227	2020-09-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9B82BD/2020	EPI_ISL_568235	2020-09-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9B9AA5/2020	EPI_ISL_568259	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9B8736/2020	EPI_ISL_568268	2020-09-10	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9B8305/2020	EPI_ISL_568272	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A6BB7/2020	EPI_ISL_568289	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/Scotland/QEUH-98F9BA/2020	EPI_ISL_568294	2020-08-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9903F4/2020	EPI_ISL_568296	2020-08-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-98F6D1/2020	EPI_ISL_568298	2020-08-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-998E37/2020	EPI_ISL_568302	2020-08-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-990224/2020	EPI_ISL_568307	2020-08-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/Scotland/QEUH-98FFC7/2020	EPI_ISL_568324	2020-08-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-98F9D8/2020	EPI_ISL_568345	2020-08-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9900EE/2020	EPI_ISL_568362	2020-08-26	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99E262/2020	EPI_ISL_568364	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/Scotland/QEUH-9A46D6/2020	EPI_ISL_568368	2020-09-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/Scotland/QEUH-9A4366/2020	EPI_ISL_568379	2020-09-01	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/Scotland/QEUH-997F80/2020	EPI_ISL_568391	2020-08-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9700F3/2020	EPI_ISL_568403	2020-08-18	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-98F03D/2020	EPI_ISL_568455	2020-08-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-98F57A/2020	EPI_ISL_568457	2020-08-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/MILK-95999B/2020	EPI_ISL_568470	2020-06-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.174	GR
hCoV-19/England/ALDP-9B6431/2020	EPI_ISL_573005	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9B6440/2020	EPI_ISL_573006	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/ALDP-9B645F/2020	EPI_ISL_573007	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9B646E/2020	EPI_ISL_573008	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9B66D1/2020	EPI_ISL_573028	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9B6756/2020	EPI_ISL_573033	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.240	GR
hCoV-19/England/ALDP-9BCAB1/2020	EPI_ISL_573048	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/ALDP-9BCBBE/2020	EPI_ISL_573059	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9BCC24/2020	EPI_ISL_573066	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9BCF2B/2020	EPI_ISL_573081	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.255	GR
hCoV-19/England/ALDP-9CC447/2020	EPI_ISL_573107	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9CC456/2020	EPI_ISL_573108	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9CCA09/2020	EPI_ISL_573124	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.308	GR
hCoV-19/England/CAMC-9BFF0A/2020	EPI_ISL_573161	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9C0258/2020	EPI_ISL_573176	2020-09-06	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9C03DD/2020	EPI_ISL_573184	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9C0425/2020	EPI_ISL_573185	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9C0452/2020	EPI_ISL_573186	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9C048F/2020	EPI_ISL_573187	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9C0540/2020	EPI_ISL_573188	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9C16B5/2020	EPI_ISL_573197	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/CAMC-9C1970/2020	EPI_ISL_573210	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.532	GR
hCoV-19/England/CAMC-9C19E9/2020	EPI_ISL_573213	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9C1A04/2020	EPI_ISL_573214	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9C1AD7/2020	EPI_ISL_573219	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9C1CE0/2020	EPI_ISL_573229	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9C1CFF/2020	EPI_ISL_573230	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9C1D29/2020	EPI_ISL_573231	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/LIVE-1D20E8/2020	EPI_ISL_573243	2020-05-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/MILK-9A7F50/2020	EPI_ISL_573248	2020-09-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.269	GR
hCoV-19/England/MILK-9C6F6A/2020	EPI_ISL_573269	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.130	GR
hCoV-19/England/MILK-9C6FD3/2020	EPI_ISL_573271	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.227	GR
hCoV-19/England/MILK-9C7084/2020	EPI_ISL_573276	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-9C70EE/2020	EPI_ISL_573281	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-9C727F/2020	EPI_ISL_573292	2020-09-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-9C736D/2020	EPI_ISL_573300	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-9C739A/2020	EPI_ISL_573303	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-286149/2020	EPI_ISL_573312	2020-07-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-286167/2020	EPI_ISL_573313	2020-07-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-286185/2020	EPI_ISL_573315	2020-08-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-2861A3/2020	EPI_ISL_573316	2020-08-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-286219/2020	EPI_ISL_573320	2020-09-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-28CBDC/2020	EPI_ISL_573323	2020-08-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-2A0AD5/2020	EPI_ISL_573360	2020-04-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-2A450D/2020	EPI_ISL_573375	2020-08-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.171	GR
hCoV-19/England/NORT-2A4682/2020	EPI_ISL_573377	2020-09-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.39	GR
hCoV-19/England/NORT-2A4804/2020	EPI_ISL_573382	2020-09-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-2A485F/2020	EPI_ISL_573385	2020-09-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-2A48F5/2020	EPI_ISL_573388	2020-09-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.269	GR
hCoV-19/England/NORT-2A49E3/2020	EPI_ISL_573392	2020-09-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-2A4A1D/2020	EPI_ISL_573393	2020-09-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.269	GR
hCoV-19/England/NORT-2A4B92/2020	EPI_ISL_573399	2020-09-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-2A4D14/2020	EPI_ISL_573403	2020-09-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-2A4D41/2020	EPI_ISL_573404	2020-09-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-2A4D9C/2020	EPI_ISL_573405	2020-09-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-2A4DC9/2020	EPI_ISL_573407	2020-09-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-2A4E5D/2020	EPI_ISL_573410	2020-09-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-2A4E7B/2020	EPI_ISL_573411	2020-09-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-2A4EA8/2020	EPI_ISL_573413	2020-09-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NOTT-11385C/2020	EPI_ISL_573437	2020-09-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NOTT-11386B/2020	EPI_ISL_573438	2020-09-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NOTT-113898/2020	EPI_ISL_573439	2020-09-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NOTT-1138A7/2020	EPI_ISL_573440	2020-09-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NOTT-1138B6/2020	EPI_ISL_573441	2020-09-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NOTT-1138F2/2020	EPI_ISL_573443	2020-09-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NOTT-11390E/2020	EPI_ISL_573444	2020-09-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NOTT-11391D/2020	EPI_ISL_573445	2020-09-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NOTT-11392C/2020	EPI_ISL_573446	2020-09-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NOTT-113986/2020	EPI_ISL_573448	2020-09-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NOTT-1139FF/2020	EPI_ISL_573449	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEB28/2020	EPI_ISL_573479	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEB37/2020	EPI_ISL_573480	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEB46/2020	EPI_ISL_573481	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEB64/2020	EPI_ISL_573482	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEB73/2020	EPI_ISL_573483	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEBEC/2020	EPI_ISL_573486	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEC07/2020	EPI_ISL_573488	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEC70/2020	EPI_ISL_573490	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AECE9/2020	EPI_ISL_573495	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AECF8/2020	EPI_ISL_573496	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AED04/2020	EPI_ISL_573497	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AED22/2020	EPI_ISL_573498	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AED40/2020	EPI_ISL_573499	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AED9B/2020	EPI_ISL_573502	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEDAA/2020	EPI_ISL_573503	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEDB9/2020	EPI_ISL_573504	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEDC8/2020	EPI_ISL_573505	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEDD7/2020	EPI_ISL_573506	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEE01/2020	EPI_ISL_573507	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEE10/2020	EPI_ISL_573508	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEE2F/2020	EPI_ISL_573509	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEE3E/2020	EPI_ISL_573510	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEE4D/2020	EPI_ISL_573511	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEF68/2020	EPI_ISL_573517	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEF77/2020	EPI_ISL_573518	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEF95/2020	EPI_ISL_573520	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEFB3/2020	EPI_ISL_573521	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9AEFD1/2020	EPI_ISL_573523	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9B3ABA/2020	EPI_ISL_573527	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9B3B4E/2020	EPI_ISL_573534	2020-09-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9B3B99/2020	EPI_ISL_573536	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9B3C2D/2020	EPI_ISL_573542	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9B3C4B/2020	EPI_ISL_573543	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9B3D57/2020	EPI_ISL_573548	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9B3EAF/2020	EPI_ISL_573556	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9B3EDC/2020	EPI_ISL_573557	2020-09-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.39	GR
hCoV-19/England/QEUH-9B3F06/2020	EPI_ISL_573558	2020-09-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9B4002/2020	EPI_ISL_573563	2020-09-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.115	GR
hCoV-19/England/QEUH-9B9FD3/2020	EPI_ISL_573569	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9BA084/2020	EPI_ISL_573575	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-9BA109/2020	EPI_ISL_573579	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9BA172/2020	EPI_ISL_573583	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9BA2F7/2020	EPI_ISL_573587	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9BA37C/2020	EPI_ISL_573588	2020-09-06	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9BA479/2020	EPI_ISL_573590	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9BA576/2020	EPI_ISL_573594	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9BA770/2020	EPI_ISL_573601	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9BA79E/2020	EPI_ISL_573602	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9BA7AD/2020	EPI_ISL_573603	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9BA8B9/2020	EPI_ISL_573609	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9BAAE0/2020	EPI_ISL_573620	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-9BAB74/2020	EPI_ISL_573625	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/QEUH-9BAB83/2020	EPI_ISL_573626	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.308	GR
hCoV-19/England/QEUH-9BAC08/2020	EPI_ISL_573630	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9BAF96/2020	EPI_ISL_573643	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.44	GR
hCoV-19/England/QEUH-9BB092/2020	EPI_ISL_573648	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9BB0CF/2020	EPI_ISL_573650	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9D16B2/2020	EPI_ISL_573653	2020-09-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9D1746/2020	EPI_ISL_573657	2020-09-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9D1791/2020	EPI_ISL_573658	2020-09-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9D17EC/2020	EPI_ISL_573660	2020-09-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9D1843/2020	EPI_ISL_573662	2020-09-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9D1861/2020	EPI_ISL_573664	2020-09-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9D188F/2020	EPI_ISL_573666	2020-09-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9D18DA/2020	EPI_ISL_573668	2020-09-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9D1904/2020	EPI_ISL_573670	2020-09-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9D19B9/2020	EPI_ISL_573672	2020-09-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9D1B77/2020	EPI_ISL_573682	2020-09-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/SHEF-CE87F/2020	EPI_ISL_573738	2020-09-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/SHEF-CF1FB/2020	EPI_ISL_573744	2020-09-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/SHEF-D2C9A/2020	EPI_ISL_573753	2020-09-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Northern Ireland/QEUH-9B3DB1/2020	EPI_ISL_573763	2020-09-03	Europe / United Kingdom / Northern Ireland	Human	Original			Oxford Nanopore				B.1.1.310	GR
hCoV-19/Scotland/CVR4338/2020	EPI_ISL_573779	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/Scotland/QEUH-9BA45B/2020	EPI_ISL_573814	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-9BA5EF/2020	EPI_ISL_573818	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-9BADD8/2020	EPI_ISL_573841	2020-09-09	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16B73A/2020	EPI_ISL_573894	2020-09-14	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16B9CB/2020	EPI_ISL_573926	2020-09-16	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16BE35/2020	EPI_ISL_573979	2020-09-18	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16BFD8/2020	EPI_ISL_573999	2020-09-17	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-A2EAF5/2020	EPI_ISL_587001	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2FCD0/2020	EPI_ISL_587005	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/ALDP-A2ED92/2020	EPI_ISL_587027	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-A2F371/2020	EPI_ISL_587030	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/ALDP-A2F432/2020	EPI_ISL_587037	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-A2EDB0/2020	EPI_ISL_587051	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-A2EC59/2020	EPI_ISL_587063	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2F7A2/2020	EPI_ISL_587065	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-A2F1A4/2020	EPI_ISL_587109	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/ALDP-A2F03E/2020	EPI_ISL_587117	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/ALDP-A2E758/2020	EPI_ISL_587121	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2EF05/2020	EPI_ISL_587122	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-A2FDEC/2020	EPI_ISL_587124	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/ALDP-A2F61E/2020	EPI_ISL_587180	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2F450/2020	EPI_ISL_587204	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/ALDP-A2F3CC/2020	EPI_ISL_587230	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A2F5E4/2020	EPI_ISL_587269	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A1E858/2020	EPI_ISL_587315	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-A1EE1A/2020	EPI_ISL_587346	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A1EE0B/2020	EPI_ISL_587354	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A2045F/2020	EPI_ISL_587603	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A209E7/2020	EPI_ISL_587604	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A1FCE2/2020	EPI_ISL_587633	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A202BF/2020	EPI_ISL_587649	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A2055C/2020	EPI_ISL_587651	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A202EC/2020	EPI_ISL_587669	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A1F9BE/2020	EPI_ISL_587696	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A2100F/2020	EPI_ISL_587697	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A20774/2020	EPI_ISL_587701	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FD058/2020	EPI_ISL_587749	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FCEAA/2020	EPI_ISL_587753	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FD243/2020	EPI_ISL_587757	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FD261/2020	EPI_ISL_587780	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FCB0D/2020	EPI_ISL_587807	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FD850/2020	EPI_ISL_587810	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FD498/2020	EPI_ISL_587838	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9FD0A3/2020	EPI_ISL_587841	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FD340/2020	EPI_ISL_587851	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FCAD3/2020	EPI_ISL_587861	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-9FCD61/2020	EPI_ISL_587863	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/ALDP-9FD86F/2020	EPI_ISL_587872	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/ALDP-9FCA88/2020	EPI_ISL_587888	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FDE9A/2020	EPI_ISL_587941	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FCF2F/2020	EPI_ISL_587990	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FCAB5/2020	EPI_ISL_587992	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Japan/IC-0119/2020	EPI_ISL_591460	2020-08-02	Asia / Japan	Human	Original		COVID-19 positive case who entered from Russian Federation.	Illumina NextSeq2000	SKESA v. 2.3.0			B.1.1	GR
hCoV-19/Japan/IC-0124/2020	EPI_ISL_591465	2020-08-14	Asia / Japan	Human	Original		COVID-19 positive case who entered from United States.	Illumina NextSeq500	A5-miseq v. 20140604			B.1.533	G
hCoV-19/Canada/ON-E55/2020	EPI_ISL_593529	2020-05-29	North America / Canada / Ontario / Ottawa	Human	Original			Illumina HiSeq				B.1.1.176	GR
hCoV-19/England/ALDP-A6D553/2020	EPI_ISL_607004	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6CC31/2020	EPI_ISL_607026	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6E59E/2020	EPI_ISL_607048	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6FB31/2020	EPI_ISL_607060	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6CC40/2020	EPI_ISL_607088	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6FD68/2020	EPI_ISL_607093	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-A6FABC/2020	EPI_ISL_607101	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6EC02/2020	EPI_ISL_607106	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6E6B9/2020	EPI_ISL_607150	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-A6EB9C/2020	EPI_ISL_607175	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6E604/2020	EPI_ISL_607185	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A6C994/2020	EPI_ISL_607187	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-A6FD59/2020	EPI_ISL_607229	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6F21E/2020	EPI_ISL_607236	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A6F885/2020	EPI_ISL_607244	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/ALDP-A6CA91/2020	EPI_ISL_607252	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6DDB5/2020	EPI_ISL_607269	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/MILK-A7C9BF/2020	EPI_ISL_607309	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7B789/2020	EPI_ISL_607320	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/MILK-A7BF63/2020	EPI_ISL_607328	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7B1D6/2020	EPI_ISL_607331	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.39	GR
hCoV-19/England/MILK-A7BEA2/2020	EPI_ISL_607337	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/MILK-A7B112/2020	EPI_ISL_607355	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-A7B938/2020	EPI_ISL_607359	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7BFFA/2020	EPI_ISL_607372	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7C779/2020	EPI_ISL_607384	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/MILK-A7B90B/2020	EPI_ISL_607385	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7B561/2020	EPI_ISL_607466	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7BDF0/2020	EPI_ISL_607479	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7B3D0/2020	EPI_ISL_607480	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7BA26/2020	EPI_ISL_607481	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7CC89/2020	EPI_ISL_607490	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7C7E2/2020	EPI_ISL_607497	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7B640/2020	EPI_ISL_607515	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-A7C6D6/2020	EPI_ISL_607529	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7B6D7/2020	EPI_ISL_607546	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-A7B525/2020	EPI_ISL_607551	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7B570/2020	EPI_ISL_607555	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A7BBBA/2020	EPI_ISL_607596	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.133	GR
hCoV-19/England/ALDP-A6EFDC/2020	EPI_ISL_607630	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6E482/2020	EPI_ISL_607631	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6E1D6/2020	EPI_ISL_607678	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A6F463/2020	EPI_ISL_607782	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-A6DFDD/2020	EPI_ISL_607783	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6E4CE/2020	EPI_ISL_607807	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6F68B/2020	EPI_ISL_607814	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6E561/2020	EPI_ISL_607830	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6DB24/2020	EPI_ISL_607852	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A705B7/2020	EPI_ISL_607856	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6F4BE/2020	EPI_ISL_607861	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6DB51/2020	EPI_ISL_607871	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6DA81/2020	EPI_ISL_607872	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/ALDP-A6ED69/2020	EPI_ISL_607877	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6DEEF/2020	EPI_ISL_607889	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6DFBF/2020	EPI_ISL_607892	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6D887/2020	EPI_ISL_607920	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6EA35/2020	EPI_ISL_607942	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-A6DB15/2020	EPI_ISL_607957	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6E437/2020	EPI_ISL_607961	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6F409/2020	EPI_ISL_607962	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6C8B5/2020	EPI_ISL_607986	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/LIVE-1D2D69/2020	EPI_ISL_612421	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-1D2DF0/2020	EPI_ISL_612425	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-1D2E0C/2020	EPI_ISL_612426	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-AB69C/2020	EPI_ISL_612439	2020-05-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-AB76C/2020	EPI_ISL_612440	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-AB896/2020	EPI_ISL_612441	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-AB948/2020	EPI_ISL_612443	2020-05-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-ABA18/2020	EPI_ISL_612448	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-ABA72/2020	EPI_ISL_612449	2020-06-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/MILK-A18EF2/2020	EPI_ISL_612474	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.39	GR
hCoV-19/England/MILK-A192F5/2020	EPI_ISL_612500	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-A1937A/2020	EPI_ISL_612507	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-A1942C/2020	EPI_ISL_612510	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/MILK-A194FF/2020	EPI_ISL_612513	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/MILK-A19556/2020	EPI_ISL_612517	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORT-1B6BEDE/2020	EPI_ISL_612551	2020-09-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-1B6C040/2020	EPI_ISL_612557	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-1B6C08C/2020	EPI_ISL_612559	2020-10-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-1B6C0B9/2020	EPI_ISL_612560	2020-10-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-1B6C0C8/2020	EPI_ISL_612561	2020-10-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-1B6C101/2020	EPI_ISL_612564	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-1B6C14D/2020	EPI_ISL_612566	2020-10-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-2A7FEE/2020	EPI_ISL_612569	2020-10-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Wales/PHWC-47EFA2/2020	EPI_ISL_612611	2020-10-13	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-47F23F/2020	EPI_ISL_612648	2020-10-14	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-A9EBC0/2020	EPI_ISL_625325	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/Wales/QEUH-AA0509/2020	EPI_ISL_625382	2020-10-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-A87D3D/2020	EPI_ISL_625396	2020-10-17	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-A8640C/2020	EPI_ISL_625398	2020-10-17	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-A862D5/2020	EPI_ISL_625399	2020-10-17	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-A6AC60/2020	EPI_ISL_625417	2020-10-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/NORW-F21B3/2020	EPI_ISL_627071	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-F2238/2020	EPI_ISL_627072	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-F2344/2020	EPI_ISL_627073	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-F32FB/2020	EPI_ISL_627074	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-F35F2/2020	EPI_ISL_627075	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-F36C2/2020	EPI_ISL_627076	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-F3DCD/2020	EPI_ISL_627077	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/QEUH-A4D1FB/2020	EPI_ISL_627079	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina		NS8_C61stop results in 50.4% truncation of the protein sequence.	info	B.1.236	G
hCoV-19/Wales/CVR4762/2020	EPI_ISL_627342	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR5106/2020	EPI_ISL_627375	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/EXET-13860C/2020	EPI_ISL_627424	2020-10-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/EXET-138790/2020	EPI_ISL_627427	2020-10-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/EXET-1388E8/2020	EPI_ISL_627430	2020-10-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/EXET-138A6A/2020	EPI_ISL_627433	2020-10-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/LOND-126C9A/2020	EPI_ISL_627464	2020-10-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-DC39B/2020	EPI_ISL_627471	2020-08-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.406	GR
hCoV-19/England/MILK-A18A67/2020	EPI_ISL_627475	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/MILK-A6A2B9/2020	EPI_ISL_627497	2020-10-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-A6A32F/2020	EPI_ISL_627499	2020-10-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/USA/NY-NYCPHL-000863/2020	EPI_ISL_632239	2020-03-25	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	Bwa version 0.7.17-r1188			B.1.1.61	GR
hCoV-19/Netherlands/ZH-EMC-831/2020	EPI_ISL_632701	2020-10-17	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.1	GR
hCoV-19/Netherlands/NB-EMC-319/2020	EPI_ISL_632772	2020-07-03	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.1.112	GR
hCoV-19/Netherlands/NB-EMC-321/2020	EPI_ISL_632774	2020-07-06	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.1.112	GR
hCoV-19/Canada/MB-NML-654/2020	EPI_ISL_632933	2020-03-13	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.1	GR
hCoV-19/USA/NY-NYCPHL-000940/2020	EPI_ISL_632981	2020-09-11	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.240	G
hCoV-19/Russia/OMS-ORINFI-1068S/2020	EPI_ISL_639915	2020-06-26	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-2114S/2020	EPI_ISL_639918	2020-07-02	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-2292S/2020	EPI_ISL_639921	2020-06-30	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1	GR
hCoV-19/Russia/OMS-ORINFI-3801S/2020	EPI_ISL_639924	2020-06-01	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1	GR
hCoV-19/Russia/OMS-ORINFI-3818S/2020	EPI_ISL_639926	2020-06-02	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-5368S/2020	EPI_ISL_639930	2020-06-05	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1	GR
hCoV-19/Russia/OMS-ORINFI-5774S/2020	EPI_ISL_639932	2020-06-07	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-6212S/2020	EPI_ISL_639933	2020-05-10	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1	GR
hCoV-19/Russia/OMS-ORINFI-6680S/2020	EPI_ISL_639935	2020-05-12	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1	GR
hCoV-19/Russia/OMS-ORINFI-7139S/2020	EPI_ISL_639937	2020-05-14	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1	GR
hCoV-19/Russia/OMS-ORINFI-8293S/2020	EPI_ISL_639939	2020-05-17	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1	GR
hCoV-19/Russia/OMS-ORINFI-858S/2020	EPI_ISL_639941	2020-06-26	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-864S/2020	EPI_ISL_639943	2020-06-26	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools	NSP11 without BLAST coverage.	warn	B.1.1	GR
hCoV-19/Russia/OMS-ORINFI-865S/2020	EPI_ISL_639944	2020-06-26	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools	NSP11 without BLAST coverage.	warn	B.1.1	GR
hCoV-19/Russia/MOS-RII-MH2805S/2020	EPI_ISL_639954	2020-09-26	Europe / Russia / Moscow / Lapino	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1	GR
hCoV-19/Russia/ORE-RII-MH2814S/2020	EPI_ISL_639961	2020-09-21	Europe / Russia / Orenburg / Orenburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1	GR
hCoV-19/Russia/RYA-RII-MH2824S/2020	EPI_ISL_639968	2020-09-26	Europe / Russia / Ryazan / Ryazan	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools	NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/Russia/SVE-RII-MH2824S/2020	EPI_ISL_639969	2020-09-18	Europe / Russia / Sverdlovsk / Asbest	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1	GR
hCoV-19/France/ARA74567/2020	EPI_ISL_639978	2020-09-17	Europe / France / Auvergne-Rhone-Alpes / Lyon	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1.1.269	GR
hCoV-19/England/CAMC-B21FE3/2020	EPI_ISL_646022	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/ALDP-B1BD97/2020	EPI_ISL_646060	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/ALDP-B1DBAA/2020	EPI_ISL_646106	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B1D603/2020	EPI_ISL_646113	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B31B64/2020	EPI_ISL_646147	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-B23F96/2020	EPI_ISL_646198	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B240ED/2020	EPI_ISL_646418	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B23C35/2020	EPI_ISL_646429	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B32143/2020	EPI_ISL_646433	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2C9DB/2020	EPI_ISL_646470	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2B435/2020	EPI_ISL_646482	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/QEUH-B2BA60/2020	EPI_ISL_646484	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-B2B5AB/2020	EPI_ISL_646519	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/QEUH-B2B8C0/2020	EPI_ISL_646553	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/ALDP-B26072/2020	EPI_ISL_646572	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2CAF6/2020	EPI_ISL_646624	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B24D9B/2020	EPI_ISL_646693	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-B2B927/2020	EPI_ISL_646700	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-B24DF5/2020	EPI_ISL_646718	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-B24F68/2020	EPI_ISL_646738	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2B4BD/2020	EPI_ISL_646748	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2C9BD/2020	EPI_ISL_646765	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2D72B/2020	EPI_ISL_646792	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-B24609/2020	EPI_ISL_646800	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B24B19/2020	EPI_ISL_646815	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B2493D/2020	EPI_ISL_646835	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2DAC8/2020	EPI_ISL_646853	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-B23822/2020	EPI_ISL_646862	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2EC76/2020	EPI_ISL_646872	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B2485E/2020	EPI_ISL_646951	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B238F5/2020	EPI_ISL_646978	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/Scotland/EDB8814/2020	EPI_ISL_652002	2020-10-26	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-A23FB5/2020	EPI_ISL_652106	2020-10-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.236	G
hCoV-19/England/MILK-ACFCA5/2020	EPI_ISL_652131	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.204	GR
hCoV-19/England/MILK-ACFEFA/2020	EPI_ISL_652145	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-AD0087/2020	EPI_ISL_652150	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.240	GR
hCoV-19/Northern Ireland/NIRE-109561/2020	EPI_ISL_652334	2020-10-13	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				AD.2	GR
hCoV-19/England/NORT-286D45/2020	EPI_ISL_652337	2020-10-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-286D72/2020	EPI_ISL_652338	2020-10-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-286D90/2020	EPI_ISL_652339	2020-10-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-286E33/2020	EPI_ISL_652340	2020-10-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-28CEA6/2020	EPI_ISL_652343	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-28CF3A/2020	EPI_ISL_652344	2020-09-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NOTT-11B7DF/2020	EPI_ISL_652379	2020-11-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/ALDP-B74F4B/2020	EPI_ISL_664917	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.67	GR
hCoV-19/England/ALDP-B7731F/2020	EPI_ISL_664937	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.67	GR
hCoV-19/England/CAMB-1B973D/2020	EPI_ISL_664943	2020-11-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.240	GR
hCoV-19/England/CAMB-1B9BF5/2020	EPI_ISL_664963	2020-11-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.240	GR
hCoV-19/England/CAMB-1B9C4D/2020	EPI_ISL_664966	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.240	GR
hCoV-19/England/CAMB-1B9C5C/2020	EPI_ISL_664967	2020-11-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.240	GR
hCoV-19/England/CAMB-1BA4EA/2020	EPI_ISL_664987	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB9324/2020	EPI_ISL_666075	2020-11-06	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Wales/PHWC-48AE88/2020	EPI_ISL_666166	2020-10-31	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1	G
hCoV-19/Wales/PHWC-48B18E/2020	EPI_ISL_666200	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-48C7E5/2020	EPI_ISL_666470	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-48CBF8/2020	EPI_ISL_666519	2020-11-07	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-48CFFC/2020	EPI_ISL_666565	2020-11-01	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-48D122/2020	EPI_ISL_666583	2020-11-04	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/France/ARA-SC045/2020	EPI_ISL_666665	2020-04-01	Europe / France / Auvergne-Rhone-Alpes / Saint-Julien-en-Genevois	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1.1	GR
hCoV-19/Ireland/DL-NVRL-20G49554/2020	EPI_ISL_666697	2020-04-06	Europe / Ireland / Donegal	Human	Original			Oxford Nanopore MinION	ARTIC v3 protocol			B.1.1	GR
hCoV-19/Ireland/DL-NVRL-20G48972/2020	EPI_ISL_666699	2020-04-05	Europe / Ireland / Donegal	Human	Original			Oxford Nanopore MinION	ARTIC v3 protocol			B.59	GR
hCoV-19/Ireland/DL-NVRL-20G48992/2020	EPI_ISL_666700	2020-04-06	Europe / Ireland / Donegal	Human	Original			Oxford Nanopore MinION	ARTIC v3 protocol			B.59	GR
hCoV-19/Ireland/DL-NVRL-20G48997/2020	EPI_ISL_666704	2020-04-05	Europe / Ireland / Donegal	Human	Original			Oxford Nanopore MinION	ARTIC v3 protocol			B.59	GR
hCoV-19/Ireland/MO-NVRL-20G48980/2020	EPI_ISL_666710	2020-04-05	Europe / Ireland / Mayo	Human	Original			Oxford Nanopore MinION	ARTIC v3 protocol			B.59	GR
hCoV-19/USA/MI-MDHHS-SC22281/2020	EPI_ISL_666947	2020-10-20	North America / USA / Michigan	Human	Original			Illumina NextSeq	bwa v. 0.7.17; bcftools v. 1.7			B.1.240	G
hCoV-19/USA/MI-MDHHS-SC22295/2020	EPI_ISL_666961	2020-10-23	North America / USA / Michigan	Human	Original			Illumina NextSeq	bwa v. 0.7.17; bcftools v. 1.7			B.1.240	G
hCoV-19/USA/CA-ALSR-4508/2020	EPI_ISL_666975	2020-10-27	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.368	GR
hCoV-19/USA/CA-ALSR-4512/2020	EPI_ISL_666977	2020-10-16	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-4513/2020	EPI_ISL_666978	2020-10-16	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-4523/2020	EPI_ISL_666984	2020-10-21	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-4533/2020	EPI_ISL_666992	2020-07-07	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/Denmark/DCGC-11788/2020	EPI_ISL_671137	2020-10-26	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.398	G
hCoV-19/Denmark/DCGC-11883/2020	EPI_ISL_671195	2020-10-26	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.159	GR
hCoV-19/Ireland/OY-NVRL-MPL81201/2020	EPI_ISL_671357	2020-04-22	Europe / Ireland / Offaly	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.59	GR
hCoV-19/Ireland/D-NVRL-20Z04493/2020	EPI_ISL_671359	2020-04-15	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1	GR
hCoV-19/Ireland/MN-NVRL-20Z06790/2020	EPI_ISL_671361	2020-04-18	Europe / Ireland / Monaghan	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol	Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Ireland/MN-NVRL-20Z06659/2020	EPI_ISL_671403	2020-04-18	Europe / Ireland / Monaghan	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol	Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Hungary/UD-55426/2020	EPI_ISL_671419	2020-08-31	Europe / Hungary / Szabolcs-Szatmar-Bereg County	Human	Original	Oropharyngeal swab		Nanopore MinION, Sanger	Geneious 10.2.4			B.1.1.163	GR
hCoV-19/Canada/ON-PHL-20-02408/2020	EPI_ISL_671590	2020-09	North America / Canada / Ontario	Human	Original	Nasopharyngeal		Illumina MiSeq	ncov2019-artic-nv (OICR v1.5)			B.1.1	GR
hCoV-19/Canada/ON-UHTC-0369/2020	EPI_ISL_671660	2020-10-01	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.176	GR
hCoV-19/Canada/ON-UHTC-0364/2020	EPI_ISL_671668	2020-10-01	North America / Canada / Ontario	Human	Original			Oxford Nanopore	ARTIC-nanopolish 1.1.3	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1.176	GR
hCoV-19/USA/NY-NYCPHL-001145/2020	EPI_ISL_671727	2020-10-23	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	BWA version 0.7.17-r1188			B.1.409	G
hCoV-19/USA/NY-NYCPHL-001151/2020	EPI_ISL_671733	2020-10-26	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	BWA version 0.7.17-r1188			B.1.236	G
hCoV-19/Ecuador/UEES-7352/2020	EPI_ISL_671985	2020	South America / Ecuador	Human	Original	Nasopharyngeal swab		Illumina MiniSeq	Sophia Genetics			B.1.1	GR
hCoV-19/Ecuador/UEES-4040/2020	EPI_ISL_671988	2020	South America / Ecuador	Human	Original	Nasopharyngeal swab		Illumina MiniSeq	Sophia Genetics			B.1.1	GR
hCoV-19/Ecuador/UEES-7435/2020	EPI_ISL_671990	2020	South America / Ecuador	Human	Original	Nasopharyngeal swab		Illumina MiniSeq	Sophia Genetics			B.1.1	GR
hCoV-19/Ecuador/UEES-4375/2020	EPI_ISL_671994	2020	South America / Ecuador	Human	Original	Nasopharyngeal swab		Illumina MiniSeq	Sophia Genetics			B.1.1	GR
hCoV-19/Ecuador/UEES-4107/2020	EPI_ISL_671999	2020	South America / Ecuador	Human	Original	Nasopharyngeal swab		Illumina MiniSeq	Sophia Genetics			B.1.1	GR
hCoV-19/USA/MN29-MDH29/2020	EPI_ISL_417196	2020-03-11	North America / USA / Minnesota	Human	Original			Nanopore MinION	ARTIC-nCoV-bioinformaticsSOP v1.0.0			B.1.1	GR
hCoV-19/Iceland/146/2020	EPI_ISL_417796	2020-03-13	Europe / Iceland / Reykjavik	Human	Original			Illumina MiSeq	Mpileup			B.1.1	GR
hCoV-19/Iceland/178/2020	EPI_ISL_417813	2020-03-15	Europe / Iceland / Reykjavik	Human	Original			Illumina MiSeq	Mpileup			B.1.1	GR
hCoV-19/Iceland/204/2020	EPI_ISL_417826	2020-03-16	Europe / Iceland / Reykjavik	Human	Original			Illumina MiSeq	Mpileup			B.1.1	GR
hCoV-19/USA/CA-CZB07/2020	EPI_ISL_417933	2020-03-18	North America / USA / California / San Francisco County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 v2.17 / iVar v1.0.1			B.1.1	GR
hCoV-19/Belgium/ULG-10006/2020	EPI_ISL_421185	2020-03-30	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/Belgium/ULG-10024/2020	EPI_ISL_421198	2020-03-30	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/Belgium/ULG-10043/2020	EPI_ISL_421210	2020-03-31	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/Portugal/PT0057/2020	EPI_ISL_421460	2020-03-20	Europe / Portugal	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	INSaFLU			B.1	G
hCoV-19/Portugal/PT0084/2020	EPI_ISL_421487	2020-03-22	Europe / Portugal	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	INSaFLU			B.1.1	GR
hCoV-19/USA/OH-OSUP0109/2020	EPI_ISL_421660	2020-04-01	North America / USA / Ohio / Columbus	Human	Original	Oropharyngeal swab		Ion Torrent				B.1.1	GR
hCoV-19/England/201360506/2020	EPI_ISL_421782	2020-03-25	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/201360508/2020	EPI_ISL_421783	2020-03-25	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/201361041/2020	EPI_ISL_421792	2020-03-26	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20134017904/2020	EPI_ISL_423096	2020-03-23	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.164	GR
hCoV-19/England/20134018004/2020	EPI_ISL_423097	2020-03-23	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.164	GR
hCoV-19/England/20134025204/2020	EPI_ISL_423129	2020-03-23	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20134064004/2020	EPI_ISL_423150	2020-03-23	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20134068504/2020	EPI_ISL_423157	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.164	GR
hCoV-19/England/201360018/2020	EPI_ISL_423198	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/201360202/2020	EPI_ISL_423239	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1	G
hCoV-19/England/201360215/2020	EPI_ISL_423246	2020-03-25	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20140070604/2020	EPI_ISL_423409	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20142023704/2020	EPI_ISL_423448	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.164	GR
hCoV-19/England/20144004804/2020	EPI_ISL_423488	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.164	GR
hCoV-19/England/20144007604/2020	EPI_ISL_423497	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20144008904/2020	EPI_ISL_423502	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.164	GR
hCoV-19/England/20144009004/2020	EPI_ISL_423503	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.164	GR
hCoV-19/England/20144022704/2020	EPI_ISL_423521	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/USA/NY-NYUMC440/2020	EPI_ISL_435507	2020-04-15	North America / USA / New York / Manhattan	Human	Original			Illumina NovaSeq (Ribo-depleted)	BWA v0.7.17, bases below 20x coverage masked			B.1.1.231	GR
hCoV-19/USA/NY-NYUMC478/2020	EPI_ISL_435543	2020-04-22	North America / USA / New York / Nassau County	Human	Original			Illumina NovaSeq (Ribo-depleted)	BWA v0.7.17, bases below 20x coverage masked			B.1.1	GR
hCoV-19/Singapore/94/2020	EPI_ISL_435699	2020-03-18	Asia / Singapore	Human	Original			Illumina MiSeq	Spades v3.6.1			B.1.1	GR
hCoV-19/Germany/BY-MVP-0003/2020	EPI_ISL_437205	2020-03-16	Europe / Germany / Bavaria / Munich	Human	Original	Nasopharyngeal swab		Illumina Hiseq 1500	ARTIC V3 amplicons, Nextera XT library, bwa v0.7.17, iVar v1.2.2			B.1.1.515	GR
hCoV-19/Germany/BY-MVP-0005/2020	EPI_ISL_437206	2020-03-18	Europe / Germany / Bavaria / Munich	Human	Original	Nasopharyngeal swab		Illumina Hiseq 1500	ARTIC V3 amplicons, Nextera XT library, bwa v0.7.17, iVar v1.2.2			B.1.1.515	GR
hCoV-19/Germany/BY-MVP-0037/2020	EPI_ISL_437236	2020-03-22	Europe / Germany / Bavaria / Munich	Human	Original	Sputum		Illumina Hiseq 1500	ARTIC V3 amplicons, Nextera XT library, bwa v0.7.17, iVar v1.2.2			B.1.1	GR
hCoV-19/Germany/BY-MVP-0040/2020	EPI_ISL_437239	2020-04-02	Europe / Germany / Bavaria / Munich	Human	Original	Nasopharyngeal swab		Illumina Hiseq 1500	ARTIC V3 amplicons, Nextera XT library, bwa v0.7.17, iVar v1.2.2			B.1.1.515	GR
hCoV-19/Germany/BY-MVP-0057/2020	EPI_ISL_437256	2020-03-20	Europe / Germany / Bavaria / Munich	Human	Original	Nasopharyngeal swab		Illumina Hiseq 1500	ARTIC V3 amplicons, Nextera XT library, bwa v0.7.17, iVar v1.2.2			B.1.1.515	GR
hCoV-19/Germany/BY-MVP-0064/2020	EPI_ISL_437263	2020-03-24	Europe / Germany / Bavaria / Munich	Human	Original	Nasopharyngeal swab		Illumina Hiseq 1500	ARTIC V3 amplicons, Nextera XT library, bwa v0.7.17, iVar v1.2.2			B.1.1.515	GR
hCoV-19/Germany/BY-MVP-0071/2020	EPI_ISL_437267	2020-03-27	Europe / Germany / Bavaria / Munich	Human	Original	Nasopharyngeal swab		Illumina Hiseq 1500	ARTIC V3 amplicons, Nextera XT library, bwa v0.7.17, iVar v1.2.2			B.1.1.515	GR
hCoV-19/Germany/BY-MVP-0073/2020	EPI_ISL_437269	2020-03-28	Europe / Germany / Bavaria / Munich	Human	Original	Nasopharyngeal swab		Illumina Hiseq 1500	ARTIC V3 amplicons, Nextera XT library, bwa v0.7.17, iVar v1.2.2			B.1.1.515	GR
hCoV-19/Germany/BY-MVP-0076/2020	EPI_ISL_437271	2020-03-30	Europe / Germany / Bavaria / Munich	Human	Original	Nasopharyngeal swab		Illumina Hiseq 1500	ARTIC V3 amplicons, Nextera XT library, bwa v0.7.17, iVar v1.2.2			B.1.1	GR
hCoV-19/Germany/BY-MVP-0086/2020	EPI_ISL_437280	2020-04-01	Europe / Germany / Bavaria / Munich	Human	Original	Nasopharyngeal swab		Illumina Hiseq 1500	ARTIC V3 amplicons, Nextera XT library, bwa v0.7.17, iVar v1.2.2			B.1.1.515	GR
hCoV-19/Germany/BY-MVP-0097/2020	EPI_ISL_437289	2020-04-03	Europe / Germany / Bavaria / Munich	Human	Original	Nasopharyngeal swab		Illumina Hiseq 1500	ARTIC V3 amplicons, Nextera XT library, bwa v0.7.17, iVar v1.2.2			B.1.1	GR
hCoV-19/India/GJ-GBRC22/2020	EPI_ISL_437451	2020-04-26	Asia / India / Gujarat / Ahmedabad	Human	Original	Oropharyngeal swab		Ion Torrent	CLC Genomics Workbench 12			B.1	G
hCoV-19/USA/CA-SR0232/2020	EPI_ISL_437572	2020-04-21	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2			B.1	G
hCoV-19/USA/CT-UW-6565/2020	EPI_ISL_437866	2020-04-02	North America / USA / Connecticut	Human	Original			Illumina				B.1.1	GR
hCoV-19/Greece/43_35679/2020	EPI_ISL_437874	2020-03-20	Europe / Greece / Athens	Human	Original	Nasopharyngeal swab		Ion Torrent	IRMA v0.6.1			B.59	GR
hCoV-19/Greece/152_33705/2020	EPI_ISL_437875	2020-03-14	Europe / Greece / Athens	Human	Original	Nasopharyngeal swab		Ion Torrent	IRMA v1.0			B.1.1	GR
hCoV-19/Greece/40_36244/2020	EPI_ISL_437897	2020-03-23	Europe / Greece / Athens	Human	Original	Nasopharyngeal swab		Ion Torrent	IRMA v1.0			B.1.1	GR
hCoV-19/Greece/41_36861/2020	EPI_ISL_437898	2020-03-28	Europe / Greece / Athens	Human	Original	Nasopharyngeal swab		Ion Torrent	IRMA v1.0			B.59	GR
hCoV-19/Austria/CeMM0089/2020	EPI_ISL_437952	2020-03-24	Europe / Austria / Innsbruck	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/Austria/CeMM0111/2020	EPI_ISL_437969	2020-03-12	Europe / Austria / Innsbruck	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/England/LOND-D3895/2020	EPI_ISL_441000	2020-04-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D3983/2020	EPI_ISL_441015	2020-04-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D3A08/2020	EPI_ISL_441022	2020-04-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D3DE1/2020	EPI_ISL_441035	2020-04-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D3E1B/2020	EPI_ISL_441038	2020-04-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D3E48/2020	EPI_ISL_441040	2020-04-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D3E57/2020	EPI_ISL_441041	2020-04-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.164	GR
hCoV-19/England/LOND-D3E66/2020	EPI_ISL_441042	2020-04-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D3EFD/2020	EPI_ISL_441047	2020-04-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-79794/2020	EPI_ISL_441053	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-798EC/2020	EPI_ISL_441082	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7A2CF/2020	EPI_ISL_441095	2020-04-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/CAMB-7A5B7/2020	EPI_ISL_441101	2020-04-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7B64A/2020	EPI_ISL_441122	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7CA89/2020	EPI_ISL_442049	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.13	GR
hCoV-19/England/CAMB-7CC74/2020	EPI_ISL_442150	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/CAMB-7DFB6/2020	EPI_ISL_442203	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7B6D1/2020	EPI_ISL_442210	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7C430/2020	EPI_ISL_442277	2020-04-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-123103/2020	EPI_ISL_442719	2020-04-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/BRIS-1239FC/2020	EPI_ISL_442729	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-123112/2020	EPI_ISL_442730	2020-04-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/BRIS-1234EC/2020	EPI_ISL_442732	2020-04-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-123121/2020	EPI_ISL_442735	2020-04-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/BRIS-12307F/2020	EPI_ISL_442739	2020-04-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1234DD/2020	EPI_ISL_442759	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1231A9/2020	EPI_ISL_442762	2020-04-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1239CF/2020	EPI_ISL_442771	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-123A08/2020	EPI_ISL_442774	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_E41stop results in 66.9% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/England/CAMB-7EC81/2020	EPI_ISL_442826	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-80C8C/2020	EPI_ISL_442886	2020-04-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/CAMB-8092B/2020	EPI_ISL_442922	2020-04-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/CAMB-7F215/2020	EPI_ISL_442935	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1B245B/2020	EPI_ISL_456680	2020-05-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B2673/2020	EPI_ISL_456702	2020-05-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B2BED/2020	EPI_ISL_456711	2020-05-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B2C71/2020	EPI_ISL_456716	2020-05-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1B2D8D/2020	EPI_ISL_456724	2020-05-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B2EC6/2020	EPI_ISL_456732	2020-05-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Scotland/CVR1893/2020	EPI_ISL_456758	2020-04-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.99	GR
hCoV-19/Scotland/CVR3149/2020	EPI_ISL_456766	2020-04-19	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.43	GR
hCoV-19/Scotland/CVR3294/2020	EPI_ISL_456778	2020-04-30	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.43	GR
hCoV-19/Scotland/CVR3298/2020	EPI_ISL_456779	2020-04-30	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.43	GR
hCoV-19/Scotland/CVR3347/2020	EPI_ISL_456783	2020-05-06	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Netherlands/Gelderland_17/2020	EPI_ISL_460653	2020-04-08	Europe / Netherlands / Gelderland	Human	Original			Nanopore				B.1.1.71	GR
hCoV-19/Netherlands/NA_589/2020	EPI_ISL_460753	2020-04-05	Europe / Netherlands	Human	Original			Nanopore				B.1.1.185	GR
hCoV-19/Netherlands/NA_593/2020	EPI_ISL_460756	2020-04-13	Europe / Netherlands	Human	Original			Nanopore				B.1.1.185	GR
hCoV-19/Netherlands/NA_603/2020	EPI_ISL_460766	2020-03-25	Europe / Netherlands	Human	Original			Nanopore				B.1.1.71	GR
hCoV-19/England/SHEF-CBB97/2020	EPI_ISL_462053	2020-04-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.137	GR
hCoV-19/Bangladesh/BCSIR-NILMRC-003/2020	EPI_ISL_462092	2020-05-23	Asia / Bangladesh / Dhaka	Human	Original	Nasopharyngeal swab		Illumina Nextseq 550	NextSeq (TM) Control Software v4			B.1.1.25	GR
hCoV-19/Belgium/PF-0326316/2020	EPI_ISL_462170	2020-03-26	Europe / Belgium / Genval	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic primer pool, Guppy, MiniMap2, CLC Genomics Workbench 20, Medaka			B.1	G
hCoV-19/Singapore/271/2020	EPI_ISL_462389	2020-03-20	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/Singapore/291/2020	EPI_ISL_462409	2020-03-17	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/Serbia/NS838-04/2020	EPI_ISL_462434	2020-04-01	Europe / Serbia / Novi Sad	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore	Medaka v. 1.0.1; ARTIC nCoV-2019 v. V3			B.1.1.319	GR
hCoV-19/Italy/APU-UniMI-809/2020	EPI_ISL_469020	2020-03-19	Europe / Italy / Apulia / Taranto	Human	Original			Illumina				B.1.1	GR
hCoV-19/Italy/APU-UniMI-857/2020	EPI_ISL_469023	2020-03-20	Europe / Italy / Apulia / Brindisi	Human	Original	Oropharyngeal swab		Illumina				B.1.1	GR
hCoV-19/Sweden/20-14785/2020	EPI_ISL_469062	2020-05-15	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-19008/2020	EPI_ISL_469064	2020-05-27	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-51758/2020	EPI_ISL_469071	2020-05-27	Europe / Sweden / Vastra Gotaland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Saudi Arabia/42952/2020	EPI_ISL_469242	2020-03-15	Asia / Saudi Arabia / Jeddah	Human	Original			unknown				B.1.1	GR
hCoV-19/Saudi Arabia/85790/2020	EPI_ISL_469245	2020-03-15	Asia / Saudi Arabia / Jeddah	Human	Original			unknown				B.1.1	GR
hCoV-19/Saudi Arabia/85791/2020	EPI_ISL_469246	2020-03-15	Asia / Saudi Arabia / Jeddah	Human	Original			unknown				B.1.1	GR
hCoV-19/Saudi Arabia/86267/2020	EPI_ISL_469247	2020-03-15	Asia / Saudi Arabia / Jeddah	Human	Original			unknown				B.1.1	GR
hCoV-19/Saudi Arabia/85790C/2020	EPI_ISL_469251	2020-03-15	Asia / Saudi Arabia / Jeddah	Human	Original			unknown				B.1.1	GR
hCoV-19/Saudi Arabia/85791C/2020	EPI_ISL_469252	2020-03-15	Asia / Saudi Arabia / Jeddah	Human	Original			unknown				B.1.1	GR
hCoV-19/England/NORT-28B1F9/2020	EPI_ISL_469302	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/NORT-28C6BD/2020	EPI_ISL_469336	2020-05-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-28C90F/2020	EPI_ISL_469340	2020-05-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12BFD4/2020	EPI_ISL_469345	2020-05-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12BD70/2020	EPI_ISL_469368	2020-05-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12C7DB/2020	EPI_ISL_469510	2020-05-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-127521/2020	EPI_ISL_469529	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12814A/2020	EPI_ISL_469570	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/BRIS-12758B/2020	EPI_ISL_469577	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12710F/2020	EPI_ISL_469588	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-127512/2020	EPI_ISL_469643	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1278FB/2020	EPI_ISL_469645	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12714B/2020	EPI_ISL_469701	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1279E9/2020	EPI_ISL_469744	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/Switzerland/LU-ETHZ-140065/2020	EPI_ISL_476113	2020-04-30	Europe / Switzerland / Lucerne	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1	G
hCoV-19/Sweden/20-51578/2020	EPI_ISL_476135	2020-05-19	Europe / Sweden / Sodermanland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-08608/2020	EPI_ISL_476144	2020-03-27	Europe / Sweden / Vastra Gotaland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Brazil/SP-L7-CD79/2020	EPI_ISL_476445	2020-03-23	South America / Brazil / São Paulo	Human	Original			Oxford Nanopore	ARTIC-nCoV			B.1.1.28	GR
hCoV-19/Brazil/SP-L9-CD118/2020	EPI_ISL_476469	2020-03-24	South America / Brazil / São Paulo	Human	Original			Oxford Nanopore	ARTIC-nCoV			B.1.1.28	GR
hCoV-19/USA/CT-Yale-314/2020	EPI_ISL_476542	2020-03-31	North America / USA / Connecticut / New Haven County / East Haven	Human	Original	Nasopharyngeal swab		Illumina MiSeq	iVAR			B.1	G
hCoV-19/Venezuela/VEN-89312/2020	EPI_ISL_476702	2020-04-02	South America / Venezuela	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/Australia/VIC2097/2020	EPI_ISL_480706	2020-06-15	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.133	GR
hCoV-19/Australia/VIC2143/2020	EPI_ISL_480744	2020-06-20	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC v3, minimap2 v2.17, ivar v1.2.2, samtools v1.10			B.1.1.133	GR
hCoV-19/England/BRIS-12CA69/2020	EPI_ISL_481858	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-292DCE/2020	EPI_ISL_489073	2020-05-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-292881/2020	EPI_ISL_489076	2020-05-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-291F23/2020	EPI_ISL_489079	2020-05-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-2928AF/2020	EPI_ISL_489085	2020-05-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-292274/2020	EPI_ISL_489086	2020-05-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-292DBF/2020	EPI_ISL_489093	2020-05-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-2928BE/2020	EPI_ISL_489099	2020-05-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-292EDA/2020	EPI_ISL_489104	2020-05-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Wales/PHWC-168357/2020	EPI_ISL_494230	2020-04-02	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-168481/2020	EPI_ISL_494245	2020-04-19	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-1687B5/2020	EPI_ISL_494286	2020-03-30	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/Wales/PHWC-168ACB/2020	EPI_ISL_494326	2020-04-19	Europe / United Kingdom / Wales	Human	Original			Illumina		NSP11 without BLAST coverage.	warn	B.1.1	GR
hCoV-19/Wales/PHWC-168D95/2020	EPI_ISL_494364	2020-04-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1	GR
hCoV-19/USA/CA-ALSR-1144/2020	EPI_ISL_494389	2020-04-27	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-1158/2020	EPI_ISL_494401	2020-04-28	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-1160/2020	EPI_ISL_494403	2020-04-28	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-1177/2020	EPI_ISL_494415	2020-04-28	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-1186/2020	EPI_ISL_494422	2020-04-28	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-1197/2020	EPI_ISL_494431	2020-04-24	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-1248/2020	EPI_ISL_494457	2020-05-06	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-1263/2020	EPI_ISL_494464	2020-05-06	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-1266/2020	EPI_ISL_494466	2020-04-28	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-1322/2020	EPI_ISL_494493	2020-04-30	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-1324/2020	EPI_ISL_494494	2020-04-30	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-1343/2020	EPI_ISL_494503	2020-05-07	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/IL-QDX-200/2020	EPI_ISL_494517	2020-04-30	North America / USA / Illinois	Human	Original	Oropharyngeal swab		Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1	GR
hCoV-19/USA/NC-QDX-201/2020	EPI_ISL_494529	2020-04-30	North America / USA / North Carolina	Human	Original	Oropharyngeal swab		Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1	GR
hCoV-19/USA/NC-QDX-202/2020	EPI_ISL_494530	2020-04-30	North America / USA / North Carolina	Human	Original	Oropharyngeal swab		Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1	GR
hCoV-19/USA/NM-QDX-209/2020	EPI_ISL_494532	2020-04-30	North America / USA / New Mexico	Human	Original	Oropharyngeal swab		Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1	GR
hCoV-19/USA/NM-QDX-210/2020	EPI_ISL_494533	2020-04-30	North America / USA / New Mexico	Human	Original	Oropharyngeal swab		Illumina MiSeq	bwa v. 0.7.17-r1188; iVar 1.2.2			B.1.1	GR
hCoV-19/USA/CA-ALSR-1398/2020	EPI_ISL_494584	2020-05-05	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-1413/2020	EPI_ISL_494588	2020-05-04	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-1522/2020	EPI_ISL_494641	2020-05-03	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-1566/2020	EPI_ISL_494662	2020-05-11	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-1597/2020	EPI_ISL_494683	2020-04-22	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-1614/2020	EPI_ISL_494687	2020-05-19	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/Northern Ireland/NIRE-106B08/2020	EPI_ISL_501003	2020-05-19	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-106573/2020	EPI_ISL_501018	2020-05-02	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-1065BF/2020	EPI_ISL_501027	2020-04-29	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-106E78/2020	EPI_ISL_501032	2020-05-21	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-106F75/2020	EPI_ISL_501040	2020-05-27	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-106986/2020	EPI_ISL_501042	2020-05-16	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-106564/2020	EPI_ISL_501050	2020-05-02	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-106C23/2020	EPI_ISL_501063	2020-05-18	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/USA/WA-UW-11293/2020	EPI_ISL_501096	2020-06-21	North America / USA / Washington	Human	Original			NextSeq 500				B.1.169	G
hCoV-19/England/BRIS-130FFA/2020	EPI_ISL_501566	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-130FAF/2020	EPI_ISL_501609	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-130EB1/2020	EPI_ISL_501611	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/EKHU-260F005/2020	EPI_ISL_501618	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/EKHU-260EFFA/2020	EPI_ISL_501621	2020-04-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/EKHU-260EFCD/2020	EPI_ISL_501628	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Latvia/083/2020	EPI_ISL_501896	2020-06-15	Europe / Latvia	Human	Original			Illumina MiSeq	bowtie2			B.1.1	GR
hCoV-19/Latvia/084/2020	EPI_ISL_501915	2020-06-16	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	bowtie2			B.1.1	GR
hCoV-19/Latvia/085/2020	EPI_ISL_501922	2020-06-16	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	bowtie2			B.1.1	GR
hCoV-19/England/CAMB-1B5A65/2020	EPI_ISL_514449	2020-08-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/PORT-2D1965/2020	EPI_ISL_514474	2020-04-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/PORT-2D267C/2020	EPI_ISL_514490	2020-03-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.164	GR
hCoV-19/Scotland/CVR3963/2020	EPI_ISL_514515	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.269	GR
hCoV-19/Scotland/EDB7075/2020	EPI_ISL_514516	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7076/2020	EPI_ISL_514517	2020-08-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7079/2020	EPI_ISL_514518	2020-08-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7080/2020	EPI_ISL_514519	2020-08-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7081/2020	EPI_ISL_514520	2020-08-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7084/2020	EPI_ISL_514521	2020-08-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7086/2020	EPI_ISL_514522	2020-08-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7088/2020	EPI_ISL_514523	2020-08-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7092/2020	EPI_ISL_514524	2020-08-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7094/2020	EPI_ISL_514526	2020-08-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7102/2020	EPI_ISL_514528	2020-08-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7103/2020	EPI_ISL_514529	2020-08-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7104/2020	EPI_ISL_514530	2020-08-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7105/2020	EPI_ISL_514531	2020-08-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7109/2020	EPI_ISL_514533	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7110/2020	EPI_ISL_514534	2020-08-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7111/2020	EPI_ISL_514535	2020-08-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7116/2020	EPI_ISL_514536	2020-08-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7118/2020	EPI_ISL_514537	2020-08-01	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7121/2020	EPI_ISL_514539	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7123/2020	EPI_ISL_514540	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7126/2020	EPI_ISL_514542	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7132/2020	EPI_ISL_514544	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7133/2020	EPI_ISL_514545	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7135/2020	EPI_ISL_514546	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7136/2020	EPI_ISL_514547	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7139/2020	EPI_ISL_514548	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7140/2020	EPI_ISL_514549	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7142/2020	EPI_ISL_514550	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7145/2020	EPI_ISL_514551	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7146/2020	EPI_ISL_514552	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7147/2020	EPI_ISL_514553	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7148/2020	EPI_ISL_514554	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7149/2020	EPI_ISL_514555	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7151/2020	EPI_ISL_514557	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7152/2020	EPI_ISL_514558	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7153/2020	EPI_ISL_514559	2020-08-05	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7154/2020	EPI_ISL_514560	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7155/2020	EPI_ISL_514561	2020-08-03	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB7156/2020	EPI_ISL_514562	2020-08-04	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/South Africa/KRISP-K002204/2020	EPI_ISL_515602	2020-07-18	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002206/2020	EPI_ISL_515604	2020-07-17	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002226/2020	EPI_ISL_515622	2020-07-21	Africa / South Africa / KwaZulu-Natal / Amajuba	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K002242/2020	EPI_ISL_515633	2020-07-21	Africa / South Africa / KwaZulu-Natal / Amajuba	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1	G
hCoV-19/South Africa/KRISP-K002243/2020	EPI_ISL_515634	2020-07-21	Africa / South Africa / KwaZulu-Natal / Zululand	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K002256/2020	EPI_ISL_515641	2020-07-21	Africa / South Africa / KwaZulu-Natal / Ugu	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.56	GR
hCoV-19/South Africa/KRISP-K002321/2020	EPI_ISL_515697	2020-07-22	Africa / South Africa / KwaZulu-Natal / King Cetshwayo	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/Switzerland/BL-UHB-42189725/2020	EPI_ISL_528049	2020-03-13	Europe / Switzerland / Basel-Land	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	in-house pipeline COVGAP			B.1	O
hCoV-19/Switzerland/BS-UHB-42190251/2020	EPI_ISL_528063	2020-03-13	Europe / Switzerland / Basel-Stadt	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	in-house pipeline COVGAP			B.1.1.71	GR
hCoV-19/England/20168039904/2020	EPI_ISL_528389	2020-04-13	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20166007904/2020	EPI_ISL_528398	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.164	GR
hCoV-19/England/20166019004/2020	EPI_ISL_528399	2020-04-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.164	GR
hCoV-19/England/20172055104/2020	EPI_ISL_528405	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20176001704/2020	EPI_ISL_528406	2020-04-14	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20178059804/2020	EPI_ISL_528407	2020-04-24	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20164077504/2020	EPI_ISL_528430	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.153	G
hCoV-19/England/OXON-B4C43/2020	EPI_ISL_535002	2020-04-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B4C8F/2020	EPI_ISL_535003	2020-04-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B4C9E/2020	EPI_ISL_535004	2020-04-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B4D5F/2020	EPI_ISL_535011	2020-05-02	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B4D8C/2020	EPI_ISL_535014	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B4F4A/2020	EPI_ISL_535022	2020-04-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/PORT-2D35D8/2020	EPI_ISL_535038	2020-04-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Scotland/CVR4038/2020	EPI_ISL_535135	2020-08-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/Scotland/CVR4039/2020	EPI_ISL_535136	2020-08-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/Scotland/CVR4041/2020	EPI_ISL_535138	2020-08-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/Scotland/CVR4053/2020	EPI_ISL_535147	2020-08-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/Scotland/CVR4055/2020	EPI_ISL_535148	2020-08-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/Scotland/CVR4062/2020	EPI_ISL_535154	2020-08-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4075/2020	EPI_ISL_535166	2020-08-31	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4083/2020	EPI_ISL_535173	2020-08-31	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4085/2020	EPI_ISL_535175	2020-08-31	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/Scotland/CVR4086/2020	EPI_ISL_535176	2020-08-31	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/Wales/PHWC-16A012/2020	EPI_ISL_535188	2020-09-05	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16A05E/2020	EPI_ISL_535192	2020-09-05	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16A1E2/2020	EPI_ISL_535214	2020-09-03	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16A2EF/2020	EPI_ISL_535230	2020-09-04	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16A3FB/2020	EPI_ISL_535246	2020-09-05	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/USA/OK-ADDL-03/2020	EPI_ISL_535362	2020-05-27	North America / USA / Oklahoma	Human	Original	Nasopharyngeal swab		Nanopore MinION	Canu			B.1.1.230	GR
hCoV-19/USA/OK-ADDL-04/2020	EPI_ISL_535363	2020-05-27	North America / USA / Oklahoma	Human	Original	Nasopharyngeal swab		Nanopore MinION	Canu			B.1.1.230	GR
hCoV-19/South Africa/KRISP-K002490/2020	EPI_ISL_535394	2020-08-07	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K002491/2020	EPI_ISL_535395	2020-08-07	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.117	GR
hCoV-19/South Africa/KRISP-K002495/2020	EPI_ISL_535396	2020-08-06	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002501/2020	EPI_ISL_535398	2020-08-07	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002504/2020	EPI_ISL_535400	2020-08-06	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.40	GR
hCoV-19/South Africa/KRISP-K002545/2020	EPI_ISL_535415	2020-07-30	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K002556/2020	EPI_ISL_535425	2020-07-29	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K002558/2020	EPI_ISL_535426	2020-07-30	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002567/2020	EPI_ISL_535433	2020-07-29	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K002581/2020	EPI_ISL_535446	2020-07-31	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002583/2020	EPI_ISL_535448	2020-08-01	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002600/2020	EPI_ISL_535464	2020-07-31	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K002603/2020	EPI_ISL_535467	2020-07-30	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K002616/2020	EPI_ISL_535480	2020-08-01	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.56	GR
hCoV-19/South Africa/KRISP-K002619/2020	EPI_ISL_535483	2020-07-31	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002627/2020	EPI_ISL_535497	2020-07-31	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002634/2020	EPI_ISL_535504	2020-08-03	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002635/2020	EPI_ISL_535505	2020-08-04	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.40	GR
hCoV-19/South Africa/KRISP-K002639/2020	EPI_ISL_535509	2020-08-03	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K002641/2020	EPI_ISL_535511	2020-08-02	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K002642/2020	EPI_ISL_535512	2020-08-02	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002646/2020	EPI_ISL_535516	2020-08-03	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K002649/2020	EPI_ISL_535519	2020-08-02	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K002658/2020	EPI_ISL_535526	2020-08-03	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.56	GR
hCoV-19/South Africa/KRISP-K002673/2020	EPI_ISL_535539	2020-08-01	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K002678/2020	EPI_ISL_535542	2020-08-03	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K002679/2020	EPI_ISL_535543	2020-08-02	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002681/2020	EPI_ISL_535545	2020-08-01	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K002684/2020	EPI_ISL_535547	2020-08-01	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K002690/2020	EPI_ISL_535552	2020-07-27	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002694/2020	EPI_ISL_535556	2020-07-27	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002702/2020	EPI_ISL_535562	2020-07-30	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002703/2020	EPI_ISL_535563	2020-07-30	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002711/2020	EPI_ISL_535570	2020-07-30	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/Switzerland/AG-ETHZ-250060/2020	EPI_ISL_535586	2020-08-18	Europe / Switzerland / Aargau	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	G
hCoV-19/Switzerland/BL-ETHZ-250064/2020	EPI_ISL_535590	2020-08-18	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/Switzerland/BL-ETHZ-250075/2020	EPI_ISL_535598	2020-08-19	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BL-ETHZ-250076/2020	EPI_ISL_535599	2020-08-19	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BL-ETHZ-250088/2020	EPI_ISL_535607	2020-08-19	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/Switzerland/BE-ETHZ-250098/2020	EPI_ISL_535614	2020-08-19	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/AG-ETHZ-250115/2020	EPI_ISL_535624	2020-08-20	Europe / Switzerland / Aargau	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/Switzerland/BS-ETHZ-250121/2020	EPI_ISL_535629	2020-08-14	Europe / Switzerland / Basel-Stadt	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/Switzerland/BL-ETHZ-250125/2020	EPI_ISL_535633	2020-08-14	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/USA/CA-CDC-4693/2020	EPI_ISL_535670	2020-06-02	North America / USA / California	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1	G
hCoV-19/USA/CA-CDC-4703/2020	EPI_ISL_535680	2020-06-04	North America / USA / California	Human	Original	Nasopharyngeal swab		Illumina MiSeq	freebayes 1.3			B.1	G
hCoV-19/Canada/QC-LSPQ-L00216190/2020	EPI_ISL_535744	2020-03-12	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.1.176	GR
hCoV-19/Canada/QC-LSPQ-L00216731/2020	EPI_ISL_535752	2020-03-13	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.1	GR
hCoV-19/Canada/QC-LSPQ-L00217527/2020	EPI_ISL_535762	2020-03-13	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.1.176	GR
hCoV-19/Canada/QC-LSPQ-L00217559/2020	EPI_ISL_535764	2020-03-12	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00217586/2020	EPI_ISL_535766	2020-03-13	North America / Canada / Quebec	Human	Original			MGI CleanPlex		Stretches of NNNs (4.39% of overall sequence).	warn	B.1.1.176	GR
hCoV-19/Canada/QC-LSPQ-L00218477/2020	EPI_ISL_535783	2020-03-14	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.1.176	GR
hCoV-19/Canada/QC-LSPQ-L00219039/2020	EPI_ISL_535787	2020-03-14	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.1.176	GR
hCoV-19/Canada/QC-LSPQ-L00220369/2020	EPI_ISL_535798	2020-03-15	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.1	GR
hCoV-19/Canada/Qc-LSPQ-L00221852/2020	EPI_ISL_535811	2020-03-15	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1.176	GR
hCoV-19/Canada/QC-LSPQ-L00226142/2020	EPI_ISL_535842	2020-03-17	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.1.176	GR
hCoV-19/Canada/QC-LSPQ-L00226167/2020	EPI_ISL_535844	2020-03-17	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.1.176	GR
hCoV-19/Canada/QC-LSPQ-L00226624/2020	EPI_ISL_535850	2020-03-18	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00227481/2020	EPI_ISL_535863	2020-03-19	North America / Canada / Quebec	Human	Original			MGI CleanPlex		Long stretches of NNNs (8.04% of overall sequence).	alert	B.1.1.176	GR
hCoV-19/Canada/QC-LSPQ-L00228149/2020	EPI_ISL_535871	2020-03-19	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00228687/2020	EPI_ISL_535875	2020-03-20	North America / Canada / Quebec	Human	Original			MGI CleanPlex		Stretches of NNNs (1.08% of overall sequence).	warn	B.1	G
hCoV-19/Canada/Qc-LSPQ-L00228950/2020	EPI_ISL_535881	2020-03-20	North America / Canada / Quebec	Human	Original			MGI CleanPlex				B.1.1.176	GR
hCoV-19/Canada/QC-LSPQ-L00229554/2020	EPI_ISL_535896	2020-03-20	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.1.176	GR
hCoV-19/Canada/QC-LSPQ-L00230720/2020	EPI_ISL_535929	2020-03-21	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.1.176	GR
hCoV-19/Canada/QC-LSPQ-L00230787/2020	EPI_ISL_535931	2020-03-21	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.1.176	GR
hCoV-19/Canada/QC-LSPQ-L00230796/2020	EPI_ISL_535932	2020-03-21	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00230798/2020	EPI_ISL_535933	2020-03-21	North America / Canada / Quebec	Human	Original			MGI CleanPlex				B.1.1.176	GR
hCoV-19/Canada/QC-LSPQ-L00230813/2020	EPI_ISL_535934	2020-03-21	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.1.176	GR
hCoV-19/Canada/QC-LSPQ-L00230821/2020	EPI_ISL_535935	2020-03-21	North America / Canada / Quebec	Human	Original			Nanopore ARTIC	Nanopolish 1.3			B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00230895/2020	EPI_ISL_535938	2020-03-21	North America / Canada / Quebec	Human	Original			MGI CleanPlex		Stretches of NNNs (2.39% of overall sequence).	warn	B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00231416/2020	EPI_ISL_535955	2020-03-22	North America / Canada / Quebec	Human	Original			MGI CleanPlex		Stretches of NNNs (2.49% of overall sequence).	warn	B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00232097/2020	EPI_ISL_535975	2020-03-22	North America / Canada / Quebec	Human	Original			MGI CleanPlex		Stretches of NNNs (3.07% of overall sequence).	warn	B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00232107/2020	EPI_ISL_535978	2020-03-22	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00232239/2020	EPI_ISL_535982	2020-03-22	North America / Canada / Quebec	Human	Original			MGI CleanPlex				B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00232447/2020	EPI_ISL_535987	2020-03-22	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1	G
hCoV-19/Canada/Qc-LSPQ-L00232511/2020	EPI_ISL_535988	2020-03-22	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00232601/2020	EPI_ISL_535989	2020-03-21	North America / Canada / Quebec	Human	Original			MGI CleanPlex		Stretches of NNNs (1.03% of overall sequence).	warn	B.1.1.176	GR
hCoV-19/England/LIVE-AAE0E/2020	EPI_ISL_540618	2020-07-28	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1	GR
hCoV-19/England/LIVE-AAF47/2020	EPI_ISL_540624	2020-07-28	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1	GR
hCoV-19/England/LIVE-AAFA1/2020	EPI_ISL_540625	2020-07-29	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1	GR
hCoV-19/England/MILK-992152/2020	EPI_ISL_540650	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.240	GR
hCoV-19/England/MILK-9921E9/2020	EPI_ISL_540658	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-992213/2020	EPI_ISL_540659	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.115	GR
hCoV-19/England/MILK-992222/2020	EPI_ISL_540660	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.115	GR
hCoV-19/England/MILK-99232F/2020	EPI_ISL_540672	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-9923B6/2020	EPI_ISL_540676	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-9923E3/2020	EPI_ISL_540678	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.227	GR
hCoV-19/England/MILK-9923F2/2020	EPI_ISL_540679	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.227	GR
hCoV-19/England/MILK-992486/2020	EPI_ISL_540683	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.227	GR
hCoV-19/England/MILK-9924A4/2020	EPI_ISL_540685	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-992529/2020	EPI_ISL_540688	2020-08-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORW-EE5BE/2020	EPI_ISL_540691	2020-09-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-EEA55/2020	EPI_ISL_540692	2020-08-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-EEA82/2020	EPI_ISL_540693	2020-08-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-EEC40/2020	EPI_ISL_540694	2020-08-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-EEC7D/2020	EPI_ISL_540695	2020-08-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/Singapore/994/2020	EPI_ISL_549002	2020-03-22	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/Norway/3210/2020	EPI_ISL_549037	2020-08-26	Europe / Norway / Viken	Human	Original	Upper respiratory secretion and tracheal secretion		Illumina MiSeq, ARTICProtocol	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.236	G
hCoV-19/Norway/2956/2020	EPI_ISL_549048	2020-07-30	Europe / Norway / Agder	Human	Original	Upper respiratory secretion and tracheal secretion		Illumina MiSeq, ARTICProtocol	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1.39	GR
hCoV-19/Norway/3168/2020	EPI_ISL_549051	2020-07-27	Europe / Norway / Oslo	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq, ARTICProtocol	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1.39	GR
hCoV-19/Norway/2958/2020	EPI_ISL_549070	2020-07-29	Europe / Norway / Vestlandet	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq, ARTICProtocol	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1	GR
hCoV-19/Norway/2965/2020	EPI_ISL_549092	2020-07-26	Europe / Norway / Viken	Human	Original	Upper respiratory secretion and tracheal secretion		Illumina MiSeq, ARTICProtocol	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1.39	GR
hCoV-19/England/NOTT-113616/2020	EPI_ISL_549518	2020-09-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NOTT-113661/2020	EPI_ISL_549519	2020-09-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.532	GR
hCoV-19/England/NOTT-11369E/2020	EPI_ISL_549520	2020-09-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NOTT-1136AD/2020	EPI_ISL_549521	2020-09-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-9963D0/2020	EPI_ISL_549530	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9968A4/2020	EPI_ISL_549538	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-997BB9/2020	EPI_ISL_549544	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9B9A4B/2020	EPI_ISL_549549	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/QEUH-9B9CBE/2020	EPI_ISL_549556	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/QEUH-9B9137/2020	EPI_ISL_549573	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B8FF2/2020	EPI_ISL_549611	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B8AF1/2020	EPI_ISL_549616	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B8806/2020	EPI_ISL_549620	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-9B9B48/2020	EPI_ISL_549625	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B9331/2020	EPI_ISL_549628	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B8E22/2020	EPI_ISL_549647	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B8B1C/2020	EPI_ISL_549651	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/QEUH-9B8F7A/2020	EPI_ISL_549662	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B9AC3/2020	EPI_ISL_549665	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B9BC0/2020	EPI_ISL_549674	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B87EB/2020	EPI_ISL_549689	2020-09-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B8C91/2020	EPI_ISL_549694	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B8F6B/2020	EPI_ISL_549703	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/QEUH-9B8FE3/2020	EPI_ISL_549717	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B9D33/2020	EPI_ISL_549734	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-9B8AE2/2020	EPI_ISL_549748	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.310	GR
hCoV-19/England/QEUH-9B8EB9/2020	EPI_ISL_549755	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/QEUH-9B9E8B/2020	EPI_ISL_549756	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B8F10/2020	EPI_ISL_549764	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B9A2D/2020	EPI_ISL_549774	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/QEUH-9B8E6E/2020	EPI_ISL_549781	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-9B837E/2020	EPI_ISL_549786	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B85A5/2020	EPI_ISL_549791	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B9F00/2020	EPI_ISL_549792	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B9A1E/2020	EPI_ISL_549794	2020-09-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/QEUH-9B8FC5/2020	EPI_ISL_549802	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B8CCE/2020	EPI_ISL_549803	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99CB78/2020	EPI_ISL_549822	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/MILK-99D281/2020	EPI_ISL_549830	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/MILK-99CE24/2020	EPI_ISL_549835	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99CCDF/2020	EPI_ISL_549839	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99CD36/2020	EPI_ISL_549842	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99CC48/2020	EPI_ISL_549848	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99CFF4/2020	EPI_ISL_549854	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99D272/2020	EPI_ISL_549855	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99CB87/2020	EPI_ISL_549856	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/MILK-99CE9D/2020	EPI_ISL_549859	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/MILK-99D764/2020	EPI_ISL_549874	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-99D3CA/2020	EPI_ISL_549875	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-99D48B/2020	EPI_ISL_549879	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99D3BB/2020	EPI_ISL_549880	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-99CBE1/2020	EPI_ISL_549886	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99D773/2020	EPI_ISL_549887	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-99D63A/2020	EPI_ISL_549888	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-99D00F/2020	EPI_ISL_549896	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99D4D6/2020	EPI_ISL_549906	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/MILK-99CD27/2020	EPI_ISL_549910	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99D755/2020	EPI_ISL_549913	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-99CDCD/2020	EPI_ISL_549915	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-99CC66/2020	EPI_ISL_549934	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-99D10C/2020	EPI_ISL_549938	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/MILK-99D342/2020	EPI_ISL_549942	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9A53DE/2020	EPI_ISL_549956	2020-09-03	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A51D4/2020	EPI_ISL_549963	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A6C1E/2020	EPI_ISL_549964	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-9A8371/2020	EPI_ISL_549966	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.198	GR
hCoV-19/England/MILK-9A6953/2020	EPI_ISL_549967	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A6A05/2020	EPI_ISL_549974	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9A83AE/2020	EPI_ISL_549977	2020-09-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-9A6D75/2020	EPI_ISL_549996	2020-09-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/MILK-970B10/2020	EPI_ISL_553011	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/Wales/MILK-9712B0/2020	EPI_ISL_553029	2020-08-18	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-970A9B/2020	EPI_ISL_553035	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-970D38/2020	EPI_ISL_553036	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-9702DF/2020	EPI_ISL_553042	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-9716E1/2020	EPI_ISL_553053	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-970C0E/2020	EPI_ISL_553061	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-97170C/2020	EPI_ISL_553063	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-97048E/2020	EPI_ISL_553065	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/MILK-97107A/2020	EPI_ISL_553067	2020-08-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.408	G
hCoV-19/England/MILK-97057C/2020	EPI_ISL_553102	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-970A8C/2020	EPI_ISL_553116	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-971599/2020	EPI_ISL_553117	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.408	G
hCoV-19/England/MILK-970406/2020	EPI_ISL_553119	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/Wales/MILK-9712ED/2020	EPI_ISL_553125	2020-08-18	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-97020C/2020	EPI_ISL_553127	2020-08-17	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-971010/2020	EPI_ISL_553131	2020-08-16	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9704AC/2020	EPI_ISL_553132	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-970D47/2020	EPI_ISL_553138	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-970EAE/2020	EPI_ISL_553158	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-970794/2020	EPI_ISL_553159	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.39	GR
hCoV-19/England/MILK-9705F4/2020	EPI_ISL_553162	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-970EEA/2020	EPI_ISL_553164	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/Wales/MILK-970B89/2020	EPI_ISL_553166	2020-08-18	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-970BF2/2020	EPI_ISL_553167	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-970D56/2020	EPI_ISL_553168	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-970336/2020	EPI_ISL_553174	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/Wales/MILK-971001/2020	EPI_ISL_553195	2020-08-16	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-970B6B/2020	EPI_ISL_553219	2020-08-18	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9712DE/2020	EPI_ISL_553223	2020-08-18	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-971335/2020	EPI_ISL_553263	2020-08-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-9708DD/2020	EPI_ISL_553264	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-970ECC/2020	EPI_ISL_553267	2020-08-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/ALDP-91F919/2020	EPI_ISL_553269	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-91F621/2020	EPI_ISL_553271	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-91F7C4/2020	EPI_ISL_553280	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-91C6E8/2020	EPI_ISL_553284	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-921D09/2020	EPI_ISL_553286	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/ALDP-91F278/2020	EPI_ISL_553290	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.95	GR
hCoV-19/England/ALDP-91F64F/2020	EPI_ISL_553300	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9231B0/2020	EPI_ISL_553308	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-907343/2020	EPI_ISL_553314	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-91F700/2020	EPI_ISL_553316	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-91F72E/2020	EPI_ISL_553317	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-91E7D4/2020	EPI_ISL_553325	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-91A811/2020	EPI_ISL_553326	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-90C5EE/2020	EPI_ISL_553335	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.15	GR
hCoV-19/England/ALDP-921E7F/2020	EPI_ISL_553339	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-91F885/2020	EPI_ISL_553340	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-91CF29/2020	EPI_ISL_553345	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-954B30/2020	EPI_ISL_553352	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/ALDP-959FB7/2020	EPI_ISL_553367	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9553A0/2020	EPI_ISL_553378	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.95	GR
hCoV-19/England/ALDP-95C93E/2020	EPI_ISL_553396	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-954B21/2020	EPI_ISL_553405	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/ALDP-954FBC/2020	EPI_ISL_553416	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-954AD9/2020	EPI_ISL_553418	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.115	GR
hCoV-19/England/ALDP-95A675/2020	EPI_ISL_553433	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95A657/2020	EPI_ISL_553450	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-954B4F/2020	EPI_ISL_553462	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/ALDP-95571D/2020	EPI_ISL_553467	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.203	GR
hCoV-19/England/ALDP-95A00E/2020	EPI_ISL_553475	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95A03B/2020	EPI_ISL_553486	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95506D/2020	EPI_ISL_553488	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-955391/2020	EPI_ISL_553489	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.95	GR
hCoV-19/England/ALDP-95A727/2020	EPI_ISL_553491	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-959FE4/2020	EPI_ISL_553507	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95530A/2020	EPI_ISL_553519	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/ALDP-95A01D/2020	EPI_ISL_553529	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-959FA8/2020	EPI_ISL_553534	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94D4C6/2020	EPI_ISL_553536	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-95D065/2020	EPI_ISL_553547	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-95A921/2020	EPI_ISL_553576	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-959FC6/2020	EPI_ISL_553578	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-954FAD/2020	EPI_ISL_553588	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95AC82/2020	EPI_ISL_555001	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-95AC55/2020	EPI_ISL_555008	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-94E79F/2020	EPI_ISL_555053	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94E814/2020	EPI_ISL_555069	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-95C7E9/2020	EPI_ISL_555081	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.1	GR
hCoV-19/England/ALDP-95A217/2020	EPI_ISL_555114	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-94F9E3/2020	EPI_ISL_555131	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-950220/2020	EPI_ISL_555134	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/ALDP-950572/2020	EPI_ISL_555160	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/ALDP-94E322/2020	EPI_ISL_555172	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94E708/2020	EPI_ISL_555181	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94FB0B/2020	EPI_ISL_555188	2020-06-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.95	GR
hCoV-19/England/ALDP-94DA5B/2020	EPI_ISL_555213	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-950554/2020	EPI_ISL_555214	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-9503E1/2020	EPI_ISL_555238	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.203	GR
hCoV-19/England/ALDP-94FBB0/2020	EPI_ISL_555246	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94F9D4/2020	EPI_ISL_555272	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-94DA97/2020	EPI_ISL_555278	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/ALDP-94DA1F/2020	EPI_ISL_555284	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-99BF5F/2020	EPI_ISL_560000	2020-08-30	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-99BF6E/2020	EPI_ISL_560001	2020-08-30	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-9ACF2E/2020	EPI_ISL_560010	2020-09-05	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-9ACF97/2020	EPI_ISL_560012	2020-09-05	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-9AD075/2020	EPI_ISL_560018	2020-09-05	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-9AF0EC/2020	EPI_ISL_560026	2020-09-03	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-9B4521/2020	EPI_ISL_560077	2020-09-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16A67A/2020	EPI_ISL_560084	2020-09-09	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16A698/2020	EPI_ISL_560086	2020-09-10	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16A6D4/2020	EPI_ISL_560090	2020-09-12	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16A7C2/2020	EPI_ISL_560105	2020-09-10	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16A926/2020	EPI_ISL_560126	2020-09-09	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16ABA8/2020	EPI_ISL_560165	2020-09-10	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16ABC6/2020	EPI_ISL_560167	2020-09-11	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16AC2D/2020	EPI_ISL_560173	2020-09-10	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16AE27/2020	EPI_ISL_560205	2020-09-08	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16AE72/2020	EPI_ISL_560210	2020-09-11	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16AF7F/2020	EPI_ISL_560226	2020-09-16	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16B0E4/2020	EPI_ISL_560244	2020-09-14	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16B14B/2020	EPI_ISL_560249	2020-09-12	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16B22A/2020	EPI_ISL_560261	2020-09-15	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Russia/SVE-RII-MH184S/2020	EPI_ISL_560309	2020-07-08	Europe / Russia / Sverdlovsk / Verkhnyaya Pyshma	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1	GR
hCoV-19/Russia/SVE-RII-MH202S/2020	EPI_ISL_560315	2020-07-17	Europe / Russia / Sverdlovsk / Ekaterinburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1	GR
hCoV-19/Russia/SVE-RII-MH231S/2020	EPI_ISL_560317	2020-08-08	Europe / Russia / Sverdlovsk / Ekaterinburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, samtools			B.1.1.387	GR
hCoV-19/Switzerland/AG-ETHZ-280086/2020	EPI_ISL_560419	2020-09-07	Europe / Switzerland / Aargau	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.39	GR
hCoV-19/Switzerland/BE-ETHZ-280110/2020	EPI_ISL_560433	2020-09-07	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/Switzerland/BE-ETHZ-280116/2020	EPI_ISL_560434	2020-09-08	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/Switzerland/BS-ETHZ-280117/2020	EPI_ISL_560471	2020-09-08	Europe / Switzerland / Basel-Stadt	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/BS-ETHZ-280227/2020	EPI_ISL_560474	2020-09-10	Europe / Switzerland / Basel-Stadt	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/GE-ETHZ-280201/2020	EPI_ISL_560475	2020-09-10	Europe / Switzerland / Geneva	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/GR-ETHZ-280154/2020	EPI_ISL_560479	2020-09-08	Europe / Switzerland / Grisons	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe	NS7a_L77stop results in 37.2% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/Switzerland/VD-ETHZ-280123/2020	EPI_ISL_560501	2020-09-08	Europe / Switzerland / Vaud	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.269	GR
hCoV-19/Switzerland/VD-ETHZ-280125/2020	EPI_ISL_560502	2020-09-08	Europe / Switzerland / Vaud	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.269	GR
hCoV-19/Switzerland/VD-ETHZ-280158/2020	EPI_ISL_560511	2020-09-09	Europe / Switzerland / Vaud	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.269	GR
hCoV-19/Switzerland/ZH-ETHZ-280119/2020	EPI_ISL_560544	2020-09-08	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/Switzerland/ZH-ETHZ-280198/2020	EPI_ISL_560552	2020-09-09	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/France/IDF-8761/2020	EPI_ISL_560643	2020-07-16	Europe / France / Île-de-France / Boulogne Billancourt	Human	Original			Illumina NextSeq 500	CLC Genomics Suite			B.1.1.406	GR
hCoV-19/England/GSTT-5393/2020	EPI_ISL_560678	2020-03-19	Europe / United Kingdom / England / London	Human	Original			Oxford Nanopore	Artic v1.0 nanopolish			B.1.1	GR
hCoV-19/England/GSTT-5396/2020	EPI_ISL_560679	2020-03-19	Europe / United Kingdom / England / London	Human	Original			Oxford Nanopore	Artic v1.0 nanopolish			B.1.1	GR
hCoV-19/England/GSTT-5777/2020	EPI_ISL_560712	2020-03-23	Europe / United Kingdom / England / London	Human	Original			Oxford Nanopore	Artic v1.0 nanopolish			B.59	GR
hCoV-19/England/GSTT-6731/2020	EPI_ISL_560722	2020-03-29	Europe / United Kingdom / England / London	Human	Original			Oxford Nanopore	Artic v1.0 nanopolish			B.1.1	GR
hCoV-19/England/GSTT-6742/2020	EPI_ISL_560724	2020-03-30	Europe / United Kingdom / England / London	Human	Original			Oxford Nanopore	Artic v1.0 nanopolish			B.1.1	GR
hCoV-19/England/GSTT-6746/2020	EPI_ISL_560726	2020-03-29	Europe / United Kingdom / England / London	Human	Original			Oxford Nanopore	Artic v1.0 nanopolish			B.1.1	GR
hCoV-19/USA/MN-MDH-1718/2020	EPI_ISL_560805	2020-08-29	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.240	G
hCoV-19/USA/MD-MDH-0217/2020	EPI_ISL_560830	2020-09-18	North America / USA / Maryland	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1	G
hCoV-19/USA/TX-DSHS-0488/2020	EPI_ISL_560932	2020-06-21	North America / USA / Texas / Hidalgo County	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa v1.2.2/ivar 0.7.17			B.1.1	GR
hCoV-19/Sweden/20-08929/2020	EPI_ISL_560977	2020-07-13	Europe / Sweden / Ostergotland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Sweden/20-08931/2020	EPI_ISL_560979	2020-07-11	Europe / Sweden / Ostergotland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Sweden/20-52281/2020	EPI_ISL_560984	2020-07-03	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-52285/2020	EPI_ISL_560985	2020-07-02	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Sweden/20-52586/2020	EPI_ISL_560988	2020-08-11	Europe / Sweden / Gavleborg	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/England/QEUH-9CA3D3/2020	EPI_ISL_567307	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C9705/2020	EPI_ISL_567308	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CA986/2020	EPI_ISL_567309	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/QEUH-9C98D5/2020	EPI_ISL_567310	2020-09-10	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C9B27/2020	EPI_ISL_567311	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C9310/2020	EPI_ISL_567317	2020-09-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CA722/2020	EPI_ISL_567335	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C934D/2020	EPI_ISL_567339	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C9468/2020	EPI_ISL_567349	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C96DB/2020	EPI_ISL_567363	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CA8A7/2020	EPI_ISL_567370	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C9C15/2020	EPI_ISL_567378	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C993C/2020	EPI_ISL_567380	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/QEUH-9CA94A/2020	EPI_ISL_567394	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C9E00/2020	EPI_ISL_567397	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C984E/2020	EPI_ISL_567407	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q90stop results in 26.4% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/QEUH-9CA0FA/2020	EPI_ISL_567412	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-9CA0AF/2020	EPI_ISL_567413	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C93E3/2020	EPI_ISL_567414	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS7a_Q90stop results in 26.4% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/QEUH-9C933E/2020	EPI_ISL_567418	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9C94E0/2020	EPI_ISL_567435	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-9C9E88/2020	EPI_ISL_567479	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CA573/2020	EPI_ISL_567484	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CA713/2020	EPI_ISL_567485	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CA063/2020	EPI_ISL_567500	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CA33D/2020	EPI_ISL_567506	2020-09-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CA2F4/2020	EPI_ISL_567512	2020-09-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C54B7/2020	EPI_ISL_567538	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C637D/2020	EPI_ISL_567555	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-9C5A88/2020	EPI_ISL_567567	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C63AA/2020	EPI_ISL_567571	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-9C639B/2020	EPI_ISL_567591	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-9C5B94/2020	EPI_ISL_567621	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C4E50/2020	EPI_ISL_567629	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C5D07/2020	EPI_ISL_567630	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-9C5AC4/2020	EPI_ISL_567663	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.408	G
hCoV-19/England/ALDP-9C4B2C/2020	EPI_ISL_567664	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-9C54F3/2020	EPI_ISL_567676	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C4D80/2020	EPI_ISL_567687	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C5912/2020	EPI_ISL_567696	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-9C5A79/2020	EPI_ISL_567711	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C5AA6/2020	EPI_ISL_567749	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C4EF6/2020	EPI_ISL_567760	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C6182/2020	EPI_ISL_567766	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C550F/2020	EPI_ISL_567777	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C4E05/2020	EPI_ISL_567780	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-9C61CE/2020	EPI_ISL_567784	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C6207/2020	EPI_ISL_567785	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C55A5/2020	EPI_ISL_567786	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C5C91/2020	EPI_ISL_567788	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C5095/2020	EPI_ISL_567807	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9C61BF/2020	EPI_ISL_567815	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C5F7A/2020	EPI_ISL_567818	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C638C/2020	EPI_ISL_567822	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-9C4BFF/2020	EPI_ISL_567825	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-9C4E9C/2020	EPI_ISL_567827	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C5587/2020	EPI_ISL_567846	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C63B9/2020	EPI_ISL_567874	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-9C5C37/2020	EPI_ISL_567878	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9C5763/2020	EPI_ISL_567879	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9C5860/2020	EPI_ISL_567881	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9BEAA0/2020	EPI_ISL_567905	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9BE75E/2020	EPI_ISL_567913	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.310	GR
hCoV-19/England/ALDP-9BE800/2020	EPI_ISL_567924	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-9BE484/2020	EPI_ISL_567928	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-9BE2E4/2020	EPI_ISL_567930	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9BC8C6/2020	EPI_ISL_567945	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-9BEDE3/2020	EPI_ISL_567978	2020-09-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.39	GR
hCoV-19/England/ALDP-9BED3E/2020	EPI_ISL_567990	2020-09-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/France/PAC-IHU-0971/2020	EPI_ISL_569019	2020-07-20	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.25	GR
hCoV-19/France/PAC-IHU-1097/2020	EPI_ISL_569051	2020-08-05	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.269	GR
hCoV-19/France/PAC-IHU-1295/2020	EPI_ISL_569110	2020-08-18	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.406	GR
hCoV-19/France/PAC-IHU-1336/2020	EPI_ISL_569123	2020-08-19	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.269	GR
hCoV-19/France/PAC-IHU-1585/2020	EPI_ISL_569214	2020-09-08	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.269	GR
hCoV-19/France/PAC-IHU-1599/2020	EPI_ISL_569223	2020-09-02	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.269	GR
hCoV-19/France/PAC-IHU-1627/2020	EPI_ISL_569236	2020-09-10	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.269	GR
hCoV-19/France/PAC-IHU-0024/2020	EPI_ISL_569252	2020-03-14	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/France/PAC-IHU-0087/2020	EPI_ISL_569302	2020-03-20	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/France/PAC-IHU-0241/2020	EPI_ISL_569403	2020-03-30	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/France/PAC-IHU-0316/2020	EPI_ISL_569449	2020-04-01	Europe / France / Provence-Alpes-Cote d'Azur / Marseille	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.254	GR
hCoV-19/Russia/OMS-ORINFI-3807S/2020	EPI_ISL_569763	2020-05-13	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1	GR
hCoV-19/Russia/OMS-ORINFI-3811S/2020	EPI_ISL_569764	2020-06-02	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-5948S/2020	EPI_ISL_569773	2020-06-07	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-6331S/2020	EPI_ISL_569774	2020-06-07	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1	GR
hCoV-19/Russia/OMS-ORINFI-9033S/2020	EPI_ISL_569775	2020-06-17	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1	GR
hCoV-19/Russia/OMS-ORINFI-3868S/2020	EPI_ISL_569781	2020-07-08	Europe / Russia / Omsk / Moskalenki	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-4761S/2020	EPI_ISL_569783	2020-06-30	Europe / Russia / Omsk / Sedelnikovo	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	O
hCoV-19/Russia/OMS-ORINFI-5207S/2020	EPI_ISL_569786	2020-07-13	Europe / Russia / Omsk / Azovo	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-8583S/2020	EPI_ISL_569790	2020-07-22	Europe / Russia / Omsk / Novovarshavka	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-1322S/2020	EPI_ISL_569799	2020-09-02	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1	GR
hCoV-19/Russia/OMS-ORINFI-4822S/2020	EPI_ISL_569800	2020-07-10	Europe / Russia / Omsk / Azovo	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-3019S/2020	EPI_ISL_569805	2020-07-06	Europe / Russia / Omsk / Azovo	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-4827S/2020	EPI_ISL_569806	2020-07-10	Europe / Russia / Omsk / Azovo	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-8942S/2020	EPI_ISL_569808	2020-07-23	Europe / Russia / Omsk / Moskalenki	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1	GR
hCoV-19/Russia/OMS-ORINFI-3873S/2020	EPI_ISL_569815	2020-07-08	Europe / Russia / Omsk / Moskalenki	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1	GR
hCoV-19/Russia/OMS-ORINFI-1630S/2020	EPI_ISL_569819	2020-06-29	Europe / Russia / Omsk / Okoneshnikovo	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1	GR
hCoV-19/Russia/OMS-ORINFI-4791S/2020	EPI_ISL_569820	2020-07-10	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-5195S/2020	EPI_ISL_569823	2020-07-13	Europe / Russia / Omsk / Azovo	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-6957S/2020	EPI_ISL_569824	2020-07-17	Europe / Russia / Omsk / Moskalenki	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1	GR
hCoV-19/Russia/OMS-ORINFI-2112S/2020	EPI_ISL_569828	2020-07-02	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1	GR
hCoV-19/Russia/OMS-ORINFI-4814S/2020	EPI_ISL_569829	2020-07-10	Europe / Russia / Omsk / Azovo	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-8436S/2020	EPI_ISL_569831	2020-07-22	Europe / Russia / Omsk / Moskalenki	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1	GR
hCoV-19/Russia/OMS-ORINFI-3961S/2020	EPI_ISL_569834	2020-07-08	Europe / Russia / Omsk / Novovarshavka	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-5204S/2020	EPI_ISL_569838	2020-07-13	Europe / Russia / Omsk / Azovo	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-8474S/2020	EPI_ISL_569839	2020-07-22	Europe / Russia / Omsk / Azovo	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-7593S/2020	EPI_ISL_569844	2020-07-20	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-4818S/2020	EPI_ISL_569845	2020-07-10	Europe / Russia / Omsk / Azovo	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-5208S/2020	EPI_ISL_569846	2020-07-13	Europe / Russia / Omsk / Azovo	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-8499S/2020	EPI_ISL_569847	2020-07-22	Europe / Russia / Omsk / Azovo	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/Russia/OMS-ORINFI-9975S/2020	EPI_ISL_569852	2020-06-22	Europe / Russia / Omsk / Omsk	Human	Original	Nasopharyngeal swab		Nanopore MinION	Minimap2, samtools			B.1.1.163	GR
hCoV-19/USA/CA-IGI-0224/2020	EPI_ISL_569898	2020-07-06	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	minimap2 v2.16-r922/iVar 1.0 reference aligned			B.1	G
hCoV-19/USA/CA-IGI-0237/2020	EPI_ISL_569906	2020-07-09	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	minimap2 v2.16-r922/iVar 1.0 reference aligned			B.1.240	G
hCoV-19/Wales/PHWC-16C12C/2020	EPI_ISL_574013	2020-09-17	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Singapore/1045/2020	EPI_ISL_574530	2020-03-24	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/USA/SC-DHEC-1148/2020	EPI_ISL_574543	2020-07-10	North America / USA / South Carolina / Georgetown County	Human	Original	Nasopharyngeal swab		Illumina	DRAGEN v. 3.5.16			B.1	G
hCoV-19/USA/SC-DHEC-1150/2020	EPI_ISL_574544	2020-07-10	North America / USA / South Carolina / Horry County	Human	Original	Nasopharyngeal swab		Illumina	DRAGEN v. 3.5.16			B.1	G
hCoV-19/USA/SC-DHEC-1109/2020	EPI_ISL_574567	2020-07-10	North America / USA / South Carolina / Georgetown County	Human	Original	Nasopharyngeal swab		Illumina	DRAGEN v. 3.5.16			B.1	G
hCoV-19/Switzerland/BE-UNIBE-170-1618/2020	EPI_ISL_574810	2020-03-18	Europe / Switzerland / Bern	Human	Original			Illumina MiSeq	bwa-mem, samtools, iVar			B.1.1	GR
hCoV-19/Switzerland/BE-UNIBE-173-2392/2020	EPI_ISL_574813	2020-03-19	Europe / Switzerland / Bern	Human	Original			Illumina MiSeq	bwa-mem, samtools, iVar			B.1	G
hCoV-19/Switzerland/BE-UNIBE-190-4089/2020	EPI_ISL_574829	2020-03-22	Europe / Switzerland / Bern	Human	Original			Illumina MiSeq	bwa-mem, samtools, iVar			B.1	G
hCoV-19/Switzerland/BE-UNIBE-199-5783/2020	EPI_ISL_574837	2020-03-26	Europe / Switzerland / Bern	Human	Original			Illumina MiSeq	bwa-mem, samtools, iVar			B.1	G
hCoV-19/Switzerland/BE-UNIBE-204-6477/2020	EPI_ISL_574842	2020-03-27	Europe / Switzerland / Bern	Human	Original			Illumina MiSeq	bwa-mem, samtools, iVar			B.1	G
hCoV-19/Switzerland/BE-UNIBE-215-0080/2020	EPI_ISL_574852	2020-04-06	Europe / Switzerland / Bern	Human	Original			Illumina MiSeq	bwa-mem, samtools, iVar			B.1	G
hCoV-19/Switzerland/BL-ETHZ-100236/2020	EPI_ISL_574886	2020-03-18	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/GE-ETHZ-100183/2020	EPI_ISL_574932	2020-03-16	Europe / Switzerland / Geneva	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/GE-ETHZ-100188/2020	EPI_ISL_574933	2020-03-16	Europe / Switzerland / Geneva	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/TI-ETHZ-100228/2020	EPI_ISL_574964	2020-03-17	Europe / Switzerland / Ticino	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/England/ALDP-9E9C97/2020	EPI_ISL_580014	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9EA1A6/2020	EPI_ISL_580018	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9EAB5D/2020	EPI_ISL_580026	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9EA9EA/2020	EPI_ISL_580028	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9EA81A/2020	EPI_ISL_580033	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9EAC78/2020	EPI_ISL_580036	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-9EA14C/2020	EPI_ISL_580113	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9EA0C7/2020	EPI_ISL_580130	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9EABF3/2020	EPI_ISL_580170	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9EA452/2020	EPI_ISL_580178	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-9EACF0/2020	EPI_ISL_580184	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-9E9BC7/2020	EPI_ISL_580202	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9EA07C/2020	EPI_ISL_580227	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A22341/2020	EPI_ISL_587391	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A1DB14/2020	EPI_ISL_587400	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A2239C/2020	EPI_ISL_587403	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A1EE83/2020	EPI_ISL_587439	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A1E454/2020	EPI_ISL_587442	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-A1DE48/2020	EPI_ISL_587460	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/England/QEUH-A22332/2020	EPI_ISL_587500	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A1F480/2020	EPI_ISL_587526	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Insertion of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-A1DFEB/2020	EPI_ISL_587549	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A1F4F9/2020	EPI_ISL_587567	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A1E894/2020	EPI_ISL_587573	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A212AF/2020	EPI_ISL_587579	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A20905/2020	EPI_ISL_587597	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F36E7/2020	EPI_ISL_588569	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F373F/2020	EPI_ISL_588570	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F376C/2020	EPI_ISL_588578	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/Scotland/QEUH-9F3104/2020	EPI_ISL_588600	2020-09-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F3C8B/2020	EPI_ISL_588635	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F3A45/2020	EPI_ISL_588641	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Sweden/20-08987/2020	EPI_ISL_594150	2020-09-16	Europe / Sweden / Ostergotland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins	Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/USA/FL-BPHL-1648/2020	EPI_ISL_594337	2020-07-03	North America / USA / Florida	Human	Original			Illumina MiSeq	bwa v0.7.17; ivar v1.2.2			B.1.1	GR
hCoV-19/USA/FL-BPHL-1685/2020	EPI_ISL_594374	2020-08-12	North America / USA / Florida	Human	Original			Illumina MiSeq	bwa v0.7.17; ivar v1.2.2			B.1.1.192	GR
hCoV-19/England/ALDP-9E75BC/2020	EPI_ISL_594479	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9EC9BB/2020	EPI_ISL_594633	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9ECA21/2020	EPI_ISL_594635	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/CVR4905/2020	EPI_ISL_594672	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/CAMC-A6546D/2020	EPI_ISL_608354	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A65333/2020	EPI_ISL_608381	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A684E2/2020	EPI_ISL_608386	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A65579/2020	EPI_ISL_608393	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A6570A/2020	EPI_ISL_608396	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/CAMC-A654C7/2020	EPI_ISL_608411	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/CAMC-A655B5/2020	EPI_ISL_608417	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/ALDP-A68BA1/2020	EPI_ISL_608418	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A684F1/2020	EPI_ISL_608422	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A64DAF/2020	EPI_ISL_608428	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A68E3F/2020	EPI_ISL_608443	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A651C0/2020	EPI_ISL_608459	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6851C/2020	EPI_ISL_608462	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6845B/2020	EPI_ISL_608468	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/CAMC-A6561C/2020	EPI_ISL_608477	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-A64D36/2020	EPI_ISL_608490	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6852B/2020	EPI_ISL_608500	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A6539D/2020	EPI_ISL_608544	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/ALDP-A68488/2020	EPI_ISL_608595	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A64BC3/2020	EPI_ISL_608602	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A65940/2020	EPI_ISL_608642	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A687E9/2020	EPI_ISL_608648	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/ALDP-A688E6/2020	EPI_ISL_608675	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/MILK-A6B230/2020	EPI_ISL_608697	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A6B1CA/2020	EPI_ISL_608708	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A69E3E/2020	EPI_ISL_608753	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-A6BAFC/2020	EPI_ISL_608771	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A6ABBE/2020	EPI_ISL_608805	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/England/MILK-A6ADC7/2020	EPI_ISL_608812	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/ALDP-A692AB/2020	EPI_ISL_608866	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6919F/2020	EPI_ISL_608880	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A67D42/2020	EPI_ISL_608903	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/England/CAMC-A647FC/2020	EPI_ISL_608912	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A691EA/2020	EPI_ISL_608948	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A64817/2020	EPI_ISL_608965	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A67FA6/2020	EPI_ISL_608979	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6941E/2020	EPI_ISL_608980	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1B6ABF/2020	EPI_ISL_612271	2020-10-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/EDB8490/2020	EPI_ISL_612372	2020-10-18	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/EXET-13803B/2020	EPI_ISL_612376	2020-09-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/EXET-138068/2020	EPI_ISL_612379	2020-09-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Wales/PHWC-48064E/2020	EPI_ISL_612914	2020-10-17	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.67	GR
hCoV-19/Wales/PHWC-480839/2020	EPI_ISL_612938	2020-10-07	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-480ACA/2020	EPI_ISL_612968	2020-09-23	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/USA/VA-DCLS-1838/2020	EPI_ISL_614130	2020-09-17	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-1839/2020	EPI_ISL_614131	2020-09-10	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/MI-MDHHS-SC22128/2020	EPI_ISL_614179	2020-10-11	North America / USA / Michigan	Human	Original			Illumina MiSeq	bwa v. 0.7.17; bcftools v. 1.7			B.1.240	G
hCoV-19/Germany/NW-HHU-218/2020	EPI_ISL_626217	2020-04-23	Europe / Germany / North Rhine-Westphalia / Essen	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.1	GR
hCoV-19/Belgium/ULG-10600/2020	EPI_ISL_626237	2020-08-30	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.236	G
hCoV-19/Belgium/ULG-10601/2020	EPI_ISL_626238	2020-08-30	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.236	G
hCoV-19/Belgium/ULG-10615/2020	EPI_ISL_626240	2020-08-31	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.1.269	GR
hCoV-19/Belgium/ULG-10608/2020	EPI_ISL_626250	2020-09-04	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.236	G
hCoV-19/Belgium/ULG-10532/2020	EPI_ISL_626320	2020-10-23	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.1.269	GR
hCoV-19/Belgium/ULG-10563/2020	EPI_ISL_626332	2020-10-23	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.398	G
hCoV-19/USA/IL-NM-1219/2020	EPI_ISL_626508	2020-06-22	North America / USA / Illinois / Chicago	Human	Original			Illumina MiSeq	ARTIC			B.1.240	G
hCoV-19/USA/IL-NM-1650/2020	EPI_ISL_626538	2020-07-21	North America / USA / Illinois / Chicago	Human	Original			Illumina MiSeq	ARTIC			B.1.1	GR
hCoV-19/Chile/AT-CMM-ATAC14/2020	EPI_ISL_626560	2020-08-07	South America / Chile / Atacama / Chañaral / El Salvador	Human	Original			Nanopore MinION	Artic Minion Procotol			B.1.1	GR
hCoV-19/Czech Republic/NRL_9505/2020	EPI_ISL_626590	2020-10-01	Europe / Czech Republic / Prague	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC-Medaka			B.1.1.204	GR
hCoV-19/Wales/PHWC-4845C5/2020	EPI_ISL_628020	2020-10-18	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-485324/2020	EPI_ISL_628169	2020-10-23	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-4855C4/2020	EPI_ISL_628196	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-485922/2020	EPI_ISL_628235	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-A322D8/2020	EPI_ISL_628343	2020-10-07	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.532	GR
hCoV-19/England/QEUH-A32302/2020	EPI_ISL_628345	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A326AF/2020	EPI_ISL_628358	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A326BE/2020	EPI_ISL_628359	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A3287C/2020	EPI_ISL_628362	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A3335C/2020	EPI_ISL_628372	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-A33547/2020	EPI_ISL_628392	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-A336CC/2020	EPI_ISL_628403	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-A49A8B/2020	EPI_ISL_628449	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A49AC7/2020	EPI_ISL_628452	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-A4B825/2020	EPI_ISL_628483	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A4BE41/2020	EPI_ISL_628530	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A4C059/2020	EPI_ISL_628540	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.204	GR
hCoV-19/England/QEUH-A4D37D/2020	EPI_ISL_628597	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A4DB2A/2020	EPI_ISL_628616	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A4DB66/2020	EPI_ISL_628617	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A6162F/2020	EPI_ISL_628624	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A616F2/2020	EPI_ISL_628628	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A61777/2020	EPI_ISL_628632	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A61953/2020	EPI_ISL_628644	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A61E90/2020	EPI_ISL_628657	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A63AB8/2020	EPI_ISL_628663	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A643CB/2020	EPI_ISL_628694	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AE4CE6/2020	EPI_ISL_633309	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/CAMC-AEB1C2/2020	EPI_ISL_633319	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/QEUH-AE4994/2020	EPI_ISL_633335	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AE4FCF/2020	EPI_ISL_633364	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AE232F/2020	EPI_ISL_633427	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AE236B/2020	EPI_ISL_633482	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AE21E9/2020	EPI_ISL_633513	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AE3045/2020	EPI_ISL_633544	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/QEUH-AE23E3/2020	EPI_ISL_633545	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AE21AD/2020	EPI_ISL_633593	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AE25ED/2020	EPI_ISL_633605	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-AE22F5/2020	EPI_ISL_633621	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/QEUH-AE2EC4/2020	EPI_ISL_633627	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AE1B91/2020	EPI_ISL_633636	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AE2714/2020	EPI_ISL_633671	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AE2B45/2020	EPI_ISL_633675	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AE1B46/2020	EPI_ISL_633676	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/QEUH-AD1244/2020	EPI_ISL_633704	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD0AD4/2020	EPI_ISL_633713	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD1BD0/2020	EPI_ISL_633729	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/QEUH-AD0A98/2020	EPI_ISL_633738	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD15C3/2020	EPI_ISL_633772	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD3989/2020	EPI_ISL_633808	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD3127/2020	EPI_ISL_633812	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD2850/2020	EPI_ISL_633822	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-AD0852/2020	EPI_ISL_633836	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD1314/2020	EPI_ISL_633855	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD0A5C/2020	EPI_ISL_633881	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD396B/2020	EPI_ISL_633890	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD387D/2020	EPI_ISL_633902	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD11DE/2020	EPI_ISL_633967	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD388C/2020	EPI_ISL_633986	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2E089/2020	EPI_ISL_646200	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B32170/2020	EPI_ISL_646205	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B31C9E/2020	EPI_ISL_646219	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2E10E/2020	EPI_ISL_646222	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2E098/2020	EPI_ISL_646241	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B318B8/2020	EPI_ISL_646267	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B31BEC/2020	EPI_ISL_646275	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B31C61/2020	EPI_ISL_646288	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2E274/2020	EPI_ISL_646295	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B32055/2020	EPI_ISL_646304	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B23BB0/2020	EPI_ISL_646307	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B321AD/2020	EPI_ISL_646315	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2DDED/2020	EPI_ISL_646344	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B319F1/2020	EPI_ISL_646353	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.398	G
hCoV-19/England/ALDP-B23F1E/2020	EPI_ISL_646363	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2E265/2020	EPI_ISL_646387	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B22C72/2020	EPI_ISL_647360	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-B22C63/2020	EPI_ISL_647375	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/CAMC-B215B4/2020	EPI_ISL_647381	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-B22D06/2020	EPI_ISL_647418	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B22DD9/2020	EPI_ISL_647439	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-B22C09/2020	EPI_ISL_647450	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B21A88/2020	EPI_ISL_647461	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/Wales/QEUH-AD4320/2020	EPI_ISL_647925	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/QEUH-AD3330/2020	EPI_ISL_647947	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-AF5FF8/2020	EPI_ISL_651418	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 9 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-AF60A9/2020	EPI_ISL_651419	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 9 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/MILK-B39ABA/2020	EPI_ISL_651527	2020-11-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/BIRM-6AA33/2020	EPI_ISL_651639	2020-11-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/CAMB-1B8640/2020	EPI_ISL_651654	2020-10-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.240	GR
hCoV-19/England/CAMB-1B8D87/2020	EPI_ISL_651686	2020-10-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.308	GR
hCoV-19/England/CAMB-1B9393/2020	EPI_ISL_651704	2020-11-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.240	GR
hCoV-19/England/CAMB-1B93C0/2020	EPI_ISL_651705	2020-11-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.240	GR
hCoV-19/England/CAMB-1B93DF/2020	EPI_ISL_651706	2020-11-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.240	GR
hCoV-19/England/CAMB-1B93EE/2020	EPI_ISL_651707	2020-11-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.240	GR
hCoV-19/England/CAMC-B23136/2020	EPI_ISL_651719	2020-11-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR5394/2020	EPI_ISL_651796	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR5398/2020	EPI_ISL_651798	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR5405/2020	EPI_ISL_651803	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.315	GR
hCoV-19/Scotland/EDB8058/2020	EPI_ISL_651957	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.315	G
hCoV-19/England/QEUH-AAED21/2020	EPI_ISL_653001	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAED7C/2020	EPI_ISL_653003	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAF42B/2020	EPI_ISL_653022	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AF55F6/2020	EPI_ISL_653029	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AF5F16/2020	EPI_ISL_653031	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/QEUH-AF62B2/2020	EPI_ISL_653049	2020-10-29	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AF62EF/2020	EPI_ISL_653051	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AF62FE/2020	EPI_ISL_653052	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AF630A/2020	EPI_ISL_653053	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AF63A0/2020	EPI_ISL_653055	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/SHEF-CDA01/2020	EPI_ISL_653083	2020-10-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/SHEF-CF1BF/2020	EPI_ISL_653091	2020-10-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/USA/FL-BPHL-2110/2020	EPI_ISL_653263	2020-03-10	North America / USA / Florida	Human	Original			Illumina MiSeq	bwa v0.7.17; ivar v1.2.2			B.1.1	GR
hCoV-19/USA/LA-EVTL722/2020	EPI_ISL_653414	2020-07-16	North America / USA / Louisiana / Caddo Parish	Human	Original	Nasopharyngeal swab		Illumina NextSeq	breseq v0.34.1; genome diff, mapping to EPI_ISL_402124	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1	G
hCoV-19/USA/LA-EVTL725/2020	EPI_ISL_653417	2020-07-16	North America / USA / Louisiana / Webster Parish	Human	Original	Nasopharyngeal swab		Illumina NextSeq	breseq v0.34.1; genome diff, mapping to EPI_ISL_402124			B.1	G
hCoV-19/USA/LA-EVTL736/2020	EPI_ISL_653427	2020-07-17	North America / USA / Louisiana / Lincoln Parish	Human	Original	Nasopharyngeal swab		Illumina NextSeq	breseq v0.34.1; genome diff, mapping to EPI_ISL_402124			B.1.1	GR
hCoV-19/USA/LA-EVTL763/2020	EPI_ISL_653454	2020-07-21	North America / USA / Louisiana / Lincoln Parish	Human	Original	Nasopharyngeal swab		Illumina NextSeq	breseq v0.34.1; genome diff, mapping to EPI_ISL_402124			B.1.1	GR
hCoV-19/USA/LA-EVTL863/2020	EPI_ISL_653554	2020-06-30	North America / USA / Louisiana / Caddo Parish	Human	Original	Nasopharyngeal swab		Illumina NextSeq	breseq v0.34.1; genome diff, mapping to EPI_ISL_402124			B.1	G
hCoV-19/USA/LA-EVTL915/2020	EPI_ISL_653606	2020-07-09	North America / USA / Louisiana / Caddo Parish	Human	Original	Nasopharyngeal swab		Illumina NextSeq	breseq v0.34.1; genome diff, mapping to EPI_ISL_402124			B.1	G
hCoV-19/England/NORT-28D063/2020	EPI_ISL_665787	2020-10-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/MILK-A563F9/2020	EPI_ISL_665850	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-A697BB/2020	EPI_ISL_665851	2020-10-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/England/NORT-28CD12/2020	EPI_ISL_665868	2020-10-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-28CD6D/2020	EPI_ISL_665869	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-28CD8B/2020	EPI_ISL_665870	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-28CD9A/2020	EPI_ISL_665871	2020-10-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORT-28D081/2020	EPI_ISL_665875	2020-10-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-A490A7/2020	EPI_ISL_665959	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/USA/CA-ALSR-4652/2020	EPI_ISL_667058	2020-11-05	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-4654/2020	EPI_ISL_667059	2020-11-06	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-4670/2020	EPI_ISL_667068	2020-11-05	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-4674/2020	EPI_ISL_667070	2020-11-10	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-4676/2020	EPI_ISL_667072	2020-11-10	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/OR-OHSU-2135/2020	EPI_ISL_667125	2020-08-05	North America / USA / Oregon / Multnomah County	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1	G
hCoV-19/USA/OR-OHSU-2165/2020	EPI_ISL_667131	2020-08-05	North America / USA / Oregon / Multnomah County	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1	G
hCoV-19/USA/OR-OHSU-2175/2020	EPI_ISL_667135	2020-08-06	North America / USA / Oregon / Multnomah County	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1	G
hCoV-19/USA/WA-OHSU-2879/2020	EPI_ISL_667380	2020-09-03	North America / USA / Washington / Clark County	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.239	G
hCoV-19/USA/CA-OHSU-2929/2020	EPI_ISL_667424	2020-09-05	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.239	G
hCoV-19/USA/OR-OHSU-2951/2020	EPI_ISL_667430	2020-08-24	North America / USA / Oregon / Multnomah County	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1	G
hCoV-19/USA/OR-OHSU-2986/2020	EPI_ISL_667449	2020-09-10	North America / USA / Oregon / Multnomah County	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)	Spike_K535stop results in 58.1% truncation of the protein sequence. NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1	G
hCoV-19/USA/OR-OHSU-3545/2020	EPI_ISL_667505	2020-10-21	North America / USA / Oregon	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.239	G
hCoV-19/USA/OR-OHSU-4117/2020	EPI_ISL_667526	2020-10-30	North America / USA / Oregon	Human	Original	Nasopharyngeal swab		Illumina Nextseq 500, Freed-Silander v1-1200bp (see https://doi.org/10.1101/2020.05.28.122648)	Trimmomatic, BWA mem, Picard/GATK (duplicates, BQSR, indel realignment, coverage), LoFreq, bcftools consensus (>50%, 10x min.)			B.1.239	G
hCoV-19/Japan/IC-0146/2020	EPI_ISL_667575	2020-09-21	Asia / Japan	Human	Original		COVID-19 positive case who entered from Mexico.	Illumina NextSeq500	SKESA v. 2.3.0			B.1	G
hCoV-19/Japan/IC-0295/2020	EPI_ISL_667724	2020-11-12	Asia / Japan	Human	Original		COVID-19 positive case who entered from Lebanon.	Illumina NextSeq500	SKESA v. 2.3.0			B.1.1.274	GR
hCoV-19/Japan/IC-0326/2020	EPI_ISL_667755	2020-08-28	Asia / Japan	Human	Original		COVID-19 positive case who entered from USA.	Illumina NextSeq500	A5-miseq v. 20140604			B.1.1	GR
hCoV-19/Japan/IC-0327/2020	EPI_ISL_667756	2020-08-30	Asia / Japan	Human	Original		COVID-19 positive case who entered from USA.	Illumina NextSeq500	A5-miseq v. 20140604			B.1.1	GR
hCoV-19/Australia/NSW1190/2020	EPI_ISL_667791	2020-10-25	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.1.39	GR
hCoV-19/England/CAMC-B79517/2020	EPI_ISL_667812	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-B7A9DE/2020	EPI_ISL_667821	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.408	G
hCoV-19/England/CAMC-B7925C/2020	EPI_ISL_667835	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-B790E9/2020	EPI_ISL_667874	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/QEUH-B7EA22/2020	EPI_ISL_667887	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B797F3/2020	EPI_ISL_667921	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-B78DB6/2020	EPI_ISL_667936	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/QEUH-B7E9E9/2020	EPI_ISL_667966	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B79984/2020	EPI_ISL_667971	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Denmark/DCGC-11909/2020	EPI_ISL_671212	2020-10-26	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.159	GR
hCoV-19/Denmark/DCGC-11940/2020	EPI_ISL_671226	2020-10-12	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.159	GR
hCoV-19/Denmark/DCGC-11946/2020	EPI_ISL_671228	2020-10-12	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.159	GR
hCoV-19/Denmark/DCGC-11948/2020	EPI_ISL_671229	2020-10-12	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.159	GR
hCoV-19/Gibraltar/204841718/2020	EPI_ISL_671287	2020	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.269	GR
hCoV-19/Gibraltar/204841735/2020	EPI_ISL_671302	2020	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.269	GR
hCoV-19/Gibraltar/204841737/2020	EPI_ISL_671304	2020	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.269	GR
hCoV-19/Gibraltar/204841745/2020	EPI_ISL_671312	2020	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.269	GR
hCoV-19/Gibraltar/204841753/2020	EPI_ISL_671320	2020	Europe / Gibraltar	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.269	GR
hCoV-19/Ireland/D-NVRL-MPA42736/2020	EPI_ISL_671338	2020-05-01	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-NVRL-20Z04751/2020	EPI_ISL_671362	2020-04-16	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.59	GR
hCoV-19/Ireland/MO-NVRL-20Z04470/2020	EPI_ISL_671366	2020-04-15	Europe / Ireland / Mayo	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.59	GR
hCoV-19/Ireland/MN-NVRL-20Z06661/2020	EPI_ISL_671367	2020-04-18	Europe / Ireland / Monaghan	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol	Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Ireland/MN-NVRL-20Z06657/2020	EPI_ISL_671368	2020-04-18	Europe / Ireland / Monaghan	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol	Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Ireland/D-NVRL-20Z04363/2020	EPI_ISL_671370	2020-04-15	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol	Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Ireland/WH-NVRL-20Z06323/2020	EPI_ISL_671371	2020-04-17	Europe / Ireland / Westmeath	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol	Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Ireland/MH-NVRL-20G44544/2020	EPI_ISL_671377	2020-03-30	Europe / Ireland / Monaghan	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol			B.59	GR
hCoV-19/Ireland/MN-NVRL-20Z06686/2020	EPI_ISL_671391	2020-04-18	Europe / Ireland / Monaghan	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol	Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Ireland/MN-NVRL-20Z06210/2020	EPI_ISL_671394	2020-04-16	Europe / Ireland / Monaghan	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore GridION	ARTIC v3 Protocol	Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/USA/CA-CZB-13397/2020	EPI_ISL_672458	2020-09-01	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.174	GR
hCoV-19/USA/CA-CZB-13425/2020	EPI_ISL_672469	2020-09-03	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1	G
hCoV-19/England/CAMC-B09619/2020	EPI_ISL_672917	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B090FD/2020	EPI_ISL_672945	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B08FC4/2020	EPI_ISL_672956	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.133	GR
hCoV-19/England/CAMC-B096A0/2020	EPI_ISL_672975	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B08DBB/2020	EPI_ISL_672991	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Belgium/ULG-6457/2020	EPI_ISL_417015	2020-03-13	Europe / Belgium / Liège	Human	Original	Nasopharyngeal swab		Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/Germany/NW-HHU-13/2020	EPI_ISL_417458	2020-03-11	Europe / Germany / North Rhine-Westphalia / Duesseldorf	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1.1	GR
hCoV-19/USA/WI-UW-16/2020	EPI_ISL_417509	2020-03-14	North America / USA / Wisconsin	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	custom -- minimap2			B.59	GR
hCoV-19/Iceland/236/2020	EPI_ISL_417564	2020-03-17	Europe / Iceland / Reykjavik	Human	Original			Illumina MiSeq	Mpileup			B.1.1	GR
hCoV-19/Singapore/38/2020	EPI_ISL_422431	2020-03-31	Asia / Singapore	Human	Original			Illumina MiSeq	Spades v3.6.1			B.1.1	GR
hCoV-19/Singapore/39/2020	EPI_ISL_422432	2020-03-31	Asia / Singapore	Human	Original			Illumina MiSeq	Spades v3.6.1			B.1.1	GR
hCoV-19/Italy/VEN-IZSVe-21-26/2020	EPI_ISL_422437	2020-03-25	Europe / Italy / Veneto / Verona	Human	Original	Oropharyngeal swab		Illumina MiSeq	BWA v0.7.12			B.1.1	GR
hCoV-19/USA/NY-PV09116/2020	EPI_ISL_422492	2020-03-19	North America / USA / New York / Nassau County	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/Netherlands/NA_299/2020	EPI_ISL_422608	2020-04-01	Europe / Netherlands	Human	Original			Nanopore				B.1.1	GR
hCoV-19/Netherlands/NA_312/2020	EPI_ISL_422621	2020-04-02	Europe / Netherlands	Human	Original			Nanopore				B.1.1.185	GR
hCoV-19/Netherlands/NA_152/2020	EPI_ISL_422687	2020-03-21	Europe / Netherlands	Human	Original			Nanopore				B.59	GR
hCoV-19/Netherlands/NA_218/2020	EPI_ISL_422753	2020-03-26	Europe / Netherlands	Human	Original			Nanopore				B.1	G
hCoV-19/Netherlands/NA_219/2020	EPI_ISL_422754	2020-03-26	Europe / Netherlands	Human	Original			Nanopore				B.1.1.71	GR
hCoV-19/Netherlands/NA_262/2020	EPI_ISL_422796	2020-03-30	Europe / Netherlands	Human	Original			Nanopore				B.1	G
hCoV-19/Netherlands/NA_89/2020	EPI_ISL_422849	2020-03-16	Europe / Netherlands	Human	Original			Nanopore				B.1.1.71	GR
hCoV-19/Netherlands/ZuidHolland_102/2020	EPI_ISL_422901	2020-03-18	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.1.71	GR
hCoV-19/England/20129096604/2020	EPI_ISL_424082	2020-03-11	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20129096804/2020	EPI_ISL_424084	2020-03-11	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Iceland/365/2020	EPI_ISL_424389	2020-03-19	Europe / Iceland / Reykjavik	Human	Original			Illumina MiSeq	Mpileup			B.1.1	GR
hCoV-19/Iceland/456/2020	EPI_ISL_424479	2020-03-20	Europe / Iceland / Reykjavik	Human	Original			Illumina MiSeq	Mpileup			B.1.1	GR
hCoV-19/Iceland/550/2020	EPI_ISL_424570	2020-03-28	Europe / Iceland / Reykjavik	Human	Original			Illumina MiSeq	Mpileup	Insertion of 1 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Iceland/554/2020	EPI_ISL_424574	2020-03-27	Europe / Iceland / Reykjavik	Human	Original			Illumina MiSeq	Mpileup			B.1.1	GR
hCoV-19/Iceland/582/2020	EPI_ISL_424602	2020-03-27	Europe / Iceland / Reykjavik	Human	Original			Illumina MiSeq	Mpileup			B.1.1	GR
hCoV-19/Belgium/ULG-10053/2020	EPI_ISL_424661	2020-04-05	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/Austria/CeMM0247/2020	EPI_ISL_438077	2020-03-21	Europe / Austria / Vienna	Human	Original	Oropharyngeal swab		Illumina NovaSeq	bwa			B.1.1	GR
hCoV-19/England/CAMB-75D0F/2020	EPI_ISL_438416	2020-03-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-76B6E/2020	EPI_ISL_438422	2020-03-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/CAMB-764FA/2020	EPI_ISL_438453	2020-03-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/CAMB-76858/2020	EPI_ISL_438468	2020-03-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-8217C/2020	EPI_ISL_438625	2020-04-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-83D68/2020	EPI_ISL_438687	2020-04-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-83FDB/2020	EPI_ISL_438720	2020-04-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-8413E/2020	EPI_ISL_438740	2020-04-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Scotland/CVR2521/2020	EPI_ISL_438923	2020-04-15	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.43	GR
hCoV-19/Scotland/CVR2746/2020	EPI_ISL_438944	2020-04-18	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.43	GR
hCoV-19/England/SHEF-C7991/2020	EPI_ISL_442013	2020-03-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.137	GR
hCoV-19/England/CAMB-7CC38/2020	EPI_ISL_442171	2020-04-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.379	GR
hCoV-19/England/CAMB-7C46D/2020	EPI_ISL_442310	2020-04-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/CAMB-7D790/2020	EPI_ISL_442340	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/SHEF-C9FBB/2020	EPI_ISL_442353	2020-04-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C9FF7/2020	EPI_ISL_442354	2020-04-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.137	GR
hCoV-19/England/SHEF-CC088/2020	EPI_ISL_442404	2020-04-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.137	GR
hCoV-19/England/SHEF-CD9C8/2020	EPI_ISL_442438	2020-04-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.137	GR
hCoV-19/England/SHEF-D2957/2020	EPI_ISL_442510	2020-03-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.137	GR
hCoV-19/England/CAMB-818E1/2020	EPI_ISL_442529	2020-04-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.13	GR
hCoV-19/England/CAMB-81B9D/2020	EPI_ISL_442561	2020-04-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.13	GR
hCoV-19/England/CAMB-819C0/2020	EPI_ISL_442572	2020-04-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.13	GR
hCoV-19/England/CAMB-80703/2020	EPI_ISL_442589	2020-04-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12316D/2020	EPI_ISL_442636	2020-04-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/BRIS-1235DA/2020	EPI_ISL_442655	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1230F7/2020	EPI_ISL_442680	2020-04-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/New Zealand/20VR1618/2020	EPI_ISL_456228	2020-03-23	Oceania / New Zealand / Southern	Human	Original	Oropharyngeal swab		Illumina MiSeq				B.1.1.254	GR
hCoV-19/New Zealand/20VR1620/2020	EPI_ISL_456230	2020-03-24	Oceania / New Zealand / Canterbury	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC protocol			B.1.1	GR
hCoV-19/Scotland/EDB5051/2020	EPI_ISL_456955	2020-03-31	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Scotland/EDB5251/2020	EPI_ISL_456996	2020-05-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Scotland/EDB5288/2020	EPI_ISL_456999	2020-05-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.14	GR
hCoV-19/Belgium/Rega-0328198/2020	EPI_ISL_458168	2020-03-28	Europe / Belgium / Braine-l'Alleud	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic prime pool, Guppy, CLC Genomics Workbench 20, Medaka			B.1.1	GR
hCoV-19/England/NORW-E8DDA/2020	EPI_ISL_461810	2020-04-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-E8E40/2020	EPI_ISL_461812	2020-04-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NOTT-1116EB/2020	EPI_ISL_461910	2020-05-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NOTT-1116FA/2020	EPI_ISL_461911	2020-05-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NOTT-11177F/2020	EPI_ISL_461919	2020-05-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NOTT-11178E/2020	EPI_ISL_461920	2020-05-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/PORT-2CFC8F/2020	EPI_ISL_461983	2020-05-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.194	GR
hCoV-19/Germany/NW-IMVUM_FI1103201/2020	EPI_ISL_463008	2020-03-11	Europe / Germany / North Rhine-Westphalia / Münster	Human	Vero E6	Oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 12			B.1.1	GR
hCoV-19/Canada/QC_AY8/2020	EPI_ISL_463956	2020-04-12	North America / Canada / Quebec	Human	Original	Nasopharyngeal swab		Nanopore MinION Mk1C	ARTIC network v3, reference-based alignment, nanopolish			B.1.1.176	GR
hCoV-19/USA/WA-UW-2293/2020	EPI_ISL_477710	2020-03-30	North America / USA / Washington	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/BIRM-610FE/2020	EPI_ISL_477749	2020-04-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.198	GR
hCoV-19/England/BIRM-612F8/2020	EPI_ISL_477758	2020-06-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/India/OR-ILSCV31650/2020	EPI_ISL_481149	2020-05-26	Asia / India / Odisha	Human	Original			Illumina NextSeq 550	Reference based			B.1.1.101	GR
hCoV-19/Germany/NW-RKI-N-0002/2020	EPI_ISL_481256	2020-03-19	Europe / Germany / North Rhine-Westphalia	Human	Original			Illumina iSeq	https://gitlab.com/RKIBioinformaticsPipelines/ncov_minipipe v1.2.0			B.1.1	GR
hCoV-19/Canada/NB_261/2020	EPI_ISL_481752	2020-04-05	North America / Canada / New Brunswick	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.1	GR
hCoV-19/Canada/NB_264/2020	EPI_ISL_481754	2020-04-07	North America / Canada / New Brunswick	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.1	GR
hCoV-19/England/BRIS-12CEB8/2020	EPI_ISL_481772	2020-04-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12CD33/2020	EPI_ISL_481867	2020-05-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12D118/2020	EPI_ISL_481876	2020-04-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12D0EE/2020	EPI_ISL_481918	2020-04-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12CA78/2020	EPI_ISL_481935	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12DFD2/2020	EPI_ISL_481999	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/cat/France/Env-Ba/2020	EPI_ISL_483063	2020-05-14	Europe / France	Felis catus	Original	Home environment		Oxford Nanopore Technologies	Bcftools mpileup v. 1.6			B.1.1.254	GR
hCoV-19/cat/France/Env-Di/2020	EPI_ISL_483064	2020-05-14	Europe / France	Felis catus	Original	Home environment		Oxford Nanopore Technologies	Bcftools mpileup v. 1.6			B.1.1.254	GR
hCoV-19/USA/CA-ALSR-0473-SAN/2020	EPI_ISL_483163	2020-04-15	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/Turkey/KU-025/2020	EPI_ISL_495435	2020-05-05	Europe / Turkey / Kars Province	Human	Original	Nasopharyngeal swab		Illumina NextSeq 550	Burrows-Wheeler Aligner v.0.7			B.1.1	GR
hCoV-19/South Africa/KRISP-0413/2020	EPI_ISL_495538	2020-07-02	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.40	GR
hCoV-19/USA/MN-MDH-1311/2020	EPI_ISL_495610	2020-03-15	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1	GR
hCoV-19/USA/WA-S2450/2020	EPI_ISL_497082	2020-06-16	North America / USA / Washington / Yakima County	Human	Original			Illumina NextSeq	Seattle Flu Assembly Pipeline			B.1.371	G
hCoV-19/USA/WA-S2599/2020	EPI_ISL_497231	2020-06-19	North America / USA / Washington / Cowlitz County	Human	Original			Illumina NextSeq	Seattle Flu Assembly Pipeline			B.1	G
hCoV-19/India/UN-N9/2020	EPI_ISL_497764	2020	Asia / India	Human	Original			Illumina MiSeq		NSP11 without BLAST coverage.	warn	B.1.1	GR
hCoV-19/Hong Kong/HKU-200723-032/2020	EPI_ISL_497799	2020-03-17	Asia / Hong Kong	Human	Original	Nasopharyngeal and throat swab		Nanopore MinION				B.1.1.254	GR
hCoV-19/USA/WA-UW-12446/2020	EPI_ISL_501111	2020-06-27	North America / USA / Washington	Human	Original			NextSeq 500				B.1.240	G
hCoV-19/USA/WA-UW-13262/2020	EPI_ISL_501125	2020-06-30	North America / USA / Washington	Human	Original			NextSeq 500		Gap of 2 nucleotides when compared to the reference sequence.	info	B.1.240	G
hCoV-19/USA/WA-UW-13306/2020	EPI_ISL_501135	2020-07-03	North America / USA / Washington	Human	Original			NextSeq 500				B.1.240	G
hCoV-19/USA/WA-UW-13317/2020	EPI_ISL_501137	2020-07-02	North America / USA / Washington	Human	Original			NextSeq 500		NSP5_L167stop results in 45.8% truncation of the protein sequence.	info	B.1.169	G
hCoV-19/USA/WA-UW-13366/2020	EPI_ISL_501144	2020-07-01	North America / USA / Washington	Human	Original			NextSeq 500				B.1.240	G
hCoV-19/Malaysia/0309/2020	EPI_ISL_501177	2020-03-22	Asia / Malaysia / Kuala Lumpur	Human	Original	Nasopharyngeal and throat swab		Illumina iSeq	Geneious Prime 2020.1			B.1.1	GR
hCoV-19/Ireland/D-NVRL-20IRL47363/2020	EPI_ISL_501274	2020-07-19	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Oxford Nanopore MinION	ARTIC v3 Protocol			B.1.1.406	GR
hCoV-19/Latvia/071/2020	EPI_ISL_501287	2020-06-06	Europe / Latvia	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	bowtie2			B.1.1	GR
hCoV-19/Belgium/ULG-10256/2020	EPI_ISL_515063	2020-07-17	Europe / Belgium / Liege	Human	Original			Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/Belgium/ULG-10263/2020	EPI_ISL_515070	2020-07-20	Europe / Belgium / Liege	Human	Original			Nanopore MinION	Artic network	NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/Belgium/ULG-10264/2020	EPI_ISL_515071	2020-07-11	Europe / Belgium / Liege	Human	Original			Nanopore MinION	Artic network	NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/USA/NV-NSPHL-A0025/2020	EPI_ISL_515312	2020-03-18	North America / USA / Nevada	Human	Original			Illumina NextSeq	Freebayes, BBtools			B.1.1	GR
hCoV-19/USA/NV-NSPHL-A0041/2020	EPI_ISL_515324	2020-03-23	North America / USA / Nevada	Human	Original			Illumina NextSeq	Freebayes, BBtools			B.59	GR
hCoV-19/USA/NV-NSPHL-A0200/2020	EPI_ISL_515454	2020-05-27	North America / USA / Nevada	Human	Original			Illumina NextSeq	Freebayes, BBtools			B.1	G
hCoV-19/USA/NV-NSPHL-A0201/2020	EPI_ISL_515455	2020-05-27	North America / USA / Nevada	Human	Original			Illumina NextSeq	Freebayes, BBtools			B.1	G
hCoV-19/South Africa/KRISP-K002179/2020	EPI_ISL_515580	2020-07-08	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K002187/2020	EPI_ISL_515586	2020-07-08	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002194/2020	EPI_ISL_515592	2020-07-16	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.40	GR
hCoV-19/South Africa/KRISP-K002196/2020	EPI_ISL_515594	2020-07-05	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002328/2020	EPI_ISL_515704	2020-07-22	Africa / South Africa / KwaZulu-Natal / King Cetshwayo	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002335/2020	EPI_ISL_515709	2020-07-23	Africa / South Africa / KwaZulu-Natal / Zululand	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K002346/2020	EPI_ISL_515718	2020-07-23	Africa / South Africa / KwaZulu-Natal / uMzinyathi	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002350/2020	EPI_ISL_515722	2020-07-21	Africa / South Africa / KwaZulu-Natal / Zululand	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K002351/2020	EPI_ISL_515723	2020-07-21	Africa / South Africa / KwaZulu-Natal / Zululand	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K002357/2020	EPI_ISL_515728	2020-07-21	Africa / South Africa / KwaZulu-Natal / Zululand	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002365/2020	EPI_ISL_515733	2020-07-22	Africa / South Africa / KwaZulu-Natal / uMkhanyakude	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002381/2020	EPI_ISL_515747	2020-07-17	Africa / South Africa / KwaZulu-Natal / iLembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K002387/2020	EPI_ISL_515753	2020-07-22	Africa / South Africa / KwaZulu-Natal / uThukela	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K002395/2020	EPI_ISL_515760	2020-07-28	Africa / South Africa / KwaZulu-Natal / Ugu	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002403/2020	EPI_ISL_515767	2020-07-24	Africa / South Africa / KwaZulu-Natal / Ugu	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.117	GR
hCoV-19/South Africa/KRISP-K002405/2020	EPI_ISL_515769	2020-07-27	Africa / South Africa / KwaZulu-Natal / Ugu	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K002407/2020	EPI_ISL_515771	2020-07-30	Africa / South Africa / KwaZulu-Natal / iLembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002428/2020	EPI_ISL_515789	2020-07-30	Africa / South Africa / KwaZulu-Natal / uMgungundlovu	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002440/2020	EPI_ISL_515796	2020-07-29	Africa / South Africa / KwaZulu-Natal / uMgungundlovu	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K001319/2020	EPI_ISL_515804	2020-07-18	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.40	GR
hCoV-19/South Africa/KRISP-K001326/2020	EPI_ISL_515811	2020-07-18	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K001341/2020	EPI_ISL_515826	2020-07-10	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.56	GR
hCoV-19/South Africa/KRISP-K001342/2020	EPI_ISL_515827	2020-07-10	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.56	GR
hCoV-19/South Africa/KRISP-K001343/2020	EPI_ISL_515828	2020-07-10	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.56	GR
hCoV-19/South Africa/KRISP-K001344/2020	EPI_ISL_515829	2020-07-13	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K001350/2020	EPI_ISL_515835	2020-06-30	Africa / South Africa / KwaZulu-Natal / uMgungundlovu	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K001354/2020	EPI_ISL_515839	2020-07-01	Africa / South Africa / KwaZulu-Natal / uMzinyathi	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K001355/2020	EPI_ISL_515840	2020-07-17	Africa / South Africa / KwaZulu-Natal / iLembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K001356/2020	EPI_ISL_515841	2020-07-16	Africa / South Africa / KwaZulu-Natal / iLembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K001359/2020	EPI_ISL_515844	2020-07-16	Africa / South Africa / KwaZulu-Natal / iLembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K001364/2020	EPI_ISL_515849	2020-07-16	Africa / South Africa / KwaZulu-Natal / iLembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K001365/2020	EPI_ISL_515850	2020-07-16	Africa / South Africa / KwaZulu-Natal / iLembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K001367/2020	EPI_ISL_515852	2020-07-16	Africa / South Africa / KwaZulu-Natal / iLembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K001368/2020	EPI_ISL_515853	2020-07-15	Africa / South Africa / KwaZulu-Natal / iLembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K001369/2020	EPI_ISL_515854	2020-07-16	Africa / South Africa / KwaZulu-Natal / iLembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K001371/2020	EPI_ISL_515856	2020-07-16	Africa / South Africa / KwaZulu-Natal / iLembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K001373/2020	EPI_ISL_515858	2020-07-17	Africa / South Africa / KwaZulu-Natal / iLembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K001374/2020	EPI_ISL_515859	2020-07-16	Africa / South Africa / KwaZulu-Natal / iLembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K001375/2020	EPI_ISL_515860	2020-07-16	Africa / South Africa / KwaZulu-Natal / iLembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K001376/2020	EPI_ISL_515861	2020-07-16	Africa / South Africa / KwaZulu-Natal / iLembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K001394/2020	EPI_ISL_515878	2020-07-18	Africa / South Africa / KwaZulu-Natal / uMkhanyakude	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K001409/2020	EPI_ISL_515892	2020-07-17	Africa / South Africa / KwaZulu-Natal / uMkhanyakude	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/England/LIVE-A736C/2020	EPI_ISL_517008	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina				B.59	GR
hCoV-19/England/LIVE-A7469/2020	EPI_ISL_517024	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-A750C/2020	EPI_ISL_517031	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/United Arab Emirates/L3290248500/2020	EPI_ISL_520694	2020-05-19	Asia / United Arab Emirates	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/United Arab Emirates/L3290250769/2020	EPI_ISL_520697	2020-05-20	Asia / United Arab Emirates	Human	Original			Illumina NovaSeq				B.1.1.203	GR
hCoV-19/United Arab Emirates/L3300059655/2020	EPI_ISL_520712	2020-06-06	Asia / United Arab Emirates	Human	Original			Illumina NovaSeq				B.1.1.133	GR
hCoV-19/United Arab Emirates/L920634181/2020	EPI_ISL_520727	2020-03-31	Asia / United Arab Emirates	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/South Korea/KCDC2664/2020	EPI_ISL_522446	2020-05-23	Asia / South Korea	Human	Original			Illumina MiSeq				B.1.1.133	GR
hCoV-19/South Korea/KCDC2669/2020	EPI_ISL_522451	2020-05-29	Asia / South Korea	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/South Korea/KCDC2681/2020	EPI_ISL_522463	2020-06-25	Asia / South Korea	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/South Korea/KCDC2708/2020	EPI_ISL_522487	2020-07-07	Asia / South Korea	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/South Korea/KCDC2709/2020	EPI_ISL_522488	2020-07-08	Asia / South Korea	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/South Korea/KCDC2716/2020	EPI_ISL_522495	2020-07-12	Asia / South Korea	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/South Korea/KCDC2717/2020	EPI_ISL_522496	2020-07-12	Asia / South Korea	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/South Korea/KCDC2719/2020	EPI_ISL_522498	2020-07-12	Asia / South Korea	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/South Korea/KCDC2726/2020	EPI_ISL_522505	2020-07-14	Asia / South Korea	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/USA/VA-DCLS-0902/2020	EPI_ISL_522778	2020-05-13	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1	G
hCoV-19/USA/VA-DCLS-0913/2020	EPI_ISL_522785	2020-05-13	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0918/2020	EPI_ISL_522789	2020-05-12	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0920/2020	EPI_ISL_522791	2020-05-13	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-0930/2020	EPI_ISL_522797	2020-05-21	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/Italy/VEN-IZSVe-50893/2020	EPI_ISL_522857	2020-04-26	Europe / Italy / Veneto / Verona	Human	Original	Oropharyngeal swab		Illumina MiSeq	BWA v0.7.12			B.1.1	GR
hCoV-19/Italy/VEN-IZSVe-54-17/2020	EPI_ISL_522860	2020-04-08	Europe / Italy / Veneto / Verona	Human	Original	Oropharyngeal swab		Illumina MiSeq	BWA v0.7.12			B.1.1	GR
hCoV-19/Italy/VEN-IZSVe-71-10/2020	EPI_ISL_522867	2020-04-10	Europe / Italy / Veneto / Verona	Human	Original	Oropharyngeal swab		Illumina MiSeq	BWA v0.7.12			B.1.1	GR
hCoV-19/USA/WI-UW-1182/2020	EPI_ISL_522937	2020-08-07	North America / USA / Wisconsin / Dane County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	custom -- minimap2			B.1.1.362	GR
hCoV-19/Mexico/CMX-INMEGEN-16/2020	EPI_ISL_522981	2020-08-06	North America / Mexico / Mexico City	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1	GR
hCoV-19/Mexico/CMX-INMEGEN-17/2020	EPI_ISL_522982	2020-08-06	North America / Mexico / Mexico City	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1	G
hCoV-19/Italy/ABR-IZSGC-TE8387/2020	EPI_ISL_529026	2020-03-30	Europe / Italy / Abruzzo	Human	Original			Swift Amplicon SARS-CoV-2 Panel+Illumina MiniSeq				B.1.1	GR
hCoV-19/England/NORW-EEACE/2020	EPI_ISL_529238	2020-08-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS3_Q38stop results in 86.5% truncation of the protein sequence. NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-EE563/2020	EPI_ISL_529240	2020-08-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-EE581/2020	EPI_ISL_529241	2020-08-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-EE5AF/2020	EPI_ISL_529242	2020-08-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-EE730/2020	EPI_ISL_529243	2020-08-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-EE76D/2020	EPI_ISL_529244	2020-08-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-EE77C/2020	EPI_ISL_529245	2020-08-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-EE78B/2020	EPI_ISL_529246	2020-08-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-EEA19/2020	EPI_ISL_529247	2020-08-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-EEAA0/2020	EPI_ISL_529248	2020-08-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-EEB16/2020	EPI_ISL_529249	2020-08-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-EEB9E/2020	EPI_ISL_529250	2020-08-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/ALDP-97F2B2/2020	EPI_ISL_529532	2020-07-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.115	GR
hCoV-19/England/ALDP-97F5B9/2020	EPI_ISL_529533	2020-08-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/England/ALDP-980236/2020	EPI_ISL_529536	2020-08-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/England/ALDP-980281/2020	EPI_ISL_529537	2020-08-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/England/ALDP-98056A/2020	EPI_ISL_529538	2020-08-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/England/ALDP-9813C9/2020	EPI_ISL_529545	2020-08-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/England/ALDP-9832F7/2020	EPI_ISL_529554	2020-07-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/England/ALDP-983303/2020	EPI_ISL_529555	2020-07-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/England/ALDP-983576/2020	EPI_ISL_529556	2020-07-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/England/ALDP-983822/2020	EPI_ISL_529557	2020-07-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/England/ALDP-98394D/2020	EPI_ISL_529559	2020-07-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/England/ALDP-9863D3/2020	EPI_ISL_529574	2020-08-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/England/BIRM-62682/2020	EPI_ISL_529618	2020-07-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.171	GR
hCoV-19/England/BIRM-62691/2020	EPI_ISL_529619	2020-07-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.171	GR
hCoV-19/England/BIRM-62707/2020	EPI_ISL_529621	2020-07-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/England/BIRM-628E6/2020	EPI_ISL_529627	2020-08-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/England/CAMB-1B5C14/2020	EPI_ISL_529657	2020-08-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.532	GR
hCoV-19/England/CAMB-1B5C23/2020	EPI_ISL_529658	2020-08-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.532	GR
hCoV-19/England/CAMB-1B5C32/2020	EPI_ISL_529659	2020-08-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.532	GR
hCoV-19/England/CAMB-1B5C41/2020	EPI_ISL_529660	2020-08-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.532	GR
hCoV-19/England/PORT-2D3383/2020	EPI_ISL_529670	2020-04-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/England/PORT-2D38FD/2020	EPI_ISL_529672	2020-04-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C6F45/2020	EPI_ISL_529682	2020-05-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-CE1A1/2020	EPI_ISL_529683	2020-05-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.171	GR
hCoV-19/Wales/PHWC-169EBF/2020	EPI_ISL_529709	2020-08-30	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-169F52/2020	EPI_ISL_529713	2020-08-28	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-169F70/2020	EPI_ISL_529715	2020-08-21	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/South Africa/KRISP-K002717/2020	EPI_ISL_529720	2020-08-14	Africa / South Africa / KwaZulu-Natal / Amajuba	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.254	GR
hCoV-19/South Africa/KRISP-K002731/2020	EPI_ISL_529729	2020-08-16	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002732/2020	EPI_ISL_529730	2020-08-15	Africa / South Africa / KwaZulu-Natal / Ugu	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K002735/2020	EPI_ISL_529733	2020-08-16	Africa / South Africa / KwaZulu-Natal / Harry Gwala	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K002736/2020	EPI_ISL_529734	2020-08-15	Africa / South Africa / KwaZulu-Natal / Ugu	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002739/2020	EPI_ISL_529737	2020-08-13	Africa / South Africa / KwaZulu-Natal / Ugu	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K002741/2020	EPI_ISL_529739	2020-08-15	Africa / South Africa / KwaZulu-Natal / King Cetshwayo	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup	NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002749/2020	EPI_ISL_529745	2020-08-16	Africa / South Africa / KwaZulu-Natal / Ugu	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002759/2020	EPI_ISL_529755	2020-08-15	Africa / South Africa / KwaZulu-Natal / Zululand	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-K002761/2020	EPI_ISL_529757	2020-08-15	Africa / South Africa / KwaZulu-Natal / iLembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.56	GR
hCoV-19/South Africa/KRISP-K002780/2020	EPI_ISL_529774	2020-08-20	Africa / South Africa / KwaZulu-Natal / iLembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002795/2020	EPI_ISL_529789	2020-08-23	Africa / South Africa / KwaZulu-Natal / iLembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/USA/VA-DCLS-1102/2020	EPI_ISL_529909	2020-06-21	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.240	G
hCoV-19/USA/VA-DCLS-1103/2020	EPI_ISL_529910	2020-06-21	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.240	G
hCoV-19/Spain/MD-H12-62/2020	EPI_ISL_529993	2020-04-12	Europe / Spain / Madrid	Human	Original	Oropharyngeal swab		Ion Torrent S5	IRMA			B.1.1	GR
hCoV-19/Spain/MD-H12-63/2020	EPI_ISL_529994	2020-04-12	Europe / Spain / Madrid	Human	Original	Oropharyngeal swab		Ion Torrent S5	IRMA			B.1.1	GR
hCoV-19/Spain/MD-H12-64/2020	EPI_ISL_529995	2020-04-12	Europe / Spain / Madrid	Human	Original	Oropharyngeal swab		Ion Torrent S5	IRMA			B.1.1	GR
hCoV-19/Canada/Qc-LSPQ-L00242384/2020	EPI_ISL_536319	2020-03-29	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00242900/2020	EPI_ISL_536340	2020-03-30	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1.133	GR
hCoV-19/Canada/Qc-LSPQ-L00243054/2020	EPI_ISL_536347	2020-03-30	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00243603/2020	EPI_ISL_536365	2020-03-29	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00243607/2020	EPI_ISL_536366	2020-03-29	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00243864/2020	EPI_ISL_536381	2020-03-31	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00244160/2020	EPI_ISL_536390	2020-03-31	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1.176	GR
hCoV-19/USA/WI-UW-1199/2020	EPI_ISL_536572	2020-08-05	North America / USA / Wisconsin / Dane County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	custom -- minimap2			B.1.1.362	GR
hCoV-19/Northern Ireland/QEUH-96510D/2020	EPI_ISL_536870	2020-08-13	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-96A2E7/2020	EPI_ISL_536872	2020-08-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Northern Ireland/QEUH-9642FC/2020	EPI_ISL_536912	2020-08-12	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-96A162/2020	EPI_ISL_536939	2020-08-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-963AF5/2020	EPI_ISL_536943	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/QEUH-96A205/2020	EPI_ISL_536958	2020-08-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-961408/2020	EPI_ISL_536964	2020-08-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9616C6/2020	EPI_ISL_536973	2020-08-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-95E0A0/2020	EPI_ISL_536990	2020-08-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/QEUH-95DD8C/2020	EPI_ISL_536996	2020-08-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-961848/2020	EPI_ISL_536998	2020-07-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/QEUH-998514/2020	EPI_ISL_540017	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/QEUH-99872D/2020	EPI_ISL_540027	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/QEUH-998453/2020	EPI_ISL_540033	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/QEUH-998B12/2020	EPI_ISL_540037	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-998954/2020	EPI_ISL_540038	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/Scotland/QEUH-990190/2020	EPI_ISL_540039	2020-08-30	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9901FA/2020	EPI_ISL_540054	2020-08-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.39	GR
hCoV-19/England/QEUH-998893/2020	EPI_ISL_540055	2020-08-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-998AE8/2020	EPI_ISL_540057	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-99856F/2020	EPI_ISL_540078	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/QEUH-998356/2020	EPI_ISL_540090	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-998972/2020	EPI_ISL_540102	2020-08-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-990136/2020	EPI_ISL_540121	2020-08-25	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-98F589/2020	EPI_ISL_540125	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-998AAC/2020	EPI_ISL_540130	2020-08-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-9A4278/2020	EPI_ISL_540140	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/QEUH-9A406F/2020	EPI_ISL_540159	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9A465E/2020	EPI_ISL_540178	2020-08-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9A44FA/2020	EPI_ISL_540188	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9A41E4/2020	EPI_ISL_540193	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9A3FDC/2020	EPI_ISL_540211	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9A4612/2020	EPI_ISL_540224	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9700D5/2020	EPI_ISL_540261	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/Northern Ireland/QEUH-96FF63/2020	EPI_ISL_540267	2020-08-18	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1.133	GR
hCoV-19/Northern Ireland/QEUH-96FFCD/2020	EPI_ISL_540280	2020-08-18	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-96F8E0/2020	EPI_ISL_540285	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-96F68C/2020	EPI_ISL_540289	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-96FF90/2020	EPI_ISL_540294	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Northern Ireland/QEUH-96FFBE/2020	EPI_ISL_540302	2020-08-18	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-96FB6F/2020	EPI_ISL_540325	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/Northern Ireland/QEUH-96FDA5/2020	EPI_ISL_540335	2020-08-18	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-96FC11/2020	EPI_ISL_540339	2020-08-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-98F2CE/2020	EPI_ISL_540346	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-98F510/2020	EPI_ISL_540365	2020-08-28	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-98F2EC/2020	EPI_ISL_540380	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-98F097/2020	EPI_ISL_540392	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-98EEF8/2020	EPI_ISL_540393	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-98F12B/2020	EPI_ISL_540402	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-98EEDA/2020	EPI_ISL_540408	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-98EF04/2020	EPI_ISL_540416	2020-08-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Belgium/ULG-10306/2020	EPI_ISL_540473	2020-07-24	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network	NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/Belgium/ULG-10310/2020	EPI_ISL_540477	2020-07-24	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network	NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/Belgium/ULG-10314/2020	EPI_ISL_540481	2020-07-27	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.1.39	G
hCoV-19/Belgium/ULG-10320/2020	EPI_ISL_540487	2020-07-27	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network	NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/Belgium/ULG-10324/2020	EPI_ISL_540491	2020-07-29	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.1.39	G
hCoV-19/Belgium/ULG-10332/2020	EPI_ISL_540499	2020-07-30	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.1.39	G
hCoV-19/Belgium/ULG-10337/2020	EPI_ISL_540504	2020-07-30	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.1.39	G
hCoV-19/Belgium/ULG-10376/2020	EPI_ISL_540543	2020-08-07	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.1.39	G
hCoV-19/England/LIVE-AA949/2020	EPI_ISL_540587	2020-08-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.130	GR
hCoV-19/England/LIVE-AA967/2020	EPI_ISL_540588	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.130	GR
hCoV-19/England/NOTT-11317F/2020	EPI_ISL_540705	2020-09-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/SHEF-CAE62/2020	EPI_ISL_540752	2020-09-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/Scotland/CVR3988/2020	EPI_ISL_540785	2020-08-31	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.255	GR
hCoV-19/Scotland/CVR4162/2020	EPI_ISL_540843	2020-08-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4169/2020	EPI_ISL_540849	2020-08-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/CVR4205/2020	EPI_ISL_540870	2020-08-31	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Wales/PHWC-16A522/2020	EPI_ISL_540901	2020-09-06	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16A57D/2020	EPI_ISL_540906	2020-09-07	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Peru/LIM-UPCH-0059/2020	EPI_ISL_540944	2020-06-17	South America / Peru / Lima / Lima	Human	Original	Oropharyngeal swab		Illumina MiSeq	MEGAHIT			B.1.1	GR
hCoV-19/Peru/CAL-UPCH-0071/2020	EPI_ISL_540953	2020-06-17	South America / Peru / Callao / Callao	Human	Original	Oropharyngeal swab		Illumina MiSeq	MEGAHIT			B.1.1	GR
hCoV-19/Peru/LIM-UPCH-0087/2020	EPI_ISL_540965	2020-06-17	South America / Peru / Lima / Lima	Human	Original	Oropharyngeal swab		Illumina MiSeq	MEGAHIT			B.1.1	GR
hCoV-19/Norway/2994/2020	EPI_ISL_549102	2020-07-22	Europe / Norway / Viken	Human	Original	Upper respiratory secretion and tracheal secretion		Illumina MiSeq, ARTICProtocol	Assembly by reference based mapping using Tanoti with iVar majority rules consensus	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.261	GR
hCoV-19/Norway/2977/2020	EPI_ISL_549103	2020-07-26	Europe / Norway / Agder	Human	Original	Upper respiratory secretion and tracheal secretion		Illumina MiSeq, ARTICProtocol	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1.39	GR
hCoV-19/Norway/2989/2020	EPI_ISL_549114	2020-07-22	Europe / Norway / More og Romsdal	Human	Original	Upper respiratory secretion and tracheal secretion		Illumina MiSeq, ARTICProtocol	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1.39	GR
hCoV-19/Norway/2990/2020	EPI_ISL_549115	2020-07-29	Europe / Norway / Oslo	Human	Original	Upper respiratory secretion and tracheal secretion		Illumina MiSeq, ARTICProtocol	Assembly by reference based mapping using Tanoti with iVar majority rules consensus	NSP11 without BLAST coverage.	warn	B.1.1.39	GR
hCoV-19/Norway/2991/2020	EPI_ISL_549116	2020-07-22	Europe / Norway / Oslo	Human	Original	Upper respiratory secretion and tracheal secretion		Illumina MiSeq, ARTICProtocol	Assembly by reference based mapping using Tanoti with iVar majority rules consensus	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.261	GR
hCoV-19/Norway/2992/2020	EPI_ISL_549117	2020-07-31	Europe / Norway / Oslo	Human	Original	Upper respiratory secretion and tracheal secretion		Illumina MiSeq, ARTICProtocol	Assembly by reference based mapping using Tanoti with iVar majority rules consensus	NSP11 without BLAST coverage.	warn	B.1.1.39	GR
hCoV-19/Norway/2993/2020	EPI_ISL_549118	2020-07-30	Europe / Norway / Oslo	Human	Original	Upper respiratory secretion and tracheal secretion		Illumina MiSeq, ARTICProtocol	Assembly by reference based mapping using Tanoti with iVar majority rules consensus	NSP11 without BLAST coverage.	warn	B.1.1.39	GR
hCoV-19/Norway/3012/2020	EPI_ISL_549119	2020-08-04	Europe / Norway / Oslo	Human	Original	Upper respiratory secretion and tracheal secretion		Illumina MiSeq, ARTICProtocol	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1.269	GR
hCoV-19/Norway/2949/2020	EPI_ISL_549143	2020-07-31	Europe / Norway / Viken	Human	Original	Upper respiratory secretion and tracheal secretion		Illumina MiSeq, ARTICProtocol	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1	GR
hCoV-19/Norway/2893/2020	EPI_ISL_549168	2020-07-13	Europe / Norway / Viken	Human	Original	Upper respiratory secretion and tracheal secretion		Illumina MiSeq, ARTICProtocol	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1.39	GR
hCoV-19/USA/FL-BPHL-1443/2020	EPI_ISL_549225	2020-09-08	North America / USA / Florida	Human	Original			Illumina NextSeq	bwa v0.7.17; ivar v1.2.2			B.1.396	G
hCoV-19/USA/FL-BPHL-1468/2020	EPI_ISL_549250	2020-05-08	North America / USA / Florida	Human	Original			Illumina NextSeq	bwa v0.7.17; ivar v1.2.2			B.1.1	GR
hCoV-19/England/NORW-EF5DB/2020	EPI_ISL_549350	2020-09-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-EF67E/2020	EPI_ISL_549351	2020-09-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-9B2004/2020	EPI_ISL_549405	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9B2462/2020	EPI_ISL_549410	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9B24F9/2020	EPI_ISL_549411	2020-09-04	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/MILK-9A8757/2020	EPI_ISL_549417	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-9A899D/2020	EPI_ISL_549437	2020-09-01	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-9AB596/2020	EPI_ISL_549444	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.171	GR
hCoV-19/England/MILK-9AB648/2020	EPI_ISL_549450	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.308	GR
hCoV-19/England/MILK-9AB675/2020	EPI_ISL_549453	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-9AB6DF/2020	EPI_ISL_549454	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-9AB709/2020	EPI_ISL_549455	2020-08-31	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-9C4676/2020	EPI_ISL_549460	2020-09-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-9C4A2F/2020	EPI_ISL_549474	2020-09-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.240	GR
hCoV-19/England/NORW-EE651/2020	EPI_ISL_549477	2020-04-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORW-EF869/2020	EPI_ISL_549480	2020-09-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.532	GR
hCoV-19/England/NOTT-1132E5/2020	EPI_ISL_549494	2020-09-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/ALDP-95615A/2020	EPI_ISL_554008	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-9562FD/2020	EPI_ISL_554019	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-957863/2020	EPI_ISL_554028	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.231	G
hCoV-19/England/ALDP-9560A8/2020	EPI_ISL_554029	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-9578BE/2020	EPI_ISL_554054	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/MILK-9577EE/2020	EPI_ISL_554057	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.231	G
hCoV-19/England/MILK-957924/2020	EPI_ISL_554058	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.231	G
hCoV-19/England/ALDP-956424/2020	EPI_ISL_554078	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/MILK-9573EA/2020	EPI_ISL_554101	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/MILK-95706B/2020	EPI_ISL_554159	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-957BA6/2020	EPI_ISL_554160	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.231	G
hCoV-19/England/ALDP-9512B6/2020	EPI_ISL_554172	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-95119B/2020	EPI_ISL_554207	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/MILK-957274/2020	EPI_ISL_554214	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-950DE3/2020	EPI_ISL_554225	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/MILK-957599/2020	EPI_ISL_554228	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/MILK-957B97/2020	EPI_ISL_554264	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.231	G
hCoV-19/England/ALDP-950E77/2020	EPI_ISL_554265	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.203	GR
hCoV-19/England/MILK-956758/2020	EPI_ISL_554300	2020-06-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/MILK-9569F8/2020	EPI_ISL_554308	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/MILK-956DCF/2020	EPI_ISL_554317	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-953C89/2020	EPI_ISL_554324	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-9556E3/2020	EPI_ISL_554326	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/ALDP-950B61/2020	EPI_ISL_554328	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/ALDP-9558ED/2020	EPI_ISL_554332	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.203	GR
hCoV-19/England/ALDP-953D77/2020	EPI_ISL_554334	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9511E6/2020	EPI_ISL_554336	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-950ABF/2020	EPI_ISL_554344	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-951289/2020	EPI_ISL_554349	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-953DA4/2020	EPI_ISL_554357	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9511D7/2020	EPI_ISL_554362	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-950B8F/2020	EPI_ISL_554363	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/ALDP-95167E/2020	EPI_ISL_554391	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-950976/2020	EPI_ISL_554393	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-953E47/2020	EPI_ISL_554394	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-950C5F/2020	EPI_ISL_554396	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95127A/2020	EPI_ISL_554406	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-9536B8/2020	EPI_ISL_554407	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-953DE0/2020	EPI_ISL_554411	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-953357/2020	EPI_ISL_554412	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-9558A1/2020	EPI_ISL_554425	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-951447/2020	EPI_ISL_554426	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-953E0B/2020	EPI_ISL_554431	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95092B/2020	EPI_ISL_554448	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-950ADD/2020	EPI_ISL_554468	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/ALDP-953ACB/2020	EPI_ISL_554483	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-953E65/2020	EPI_ISL_554486	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95369A/2020	EPI_ISL_554496	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-951298/2020	EPI_ISL_554507	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-950CD7/2020	EPI_ISL_554518	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-953E83/2020	EPI_ISL_554520	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9531B7/2020	EPI_ISL_554522	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.203	GR
hCoV-19/England/ALDP-953CA7/2020	EPI_ISL_554525	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-953E74/2020	EPI_ISL_554532	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-955786/2020	EPI_ISL_554542	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/ALDP-951641/2020	EPI_ISL_554556	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-951429/2020	EPI_ISL_554557	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-950B07/2020	EPI_ISL_554562	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-950B43/2020	EPI_ISL_554578	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-953E1A/2020	EPI_ISL_554579	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-951456/2020	EPI_ISL_554580	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-954286/2020	EPI_ISL_554589	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.254	GR
hCoV-19/England/ALDP-95364F/2020	EPI_ISL_554600	2020-06-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-955944/2020	EPI_ISL_554604	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/ALDP-94467E/2020	EPI_ISL_554617	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-958194/2020	EPI_ISL_554629	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/ALDP-9446BA/2020	EPI_ISL_554640	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-957C85/2020	EPI_ISL_554665	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/MILK-957C76/2020	EPI_ISL_554683	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-944052/2020	EPI_ISL_554694	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/MILK-958370/2020	EPI_ISL_554705	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-957CA3/2020	EPI_ISL_554713	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/MILK-958422/2020	EPI_ISL_554721	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/MILK-9581A3/2020	EPI_ISL_554744	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.231	G
hCoV-19/England/ALDP-944289/2020	EPI_ISL_554756	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-95998C/2020	EPI_ISL_554769	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/MILK-958853/2020	EPI_ISL_554773	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides found at refpos 21991.	info	B.1.1.97	GR
hCoV-19/England/MILK-958A99/2020	EPI_ISL_554786	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-944007/2020	EPI_ISL_554802	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS3_E261stop results in 5.5% truncation of the protein sequence.	info	B.1.238	G
hCoV-19/England/MILK-957C94/2020	EPI_ISL_554826	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/MILK-957C67/2020	EPI_ISL_554829	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-944043/2020	EPI_ISL_554834	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-95AAB5/2020	EPI_ISL_554867	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-95A781/2020	EPI_ISL_554892	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95ABB2/2020	EPI_ISL_554903	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/ALDP-95AC46/2020	EPI_ISL_554913	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS3_E242stop results in 12.4% truncation of the protein sequence.	info	B.1.1.203	GR
hCoV-19/England/ALDP-94D657/2020	EPI_ISL_554952	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95A9B8/2020	EPI_ISL_554967	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-959EBA/2020	EPI_ISL_554968	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.203	GR
hCoV-19/England/ALDP-94D824/2020	EPI_ISL_554973	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-95CA86/2020	EPI_ISL_554986	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-95C2AC/2020	EPI_ISL_554988	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95CDE7/2020	EPI_ISL_554992	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95A9D6/2020	EPI_ISL_554997	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94F43D/2020	EPI_ISL_556010	2020-06-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-94AA4F/2020	EPI_ISL_556026	2020-07-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-94CFA8/2020	EPI_ISL_556034	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.203	GR
hCoV-19/England/ALDP-94F5EF/2020	EPI_ISL_556045	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-9496A6/2020	EPI_ISL_556063	2020-07-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-6D9161/2020	EPI_ISL_556074	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-95DAFE/2020	EPI_ISL_556087	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-63F54F/2020	EPI_ISL_556102	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-6D1406/2020	EPI_ISL_556103	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-6422BB/2020	EPI_ISL_556109	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-94EB0C/2020	EPI_ISL_556111	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.253	GR
hCoV-19/England/ALDP-6C9A0F/2020	EPI_ISL_556129	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/ALDP-6C993F/2020	EPI_ISL_556149	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/ALDP-6CE24E/2020	EPI_ISL_556200	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-95D900/2020	EPI_ISL_556211	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.231	G
hCoV-19/England/ALDP-6CB6BE/2020	EPI_ISL_556225	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-6D29AC/2020	EPI_ISL_556228	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-95D8F4/2020	EPI_ISL_556232	2020-06-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.231	G
hCoV-19/Northern Ireland/MILK-95D9A6/2020	EPI_ISL_556233	2020-06-19	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94EB48/2020	EPI_ISL_556256	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/ALDP-94EB84/2020	EPI_ISL_556262	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1	GR
hCoV-19/England/MILK-64287D/2020	EPI_ISL_556275	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/ALDP-6C66A4/2020	EPI_ISL_556290	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/CAMC-94B5E3/2020	EPI_ISL_556309	2020-07-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-94A7DF/2020	EPI_ISL_556314	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94D45D/2020	EPI_ISL_556341	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-94B64A/2020	EPI_ISL_556357	2020-07-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-94A177/2020	EPI_ISL_556362	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.203	GR
hCoV-19/England/ALDP-94F707/2020	EPI_ISL_556377	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.203	GR
hCoV-19/England/ALDP-94A7EE/2020	EPI_ISL_556419	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-94B1FE/2020	EPI_ISL_556425	2020-07-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-94F1FA/2020	EPI_ISL_556444	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-94B853/2020	EPI_ISL_556446	2020-07-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-94F1EB/2020	EPI_ISL_556460	2020-06-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94A441/2020	EPI_ISL_556470	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/CAMC-94B5D4/2020	EPI_ISL_556488	2020-07-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/CAMC-94908A/2020	EPI_ISL_556494	2020-07-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/CAMC-94A326/2020	EPI_ISL_556508	2020-07-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/CAMC-94AC49/2020	EPI_ISL_556531	2020-07-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/CAMC-947471/2020	EPI_ISL_556532	2020-07-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/CAMC-949372/2020	EPI_ISL_556535	2020-07-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/CAMC-9490B7/2020	EPI_ISL_556546	2020-07-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/CAMC-947875/2020	EPI_ISL_556553	2020-07-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/CAMC-949E62/2020	EPI_ISL_556554	2020-07-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/CAMC-94763F/2020	EPI_ISL_556560	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/CAMC-949390/2020	EPI_ISL_556563	2020-07-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/CAMC-946FDB/2020	EPI_ISL_556564	2020-07-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/CAMC-948F33/2020	EPI_ISL_556565	2020-07-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/CAMC-949E08/2020	EPI_ISL_556567	2020-07-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.97	GR
hCoV-19/England/CAMC-9473DE/2020	EPI_ISL_556569	2020-07-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-8C9232/2020	EPI_ISL_556577	2020-06-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-8CABBE/2020	EPI_ISL_556592	2020-06-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-8E49F0/2020	EPI_ISL_556594	2020-06-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-8E68B5/2020	EPI_ISL_556599	2020-06-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-8F6D95/2020	EPI_ISL_556600	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-8F6928/2020	EPI_ISL_556605	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-8F1CBB/2020	EPI_ISL_556620	2020-06-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/Gambia/NPHL-1514/2020	EPI_ISL_561232	2020	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/NPHL-2736/2020	EPI_ISL_561291	2020-07-25	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.242	GR
hCoV-19/Gambia/NPHL-2785/2020	EPI_ISL_561297	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.242	GR
hCoV-19/India/HR-IMT-CB126/2020	EPI_ISL_561343	2020-08-27	Asia / India / Haryana	Human	Original	Nasopharyngeal swab		Nanopore MinION	EzCOVID19			B.1.1	O
hCoV-19/Spain/CN-IBV-97006490/2020	EPI_ISL_561370	2020-03-26	Africa / Canary Islands / Las Palmas de Gran Canaria	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1.71	GR
hCoV-19/Wales/PHWC-16CAD6/2020	EPI_ISL_574133	2020-09-22	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16CD28/2020	EPI_ISL_574160	2020-09-24	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-16D4E6/2020	EPI_ISL_574245	2020-09-22	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/USA/LA-EVTL252/2020	EPI_ISL_574386	2020-08-22	North America / USA / Louisiana / Madison Parish	Human	Original	Nasopharyngeal swab		Illumina NextSeq	breseq v0.34.1; genome diff, mapping to EPI_ISL_402124			B.1	G
hCoV-19/USA/LA-EVTL264/2020	EPI_ISL_574398	2020-08-22	North America / USA / Louisiana / Madison Parish	Human	Original	Nasopharyngeal swab		Illumina NextSeq	breseq v0.34.1; genome diff, mapping to EPI_ISL_402124			B.1	G
hCoV-19/USA/LA-EVTL286/2020	EPI_ISL_574420	2020-08-26	North America / USA / Louisiana / Madison Parish	Human	Original	Nasopharyngeal swab		Illumina NextSeq	breseq v0.34.1; genome diff, mapping to EPI_ISL_402124			B.1	G
hCoV-19/USA/LA-EVTL291/2020	EPI_ISL_574425	2020-08-26	North America / USA / Louisiana / Madison Parish	Human	Original	Nasopharyngeal swab		Illumina NextSeq	breseq v0.34.1; genome diff, mapping to EPI_ISL_402124			B.1	G
hCoV-19/England/MILK-97645B/2020	EPI_ISL_575806	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-976576/2020	EPI_ISL_575815	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-976637/2020	EPI_ISL_575826	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/Wales/MILK-973175/2020	EPI_ISL_575842	2020-08-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-976804/2020	EPI_ISL_575843	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/MILK-97454B/2020	EPI_ISL_575858	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-9747FA/2020	EPI_ISL_575861	2020-08-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/MILK-974587/2020	EPI_ISL_575864	2020-08-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/Wales/MILK-973157/2020	EPI_ISL_575867	2020-08-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-97642E/2020	EPI_ISL_575886	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-976655/2020	EPI_ISL_575891	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/Wales/MILK-9762D9/2020	EPI_ISL_575901	2020-08-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-976628/2020	EPI_ISL_575907	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/Wales/MILK-97312A/2020	EPI_ISL_575942	2020-08-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-97641F/2020	EPI_ISL_575951	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-97353D/2020	EPI_ISL_575958	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9730F0/2020	EPI_ISL_575965	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-976260/2020	EPI_ISL_575980	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-9735D3/2020	EPI_ISL_575981	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/MILK-9C3817/2020	EPI_ISL_575990	2020-09-08	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DAE75/2020	EPI_ISL_581003	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DADC3/2020	EPI_ISL_581015	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9E0F79/2020	EPI_ISL_581025	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/England/QEUH-9DCC79/2020	EPI_ISL_581027	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/Wales/MILK-9E0FC4/2020	EPI_ISL_581029	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9E1312/2020	EPI_ISL_581041	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/QEUH-9DC56F/2020	EPI_ISL_581059	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/QEUH-9DABE7/2020	EPI_ISL_581077	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DADE1/2020	EPI_ISL_581081	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DAFDC/2020	EPI_ISL_581096	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DAE1B/2020	EPI_ISL_581104	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9DE5D6/2020	EPI_ISL_581141	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-9DE5A9/2020	EPI_ISL_581146	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-9DE749/2020	EPI_ISL_581166	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/MILK-9E1F0F/2020	EPI_ISL_581169	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9E2F59/2020	EPI_ISL_581172	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/England/MILK-9E2171/2020	EPI_ISL_581179	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9E2047/2020	EPI_ISL_581198	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9E1D9C/2020	EPI_ISL_581215	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/MILK-9E25EE/2020	EPI_ISL_581216	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/MILK-9E1DE7/2020	EPI_ISL_581233	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/MILK-9E32E6/2020	EPI_ISL_581238	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/Wales/MILK-9E2038/2020	EPI_ISL_581243	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9E2FC2/2020	EPI_ISL_581248	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/MILK-9E25FD/2020	EPI_ISL_581249	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/MILK-9E1D8D/2020	EPI_ISL_581258	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/MILK-9E2E98/2020	EPI_ISL_581302	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9E2AA3/2020	EPI_ISL_581306	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CB23F/2020	EPI_ISL_581367	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/MILK-976400/2020	EPI_ISL_581368	2020-08-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-9C4CB0/2020	EPI_ISL_581378	2020-09-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-97786D/2020	EPI_ISL_581389	2020-07-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/QEUH-99817A/2020	EPI_ISL_581392	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-98F325/2020	EPI_ISL_581395	2020-08-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-96A029/2020	EPI_ISL_581403	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95C2E8/2020	EPI_ISL_581416	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.95	GR
hCoV-19/England/ALDP-4F393E/2020	EPI_ISL_581446	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/MILK-4BC157/2020	EPI_ISL_581447	2020-06-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/USA/VA-DCLS-1530/2020	EPI_ISL_581526	2020-08-08	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.240	G
hCoV-19/USA/VA-DCLS-1536/2020	EPI_ISL_581531	2020-08-07	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.240	G
hCoV-19/USA/VA-DCLS-1540/2020	EPI_ISL_581535	2020-08-07	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/VA-DCLS-1547/2020	EPI_ISL_581538	2020-08-07	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.240	G
hCoV-19/USA/VA-DCLS-1548/2020	EPI_ISL_581539	2020-08-07	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.240	G
hCoV-19/USA/VA-DCLS-1550/2020	EPI_ISL_581540	2020-08-07	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.240	G
hCoV-19/Belgium/ULG-10428/2020	EPI_ISL_581586	2020-08-14	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network	NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/ALDP-9FD6A1/2020	EPI_ISL_588000	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FD1BF/2020	EPI_ISL_588003	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FDE30/2020	EPI_ISL_588013	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FCCA0/2020	EPI_ISL_588016	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9FD89C/2020	EPI_ISL_588023	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FCEC8/2020	EPI_ISL_588025	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9FCC19/2020	EPI_ISL_588032	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-9FDEF4/2020	EPI_ISL_588045	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FA4F5/2020	EPI_ISL_588060	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FAA3F/2020	EPI_ISL_588082	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FB227/2020	EPI_ISL_588083	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FA792/2020	EPI_ISL_588097	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FAB3C/2020	EPI_ISL_588110	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/QEUH-9FB281/2020	EPI_ISL_588119	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FB209/2020	EPI_ISL_588121	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FA422/2020	EPI_ISL_588150	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FADDC/2020	EPI_ISL_588158	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/QEUH-9FA835/2020	EPI_ISL_588170	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FAA11/2020	EPI_ISL_588193	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-9FAF03/2020	EPI_ISL_588206	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FAEE8/2020	EPI_ISL_588208	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FA738/2020	EPI_ISL_588213	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FB078/2020	EPI_ISL_588216	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FB0E1/2020	EPI_ISL_588221	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FA589/2020	EPI_ISL_588248	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FA6E0/2020	EPI_ISL_588263	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FAE60/2020	EPI_ISL_588268	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FAE9D/2020	EPI_ISL_588270	2020-09-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F4EA2/2020	EPI_ISL_588308	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F5A9E/2020	EPI_ISL_588326	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F523C/2020	EPI_ISL_588331	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F5ABC/2020	EPI_ISL_588332	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F5ACB/2020	EPI_ISL_588341	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F5BD7/2020	EPI_ISL_588356	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F4877/2020	EPI_ISL_588357	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F484A/2020	EPI_ISL_588367	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F582B/2020	EPI_ISL_588368	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/QEUH-9F58FE/2020	EPI_ISL_588371	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F4FFA/2020	EPI_ISL_588375	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/QEUH-9F5A61/2020	EPI_ISL_588377	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F51D5/2020	EPI_ISL_588378	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F5ADA/2020	EPI_ISL_588382	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F49A1/2020	EPI_ISL_588397	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F5D86/2020	EPI_ISL_588398	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-9F5FEA/2020	EPI_ISL_588400	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-9F4A80/2020	EPI_ISL_588407	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F49ED/2020	EPI_ISL_588413	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_C61stop results in 50.4% truncation of the protein sequence.	info	B.1.236	G
hCoV-19/England/QEUH-9F5C10/2020	EPI_ISL_588418	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F58D0/2020	EPI_ISL_588423	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/QEUH-9F5A52/2020	EPI_ISL_588432	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/QEUH-9F474D/2020	EPI_ISL_588472	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F409D/2020	EPI_ISL_588490	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F3A54/2020	EPI_ISL_588492	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F36F6/2020	EPI_ISL_588499	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F374E/2020	EPI_ISL_588506	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F42D3/2020	EPI_ISL_588508	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/QEUH-9F3DA6/2020	EPI_ISL_588534	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F40D9/2020	EPI_ISL_588535	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F332C/2020	EPI_ISL_588543	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F3DC4/2020	EPI_ISL_588547	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-9F33FF/2020	EPI_ISL_588557	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F3896/2020	EPI_ISL_588701	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F3C6D/2020	EPI_ISL_588718	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F5EDE/2020	EPI_ISL_588741	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F609B/2020	EPI_ISL_588750	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/QEUH-9F6426/2020	EPI_ISL_588765	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F8916/2020	EPI_ISL_588778	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F898F/2020	EPI_ISL_588788	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F9362/2020	EPI_ISL_588789	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F89AD/2020	EPI_ISL_588801	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F803F/2020	EPI_ISL_588807	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F873A/2020	EPI_ISL_588816	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F8BD4/2020	EPI_ISL_588825	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F82EE/2020	EPI_ISL_588859	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F5630/2020	EPI_ISL_588875	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F92FC/2020	EPI_ISL_588876	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F8336/2020	EPI_ISL_588878	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F8925/2020	EPI_ISL_588885	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F921A/2020	EPI_ISL_588894	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F57D3/2020	EPI_ISL_588910	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/QEUH-9F93F9/2020	EPI_ISL_588943	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F63CF/2020	EPI_ISL_588951	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/QEUH-9F8961/2020	EPI_ISL_588990	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-9F87EF/2020	EPI_ISL_588998	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Australia/QLD1093/2020	EPI_ISL_593612	2020-03-28	Oceania / Australia / Queensland	Human	Original			Illumina	Samtools / iVar			B.1.1	GR
hCoV-19/Australia/NSW1056/2020	EPI_ISL_593655	2020-07-12	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.1.133	GR
hCoV-19/Australia/NSW1037/2020	EPI_ISL_593689	2020-06-30	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.1.133	GR
hCoV-19/Australia/NSW1039/2020	EPI_ISL_593691	2020-06-30	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.1.254	GR
hCoV-19/Australia/NSW1040/2020	EPI_ISL_593692	2020-06-29	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.1.133	GR
hCoV-19/Australia/NSW1109/2020	EPI_ISL_593724	2020-08-15	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1	G
hCoV-19/England/204221398/2020	EPI_ISL_593793	2020	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			AD.2	GR
hCoV-19/England/204221402/2020	EPI_ISL_593796	2020	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.71	GR
hCoV-19/England/204221523/2020	EPI_ISL_593844	2020	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			AD.2	GR
hCoV-19/England/204221423/2020	EPI_ISL_593984	2020	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)	Gap of 6 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/204221434/2020	EPI_ISL_593985	2020	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Wales/PHWC-47DFA3/2020	EPI_ISL_595389	2020-10-10	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-47EF48/2020	EPI_ISL_595615	2020-10-08	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.236	G
hCoV-19/Scotland/QEUH-9F6BB8/2020	EPI_ISL_595618	2020-09-25	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-9F6FBC/2020	EPI_ISL_595650	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.532	GR
hCoV-19/Scotland/QEUH-9F7100/2020	EPI_ISL_595662	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9F7276/2020	EPI_ISL_595673	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9F73FB/2020	EPI_ISL_595685	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-9F756E/2020	EPI_ISL_595686	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9F76D4/2020	EPI_ISL_595694	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9F772C/2020	EPI_ISL_595698	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/QEUH-9F774A/2020	EPI_ISL_595700	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9F7980/2020	EPI_ISL_595714	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9F7EEB/2020	EPI_ISL_595721	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/QEUH-9F7F15/2020	EPI_ISL_595723	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/QEUH-9F8099/2020	EPI_ISL_595725	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9F80E4/2020	EPI_ISL_595729	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9F8390/2020	EPI_ISL_595734	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9F9BE2/2020	EPI_ISL_595753	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9F9DDD/2020	EPI_ISL_595767	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-9F9F40/2020	EPI_ISL_595779	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.39	GR
hCoV-19/Scotland/QEUH-A013FD/2020	EPI_ISL_595811	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.532	GR
hCoV-19/England/QEUH-A016E5/2020	EPI_ISL_595816	2020-09-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.308	GR
hCoV-19/England/QEUH-A01C10/2020	EPI_ISL_595829	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-A01C7A/2020	EPI_ISL_595833	2020-10-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Scotland/QEUH-A3152B/2020	EPI_ISL_595899	2020-10-05	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A31594/2020	EPI_ISL_595904	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.130	GR
hCoV-19/England/QEUH-A31770/2020	EPI_ISL_595908	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A317AD/2020	EPI_ISL_595910	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-A48EBD/2020	EPI_ISL_595936	2020-10-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-A4C5D2/2020	EPI_ISL_595983	2020-10-07	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A4C6A2/2020	EPI_ISL_595989	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-A6C5AF/2020	EPI_ISL_608001	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6D33B/2020	EPI_ISL_608013	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6D2D4/2020	EPI_ISL_608029	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6C8D3/2020	EPI_ISL_608051	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A701D1/2020	EPI_ISL_608067	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-A6D74E/2020	EPI_ISL_608101	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6D702/2020	EPI_ISL_608106	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6CF0B/2020	EPI_ISL_608128	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6CF56/2020	EPI_ISL_608153	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6CB16/2020	EPI_ISL_608156	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A701B3/2020	EPI_ISL_608182	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-A6D1E6/2020	EPI_ISL_608253	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6D377/2020	EPI_ISL_608277	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A6C7F4/2020	EPI_ISL_608291	2020-10-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A3E8F8/2020	EPI_ISL_609610	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A3F8E8/2020	EPI_ISL_609635	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/CAMC-A3E4F4/2020	EPI_ISL_609637	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A3F4E4/2020	EPI_ISL_609648	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A3E728/2020	EPI_ISL_609649	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A3E4E5/2020	EPI_ISL_609668	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A3E8E9/2020	EPI_ISL_609710	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A3E3F7/2020	EPI_ISL_609719	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A3F9C7/2020	EPI_ISL_609748	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/CAMC-A3E430/2020	EPI_ISL_609752	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/204180580/2020	EPI_ISL_609855	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.308	GR
hCoV-19/England/204191267/2020	EPI_ISL_609860	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			AD.2	GR
hCoV-19/England/204380928/2020	EPI_ISL_609902	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.240	GR
hCoV-19/England/204380929/2020	EPI_ISL_609903	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.240	GR
hCoV-19/England/204380930/2020	EPI_ISL_609904	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.240	GR
hCoV-19/England/204380931/2020	EPI_ISL_609905	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.240	GR
hCoV-19/England/204380932/2020	EPI_ISL_609906	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.240	GR
hCoV-19/England/204380933/2020	EPI_ISL_609907	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.240	GR
hCoV-19/England/204380934/2020	EPI_ISL_609908	2020-10-16	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.240	GR
hCoV-19/Wales/PHWC-4810B8/2020	EPI_ISL_613033	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-4813DD/2020	EPI_ISL_613065	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-48156E/2020	EPI_ISL_613085	2020-10-17	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-4817C2/2020	EPI_ISL_613110	2020-10-18	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-48181A/2020	EPI_ISL_613115	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-481980/2020	EPI_ISL_613129	2020-10-17	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-481C1E/2020	EPI_ISL_613156	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-481C78/2020	EPI_ISL_613161	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-481DC0/2020	EPI_ISL_613170	2020-10-12	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-48212D/2020	EPI_ISL_613200	2020-10-20	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-48272B/2020	EPI_ISL_613239	2020-10-21	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.67	GR
hCoV-19/Scotland/QEUH-A769D3/2020	EPI_ISL_613341	2020-10-15	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.532	GR
hCoV-19/Scotland/QEUH-A76A0D/2020	EPI_ISL_613344	2020-10-15	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.532	GR
hCoV-19/England/QEUH-A78036/2020	EPI_ISL_613353	2020-10-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/SHEF-C1AD0/2020	EPI_ISL_613359	2020-10-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/SHEF-C5605/2020	EPI_ISL_613367	2020-10-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C6CA8/2020	EPI_ISL_613371	2020-10-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/USA/MN-MDH-1894/2020	EPI_ISL_613532	2020-10-24	North America / USA / Minnesota	Human	Original	Nares		Illumina	StaPH-B Toolkit - Monroe v. 1.1.1			B.1	G
hCoV-19/England/204400614/2020	EPI_ISL_613634	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.240	GR
hCoV-19/England/204400615/2020	EPI_ISL_613635	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.240	GR
hCoV-19/USA/FL-BPHL-1729/2020	EPI_ISL_613855	2020-10-01	North America / USA / Florida	Human	Original			Illumina MiSeq	bwa v0.7.17; ivar v1.2.2			B.1.396	G
hCoV-19/Sweden/20-22139/2020	EPI_ISL_615081	2020-05-24	Europe / Sweden / Skane	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Sweden/20-51687/2020	EPI_ISL_615087	2020-05-24	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1	G
hCoV-19/Sweden/20-52817/2020	EPI_ISL_615103	2020-06-28	Europe / Sweden / Gavleborg	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins	NS8_Y31stop results in 75.2% truncation of the protein sequence.	info	B.1.1.261	GR
hCoV-19/USA/TX-DSHS-1121/2020	EPI_ISL_615158	2020-06-21	North America / USA / Texas / Hidalgo County	Human	Original	Nasopharyngeal swab		Illumina MiSeq	bwa v1.2.2/ivar 0.7.17			B.1.396	G
hCoV-19/Denmark/DCGC-5290/2020	EPI_ISL_615221	2020-09-14	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1.198	GR
hCoV-19/Denmark/DCGC-3709/2020	EPI_ISL_615487	2020-08-31	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				AQ.2	GR
hCoV-19/Denmark/DCGC-5940/2020	EPI_ISL_620205	2020-10-05	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.159	GR
hCoV-19/Denmark/DCGC-6489/2020	EPI_ISL_620389	2020-10-05	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-5580/2020	EPI_ISL_620905	2020-09-28	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.159	GR
hCoV-19/Denmark/DCGC-5768/2020	EPI_ISL_620955	2020-09-28	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.159	GR
hCoV-19/Denmark/DCGC-5770/2020	EPI_ISL_620957	2020-09-28	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.159	GR
hCoV-19/Denmark/DCGC-5773/2020	EPI_ISL_620960	2020-09-28	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.159	GR
hCoV-19/Denmark/DCGC-5798/2020	EPI_ISL_620985	2020-09-28	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.159	GR
hCoV-19/Denmark/DCGC-5799/2020	EPI_ISL_620986	2020-09-28	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.159	GR
hCoV-19/England/MILK-A6A459/2020	EPI_ISL_627505	2020-10-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.236	G
hCoV-19/Northern Ireland/NIRE-1089C0/2020	EPI_ISL_627520	2020-10-11	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				AD.2	GR
hCoV-19/Northern Ireland/NIRE-1089EE/2020	EPI_ISL_627522	2020-10-11	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				AD.2	GR
hCoV-19/England/NORW-F01F1/2020	EPI_ISL_627570	2020-10-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.236	G
hCoV-19/England/NORW-F14F7/2020	EPI_ISL_627599	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/NORW-F1503/2020	EPI_ISL_627600	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/NORW-F1512/2020	EPI_ISL_627601	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/NORW-F15A9/2020	EPI_ISL_627606	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/NORW-F20B6/2020	EPI_ISL_627654	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/NORW-F3E15/2020	EPI_ISL_627665	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.240	GR
hCoV-19/Wales/PHWC-4833AE/2020	EPI_ISL_627811	2020-09-06	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-48370C/2020	EPI_ISL_627851	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-483881/2020	EPI_ISL_627865	2020-09-18	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-4841EF/2020	EPI_ISL_627976	2020-10-16	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-ACE972/2020	EPI_ISL_629143	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC7D8C/2020	EPI_ISL_629154	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-ACE356/2020	EPI_ISL_629166	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACC0F7/2020	EPI_ISL_629174	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC842C/2020	EPI_ISL_629211	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACC18B/2020	EPI_ISL_629247	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-ACC8C2/2020	EPI_ISL_629263	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC8608/2020	EPI_ISL_629310	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC7D7D/2020	EPI_ISL_629327	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-ACBE94/2020	EPI_ISL_629341	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC7D9B/2020	EPI_ISL_629372	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACE4AE/2020	EPI_ISL_629383	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/MILK-AC8565/2020	EPI_ISL_629458	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-ACF7C2/2020	EPI_ISL_629461	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/MILK-AC89F0/2020	EPI_ISL_629469	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACEFBC/2020	EPI_ISL_629471	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-AC8028/2020	EPI_ISL_629473	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/MILK-AC8FFE/2020	EPI_ISL_629477	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC8F1C/2020	EPI_ISL_629513	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/MILK-AC8170/2020	EPI_ISL_629518	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACF3A0/2020	EPI_ISL_629539	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC8DD6/2020	EPI_ISL_629543	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACE769/2020	EPI_ISL_629555	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC8E6A/2020	EPI_ISL_629556	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.39	GR
hCoV-19/England/MILK-ACE74B/2020	EPI_ISL_629569	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC828C/2020	EPI_ISL_629582	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACEEFB/2020	EPI_ISL_629601	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACE70F/2020	EPI_ISL_629617	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC7F77/2020	EPI_ISL_629619	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-AC81CB/2020	EPI_ISL_629622	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACEEEC/2020	EPI_ISL_629634	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACF4CB/2020	EPI_ISL_629659	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/England/MILK-AC7CAD/2020	EPI_ISL_629664	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACE9BE/2020	EPI_ISL_629673	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC90CD/2020	EPI_ISL_629694	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC8E5B/2020	EPI_ISL_629698	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC8F3A/2020	EPI_ISL_629707	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/MILK-ACEA24/2020	EPI_ISL_629708	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/MILK-ACF2B2/2020	EPI_ISL_629713	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACEE0A/2020	EPI_ISL_629737	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACEA33/2020	EPI_ISL_629746	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/QEUH-AD3D7E/2020	EPI_ISL_629757	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD260B/2020	EPI_ISL_629761	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD09C8/2020	EPI_ISL_629762	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD2F4C/2020	EPI_ISL_629770	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD24F2/2020	EPI_ISL_629804	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-AD1EF5/2020	EPI_ISL_629834	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD25C2/2020	EPI_ISL_629835	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD2DE8/2020	EPI_ISL_629880	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD1CEC/2020	EPI_ISL_629889	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD1C46/2020	EPI_ISL_629892	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD3E3F/2020	EPI_ISL_629895	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/QEUH-AD2AE1/2020	EPI_ISL_629908	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD22BC/2020	EPI_ISL_629918	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD2674/2020	EPI_ISL_629929	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD2FF1/2020	EPI_ISL_629946	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD0F5D/2020	EPI_ISL_629947	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD2726/2020	EPI_ISL_629965	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD29B7/2020	EPI_ISL_629988	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/NY-NYCPHL-000983/2020	EPI_ISL_633010	2020-10-01	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.240	G
hCoV-19/USA/NY-NYCPHL-000989/2020	EPI_ISL_633015	2020-08-27	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.231	GR
hCoV-19/USA/NY-NYCPHL-000990/2020	EPI_ISL_633016	2020-08-31	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1	G
hCoV-19/USA/NY-NYCPHL-001004/2020	EPI_ISL_633027	2020-10-05	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.231	GR
hCoV-19/USA/NY-NYCPHL-001008/2020	EPI_ISL_633029	2020-10-06	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.1.231	GR
hCoV-19/USA/NY-NYCPHL-001016/2020	EPI_ISL_633035	2020-09-10	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.240	G
hCoV-19/USA/NY-NYCPHL-001019/2020	EPI_ISL_633037	2020-09-16	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.240	G
hCoV-19/USA/NY-NYCPHL-001029/2020	EPI_ISL_633045	2020-09-29	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188			B.1.396	G
hCoV-19/USA/NY-NYCPHL-001074/2020	EPI_ISL_633075	2020-10-15	North America / USA / New York / New York City	Human	Original			Illumina MiSeq	bwa version 0.7.17-r1188	NS8_E64stop results in 47.9% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/England/CAMC-AEB1B3/2020	EPI_ISL_633104	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/QEUH-AE4FB0/2020	EPI_ISL_633113	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AE51D7/2020	EPI_ISL_633138	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/QEUH-AE53C2/2020	EPI_ISL_633168	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AE5438/2020	EPI_ISL_633179	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AE4F92/2020	EPI_ISL_633181	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AE4E2C/2020	EPI_ISL_633190	2020-10-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-AEA785/2020	EPI_ISL_633265	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-AEACE0/2020	EPI_ISL_633267	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD1E6E/2020	EPI_ISL_634606	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD1ED7/2020	EPI_ISL_634618	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD4609/2020	EPI_ISL_634625	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/QEUH-AD5A1B/2020	EPI_ISL_634629	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD19F4/2020	EPI_ISL_634634	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD578D/2020	EPI_ISL_634640	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD0FE4/2020	EPI_ISL_634645	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD19D6/2020	EPI_ISL_634664	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD5B45/2020	EPI_ISL_634669	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD5C60/2020	EPI_ISL_634684	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD442D/2020	EPI_ISL_634697	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD1639/2020	EPI_ISL_634711	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD1F89/2020	EPI_ISL_634725	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD0FB7/2020	EPI_ISL_634730	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/QEUH-AD3A59/2020	EPI_ISL_634753	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-AA1C30/2020	EPI_ISL_634759	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-AA1C6D/2020	EPI_ISL_634764	2020-10-22	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/USA/MN-MDH-1996/2020	EPI_ISL_634870	2020-10-29	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.240	G
hCoV-19/South Africa/KRISP-K003991/2020	EPI_ISL_634979	2020-09-25	Africa / South Africa / KwaZulu-Natal / ilembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.56	GR
hCoV-19/South Africa/KRISP-K003993/2020	EPI_ISL_634981	2020-09-28	Africa / South Africa / KwaZulu-Natal / Zululand	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K004005/2020	EPI_ISL_634990	2020-09-29	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K004014/2020	EPI_ISL_634999	2020-10-12	Africa / South Africa / KwaZulu-Natal / ugu	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/NHLS-UCT-GS-0015/2020	EPI_ISL_640017	2020-08-11	Africa / South Africa / Western Cape / Oudtshoorn	Human	Original			Illumina MiSeq				B.1	G
hCoV-19/South Africa/NHLS-UCT-GS-0027/2020	EPI_ISL_640028	2020-08-18	Africa / South Africa / Western Cape / Mitchells Plain	Human	Original			Illumina MiSeq				B.1.1.57	GR
hCoV-19/South Africa/NHLS-UCT-GS-1990/2020	EPI_ISL_640049	2020-08-25	Africa / South Africa / Western Cape / George	Human	Original			Illumina MiSeq				B.1.1.40	GR
hCoV-19/South Africa/NHLS-UCT-GS-0146/2020	EPI_ISL_640065	2020-06-29	Africa / South Africa / Western Cape / Mitchells Plain	Human	Original			Illumina MiSeq				B.1.1.40	GR
hCoV-19/South Africa/NHLS-UCT-GS-0286/2020	EPI_ISL_640067	2020-07-08	Africa / South Africa / Western Cape / Western	Human	Original			Illumina MiSeq				B.1.1.40	GR
hCoV-19/South Africa/NHLS-UCT-GS-1433/2020	EPI_ISL_640072	2020-08-11	Africa / South Africa / Western Cape / Klipfontein	Human	Original			Illumina MiSeq				B.1.1.34	GR
hCoV-19/South Africa/NHLS-UCT-GS-0804/2020	EPI_ISL_640075	2020-07-23	Africa / South Africa / Western Cape / Northern	Human	Original			Illumina MiSeq				B.1	G
hCoV-19/South Africa/NHLS-UCT-GS-3231/2020	EPI_ISL_640082	2020-04-26	Africa / South Africa / Western Cape / Klipfontein	Human	Original			Illumina MiSeq				B.1.1.40	GR
hCoV-19/South Africa/NHLS-UCT-GS-2092/2020	EPI_ISL_640084	2020-09-25	Africa / South Africa / Western Cape / Western	Human	Original			Illumina MiSeq				B.1	G
hCoV-19/South Africa/NHLS-UCT-GS-1770/2020	EPI_ISL_640107	2020-09-01	Africa / South Africa / Western Cape / Southern	Human	Original			Illumina MiSeq				B.1	G
hCoV-19/South Africa/NHLS-UCT-GS-1777/2020	EPI_ISL_640111	2020-09-04	Africa / South Africa / Western Cape / Western	Human	Original			Illumina MiSeq				B.1.1.40	GR
hCoV-19/South Africa/NHLS-UCT-GS-1855/2020	EPI_ISL_640115	2020-09-09	Africa / South Africa / Western Cape / Southern	Human	Original			Illumina MiSeq				B.1	G
hCoV-19/South Africa/NHLS-UCT-GS-2085/2020	EPI_ISL_640128	2020-09-23	Africa / South Africa / Western Cape / Western	Human	Original			Illumina MiSeq				B.1.1.507	GR
hCoV-19/South Africa/NHLS-UCT-GS-3468/2020	EPI_ISL_640133	2020-10-01	Africa / South Africa / Western Cape / Western	Human	Original			Illumina MiSeq				B.1.1.507	GR
hCoV-19/South Africa/NHLS-UCT-GS-3469/2020	EPI_ISL_640134	2020-10-01	Africa / South Africa / Western Cape / Western	Human	Original			Illumina MiSeq				B.1.1.507	GR
hCoV-19/South Africa/NHLS-UCT-GS-3516/2020	EPI_ISL_640139	2020-10-09	Africa / South Africa / Western Cape / Western	Human	Original			Illumina MiSeq				B.1	G
hCoV-19/South Africa/NHLS-UCT-GS-3522/2020	EPI_ISL_640141	2020-10-11	Africa / South Africa / Western Cape / Southern	Human	Original			Illumina MiSeq				B.1.1.507	GR
hCoV-19/England/QEUH-B2D9DA/2020	EPI_ISL_647014	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B23743/2020	EPI_ISL_647015	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2D776/2020	EPI_ISL_647050	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B24663/2020	EPI_ISL_647057	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-B2DD47/2020	EPI_ISL_647061	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2ED28/2020	EPI_ISL_647110	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B245FD/2020	EPI_ISL_647116	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B22EC7/2020	EPI_ISL_647208	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/CAMC-B2252C/2020	EPI_ISL_647233	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B21341/2020	EPI_ISL_647249	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B21F7A/2020	EPI_ISL_647276	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-B22DBB/2020	EPI_ISL_647299	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-B2288D/2020	EPI_ISL_647314	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B22D60/2020	EPI_ISL_647319	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B21F89/2020	EPI_ISL_647390	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B20746/2020	EPI_ISL_647571	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-B20F99/2020	EPI_ISL_647595	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B1A93A/2020	EPI_ISL_647630	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/CAMC-B1FCB4/2020	EPI_ISL_647670	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B20EAB/2020	EPI_ISL_647676	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B20A4D/2020	EPI_ISL_647763	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B206EF/2020	EPI_ISL_647772	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B212CC/2020	EPI_ISL_647794	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/Wales/MILK-B0639D/2020	EPI_ISL_647820	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-B06236/2020	EPI_ISL_647823	2020-10-24	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/QEUH-AE1D13/2020	EPI_ISL_647874	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/QEUH-AE1C34/2020	EPI_ISL_647881	2020-10-26	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/PHWC-48A082/2020	EPI_ISL_652519	2020-11-03	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1	G
hCoV-19/Wales/PHWC-48A152/2020	EPI_ISL_652527	2020-10-29	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-A9D165/2020	EPI_ISL_652659	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-A9F840/2020	EPI_ISL_652682	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.67	GR
hCoV-19/Wales/QEUH-A9F9A7/2020	EPI_ISL_652689	2020-10-19	Europe / United Kingdom / Wales	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-AA00AE/2020	EPI_ISL_652706	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-AA0114/2020	EPI_ISL_652708	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-AAA8AC/2020	EPI_ISL_652716	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAAC73/2020	EPI_ISL_652737	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAAE13/2020	EPI_ISL_652746	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAAF4D/2020	EPI_ISL_652756	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAB01C/2020	EPI_ISL_652766	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAB45C/2020	EPI_ISL_652791	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAC136/2020	EPI_ISL_652845	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAC6EC/2020	EPI_ISL_652867	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAC6FB/2020	EPI_ISL_652868	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAC85F/2020	EPI_ISL_652877	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAC88C/2020	EPI_ISL_652879	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAC92F/2020	EPI_ISL_652883	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Scotland/QEUH-AAC9F2/2020	EPI_ISL_652884	2020-10-21	Europe / United Kingdom / Scotland	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AACD9C/2020	EPI_ISL_652915	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AADB28/2020	EPI_ISL_652947	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AADDC8/2020	EPI_ISL_652949	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AADED4/2020	EPI_ISL_652959	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAEA2A/2020	EPI_ISL_652978	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAEA75/2020	EPI_ISL_652980	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.532	GR
hCoV-19/England/QEUH-AAEAFD/2020	EPI_ISL_652983	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.532	GR
hCoV-19/England/QEUH-AAEB36/2020	EPI_ISL_652986	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAEC60/2020	EPI_ISL_652993	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAEC7F/2020	EPI_ISL_652994	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/QEUH-AAECAC/2020	EPI_ISL_652997	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/Spain/MD-IBV-99009632/2020	EPI_ISL_654369	2020-08-06	Europe / Spain / Madrid / Madrid	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1.269	GR
hCoV-19/Sweden/20-52706/2020	EPI_ISL_654507	2020-06-14	Europe / Sweden / Jonkoping	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.261	GR
hCoV-19/Sweden/20-23680/2020	EPI_ISL_654508	2020-10-05	Europe / Sweden	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins	Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Spain/CT-IBV-97007979/2020	EPI_ISL_654520	2020-09-22	Europe / Spain / Catalunya / Badalona	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1.39	GR
hCoV-19/Spain/CT-IBV-97007980/2020	EPI_ISL_654521	2020-09-30	Europe / Spain / Catalunya / Badalona	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1.39	GR
hCoV-19/Spain/CT-IBV-97007953/2020	EPI_ISL_654538	2020-09-21	Europe / Spain / Catalunya / Badalona	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1.39	GR
hCoV-19/Spain/AS-IBV-98006608/2020	EPI_ISL_654652	2020-03-13	Europe / Spain / Asturias / Oviedo	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/USA/MN-MDH-2022/2020	EPI_ISL_654703	2020-11-02	North America / USA / Minnesota	Human	Original			Illumina MiSeq	minimap2/ivar			B.1	G
hCoV-19/Sweden/20-52716/2020	EPI_ISL_654899	2020-07-07	Europe / Sweden / Jonkoping	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Sweden/20-22124/2020	EPI_ISL_654943	2020-07-14	Europe / Sweden / Orebro	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Sweden/20-52831/2020	EPI_ISL_654956	2020-09-07	Europe / Sweden / Vastra Gotaland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins	Insertion of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/QEUH-B7F20B/2020	EPI_ISL_668001	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B7981E/2020	EPI_ISL_668002	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B78ED1/2020	EPI_ISL_668068	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B790CB/2020	EPI_ISL_668069	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B79A54/2020	EPI_ISL_668072	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B7EA31/2020	EPI_ISL_668096	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B79966/2020	EPI_ISL_668122	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B80674/2020	EPI_ISL_668165	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/QEUH-B7C07D/2020	EPI_ISL_668203	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B814C4/2020	EPI_ISL_668231	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/QEUH-B7FD37/2020	EPI_ISL_668241	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B77D3F/2020	EPI_ISL_668251	2020-11-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B7C15C/2020	EPI_ISL_668259	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B7C110/2020	EPI_ISL_668287	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B7E8A0/2020	EPI_ISL_668330	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B806ED/2020	EPI_ISL_668360	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.408	G
hCoV-19/Denmark/DCGC-9473/2020	EPI_ISL_668720	2020-11-09	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.159	GR
hCoV-19/Denmark/DCGC-9247/2020	EPI_ISL_668872	2020-11-16	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.398	G
hCoV-19/Denmark/DCGC-9458/2020	EPI_ISL_668981	2020-11-09	Europe / Denmark / Syddanmark	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1	GR
hCoV-19/Denmark/DCGC-9476/2020	EPI_ISL_668990	2020-11-09	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.398	G
hCoV-19/Denmark/DCGC-9485/2020	EPI_ISL_668995	2020-11-09	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.398	G
hCoV-19/Ecuador/UEES-7463/2020	EPI_ISL_672001	2020	South America / Ecuador	Human	Original	Nasopharyngeal swab		Illumina MiniSeq	Sophia Genetics			B.1.1	GR
hCoV-19/Ecuador/UEES-7501/2020	EPI_ISL_672008	2020	South America / Ecuador	Human	Original	Nasopharyngeal swab		Illumina MiniSeq	Sophia Genetics			B.1.1	GR
hCoV-19/Ecuador/UEES-7332/2020	EPI_ISL_672011	2020	South America / Ecuador	Human	Original	Nasopharyngeal swab		Illumina MiniSeq	Sophia Genetics			B.1.1.411	GR
hCoV-19/USA/CA-CZB-5745/2020	EPI_ISL_672087	2020-07-14	North America / USA / California / San Luis Obispo County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar	NS8_E19stop results in 85.1% truncation of the protein sequence.	info	B.1	G
hCoV-19/USA/CA-CZB-13501/2020	EPI_ISL_672098	2020-10-28	North America / USA / California / Madera County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.239	GR
hCoV-19/USA/CA-CZB-13497/2020	EPI_ISL_672099	2020-10-28	North America / USA / California / Madera County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.239	GR
hCoV-19/USA/CA-CZB-13491/2020	EPI_ISL_672100	2020-10-23	North America / USA / California / Madera County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.239	G
hCoV-19/USA/CA-CZB-13471/2020	EPI_ISL_672101	2020-10-22	North America / USA / California / Madera County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.239	G
hCoV-19/USA/CA-CZB-13470/2020	EPI_ISL_672102	2020-10-22	North America / USA / California / Madera County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.239	G
hCoV-19/USA/CA-CZB-9552/2020	EPI_ISL_672130	2020-04-14	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.61	GR
hCoV-19/USA/CA-CZB-10006/2020	EPI_ISL_672185	2020-07-11	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1	G
hCoV-19/USA/CA-CZB-10013/2020	EPI_ISL_672189	2020-04-09	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1	G
hCoV-19/USA/CA-CZB-10039/2020	EPI_ISL_672196	2020-06-12	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1	G
hCoV-19/USA/CA-CZB-5757/2020	EPI_ISL_672358	2020-07-17	North America / USA / California / San Luis Obispo County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1	G
hCoV-19/USA/CA-CZB-12951/2020	EPI_ISL_672372	2020-09-23	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1	GR
hCoV-19/USA/UT-UPHL-201225905/2020	EPI_ISL_672550	2020-03-31	North America / USA / Utah	Human	Original			Illumina MiSeq	BWA + Ivar 1.2.2			B.1	G
hCoV-19/England/QEUH-BA3426/2020	EPI_ISL_672770	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-BA13A3/2020	EPI_ISL_672805	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-BA3392/2020	EPI_ISL_672837	2020-11-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Portugal/PT0022/2020	EPI_ISL_418007	2020-03-13	Europe / Portugal	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0034/2020	EPI_ISL_418019	2020-03-15	Europe / Portugal	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	INSaFLU			B.1.1	GR
hCoV-19/Portugal/PT0038/2020	EPI_ISL_418023	2020-03-17	Europe / Portugal	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	INSaFLU			B.1.1	GR
hCoV-19/Greece/10/2020	EPI_ISL_418263	2020-03-18	Europe / Greece / Athens	Human	Original							B.59	GR
hCoV-19/England/SHEF-BFF9A/2020	EPI_ISL_418316	2020-03-25	Europe / United Kingdom / England / South Yorkshire	Human	Original	Nose and Throat swab		Nanopore		Stretches of NNNs (1.37% of overall sequence).		B.1.1.137	GR
hCoV-19/England/SHEF-BFFB8/2020	EPI_ISL_418318	2020-03-25	Europe / United Kingdom / England / South Yorkshire	Human	Original	Nose and Throat swab		Nanopore				B.1.1.137	GR
hCoV-19/Belgium/ULG-9634/2020	EPI_ISL_418651	2020-03-22	Europe / Belgium / Liège	Human	Original	Nasopharyngeal swab		Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/Belgium/ULG-9735/2020	EPI_ISL_418661	2020-03-22	Europe / Belgium / Liège	Human	Original	Nasopharyngeal swab		Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/Belgium/ULG-9741/2020	EPI_ISL_418664	2020-03-22	Europe / Belgium / Liège	Human	Original	Nasopharyngeal swab		Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/England/20124096802/2020	EPI_ISL_418733	2020-03-18	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Canada/MB_10/2020	EPI_ISL_418813	2020-03-13	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.1	GR
hCoV-19/England/20146025304/2020	EPI_ISL_423582	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20148004704/2020	EPI_ISL_423587	2020-04-03	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.164	GR
hCoV-19/England/20132108504/2020	EPI_ISL_423851	2020-03-23	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.164	GR
hCoV-19/England/20129000404/2020	EPI_ISL_423973	2020-03-20	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/CAMB-7476C/2020	EPI_ISL_425332	2020-03-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore MinION		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/CAMB-76DB3/2020	EPI_ISL_425428	2020-03-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore MinION				B.1.1	GR
hCoV-19/England/NOTT-10E5A8/2020	EPI_ISL_425565	2020-03-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/NOTT-10E8FA/2020	EPI_ISL_425611	2020-03-29	Europe / United Kingdom / England	Human	Original			Oxford Nanopore GridION				B.1	G
hCoV-19/Scotland/CVR74/2020	EPI_ISL_425804	2020-03-07	Europe / United Kingdom / Scotland	Human	Original			ILLUMINA MiSeq				B.1.1	GR
hCoV-19/Scotland/EDB016/2020	EPI_ISL_425822	2020-03-11	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore MinION				B.1.1	GR
hCoV-19/Scotland/EDB300/2020	EPI_ISL_425967	2020-03-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/Scotland/EDB378/2020	EPI_ISL_425987	2020-03-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/Scotland/EDB396/2020	EPI_ISL_425996	2020-03-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1.1	GR
hCoV-19/England/CAMB-75AF9/2020	EPI_ISL_438319	2020-03-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E19stop results in 85.1% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/England/CAMB-75D1E/2020	EPI_ISL_438355	2020-03-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-75FCD/2020	EPI_ISL_438360	2020-03-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-762D2/2020	EPI_ISL_438362	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.13	GR
hCoV-19/England/CAMB-81034/2020	EPI_ISL_438558	2020-04-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-811AA/2020	EPI_ISL_438577	2020-04-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-81E1C/2020	EPI_ISL_438581	2020-04-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-725BF/2020	EPI_ISL_439905	2020-03-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-720DC/2020	EPI_ISL_439934	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-71CBB/2020	EPI_ISL_439947	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.13	GR
hCoV-19/England/CAMB-7EAD2/2020	EPI_ISL_443003	2020-04-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.198	GR
hCoV-19/England/CAMB-7E94E/2020	EPI_ISL_443074	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Singapore/97/2020	EPI_ISL_443189	2020-03-18	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/Singapore/105/2020	EPI_ISL_443197	2020-03-18	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1.71	GR
hCoV-19/Singapore/127/2020	EPI_ISL_443219	2020-03-20	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/Singapore/157/2020	EPI_ISL_443249	2020-03-20	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1.71	GR
hCoV-19/France/BRE-5325/2020	EPI_ISL_443267	2020-03-18	Europe / France / Bretagne / Brest	Human	Original	Nasopharyngeal swab		Illumina NextSeq 500	CLC Genomics Suite			B.1.1.254	GR
hCoV-19/France/BRE-5447/2020	EPI_ISL_443280	2020-04-01	Europe / France / Bretagne / Brest	Human	Original	Nasopharyngeal swab		Illumina NextSeq 500	CLC Genomics Suite			B.1.1	GR
hCoV-19/England/CAMB-830E7/2020	EPI_ISL_443386	2020-04-13	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1.379	GR
hCoV-19/England/CAMB-830AB/2020	EPI_ISL_443402	2020-04-14	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-82D3C/2020	EPI_ISL_443427	2020-04-12	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1.13	GR
hCoV-19/England/CAMB-82974/2020	EPI_ISL_443535	2020-04-14	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-843FC/2020	EPI_ISL_443566	2020-04-16	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-82446/2020	EPI_ISL_443592	2020-04-12	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1.194	GR
hCoV-19/England/BRIS-125D1C/2020	EPI_ISL_443691	2020-03-30	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1	GR
hCoV-19/England/BRIS-125909/2020	EPI_ISL_443774	2020-03-29	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-125BF4/2020	EPI_ISL_443781	2020-03-30	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-124C89/2020	EPI_ISL_443835	2020-03-26	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-124CA7/2020	EPI_ISL_443862	2020-03-26	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1258C0/2020	EPI_ISL_443866	2020-03-29	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-124D0E/2020	EPI_ISL_443897	2020-03-26	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1252B3/2020	EPI_ISL_443904	2020-03-26	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-125B4F/2020	EPI_ISL_443916	2020-03-30	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-125CC4/2020	EPI_ISL_443922	2020-03-30	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/BRIS-12549F/2020	EPI_ISL_443936	2020-03-26	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1.71	GR
hCoV-19/England/BRIS-1251B6/2020	EPI_ISL_443938	2020-03-27	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-125972/2020	EPI_ISL_443968	2020-03-29	Europe / United Kingdom / England	Human	Original		unknown	Illumina NovaSeq				B.1.1.164	GR
hCoV-19/Canada/Qc-LSPQ-L00241192/2020	EPI_ISL_450312	2020-03-27	North America / Canada / Quebec	Human	Original			MGI		Stretches of NNNs (2.43% of overall sequence).	warn	B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00241245/2020	EPI_ISL_450315	2020-03-27	North America / Canada / Quebec	Human	Original			MGI				B.1	G
hCoV-19/USA/UT-03486/2020	EPI_ISL_450548	2020-04-03	North America / USA / Utah	Human	Original			Illumina MiSeq	BWA + Ivar 1.2			B.1	G
hCoV-19/Scotland/EDB5351/2020	EPI_ISL_457006	2020-05-23	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/England/EXET-1354AB/2020	EPI_ISL_457066	2020-04-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/EXET-13570C/2020	EPI_ISL_457090	2020-04-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/EXET-135766/2020	EPI_ISL_457095	2020-04-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/EXET-135775/2020	EPI_ISL_457096	2020-04-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/EXET-135906/2020	EPI_ISL_457115	2020-04-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/EXET-135933/2020	EPI_ISL_457117	2020-04-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/EXET-135A6D/2020	EPI_ISL_457130	2020-04-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/EXET-135AA9/2020	EPI_ISL_457132	2020-03-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/EXET-135B5B/2020	EPI_ISL_457137	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.164	GR
hCoV-19/England/EXET-135BC4/2020	EPI_ISL_457143	2020-04-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.164	GR
hCoV-19/England/EXET-135C3A/2020	EPI_ISL_457149	2020-04-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.164	GR
hCoV-19/England/EXET-135CA3/2020	EPI_ISL_457153	2020-04-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.164	GR
hCoV-19/England/EXET-135D91/2020	EPI_ISL_457164	2020-04-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/EXET-1360C4/2020	EPI_ISL_457196	2020-04-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.164	GR
hCoV-19/England/EXET-136352/2020	EPI_ISL_457222	2020-04-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.164	GR
hCoV-19/England/EXET-1363CB/2020	EPI_ISL_457224	2020-04-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.164	GR
hCoV-19/England/EXET-136871/2020	EPI_ISL_457238	2020-04-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.164	GR
hCoV-19/England/EXET-136C57/2020	EPI_ISL_457258	2020-04-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.164	GR
hCoV-19/England/LOND-D58C0/2020	EPI_ISL_457273	2020-04-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D58DF/2020	EPI_ISL_457274	2020-04-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.164	GR
hCoV-19/England/LOND-D5918/2020	EPI_ISL_457278	2020-04-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D5945/2020	EPI_ISL_457281	2020-04-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D5990/2020	EPI_ISL_457284	2020-04-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D59AF/2020	EPI_ISL_457285	2020-04-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D59FA/2020	EPI_ISL_457289	2020-04-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORW-EACBD/2020	EPI_ISL_457368	2020-05-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-EAD80/2020	EPI_ISL_457374	2020-04-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-EB00B/2020	EPI_ISL_457405	2020-04-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-EB029/2020	EPI_ISL_457407	2020-04-30	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-EBBA0/2020	EPI_ISL_457485	2020-05-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/NORW-EC8B7/2020	EPI_ISL_457569	2020-05-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/SHEF-C27F6/2020	EPI_ISL_457594	2020-05-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C3C50/2020	EPI_ISL_457602	2020-04-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.137	GR
hCoV-19/England/SHEF-C8514/2020	EPI_ISL_457627	2020-04-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.137	GR
hCoV-19/England/SHEF-CDA2F/2020	EPI_ISL_457659	2020-04-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.137	GR
hCoV-19/England/SHEF-D0F75/2020	EPI_ISL_457680	2020-03-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.137	GR
hCoV-19/Oman/205028718/2020	EPI_ISL_457702	2020-04-12	Asia / Oman / Muscat	Human	Original	Oropharyngeal swab		Ion Torrent	AssemblyTrinity			B.1.1	GR
hCoV-19/Italy/AVA-AMVRC-4875/2020	EPI_ISL_457724	2020-03-15	Europe / Italy / Valle d'Aosta	Human	Vero E6			Illumina MiSeq				B.1.1	GR
hCoV-19/Kenya/NIC_087/2020	EPI_ISL_457829	2020-03	Africa / Kenya	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/England/BRIS-1261A6/2020	EPI_ISL_459005	2020-04-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-126470/2020	EPI_ISL_459014	2020-04-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-126795/2020	EPI_ISL_459015	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/BRIS-126856/2020	EPI_ISL_459038	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1260E5/2020	EPI_ISL_459064	2020-04-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Northern Ireland/NIRE-FBA64/2020	EPI_ISL_459331	2020-04-11	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-FAB17/2020	EPI_ISL_459344	2020-04-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-FA801/2020	EPI_ISL_459382	2020-04-15	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Canada/BC_27285211/2020	EPI_ISL_463268	2020-03	North America / Canada / British Columbia	Human	Original			Oxford Nanopore	ARTIC protocol			B.1.1	GR
hCoV-19/England/20118051204/2020	EPI_ISL_464925	2020-03-13	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Hungary/UD-9953/2020	EPI_ISL_477013	2020-04-22	Europe / Hungary / Szabolcs-Szatmar-Bereg County	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic network protocol			B.59	GR
hCoV-19/Scotland/CVR1898/2020	EPI_ISL_477828	2020-04-08	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/CVR2251/2020	EPI_ISL_477885	2020-04-12	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.43	GR
hCoV-19/Scotland/CVR2306/2020	EPI_ISL_477898	2020-04-13	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.43	GR
hCoV-19/Scotland/CVR2371/2020	EPI_ISL_477920	2020-04-13	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/CVR2421/2020	EPI_ISL_477936	2020-04-14	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/CVR2441/2020	EPI_ISL_477939	2020-04-14	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.43	GR
hCoV-19/Scotland/CVR2517/2020	EPI_ISL_477960	2020-04-15	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.164	GR
hCoV-19/Scotland/CVR2566/2020	EPI_ISL_477973	2020-04-16	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/CVR2574/2020	EPI_ISL_477977	2020-04-16	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/CVR2619/2020	EPI_ISL_477989	2020-04-17	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.43	GR
hCoV-19/England/BRIS-12DBFC/2020	EPI_ISL_482001	2020-05-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12DC53/2020	EPI_ISL_482007	2020-05-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/TBSD-248909C/2020	EPI_ISL_482065	2020-04-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-101402/2020	EPI_ISL_482101	2020-04-29	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LOND-D6786/2020	EPI_ISL_482176	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/LOND-D67B3/2020	EPI_ISL_482186	2020-04-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/LOND-D66D4/2020	EPI_ISL_482187	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/LOND-D681A/2020	EPI_ISL_482200	2020-04-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/LOND-D615B/2020	EPI_ISL_482202	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/LOND-D6328/2020	EPI_ISL_482211	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LOND-D6795/2020	EPI_ISL_482212	2020-04-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/LOND-D614C/2020	EPI_ISL_482217	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/USA/OR-PROV-004/2020	EPI_ISL_482295	2020-04-04	North America / USA / Oregon	Human	Original			Illumina NovaSeq 6000	BWA mem, Freebayes, vcffilter, bcftools consensus (AF >=50%, min DP > 100)			B.1.1	GR
hCoV-19/Bangladesh/BCSIR-NILMRC-118a/2020	EPI_ISL_482487	2020-06-18	Asia / Bangladesh / Dhaka / Dhaka / Keraniganj Upazila	Human	Original	Nasopharyngeal swab		MiniSeq	DRAGEN RNA Pathogen Detection 3.5.14			B.1.1	GR
hCoV-19/Bangladesh/BCSIR-NILMRC-118/2020	EPI_ISL_482700	2020-06-18	Asia / Bangladesh / Dhaka / Dhaka / Keraniganj Upazila	Human	Original	Nasopharyngeal swab		MiniSeq	DRAGEN RNA Pathogen Detection 3.5.14			B.1.1	GR
hCoV-19/Bangladesh/BCSIR-NILMRC-004-2/2020	EPI_ISL_482701	2020-05-21	Asia / Bangladesh / Dhaka / Dhaka / Uttara	Human	Original	Nasopharyngeal swab		Illumina Nextseq 550	DRAGEN RNA Pathogen Detection 3.5.14			B.1.1.25	GR
hCoV-19/South Africa/KRISP-0175/2020	EPI_ISL_482702	2020-06-05	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-0178/2020	EPI_ISL_482704	2020-06-05	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1	GR
hCoV-19/South Africa/KRISP-0190/2020	EPI_ISL_482709	2020-06-06	Africa / South Africa / KwaZulu-Natal	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/England/GSTT-265D703/2020	EPI_ISL_484002	2020-03-24	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/GSTT-265DBE9/2020	EPI_ISL_484079	2020-03-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/GSTT-265DC5F/2020	EPI_ISL_484085	2020-03-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/GSTT-265DFB0/2020	EPI_ISL_484134	2020-03-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/GSTT-265E070/2020	EPI_ISL_484145	2020-03-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-29DC8A/2020	EPI_ISL_484313	2020-05-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NOTT-112143/2020	EPI_ISL_484346	2020-06-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.171	GR
hCoV-19/England/NOTT-112301/2020	EPI_ISL_484369	2020-04-22	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NOTT-11232F/2020	EPI_ISL_484371	2020-05-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NOTT-11251A/2020	EPI_ISL_484389	2020-05-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/PORT-2D115E/2020	EPI_ISL_484407	2020-06-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.194	GR
hCoV-19/Switzerland/ZH-ETHZ-190005/2020	EPI_ISL_498623	2020-07-03	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/USA/CA-QDX-221/2020	EPI_ISL_498697	2020-04-10	North America / USA / California	Human	Original			Illumina MiSeq	BWA v. 0.7.17-r1188; IVar 1.2.2			B.59	GR
hCoV-19/USA/NC-QDX-253/2020	EPI_ISL_498732	2020-04-30	North America / USA / North Carolina	Human	Original			Illumina MiSeq	BWA v. 0.7.17-r1188; IVar 1.2.2			B.1.1	GR
hCoV-19/USA/NC-QDX-254/2020	EPI_ISL_498733	2020-04-30	North America / USA / North Carolina	Human	Original			Illumina MiSeq	BWA v. 0.7.17-r1188; IVar 1.2.2			B.1.1	GR
hCoV-19/Bangladesh/BCSIR-NILMRC-306/2020	EPI_ISL_498786	2020-07-18	Asia / Bangladesh / Sylhet / Moulvibazar	Human	Original	Nasopharyngeal swab		NextSeq 550	DRAGEN RNA Pathogen Detection 3.5.14			B.1.1.25	GR
hCoV-19/Bangladesh/BCSIR-NILMRC-328/2020	EPI_ISL_498794	2020-06-03	Asia / Bangladesh / Mymensingh	Human	Original	Nasopharyngeal swab		NextSeq 550	DRAGEN RNA Pathogen Detection 3.5.14			B.1.1.25	GR
hCoV-19/Bangladesh/BCSIR-NILMRC-338/2020	EPI_ISL_498797	2020-07-15	Asia / Bangladesh / Rajshahi	Human	Original	Nasopharyngeal swab		NextSeq 550	DRAGEN RNA Pathogen Detection 3.5.14			B.1.1.25	GR
hCoV-19/USA/MI-MDHHS-SC21685/2020	EPI_ISL_516412	2020-07-08	North America / USA / Michigan	Human	Original			Illumina MiSeq	bwa v. 0.7.17; bcftools v. 1.7			B.1.1.437	GR
hCoV-19/USA/WI-UW-1077/2020	EPI_ISL_516503	2020-07-26	North America / USA / Wisconsin / Dane County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	Custom -- minimap2			B.1.1.437	GR
hCoV-19/USA/WI-UW-1078/2020	EPI_ISL_516504	2020-07-26	North America / USA / Wisconsin / Rock County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	Custom -- minimap2			B.1	G
hCoV-19/Switzerland/AG-ETHZ-230003/2020	EPI_ISL_516554	2020-07-31	Europe / Switzerland / Aargau	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/AG-ETHZ-230004/2020	EPI_ISL_516555	2020-07-31	Europe / Switzerland / Aargau	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/SZ-ETHZ-230005/2020	EPI_ISL_516556	2020-07-31	Europe / Switzerland / Schwyz	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BL-ETHZ-230017/2020	EPI_ISL_516560	2020-08-02	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/Switzerland/ZH-ETHZ-230031/2020	EPI_ISL_516572	2020-08-04	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-230032/2020	EPI_ISL_516573	2020-08-04	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-230033/2020	EPI_ISL_516574	2020-08-04	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-230036/2020	EPI_ISL_516576	2020-08-04	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-230037/2020	EPI_ISL_516577	2020-08-04	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe	NSP11 without BLAST coverage.	warn	B.1.236	G
hCoV-19/Switzerland/ZH-ETHZ-230042/2020	EPI_ISL_516581	2020-08-03	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-230043/2020	EPI_ISL_516582	2020-08-03	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/SZ-ETHZ-230044/2020	EPI_ISL_516583	2020-08-03	Europe / Switzerland / Schwyz	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-230045/2020	EPI_ISL_516584	2020-08-03	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/Switzerland/BL-ETHZ-230046/2020	EPI_ISL_516585	2020-08-04	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BL-ETHZ-230047/2020	EPI_ISL_516586	2020-08-04	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.406	GR
hCoV-19/Switzerland/BE-ETHZ-230052/2020	EPI_ISL_516590	2020-08-04	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-230055/2020	EPI_ISL_516592	2020-08-05	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-230058/2020	EPI_ISL_516594	2020-08-05	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-230059/2020	EPI_ISL_516595	2020-08-05	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-230060/2020	EPI_ISL_516596	2020-08-05	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-230070/2020	EPI_ISL_516605	2020-08-05	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/USA/VA-DCLS-0840/2020	EPI_ISL_516707	2020-05-05	North America / USA / Virginia	Human	Original			Illumina MiSeq	minimap2/ivar			B.1.1.231	GR
hCoV-19/USA/CA-CZB-3652/2020	EPI_ISL_516727	2020-07-18	North America / USA / California / Madera County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	minimap2 / iVar			B.1.1.139	GR
hCoV-19/USA/SC-20-1568-T07/2020	EPI_ISL_516768	2020-07-07	North America / USA / South Carolina	Human	Original			Ion Torrent				B.1	G
hCoV-19/USA/SC-20-1577-T07/2020	EPI_ISL_516770	2020-07-07	North America / USA / South Carolina	Human	Original			Ion Torrent				B.1	G
hCoV-19/USA/SC-20-1936-T00/2020	EPI_ISL_516779	2020-07-15	North America / USA / South Carolina	Human	Original			Ion Torrent				B.1	G
hCoV-19/England/LOND-125F814/2020	EPI_ISL_516873	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LOND-125FD9D/2020	EPI_ISL_516877	2020-04-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Moldova/ICGEB_MD1/2020	EPI_ISL_516934	2020-06-18	Europe / Moldova / Chisinau	Human	Original	Nasopharyngeal swab		Illumina Nano Miseq	MEGAHIT v1.2.9			B.1.1	GR
hCoV-19/Moldova/ICGEB_MD6/2020	EPI_ISL_516938	2020-06-17	Europe / Moldova / Rabnita	Human	Original	Nasopharyngeal swab		Illumina Nano Miseq	MEGAHIT v1.2.9Ni			B.1.1	GR
hCoV-19/England/CAMB-1B5B35/2020	EPI_ISL_516995	2020-08-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/CAMB-1B5B44/2020	EPI_ISL_516996	2020-08-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/South Africa/KRISP-K002455/2020	EPI_ISL_518041	2020-07-13	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002456/2020	EPI_ISL_518042	2020-07-09	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002457/2020	EPI_ISL_518043	2020-07-07	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002464/2020	EPI_ISL_518047	2020-07-14	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002465/2020	EPI_ISL_518048	2020-06-25	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K002474/2020	EPI_ISL_518052	2020-06-29	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/Netherlands/ZH-EMC-419/2020	EPI_ISL_523759	2020-08-10	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.1.39	GR
hCoV-19/Netherlands/ZH-EMC-424/2020	EPI_ISL_523763	2020-08-11	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-240005/2020	EPI_ISL_523860	2020-08-07	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BE-ETHZ-240015/2020	EPI_ISL_523866	2020-08-08	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe	NSP11 without BLAST coverage.	warn	B.1.236	G
hCoV-19/Switzerland/ZH-ETHZ-240047/2020	EPI_ISL_523889	2020-08-12	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BL-ETHZ-240050/2020	EPI_ISL_523891	2020-08-12	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-240051/2020	EPI_ISL_523892	2020-08-12	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BE-ETHZ-240055/2020	EPI_ISL_523896	2020-08-12	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-240060/2020	EPI_ISL_523900	2020-08-12	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BE-ETHZ-240061/2020	EPI_ISL_523901	2020-08-13	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe	NSP11 without BLAST coverage.	warn	B.1.236	G
hCoV-19/Switzerland/BE-ETHZ-240065/2020	EPI_ISL_523905	2020-08-13	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BE-ETHZ-240066/2020	EPI_ISL_523906	2020-08-13	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-240071/2020	EPI_ISL_523909	2020-08-09	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/SO-ETHZ-240073/2020	EPI_ISL_523911	2020-08-10	Europe / Switzerland / Solothurn	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/Switzerland/ZH-ETHZ-240075/2020	EPI_ISL_523913	2020-08-10	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.269	O
hCoV-19/Switzerland/BE-ETHZ-240080/2020	EPI_ISL_523918	2020-08-11	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BE-ETHZ-240086/2020	EPI_ISL_523922	2020-08-12	Europe / Switzerland / Bern	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe	NSP11 without BLAST coverage.	warn	B.1.236	G
hCoV-19/Switzerland/ZH-ETHZ-240091/2020	EPI_ISL_523926	2020-08-13	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/Canada/Qc-LSPQ-L00232941/2020	EPI_ISL_536002	2020-03-22	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00233003/2020	EPI_ISL_536006	2020-03-22	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00233038/2020	EPI_ISL_536007	2020-03-22	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00233115/2020	EPI_ISL_536009	2020-03-22	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00234302/2020	EPI_ISL_536050	2020-03-23	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00234347/2020	EPI_ISL_536052	2020-03-23	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00234442/2020	EPI_ISL_536054	2020-03-23	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00234639/2020	EPI_ISL_536065	2020-03-23	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00234652/2020	EPI_ISL_536066	2020-03-23	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00234877/2020	EPI_ISL_536076	2020-03-23	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00234887/2020	EPI_ISL_536079	2020-03-23	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00235107/2020	EPI_ISL_536086	2020-03-23	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00235295/2020	EPI_ISL_536094	2020-03-24	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1	G
hCoV-19/Canada/Qc-LSPQ-L00235424/2020	EPI_ISL_536097	2020-03-24	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00235607/2020	EPI_ISL_536102	2020-03-24	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00236212/2020	EPI_ISL_536120	2020-03-24	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00236215/2020	EPI_ISL_536121	2020-03-24	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00236430/2020	EPI_ISL_536130	2020-03-24	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1	GR
hCoV-19/Canada/Qc-LSPQ-L00236536/2020	EPI_ISL_536134	2020-03-24	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00236620/2020	EPI_ISL_536144	2020-03-24	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00236905/2020	EPI_ISL_536151	2020-03-25	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00236922/2020	EPI_ISL_536152	2020-03-25	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00236940/2020	EPI_ISL_536153	2020-03-25	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00236943/2020	EPI_ISL_536154	2020-03-25	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00237011/2020	EPI_ISL_536157	2020-03-25	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1.176	GR
hCoV-19/Canada/Qc-LSPQ-L00237886/2020	EPI_ISL_536198	2020-03-25	North America / Canada / Quebec	Human	Original			Illumina NexteraFlex				B.1.1.176	GR
hCoV-19/USA/WI-UW-1228/2020	EPI_ISL_536601	2020-08-15	North America / USA / Wisconsin / Dane County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	custom -- minimap2			B.1.1.362	GR
hCoV-19/USA/WI-UW-1235/2020	EPI_ISL_536608	2020-08-17	North America / USA / Wisconsin / Dane County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	custom -- minimap2			B.1.240	G
hCoV-19/USA/WI-UW-1260/2020	EPI_ISL_536633	2020-08-21	North America / USA / Wisconsin / Dane County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	custom -- minimap2			B.1.240	G
hCoV-19/USA/WI-UW-1279/2020	EPI_ISL_536651	2020-08-21	North America / USA / Wisconsin / Dane County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	custom -- minimap2			B.1.240	G
hCoV-19/USA/WI-UW-1283/2020	EPI_ISL_536655	2020-08-21	North America / USA / Wisconsin / Dane County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	custom -- minimap2			B.1.240	G
hCoV-19/USA/WI-UW-1303/2020	EPI_ISL_536675	2020-08-29	North America / USA / Wisconsin / Dane County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	custom -- minimap2			B.1.240	G
hCoV-19/USA/WI-UW-1361/2020	EPI_ISL_536732	2020-09-07	North America / USA / Wisconsin / Dane County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	custom -- minimap2			B.1.1	GR
hCoV-19/USA/WI-UW-1368/2020	EPI_ISL_536739	2020-09-08	North America / USA / Wisconsin / Dane County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	custom -- minimap2			B.1.1	G
hCoV-19/USA/WI-UW-1370/2020	EPI_ISL_536741	2020-09-05	North America / USA / Wisconsin / Dane County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	custom -- minimap2			B.1.1	GR
hCoV-19/USA/WI-UW-1374/2020	EPI_ISL_536745	2020-09-04	North America / USA / Wisconsin / Dane County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	custom -- minimap2			B.1.1	GR
hCoV-19/USA/WI-UW-1375/2020	EPI_ISL_536746	2020-09-05	North America / USA / Wisconsin / Dane County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	custom -- minimap2			B.1.1	GR
hCoV-19/USA/WI-UW-1384/2020	EPI_ISL_536755	2020-09-05	North America / USA / Wisconsin / Dane County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	custom -- minimap2			B.1.1	GR
hCoV-19/England/QEUH-963AC8/2020	EPI_ISL_536825	2020-08-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-964371/2020	EPI_ISL_536841	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-96A214/2020	EPI_ISL_536863	2020-08-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9643AE/2020	EPI_ISL_536881	2020-08-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/QEUH-96446F/2020	EPI_ISL_536885	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/QEUH-964696/2020	EPI_ISL_536896	2020-08-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/USA/FL-BPHL-1203/2020	EPI_ISL_541176	2020-07-22	North America / USA / Florida	Human	Original			Illumina	Bwa v. 0.7.17; ivar v. 1.2.2			B.1.1.231	GR
hCoV-19/USA/FL-BPHL-1347/2020	EPI_ISL_541285	2020-07-15	North America / USA / Florida	Human	Original			Illumina	Bwa v. 0.7.17; ivar v. 1.2.2			B.1.1	GR
hCoV-19/Brazil/SE-FIOCRUZ-6529/2020	EPI_ISL_541372	2020-03-27	South America / Brazil / Sergipe / Aracaju	Human	Original	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 12			B.1.1.28	GR
hCoV-19/Brazil/SE-FIOCRUZ-6530/2020	EPI_ISL_541373	2020-03-20	South America / Brazil / Sergipe / Aracaju	Human	Original	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 12			B.59	GR
hCoV-19/Brazil/SE-FIOCRUZ-6533/2020	EPI_ISL_541374	2020-03-19	South America / Brazil / Sergipe / Aracaju	Human	Original	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 12			B.1.1	GR
hCoV-19/Brazil/SE-FIOCRUZ-6544/2020	EPI_ISL_541378	2020-04-26	South America / Brazil / Sergipe / Estancia	Human	Original	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 12			B.1.1	GR
hCoV-19/Brazil/SE-FIOCRUZ-6561/2020	EPI_ISL_541384	2020-04-27	South America / Brazil / Sergipe / Nossa Senhora do Socorro	Human	Original	Nasopharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 12			B.1.1	GR
hCoV-19/Switzerland/AG-ETHZ-270046/2020	EPI_ISL_541402	2020-09-01	Europe / Switzerland / Aargau	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/AG-ETHZ-270165/2020	EPI_ISL_541412	2020-08-28	Europe / Switzerland / Aargau	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/AG-ETHZ-270172/2020	EPI_ISL_541414	2020-08-29	Europe / Switzerland / Aargau	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BL-ETHZ-270134/2020	EPI_ISL_541450	2020-08-28	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BL-ETHZ-270149/2020	EPI_ISL_541452	2020-08-28	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BL-ETHZ-270150/2020	EPI_ISL_541453	2020-08-28	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BL-ETHZ-270159/2020	EPI_ISL_541455	2020-08-28	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/BL-ETHZ-270160/2020	EPI_ISL_541456	2020-08-28	Europe / Switzerland / Basel-Landschaft	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/ZH-ETHZ-270039/2020	EPI_ISL_541510	2020-09-02	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/Switzerland/ZH-ETHZ-270100/2020	EPI_ISL_541520	2020-09-03	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1	GR
hCoV-19/Switzerland/ZH-ETHZ-270119/2020	EPI_ISL_541522	2020-09-03	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/Switzerland/ZH-ETHZ-270128/2020	EPI_ISL_541523	2020-09-03	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.236	G
hCoV-19/USA/IL-UW-1439/2020	EPI_ISL_541540	2020-09-12	North America / USA / Illinois / Cook County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	custom -- minimap2			B.1.396	G
hCoV-19/USA/IL-UW-1488/2020	EPI_ISL_541543	2020-09-14	North America / USA / Illinois / Winnebago County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	custom -- minimap2			B.1.396	G
hCoV-19/USA/IL-UW-1490/2020	EPI_ISL_541544	2020-09-15	North America / USA / Illinois / Winnebago County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	custom -- minimap2			B.1.396	G
hCoV-19/USA/WI-UW-1486/2020	EPI_ISL_541616	2020-09-16	North America / USA / Wisconsin / Dane County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	custom -- minimap2			B.1.1	GR
hCoV-19/USA/WI-UW-1504/2020	EPI_ISL_541630	2020-09-15	North America / USA / Wisconsin / Dane County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	custom -- minimap2			B.1.1	GR
hCoV-19/USA/WI-UW-1506/2020	EPI_ISL_541632	2020-09-16	North America / USA / Wisconsin / Dane County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	custom -- minimap2			B.1.1	GR
hCoV-19/USA/WI-UW-1515/2020	EPI_ISL_541641	2020-09-16	North America / USA / Wisconsin / Dane County	Human	Original	Nasal swab		Nanopore GridION -- ARTIC protocol	custom -- minimap2			B.1.1	GR
hCoV-19/USA/SC-DHEC-1095/2020	EPI_ISL_541670	2020-07-10	North America / USA / South Carolina / Georgetown County	Human	Original	Nasopharyngeal swab		Illumina	DRAGEN v. 3.5.15			B.1	G
hCoV-19/USA/SC-DHEC-0935/2020	EPI_ISL_541674	2020-06-26	North America / USA / South Carolina / Horry County	Human	Original	Nasopharyngeal swab		Illumina	DRAGEN v. 3.5.15			B.1	G
hCoV-19/England/LOND-1286E30/2020	EPI_ISL_541760	2020-03-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/QEUH-9993A0/2020	EPI_ISL_541790	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-998FAD/2020	EPI_ISL_541800	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-99908B/2020	EPI_ISL_541803	2020-08-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-998FF8/2020	EPI_ISL_541810	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.269	GR
hCoV-19/England/QEUH-999407/2020	EPI_ISL_541815	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/QEUH-9990D6/2020	EPI_ISL_541834	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-99906D/2020	EPI_ISL_541836	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-998F52/2020	EPI_ISL_541837	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Lithuania/MR-LUHS-Eilnr7/2020	EPI_ISL_541870	2020-04-04	Europe / Lithuania / Kauno apskritis	Human	Original			Illumina NextSeq 550				B.1.1	GR
hCoV-19/USA/TX-HMH-3635/2020	EPI_ISL_543085	2020-06-15	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.396	G
hCoV-19/USA/TX-HMH-3645/2020	EPI_ISL_543091	2020-06-15	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.230	GR
hCoV-19/USA/TX-HMH-3747/2020	EPI_ISL_543159	2020-06-16	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.230	GR
hCoV-19/England/ALDP-9502C6/2020	EPI_ISL_555310	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.95	GR
hCoV-19/England/ALDP-9519C0/2020	EPI_ISL_555313	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/ALDP-94E0A3/2020	EPI_ISL_555323	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-951869/2020	EPI_ISL_555341	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9545C9/2020	EPI_ISL_555345	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95449F/2020	EPI_ISL_555365	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-94E119/2020	EPI_ISL_555380	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-95474B/2020	EPI_ISL_555404	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.203	GR
hCoV-19/England/ALDP-955A8D/2020	EPI_ISL_555414	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/ALDP-951A27/2020	EPI_ISL_555425	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9518D2/2020	EPI_ISL_555454	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-951887/2020	EPI_ISL_555456	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94DFF2/2020	EPI_ISL_555463	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.254	GR
hCoV-19/England/ALDP-951878/2020	EPI_ISL_555469	2020-06-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/ALDP-95ADBC/2020	EPI_ISL_555516	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/ALDP-95ACDD/2020	EPI_ISL_555520	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/ALDP-95AD8F/2020	EPI_ISL_555529	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-66A8D9/2020	EPI_ISL_555538	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-952446/2020	EPI_ISL_555559	2020-06-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-94E207/2020	EPI_ISL_555567	2020-06-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/ALDP-65CAB6/2020	EPI_ISL_555586	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94E2DA/2020	EPI_ISL_555619	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-65DB2B/2020	EPI_ISL_555634	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-6634FA/2020	EPI_ISL_555654	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-94E270/2020	EPI_ISL_555669	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-94E261/2020	EPI_ISL_555671	2020-06-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-661F46/2020	EPI_ISL_555684	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-95B058/2020	EPI_ISL_555698	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.253	GR
hCoV-19/England/ALDP-65D9C7/2020	EPI_ISL_555722	2020-07-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-95AD9E/2020	EPI_ISL_555744	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/ALDP-9449A2/2020	EPI_ISL_555758	2020-06-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/ALDP-95AEAA/2020	EPI_ISL_555761	2020-06-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94F7F8/2020	EPI_ISL_555764	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-94A9BB/2020	EPI_ISL_555782	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94A63C/2020	EPI_ISL_555795	2020-06-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/ALDP-94B53E/2020	EPI_ISL_555800	2020-06-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-94FAB3/2020	EPI_ISL_555801	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-94D0E0/2020	EPI_ISL_555834	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-94C6FE/2020	EPI_ISL_555849	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94CF5D/2020	EPI_ISL_555851	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-94CD08/2020	EPI_ISL_555857	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-949688/2020	EPI_ISL_555864	2020-07-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/CAMC-948CF0/2020	EPI_ISL_555875	2020-07-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-94F4E2/2020	EPI_ISL_555894	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94D183/2020	EPI_ISL_555912	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-94F637/2020	EPI_ISL_555924	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94CC83/2020	EPI_ISL_555963	2020-06-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94D11A/2020	EPI_ISL_555966	2020-06-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94F400/2020	EPI_ISL_555969	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94CEF6/2020	EPI_ISL_555975	2020-06-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-94F2AC/2020	EPI_ISL_555984	2020-06-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-8E2FF0/2020	EPI_ISL_557109	2020-06-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-8D4D06/2020	EPI_ISL_557127	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-8E2C53/2020	EPI_ISL_557135	2020-06-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-8D1255/2020	EPI_ISL_557136	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.203	GR
hCoV-19/England/ALDP-8DF7B2/2020	EPI_ISL_557157	2020-06-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-8D5619/2020	EPI_ISL_557163	2020-06-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-8FFDBA/2020	EPI_ISL_557164	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-878C34/2020	EPI_ISL_557168	2020-07-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/England/MILK-803C6B/2020	EPI_ISL_557172	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-8305A6/2020	EPI_ISL_557174	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.97	GR
hCoV-19/England/MILK-83247A/2020	EPI_ISL_557175	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.198	GR
hCoV-19/England/MILK-83A964/2020	EPI_ISL_557179	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.97	GR
hCoV-19/England/MILK-837C9B/2020	EPI_ISL_557183	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.15	GR
hCoV-19/England/MILK-818E9A/2020	EPI_ISL_557190	2020-07-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-848D67/2020	EPI_ISL_557191	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/England/MILK-828A57/2020	EPI_ISL_557212	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.231	G
hCoV-19/England/MILK-81D527/2020	EPI_ISL_557214	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.198	GR
hCoV-19/England/MILK-817D52/2020	EPI_ISL_557217	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/MILK-832823/2020	EPI_ISL_557221	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-8009A3/2020	EPI_ISL_557224	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.97	GR
hCoV-19/England/MILK-830360/2020	EPI_ISL_557251	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.97	GR
hCoV-19/England/MILK-84AE35/2020	EPI_ISL_557252	2020-07-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-854278/2020	EPI_ISL_557253	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.97	GR
hCoV-19/England/MILK-8054CB/2020	EPI_ISL_557257	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.39	GR
hCoV-19/England/MILK-8461E5/2020	EPI_ISL_557261	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-8328F6/2020	EPI_ISL_557263	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-85465E/2020	EPI_ISL_557279	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.97	GR
hCoV-19/England/MILK-800BDA/2020	EPI_ISL_557282	2020-07-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-848286/2020	EPI_ISL_557285	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.231	G
hCoV-19/England/MILK-830E9C/2020	EPI_ISL_557293	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-84490D/2020	EPI_ISL_557297	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-818DBB/2020	EPI_ISL_557298	2020-07-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-83982C/2020	EPI_ISL_557303	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-80900F/2020	EPI_ISL_557307	2020-07-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/MILK-84F8BA/2020	EPI_ISL_557311	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-829D4E/2020	EPI_ISL_557318	2020-07-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.231	G
hCoV-19/England/MILK-809755/2020	EPI_ISL_557321	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-82CCA8/2020	EPI_ISL_557327	2020-07-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.97	GR
hCoV-19/England/MILK-84D1B1/2020	EPI_ISL_557328	2020-07-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.25	GR
hCoV-19/England/MILK-817A4C/2020	EPI_ISL_557334	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/MILK-824174/2020	EPI_ISL_557336	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/MILK-878F95/2020	EPI_ISL_557342	2020-07-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.97	GR
hCoV-19/England/MILK-8327EA/2020	EPI_ISL_557344	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-83D8EC/2020	EPI_ISL_557347	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-6F2D8C/2020	EPI_ISL_557357	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.231	G
hCoV-19/England/MILK-6F7B8D/2020	EPI_ISL_557369	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.15	GR
hCoV-19/England/MILK-85D321/2020	EPI_ISL_557372	2020-07-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.97	GR
hCoV-19/England/ALDP-6FBFF6/2020	EPI_ISL_557373	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-876BA2/2020	EPI_ISL_557377	2020-07-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-85E3E4/2020	EPI_ISL_557384	2020-07-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.97	GR
hCoV-19/England/MILK-74EE41/2020	EPI_ISL_557389	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.15	GR
hCoV-19/England/MILK-8579E9/2020	EPI_ISL_557391	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-874069/2020	EPI_ISL_557394	2020-07-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-7521AB/2020	EPI_ISL_557395	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.15	GR
hCoV-19/England/MILK-873B4B/2020	EPI_ISL_557400	2020-07-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-74BA22/2020	EPI_ISL_557401	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.15	GR
hCoV-19/England/MILK-6F3CD9/2020	EPI_ISL_557407	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.231	G
hCoV-19/England/MILK-6F5A0A/2020	EPI_ISL_557410	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.15	GR
hCoV-19/England/MILK-6EF371/2020	EPI_ISL_557437	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.15	GR
hCoV-19/England/ALDP-749505/2020	EPI_ISL_557447	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/ALDP-7474FB/2020	EPI_ISL_557449	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-746FBF/2020	EPI_ISL_557454	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-8664D7/2020	EPI_ISL_557455	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-6F58B5/2020	EPI_ISL_557456	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/MILK-870777/2020	EPI_ISL_557459	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-6F100C/2020	EPI_ISL_557461	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-86BDF5/2020	EPI_ISL_557464	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.15	GR
hCoV-19/England/MILK-6F57A9/2020	EPI_ISL_557465	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.15	GR
hCoV-19/England/ALDP-74419D/2020	EPI_ISL_557469	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/MILK-82A7A9/2020	EPI_ISL_557473	2020-07-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.25	GR
hCoV-19/England/ALDP-74431F/2020	EPI_ISL_557488	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/MILK-85324C/2020	EPI_ISL_557489	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/MILK-6F65EA/2020	EPI_ISL_557496	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/ALDP-706CC3/2020	EPI_ISL_557606	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-7054AE/2020	EPI_ISL_557613	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/ALDP-722D28/2020	EPI_ISL_557623	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-6EA9A1/2020	EPI_ISL_557634	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-6E8F38/2020	EPI_ISL_557637	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-720CD2/2020	EPI_ISL_557640	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-71D2C7/2020	EPI_ISL_557641	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-6E492F/2020	EPI_ISL_557645	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-6E26C0/2020	EPI_ISL_557657	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-722FB9/2020	EPI_ISL_557683	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-721415/2020	EPI_ISL_557695	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-6DF918/2020	EPI_ISL_557723	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.109	GR
hCoV-19/England/ALDP-71D9C2/2020	EPI_ISL_557724	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-70A5E2/2020	EPI_ISL_557734	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-700C32/2020	EPI_ISL_557736	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-70704E/2020	EPI_ISL_557737	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1	GR
hCoV-19/England/MILK-6285D0/2020	EPI_ISL_557742	2020-07-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/ALDP-6BB648/2020	EPI_ISL_557761	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/MILK-619095/2020	EPI_ISL_557789	2020-07-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-62AD4F/2020	EPI_ISL_557800	2020-07-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-625A10/2020	EPI_ISL_557802	2020-07-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides found at refpos 514.	info	B.1.1	GR
hCoV-19/England/ALDP-6B81E0/2020	EPI_ISL_557804	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-6B1D3E/2020	EPI_ISL_557815	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-6C091A/2020	EPI_ISL_557818	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-628FB4/2020	EPI_ISL_557821	2020-07-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-62D447/2020	EPI_ISL_557822	2020-07-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-62D632/2020	EPI_ISL_557823	2020-07-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-6BB693/2020	EPI_ISL_557831	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-6BD479/2020	EPI_ISL_557834	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-6BAB59/2020	EPI_ISL_557835	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-6C0DF0/2020	EPI_ISL_557836	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-6BE812/2020	EPI_ISL_557841	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-6BCD8E/2020	EPI_ISL_557844	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-61A3F5/2020	EPI_ISL_557847	2020-07-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.231	G
hCoV-19/England/ALDP-6BCB75/2020	EPI_ISL_557862	2020-07-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-6C3030/2020	EPI_ISL_557872	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.203	GR
hCoV-19/England/MILK-628F78/2020	EPI_ISL_557879	2020-07-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-63A025/2020	EPI_ISL_557890	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-622381/2020	EPI_ISL_557894	2020-07-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-63BE2A/2020	EPI_ISL_557919	2020-07-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.15	GR
hCoV-19/England/ALDP-6C1409/2020	EPI_ISL_557923	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-6BB226/2020	EPI_ISL_557929	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/ALDP-6BD52B/2020	EPI_ISL_557930	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-6B9FF4/2020	EPI_ISL_557935	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-6BB5D2/2020	EPI_ISL_557939	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-62ACF7/2020	EPI_ISL_557947	2020-07-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-623809/2020	EPI_ISL_557949	2020-07-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-6BAC0B/2020	EPI_ISL_557951	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/Gambia/GC19-1503/2020	EPI_ISL_561021	2020-05-14	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/GC19-1818/2020	EPI_ISL_561034	2020-05-28	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/GC19-1983/2020	EPI_ISL_561038	2020-06-07	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1	GR
hCoV-19/Gambia/GC19-3266/2020	EPI_ISL_561055	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1	G
hCoV-19/Gambia/GC19-3398/2020	EPI_ISL_561070	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.242	GR
hCoV-19/Gambia/GC19-3768/2020	EPI_ISL_561071	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.242	GR
hCoV-19/Gambia/GC19-3798/2020	EPI_ISL_561080	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.242	GR
hCoV-19/Gambia/GC19-3799/2020	EPI_ISL_561081	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.242	GR
hCoV-19/Gambia/GC19-3099/2020	EPI_ISL_561164	2020-07-25	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.242	GR
hCoV-19/Gambia/GC19-3407/2020	EPI_ISL_561174	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.242	G
hCoV-19/Gambia/GC19-3418/2020	EPI_ISL_561176	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.242	G
hCoV-19/Gambia/GC19-3535/2020	EPI_ISL_561194	2020-07-27	Africa / Gambia / Kombo	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	ARTIC protocol			B.1.1.242	GR
hCoV-19/Scotland/QEUH-9DA877/2020	EPI_ISL_575373	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9DA80E/2020	EPI_ISL_575385	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/Scotland/QEUH-9DA9DE/2020	EPI_ISL_575388	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/England/ALDP-9CAE5A/2020	EPI_ISL_575414	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CBF65/2020	EPI_ISL_575435	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CB27B/2020	EPI_ISL_575451	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/ALDP-9CB7C7/2020	EPI_ISL_575501	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/ALDP-9CB123/2020	EPI_ISL_575503	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CACAB/2020	EPI_ISL_575512	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/ALDP-9CAEA5/2020	EPI_ISL_575513	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CC0BC/2020	EPI_ISL_575524	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CBB70/2020	EPI_ISL_575573	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/ALDP-9CAA65/2020	EPI_ISL_575584	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CAF57/2020	EPI_ISL_575593	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/ALDP-9CBCF5/2020	EPI_ISL_575597	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CB1AB/2020	EPI_ISL_575622	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CB730/2020	EPI_ISL_575627	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/ALDP-9CAFC0/2020	EPI_ISL_575639	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CC034/2020	EPI_ISL_575656	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CBD98/2020	EPI_ISL_575665	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CBB61/2020	EPI_ISL_575667	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/ALDP-9CBF74/2020	EPI_ISL_575675	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-9CB26C/2020	EPI_ISL_575682	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/ALDP-9CAE4B/2020	EPI_ISL_575717	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CAD11/2020	EPI_ISL_575722	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CAF93/2020	EPI_ISL_575739	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9CAEB4/2020	EPI_ISL_575748	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-973139/2020	EPI_ISL_575763	2020-08-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-973588/2020	EPI_ISL_575771	2020-08-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-97643D/2020	EPI_ISL_575775	2020-08-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-974842/2020	EPI_ISL_575785	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-974A2E/2020	EPI_ISL_575791	2020-08-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-976716/2020	EPI_ISL_575792	2020-08-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/MILK-97644C/2020	EPI_ISL_575793	2020-08-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-9E6C21/2020	EPI_ISL_580309	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-9E6720/2020	EPI_ISL_580355	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9EC0B6/2020	EPI_ISL_580367	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9E60E9/2020	EPI_ISL_580381	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9E72E2/2020	EPI_ISL_580406	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9E6CB8/2020	EPI_ISL_580412	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9EC1FF/2020	EPI_ISL_580421	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9E6948/2020	EPI_ISL_580423	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9E707F/2020	EPI_ISL_580445	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9EC1D1/2020	EPI_ISL_580471	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9E6BAC/2020	EPI_ISL_580490	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9EC58A/2020	EPI_ISL_580499	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9E6FEC/2020	EPI_ISL_580504	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9E73EF/2020	EPI_ISL_580521	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9E691B/2020	EPI_ISL_580523	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9E6FCE/2020	EPI_ISL_580528	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/CAMC-9EC57B/2020	EPI_ISL_580557	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9EC687/2020	EPI_ISL_580564	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/ALDP-9E65F9/2020	EPI_ISL_580580	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/ALDP-9E625C/2020	EPI_ISL_580591	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9EC2ED/2020	EPI_ISL_580593	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9E674E/2020	EPI_ISL_580615	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9EC308/2020	EPI_ISL_580618	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9E6EEF/2020	EPI_ISL_580622	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/England/ALDP-9EDA8A/2020	EPI_ISL_580681	2020-05-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9EDA4E/2020	EPI_ISL_580691	2020-05-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9ED871/2020	EPI_ISL_580723	2020-05-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9EE63A/2020	EPI_ISL_580757	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9ED729/2020	EPI_ISL_580787	2020-05-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9EDA6C/2020	EPI_ISL_580788	2020-05-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9EE834/2020	EPI_ISL_580802	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9EE8E9/2020	EPI_ISL_580820	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9EE588/2020	EPI_ISL_580832	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9EDB5A/2020	EPI_ISL_580835	2020-05-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/QEUH-9DCAAC/2020	EPI_ISL_580874	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9E1181/2020	EPI_ISL_580877	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DC620/2020	EPI_ISL_580878	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DC6A8/2020	EPI_ISL_580911	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DC6D5/2020	EPI_ISL_580934	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DADD2/2020	EPI_ISL_580943	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DABBA/2020	EPI_ISL_580949	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DACF3/2020	EPI_ISL_580953	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DAE66/2020	EPI_ISL_580964	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DAD2D/2020	EPI_ISL_580997	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Canada/MB-NML-795/2020	EPI_ISL_582314	2020-06-14	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1.1	GR
hCoV-19/Canada/MB-NML-1174/2020	EPI_ISL_582493	2020-07-23	North America / Canada / Manitoba	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC Network Protocol v1			B.1	G
hCoV-19/United Arab Emirates/skmc-3119719/2020	EPI_ISL_582642	2020-08-25	Asia / United Arab Emirates	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1.133	GR
hCoV-19/United Arab Emirates/skmc-3111681/2020	EPI_ISL_582647	2020-08-29	Asia / United Arab Emirates	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1.133	GR
hCoV-19/United Arab Emirates/skmc-3122376/2020	EPI_ISL_582649	2020-08-29	Asia / United Arab Emirates	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1	GR
hCoV-19/United Arab Emirates/skmc-3124949/2020	EPI_ISL_582657	2020-08-29	Asia / United Arab Emirates	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1.315	GR
hCoV-19/United Arab Emirates/skmc-3358771/2020	EPI_ISL_582659	2020-09-03	Asia / United Arab Emirates	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1.315	GR
hCoV-19/United Arab Emirates/skmc-3890804/2020	EPI_ISL_582680	2020-09-23	Asia / United Arab Emirates	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1.133	GR
hCoV-19/United Arab Emirates/skmc-3890161/2020	EPI_ISL_582681	2020-09-23	Asia / United Arab Emirates	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1.315	GR
hCoV-19/Sweden/20-21498/2020	EPI_ISL_582777	2020-05-28	Europe / Sweden / Uppsala	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction using torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Sweden/20-21507/2020	EPI_ISL_582781	2020-07-04	Europe / Sweden / Uppsala	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction using torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Sweden/20-21509/2020	EPI_ISL_582782	2020-07-07	Europe / Sweden / Uppsala	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction using torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Sweden/20-51975/2020	EPI_ISL_582796	2020-06-07	Europe / Sweden / Sormland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction using torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-52534/2020	EPI_ISL_582801	2020-08-05	Europe / Sweden / Gavleborg	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction using torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Sweden/20-52673/2020	EPI_ISL_582805	2020-08-17	Europe / Sweden / Halland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Consensus extraction using torrent suite variantCaller with fill from reference and majority wins			B.1.1.39	GR
hCoV-19/England/QEUH-9F8BA7/2020	EPI_ISL_589008	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9F2132/2020	EPI_ISL_589028	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F9890/2020	EPI_ISL_589032	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F95C6/2020	EPI_ISL_589044	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F7908/2020	EPI_ISL_589049	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9F283D/2020	EPI_ISL_589057	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F7E27/2020	EPI_ISL_589069	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F961E/2020	EPI_ISL_589076	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9F268E/2020	EPI_ISL_589091	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9F235A/2020	EPI_ISL_589097	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9F2114/2020	EPI_ISL_589099	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F7E63/2020	EPI_ISL_589112	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F9809/2020	EPI_ISL_589120	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F74DA/2020	EPI_ISL_589128	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F7434/2020	EPI_ISL_589139	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F95E4/2020	EPI_ISL_589142	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F74E9/2020	EPI_ISL_589150	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F78A1/2020	EPI_ISL_589155	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F963C/2020	EPI_ISL_589156	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9F2105/2020	EPI_ISL_589171	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9F7522/2020	EPI_ISL_589180	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F7A50/2020	EPI_ISL_589181	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F7C3C/2020	EPI_ISL_589186	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E106stop results in 13.2% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/QEUH-9F7E36/2020	EPI_ISL_589189	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F75F5/2020	EPI_ISL_589207	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F9A8B/2020	EPI_ISL_589210	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9F2A55/2020	EPI_ISL_589233	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NSP11 without BLAST coverage.	warn	AD.2	GR
hCoV-19/England/MILK-9F2958/2020	EPI_ISL_589237	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F7D84/2020	EPI_ISL_589238	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F7865/2020	EPI_ISL_589245	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9F2730/2020	EPI_ISL_589247	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F7AAB/2020	EPI_ISL_589254	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F7C5A/2020	EPI_ISL_589263	2020-09-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9ED49B/2020	EPI_ISL_589288	2020-05-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9E59B2/2020	EPI_ISL_589294	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9ECC0D/2020	EPI_ISL_589297	2020-04-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	GR
hCoV-19/England/ALDP-9E57A9/2020	EPI_ISL_589337	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/MILK-9ECCB2/2020	EPI_ISL_589355	2020-04-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.71	GR
hCoV-19/England/ALDP-9ECFC8/2020	EPI_ISL_589356	2020-05-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/ALDP-9ED352/2020	EPI_ISL_589405	2020-05-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9ED6C2/2020	EPI_ISL_589422	2020-05-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/ALDP-9EE0A5/2020	EPI_ISL_589424	2020-05-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.97	GR
hCoV-19/England/ALDP-9E57D6/2020	EPI_ISL_589429	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/MILK-9ECC2B/2020	EPI_ISL_589430	2020-04-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9ED440/2020	EPI_ISL_589446	2020-05-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/ALDP-9EE272/2020	EPI_ISL_589454	2020-05-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.97	GR
hCoV-19/England/ALDP-9ED1FE/2020	EPI_ISL_589464	2020-05-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9ED45F/2020	EPI_ISL_589468	2020-05-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9E56F7/2020	EPI_ISL_589472	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-9EDF5E/2020	EPI_ISL_589476	2020-05-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9EDDCD/2020	EPI_ISL_589480	2020-05-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9E59EF/2020	EPI_ISL_589482	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9ED282/2020	EPI_ISL_589490	2020-05-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9ED097/2020	EPI_ISL_589506	2020-05-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9ED46E/2020	EPI_ISL_589512	2020-05-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.208	GR
hCoV-19/England/MILK-9ECD73/2020	EPI_ISL_589520	2020-04-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9EDEF7/2020	EPI_ISL_589524	2020-05-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/ALDP-9E5712/2020	EPI_ISL_589530	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-9ECEAD/2020	EPI_ISL_589552	2020-05-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-9EE10C/2020	EPI_ISL_589565	2020-05-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9F0D4F/2020	EPI_ISL_589579	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/MILK-9F0FC1/2020	EPI_ISL_589585	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/MILK-9F135B/2020	EPI_ISL_589586	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9F1AB0/2020	EPI_ISL_589587	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/MILK-9F1018/2020	EPI_ISL_589588	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/MILK-9F1801/2020	EPI_ISL_589592	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/MILK-9F0A75/2020	EPI_ISL_589615	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9F0A1B/2020	EPI_ISL_589624	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9F0D30/2020	EPI_ISL_589638	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9F1115/2020	EPI_ISL_589656	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9F133D/2020	EPI_ISL_589673	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9F1B08/2020	EPI_ISL_589680	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/MILK-9F1B17/2020	EPI_ISL_589691	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/England/MILK-9F134C/2020	EPI_ISL_589739	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9F1B26/2020	EPI_ISL_589740	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/QEUH-9E53E1/2020	EPI_ISL_589775	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9E492C/2020	EPI_ISL_589777	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9E2214/2020	EPI_ISL_589796	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9D4C26/2020	EPI_ISL_589800	2020-09-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-9CBBAD/2020	EPI_ISL_589802	2020-09-16	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D09F6/2020	EPI_ISL_589811	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D0835/2020	EPI_ISL_589816	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CFDC1/2020	EPI_ISL_589820	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D01D0/2020	EPI_ISL_589825	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D0B5A/2020	EPI_ISL_589834	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D0361/2020	EPI_ISL_589836	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/QEUH-9CFF70/2020	EPI_ISL_589839	2020-09-14	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D1193/2020	EPI_ISL_589863	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D0000/2020	EPI_ISL_589869	2020-09-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/QEUH-9D0756/2020	EPI_ISL_589874	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D02CE/2020	EPI_ISL_589878	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D07ED/2020	EPI_ISL_589882	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D08DB/2020	EPI_ISL_589884	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CFDB2/2020	EPI_ISL_589885	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D0194/2020	EPI_ISL_589886	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D02EC/2020	EPI_ISL_589888	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D0B0F/2020	EPI_ISL_589893	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CFD94/2020	EPI_ISL_589897	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D0E7F/2020	EPI_ISL_589898	2020-09-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D06E0/2020	EPI_ISL_589899	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D01C1/2020	EPI_ISL_589901	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D05D4/2020	EPI_ISL_589903	2020-09-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D1236/2020	EPI_ISL_589914	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D08BD/2020	EPI_ISL_589956	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D02FB/2020	EPI_ISL_589959	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D0F30/2020	EPI_ISL_589966	2020-09-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/QEUH-9D0273/2020	EPI_ISL_589981	2020-09-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/QEUH-9CFF52/2020	EPI_ISL_589984	2020-09-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D0668/2020	EPI_ISL_589985	2020-09-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9D0A20/2020	EPI_ISL_589988	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9CFE82/2020	EPI_ISL_589990	2020-09-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9EF47B/2020	EPI_ISL_594918	2020-09-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/MILK-A17F87/2020	EPI_ISL_595003	2020-10-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-A180DE/2020	EPI_ISL_595017	2020-10-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.240	GR
hCoV-19/England/MILK-A1D6E6/2020	EPI_ISL_595077	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/MILK-A1D710/2020	EPI_ISL_595079	2020-10-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/NORW-EFE0D/2020	EPI_ISL_595161	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-F0768/2020	EPI_ISL_595190	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-F0BD5/2020	EPI_ISL_595201	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-F0BF3/2020	EPI_ISL_595203	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-F0C1E/2020	EPI_ISL_595205	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-F0C2D/2020	EPI_ISL_595206	2020-10-13	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-F0CC3/2020	EPI_ISL_595212	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-F0CE1/2020	EPI_ISL_595213	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-F1309/2020	EPI_ISL_595224	2020-10-15	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NORW-F1460/2020	EPI_ISL_595229	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/NOTT-115F64/2020	EPI_ISL_595296	2020-10-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/CAMC-A585A6/2020	EPI_ISL_596956	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A580A5/2020	EPI_ISL_596962	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/CAMC-A585D3/2020	EPI_ISL_596994	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A05EDA/2020	EPI_ISL_600003	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-A05A03/2020	EPI_ISL_600015	2020-09-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A05D28/2020	EPI_ISL_600030	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A06808/2020	EPI_ISL_600035	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/MILK-A05E16/2020	EPI_ISL_600051	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/England/MILK-A0670B/2020	EPI_ISL_600055	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A064D7/2020	EPI_ISL_600071	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-A060C4/2020	EPI_ISL_600114	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A0007F/2020	EPI_ISL_600149	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A00103/2020	EPI_ISL_600173	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FFC07/2020	EPI_ISL_600177	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FF96A/2020	EPI_ISL_600196	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/Scotland/QEUH-9FFF1D/2020	EPI_ISL_600213	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FFC9E/2020	EPI_ISL_600217	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FFF95/2020	EPI_ISL_600236	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FFF59/2020	EPI_ISL_600243	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A0009D/2020	EPI_ISL_600247	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FFA2B/2020	EPI_ISL_600248	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FF1EA/2020	EPI_ISL_600278	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A0031C/2020	EPI_ISL_600288	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FF654/2020	EPI_ISL_600294	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9FFED4/2020	EPI_ISL_600296	2020-10-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FF2AB/2020	EPI_ISL_600305	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FFBDD/2020	EPI_ISL_600319	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FF5B1/2020	EPI_ISL_600323	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A00130/2020	EPI_ISL_600324	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A000BB/2020	EPI_ISL_600343	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A00006/2020	EPI_ISL_600363	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A000CA/2020	EPI_ISL_600379	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A00464/2020	EPI_ISL_600390	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9FFF3B/2020	EPI_ISL_600402	2020-09-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A008FF/2020	EPI_ISL_600417	2020-10-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-9FFFE0/2020	EPI_ISL_600493	2020-10-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9FB676/2020	EPI_ISL_600563	2020-09-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/Scotland/QEUH-9FB3E8/2020	EPI_ISL_600580	2020-09-29	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9F4419/2020	EPI_ISL_600636	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9F4516/2020	EPI_ISL_600657	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/Scotland/QEUH-9F5FBD/2020	EPI_ISL_600684	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9F4A71/2020	EPI_ISL_600695	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.315	GR
hCoV-19/Scotland/QEUH-9F6B12/2020	EPI_ISL_600704	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/Scotland/QEUH-9F6945/2020	EPI_ISL_600724	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9F4CA8/2020	EPI_ISL_600730	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/Scotland/QEUH-9F4CE4/2020	EPI_ISL_600738	2020-09-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/England/QEUH-9F38F0/2020	EPI_ISL_600770	2020-09-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F2C7D/2020	EPI_ISL_600795	2020-09-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9F2C04/2020	EPI_ISL_600814	2020-09-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-9E4F0C/2020	EPI_ISL_600945	2020-09-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.315	GR
hCoV-19/Scotland/QEUH-9E51BA/2020	EPI_ISL_600978	2020-09-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9E52A8/2020	EPI_ISL_600993	2020-09-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9E4A74/2020	EPI_ISL_600996	2020-09-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9CF480/2020	EPI_ISL_602002	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/Scotland/QEUH-9CE2F0/2020	EPI_ISL_602011	2020-09-16	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9C4333/2020	EPI_ISL_602029	2020-09-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/Scotland/QEUH-9B4A7D/2020	EPI_ISL_602045	2020-09-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/Scotland/QEUH-9B5089/2020	EPI_ISL_602052	2020-09-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9B4CE0/2020	EPI_ISL_602084	2020-09-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9B8EC8/2020	EPI_ISL_602142	2020-09-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Wales/MILK-9A6908/2020	EPI_ISL_602145	2020-09-01	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-99DD9F/2020	EPI_ISL_602149	2020-08-30	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A6463B/2020	EPI_ISL_609014	2020-10-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/ALDP-A6802A/2020	EPI_ISL_609031	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A69108/2020	EPI_ISL_609034	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-A68B29/2020	EPI_ISL_609070	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A648F9/2020	EPI_ISL_609088	2020-10-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/CAMC-A646D1/2020	EPI_ISL_609091	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A646FF/2020	EPI_ISL_609099	2020-10-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A64E9D/2020	EPI_ISL_609142	2020-10-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/Wales/CAMC-A58E9C/2020	EPI_ISL_609166	2020-10-09	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A5E1BB/2020	EPI_ISL_609197	2020-10-12	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-A4FF2C/2020	EPI_ISL_609210	2020-10-07	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/ALDP-A51B9C/2020	EPI_ISL_609217	2020-10-07	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-A47B99/2020	EPI_ISL_609253	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-A47B5D/2020	EPI_ISL_609265	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-A477B3/2020	EPI_ISL_609275	2020-10-05	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-A45C01/2020	EPI_ISL_609303	2020-10-06	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A41494/2020	EPI_ISL_609308	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A41713/2020	EPI_ISL_609338	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A42071/2020	EPI_ISL_609348	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/CAMC-A422A8/2020	EPI_ISL_609360	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A4194A/2020	EPI_ISL_609412	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A40F67/2020	EPI_ISL_609416	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/CAMC-A4231E/2020	EPI_ISL_609420	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 7 nucleotides when compared to the reference sequence.	info	B.1.532	GR
hCoV-19/England/CAMC-A41054/2020	EPI_ISL_609428	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-A41C8D/2020	EPI_ISL_609449	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A41801/2020	EPI_ISL_609455	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A41704/2020	EPI_ISL_609488	2020-10-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A41B26/2020	EPI_ISL_609503	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/England/CAMC-A419D1/2020	EPI_ISL_609520	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A40E4C/2020	EPI_ISL_609530	2020-10-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-A3EC47/2020	EPI_ISL_609594	2020-10-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/USA/MI-MDHHS-SC22165/2020	EPI_ISL_614216	2020-10-12	North America / USA / Michigan	Human	Original			Illumina NextSeq	bwa v. 0.7.17; bcftools v. 1.7			B.1.240	G
hCoV-19/USA/MI-MDHHS-SC22181/2020	EPI_ISL_614232	2020-10-12	North America / USA / Michigan	Human	Original			Illumina NextSeq	bwa v. 0.7.17; bcftools v. 1.7			B.1.240	G
hCoV-19/Faroe Islands/HFS-60/2020	EPI_ISL_614308	2020-08-04	Europe / Faroe Islands	Human	Original	Oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20			B.1.1.261	GR
hCoV-19/Faroe Islands/HFS-71/2020	EPI_ISL_614310	2020-08-04	Europe / Faroe Islands	Human	Original	Oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20			B.1.1.261	GR
hCoV-19/Faroe Islands/HFS-74/2020	EPI_ISL_614311	2020-08-05	Europe / Faroe Islands	Human	Original	Oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20			B.1.1.261	GR
hCoV-19/Faroe Islands/HFS-77/2020	EPI_ISL_614312	2020-08-05	Europe / Faroe Islands	Human	Original	Oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20			B.1.1.261	GR
hCoV-19/Denmark/DCGC-900/2020	EPI_ISL_614464	2020-05-18	Europe / Denmark	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Switzerland/AG-ETHZ-331076/2020	EPI_ISL_614894	2020-10-20	Europe / Switzerland / Aargau	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.269	GR
hCoV-19/Switzerland/BS-ETHZ-330422/2020	EPI_ISL_614899	2020-10-18	Europe / Switzerland / Basel-Stadt	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.39	GR
hCoV-19/Switzerland/BS-ETHZ-330425/2020	EPI_ISL_614901	2020-10-18	Europe / Switzerland / Basel-Stadt	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BS-ETHZ-330428/2020	EPI_ISL_614902	2020-10-18	Europe / Switzerland / Basel-Stadt	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BS-ETHZ-330430/2020	EPI_ISL_614904	2020-10-18	Europe / Switzerland / Basel-Stadt	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/BS-ETHZ-330433/2020	EPI_ISL_614906	2020-10-18	Europe / Switzerland / Basel-Stadt	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-331069/2020	EPI_ISL_614965	2020-10-20	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-331072/2020	EPI_ISL_614967	2020-10-20	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe	Gap of 12 nucleotides when compared to the reference sequence.	info	B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-331077/2020	EPI_ISL_614971	2020-10-20	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-331451/2020	EPI_ISL_614974	2020-10-21	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-331460/2020	EPI_ISL_614976	2020-10-21	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Switzerland/ZH-ETHZ-331463/2020	EPI_ISL_614977	2020-10-21	Europe / Switzerland / Zurich	Human	Original	Oropharyngeal swab		Illumina MiSeq	V-pipe			B.1.1.39	GR
hCoV-19/Denmark/DCGC-3371/2020	EPI_ISL_616128	2020-08-31	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-3384/2020	EPI_ISL_616143	2020-08-31	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				AQ.2	GR
hCoV-19/Denmark/DCGC-3266/2020	EPI_ISL_616184	2020-08-31	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				AQ.2	GR
hCoV-19/Denmark/DCGC-2548/2020	EPI_ISL_616524	2020-08-17	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.236	G
hCoV-19/Denmark/DCGC-2549/2020	EPI_ISL_616525	2020-08-17	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.236	G
hCoV-19/Denmark/DCGC-2551/2020	EPI_ISL_616527	2020-08-17	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-2911/2020	EPI_ISL_616545	2020-08-17	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2765/2020	EPI_ISL_616599	2020-08-24	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.236	G
hCoV-19/Denmark/DCGC-2776/2020	EPI_ISL_616611	2020-08-24	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2813/2020	EPI_ISL_616649	2020-08-17	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.261	GR
hCoV-19/Denmark/DCGC-2956/2020	EPI_ISL_616717	2020-08-24	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				AQ.2	GR
hCoV-19/Denmark/DCGC-2972/2020	EPI_ISL_616734	2020-08-24	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.39	GR
hCoV-19/Denmark/DCGC-2975/2020	EPI_ISL_616737	2020-08-24	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/USA/MI-UM-10036476828/2020	EPI_ISL_628829	2020-10-16	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.240	G
hCoV-19/USA/MI-UM-10036484282/2020	EPI_ISL_628833	2020-10-16	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.240	G
hCoV-19/USA/MI-UM-10036483226/2020	EPI_ISL_628849	2020-10-16	North America / USA / Michigan	Human	Original	Nasopharyngeal swab		Illumina MiSeq		NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1	G
hCoV-19/Chile/RM-CMM-0039M/2020	EPI_ISL_629017	2020-04-24	South America / Chile / Region Metropolitana de Santiago / Santiago	Human	Original			Nanopore MinION	Artic Minion Procotol			B.1	G
hCoV-19/Chile/RM-CMM-0071M/2020	EPI_ISL_629019	2020-05-01	South America / Chile / Region Metropolitana de Santiago / Santiago	Human	Original			Nanopore MinION	Artic Minion Procotol			B.1	G
hCoV-19/Chile/RM-CMM-0089M/2020	EPI_ISL_629021	2020-05-01	South America / Chile / Region Metropolitana de Santiago / Santiago	Human	Original			Nanopore MinION	Artic Minion Procotol			B.1	G
hCoV-19/Chile/RM-CMM-0000B/2020	EPI_ISL_629023	2020-03-13	South America / Chile / Region Metropolitana de Santiago / Santiago	Human	Original			Nanopore MinION	Artic Minion Procotol			B.1.1	GR
hCoV-19/England/QEUH-AD07BF/2020	EPI_ISL_634008	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD30A2/2020	EPI_ISL_634015	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD48C7/2020	EPI_ISL_634016	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/QEUH-AD04E5/2020	EPI_ISL_634028	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD3743/2020	EPI_ISL_634039	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD37AD/2020	EPI_ISL_634106	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/QEUH-AD3C71/2020	EPI_ISL_634142	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD4A1C/2020	EPI_ISL_634152	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD37CB/2020	EPI_ISL_634173	2020-10-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD491F/2020	EPI_ISL_634210	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD33F4/2020	EPI_ISL_634213	2020-10-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-AD2CEB/2020	EPI_ISL_634246	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACC570/2020	EPI_ISL_634269	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC7E4D/2020	EPI_ISL_634276	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC80BF/2020	EPI_ISL_634284	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AD002D/2020	EPI_ISL_634305	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACD6B8/2020	EPI_ISL_634315	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC8125/2020	EPI_ISL_634336	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC79C4/2020	EPI_ISL_634346	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACCB05/2020	EPI_ISL_634361	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-ACD533/2020	EPI_ISL_634396	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1.204	GR
hCoV-19/England/MILK-ACD5D9/2020	EPI_ISL_634424	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/MILK-ACC4DD/2020	EPI_ISL_634425	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC7988/2020	EPI_ISL_634448	2020-10-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-AC7BDD/2020	EPI_ISL_634472	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/MILK-ACD1A8/2020	EPI_ISL_634473	2020-10-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-ACD779/2020	EPI_ISL_634503	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-ACC4EC/2020	EPI_ISL_634506	2020-10-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD1F2F/2020	EPI_ISL_634526	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD19C7/2020	EPI_ISL_634562	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-AD16B1/2020	EPI_ISL_634584	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 6 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/QEUH-AD5E6A/2020	EPI_ISL_634585	2020-10-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/France/OCC-SC417/2020	EPI_ISL_641552	2020-03-14	Europe / France / Occitanie / Toulouse	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1.1.254	GR
hCoV-19/Belgium/ULG-10737/2020	EPI_ISL_641579	2020-09-18	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.1.269	GR
hCoV-19/England/QEUH-B14596/2020	EPI_ISL_641636	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B141ED/2020	EPI_ISL_641673	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B14226/2020	EPI_ISL_641708	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B14569/2020	EPI_ISL_641729	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B1396E/2020	EPI_ISL_641748	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B14217/2020	EPI_ISL_641752	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B137CE/2020	EPI_ISL_641753	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B13904/2020	EPI_ISL_641768	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B13843/2020	EPI_ISL_641770	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B14068/2020	EPI_ISL_641793	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B13069/2020	EPI_ISL_641796	2020-11-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B0F0E8/2020	EPI_ISL_641798	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Singapore/433nan/2020	EPI_ISL_648065	2020-03-19	Asia / Singapore	Human	Original			Nanopore				B.1	G
hCoV-19/Singapore/94nan/2020	EPI_ISL_648079	2020-03-18	Asia / Singapore	Human	Original			Nanopore				B.1.1	GR
hCoV-19/Sweden/20-52765/2020	EPI_ISL_648132	2020-08-13	Europe / Sweden / Kronoberg	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.236	G
hCoV-19/Sweden/20-53084/2020	EPI_ISL_648135	2020-10-06	Europe / Sweden	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.236	G
hCoV-19/Sweden/20-53091/2020	EPI_ISL_648138	2020-07-13	Europe / Sweden	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Sweden/20-53087/2020	EPI_ISL_648143	2020-07-26	Europe / Sweden	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Sweden/20-52742/2020	EPI_ISL_648169	2020-08-04	Europe / Sweden / Vastra Gotaland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Sweden/20-53127/2020	EPI_ISL_648171	2020-09-04	Europe / Sweden	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.406	G
hCoV-19/Sweden/20-53129/2020	EPI_ISL_648172	2020-09-23	Europe / Sweden	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.406	G
hCoV-19/Sweden/20-53130/2020	EPI_ISL_648174	2020-09-28	Europe / Sweden	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.406	G
hCoV-19/Sweden/20-08977/2020	EPI_ISL_648182	2020-08-09	Europe / Sweden / Skane	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.39	GR
hCoV-19/Sweden/20-22144/2020	EPI_ISL_648184	2020-05-23	Europe / Sweden / Skane	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-23685/2020	EPI_ISL_648191	2020-10-07	Europe / Sweden	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.236	G
hCoV-19/USA/CA-CZB-12313/2020	EPI_ISL_648397	2020-10-07	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1	G
hCoV-19/USA/CA-CZB-12791/2020	EPI_ISL_648447	2020-10-14	North America / USA / California / Santa Clara County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.239	G
hCoV-19/USA/CA-CZB-12387/2020	EPI_ISL_648508	2020-10-06	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.403	GR
hCoV-19/USA/CA-CZB-12857/2020	EPI_ISL_648513	2020-10-13	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.403	GR
hCoV-19/USA/CA-CZB-12858/2020	EPI_ISL_648514	2020-10-13	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.1.403	GR
hCoV-19/USA/CA-CZB-12865/2020	EPI_ISL_648520	2020-10-15	North America / USA / California / Orange County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1	G
hCoV-19/USA/CA-CZB-12380/2020	EPI_ISL_648541	2020-10-06	North America / USA / California / Tulare County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1.240	G
hCoV-19/USA/CA-CZB-10621/2020	EPI_ISL_648551	2020-09-03	North America / USA / California / Madera County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NovaSeq	Minimap2 / iVar			B.1	G
hCoV-19/USA/CA-ALSR-4106/2020	EPI_ISL_648826	2020-07-02	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-4107/2020	EPI_ISL_648827	2020-07-02	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-4123/2020	EPI_ISL_648832	2020-07-02	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-4124/2020	EPI_ISL_648833	2020-07-02	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-4130/2020	EPI_ISL_648838	2020-07-02	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-4131/2020	EPI_ISL_648839	2020-07-02	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-4139/2020	EPI_ISL_648843	2020-07-02	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-4140/2020	EPI_ISL_648844	2020-07-02	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-4142/2020	EPI_ISL_648846	2020-06-25	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-4146/2020	EPI_ISL_648850	2020-06-27	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.240	G
hCoV-19/USA/CA-ALSR-4148/2020	EPI_ISL_648851	2020-06-24	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-4155/2020	EPI_ISL_648856	2020-06-25	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-4171/2020	EPI_ISL_648862	2020-07-02	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-4172/2020	EPI_ISL_648863	2020-07-02	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-4173/2020	EPI_ISL_648864	2020-07-02	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-4176/2020	EPI_ISL_648865	2020-07-02	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-4177/2020	EPI_ISL_648866	2020-07-02	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-4184/2020	EPI_ISL_648870	2020-08-06	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-4188/2020	EPI_ISL_648874	2020-06-20	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-4192/2020	EPI_ISL_648878	2020-08-12	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-4197/2020	EPI_ISL_648882	2020-08-03	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-4256/2020	EPI_ISL_648918	2020-06-15	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-4283/2020	EPI_ISL_648935	2020-10-06	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.322	GR
hCoV-19/USA/CA-ALSR-4286/2020	EPI_ISL_648938	2020-10-01	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-4293/2020	EPI_ISL_648945	2020-09-28	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-4294/2020	EPI_ISL_648946	2020-10-01	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-4302/2020	EPI_ISL_648952	2020-10-01	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-4305/2020	EPI_ISL_648955	2020-10-09	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	NS8_S54stop results in 56.2% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/USA/CA-ALSR-4309/2020	EPI_ISL_648959	2020-10-01	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-4317/2020	EPI_ISL_648966	2020-10-16	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	NS8_S54stop results in 56.2% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/USA/CA-ALSR-4351/2020	EPI_ISL_648986	2020-07-21	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.240	G
hCoV-19/USA/CA-ALSR-4364/2020	EPI_ISL_648990	2020-08-04	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/Italy/APU-IZSPB_306PT/2020	EPI_ISL_653800	2020-11-03	Europe / Italy / Apulia / Bari / Alberobello	Human	Original	Nasopharyngeal swab		Illumina MiSeq	SPAdes			B.1.1.39	GR
hCoV-19/India/DL-NIBG-MN15/2020	EPI_ISL_653841	2020-06-18	Asia / India / Delhi	Human	Original			Illumina MiSeq	CLC Genomics Workbench 20			B.1.1	GR
hCoV-19/Russia/MOS-CRIE7165818/2020	EPI_ISL_653930	2020-08-24	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1	GR
hCoV-19/Russia/MOS-CRIE7141819/2020	EPI_ISL_653932	2020-08-24	Europe / Russia / Moscow	Human	Original	Oropharyngeal swab		Illumina HiSeq	assembled using Trimmomatic-Cutadapt-bowtie2-GATK-BCFtools-BEDTools			B.1.1	GR
hCoV-19/England/204400610/2020	EPI_ISL_653960	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			AD.2	GR
hCoV-19/England/204462584/2020	EPI_ISL_653986	2020-10-28	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1.255	GR
hCoV-19/Spain/MD-IBV-99008533/2020	EPI_ISL_654081	2020-09-21	Europe / Spain / Madrid / Madrid	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1	GR
hCoV-19/England/ALDP-B5B1AE/2020	EPI_ISL_655548	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-B62BA6/2020	EPI_ISL_655580	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B5E730/2020	EPI_ISL_655620	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-B5B5EE/2020	EPI_ISL_655630	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-B5CC8E/2020	EPI_ISL_655638	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B677F8/2020	EPI_ISL_655660	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B5C626/2020	EPI_ISL_655700	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B67901/2020	EPI_ISL_655807	2020-11-10	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-B5CB54/2020	EPI_ISL_655812	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-B5C8D5/2020	EPI_ISL_655813	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-B5BEF2/2020	EPI_ISL_655908	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B5CCE8/2020	EPI_ISL_655916	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Norway/4764/2020	EPI_ISL_668400	2020-10-22	Europe / Norway / Viken	Human	Original	Nasopharyngeal and throat swab		Illumina MiSeq, ARTICProtocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1.451	GR
hCoV-19/England/CAMC-B09479/2020	EPI_ISL_673016	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B0A609/2020	EPI_ISL_673082	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B099A7/2020	EPI_ISL_673093	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B09B0B/2020	EPI_ISL_673121	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-B0A047/2020	EPI_ISL_673136	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B098F5/2020	EPI_ISL_673155	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	AD.2	GR
hCoV-19/England/CAMC-B09B1A/2020	EPI_ISL_673168	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-B0A171/2020	EPI_ISL_673173	2020-10-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B097BC/2020	EPI_ISL_673196	2020-10-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-B08DAC/2020	EPI_ISL_673212	2020-10-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B9ABA5/2020	EPI_ISL_673242	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-B99229/2020	EPI_ISL_673334	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/CAMC-B9AE06/2020	EPI_ISL_673441	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B98DED/2020	EPI_ISL_673570	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/England/CAMC-B98785/2020	EPI_ISL_673576	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-B9870D/2020	EPI_ISL_673685	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B9871C/2020	EPI_ISL_673689	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B954EB/2020	EPI_ISL_673708	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.408	G
hCoV-19/England/CAMC-B9872B/2020	EPI_ISL_673741	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-B987A3/2020	EPI_ISL_673772	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-B98749/2020	EPI_ISL_673775	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-B95515/2020	EPI_ISL_673785	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B952C3/2020	EPI_ISL_673803	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B9530C/2020	EPI_ISL_673812	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/CAMC-B99EAD/2020	EPI_ISL_673816	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B9AEAC/2020	EPI_ISL_673850	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B86395/2020	EPI_ISL_673912	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/MILK-B8D2FB/2020	EPI_ISL_673953	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8692A/2020	EPI_ISL_673959	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/MILK-B8D48C/2020	EPI_ISL_673982	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-B8E6C1/2020	EPI_ISL_673997	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B9620E/2020	EPI_ISL_675000	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B95B40/2020	EPI_ISL_675051	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B974F8/2020	EPI_ISL_675057	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-A9D2EA/2020	EPI_ISL_680564	2020-10-20	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Wales/PHWC-48D535/2020	EPI_ISL_680640	2020-11-12	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-48D553/2020	EPI_ISL_680642	2020-11-13	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-48DC21/2020	EPI_ISL_680739	2020-11-05	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-48DCC7/2020	EPI_ISL_680745	2020-11-05	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-2465F/2020	EPI_ISL_419434	2020-03-17	Europe / United Kingdom / Wales	Human	Original	Dry swab		Illumina	iVar consensus			B.1.1	GR
hCoV-19/Germany/NW-HHU-27/2020	EPI_ISL_419544	2020-03-15	Europe / Germany / North Rhine-Westphalia / Duesseldorf	Human	Original	Oropharyngeal swab		Nanopore MinION	ARTIC Protocol			B.1	GH
hCoV-19/USA/GA_2741/2020	EPI_ISL_419556	2020-02-29	North America / USA / Georgia	Human	Original	Nasopharyngeal swab		Sanger dideoxy sequencing	Sequencher 5.4.6			B.1.1.61	GR
hCoV-19/USA/GA_2742/2020	EPI_ISL_419557	2020-02-29	North America / USA / Georgia	Human	Original	Oropharyngeal swab		Sanger dideoxy sequencing	Sequencher 5.4.6			B.1.1.61	GR
hCoV-19/Australia/VIC29/2020	EPI_ISL_419748	2020-03-10	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC V1 amplicons, Nextera XT library, minimap2 v2.17, ivar v1.1, samtools v1.10			B.1.1.71	GR
hCoV-19/Australia/VIC37/2020	EPI_ISL_419754	2020-03-11	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC V1 amplicons, Nextera XT library, minimap2 v2.17, ivar v1.1, samtools v1.10			B.1.1	GR
hCoV-19/Australia/VIC52/2020	EPI_ISL_419768	2020-03-12	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC V1 amplicons, Nextera XT library, minimap2 v2.17, ivar v1.1, samtools v1.10			B.1.1.71	GR
hCoV-19/Australia/VIC90/2020	EPI_ISL_419801	2020-03-15	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC V1 amplicons, Nextera XT library, minimap2 v2.17, ivar v1.1, samtools v1.10			B.1.1	GR
hCoV-19/Australia/VIC91/2020	EPI_ISL_419804	2020-03-15	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC V1 amplicons, Nextera XT library, minimap2 v2.17, ivar v1.1, samtools v1.10			B.1	G
hCoV-19/Australia/VIC106/2020	EPI_ISL_419820	2020-03-17	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC V1 amplicons, Nextera XT library, minimap2 v2.17, ivar v1.1, samtools v1.10			B.1	G
hCoV-19/Australia/VIC239/2020	EPI_ISL_419934	2020-03-21	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC V1 amplicons, Nextera XT library, minimap2 v2.17, ivar v1.1, samtools v1.10			B.1.1	GR
hCoV-19/Australia/VIC249/2020	EPI_ISL_419944	2020-03-21	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 550	ARTIC V1 amplicons, Nextera XT library, minimap2 v2.17, ivar v1.1, samtools v1.10			B.1.1.254	GR
hCoV-19/USA/NY-NYUMC150/2020	EPI_ISL_424957	2020-04-01	North America / USA / New York / Bronx	Human	Original			Targeted capture, Illumina Novaseq	bwa/0.7.17, mapped to NC_045512v2, bases below 30x coverage masked			B.1.1	GR
hCoV-19/Taiwan/CGMH-CGU-18/2020	EPI_ISL_424974	2020-03-18	Asia / Taiwan / Taoyuan	Human	LLC-MK2	Throat swab		Illumina Miseq, assembled sequences	SPAdes Version 3.14.0			B.1.1	GR
hCoV-19/England/CAMB-7386A/2020	EPI_ISL_425246	2020-03-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore MinION				B.1.1.398	GR
hCoV-19/England/CAMB-738C4/2020	EPI_ISL_425251	2020-03-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore MinION				B.1.1	GR
hCoV-19/England/CAMB-739EF/2020	EPI_ISL_425264	2020-03-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore MinION				B.1.1	GR
hCoV-19/England/CAMB-74386/2020	EPI_ISL_425283	2020-03-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore MinION				B.1.1	GR
hCoV-19/Scotland/CVR68/2020	EPI_ISL_425799	2020-03-09	Europe / United Kingdom / Scotland	Human	Original			ILLUMINA MiSeq				B.1.1	GR
hCoV-19/Scotland/EDB024/2020	EPI_ISL_425830	2020-03-12	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore MinION				B.1	G
hCoV-19/Scotland/EDB033/2020	EPI_ISL_425839	2020-03-13	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore MinION				B.1.1	GR
hCoV-19/Scotland/EDB151/2020	EPI_ISL_425919	2020-03-24	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore GridION				B.1	G
hCoV-19/USA/UT-069/2020	EPI_ISL_430021	2020-03-16	North America / USA / Utah	Human	Original			Illumina MiSeq	BWA + Ivar 1.2	Stretches of NNNs (1.05% of overall sequence).		B.59	GR
hCoV-19/USA/UT-0513/2020	EPI_ISL_430059	2020-04-03	North America / USA / Utah	Human	Original			Illumina MiSeq	BWA + Ivar 1.2			B.1	G
hCoV-19/Australia/VIC-CBA5/2020	EPI_ISL_430065	2020-04-08	Oceania / Australia / Victoria	Human	Original	Oropharyngeal swab		Ion Torrent, AmpliSeq panel	Torrent Suite 5.10.1, IGV 2.6.3, MEGA 7			B.1.1.71	GR
hCoV-19/Russia/StPetersburg-RII4917S/2020	EPI_ISL_430070	2020-04-07	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1.71	GR
hCoV-19/Russia/StPetersburg-RII6061S/2020	EPI_ISL_430108	2020-04-15	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1	G
hCoV-19/USA/NJ-NYUMC344/2020	EPI_ISL_430371	2020-04-08	North America / USA / New Jersey / Hudson County	Human	Original			Ribo-depleted, Illumina Novaseq	BWA v0.7.17, bases below 20x coverage masked			B.1.1.231	GR
hCoV-19/USA/NY-NYUMC386/2020	EPI_ISL_430413	2020-04-09	North America / USA / New York / Nassau County	Human	Original			Ribo-depleted, Illumina Novaseq	BWA v0.7.17, bases below 20x coverage masked			B.1.1	GR
hCoV-19/Australia/VIC1037/2020	EPI_ISL_430533	2020-04-03	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC V3 amplicons, Nextera XT library, minimap2 v2.17, ivar v1.2.1, samtools v1.10			B.1.1.198	GR
hCoV-19/Australia/VIC1012/2020	EPI_ISL_430548	2020-04-01	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC V3 amplicons, Nextera XT library, minimap2 v2.17, ivar v1.2.1, samtools v1.10			B.1.1	GR
hCoV-19/Australia/VIC957/2020	EPI_ISL_430649	2020-03-27	Oceania / Australia / Victoria	Human	Original			Illumina NextSeq 500	ARTIC V3 amplicons, Nextera XT library, minimap2 v2.17, ivar v1.2.1, samtools v1.10			B.1.1	GR
hCoV-19/Argentina/PAIS-A0005/2020	EPI_ISL_430797	2020-03-27	South America / Argentina / Buenos Aires / Bahia Blanca	Human	Original	Nasopharyngeal swab		Illumina NextSeq500	BWA MEM	Gap of 44 nucleotides when compared to the reference sequence (confirmed by the submitter).	info	B.1.1	GR
hCoV-19/Argentina/PAIS-A0014/2020	EPI_ISL_430805	2020-04-01	South America / Argentina / Buenos Aires / Bahia Blanca	Human	Original	Nasopharyngeal swab		Illumina NextSeq500	BWA MEM	Gap of 44 nucleotides when compared to the reference sequence (confirmed by the submitter).	info	B.1.1	GR
hCoV-19/Scotland/CVR2939/2020	EPI_ISL_439000	2020-04-22	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.43	GR
hCoV-19/Scotland/CVR2990/2020	EPI_ISL_439006	2020-04-23	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.43	GR
hCoV-19/Scotland/CVR3094/2020	EPI_ISL_439034	2020-04-25	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.164	GR
hCoV-19/Scotland/CVR910/2020	EPI_ISL_439134	2020-03-27	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Scotland/EDB1992/2020	EPI_ISL_439150	2020-04-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/Scotland/EDB2125/2020	EPI_ISL_439160	2020-04-17	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.43	GR
hCoV-19/Scotland/EDB2263/2020	EPI_ISL_439177	2020-04-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Scotland/EDB2268/2020	EPI_ISL_439178	2020-04-21	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/Scotland/EDB2543/2020	EPI_ISL_439227	2020-04-24	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/Scotland/EDB2554/2020	EPI_ISL_439228	2020-04-23	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.43	GR
hCoV-19/Scotland/EDB2614/2020	EPI_ISL_439243	2020-04-25	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.14	GR
hCoV-19/Scotland/EDB2650/2020	EPI_ISL_439249	2020-04-26	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.43	GR
hCoV-19/Scotland/EDB3532/2020	EPI_ISL_439281	2020-04-13	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/Scotland/EDB3555/2020	EPI_ISL_439283	2020-04-14	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/Scotland/EDB3645/2020	EPI_ISL_439303	2020-04-27	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/Scotland/EDB3781/2020	EPI_ISL_439322	2020-04-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/Scotland/EDB3795/2020	EPI_ISL_439326	2020-04-29	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/Scotland/EDB3864/2020	EPI_ISL_439344	2020-04-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/England/CAMB-77B12/2020	EPI_ISL_439373	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7780C/2020	EPI_ISL_439386	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-779CD/2020	EPI_ISL_439393	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-777A5/2020	EPI_ISL_439404	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.13	GR
hCoV-19/England/CAMB-7775A/2020	EPI_ISL_439421	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7749F/2020	EPI_ISL_439424	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7614E/2020	EPI_ISL_439469	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-75B05/2020	EPI_ISL_439482	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/CAMB-7774B/2020	EPI_ISL_439496	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-77B30/2020	EPI_ISL_439510	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-72A83/2020	EPI_ISL_439614	2020-03-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-7219D/2020	EPI_ISL_439625	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/CAMB-71AC0/2020	EPI_ISL_439659	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-71B54/2020	EPI_ISL_439664	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/EDB3944/2020	EPI_ISL_439669	2020-04-30	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/England/LIVE-98FD3/2020	EPI_ISL_439681	2020-04-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LIVE-99048/2020	EPI_ISL_439687	2020-04-07	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1	GR
hCoV-19/England/LIVE-993F4/2020	EPI_ISL_439719	2020-04-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LIVE-9993E/2020	EPI_ISL_439775	2020-04-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LIVE-999E3/2020	EPI_ISL_439785	2020-04-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LIVE-99AC2/2020	EPI_ISL_439795	2020-04-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/England/LIVE-99C08/2020	EPI_ISL_439808	2020-04-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/England/LIVE-99CCC/2020	EPI_ISL_439812	2020-04-12	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LIVE-99EE4/2020	EPI_ISL_439827	2020-04-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LIVE-9A1CC/2020	EPI_ISL_439857	2020-04-17	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LIVE-9A26F/2020	EPI_ISL_439861	2020-04-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-72230/2020	EPI_ISL_439891	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/LOND-D4005/2020	EPI_ISL_444083	2020-04-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D408D/2020	EPI_ISL_444091	2020-04-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D41E4/2020	EPI_ISL_444100	2020-04-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D42A5/2020	EPI_ISL_444110	2020-04-06	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D4445/2020	EPI_ISL_444122	2020-04-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D4964/2020	EPI_ISL_444159	2020-04-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D4B5F/2020	EPI_ISL_444181	2020-04-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_Q27stop results in 78.5% truncation of the protein sequence.	info	B.1.1	GR
hCoV-19/England/LOND-D4FDB/2020	EPI_ISL_444189	2020-04-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D4FEA/2020	EPI_ISL_444190	2020-04-14	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.164	GR
hCoV-19/England/LOND-D50F5/2020	EPI_ISL_444202	2020-04-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D52E0/2020	EPI_ISL_444207	2020-04-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.164	GR
hCoV-19/England/LOND-D52FF/2020	EPI_ISL_444208	2020-04-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D531A/2020	EPI_ISL_444210	2020-04-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D5329/2020	EPI_ISL_444211	2020-04-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.164	GR
hCoV-19/England/LOND-D5550/2020	EPI_ISL_444233	2020-04-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D5D58/2020	EPI_ISL_444245	2020-04-18	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.164	GR
hCoV-19/England/LOND-D5E19/2020	EPI_ISL_444249	2020-04-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/England/LOND-D5EDD/2020	EPI_ISL_444258	2020-04-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D5F25/2020	EPI_ISL_444263	2020-04-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/BIRM-5E2A3/2020	EPI_ISL_444279	2020-04-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/BIRM-5E30A/2020	EPI_ISL_444285	2020-04-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1AAE67/2020	EPI_ISL_444320	2020-04-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1AB701/2020	EPI_ISL_444328	2020-04-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.208	GR
hCoV-19/England/CAMB-1ABF81/2020	EPI_ISL_444353	2020-04-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1AC0F6/2020	EPI_ISL_444372	2020-04-28	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-7B219/2020	EPI_ISL_444395	2020-04-10	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/CAMB-7FDAB/2020	EPI_ISL_444413	2020-04-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-80F1A/2020	EPI_ISL_444447	2020-04-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/USA/NY-NYUMC514/2020	EPI_ISL_444631	2020-03-30	North America / USA / New York / Queens	Human	Original			Ribo-depleted, Illumina Novaseq	BWA v0.7.17, bases below 20x coverage masked			B.1.1.231	GR
hCoV-19/USA/NY-NYUMC556/2020	EPI_ISL_444673	2020-03-31	North America / USA / New York / Queens	Human	Original			Ribo-depleted, Illumina Novaseq	BWA v0.7.17, bases below 20x coverage masked			B.1.1.231	GR
hCoV-19/USA/NY-NYUMC601/2020	EPI_ISL_444718	2020-04-03	North America / USA / New York / Queens	Human	Original			Ribo-depleted, Illumina Novaseq	BWA v0.7.17, bases below 20x coverage masked			B.1.1	GR
hCoV-19/USA/NY-PV09422/2020	EPI_ISL_450101	2020-03-13	North America / USA / New York / Brooklyn	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/USA/NY-PV09436/2020	EPI_ISL_450113	2020-03-10	North America / USA / New York	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/USA/NY-PV09481/2020	EPI_ISL_450153	2020-03-20	North America / USA / New York / Manhattan	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1.61	GR
hCoV-19/USA/NY-PV09495/2020	EPI_ISL_450167	2020-03-20	North America / USA / New York / Brooklyn	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.1	GR
hCoV-19/USA/CA-UCSF-UC40/2020	EPI_ISL_450232	2020-03-15	North America / USA / California / San Francisco County	Human	Original			Illumina NovaSeq with MSSPE	BBMap v38.81			B.1.1	GR
hCoV-19/USA/CA-UCSF-UC46/2020	EPI_ISL_450238	2020-03-17	North America / USA / California / San Francisco County	Human	Original			Illumina NovaSeq with MSSPE	BBMap v38.81			B.1.1	GR
hCoV-19/USA/CA-UCSF-UC47/2020	EPI_ISL_450239	2020-03-20	North America / USA / California / San Francisco County	Human	Original			Illumina NovaSeq with MSSPE	BBMap v38.81			B.1	G
hCoV-19/Russia/StPetersburg-RII7340V/2020	EPI_ISL_450251	2020-04-20	Europe / Russia / Saint Petersburg	Human	Vero P1	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Russia/StPetersburg-RII7505S/2020	EPI_ISL_450255	2020-04-20	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Nanopore MinION	minimap2, UGENE v. 33			B.1.1	GR
hCoV-19/Sweden/20-06097/2020	EPI_ISL_450807	2020-03-20	Europe / Sweden / Skane	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-06695/2020	EPI_ISL_450809	2020-03-31	Europe / Sweden / Stockholm	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-07734/2020	EPI_ISL_450814	2020-04-22	Europe / Sweden / Halland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-07860/2020	EPI_ISL_450821	2020-04-23	Europe / Sweden / Jamtland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Sweden/20-07861/2020	EPI_ISL_450822	2020-04-23	Europe / Sweden / Jamtland	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Sweden/20-14089/2020	EPI_ISL_450827	2020-04-27	Europe / Sweden / Uppsala	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1	GR
hCoV-19/Sweden/20-51044/2020	EPI_ISL_450831	2020-04-27	Europe / Sweden / Jonkoping	Human	Original			Ion Torrent S5 XL, Ion AmpliSeq SARS-CoV-2	Torrent suite variantCaller with fill from reference and majority wins			B.1.1.261	GR
hCoV-19/Belgium/Rega-0319265/2020	EPI_ISL_458235	2020-03-19	Europe / Belgium / Sint-Truiden	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic prime pool, Guppy, CLC Genomics Workbench 20, Medaka			B.1	G
hCoV-19/USA/CA-SR0364/2020	EPI_ISL_458247	2020-04-14	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2			B.1	G
hCoV-19/USA/CA-SR0399/2020	EPI_ISL_458272	2020-04-21	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2			B.1	G
hCoV-19/USA/CA-SR0410/2020	EPI_ISL_458280	2020-04-21	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2			B.1.1	GR
hCoV-19/England/BRIS-129A99/2020	EPI_ISL_458320	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12A61C/2020	EPI_ISL_458345	2020-04-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/BRIS-12A1A2/2020	EPI_ISL_458381	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12A54C/2020	EPI_ISL_458385	2020-04-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/BRIS-129C48/2020	EPI_ISL_458416	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/BRIS-12A60D/2020	EPI_ISL_458445	2020-04-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/BRIS-12A791/2020	EPI_ISL_458483	2020-04-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/BRIS-12AA2F/2020	EPI_ISL_458490	2020-04-28	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-12A53D/2020	EPI_ISL_458492	2020-04-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/BRIS-12A1EE/2020	EPI_ISL_458509	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/NORT-28900D/2020	EPI_ISL_458607	2020-03-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-2890B2/2020	EPI_ISL_458613	2020-03-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-289717/2020	EPI_ISL_458635	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-289823/2020	EPI_ISL_458656	2020-04-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-289656/2020	EPI_ISL_458664	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-2896DE/2020	EPI_ISL_458689	2020-03-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/NORT-28939B/2020	EPI_ISL_458711	2020-03-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-1287FD/2020	EPI_ISL_458755	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-129817/2020	EPI_ISL_458768	2020-03-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.164	GR
hCoV-19/England/BRIS-1291B2/2020	EPI_ISL_458775	2020-04-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-128A9A/2020	EPI_ISL_458798	2020-04-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/BRIS-128A12/2020	EPI_ISL_458832	2020-04-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/BRIS-1286B4/2020	EPI_ISL_458888	2020-04-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/England/BRIS-126829/2020	EPI_ISL_458969	2020-04-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.171	GR
hCoV-19/Scotland/GCVR-173D2E/2020	EPI_ISL_459103	2020-04-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/GCVR-173D5B/2020	EPI_ISL_459118	2020-04-06	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.43	GR
hCoV-19/Scotland/GCVR-172B9E/2020	EPI_ISL_459137	2020-04-05	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/GCVR-173CD6/2020	EPI_ISL_459147	2020-04-07	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AF925/2020	EPI_ISL_459251	2020-05-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AEF8E/2020	EPI_ISL_459252	2020-04-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMB-1AEFCA/2020	EPI_ISL_459265	2020-04-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Belgium/WLM-0406275/2020	EPI_ISL_464069	2020-04-06	Europe / Belgium / Hannut	Human	Original	Oropharyngeal swab		Nanopore MinION	Artic primer pool, Guppy, MiniMap2, CLC Genomics Workbench 20, Medaka			B.1.1	GR
hCoV-19/South Africa/Tygerberg_34/2020	EPI_ISL_464145	2020-04-03	Africa / South Africa / Western Cape / Cape Town Metro	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/Tygerberg_44/2020	EPI_ISL_464153	2020-04-09	Africa / South Africa / Western Cape / Cape Town Metro	Human	Original	Oropharyngeal swab		Oxford Nanopore GridION	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/England/201041387/2020	EPI_ISL_464347	2020-03-02	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/201060025/2020	EPI_ISL_464368	2020-03-02	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/201080064/2020	EPI_ISL_464452	2020-03-03	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20109000104/2020	EPI_ISL_464488	2020-03-04	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20109000204/2020	EPI_ISL_464489	2020-03-04	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20109002804/2020	EPI_ISL_464507	2020-03-04	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/20109002904/2020	EPI_ISL_464508	2020-03-04	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/201160004/2020	EPI_ISL_464772	2020-03-09	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/England/201161180/2020	EPI_ISL_464817	2020-03-10	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			B.1.1	GR
hCoV-19/Scotland/CVR3139/2020	EPI_ISL_478053	2020-04-28	Europe / United Kingdom / Scotland	Human	Original			Illumina				B.1.1.43	GR
hCoV-19/Scotland/EDB4599/2020	EPI_ISL_478167	2020-05-07	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.14	GR
hCoV-19/Scotland/EDB4634/2020	EPI_ISL_478171	2020-05-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Scotland/EDB4648/2020	EPI_ISL_478176	2020-05-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.14	GR
hCoV-19/Scotland/EDB4649/2020	EPI_ISL_478177	2020-05-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.14	GR
hCoV-19/Scotland/EDB4652/2020	EPI_ISL_478179	2020-05-08	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.14	GR
hCoV-19/Scotland/EDB4869/2020	EPI_ISL_478192	2020-05-12	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.14	GR
hCoV-19/Scotland/EDB4873/2020	EPI_ISL_478194	2020-05-12	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1.14	GR
hCoV-19/England/LIVE-A0C2C/2020	EPI_ISL_478392	2020-06-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D4E83/2020	EPI_ISL_478406	2020-04-13	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.164	GR
hCoV-19/England/LOND-D6BB7/2020	EPI_ISL_478412	2020-03-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D6C96/2020	EPI_ISL_478418	2020-03-31	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D6D2A/2020	EPI_ISL_478426	2020-04-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 2 nucleotide(s) found at refpos 27720 (FRAMESHIFT). Gap of 2 nucleotides when compared to the reference sequence. Submitter Note: we have confirmed frameshift.	info	B.1.1	GR
hCoV-19/England/LOND-D6DC0/2020	EPI_ISL_478434	2020-04-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D6DDF/2020	EPI_ISL_478435	2020-04-02	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LOND-D6E63/2020	EPI_ISL_478440	2020-04-03	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.164	GR
hCoV-19/England/LOND-D72A2/2020	EPI_ISL_478469	2020-04-11	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1	G
hCoV-19/England/NORT-283B11/2020	EPI_ISL_478519	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-283F60/2020	EPI_ISL_478528	2020-04-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-284CA4/2020	EPI_ISL_478588	2020-03-26	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-294F7B/2020	EPI_ISL_478623	2020	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-295C19/2020	EPI_ISL_478658	2020-04-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Australia/NSW563/2020	EPI_ISL_478675	2020-03-23	Oceania / Australia / New South Wales / Sydney	Human	Original			Illumina iSeq				B.1.1	GR
hCoV-19/England/OXON-AF337/2020	EPI_ISL_478729	2020-04-12	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AF3BF/2020	EPI_ISL_478731	2020-04-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AF3DD/2020	EPI_ISL_478732	2020-04-14	Europe / United Kingdom / England	Human	Original			Illumina		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.194	GR
hCoV-19/England/OXON-AF3FB/2020	EPI_ISL_478734	2020-04-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AF416/2020	EPI_ISL_478736	2020-04-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AF452/2020	EPI_ISL_478740	2020-04-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AF58C/2020	EPI_ISL_478752	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AF5D7/2020	EPI_ISL_478754	2020-04-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AF601/2020	EPI_ISL_478756	2020-04-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AF610/2020	EPI_ISL_478757	2020-04-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AF67A/2020	EPI_ISL_478761	2020-04-14	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AF6A7/2020	EPI_ISL_478762	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AF6C5/2020	EPI_ISL_478763	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.231	G
hCoV-19/England/OXON-AF70E/2020	EPI_ISL_478764	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AF759/2020	EPI_ISL_478768	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AF7B3/2020	EPI_ISL_478771	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AF7D1/2020	EPI_ISL_478773	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AF81A/2020	EPI_ISL_478775	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AF883/2020	EPI_ISL_478780	2020-04-08	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AF9BD/2020	EPI_ISL_478790	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AF9EA/2020	EPI_ISL_478793	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AFA32/2020	EPI_ISL_478797	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AFA9C/2020	EPI_ISL_478801	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AFABA/2020	EPI_ISL_478802	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AFAE7/2020	EPI_ISL_478804	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AFB20/2020	EPI_ISL_478805	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AFBC6/2020	EPI_ISL_478811	2020-04-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AFBD5/2020	EPI_ISL_478812	2020-04-15	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AFC3C/2020	EPI_ISL_478814	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AFCB4/2020	EPI_ISL_478819	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.164	GR
hCoV-19/England/OXON-AFD0C/2020	EPI_ISL_478822	2020-04-09	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-AFD75/2020	EPI_ISL_478826	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AFDB1/2020	EPI_ISL_478827	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AFF15/2020	EPI_ISL_478836	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AFF7F/2020	EPI_ISL_478839	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-AFF9D/2020	EPI_ISL_478841	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B001E/2020	EPI_ISL_478845	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B003C/2020	EPI_ISL_478847	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B005A/2020	EPI_ISL_478848	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B00A5/2020	EPI_ISL_478853	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B011B/2020	EPI_ISL_478857	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B0193/2020	EPI_ISL_478861	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B01A2/2020	EPI_ISL_478862	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B01B1/2020	EPI_ISL_478863	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B01DF/2020	EPI_ISL_478864	2020-04-19	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B0351/2020	EPI_ISL_478875	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B03BB/2020	EPI_ISL_478877	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B0412/2020	EPI_ISL_478879	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B055B/2020	EPI_ISL_478887	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B0597/2020	EPI_ISL_478889	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B063A/2020	EPI_ISL_478893	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B0694/2020	EPI_ISL_478898	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B07BF/2020	EPI_ISL_478907	2020-04-20	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B07FB/2020	EPI_ISL_478911	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B0843/2020	EPI_ISL_478914	2020-04-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B08DA/2020	EPI_ISL_478917	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B0904/2020	EPI_ISL_478919	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B0913/2020	EPI_ISL_478920	2020-04-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B0A4D/2020	EPI_ISL_478929	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B0A89/2020	EPI_ISL_478932	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B0BFF/2020	EPI_ISL_478945	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B0C38/2020	EPI_ISL_478948	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1	G
hCoV-19/England/OXON-B0C56/2020	EPI_ISL_478949	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1	G
hCoV-19/England/OXON-B0CDE/2020	EPI_ISL_478954	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B0CED/2020	EPI_ISL_478955	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B0D53/2020	EPI_ISL_478960	2020-04-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B0EF6/2020	EPI_ISL_478976	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B0FB7/2020	EPI_ISL_478984	2020-04-10	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B0FE4/2020	EPI_ISL_478985	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B102C/2020	EPI_ISL_478988	2020	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.194	GR
hCoV-19/England/OXON-B103B/2020	EPI_ISL_478989	2020-04-13	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B1095/2020	EPI_ISL_478992	2020-04-16	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/OXON-B1165/2020	EPI_ISL_478999	2020-04-17	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/USA/CA-ALSR-0543-SAN/2020	EPI_ISL_483213	2020-05-04	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-0563-SAN/2020	EPI_ISL_483225	2020-05-10	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-0566-IPL/2020	EPI_ISL_483227	2020-05-12	North America / USA / California / Imperial County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-0637-SAN/2020	EPI_ISL_483272	2020-04-27	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1	G
hCoV-19/USA/CA-ALSR-0668-SAN/2020	EPI_ISL_483290	2020-05-01	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-0928-SAN/2020	EPI_ISL_483418	2020-04-27	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1	G
hCoV-19/USA/CA-ALSR-0934-SAN/2020	EPI_ISL_483423	2020-05-01	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-1052-SAN/2020	EPI_ISL_483484	2020-06-21	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	NS6_E55stop results in 11.5% truncation of the protein sequence.	info	B.1	G
hCoV-19/USA/CA-ALSR-1053-SAN/2020	EPI_ISL_483485	2020-06-21	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	NS6_E55stop results in 11.5% truncation of the protein sequence.	info	B.1	G
hCoV-19/USA/CA-ALSR-1056-SAN/2020	EPI_ISL_483487	2020-06-20	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-1060-SAN/2020	EPI_ISL_483491	2020-06-20	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-1072-SAN/2020	EPI_ISL_483500	2020-06-22	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-1081-SAN/2020	EPI_ISL_483508	2020-06-23	North America / USA / California / San Diego County	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/Singapore/590/2020	EPI_ISL_483613	2020-03-26	Asia / Singapore	Human	Original			Illumina MiSeq				B.1.1	GR
hCoV-19/Bangladesh/BCSIR-NILMRC-181/2020	EPI_ISL_483629	2020-06-20	Asia / Bangladesh / Rajshahi / Pabna	Human	Original	Nasopharyngeal swab		MiniSeq	DRAGEN RNA Pathogen Detection 3.5.14			B.1.1.25	GR
hCoV-19/Bangladesh/BCSIR-NILMRC-198/2020	EPI_ISL_483642	2020-06-20	Asia / Bangladesh / Chittagong / Chandpur	Human	Original	Nasopharyngeal swab		MiniSeq	DRAGEN RNA Pathogen Detection 3.5.14			B.1.1	GR
hCoV-19/Bangladesh/BCSIR-NILMRC-210/2020	EPI_ISL_483691	2020-06-14	Asia / Bangladesh / Sylhet / Habiganj	Human	Original	Nasopharyngeal swab		MiniSeq	DRAGEN RNA Pathogen Detection 3.5.14			B.1.1	GR
hCoV-19/India/GJ-GBRC246/2020	EPI_ISL_483827	2020-06-19	Asia / India / Gujarat / Prantij	Human	Original			Ion Torrent	CLC Genomics Workbench 12			B.1	G
hCoV-19/England/BIRM-60781/2020	EPI_ISL_483887	2020-06-05	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/CAMB-1B51D9/2020	EPI_ISL_483914	2020-06-23	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.115	GR
hCoV-19/England/GSTT-265D4B1/2020	EPI_ISL_483966	2020-03-19	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LIVE-A198E/2020	EPI_ISL_484254	2020-06-09	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LIVE-A1B1F/2020	EPI_ISL_484262	2020-06-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/LIVE-A1B4C/2020	EPI_ISL_484263	2020-06-16	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-296AB4/2020	EPI_ISL_484273	2020-04-27	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/NORT-29CB24/2020	EPI_ISL_484292	2020-05-01	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Hong Kong/HKU-200723-052/2020	EPI_ISL_497819	2020-03-27	Asia / Hong Kong	Human	Original	Saliva		Nanopore MinION				B.1.1	GR
hCoV-19/Hong Kong/HKU-200723-079/2020	EPI_ISL_497846	2020-03-20	Asia / Hong Kong	Human	Original	Nasopharyngeal and throat swab		Nanopore MinION				B.1.1	GR
hCoV-19/Hong Kong/HKU-200723-097/2020	EPI_ISL_497864	2020-03-18	Asia / Hong Kong	Human	Original	Nasopharyngeal and throat swab		Nanopore MinION				B.1.1.198	GR
hCoV-19/Zhejiang/SX0715/2020	EPI_ISL_497950	2020-07-15	Asia / China / Zhejiang	Human	Original			Sanger, Nanopore MinION				B.1.1	GR
hCoV-19/South Africa/KRISP-0491/2020	EPI_ISL_498062	2020-07-07	Africa / South Africa / KwaZulu-Natal / uMkhanyakude	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-0502/2020	EPI_ISL_498070	2020-07-11	Africa / South Africa / KwaZulu-Natal / uMgungundlovu	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-0503/2020	EPI_ISL_498071	2020-07-11	Africa / South Africa / KwaZulu-Natal / uMgungundlovu	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-0545/2020	EPI_ISL_498086	2020-07-14	Africa / South Africa / KwaZulu-Natal / Harry Gwala	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-0548/2020	EPI_ISL_498087	2020-07-15	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-0550/2020	EPI_ISL_498089	2020-07-15	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-0556/2020	EPI_ISL_498095	2020-07-15	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-0563/2020	EPI_ISL_498102	2020-07-15	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.34	GR
hCoV-19/South Africa/KRISP-0570/2020	EPI_ISL_498108	2020-07-02	Africa / South Africa / KwaZulu-Natal / uMgungundlovu	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.56	GR
hCoV-19/South Africa/KRISP-0571/2020	EPI_ISL_498109	2020-07-14	Africa / South Africa / KwaZulu-Natal / uMzinyathi	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.56	GR
hCoV-19/South Africa/KRISP-0577/2020	EPI_ISL_498115	2020-07-09	Africa / South Africa / KwaZulu-Natal / iLembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.56	GR
hCoV-19/South Africa/KRISP-0579/2020	EPI_ISL_498117	2020-07-08	Africa / South Africa / KwaZulu-Natal / iLembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-0581/2020	EPI_ISL_498119	2020-07-09	Africa / South Africa / KwaZulu-Natal / iLembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-0582/2020	EPI_ISL_498120	2020-07-09	Africa / South Africa / KwaZulu-Natal / iLembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.56	GR
hCoV-19/South Africa/KRISP-0583/2020	EPI_ISL_498121	2020-07-09	Africa / South Africa / KwaZulu-Natal / iLembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.56	GR
hCoV-19/South Africa/KRISP-0586/2020	EPI_ISL_498124	2020-07-08	Africa / South Africa / KwaZulu-Natal / iLembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-0587/2020	EPI_ISL_498125	2020-07-09	Africa / South Africa / KwaZulu-Natal / iLembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.56	GR
hCoV-19/Belgium/ULG-10223/2020	EPI_ISL_498129	2020-05-15	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.1.71	GR
hCoV-19/Belgium/ULG-10226/2020	EPI_ISL_498132	2020-05-15	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.1.71	GR
hCoV-19/Belgium/ULG-10232/2020	EPI_ISL_498138	2020-05-16	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.1.71	GR
hCoV-19/Vietnam/HCMC-35008/2020	EPI_ISL_498184	2020-03-19	Asia / Vietnam / Ho Chi Minh City	Human	unknown	Nasal and Throat Swab		Illumina MiSeq, Sanger	Geneious Prime 2019.2.1			B.1.1	GR
hCoV-19/Vietnam/HCMC-35010/2020	EPI_ISL_498186	2020-03-18	Asia / Vietnam / Ho Chi Minh City	Human	unknown	Nasal and Throat Swab		Illumina MiSeq, Sanger	Geneious Prime 2019.2.1			B.1.1	GR
hCoV-19/Bangladesh/BCSIR-NILMRC-260/2020	EPI_ISL_498254	2020-07-07	Asia / Bangladesh / Khulna / Jessore	Human	Original	Nasopharyngeal swab		Illumina Nextseq 550	DRAGEN RNA Pathogen Detection 3.5.14			B.1.1.25	GR
hCoV-19/USA/FL-QDX-228/2020	EPI_ISL_498709	2020-04-18	North America / USA / Florida	Human	Original			Illumina MiSeq	BWA v. 0.7.17-r1188; IVar 1.2.2			B.1.1.231	GR
hCoV-19/USA/NC-QDX-252/2020	EPI_ISL_498731	2020-04-30	North America / USA / North Carolina	Human	Original			Illumina MiSeq	BWA v. 0.7.17-r1188; IVar 1.2.2			B.1.1	GR
hCoV-19/Bangladesh/BCSIR-NILMRC-275/2020	EPI_ISL_498811	2020-07-19	Asia / Bangladesh / Chittagong	Human	Original	Nasopharyngeal swab		NextSeq 550	DRAGEN RNA Pathogen Detection 3.5.14			B.1.1.25	GR
hCoV-19/Bangladesh/BCSIR-NILMRC-261/2020	EPI_ISL_503958	2020-07-07	Asia / Bangladesh / Khulna / Jessore	Human	Original	Nasopharyngeal swab		NextSeq 550	DRAGEN RNA Pathogen Detection 3.5.14			B.1.1.25	GR
hCoV-19/England/LIVE-A76AF/2020	EPI_ISL_517055	2020-03-28	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-A83B6/2020	EPI_ISL_517155	2020-03-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-A8F0D/2020	EPI_ISL_517232	2020-03-26	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-A9221/2020	EPI_ISL_517279	2020-03-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-A924F/2020	EPI_ISL_517281	2020-03-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1	G
hCoV-19/England/LIVE-A92F4/2020	EPI_ISL_517292	2020-03-25	Europe / United Kingdom / England	Human	Original			Illumina				B.1	G
hCoV-19/England/LIVE-A9A65/2020	EPI_ISL_517313	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-A9CF6/2020	EPI_ISL_517352	2020-03-24	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/LIVE-AA3E1/2020	EPI_ISL_517448	2020-03-23	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1	GR
hCoV-19/England/PORT-2D373C/2020	EPI_ISL_517537	2020-04-15	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/England/SHEF-C3AED/2020	EPI_ISL_517548	2020-07-30	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				B.1.1.227	GR
hCoV-19/Scotland/CVR3964/2020	EPI_ISL_517580	2020-08-09	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				B.1.1	GR
hCoV-19/Scotland/EDB7181/2020	EPI_ISL_517589	2020-08-07	Europe / United Kingdom / Scotland	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Wales/PHWC-169B03/2020	EPI_ISL_517590	2020-07-24	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.227	GR
hCoV-19/Wales/PHWC-169B30/2020	EPI_ISL_517593	2020-07-28	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.269	GR
hCoV-19/Wales/PHWC-169BD6/2020	EPI_ISL_517601	2020-08-01	Europe / United Kingdom / Wales	Human	Original			Illumina				B.1.1.171	GR
hCoV-19/Netherlands/NB-EMC-231/2020	EPI_ISL_523354	2020-05-01	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.1.185	GR
hCoV-19/Netherlands/NB-EMC-232/2020	EPI_ISL_523355	2020-05-01	Europe / Netherlands / Noord-Brabant	Human	Original			Nanopore				B.1.1.185	GR
hCoV-19/Netherlands/OV-EMC-55/2020	EPI_ISL_523439	2020-05-07	Europe / Netherlands / Overijssel	Human	Original			Nanopore				B.1.1	GR
hCoV-19/Netherlands/OV-EMC-58/2020	EPI_ISL_523442	2020-05-14	Europe / Netherlands / Overijssel	Human	Original			Nanopore				B.1.1	GR
hCoV-19/Netherlands/OV-EMC-76/2020	EPI_ISL_523460	2020-06-24	Europe / Netherlands / Overijssel	Human	Original			Nanopore				B.1.236	G
hCoV-19/Mexico/CMX-INMEGEN-22/2020	EPI_ISL_523500	2020-08-06	North America / Mexico / Mexico City	Human	Original	Nasopharyngeal swab		Nanopore MinION				B.1.1.322	GR
hCoV-19/Netherlands/UT-EMC-66/2020	EPI_ISL_523543	2020-08-07	Europe / Netherlands / Utrecht	Human	Original			Nanopore				B.1.1.269	GR
hCoV-19/Netherlands/ZE-EMC-50/2020	EPI_ISL_523549	2020-05-12	Europe / Netherlands / Zeeland	Human	Original			Nanopore				B.1.1.71	GR
hCoV-19/Netherlands/ZH-EMC-235/2020	EPI_ISL_523577	2020-06-12	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.1.112	GR
hCoV-19/Netherlands/ZH-EMC-236/2020	EPI_ISL_523578	2020-06-12	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.1.112	GR
hCoV-19/Netherlands/ZH-EMC-254/2020	EPI_ISL_523596	2020-06-30	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.1.112	GR
hCoV-19/Netherlands/ZH-EMC-257/2020	EPI_ISL_523599	2020-06-15	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.1.112	GR
hCoV-19/Netherlands/ZH-EMC-258/2020	EPI_ISL_523600	2020-06-08	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.1.112	GR
hCoV-19/Netherlands/ZH-EMC-264/2020	EPI_ISL_523606	2020-05-04	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.1.71	GR
hCoV-19/Netherlands/ZH-EMC-272/2020	EPI_ISL_523614	2020-05-08	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.1.112	GR
hCoV-19/Netherlands/ZH-EMC-278/2020	EPI_ISL_523620	2020-06-18	Europe / Netherlands / Zuid-Holland	Human	Original			Nanopore				B.1.1.112	GR
hCoV-19/Wales/QEUH-96163F/2020	EPI_ISL_537016	2020-08-03	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/QEUH-9614EA/2020	EPI_ISL_537018	2020-08-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-961954/2020	EPI_ISL_537025	2020-08-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-961462/2020	EPI_ISL_537027	2020-07-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-96168A/2020	EPI_ISL_537038	2020-08-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9615E7/2020	EPI_ISL_537055	2020-08-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-95DF3B/2020	EPI_ISL_537067	2020-08-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-96170F/2020	EPI_ISL_537069	2020-08-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/QEUH-96166C/2020	EPI_ISL_537085	2020-08-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/QEUH-95E2C8/2020	EPI_ISL_537091	2020-08-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-96158D/2020	EPI_ISL_537109	2020-07-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-9616D5/2020	EPI_ISL_537112	2020-08-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/QEUH-95E33E/2020	EPI_ISL_537124	2020-08-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-961DB2/2020	EPI_ISL_537132	2020-07-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/QEUH-95DCE9/2020	EPI_ISL_537138	2020-08-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-95DE10/2020	EPI_ISL_537139	2020-08-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/QEUH-9618FD/2020	EPI_ISL_537146	2020-07-31	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-997F17/2020	EPI_ISL_537154	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-997CE3/2020	EPI_ISL_537156	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9981A7/2020	EPI_ISL_537158	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-997EDE/2020	EPI_ISL_537161	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-997EB0/2020	EPI_ISL_537163	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/QEUH-997F44/2020	EPI_ISL_537164	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-997F35/2020	EPI_ISL_537177	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9981B6/2020	EPI_ISL_537181	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9981D4/2020	EPI_ISL_537190	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.39	GR
hCoV-19/England/QEUH-997E29/2020	EPI_ISL_537191	2020-08-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.242	GR
hCoV-19/England/QEUH-9982A4/2020	EPI_ISL_537192	2020-08-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.39	GR
hCoV-19/England/QEUH-997DA4/2020	EPI_ISL_537195	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/QEUH-997F08/2020	EPI_ISL_537198	2020-08-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-997D59/2020	EPI_ISL_537202	2020-08-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Spain/CN-IBV-97006516/2020	EPI_ISL_537721	2020-04-02	Africa / Canary Islands / Las Palmas de Gran Canaria	Human	Original			Illumina MiSeq	BWA/IVAR			B.1	G
hCoV-19/Italy/LOM-UniMI-L103/2020	EPI_ISL_542101	2020-03-09	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1	GR
hCoV-19/Italy/LOM-UniMI-L113/2020	EPI_ISL_542110	2020-03-09	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1.61	GR
hCoV-19/Italy/LOM-UniMI-L138/2020	EPI_ISL_542134	2020-03-16	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1	GR
hCoV-19/Italy/LOM-UniMI-L141/2020	EPI_ISL_542137	2020-03-19	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1	GR
hCoV-19/Italy/LOM-UniMI-L145/2020	EPI_ISL_542140	2020-03-19	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Italy/LOM-UniMI-L146/2020	EPI_ISL_542141	2020-03-19	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1	GR
hCoV-19/Italy/LOM-UniMI-L153/2020	EPI_ISL_542148	2020-03-15	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500		Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.1	GR
hCoV-19/Italy/LOM-UniMI-L157/2020	EPI_ISL_542152	2020-03-19	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1	GR
hCoV-19/Italy/LOM-UniMI-L159/2020	EPI_ISL_542154	2020-03-13	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1	GR
hCoV-19/Italy/LOM-UniMI-L214/2020	EPI_ISL_542201	2020-03-12	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1	GR
hCoV-19/Italy/LOM-UniMI-L219/2020	EPI_ISL_542206	2020-03-15	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1	GR
hCoV-19/Italy/LOM-UniMI-L222/2020	EPI_ISL_542209	2020-03-13	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1	GR
hCoV-19/Italy/LOM-UniMI-L224/2020	EPI_ISL_542211	2020-03-13	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1.61	GR
hCoV-19/Italy/LOM-UniMI-L280/2020	EPI_ISL_542244	2020-02-28	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1	GR
hCoV-19/Italy/LOM-UniMI-L310/2020	EPI_ISL_542263	2020-02-29	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1.61	GR
hCoV-19/Italy/LOM-UniMI-L319/2020	EPI_ISL_542270	2020-03-01	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1.61	GR
hCoV-19/Italy/LOM-UniMI-L380/2020	EPI_ISL_542306	2020-03-08	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1	GR
hCoV-19/Italy/LOM-UniMI-L399/2020	EPI_ISL_542321	2020-03-06	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1.71	GR
hCoV-19/Italy/LOM-UniMI-L425/2020	EPI_ISL_542344	2020-03-10	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1	GR
hCoV-19/Italy/LOM-UniMI-L435/2020	EPI_ISL_542354	2020-03-20	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1.71	GR
hCoV-19/Italy/LOM-UniMI-L461/2020	EPI_ISL_542377	2020-03-25	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1.71	GR
hCoV-19/Italy/LOM-UniMI-L475/2020	EPI_ISL_542388	2020-03-30	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1.71	GR
hCoV-19/Italy/LOM-UniMI-L476/2020	EPI_ISL_542389	2020-04-01	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1	GR
hCoV-19/Italy/LOM-UniMI-L57/2020	EPI_ISL_542404	2020-03-04	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1.61	GR
hCoV-19/Italy/LOM-UniMI-L86/2020	EPI_ISL_542430	2020-03-04	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1	GR
hCoV-19/Italy/LOM-UniMI-L96/2020	EPI_ISL_542440	2020-03-06	Europe / Italy / Lombardy	Human	Original	Nasopharyngeal swab		CleanPlex SARS-CoV-2 Research and Surveillance Panel; Illumina NextSeq 500				B.1.1.61	GR
hCoV-19/USA/TX-HMH-1189/2020	EPI_ISL_542577	2020-04-22	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.61	GR
hCoV-19/USA/TX-HMH-1503/2020	EPI_ISL_542759	2020-04-30	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.61	GR
hCoV-19/USA/NM-UNM-00575/2020	EPI_ISL_542989	2020-08-07	North America / USA / New Mexico	Human	Original			Illumina MiSeq; ARTIC V3	bwa/iVar			B.1	G
hCoV-19/USA/TX-HMH-3573/2020	EPI_ISL_543033	2020-06-15	North America / USA / Texas / Houston	Human	Original			Oxford Nanopore	ARTIC V3			B.1.1.230	GR
hCoV-19/England/CAMC-94B71A/2020	EPI_ISL_556646	2020-07-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1	GR
hCoV-19/England/CAMC-94C1FD/2020	EPI_ISL_556650	2020-07-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/CAMC-94A5D5/2020	EPI_ISL_556654	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/CAMC-946199/2020	EPI_ISL_556655	2020-07-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-94AD46/2020	EPI_ISL_556666	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/CAMC-94C2CD/2020	EPI_ISL_556669	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-945FCD/2020	EPI_ISL_556671	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/CAMC-9460BA/2020	EPI_ISL_556673	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/CAMC-94632A/2020	EPI_ISL_556677	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-945BE7/2020	EPI_ISL_556693	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/CAMC-94C324/2020	EPI_ISL_556701	2020-07-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.15	GR
hCoV-19/England/CAMC-94BF21/2020	EPI_ISL_556704	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/CAMC-94C175/2020	EPI_ISL_556715	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/CAMC-94BE9D/2020	EPI_ISL_556716	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.97	GR
hCoV-19/England/CAMC-949F32/2020	EPI_ISL_556718	2020-07-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/CAMC-9461C6/2020	EPI_ISL_556723	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/CAMC-945B7E/2020	EPI_ISL_556731	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/CAMC-94A748/2020	EPI_ISL_556747	2020-07-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/CAMC-945B23/2020	EPI_ISL_556763	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/CAMC-94971C/2020	EPI_ISL_556771	2020-07-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.238	G
hCoV-19/England/CAMC-945701/2020	EPI_ISL_556774	2020-07-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/CAMC-946DB3/2020	EPI_ISL_556775	2020-07-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/CAMC-9458B3/2020	EPI_ISL_556778	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-9493FA/2020	EPI_ISL_556782	2020-07-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/CAMC-9454DD/2020	EPI_ISL_556786	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/CAMC-94531C/2020	EPI_ISL_556788	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/CAMC-945507/2020	EPI_ISL_556789	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/CAMC-945473/2020	EPI_ISL_556790	2020-07-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.97	GR
hCoV-19/England/CAMC-948522/2020	EPI_ISL_556805	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.97	GR
hCoV-19/England/CAMC-9485C8/2020	EPI_ISL_556809	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/CAMC-94881A/2020	EPI_ISL_556810	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/CAMC-948513/2020	EPI_ISL_556811	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/CAMC-9458C2/2020	EPI_ISL_556814	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/CAMC-94915A/2020	EPI_ISL_556816	2020-07-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.97	GR
hCoV-19/England/CAMC-948BF3/2020	EPI_ISL_556823	2020-07-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/CAMC-9414FF/2020	EPI_ISL_556830	2020-07-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/CAMC-941A39/2020	EPI_ISL_556831	2020-07-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/CAMC-9418F3/2020	EPI_ISL_556840	2020-07-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/CAMC-94137A/2020	EPI_ISL_556841	2020-07-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/CAMC-941592/2020	EPI_ISL_556842	2020-07-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/CAMC-941C8E/2020	EPI_ISL_556843	2020-07-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-941B18/2020	EPI_ISL_556844	2020-07-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-941987/2020	EPI_ISL_556846	2020-07-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/CAMC-941C24/2020	EPI_ISL_556850	2020-07-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-941D12/2020	EPI_ISL_556851	2020-07-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/CAMC-9412F5/2020	EPI_ISL_556854	2020-07-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		Gap of 2 nucleotides when compared to the reference sequence.	info	B.1.1.227	GR
hCoV-19/England/CAMC-941BBE/2020	EPI_ISL_556858	2020-07-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/CAMC-94286B/2020	EPI_ISL_556864	2020-07-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/CAMC-9427C8/2020	EPI_ISL_556868	2020-07-27	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/CAMC-9422D6/2020	EPI_ISL_556869	2020-07-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/CAMC-942713/2020	EPI_ISL_556872	2020-07-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/CAMC-94323F/2020	EPI_ISL_556879	2020-07-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/CAMC-942FFD/2020	EPI_ISL_556882	2020-07-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/CAMC-942009/2020	EPI_ISL_556888	2020-07-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/CAMC-942582/2020	EPI_ISL_556889	2020-07-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.15	GR
hCoV-19/England/CAMC-942054/2020	EPI_ISL_556890	2020-07-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/CAMC-941FD0/2020	EPI_ISL_556891	2020-07-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/CAMC-942CC9/2020	EPI_ISL_556893	2020-07-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/CAMC-943017/2020	EPI_ISL_556895	2020-07-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/CAMC-942063/2020	EPI_ISL_556896	2020-07-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/CAMC-942A29/2020	EPI_ISL_556899	2020-07-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/CAMC-942555/2020	EPI_ISL_556901	2020-07-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/CAMC-9425CE/2020	EPI_ISL_556902	2020-07-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.15	GR
hCoV-19/England/CAMC-941F3A/2020	EPI_ISL_556909	2020-07-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/CAMC-942115/2020	EPI_ISL_556912	2020-07-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.406	GR
hCoV-19/England/CAMC-94671F/2020	EPI_ISL_556916	2020-07-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/CAMC-9467A6/2020	EPI_ISL_556922	2020-07-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/CAMC-947A15/2020	EPI_ISL_556923	2020-07-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/CAMC-944EEF/2020	EPI_ISL_556931	2020-07-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.97	GR
hCoV-19/England/CAMC-944F28/2020	EPI_ISL_556948	2020-07-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.115	GR
hCoV-19/England/ALDP-8FEFF1/2020	EPI_ISL_556986	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-8D19D8/2020	EPI_ISL_556987	2020-06-26	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-8BA674/2020	EPI_ISL_556998	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-8D74A4/2020	EPI_ISL_557045	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-8FEF3D/2020	EPI_ISL_557062	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-8FF2E8/2020	EPI_ISL_557063	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-8DF873/2020	EPI_ISL_557064	2020-06-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-8DE1C4/2020	EPI_ISL_557076	2020-06-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-9015CB/2020	EPI_ISL_557093	2020-06-24	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-8E2B29/2020	EPI_ISL_557095	2020-06-25	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-86C34D/2020	EPI_ISL_557514	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.97	GR
hCoV-19/England/ALDP-6FD880/2020	EPI_ISL_557518	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-749A33/2020	EPI_ISL_557523	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.15	GR
hCoV-19/England/ALDP-746DD3/2020	EPI_ISL_557533	2020-06-29	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/MILK-86E6AC/2020	EPI_ISL_557538	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.15	GR
hCoV-19/England/MILK-86F90C/2020	EPI_ISL_557552	2020-07-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.198	GR
hCoV-19/England/ALDP-71D91D/2020	EPI_ISL_557561	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-6E9052/2020	EPI_ISL_557566	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-6E261B/2020	EPI_ISL_557567	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.171	GR
hCoV-19/England/ALDP-6EA6C8/2020	EPI_ISL_557568	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/ALDP-71DACF/2020	EPI_ISL_557575	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/England/ALDP-725156/2020	EPI_ISL_557597	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-6EB050/2020	EPI_ISL_557648	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-6E95EA/2020	EPI_ISL_557671	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-7210F3/2020	EPI_ISL_557673	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-70B4A8/2020	EPI_ISL_557674	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-721196/2020	EPI_ISL_557677	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-703437/2020	EPI_ISL_557702	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-6EAB14/2020	EPI_ISL_557703	2020-06-30	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/ALDP-7211B4/2020	EPI_ISL_557707	2020-07-01	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/Scotland/QEUH-9C92C8/2020	EPI_ISL_576062	2020-09-14	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/Mexico/NLE-InDRE-60/2020	EPI_ISL_576263	2020-08-14	North America / Mexico / Nuevo Leon	Human	Original	Oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 20			B.1.1	GR
hCoV-19/Mexico/SLP-InDRE-69/2020	EPI_ISL_576272	2020-08-21	North America / Mexico / San Luis Potosi	Human	Original	Oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 21			B.1.189	G
hCoV-19/Mexico/COL-InDRE-75/2020	EPI_ISL_576278	2020-08-24	North America / Mexico / Colima	Human	Original	Oropharyngeal swab		Illumina MiSeq	CLC Genomics Workbench 27			B.1.396	G
hCoV-19/USA/un-UW-12782/2020	EPI_ISL_576404	2020-06-29	North America / USA	Human	Original			Illumina	custom			B.1.1	GR
hCoV-19/USA/WA-UW-12787/2020	EPI_ISL_576405	2020-06-29	North America / USA / Washington	Human	Original			Illumina	custom			B.1.240	G
hCoV-19/USA/WA-UW-23340/2020	EPI_ISL_576428	2020-08-07	North America / USA / Washington	Human	Original			Illumina	custom	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1.240	G
hCoV-19/USA/WA-UW-23391/2020	EPI_ISL_576442	2020-08-11	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1.61	GR
hCoV-19/USA/WA-UW-23415/2020	EPI_ISL_576449	2020-08-10	North America / USA / Washington	Human	Original			Illumina	custom	NS7b_E39stop results in 11.6% truncation of the protein sequence.	info	B.1	G
hCoV-19/USA/WA-UW-23597/2020	EPI_ISL_576482	2020-08-10	North America / USA / Washington	Human	Original			Illumina	custom			B.1.1.337	GR
hCoV-19/USA/un-UW-6997/2020	EPI_ISL_576495	2020-03-11	North America / USA	Human	Original			Illumina	custom			B.1.1	GR
hCoV-19/USA/CA-IGI-0353/2020	EPI_ISL_576539	2020-06-26	North America / USA / California / Alameda County	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	Minimap2 v2.16-r922/iVar 1.2.2 reference aligned			B.1.240	G
hCoV-19/England/ALDP-9D75CE/2020	EPI_ISL_576570	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9D783E/2020	EPI_ISL_576589	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9D785C/2020	EPI_ISL_576591	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9D78B6/2020	EPI_ISL_576595	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.532	GR
hCoV-19/England/ALDP-9D7DE4/2020	EPI_ISL_576631	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9D7DF3/2020	EPI_ISL_576632	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9D7FA2/2020	EPI_ISL_576636	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9D80F9/2020	EPI_ISL_576639	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.165	G
hCoV-19/England/ALDP-9D9070/2020	EPI_ISL_576694	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.255	GR
hCoV-19/England/ALDP-9D90DA/2020	EPI_ISL_576697	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.67	GR
hCoV-19/England/ALDP-9D923E/2020	EPI_ISL_576710	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9D9298/2020	EPI_ISL_576714	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9D95AE/2020	EPI_ISL_576742	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9D992A/2020	EPI_ISL_576773	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.308	GR
hCoV-19/England/ALDP-9D99FD/2020	EPI_ISL_576784	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E19stop results in 85.1% truncation of the protein sequence.	info	AD.2	GR
hCoV-19/England/ALDP-9D9A81/2020	EPI_ISL_576789	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9D9BD9/2020	EPI_ISL_576800	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9D9C5E/2020	EPI_ISL_576806	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.67	GR
hCoV-19/England/ALDP-9D9DE2/2020	EPI_ISL_576818	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9D9E0D/2020	EPI_ISL_576820	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.67	GR
hCoV-19/England/ALDP-9DA042/2020	EPI_ISL_576839	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.255	GR
hCoV-19/England/ALDP-9DA0F7/2020	EPI_ISL_576846	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.67	GR
hCoV-19/England/ALDP-9DA103/2020	EPI_ISL_576847	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.67	GR
hCoV-19/England/ALDP-9DA17C/2020	EPI_ISL_576854	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/ALDP-9DA2D3/2020	EPI_ISL_576861	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMB-1B634B/2020	EPI_ISL_576900	2020-09-21	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/CAMC-9DFA03/2020	EPI_ISL_576922	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.308	GR
hCoV-19/England/CAMC-9DFBD3/2020	EPI_ISL_576926	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9DFDCE/2020	EPI_ISL_576938	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/CAMC-9DFE34/2020	EPI_ISL_576939	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina				AD.2	GR
hCoV-19/England/MILK-9917AC/2020	EPI_ISL_576992	2020-08-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/MILK-9917D9/2020	EPI_ISL_576994	2020-08-25	Europe / United Kingdom / England	Human	Original			Oxford Nanopore		Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.1.269	GR
hCoV-19/Belgium/ULG-10449/2020	EPI_ISL_581624	2020-08-26	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.236	G
hCoV-19/Belgium/ULG-10453/2020	EPI_ISL_581627	2020-08-26	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/Belgium/ULG-10457/2020	EPI_ISL_581630	2020-08-28	Europe / Belgium / Liège	Human	Original			Nanopore MinION	Artic network			B.1.1	GR
hCoV-19/Switzerland/BS-42224191/2020	EPI_ISL_581687	2020-04-08	Europe / Switzerland / Basel-Stadt	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	in-house pipeline COVGAP			B.1	G
hCoV-19/Switzerland/BL-42340977/2020	EPI_ISL_581896	2020-07-06	Europe / Switzerland / Basel-Land	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	in-house pipeline COVGAP			B.1.1	GR
hCoV-19/Switzerland/SG-42341324/2020	EPI_ISL_581898	2020-07-06	Europe / Switzerland / St. Gallen	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	in-house pipeline COVGAP			B.1.1.39	GR
hCoV-19/Switzerland/BS-65254283/2020	EPI_ISL_581961	2020-08-03	Europe / Switzerland / Basel-Stadt	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	in-house pipeline COVGAP			B.1.1.39	GR
hCoV-19/Switzerland/BL-42402436/2020	EPI_ISL_581973	2020-08-19	Europe / Switzerland / Basel-Land	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	in-house pipeline COVGAP			B.1.1.39	GR
hCoV-19/Switzerland/BS-42412257/2020	EPI_ISL_581986	2020-08-26	Europe / Switzerland / Basel-Stadt	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	in-house pipeline COVGAP			B.1.1.39	GR
hCoV-19/Switzerland/BS-UHB-65255924/2020	EPI_ISL_582000	2020-08-17	Europe / Switzerland / Basel-Stadt	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina NextSeq 500	in-house pipeline COVGAP			B.1.236	G
hCoV-19/Portugal/PT0939/2020	EPI_ISL_582514	2020-04-08	Europe / Portugal	Human	Original			Illumina NextSeq 550	INSaFLU	Submitter Note: Submitter confirmed the indel. It was inspected and detected with high coverage. Stretches of NNNs (1.64% of overall sequence). Insertion of 1 nucleotide(s) found at refpos 10450 (FRAMESHIFT). NSP5 without BLAST coverage.	info	B.1.1	GR
hCoV-19/England/QEUH-A4CF98/2020	EPI_ISL_596073	2020-10-03	Europe / United Kingdom / England	Human	Original			Illumina		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/QEUH-A4D146/2020	EPI_ISL_596095	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.165	G
hCoV-19/England/QEUH-A4D3C8/2020	EPI_ISL_596111	2020-10-05	Europe / United Kingdom / England	Human	Original			Illumina				B.1.1.255	GR
hCoV-19/England/SHEF-C2495/2020	EPI_ISL_596192	2020-10-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/SHEF-D09FF/2020	EPI_ISL_596222	2020-10-08	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Russia/SPE-RII-32995S/2020	EPI_ISL_596231	2020-09-04	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/SPE-RII-35212S/2020	EPI_ISL_596245	2020-09-24	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/SPE-RII-MH1008S/2020	EPI_ISL_596251	2020-09-04	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.163	GR
hCoV-19/Russia/SVE-RII-MH1412S/2020	EPI_ISL_596271	2020-09-07	Europe / Russia / Sverdlovsk / Ekaterinburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.387	GR
hCoV-19/Russia/SVE-RII-MH1436S/2020	EPI_ISL_596274	2020-09-12	Europe / Russia / Sverdlovsk / Ekaterinburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/SVE-RII-MH1444S/2020	EPI_ISL_596278	2020-09-08	Europe / Russia / Sverdlovsk / Ekaterinburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.163	GR
hCoV-19/Russia/SPE-RII-MH1519S/2020	EPI_ISL_596288	2020-09-11	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/SPE-RII-MH1524S/2020	EPI_ISL_596291	2020-09-12	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/SVE-RII-MH1613S/2020	EPI_ISL_596296	2020-09-07	Europe / Russia / Sverdlovsk / Ekaterinburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/KK-RII-MH1680S/2020	EPI_ISL_596311	2020-09-03	Europe / Russia / Khakassia / Abakan	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/KK-RII-MH1681S/2020	EPI_ISL_596312	2020-09-03	Europe / Russia / Khakassia / Abakan	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/MOW-RII-MH1982S/2020	EPI_ISL_596327	2020-05-30	Europe / Russia / Moscow	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/MOW-RII-MH1984S/2020	EPI_ISL_596329	2020-06-01	Europe / Russia / Moscow	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/MOW-RII-MH1985S/2020	EPI_ISL_596330	2020-06-01	Europe / Russia / Moscow	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/MOW-RII-MH1998S/2020	EPI_ISL_596342	2020-06-10	Europe / Russia / Moscow	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.163	GR
hCoV-19/Russia/MOW-RII-MH2003S/2020	EPI_ISL_596345	2020-06-19	Europe / Russia / Moscow	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.163	GR
hCoV-19/Russia/SPE-RII-MH939S/2020	EPI_ISL_596357	2020-09-06	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/SPE-RII-MH943S/2020	EPI_ISL_596358	2020-09-06	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1	GR
hCoV-19/Russia/SPE-RII-MH958S/2020	EPI_ISL_596365	2020-09-03	Europe / Russia / Saint Petersburg	Human	Original	Nasopharyngeal swab		Illumina MiSeq	tanoti + samtools + ivar			B.1.1.163	GR
hCoV-19/USA/WA-S2860/2020	EPI_ISL_596391	2020-09-17	North America / USA / Washington / King County	Human	Original			Illumina NextSeq	Seattle Flu Assembly Pipeline			B.1.396	G
hCoV-19/USA/WA-S2864/2020	EPI_ISL_596395	2020-09-19	North America / USA / Washington / King County	Human	Original			Illumina NextSeq	Seattle Flu Assembly Pipeline			B.1.1.337	GR
hCoV-19/USA/WA-S2876/2020	EPI_ISL_596407	2020-09-24	North America / USA / Washington / King County	Human	Original			Illumina NextSeq	Seattle Flu Assembly Pipeline			B.1	G
hCoV-19/Singapore/1074/2020	EPI_ISL_596464	2020-10-06	Asia / Singapore	Human	Original			Illumina MiSeq				B.1	G
hCoV-19/Singapore/1084/2020	EPI_ISL_596474	2020-09-21	Asia / Singapore	Human	Original			Illumina MiSeq				B.1	G
hCoV-19/Singapore/1085/2020	EPI_ISL_596475	2020-09-21	Asia / Singapore	Human	Original			Illumina MiSeq				B.1	G
hCoV-19/Singapore/1087/2020	EPI_ISL_596477	2020-09-25	Asia / Singapore	Human	Original			Illumina MiSeq				B.1	G
hCoV-19/Ireland/D-SVUH-R9588/2020	EPI_ISL_596628	2020-04-29	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-SVUH-R9212/2020	EPI_ISL_596629	2020-04-27	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-SVUH-R9485/2020	EPI_ISL_596630	2020-04-28	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-SVUH-R9592/2020	EPI_ISL_596631	2020-04-29	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-SVUH-R9593/2020	EPI_ISL_596632	2020-04-29	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-SVUH-R9585/2020	EPI_ISL_596636	2020-04-29	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-SVUH-R9591/2020	EPI_ISL_596637	2020-04-29	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-SVUH-R9218/2020	EPI_ISL_596639	2020-04-27	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-SVUH-R9582/2020	EPI_ISL_596640	2020-04-29	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-SVUH-R6408/2020	EPI_ISL_596645	2020-04-03	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-SVUH-R5890/2020	EPI_ISL_596646	2020-03-29	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-SVUH-R5391/2020	EPI_ISL_596648	2020-03-24	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-SVUH-R6519/2020	EPI_ISL_596650	2020-04-04	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-SVUH-R8382/2020	EPI_ISL_596651	2020-04-09	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-SVUH-R7175/2020	EPI_ISL_596652	2020-04-09	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-SVUH-R5732/2020	EPI_ISL_596653	2020-03-27	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-SVUH-R6370/2020	EPI_ISL_596654	2020-04-03	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-SVUH-R6989/2020	EPI_ISL_596655	2020-04-08	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-SVUH-R6565/2020	EPI_ISL_596659	2020-04-05	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-SVUH-R6716/2020	EPI_ISL_596660	2020-04-06	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-SVUH-R6717/2020	EPI_ISL_596661	2020-04-06	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-SVUH-R7377/2020	EPI_ISL_596663	2020-04-11	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-SVUH-R6617/2020	EPI_ISL_596664	2020-04-05	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-SVUH-R6766/2020	EPI_ISL_596665	2020-03-31	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	ARTIC v3 Protocol			B.1.1.267	GR
hCoV-19/Ireland/D-SVUH-R5662/2020	EPI_ISL_596668	2020-03-27	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	ARTIC v3 Protocol			B.1.1.174	GR
hCoV-19/Ireland/D-SVUH-R6380/2020	EPI_ISL_596669	2020-04-03	Europe / Ireland / Dublin	Human	Original	Nasopharyngeal and oropharyngeal swab		Illumina MiSeq	ARTIC v3 Protocol			B.1.1.174	GR
hCoV-19/Scotland/QEUH-9E5439/2020	EPI_ISL_601005	2020-09-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/Scotland/QEUH-9E4EB4/2020	EPI_ISL_601011	2020-09-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/Scotland/QEUH-9E435B/2020	EPI_ISL_601042	2020-09-23	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9E55DC/2020	EPI_ISL_601067	2020-09-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/Scotland/QEUH-9E54EE/2020	EPI_ISL_601078	2020-09-24	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9DC408/2020	EPI_ISL_601161	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9DC347/2020	EPI_ISL_601184	2020-09-22	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9DE6B5/2020	EPI_ISL_601197	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9DEA6E/2020	EPI_ISL_601208	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9DEA7D/2020	EPI_ISL_601210	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9DE6E2/2020	EPI_ISL_601216	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9DEDFC/2020	EPI_ISL_601227	2020-09-21	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DBE65/2020	EPI_ISL_601236	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9E02DA/2020	EPI_ISL_601280	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9E06B0/2020	EPI_ISL_601298	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.236	G
hCoV-19/England/MILK-9E096C/2020	EPI_ISL_601320	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9E03D7/2020	EPI_ISL_601343	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9E0647/2020	EPI_ISL_601360	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9E0CAF/2020	EPI_ISL_601404	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/MILK-9E07EA/2020	EPI_ISL_601417	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9E0AE1/2020	EPI_ISL_601418	2020-09-21	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.39	GR
hCoV-19/England/QEUH-9DA72F/2020	EPI_ISL_601446	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9E097B/2020	EPI_ISL_601449	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9E0999/2020	EPI_ISL_601456	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-9DBFAE/2020	EPI_ISL_601461	2020-09-22	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9E0331/2020	EPI_ISL_601474	2020-09-20	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.227	GR
hCoV-19/Wales/MILK-9E087E/2020	EPI_ISL_601475	2020-09-20	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9D400C/2020	EPI_ISL_601496	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/Wales/MILK-9D3F6A/2020	EPI_ISL_601509	2020-09-18	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9D4BB0/2020	EPI_ISL_601518	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-9D46EC/2020	EPI_ISL_601521	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/Wales/MILK-9D4CEA/2020	EPI_ISL_601527	2020-09-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9D3DBB/2020	EPI_ISL_601537	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9D4F1E/2020	EPI_ISL_601543	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9D46DD/2020	EPI_ISL_601556	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9D4B56/2020	EPI_ISL_601575	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/MILK-9D4761/2020	EPI_ISL_601582	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1	G
hCoV-19/England/MILK-9D4549/2020	EPI_ISL_601592	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9D1EF6/2020	EPI_ISL_601606	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9D3D33/2020	EPI_ISL_601612	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9D4CBD/2020	EPI_ISL_601620	2020-09-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9D1F8A/2020	EPI_ISL_601627	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.133	GR
hCoV-19/England/MILK-9D3E30/2020	EPI_ISL_601645	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.39	GR
hCoV-19/England/MILK-9D4F87/2020	EPI_ISL_601647	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9D46CE/2020	EPI_ISL_601677	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Wales/MILK-9D3FB5/2020	EPI_ISL_601684	2020-09-18	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9D3FD3/2020	EPI_ISL_601689	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9D4B47/2020	EPI_ISL_601692	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.204	GR
hCoV-19/England/MILK-9D402A/2020	EPI_ISL_601695	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9D48AA/2020	EPI_ISL_601702	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/Wales/MILK-9D4CDB/2020	EPI_ISL_601705	2020-09-19	Europe / United Kingdom / Wales	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9D4716/2020	EPI_ISL_601708	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9D3EF4/2020	EPI_ISL_601713	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/MILK-9D3EE5/2020	EPI_ISL_601722	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/MILK-9D47AD/2020	EPI_ISL_601723	2020-09-18	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9D2068/2020	EPI_ISL_601730	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9D4BCF/2020	EPI_ISL_601744	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9D45EF/2020	EPI_ISL_601774	2020-09-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-9D22CC/2020	EPI_ISL_601778	2020-09-19	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-9D3E8B/2020	EPI_ISL_601784	2020-09-16	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-9CE991/2020	EPI_ISL_601940	2020-09-17	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/Denmark/DCGC-4270/2020	EPI_ISL_615707	2020-09-07	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				AQ.2	GR
hCoV-19/Denmark/DCGC-3930/2020	EPI_ISL_615841	2020-09-14	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				AQ.2	GR
hCoV-19/Denmark/DCGC-3105/2020	EPI_ISL_615921	2020-08-31	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				AQ.2	GR
hCoV-19/Denmark/DCGC-3173/2020	EPI_ISL_615995	2020-08-31	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				AQ.2	GR
hCoV-19/Denmark/DCGC-2581/2020	EPI_ISL_616418	2020-08-17	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2582/2020	EPI_ISL_616419	2020-08-17	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2586/2020	EPI_ISL_616423	2020-08-17	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2721/2020	EPI_ISL_616466	2020-08-17	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.236	G
hCoV-19/Denmark/DCGC-2722/2020	EPI_ISL_616467	2020-08-17	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.236	G
hCoV-19/Denmark/DCGC-2741/2020	EPI_ISL_616486	2020-08-17	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.236	G
hCoV-19/Denmark/DCGC-2865/2020	EPI_ISL_616559	2020-08-17	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.1.269	GR
hCoV-19/Denmark/DCGC-2868/2020	EPI_ISL_616562	2020-08-24	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.236	G
hCoV-19/Denmark/DCGC-5814/2020	EPI_ISL_621001	2020-09-28	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.159	GR
hCoV-19/Denmark/DCGC-5815/2020	EPI_ISL_621002	2020-09-28	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.159	GR
hCoV-19/Denmark/DCGC-5822/2020	EPI_ISL_621009	2020-09-28	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION				B.1.1.159	GR
hCoV-19/Denmark/DCGC-4774/2020	EPI_ISL_621384	2020-09-21	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1	GR
hCoV-19/Denmark/DCGC-4792/2020	EPI_ISL_621402	2020-09-21	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.236	G
hCoV-19/Denmark/DCGC-4823/2020	EPI_ISL_621433	2020-09-21	Europe / Denmark / Syddanmark	Human	Original			Nanopore MinION				B.1.398	G
hCoV-19/Denmark/DCGC-4828/2020	EPI_ISL_621438	2020-09-21	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		NS6_Q8stop results in 88.5% truncation of the protein sequence.	info	B.1.1.159	GR
hCoV-19/Denmark/DCGC-4925/2020	EPI_ISL_621463	2020-09-21	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.236	G
hCoV-19/Denmark/DCGC-4952/2020	EPI_ISL_621490	2020-09-21	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.44	GR
hCoV-19/Denmark/DCGC-4846/2020	EPI_ISL_621531	2020-09-21	Europe / Denmark / Midtjylland	Human	Original			Nanopore MinION				B.1.1.159	GR
hCoV-19/Denmark/DCGC-4853/2020	EPI_ISL_621539	2020-09-21	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.1.308	GR
hCoV-19/Denmark/DCGC-4899/2020	EPI_ISL_621585	2020-09-21	Europe / Denmark / Sjaelland	Human	Original			Nanopore MinION				B.1.236	G
hCoV-19/Denmark/DCGC-5061/2020	EPI_ISL_621599	2020-09-21	Europe / Denmark / Nordjylland	Human	Original			Nanopore MinION		NS6_Q8stop results in 88.5% truncation of the protein sequence.	info	B.1.1.159	GR
hCoV-19/Denmark/DCGC-6338/2020	EPI_ISL_621823	2020-09-21	Europe / Denmark	Human	Original			Nanopore MinION				B.1.236	G
hCoV-19/Denmark/DCGC-4694/2020	EPI_ISL_621926	2020-09-21	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.236	G
hCoV-19/Denmark/DCGC-4155/2020	EPI_ISL_621975	2020-09-21	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				AQ.2	GR
hCoV-19/Denmark/DCGC-4160/2020	EPI_ISL_621980	2020-09-21	Europe / Denmark / Hovedstaden	Human	Original			Nanopore MinION				B.1.236	G
hCoV-19/South Africa/KRISP-K004021/2020	EPI_ISL_635004	2020-10-13	Africa / South Africa / KwaZulu-Natal / Harry Gwala	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.56	GR
hCoV-19/South Africa/KRISP-K004027/2020	EPI_ISL_635009	2020-10-14	Africa / South Africa / KwaZulu-Natal / Ilembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.56	GR
hCoV-19/South Africa/KRISP-K004029/2020	EPI_ISL_635010	2020-10-09	Africa / South Africa / KwaZulu-Natal / Ilembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K004030/2020	EPI_ISL_635011	2020-10-12	Africa / South Africa / KwaZulu-Natal / Ugu	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K004031/2020	EPI_ISL_635012	2020-10-12	Africa / South Africa / KwaZulu-Natal / Ugu	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K004032/2020	EPI_ISL_635013	2020-10-12	Africa / South Africa / KwaZulu-Natal / Ugu	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K004034/2020	EPI_ISL_635015	2020-10-14	Africa / South Africa / KwaZulu-Natal / Zululand	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K004037/2020	EPI_ISL_635018	2020-10-15	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.507	GR
hCoV-19/South Africa/KRISP-K004047/2020	EPI_ISL_635026	2020-10-20	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K004049/2020	EPI_ISL_635028	2020-10-20	Africa / South Africa / KwaZulu-Natal / Ugu	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1	G
hCoV-19/South Africa/KRISP-K004055/2020	EPI_ISL_635034	2020-10-19	Africa / South Africa / KwaZulu-Natal / Ugu	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1	G
hCoV-19/South Africa/KRISP-K004068/2020	EPI_ISL_635046	2020-10-20	Africa / South Africa / KwaZulu-Natal / Ugu	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	G
hCoV-19/South Africa/KRISP-K004075/2020	EPI_ISL_635052	2020-10-18	Africa / South Africa / KwaZulu-Natal / Umkhanyakude	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/Norway/4276/2020	EPI_ISL_635143	2020-10-10	Europe / Norway / Agder	Human	Original	Nasopharyngeal swab		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1.451	GR
hCoV-19/Norway/4282/2020	EPI_ISL_635189	2020-10-11	Europe / Norway / Agder	Human	Original	Nasopharyngeal swab		Illumina MiSeq, ARTIC protocol v3	Assembly by reference based mapping using Tanoti with iVar majority rules consensus			B.1.1.451	GR
hCoV-19/Slovenia/V0-2949/2020	EPI_ISL_635284	2020-04-01	Europe / Slovenia	Human	Original	Oropharyngeal swab		Illumina MiSeq	SPAdes 3.14			B.1.1	GR
hCoV-19/Slovenia/V0-3902/2020	EPI_ISL_635286	2020-04-03	Europe / Slovenia	Human	Original	Oropharyngeal swab		Illumina MiSeq	SPAdes 3.14			B.1.1	GR
hCoV-19/USA/CA-ALSR-2011/2020	EPI_ISL_635304	2020-05-14	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-2067/2020	EPI_ISL_635332	2020-05-27	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-2069/2020	EPI_ISL_635333	2020-05-22	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-2070/2020	EPI_ISL_635334	2020-06-01	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-2073/2020	EPI_ISL_635335	2020-05-22	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-2093/2020	EPI_ISL_635344	2020-05-29	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.239	G
hCoV-19/USA/CA-ALSR-2096/2020	EPI_ISL_635346	2020-05-24	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.399	G
hCoV-19/USA/CA-ALSR-2106/2020	EPI_ISL_635349	2020-05-22	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-2114/2020	EPI_ISL_635352	2020-05-28	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-2121/2020	EPI_ISL_635356	2020-05-29	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-2160/2020	EPI_ISL_635364	2020-06-02	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-2218/2020	EPI_ISL_635390	2020-06-25	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-2219/2020	EPI_ISL_635391	2020-06-03	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-2232/2020	EPI_ISL_635396	2020-06-29	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1	GR
hCoV-19/USA/CA-ALSR-2234/2020	EPI_ISL_635397	2020-06-29	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1	GR
hCoV-19/USA/CA-ALSR-2268/2020	EPI_ISL_635401	2020-06-29	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-2269/2020	EPI_ISL_635402	2020-06-29	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-2287/2020	EPI_ISL_635412	2020-07-08	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 3 nucleotides when compared to the reference sequence.	info	B.1.239	G
hCoV-19/USA/CA-ALSR-2302/2020	EPI_ISL_635421	2020-07-09	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-2308/2020	EPI_ISL_635423	2020-07-09	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-2318/2020	EPI_ISL_635428	2020-07-09	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-2417/2020	EPI_ISL_635469	2020-05-27	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-2420/2020	EPI_ISL_635470	2020-07-06	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	Gap of 9 nucleotides when compared to the reference sequence.	info	B.1	G
hCoV-19/Mexico/BCN-ALSR-2485/2020	EPI_ISL_635496	2020-05-26	North America / Mexico / Baja California / Tijuana	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/Mexico/BCN-ALSR-2490/2020	EPI_ISL_635499	2020-05-29	North America / Mexico / Baja California / Tijuana	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	NS6_E55stop results in 11.5% truncation of the protein sequence.	info	B.1	G
hCoV-19/Mexico/BCN-ALSR-2493/2020	EPI_ISL_635502	2020-05-29	North America / Mexico / Baja California / Tijuana	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/Mexico/BCN-ALSR-2497/2020	EPI_ISL_635506	2020-06-01	North America / Mexico / Baja California / Tijuana	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/Mexico/BCN-ALSR-2500/2020	EPI_ISL_635508	2020-06-03	North America / Mexico / Baja California / Tijuana	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/Mexico/BCN-ALSR-2504/2020	EPI_ISL_635510	2020-06-05	North America / Mexico / Baja California / Tijuana	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/Mexico/BCN-ALSR-2506/2020	EPI_ISL_635511	2020-06-06	North America / Mexico / Baja California / Tijuana	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/Mexico/BCN-ALSR-2512/2020	EPI_ISL_635517	2020-06-12	North America / Mexico / Baja California / Tijuana	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/Mexico/BCN-ALSR-2514/2020	EPI_ISL_635519	2020-06-15	North America / Mexico / Baja California / Tijuana	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/Mexico/BCN-ALSR-2516/2020	EPI_ISL_635521	2020-06-15	North America / Mexico / Baja California / Tijuana	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/Mexico/BCN-ALSR-2519/2020	EPI_ISL_635523	2020-06-15	North America / Mexico / Baja California / Tijuana	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/Mexico/BCN-ALSR-2529/2020	EPI_ISL_635533	2020-06-22	North America / Mexico / Baja California / Tijuana	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/Mexico/BCN-ALSR-2530/2020	EPI_ISL_635534	2020-06-22	North America / Mexico / Baja California / Tijuana	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/Mexico/BCN-ALSR-2535/2020	EPI_ISL_635538	2020-06-23	North America / Mexico / Baja California / Tijuana	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/Mexico/BCN-ALSR-2539/2020	EPI_ISL_635542	2020-06-24	North America / Mexico / Baja California / Tijuana	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/Mexico/BCN-ALSR-2540/2020	EPI_ISL_635543	2020-06-24	North America / Mexico / Baja California / Tijuana	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/Mexico/BCN-ALSR-2543/2020	EPI_ISL_635546	2020-06-25	North America / Mexico / Baja California / Tijuana	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/Mexico/BCN-ALSR-2550/2020	EPI_ISL_635553	2020-07-01	North America / Mexico / Baja California / Tijuana	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/Mexico/BCN-ALSR-2553/2020	EPI_ISL_635556	2020-07-02	North America / Mexico / Baja California / Tijuana	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/Mexico/BCN-ALSR-2555/2020	EPI_ISL_635558	2020-07-03	North America / Mexico / Baja California / Tijuana	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/Mexico/BCN-ALSR-2557/2020	EPI_ISL_635560	2020-07-04	North America / Mexico / Baja California / Tijuana	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/Mexico/BCN-ALSR-2561/2020	EPI_ISL_635564	2020-07-06	North America / Mexico / Baja California / Tijuana	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/Mexico/BCN-ALSR-2563/2020	EPI_ISL_635566	2020-07-06	North America / Mexico / Baja California / Tijuana	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/Mexico/BCN-ALSR-2573/2020	EPI_ISL_635574	2020-07-16	North America / Mexico / Baja California / Tijuana	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/Mexico/BCN-ALSR-2574/2020	EPI_ISL_635575	2020-07-16	North America / Mexico / Baja California / Tijuana	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-2607/2020	EPI_ISL_635584	2020-07-11	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2	NS8_Y42stop results in 66.1% truncation of the protein sequence.	info	B.1.239	G
hCoV-19/USA/CA-ALSR-2614/2020	EPI_ISL_635587	2020-07-11	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-2627/2020	EPI_ISL_635595	2020-07-11	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-2642/2020	EPI_ISL_635607	2020-07-12	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-2657/2020	EPI_ISL_635613	2020-07-09	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-2666/2020	EPI_ISL_635617	2020-07-09	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-2776/2020	EPI_ISL_635674	2020-07-14	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-2820/2020	EPI_ISL_635696	2020-07-24	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-2901/2020	EPI_ISL_635727	2020-07-11	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-2909/2020	EPI_ISL_635731	2020-08-03	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-2972/2020	EPI_ISL_635762	2020-09-02	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/Jordan/MA-ALSR-2581/2020	EPI_ISL_635779	2020-06-01	Asia / Jordan / Mafraq	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/Jordan/MA-ALSR-2583/2020	EPI_ISL_635780	2020-06-04	Asia / Jordan / Mafraq	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-3018/2020	EPI_ISL_635790	2020-08-04	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-3040/2020	EPI_ISL_635808	2020-08-28	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-3045/2020	EPI_ISL_635810	2020-08-26	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-3051/2020	EPI_ISL_635815	2020-08-28	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-3057/2020	EPI_ISL_635819	2020-07-30	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-3060/2020	EPI_ISL_635822	2020-07-30	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-3074/2020	EPI_ISL_635829	2020-09-02	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-3157/2020	EPI_ISL_635885	2020-08-24	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.396	G
hCoV-19/USA/CA-ALSR-3168/2020	EPI_ISL_635895	2020-06-03	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-3193/2020	EPI_ISL_635907	2020-06-02	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-3224/2020	EPI_ISL_635922	2020-07-30	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-3264/2020	EPI_ISL_635939	2020-09-02	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-3266/2020	EPI_ISL_635941	2020-09-06	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-3304/2020	EPI_ISL_635954	2020-09-21	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-3341/2020	EPI_ISL_635972	2020-09-17	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-3381/2020	EPI_ISL_635992	2020-05-29	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-3382/2020	EPI_ISL_635993	2020-05-29	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-4435/2020	EPI_ISL_649028	2020-09-25	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-4440/2020	EPI_ISL_649032	2020-09-28	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-4447/2020	EPI_ISL_649034	2020-09-28	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/USA/CA-ALSR-4464/2020	EPI_ISL_649046	2020-10-20	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.239	G
hCoV-19/USA/CA-ALSR-4473/2020	EPI_ISL_649050	2020-10-19	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1.1.322	GR
hCoV-19/USA/CA-ALSR-4474/2020	EPI_ISL_649051	2020-09-24	North America / USA / California / San Diego	Human	Original	Nasopharyngeal swab		Illumina	iVar 1.2.2			B.1	G
hCoV-19/Belgium/ITM_C5189_200701416/2020	EPI_ISL_649154	2020-06-30	Europe / Belgium / Brussels	Human	Original	Oropharyngeal swab		Nanopore MinION	BWA-MEM			B.1.1.254	GR
hCoV-19/England/ALDP-B483CC/2020	EPI_ISL_649195	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-B48344/2020	EPI_ISL_649198	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.408	G
hCoV-19/England/ALDP-B49352/2020	EPI_ISL_649213	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B483F9/2020	EPI_ISL_649254	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-B48EAD/2020	EPI_ISL_649275	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B4802F/2020	EPI_ISL_649301	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-B4913A/2020	EPI_ISL_649326	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/ALDP-B47FD8/2020	EPI_ISL_649378	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B48766/2020	EPI_ISL_649398	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.165	G
hCoV-19/England/ALDP-B47E9F/2020	EPI_ISL_649400	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B4864B/2020	EPI_ISL_649443	2020-11-06	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B47EAE/2020	EPI_ISL_649444	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B47F41/2020	EPI_ISL_649453	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B48757/2020	EPI_ISL_649456	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B4872A/2020	EPI_ISL_649469	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-B12FA9/2020	EPI_ISL_649510	2020-11-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B024E9/2020	EPI_ISL_649555	2020-10-23	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-A8C855/2020	EPI_ISL_649558	2020-10-17	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-B118DC/2020	EPI_ISL_649573	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-B13263/2020	EPI_ISL_649574	2020-11-03	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-B12589/2020	EPI_ISL_649622	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-B125B6/2020	EPI_ISL_649624	2020-11-02	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-AE28B7/2020	EPI_ISL_649651	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-AE26AE/2020	EPI_ISL_649652	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-AE4A0A/2020	EPI_ISL_649667	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/Scotland/QEUH-AD1402/2020	EPI_ISL_649717	2020-10-27	Europe / United Kingdom / Scotland	Human	Original			Illumina NovaSeq				B.1.1.44	GR
hCoV-19/England/204321411/2020	EPI_ISL_649824	2020-10-19	Europe / United Kingdom / England	Human	Original			Illumina NextSeq	PHE pipeline (BWA-SAMtools-Quasibam)			AD.2	GR
hCoV-19/Italy/APU-IZSPB-193APT/2020	EPI_ISL_649940	2020-08-28	Europe / Italy / Apulia / Foggia	Human	Vero	Nasopharyngeal swab		Illumina MiSeq	SPAdes			B.1.1	GR
hCoV-19/England/QEUH-B6C92A/2020	EPI_ISL_655008	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6B9B2/2020	EPI_ISL_655015	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B69EA6/2020	EPI_ISL_655020	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B69C60/2020	EPI_ISL_655026	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B684C3/2020	EPI_ISL_655042	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B682D8/2020	EPI_ISL_655059	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-B6C08F/2020	EPI_ISL_655060	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.67	GR
hCoV-19/England/QEUH-B69E5B/2020	EPI_ISL_655062	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B67CBD/2020	EPI_ISL_655079	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B68CCB/2020	EPI_ISL_655095	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.532	GR
hCoV-19/England/QEUH-B6BE2C/2020	EPI_ISL_655120	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B69F94/2020	EPI_ISL_655162	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6BE59/2020	EPI_ISL_655189	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6C957/2020	EPI_ISL_655201	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B66AA5/2020	EPI_ISL_655203	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6C0AD/2020	EPI_ISL_655221	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B6C975/2020	EPI_ISL_655235	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B66A5A/2020	EPI_ISL_655242	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B66A1E/2020	EPI_ISL_655266	2020-11-11	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B5BBEC/2020	EPI_ISL_655282	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B62CC1/2020	EPI_ISL_655315	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B5B8A9/2020	EPI_ISL_655321	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B5B51B/2020	EPI_ISL_655325	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-B5B27E/2020	EPI_ISL_655340	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.408	G
hCoV-19/England/ALDP-B62AD6/2020	EPI_ISL_655355	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B5B5B1/2020	EPI_ISL_655361	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B5AF3C/2020	EPI_ISL_655368	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B5B4A5/2020	EPI_ISL_655383	2020-11-09	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B63088/2020	EPI_ISL_655384	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B62CA3/2020	EPI_ISL_655391	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B63D54/2020	EPI_ISL_655430	2020-11-07	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq		NS8_E110stop results in 9.9% truncation of the protein sequence. NS8_Q18stop results in 86.0% truncation of the protein sequence.	info	B.1.1.198	GR
hCoV-19/England/ALDP-B5B584/2020	EPI_ISL_655474	2020-11-08	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2EC2B/2020	EPI_ISL_660029	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B30BB0/2020	EPI_ISL_660033	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2D2C0/2020	EPI_ISL_660046	2020-11-04	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B30B47/2020	EPI_ISL_660047	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B30C08/2020	EPI_ISL_660058	2020-11-02	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B2F8BD/2020	EPI_ISL_660059	2020-11-03	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/Ecuador/ZZL-4/2020	EPI_ISL_660070	2020-10-26	South America / Ecuador / Quito	Human	Original			Illumina MiSeq				B.1.1	O
hCoV-19/USA/MD-MDH-0394/2020	EPI_ISL_660088	2020-11-02	North America / USA / Maryland	Human	Original	Nasopharyngeal swab		Illumina MiSeq				B.1.240	G
hCoV-19/USA/MD-MDH-0390/2020	EPI_ISL_660099	2020-10-27	North America / USA / Maryland	Human	Original	Nasal swab		Illumina MiSeq		Gap of 1 nucleotides when compared to the reference sequence.	info	B.1.240	G
hCoV-19/South Africa/Tygerberg_359_CC2/2020	EPI_ISL_660154	2020-10-12	Africa / South Africa / Western Cape / Cape Town	Human	Original	Oropharyngeal swab		Oxford Nanopore Technologies	Genome Detective 1.126 bcftools mpileup			B.1	G
hCoV-19/South Africa/KRISP-K004294/2020	EPI_ISL_660175	2020-07-27	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K004306/2020	EPI_ISL_660185	2020-10-05	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K004311/2020	EPI_ISL_660189	2020-10-26	Africa / South Africa / KwaZulu-Natal / uMkhanyakude	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K004313/2020	EPI_ISL_660191	2020-10-25	Africa / South Africa / KwaZulu-Natal / Ugu	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K004315/2020	EPI_ISL_660192	2020-10-27	Africa / South Africa / KwaZulu-Natal / Harry Gwala	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.507	GR
hCoV-19/South Africa/KRISP-K004325/2020	EPI_ISL_660201	2020-10-27	Africa / South Africa / KwaZulu-Natal / Harry Gwala	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.507	GR
hCoV-19/South Africa/KRISP-K004326/2020	EPI_ISL_660202	2020-10-25	Africa / South Africa / KwaZulu-Natal / Ugu	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1	G
hCoV-19/South Africa/KRISP-K004330/2020	EPI_ISL_660206	2020-10-24	Africa / South Africa / KwaZulu-Natal / Harry Gwala	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.507	GR
hCoV-19/South Africa/KRISP-K004336/2020	EPI_ISL_660212	2020-10-26	Africa / South Africa / KwaZulu-Natal / Ugu	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K004340/2020	EPI_ISL_660216	2020-10-29	Africa / South Africa / KwaZulu-Natal / Ugu	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K004534-CS1/2020	EPI_ISL_660232	2020-11-17	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.507	GR
hCoV-19/South Africa/KRISP-K004536/2020	EPI_ISL_660234	2020-10-18	Africa / South Africa / KwaZulu-Natal / Harry Gwala	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.507	GR
hCoV-19/South Africa/KRISP-K004540/2020	EPI_ISL_660238	2020-10-18	Africa / South Africa / KwaZulu-Natal / iLembe	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.56	GR
hCoV-19/South Africa/KRISP-K004552/2020	EPI_ISL_660249	2020-10-27	Africa / South Africa / KwaZulu-Natal / Harry Gwala	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.507	GR
hCoV-19/South Africa/KRISP-K004553/2020	EPI_ISL_660250	2020-10-27	Africa / South Africa / KwaZulu-Natal / Harry Gwala	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.507	GR
hCoV-19/South Africa/KRISP-K004723-CS1/2020	EPI_ISL_660256	2020-11-18	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.507	GR
hCoV-19/Spain/CT-IBV-99009902/2020	EPI_ISL_660299	2020-08-08	Europe / Spain / Catalunya / Badalona	Human	Original			Illumina MiSeq	BWA/IVAR			B.1.1.406	GR
hCoV-19/France/ARA-SC381/2020	EPI_ISL_660354	2020-03-14	Europe / France / Auvergne-Rhone-Alpes / Clermond-Ferrand	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1.1.71	GR
hCoV-19/France/ARA-SC406/2020	EPI_ISL_660365	2020-04-21	Europe / France / Auvergne-Rhone-Alpes / Clermond-Ferrand	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1	G
hCoV-19/France/ARA-SC408/2020	EPI_ISL_660367	2020-04-26	Europe / France / Auvergne-Rhone-Alpes / Clermond-Ferrand	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1	G
hCoV-19/Czech Republic/NRL-9965/2020	EPI_ISL_660558	2020-09-29	Europe / Czech Republic / South Moravian Region / Brno	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC-Medaka			B.1.1.39	GR
hCoV-19/Czech Republic/NRL-9964/2020	EPI_ISL_660597	2020-09-22	Europe / Czech Republic / South Moravian Region / Brno	Human	Original	Nasopharyngeal swab		Nanopore MinION	ARTIC-Medaka			B.1.1	GR
hCoV-19/South Africa/KRISP-K004601/2020	EPI_ISL_660630	2020-11-05	Africa / South Africa / KwaZulu-Natal / Ugu	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/South Africa/KRISP-K004610/2020	EPI_ISL_660635	2020-11-04	Africa / South Africa / KwaZulu-Natal / eThekwini	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1	GR
hCoV-19/South Africa/KRISP-K004616/2020	EPI_ISL_660638	2020-11-04	Africa / South Africa / KwaZulu-Natal / uMkhanyakude	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.56	GR
hCoV-19/South Africa/KRISP-K004640/2020	EPI_ISL_660655	2020-11-03	Africa / South Africa / KwaZulu-Natal / Ugu	Human	Original	Oropharyngeal swab		Illumina MiSeq	Genome Detective 1.126 bcftools mpileup			B.1.1.273	GR
hCoV-19/France/OCC-SC429/2020	EPI_ISL_660668	2020-04-14	Europe / France / Occitanie / Toulouse	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1.1.254	GR
hCoV-19/France/OCC-SC433/2020	EPI_ISL_660670	2020-05-25	Europe / France / Occitanie / Toulouse	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1.1.254	GR
hCoV-19/France/OCC-SC515/2020	EPI_ISL_660704	2020-04-27	Europe / France / Occitanie / Montpellier	Human	Original	Nasopharyngeal swab		Illumina NextSeq	bwa, samtools, custom			B.1.1	GR
hCoV-19/USA/WI-GMF-23569/2020	EPI_ISL_660875	2020-10-02	North America / USA / Wisconsin / Crawford County	Human	Original			Ion Torrent				B.1	G
hCoV-19/USA/IA-GMF-26895/2020	EPI_ISL_660964	2020-10-20	North America / USA / Iowa / Allamakee County	Human	Original			Ion Torrent				B.1.240	G
hCoV-19/USA/WI-GMF-27069/2020	EPI_ISL_660968	2020-10-21	North America / USA / Wisconsin / Adams County	Human	Original			Ion Torrent				B.1.1.337	GR
hCoV-19/USA/WI-GMF-27242/2020	EPI_ISL_660974	2020-10-23	North America / USA / Wisconsin / Adams County	Human	Original			Ion Torrent				B.1.1.337	GR
hCoV-19/Denmark/DCGC-9500/2020	EPI_ISL_669004	2020-11-09	Europe / Denmark / Sjaelland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.39	GR
hCoV-19/Denmark/DCGC-9582/2020	EPI_ISL_669048	2020-11-09	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.398	G
hCoV-19/Denmark/DCGC-9594/2020	EPI_ISL_669054	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.160	GR
hCoV-19/Denmark/DCGC-9604/2020	EPI_ISL_669062	2020-11-09	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.159	GR
hCoV-19/Denmark/DCGC-9619/2020	EPI_ISL_669070	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.160	GR
hCoV-19/Denmark/DCGC-9671/2020	EPI_ISL_669100	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-9706/2020	EPI_ISL_669120	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.160	GR
hCoV-19/Denmark/DCGC-9804/2020	EPI_ISL_669193	2020-11-09	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.398	G
hCoV-19/Denmark/DCGC-9837/2020	EPI_ISL_669215	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.39	GR
hCoV-19/Denmark/DCGC-9995/2020	EPI_ISL_669319	2020-11-09	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.398	G
hCoV-19/Denmark/DCGC-10019/2020	EPI_ISL_669339	2020-11-09	Europe / Denmark / Nordjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.1.159	GR
hCoV-19/Denmark/DCGC-10036/2020	EPI_ISL_669351	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-10071/2020	EPI_ISL_669377	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-10100/2020	EPI_ISL_669393	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-10102/2020	EPI_ISL_669394	2020-11-09	Europe / Denmark / Midtjylland	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			B.1.398	G
hCoV-19/Denmark/DCGC-10501/2020	EPI_ISL_669670	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0	Gap of 6 nucleotides when compared to the reference sequence.	info	B.1.398	G
hCoV-19/Denmark/DCGC-10232/2020	EPI_ISL_669847	2020-11-09	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-10343/2020	EPI_ISL_669913	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-10344/2020	EPI_ISL_669914	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-10382/2020	EPI_ISL_669933	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/Denmark/DCGC-10411/2020	EPI_ISL_669952	2020-11-02	Europe / Denmark / Hovedstaden	Human	Original			Oxford Nanopore	ARTIC-ncov2019 v1.1.0			AD.1	GR
hCoV-19/England/MILK-B8D307/2020	EPI_ISL_674011	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B85DB6/2020	EPI_ISL_674023	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8D343/2020	EPI_ISL_674024	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8D2BF/2020	EPI_ISL_674044	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B86966/2020	EPI_ISL_674097	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/MILK-B85DA7/2020	EPI_ISL_674111	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8D3DA/2020	EPI_ISL_674122	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8D2CE/2020	EPI_ISL_674141	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B8525D/2020	EPI_ISL_674174	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B84A0B/2020	EPI_ISL_674193	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8857F/2020	EPI_ISL_674279	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/ALDP-B839D2/2020	EPI_ISL_674311	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B882B4/2020	EPI_ISL_674336	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.408	G
hCoV-19/England/ALDP-B84F2A/2020	EPI_ISL_674396	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B83D30/2020	EPI_ISL_674404	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B85536/2020	EPI_ISL_674408	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8C502/2020	EPI_ISL_674453	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/ALDP-B839F0/2020	EPI_ISL_674462	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B7D71D/2020	EPI_ISL_674498	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/QEUH-B7F4C9/2020	EPI_ISL_674545	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8F8E8/2020	EPI_ISL_674554	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8F596/2020	EPI_ISL_674574	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.130	GR
hCoV-19/England/MILK-B8F8D9/2020	EPI_ISL_674611	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8E931/2020	EPI_ISL_674660	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1	GR
hCoV-19/England/MILK-B8DD36/2020	EPI_ISL_674675	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.240	GR
hCoV-19/England/MILK-B8EC0B/2020	EPI_ISL_674693	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8F88E/2020	EPI_ISL_674702	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8ECB0/2020	EPI_ISL_674709	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8E8F8/2020	EPI_ISL_674737	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.39	GR
hCoV-19/England/QEUH-B7D65C/2020	EPI_ISL_674746	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8EBA4/2020	EPI_ISL_674787	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/MILK-B8E9B9/2020	EPI_ISL_674811	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.255	GR
hCoV-19/England/MILK-B9762F/2020	EPI_ISL_674819	2020-11-14	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.347	GR
hCoV-19/England/CAMC-B982B1/2020	EPI_ISL_674845	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				AD.2	GR
hCoV-19/England/CAMC-B97F8E/2020	EPI_ISL_674922	2020-11-15	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.1.308	GR
hCoV-19/England/MILK-B9704F/2020	EPI_ISL_674967	2020-11-13	Europe / United Kingdom / England	Human	Original			Illumina NovaSeq				B.1.408	G
hCoV-19/England/QEUH-A9D6B1/2020	EPI_ISL_680019	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-A9D6EE/2020	EPI_ISL_680020	2020-10-20	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-B2C759/2020	EPI_ISL_680078	2020-11-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/England/QEUH-B2C7A4/2020	EPI_ISL_680080	2020-11-04	Europe / United Kingdom / England	Human	Original			Oxford Nanopore				AD.2	GR
hCoV-19/Northern Ireland/NIRE-233099/2020	EPI_ISL_680251	2020-09-27	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1	GR
hCoV-19/Northern Ireland/NIRE-23314B/2020	EPI_ISL_680258	2020-09-14	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-2331C3/2020	EPI_ISL_680265	2020-09-10	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-2331F0/2020	EPI_ISL_680266	2020-09-23	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-23322A/2020	EPI_ISL_680268	2020-09-24	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-233248/2020	EPI_ISL_680270	2020-09-23	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-233257/2020	EPI_ISL_680271	2020-09-23	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-233293/2020	EPI_ISL_680274	2020-09-25	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-2332DF/2020	EPI_ISL_680277	2020-09-27	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.310	GR
hCoV-19/Northern Ireland/NIRE-2340F2/2020	EPI_ISL_680344	2020-10-13	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				B.1.1.240	GR
hCoV-19/Northern Ireland/NIRE-2341D1/2020	EPI_ISL_680352	2020-10-14	Europe / United Kingdom / Northern Ireland	Human	Original			Illumina				AD.2	GR
hCoV-19/Wales/PHWC-48E7C5/2020	EPI_ISL_680912	2020-11-12	Europe / United Kingdom / Wales	Human	Original			Illumina				AD.2	GR
